PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cruz, M; Turok, N; Vielva, P; Martinez-Gonzalez, E; Hobson, M				Cruz, M.; Turok, N.; Vielva, P.; Martinez-Gonzalez, E.; Hobson, M.			A cosmic microwave background feature consistent with a cosmic texture	SCIENCE			English	Article							PROBE WMAP OBSERVATIONS; GAUSSIAN COLD SPOT; ANISOTROPY-PROBE; GLOBAL TEXTURE; ORIGIN; VOIDS	The Cosmic Microwave Background provides our most ancient image of the universe and our best tool for studying its early evolution. Theories of high-energy physics predict the formation of various types of topological defects in the very early universe, including cosmic texture, which would generate hot and cold spots in the Cosmic Microwave Background. We show through a Bayesian statistical analysis that the most prominent 5 degrees-radius cold spot observed in all- sky images, which is otherwise hard to explain, is compatible with having being caused by a texture. From this model, we constrain the fundamental symmetry-breaking energy scale to be phi(0) approximate to 8.7 x 10(15) gigaelectron volts. If confirmed, this detection of a cosmic defect will probe physics at energies exceeding any conceivable terrestrial experiment.	Univ Cantabria, CSIC, Inst Fis Cantabria, E-39005 Santander, Spain; Univ Cantabria, Dept Fis Moderna, E-39005 Santander, Spain; Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA); Universidad de Cantabria; University of Cambridge; University of Cambridge	Cruz, M (corresponding author), Univ Cantabria, CSIC, Inst Fis Cantabria, Ave Castros, E-39005 Santander, Spain.	cruz@ifca.unican.es	Cruz, Marcos/N-3429-2014; Vielva, Patricio/ABC-9916-2021; Vielva, Patricio/F-6745-2014; Martinez-Gonzalez, Enrique/AAB-2741-2019; Martinez-Gonzalez, Enrique/E-9534-2015	Cruz, Marcos/0000-0002-4767-530X; Vielva, Patricio/0000-0003-0051-272X; Vielva, Patricio/0000-0003-0051-272X; Martinez-Gonzalez, Enrique/0000-0002-0179-8590				Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Betemps MA, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.094010; Bevis N, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043508; Bridges M, 2007, MON NOT R ASTRON SOC, V377, P1473, DOI 10.1111/j.1365-2966.2007.11616.x; Copi CJ, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.023507; CRITTENDEN RG, 1995, PHYS REV D, V52, pR5402, DOI 10.1103/PhysRevD.52.R5402; Cruz M, 2007, ASTROPHYS J, V655, P11, DOI 10.1086/509703; Cruz M, 2006, MON NOT R ASTRON SOC, V369, P57, DOI 10.1111/j.1365-2966.2006.10312.x; Cruz M, 2005, MON NOT R ASTRON SOC, V356, P29, DOI 10.1111/j.1365-2966.2004.08419.x; Durrer R, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.123005; ENNETT DP, 1993, ASTROPHYS J, V406, pL; Eriksen HK, 2007, ASTROPHYS J, V660, pL81, DOI 10.1086/518091; Hinshaw G, 2007, ASTROPHYS J SUPPL S, V170, P288, DOI 10.1086/513698; Hobson MP, 2003, MON NOT R ASTRON SOC, V338, P765, DOI 10.1046/j.1365-8711.2003.06094.x; Hoyle F, 2004, ASTROPHYS J, V607, P751, DOI 10.1086/386279; Inoue KT, 2007, ASTROPHYS J, V664, P650, DOI 10.1086/517603; Jaffe TR, 2006, ASTROPHYS J, V644, P701, DOI 10.1086/503893; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Land K, 2007, MON NOT R ASTRON SOC, V378, P153, DOI 10.1111/j.1365-2966.2007.11749.x; McEwen JD, 2006, MON NOT R ASTRON SOC, V371, pL50, DOI 10.1111/j.1745-3933.2006.00206.x; PEN UL, 1994, PHYS REV D, V49, P692, DOI 10.1103/PhysRevD.49.692; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; TOMITA K, 2005, PHYS REV D, V72, P10; TUROK N, 1989, PHYS REV LETT, V63, P2625, DOI 10.1103/PhysRevLett.63.2625; TUROK N, 1990, PHYS REV LETT, V64, P2736, DOI 10.1103/PhysRevLett.64.2736; Vilenkin A., 2000, COSMIC STRINGS OTHER; Wiaux Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.151303	28	120	122	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1612	1614		10.1126/science.1148694	http://dx.doi.org/10.1126/science.1148694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	17962521	Green Submitted			2022-12-28	WOS:000251421700042
J	Chakhalian, J; Freeland, JW; Habermeier, HU; Cristiani, G; Khaliullin, G; van Veenendaal, M; Keimer, B				Chakhalian, J.; Freeland, J. W.; Habermeier, H.-U.; Cristiani, G.; Khaliullin, G.; van Veenendaal, M.; Keimer, B.			Orbital reconstruction and covalent bonding at an oxide interface	SCIENCE			English	Article							X-RAY-ABSORPTION; SUPERLATTICES; SPECTROSCOPY; HETEROSTRUCTURES	Orbital reconstructions and covalent bonding must be considered as important factors in the rational design of oxide heterostructures with engineered physical properties. We have investigated the interface between high-temperature superconducting (Y, Ca) Ba2Cu3O7 and metallic La0.67Ca0.33MnO3 by resonant x-ray spectroscopy. A charge of about -0.2 electron is transferred from Mn to Cu ions across the interface and induces a major reconstruction of the orbital occupation and orbital symmetry in the interfacial CuO2 layers. In particular, the Cu d(3z2-r2) orbital, which is fully occupied and electronically inactive in the bulk, is partially occupied at the interface. Supported by exact-diagonalization calculations, these data indicate the formation of a strong chemical bond between Cu and Mn atoms across the interface. Orbital reconstructions and associated covalent bonding are thus important factors in determining the physical properties of oxide heterostructures.	Univ Arkansas, Fayetteville, AR 72701 USA; Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; No Illinois Univ, Dept Phys, De Kalb, IL 60115 USA	University of Arkansas System; University of Arkansas Fayetteville; Max Planck Society; United States Department of Energy (DOE); Argonne National Laboratory; Northern Illinois University	Chakhalian, J (corresponding author), Univ Arkansas, Fayetteville, AR 72701 USA.	jchakhal@uark.edu	Chakhalian, Jak/F-2274-2015	Keimer, Bernhard/0000-0001-5220-9023				ABBATE M, 1992, PHYS REV B, V46, P4511, DOI 10.1103/PhysRevB.46.4511; Chakhalian J, 2006, NAT PHYS, V2, P244, DOI 10.1038/nphys272; CHEN CT, 1991, PHYS REV LETT, V66, P104, DOI 10.1103/PhysRevLett.66.104; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; DEGROOT FMF, 1994, J ELECTRON SPECTROSC, V67, P529, DOI 10.1016/0368-2048(93)02041-J; Habermeier HU, 2001, PHYSICA C, V364, P298, DOI 10.1016/S0921-4534(01)00775-4; Holden T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064505; Ke X, 2004, APPL PHYS LETT, V84, P5458, DOI 10.1063/1.1767955; Kourkoutis LF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.256803; Lee WC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075106; NUCKER N, 1995, PHYS REV B, V51, P8529, DOI 10.1103/PhysRevB.51.8529; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.235108; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; Ruegg A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195117; Sefrioui Z, 2002, APPL PHYS LETT, V81, P4568, DOI 10.1063/1.1526463; Stahn J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.140509; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Thulasi S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125307; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tsukazaki A, 2007, SCIENCE, V315, P1388, DOI 10.1126/science.1137430; Ueda K, 1998, SCIENCE, V280, P1064, DOI 10.1126/science.280.5366.1064; VANVEENENDAAL MA, 1993, PHYS REV B, V47, P11462, DOI 10.1103/PhysRevB.47.11462; Varela M, 2003, SOLID STATE ELECTRON, V47, P2245, DOI 10.1016/S0038-1101(03)00205-3; Yamada H, 2004, SCIENCE, V305, P646, DOI 10.1126/science.1098867; Yunoki S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064532; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759	28	397	404	6	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1114	1117		10.1126/science.1149338	http://dx.doi.org/10.1126/science.1149338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	17932255				2022-12-28	WOS:000250957900039
J	Rasmussen, SGF; Choi, HJ; Rosenbaum, DM; Kobilka, TS; Thian, FS; Edwards, PC; Burghammer, M; Ratnala, VRP; Sanishvili, R; Fischetti, RF; Schertler, GFX; Weis, WI; Kobilka, BK				Rasmussen, Soren G. F.; Choi, Hee-Jung; Rosenbaum, Daniel M.; Kobilka, Tong Sun; Thian, Foon Sun; Edwards, Patricia C.; Burghammer, Manfred; Ratnala, Venkata R. P.; Sanishvili, Ruslan; Fischetti, Robert F.; Schertler, Gebhard F. X.; Weis, William I.; Kobilka, Brian K.			Crystal structure of the human beta(2) adrenergic G-protein-coupled receptor	NATURE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; BOVINE RHODOPSIN; LIGAND-BINDING; ACTIVATION; DOMAIN; AGONISTS; BACTERIORHODOPSIN; CRYSTALLOGRAPHY; CRYSTALLIZATION	Structural analysis of G-protein-coupled receptors (GPCRs) for hormones and neurotransmitters has been hindered by their low natural abundance, inherent structural flexibility, and instability in detergent solutions. Here we report a structure of the human beta 2 adrenoceptor (beta(2)AR), which was crystallized in a lipid environment when bound to an inverse agonist and in complex with a Fab that binds to the third intracellular loop. Diffraction data were obtained by high-brilliance microcrystallography and the structure determined at 3.4 angstrom / 3.7 angstrom resolution. The cytoplasmic ends of the beta(2)AR transmembrane segments and the connecting loops are well resolved, whereas the extracellular regions of the beta(2)AR are not seen. The beta(2)AR structure differs from rhodopsin in having weaker interactions between the cytoplasmic ends of transmembrane (TM) 3 and TM6, involving the conserved E/DRY sequences. These differences may be responsible for the relatively high basal activity and structural instability of the beta(2)AR, and contribute to the challenges in obtaining diffraction-quality crystals of non-rhodopsin GPCRs.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; European Synchrotron Radiat Facil, F-38043 Grenoble 9, France; Argonne Natl Lab, Biosci Div, GM CA CAT, Argonne, IL 60439 USA	Stanford University; Stanford University; MRC Laboratory Molecular Biology; European Synchrotron Radiation Facility (ESRF); United States Department of Energy (DOE); Argonne National Laboratory	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	kobilka@stanford.edu	Weis, William I/G-1437-2011; Schertler, Gebhard/M-9512-2014	Weis, William I/0000-0002-5583-6150; Choi, Hee-Jung/0000-0002-1167-1526; Kobilka, Brian/0000-0001-5958-3990; Rasmussen, Soren/0000-0002-1853-1841; Schertler, Gebhard F.X./0000-0002-5846-6810	Medical Research Council [MC_U105178937] Funding Source: Medline; MRC [MC_U105178937] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; CARON MG, 1979, J BIOL CHEM, V254, P2923; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; KOBILKA BK, 2006, BIOCHIM BIOPHYS ACTA, V1768, P794; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Samama P, 1997, P NATL ACAD SCI USA, V94, P137, DOI 10.1073/pnas.94.1.137; Scheer A, 2000, MOL PHARMACOL, V57, P219; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRADER CD, 1989, J BIOL CHEM, V264, P13572; SURYANARAYANA S, 1991, J BIOL CHEM, V266, P15488; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; TOTA MR, 1990, J BIOL CHEM, V265, P16891; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	46	1558	1627	5	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					383	U4		10.1038/nature06325	http://dx.doi.org/10.1038/nature06325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17952055				2022-12-28	WOS:000250918600046
J	Adamkovics, M; Wong, MH; Laver, C; de Pater, I				Adamkovics, Mate; Wong, Michael H.; Laver, Conor; de Pater, Imke			Widespread morning drizzle on Titan	SCIENCE			English	Article							MIDLATITUDE CLOUDS; METHANE; SURFACE; ATMOSPHERE; ETHANE; RATES	Precipitation is expected in Titan's atmosphere, yet it has not been directly observed, and the geographical regions where rain occurs are unknown. Here we present near-infrared spectra from the Very Large Telescope and W. M. Keck Observatories that reveal an enhancement of opacity in Titan's troposphere on the morning side of the leading hemisphere. Retrieved extinction profiles are consistent with condensed methane in clouds at an altitude near 30 kilometers and concomitant methane drizzle below. The moisture encompasses the equatorial region over Titan's brightest continent, Xanadu. Diurnal temperature gradients that cause variations in methane relative humidity, winds, and topography may each be a contributing factor to the condensation mechanism. The clouds and precipitation are optically thin at 2.0 micrometers, and models of "subvisible" clouds suggest that the droplets are 0.1 millimeter or larger.	Univ Calif Berkeley, Dept Astron, Berkeley, CA 94611 USA; Univ Calif Berkeley, Ctr Integrat Planetary Sci, Berkeley, CA 94611 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Adamkovics, M (corresponding author), Univ Calif Berkeley, Dept Astron, Berkeley, CA 94611 USA.	mate@berkeley.edu		Adamkovics, Mate/0000-0003-1869-0938				Adamkovics M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019929; ADAMKOVICS M, 2006, J GEOPHYS RES-PLANET, V111, P7; Atreya SK, 2006, PLANET SPACE SCI, V54, P1177, DOI 10.1016/j.pss.2006.05.028; Barnes JW, 2007, ICARUS, V186, P242, DOI 10.1016/j.icarus.2006.08.021; Barth EL, 2006, ICARUS, V182, P230, DOI 10.1016/j.icarus.2005.12.017; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Eisenhauer F, 2003, P SOC PHOTO-OPT INS, V4841, P1548, DOI 10.1117/12.459468; Griffith CA, 2006, SCIENCE, V313, P1620, DOI 10.1126/science.1128245; GRIFFITH CA, 1993, NATURE, V364, P511, DOI 10.1038/364511a0; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Grundy WM, 2002, ICARUS, V155, P486, DOI 10.1006/icar.2001.6726; Hueso R, 2006, NATURE, V442, P428, DOI 10.1038/nature04933; Larkin JE, 2003, P SOC PHOTO-OPT INS, V4841, P1600, DOI 10.1117/12.461775; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; Perron JT, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002602; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Tokano T, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002704; Tokano T, 2006, NATURE, V442, P432, DOI 10.1038/nature04948; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; TOON OB, 1989, J GEOPHYS RES-ATMOS, V94, P16287, DOI 10.1029/JD094iD13p16287	23	44	44	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					962	965		10.1126/science.1146244	http://dx.doi.org/10.1126/science.1146244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17932256				2022-12-28	WOS:000250788500039
J	Wiita, AP; Perez-Jimenez, R; Walther, KA; Grater, F; Berne, BJ; Holmgren, A; Sanchez-Ruiz, JM; Fernandez, JM				Wiita, Arun P.; Perez-Jimenez, Raul; Walther, Kirstin A.; Graeter, Frauke; Berne, B. J.; Holmgren, Arne; Sanchez-Ruiz, Jose M.; Fernandez, Julio M.			Probing the chemistry of thioredoxin catalysis with force	NATURE			English	Article							ESCHERICHIA-COLI THIOREDOXIN; ACTIVE-SITE; SINGLE PROTEIN; DISULFIDE; MECHANISM; BOND; REDUCTION; RESIDUES; KINETICS; PEPTIDE	Thioredoxins are enzymes that catalyse disulphide bond reduction in all living organisms(1). Although catalysis is thought to proceed through a substitution nucleophilic bimolecular (S(N)2) reaction(1,2), the role of the enzyme in modulating this chemical reaction is unknown. Here, using single-molecule force-clamp spectroscopy(3,4), we investigate the catalytic mechanism of Escherichia coli thioredoxin (Trx). We applied mechanical force in the range of 25-600 pN to a disulphide bond substrate and monitored the reduction of these bonds by individual enzymes. We detected two alternative forms of the catalytic reaction, the first requiring a reorientation of the substrate disulphide bond, causing a shortening of the substrate polypeptide by 0.79 +/- 0.09 angstrom (+/- s.e.m.), and the second elongating the substrate disulphide bond by 0.17 +/- 0.02 angstrom (+/- s.e.m.). These results support the view that the Trx active site regulates the geometry of the participating sulphur atoms with sub-angstrom precision to achieve efficient catalysis. Our results indicate that substrate conformational changes may be important in the regulation of Trx activity under conditions of oxidative stress and mechanical injury, such as those experienced in cardiovascular disease(5,6). Furthermore, single-molecule atomic force microscopy techniques, as shown here, can probe dynamic rearrangements within an enzyme's active site during catalysis that cannot be resolved with any other current structural biological technique.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Grad Program Neurobiol & Behav, New York, NY 10027 USA; Columbia Univ, Dept Phys, New York, NY 10027 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA; Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain	Columbia University; Columbia University; Columbia University; Columbia University; Karolinska Institutet; University of Granada	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jfernandez@columbia.edu	Perez-Jimenez, Raul/C-3085-2017; Sanchez-Ruiz, Jose/H-2849-2015; Gräter, Frauke/D-3450-2009	Perez-Jimenez, Raul/0000-0001-7094-6799; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Gräter, Frauke/0000-0003-2891-3381	NIGMS NIH HHS [R01 GM043340, R01 GM043340-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043340] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1967, EUR J BIOCHEM, V2, P187, DOI 10.1111/j.1432-1033.1967.tb00125.x; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1979, BIOCHEMISTRY-US, V18, P5591, DOI 10.1021/bi00592a011; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; JORGENSEN WL, 1985, J AM CHEM SOC, V107, P569, DOI 10.1021/ja00289a008; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; PAPPAS JA, 1977, J AM CHEM SOC, V99, P2926, DOI 10.1021/ja00451a013; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Perez-Jimenez R, 2005, BIOPHYS CHEM, V115, P105, DOI 10.1016/j.bpc.2004.12.012; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; ROSENFIELD RE, 1977, J AM CHEM SOC, V99, P4860, DOI 10.1021/ja00456a072; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; SIGWORTH FJ, 1980, NATURE, V287, P447, DOI 10.1038/287447a0; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6	42	214	221	5	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					124	+		10.1038/nature06231	http://dx.doi.org/10.1038/nature06231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972886	Green Accepted			2022-12-28	WOS:000250585800050
J	Paulus, MP				Paulus, Martin P.			Decision-making dysfunctions in psychiatry - Altered homeostatic processing?	SCIENCE			English	Review							DELAYED REWARDS; PREFRONTAL CORTEX; SUBSTANCE-ABUSERS; ORBITOFRONTAL CORTEX; IMPULSIVE BEHAVIOR; DEPENDENT PATIENTS; ERROR; METHAMPHETAMINE; UNCERTAINTY; ACTIVATION	Decision-making consists of selecting an action from a set of available options. This results in an outcome that changes the state of the decision-maker. Therefore, decision-making is part of a homeostatic process. Individuals with psychiatric disorders show altered decision-making. They select options that are either non-optimal or nonhomeostatic. These dysfunctional patterns of decision-making in individuals with psychiatric disorders may fundamentally relate to problems with homeostatic regulation. These may manifest themselves in (i) how the length of time between decisions and their outcomes influences subsequent decision-making, (ii) how gain and loss feedback are integrated to determine the optimal decision, (iii) how individuals adapt their decision strategies to match the specific context, or (iv) how seemingly maladaptive responses result from an attempt to establish an unstable homeostatic balance.	Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; Vet Affairs Hlth Care Syst San Diego, La Jolla, CA 92161 USA	University of California System; University of California San Diego	Paulus, MP (corresponding author), Univ Calif San Diego, Dept Psychiat, 8950 Villa La Jolla Dr, La Jolla, CA 92037 USA.	mpaulus@ucsd.edu			NIDA NIH HHS [R01DA018307, R01DA016663] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018307, R01DA016663] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AINSLIE G, 1992, PICOECONOMICS STRATE, P56; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Blanchette I, 2003, J EXP PSYCHOL GEN, V132, P294, DOI 10.1037/0096-3445.132.2.294; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cherek DR, 2001, PSYCHOPHARMACOLOGY, V157, P221, DOI 10.1007/s002130100812; Christodouiou T, 2006, EUR PSYCHIAT, V21, P270, DOI 10.1016/j.eurpsy.2006.04.006; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig ADB, 2003, TRENDS NEUROSCI, V26, P303, DOI 10.1016/S0166-2236(03)00123-1; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Dom G, 2005, BRIT J PSYCHIAT, V187, P209, DOI 10.1192/bjp.187.3.209; Dom G, 2006, ALCOHOL CLIN EXP RES, V30, P1670, DOI 10.1111/j.1530-0277.2006.00202.x; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gonzalez R, 2007, J CLIN EXP NEUROPSYC, V29, P155, DOI 10.1080/13803390600582446; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Hutton SB, 2002, SCHIZOPHR RES, V55, P249, DOI 10.1016/S0920-9964(01)00216-X; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kollins SH, 2003, ADDICT BEHAV, V28, P1167, DOI 10.1016/S0306-4603(02)00220-4; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Krain AL, 2006, J CHILD PSYCHOL PSYC, V47, P1023, DOI 10.1111/j.1469-7610.2006.01677.x; Ladouceur R, 2000, BEHAV RES THER, V38, P933, DOI 10.1016/S0005-7967(99)00133-3; Lane SD, 2005, PSYCHOPHARMACOLOGY, V181, P364, DOI 10.1007/s00213-005-2265-8; Lane SD, 2005, NEUROPSYCHOPHARMACOL, V30, P800, DOI 10.1038/sj.npp.1300620; Lawrence NS, 2006, NEUROPSYCHOLOGY, V20, P409, DOI 10.1037/0894-4105.20.4.409; Leland DS, 2006, NEUROIMAGE, V33, P725, DOI 10.1016/j.neuroimage.2006.07.011; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Ludewig K, 2003, PSYCHIAT RES, V119, P293, DOI 10.1016/S0165-1781(03)00103-3; Madden GJ, 1999, EXP CLIN PSYCHOPHARM, V7, P284, DOI 10.1037/1064-1297.7.3.284; McCartney J, 1997, SUBST USE MISUSE, V32, P2061, DOI 10.3109/10826089709035620; McDonald J, 2003, NEUROPSYCHOPHARMACOL, V28, P1356, DOI 10.1038/sj.npp.1300176; Minassian A, 2004, J AFFECT DISORDERS, V82, P203, DOI 10.1016/j.jad.2003.11.010; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Monterosso JR, 2007, HUM BRAIN MAPP, V28, P383, DOI 10.1002/hbm.20281; Murphy FC, 2001, PSYCHOL MED, V31, P679, DOI 10.1017/S0033291701003804; Must A, 2006, J AFFECT DISORDERS, V90, P209, DOI 10.1016/j.jad.2005.12.005; Nielen MMA, 2002, J AFFECT DISORDERS, V69, P257, DOI 10.1016/S0165-0327(00)00381-5; Ortner CNM, 2003, ALCOHOL ALCOHOLISM, V38, P151, DOI 10.1093/alcalc/agg041; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 1996, AM J PSYCHIAT, V153, P714; Paulus MP, 2004, BIOL PSYCHIAT, V55, P1179, DOI 10.1016/j.biopsych.2004.02.023; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2003, NEUROPSYCHOPHARMACOL, V28, P795, DOI 10.1038/sj.npp.1300108; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Paulus MP, 1999, SCHIZOPHR RES, V35, P69, DOI 10.1016/S0920-9964(98)00108-X; Paulus MP, 1999, BIOL PSYCHIAT, V46, P662, DOI 10.1016/S0006-3223(99)00086-4; Petry NM, 1999, DRUG ALCOHOL DEPEN, V56, P25, DOI 10.1016/S0376-8716(99)00010-1; Petry NM, 2002, PSYCHOPHARMACOLOGY, V162, P425, DOI 10.1007/s00213-002-1115-1; Pietras CJ, 2001, J EXP ANAL BEHAV, V76, P1, DOI 10.1901/jeab.2001.76-1; Pirastu R, 2006, DRUG ALCOHOL DEPEN, V83, P163, DOI 10.1016/j.drugalcdep.2005.11.008; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Quednow BB, 2007, PSYCHOPHARMACOLOGY, V189, P517, DOI 10.1007/s00213-005-0256-4; Rahman S, 2006, NEUROPSYCHOPHARMACOL, V31, P651, DOI 10.1038/sj.npp.1300886; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Reynolds B, 2004, PHARMACOL BIOCHEM BE, V79, P17, DOI 10.1016/j.pbb.2004.06.011; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rottenstreich Y, 2001, PSYCHOL SCI, V12, P185, DOI 10.1111/1467-9280.00334; Sachdev PS, 2005, AUST NZ J PSYCHIAT, V39, P757, DOI 10.1080/j.1440-1614.2005.01680.x; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Simmons A, 2004, NEUROREPORT, V15, P2261, DOI 10.1097/00001756-200410050-00024; SLOVIC P, 1995, AM PSYCHOL, V50, P364, DOI 10.1037/0003-066X.50.5.364; Stroup S, 2005, SCHIZOPHR RES, V80, P1, DOI 10.1016/j.schres.2005.08.007; Turnbull OH, 2006, NEUROPSYCHOLOGY, V20, P290, DOI 10.1037/0894-4105.20.3.290; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P90, DOI 10.1017/S1355617706060127; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V86, P139, DOI 10.1016/j.drugalcdep.2006.05.024; Vollenweider FX, 2005, J PSYCHOPHARMACOL, V19, P366, DOI 10.1177/0269881105053287; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed	87	222	236	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					602	606		10.1126/science.1142997	http://dx.doi.org/10.1126/science.1142997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223XL	17962553				2022-12-28	WOS:000250409200034
J	Chokshi, DA; Rajkumar, R				Chokshi, Dave A.; Rajkumar, Rahul			Leveraging university research to advance global health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WORLD; DRUGS		Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	University of Pennsylvania; Harvard University; Brigham & Women's Hospital	Chokshi, DA (corresponding author), Univ Penn, Sch Med, 3434 Sansom St,Floor 2, Philadelphia, PA 19104 USA.	daveash@med.upenn.edu		Chokshi, Dave/0000-0001-7467-4591				[Anonymous], 2005, PREV CHRON DIS VIT I; BREWSTER A, 2005, INNOVATION STRATEGY, V1, P14; Chaifetz S, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-1; Chen IF, 2006, CELL, V124, P661, DOI 10.1016/j.cell.2006.02.014; Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Coloma J, 2005, PLOS PATHOG, V1, P99, DOI 10.1371/journal.ppat.0010021; FREIRE MC, 2002, J ASS U TECHNOLOGY M, V14, P1; HAYNES B, 2005, I MED REG M DURH NC; HOTEZ P, 2005, G WASHINGTON U NEGLE; Kapczynski A, 2003, SCIENCE, V301, P1629, DOI 10.1126/science.301.5640.1629; Kapczynski A., 2005, BERKELEY TECHNOLOGY, V20, P1031; Kim JY, 2006, NEW ENGL J MED, V355, P645, DOI 10.1056/NEJMp068166; *MED FRONT, 2007, UNT WEB PRIC RED PRI; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Ropars AL, 2005, NEW LANDSCAPE NEGLEC; Salicrup LA, 2006, BIOTECHNOL ADV, V24, P69, DOI 10.1016/j.biotechadv.2005.06.004; Sobolski GK, 2005, JAMA-J AM MED ASSOC, V294, P3137, DOI 10.1001/jama.294.24.3137; *TECHN MAN GLOB HL, 2006, AC LIC GLOB HLTH PRO; Wainberg MA, 2005, NEW ENGL J MED, V352, P747, DOI 10.1056/NEJMp048356; Westgate T, 2006, CHEM WORLD-UK, V3, P8; *WHO COMM INN INT, 2006, PUBL HLTH INN INT PR	22	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1934	1936		10.1001/jama.298.16.1934	http://dx.doi.org/10.1001/jama.298.16.1934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954546				2022-12-28	WOS:000250356700027
J	Pisarev, AV; Hellen, CUT; Pestova, TV				Pisarev, Andrey V.; Hellen, Christopher U. T.; Pestova, Tatyana V.			Recycling of eukaryotic posttermination ribosomal complexes	CELL			English	Article							INITIATOR TRANSFER-RNA; TRANSLATION INITIATION; PROTEIN-SYNTHESIS; KINETIC-ANALYSIS; 80S RIBOSOME; FACTOR EIF3; IN-VITRO; SUBUNIT; RELEASE; BINDING	After translational termination, mRNA and P site deacylated tRNA remain associated with ribosomes in posttermination complexes ( post-TCs), which must therefore be recycled by releasing mRNA and deacylated tRNA and by dissociating ribosomes into subunits. Recycling of bacterial post-TCs requires elongation factor EF-G and a ribosome recycling factor RRF. Eukaryotes do not encode a RRF homolog, and their mechanism of ribosomal recycling is unknown. We investigated eukaryotic recycling using post-TCs assembled on a model mRNA encoding a tetrapeptide followed by a UAA stop codon and report that initiation factors elF3, elF1, elF1A, and elF3j, a loosely associated subunit of eIF3, can promote recycling of eukaryotic post-TCs. elF3 is the principal factor that promotes splitting of posttermination ribosomes into 60S subunits and tRNA- and mRNA bound 40S subunits. Its activity is enhanced by elFs 3j, 1, and 1A. elF1 also mediates release of P site tRNA, whereas eIF3j ensures subsequent dissociation of mRNA.	Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Lomonosov Moscow State University	Pestova, TV (corresponding author), Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA.	tatyana.pestova@downstate.edu			NIGMS NIH HHS [R01 GM080623, R01 GM080623-01, GM80623] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080623] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Demeshkina N, 2007, NUCLEIC ACIDS RES, V35, P4597, DOI 10.1093/nar/gkm468; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Mitkevich VA, 2006, NUCLEIC ACIDS RES, V34, P3947, DOI 10.1093/nar/gkl549; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Valasek L, 1999, J BIOL CHEM, V274, P27567, DOI 10.1074/jbc.274.39.27567; Wilson DN, 2005, EMBO J, V24, P251, DOI 10.1038/sj.emboj.7600525; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	31	159	161	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					286	299		10.1016/j.cell.2007.08.041	http://dx.doi.org/10.1016/j.cell.2007.08.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956730	Bronze, Green Accepted			2022-12-28	WOS:000250507700019
J	Campbell, EG; Weissman, JS; Ehringhaus, S; Rao, SR; Moy, B; Feibelmann, S; Goold, SD				Campbell, Eric G.; Weissman, Joel S.; Ehringhaus, Susan; Rao, Sowmya R.; Moy, Beverly; Feibelmann, Sandra; Goold, Susan Dorr			Institutional academic-industry relationships	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONFLICTS-OF-INTEREST; PHARMACEUTICAL-INDUSTRY; PHYSICIANS; COMPANIES; GIFTS	Context Institutional academic-industry relationships have the potential of creating institutional conflicts of interest. To date there are no empirical data to support the establishment and evaluation of institutional policies and practices related to managing these relationships. Objective To conduct a national survey of department chairs about the nature, extent, and consequences of institutional-academic industry relationships for medical schools and teaching hospitals. Design, Setting, and Participants National survey of department chairs in the 125 accredited allopathic medical schools and the 15 largest independent teaching hospitals in the United States, administered between February 2006 and October 2006. Main Outcome Measure Types of relationships with industry. Results A total of 459 of 688 eligible department chairs completed the survey, yielding an overall response rate of 67%. Almost two-thirds (60%) of department chairs had some form of personal relationship with industry, including serving as a consultant (27%), a member of a scientific advisory board (27%), a paid speaker (14%), an officer (7%), a founder (9%), or a member of the board of directors (11%). Two-thirds (67%) of departments as administrative units had relationships with industry. Clinical departments were more likely than nonclinical departments to receive research equipment (17% vs 10%, P=.04), unrestricted funds (19% vs 3%, P<.001), residency or fellowship training support (37% vs 2%, P<.001), and continuing medial education support (65% vs 3%, P<.001). However, nonclinical departments were more likely to receive funding from intellectual property licensing(27% vs 16%, P=.01). More than two-thirds of chairs perceived that having a relationship with industry had no effect on their professional activities, 72% viewed a chair's engaging in more than 1 industry-related activity (substantial role in a start-up company, consulting, or serving on a company's board) as having a negative impact on a department's ability to conduct independent unbiased research. Conclusion Overall, institutional academic-industry relationships are highly prevalent and underscore the need for their active disclosure and management.	Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Assoc Amer Med Coll, Washington, DC 20037 USA	Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; Association of American Medical Colleges	Campbell, EG (corresponding author), Inst Hlth Policy, 50 Staniford St, Boston, MA 02114 USA.	ecampbell@partners.org	Goold, Susan Dorr/N-6930-2014	Goold, Susan Dorr/0000-0002-0258-9774				[Anonymous], STAND DEF FIN DISP C; *ASS AM U, 2001, REP IND I CONFL INT; Association of American Medical Colleges, 2002, PROT SUBJ PRES TRUST; Avorn J, 2004, POWERFUL MED BENEFIT; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Blumenthal D, 2004, NEW ENGL J MED, V351, P1885, DOI 10.1056/NEJMhpr042734; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Bok D., 2003, U MARKETPLACE COMMER; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell Eric G, 2004, Account Res, V11, P103, DOI 10.1080/03050620490512296; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; FOWLER FJ, 1995, APPL SOCIAL RES METH, V38; Halperin EC, 2004, INT J RADIAT ONCOL, V59, P1477, DOI 10.1016/j.ijrobp.2004.01.052; Kassirer J. P., 2005, TAKE MED COMPLICITY; KRINSKY S, 2004, SCI PRIVATE INTEREST; Rothman DJ, 2000, NEW ENGL J MED, V342, P1284, DOI 10.1056/NEJM200004273421711; Studdert DM, 2004, NEW ENGL J MED, V351, P1891, DOI 10.1056/NEJMlim042229; WILLIAMSON E, 2004, NY TIMES        0613, pA21; WILLIAMSON E, 2004, NY TIMES        0613, pA1	19	113	116	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1779	1786		10.1001/jama.298.15.1779	http://dx.doi.org/10.1001/jama.298.15.1779			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940234				2022-12-28	WOS:000250187300021
J	Ganser-Pornillos, BK; Cheng, A; Yeager, M				Ganser-Pornillos, Barbie K.; Cheng, Anchi; Yeager, Mark			Structure of full-length HIV-1CA: a model for the mature capsid lattice	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ROUS-SARCOMA-VIRUS; AMINO-TERMINAL DOMAIN; ELECTRON-MICROSCOPY; IN-VITRO; DIMERIZATION DOMAIN; CRYSTAL-STRUCTURES; SELF-ASSOCIATION; PROTEIN; RESOLUTION	The capsids of mature retroviruses perform the essential function of organizing the viral genome for efficient replication. These capsids are modeled as fullerene structures composed of closed hexameric arrays of the viral CA protein, but a high-resolution structure of the lattice has remained elusive. A three-dimensional map of two-dimensional crystals of the R18L mutant of HIV-1 CA was derived by electron cryocrystallography. The docking of high-resolution domain structures into the map yielded the first unambiguous model for full-length HIV-1 CA. Three important protein-protein assembly interfaces are required for capsid formation. Each CA hexamer is composed of an inner ring of six N-terminal domains and an outer ring of C-terminal domains that form dimeric linkers connecting neighboring hexamers. Interactions between the two domains of CA further stabilize the hexamer and provide a structural explanation for the mechanism of action of known HIV-1 assembly inhibitors.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Clin, Div Cardiovasc Dis, La Jolla, CA 92037 USA; Univ Virginia Hlth Syst, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Scripps Research Institute; Scripps Research Institute; University of Virginia	Yeager, M (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yeager@scripps.edu			NCRR NIH HHS [P41 RR017573, P41 RR17573] Funding Source: Medline; NIAID NIH HHS [T32-AI07244] Funding Source: Medline; NIGMS NIH HHS [R01 GM066087] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066087] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2006, J MOL BIOL, V355, P157, DOI 10.1016/j.jmb.2005.10.025; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Cheng AC, 2004, ACTA CRYSTALLOGR A, V60, P351, DOI 10.1107/S0108767304010396; COMILESCU CC, 2000, J MOL BIOL, V306, P783; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gottlinger HG, 2001, AIDS, V15, pS13; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kotov A, 1999, J VIROL, V73, P8824, DOI 10.1128/JVI.73.10.8824-8830.1999; Krausslich H.G., 1996, MORPHOGENESIS MATURA; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mayo K, 2003, J MOL BIOL, V325, P225, DOI 10.1016/S0022-2836(02)01176-2; Mayo K, 2002, J MOL BIOL, V316, P667, DOI 10.1006/jmbi.2001.5354; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Parker SD, 2001, J VIROL, V75, P9543, DOI 10.1128/JVI.75.19.9543-9548.2001; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445; Vogt V. M., 1997, P27; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299	53	262	273	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					70	79		10.1016/j.cell.2007.08.018	http://dx.doi.org/10.1016/j.cell.2007.08.018			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923088	Bronze			2022-12-28	WOS:000249934700012
J	Liu, QL; Hendrickson, WA				Liu, Qinglian; Hendrickson, Wayne A.			Insights into Hsp70 chaperone activity from a crystal structure of the yeast Hsp110 Sse1	CELL			English	Article							SHOCK COGNATE PROTEIN; NUCLEOTIDE EXCHANGE FACTORS; MOLECULAR CHAPERONE; SUBSTRATE-BINDING; ALLOSTERIC REGULATION; PEPTIDE-BINDING; INTERDOMAIN COMMUNICATION; CONFORMATIONAL-CHANGES; CYTOSOLIC HSP70; ATPASE FRAGMENT	Classic Hsp70 chaperones assist in diverse processes of protein folding and translocation, and Hsp110s had seemed by sequence to be distant relatives within an Hsp70 superfamily. The 2.4 angstrom resolution structure of Sse1 with ATP shows that Hsp110s are indeed Hsp70 relatives, and it provides insight into allosteric coupling between sites for ATP and polypeptidesubstrate binding in Hsp70s. Subdomain structures are similar in intact Sse1( ATP) and in the separate Hsp70 domains, but conformational dispositions are radically different. Interfaces between Sse1 domains are extensive, intimate, and conservative in sequence with Hsp70s. We propose that Sse1( ATP) may be an evolutionary vestige of the Hsp70( ATP) state, and an analysis of 64 mutant variants in Sse1 and three Hsp70 homologs supports this hypothesis. An atomic-level understanding of Hsp70 communication between ATP and substratebinding domains follows. Requirements on Sse1 for yeast viability are in keeping with the distinct function of Hsp110s as nucleotide exchange factors.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34102, R01 GM034102-21, R01 GM034102, R01 GM034102-22, R01 GM034102-23, R37 GM034102] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker J, 1996, MOL CELL BIOL, V16, P4378; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Johnson ER, 1999, BIOCHEMISTRY-US, V38, P10823, DOI 10.1021/bi990816g; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Moro F, 2006, PROTEIN SCI, V15, P223, DOI 10.1110/ps.051732706; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	43	184	188	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					106	120		10.1016/j.cell.2007.08.039	http://dx.doi.org/10.1016/j.cell.2007.08.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923091	Bronze, Green Accepted			2022-12-28	WOS:000249934700015
J	Montell, C				Montell, Craig			Dynamic regulation of the INAD signaling scaffold becomes crystal clear	CELL			English	Editorial Material							MEMBRANE-LIPIDS; PDZ DOMAINS; PHOTORECEPTORS	PDZ domains are common building blocks of scaffold proteins that enhance specificity and speed in signal transduction cascades. Although PDZ modules are often viewed as passive participants, Mishra et al. ( 2007) now show that a PDZ domain in INAD, a scaffold protein in photoreceptor cells of the fruit fly, undergoes a light-dependent conformational change, which has important consequences for signaling and animal behavior.	Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482				Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; KAGAN VE, 1973, BIOCHIM BIOPHYS ACTA, V330, P76, DOI 10.1016/0005-2736(73)90285-X; Lu SP, 2007, FREE RADICAL BIO MED, V42, P936, DOI 10.1016/j.freeradbiomed.2006.11.027; Matsumoto H, 1999, Novartis Found Symp, V224, P225; MISHRA P, 2007, CELL; Sanxaridis PD, 2007, MOL CELL NEUROSCI, V36, P36, DOI 10.1016/j.mcn.2007.05.006; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Zimmermann P, 2006, BBA-MOL CELL BIOL L, V1761, P947, DOI 10.1016/j.bbalip.2006.04.003	10	17	17	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					19	21		10.1016/j.cell.2007.09.022	http://dx.doi.org/10.1016/j.cell.2007.09.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923082	Bronze			2022-12-28	WOS:000249934700005
J	Kimoto, K; Asaka, T; Nagai, T; Saito, M; Matsui, Y; Ishizuka, K				Kimoto, Koji; Asaka, Toru; Nagai, Takuro; Saito, Mitsuhiro; Matsui, Yoshio; Ishizuka, Kazuo			Element-selective imaging of atomic columns in a crystal using STEM and EELS	NATURE			English	Article							INELASTIC-SCATTERING; ELECTRON-MICROSCOPY; LOSS SPECTROSCOPY	Microstructure characterization has become indispensable to the study of complex materials, such as strongly correlated oxides, and can obtain useful information about the origin of their physical properties. Although atomically resolved measurements have long been possible, an important goal in microstructure characterization is to achieve element-selective imaging at atomic resolution. A combination of scanning transmission electron microscopy (STEM) and electron energy-loss spectroscopy (EELS)(1,2) is a promising technique for atomic-column analysis. However, two-dimensional analysis has not yet been performed owing to several difficulties, such as delocalization in inelastic scattering or instrumentation instabilities. Here we demonstrate atomic-column imaging of a crystal specimen using localized inelastic scattering and a stabilized scanning transmission electron microscope(3). The atomic columns of La, Mn and O in the layered manganite La1.2Sr1.8Mn2O7 are visualized as two-dimensional images.	Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; HREM Res Inc, Higashimatsuyama, Saitama 3550055, Japan	National Institute for Materials Science	Kimoto, K (corresponding author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan.	kimoto.koji@nims.go.jp	NAGAI, Takuro/H-2630-2011; KIMOTO, Koji/H-2708-2011; Saito, Mitsuhiro/A-4859-2010; MATSUI, Yoshio/H-2685-2011	KIMOTO, Koji/0000-0002-3927-0492; MATSUI, Yoshio/0000-0003-2044-3450				Allen LJ, 2006, ULTRAMICROSCOPY, V106, P1001, DOI 10.1016/j.ultramic.2006.05.011; ANN CC, 2004, TRANSMISSION ELECT E; Asaka T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.227204; BATSON PE, 1993, NATURE, V366, P727, DOI 10.1038/366727a0; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Battle PD, 1997, CHEM MATER, V9, P552, DOI 10.1021/cm960398r; Bosman M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.086102; COLLIEX C, 1999, INT TABLES CRYSTALLO, VC, P387; Egerton R.F., 2011, ELECT ENERGY LOSS SP; HOWIE A, 1963, PROC R SOC LON SER-A, V271, P268, DOI 10.1098/rspa.1963.0017; JEANGUILLAUME C, 1989, ULTRAMICROSCOPY, V28, P252, DOI 10.1016/0304-3991(89)90304-5; Kimoto K, 2003, ULTRAMICROSCOPY, V96, P335, DOI 10.1016/S0304-3991(03)00099-8; Kimoto K, 2007, J ELECTRON MICROSC, V56, P17, DOI 10.1093/jmicro/dfl043; Kimura T, 2000, ANNU REV MATER SCI, V30, P451, DOI 10.1146/annurev.matsci.30.1.451; Kimura T, 1998, PHYS REV LETT, V81, P5920, DOI 10.1103/PhysRevLett.81.5920; Muller DA, 2004, NATURE, V430, P657, DOI 10.1038/nature02756; MULLER DA, 1995, ULTRAMICROSCOPY, V59, P195, DOI 10.1016/0304-3991(95)00029-Z; Muller DA, 2001, J ELECTRON MICROSC, V50, P219, DOI 10.1093/jmicro/50.3.219; Oxley MP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064303; Oxley MP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203906; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; Pennycook SJ, 1999, NATO ADV SCI I E-APP, V364, P161; Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280; Varela M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095502	24	279	280	2	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					702	704		10.1038/nature06352	http://dx.doi.org/10.1038/nature06352			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	17965728				2022-12-28	WOS:000251209700049
J	Bulkmans, NWJ; Berkhof, J; Rozendaal, L; van Kemenade, FJ; Boeke, AJP; Bulk, S; Voorhorst, FJ; Verheijen, RHM; Groningen, K; Boon, ME; Ruitinga, W; van Ballegooijen, M; Snijders, PJF; Meijer, CJLM				Bulkmans, N. W. J.; Berkhof, J.; Rozendaal, L.; van Kemenade, F. J.; Boeke, A. J. P.; Bulk, S.; Voorhorst, F. J.; Verheijen, R. H. M.; Groningen, Kvan; Boon, M. E.; Ruitinga, W.; van Ballegooijen, M.; Snijders, P. J. F.; Meijer, C. J. L. M.			Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial	LANCET			English	Article							RISK HUMAN-PAPILLOMAVIRUS; LIQUID-BASED CYTOLOGY; BASE-LINE; CLINICAL-RELEVANCE; NATURAL-HISTORY; ABSOLUTE RISK; WOMEN; POPULATION; LESIONS; ABNORMALITIES	Background Tests for the DNA of high-risk types of human papillornavirus (HPV) have a higher sensitivity for cervical intraepithelial neoplasia grade 3 or worse (CIN3+) than does cytological testing, but the necessity of such testing in cervical screening has been debated. Our aim was to determine whether the effectiveness of cervical screening improves when HPV DNA testing is implemented. Methods Women aged 29-56 years who were participating in the regular cervical screening programme in the Netherlands were randomly assigned to combined cytological and HPV DNA testing or to conventional cytological testing only. After 5 years, combined cytological and HPV DNA testing were done in both groups. The primary outcome measure was the number of CIN3+ lesions detected. Analyses were done by intention to treat. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN20781131. Findings 8575 women in the intervention group and 8580 in the control group were recruited, followed up for sufficient time (>= 6.5 years), and met eligibility criteria for our analyses. More CIN3+ lesions were detected at baseline in the intervention group than in the control group (68/8575 vs 40/8580, 70% increase, 95% CI 15-151; p=0.007). The number of CIN3+ lesions detected in the subsequent round was lower in the intervention group than in the control group (24/8413 vs 54/8456, 55% decrease, 95% CI 28-72; p=0-001). The number of CIN3+ lesions over the two rounds did not differ between groups. Interpretation The implementation of HPV DNA testing in cervical screening leads to earlier detection of CIN3+ lesions. Earlier detection of such lesions could permit an extension of the screening interval.	Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands; Vrije Univ Amsterdam Med Ctr, Inst Res Extramural Med, NL-1007 MB Amsterdam, Netherlands; Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynaecol, NL-1007 MB Amsterdam, Netherlands; Spaarne Ziekenhuis, Hoofddorp, Netherlands; Leiden Cytol & Pathol Lab, NL-2301 GB Leiden, Netherlands; Kennemer Gasthuis, Dept Pathol, Haarlem, Netherlands; Erasmus Univ, Dept Publ Hlth & Social Med, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Spaarne Hospital; Spaarne Hospital; Erasmus University Rotterdam	Meijer, CJLM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pathol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	cjlm.meijer@vumc.nl						AARELEID T, 1993, EUR J CANCER, V29A, P745, DOI 10.1016/S0959-8049(05)80359-4; Anderson MC, 1995, OBSTET GYNAECOLOGICA, P292; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Bos AB, 2002, EUR J CANCER, V38, P827, DOI 10.1016/S0959-8049(02)00026-6; Brink AATP, 2005, CYTOPATHOLOGY, V16, P7, DOI 10.1111/j.1365-2303.2004.00227.x; Bulk S, 2003, BRIT J CANCER, V89, P834, DOI 10.1038/sj.bjc.6601157; Bulk S, 2004, J CLIN PATHOL, V57, P388, DOI 10.1136/jcp.2003.011841; Bulk S, 2007, INT J CANCER, V121, P361, DOI 10.1002/ijc.22677; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Castle PE, 2002, CANCER-AM CANCER SOC, V95, P2145, DOI 10.1002/cncr.10927; Clavel C, 1998, J CLIN PATHOL, V51, P737, DOI 10.1136/jcp.51.10.737; Clavel C, 2001, BRIT J CANCER, V84, P1616, DOI 10.1054/bjoc.2001.1845; Crosbie EJ, 2006, CLIN SCI, V110, P543, DOI 10.1042/CS20050230; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; de Sanjose S, 1999, DIAGN MOL PATHOL, V8, P26, DOI 10.1097/00019606-199903000-00005; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; Franco Eduardo L, 2003, J Natl Cancer Inst Monogr, P89; Hesselink AT, 2006, J CLIN MICROBIOL, V44, P3680, DOI 10.1128/JCM.02078-05; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; HOPMAN EH, 1995, GYNECOL ONCOL, V58, P206, DOI 10.1006/gyno.1995.1212; Hopman EH, 2000, BRIT J OBSTET GYNAEC, V107, P600, DOI 10.1111/j.1471-0528.2000.tb13299.x; Jacobs MV, 1999, J CLIN PATHOL, V52, P498, DOI 10.1136/jcp.52.7.498; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Kotaniemi-Talonen L, 2005, BRIT J CANCER, V93, P862, DOI 10.1038/sj.bjc.6602799; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Lorincz AT, 2003, ARCH PATHOL LAB MED, V127, P959; Mayrand MH, 2006, INT J CANCER, V119, P615, DOI 10.1002/ijc.21897; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; NIEMINEN P, 1995, OBSTET GYNECOL, V85, P1017, DOI 10.1016/0029-7844(95)00063-W; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Petry KU, 2003, BRIT J CANCER, V88, P1570, DOI 10.1038/sj.bjc.6600918; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Rozendaal L, 2000, J CLIN PATHOL, V53, P606, DOI 10.1136/jcp.53.8.606; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Smith RA, 2005, CA-CANCER J CLIN, V55, P31, DOI 10.3322/canjclin.55.1.31; Snijders PJF, 2003, J PATHOL, V201, P1, DOI 10.1002/path.1433; Stoler MH, 2007, AM J CLIN PATHOL, V127, P335, DOI 10.1309/RNF3C01JKADQCLKP; van Ballegooijen M, 2000, EUR J CANCER, V36, P2244, DOI 10.1016/S0959-8049(00)00317-8; van den Akker-van Marle ME, 2002, JNCI-J NATL CANCER I, V94, P193; WILLARD KE, 1986, MED DECIS MAKING, V6, P93, DOI 10.1177/0272989X8600600206; WRIGHT TC, 1992, JACOSTEINS PATHOLOGY, P248	52	472	493	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2007	370	9601					1764	1772		10.1016/S0140-6736(07)61450-0	http://dx.doi.org/10.1016/S0140-6736(07)61450-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	17919718				2022-12-28	WOS:000251140500020
J	Rust, MJ; Markson, JS; Lane, WS; Fisher, DS; O'Shea, EK				Rust, Michael J.; Markson, Joseph S.; Lane, William S.; Fisher, Daniel S.; O'Shea, Erin K.			Ordered phosphorylation governs oscillation of a three-protein circadian clock	SCIENCE			English	Article							KAIC PHOSPHORYLATION; SYNECHOCOCCUS-ELONGATUS; CRYSTAL-STRUCTURE; PROTEIN KAIA; RHYTHM; MODEL; CYCLE	The simple circadian oscillator found in cyanobacteria can be reconstituted in vitro using three proteins-KaiA, KaiB, and KaiC. The total phosphorylation level of KaiC oscillates with a circadian period, but the mechanism underlying its sustained oscillation remains unclear. We have shown that four forms of KaiC differing in their phosphorylation state appear in an ordered pattern arising from the intrinsic autokinase and autophosphatase rates of KaiC and their modulation by KaiA. Kinetic and biochemical data indicate that one of these phosphoforms inhibits the activity of KaiA through interaction with KaiB, providing the crucial feedback that sustains oscillation. A mathematical model constrained by experimental data quantitatively reproduces the circadian period and the distinctive dynamics of the four phosphoforms.	Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular & Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Microchem & Prote Anal Facil, Cambridge, MA 02138 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Stanford University	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular & Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Fisher, Daniel S/A-4134-2011	Markson, Joseph/0000-0002-3167-3887; Fisher, Daniel/0000-0002-5559-2491				Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Emberly E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.038303; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kurosawa G, 2006, BIOPHYS J, V91, P2015, DOI 10.1529/biophysj.105.076554; Mehra A, 2006, PLOS COMPUT BIOL, V2, P816, DOI 10.1371/journal.pcbi.0020096; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Miyoshi F, 2007, J BIOL RHYTHM, V22, P69, DOI 10.1177/0748730406295749; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Takigawa-Imamura H, 2006, J BIOL RHYTHM, V21, P405, DOI 10.1177/0748730406291329; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; Yoda M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000408	27	258	271	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					809	812		10.1126/science.1148596	http://dx.doi.org/10.1126/science.1148596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17916691	Green Accepted			2022-12-28	WOS:000250583900044
J	Kording, K				Koerding, Konrad			Decision theory: What "should" the nervous system do?	SCIENCE			English	Review							BAYESIAN-INFERENCE; NEURAL BASIS; MODELS; DENSITY; BRAIN	The purpose of our nervous system is to allow us to successfully interact with our environment. This normative idea is formalized by decision theory that defines which choices would be most beneficial. We live in an uncertain world, and each decision may have many possible outcomes; choosing the best decision is thus complicated. Bayesian decision theory formalizes these problems in the presence of uncertainty and often provides compact models that predict observed behavior. With its elegant formalization of the problems faced by the nervous system, it promises to become a major inspiration for studies in neuroscience.	Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Dept Appl Math, Inst Neurosci, Chicago, IL 60611 USA; Rehabil Inst Chicago, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Shirley Ryan AbilityLab	Kording, K (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Room O-922,345 E Super St, Chicago, IL 60611 USA.	kk@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499				Bernoulli D., 1738, COMMENTARII ACAD SCI; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Green DM, 1966, SIGNAL DETECTION THE; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; Kagel JH, 1995, HDB EXPT EC; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knill DC, 1996, PERCEPTION BAYESIAN; Koehler JJ, 1996, BEHAV BRAIN SCI, V19, P1, DOI 10.1017/S0140525X00041157; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, PLOS BIOL, V2, P1652, DOI 10.1371/journal.pbio.0020330; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MALONEY LT, 2006, INTEGRATED MODELS CO; Marr D., 1982, VISION COMPUTATIONAL, DOI [10.7551/mitpress/9780262514620.001.0001, DOI 10.7551/MITPRESS/9780262514620.001.0001]; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Ng A.Y., 2000, MACHINE LEARNING, V1, P2; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Sangrey TD, 2004, J NEUROPHYSIOL, V91, P2541, DOI 10.1152/jn.00646.2003; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tenebaum JB, 2001, BEHAV BRAIN SCI, V24, P629, DOI 10.1017/S0140525X01000061; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; WEIBEL ER, 1998, PRINCIPLES ANIMAL DE; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; WOLPERT DM, IN PRESS OXFORD COMP; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	44	189	198	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					606	610		10.1126/science.1142998	http://dx.doi.org/10.1126/science.1142998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962554				2022-12-28	WOS:000250409200035
J	Lee, H; Dellatore, SM; Miller, WM; Messersmith, PB				Lee, Haeshin; Dellatore, Shara M.; Miller, William M.; Messersmith, Phillip B.			Mussel-inspired surface chemistry for multifunctional coatings	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; HYALURONIC-ACID; MYTILUS-EDULIS; CROSS-LINKING; ADHESIVE; DOPAMINE; POLYMERS; NANOPARTICLES; PROTEINS; BIOLOGY	We report a method to form multifunctional polymer coatings through simple dip-coating of objects in an aqueous solution of dopamine. Inspired by the composition of adhesive proteins in mussels, we used dopamine self-polymerization to form thin, surface-adherent polydopamine films onto a wide range of inorganic and organic materials, including noble metals, oxides, polymers, semiconductors, and ceramics. Secondary reactions can be used to create a variety of ad-layers, including self-assembled monolayers through deposition of long-chain molecular building blocks, metal films by electroless metallization, and bioinert and bioactive surfaces via grafting of macromolecules.	Northwestern Univ, Inst BioNanotechnol Med, Evanston, IL 60208 USA	Northwestern University	Messersmith, PB (corresponding author), Northwestern Univ, Inst BioNanotechnol Med, 2145 Sheridan Rd, Evanston, IL 60208 USA.	philm@northwestern.edu	Miller, William M/B-7650-2009; Messersmith, Phil/B-6695-2009; Lee, Haeshin/C-1720-2011	Lee, Haeshin/0000-0003-3961-9727; Messersmith, Phillip/0000-0002-1197-333X; Miller, William/0000-0003-0750-6314	NHLBI NIH HHS [HL 74151, R01 HL074151, R01 HL074151-04] Funding Source: Medline; NIDCR NIH HHS [R01 DE014193-03, R37 DE014193, R01 DE014193, DE 14193] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE014193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014193] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434; CHARBONNIER M, 1999, RRD MACROMOL RES 1, V4, P27; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011; Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee H, 2006, MACROMOLECULES, V39, P23, DOI 10.1021/ma051929c; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Li YL, 2006, THIN SOLID FILMS, V497, P270, DOI 10.1016/j.tsf.2005.10.048; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Montagna W, 1993, BLACK SKIN STRUCTURE; Paunesku T, 2003, NAT MATER, V2, P343, DOI 10.1038/nmat875; PIERPONT CG, 1994, PROG INORG CHEM, V41, P331, DOI 10.1002/9780470166420.ch5; PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032; Ratner B.D., 2004, BIOMATERIALS SCI INT; ROBERTS GG, 1990, LANGMUIRBLODGETT FIL; Ryu DY, 2005, SCIENCE, V308, P236, DOI 10.1126/science.1106604; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534; Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802; Young G. A., 1982, ADHESION, V6; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zurcher S, 2006, J AM CHEM SOC, V128, P1064, DOI 10.1021/ja056256s	33	7717	8039	339	7517	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					426	430		10.1126/science.1147241	http://dx.doi.org/10.1126/science.1147241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947576	Green Accepted			2022-12-28	WOS:000250230400039
J	Pardal, R; Ortega-Saenz, P; Duran, R; Lopez-Barneo, J				Pardal, Ricardo; Ortega-Saenz, Patricia; Duran, Rocio; Lopez-Barneo, Jose			Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body	CELL			English	Article							CARDIAC NEURAL CREST; SELF-RENEWAL; INTRASTRIATAL TRANSPLANTATION; PARKINSONIAN RATS; BASIC FGF; NEURONS; OXYGEN; PROLIFERATION; HYPOXIA; DIFFERENTIATION	Neurogenesis is known to occur in the specific niches of the adult mammalian brain, but whether germinal centers exist in the neural-crest-derived peripheral nervous system is unknown. We have discovered stem cells in the adult carotid body (CB), an oxygen-sensing organ of the sympathoadrenal lineage that grows in chronic hypoxemia. Production of new neuron like CB glomus cells depends on a population of stem cells, which form multipotent and self-renewing colonies in vitro. Cell fate mapping experiments indicate that, unexpectedly, CB stem cells are the glia-like sustentacular cells and can be identified using glial markers. Remarkably, stem cell-derived glomus cells have the same complex chemosensory properties as mature in situ glomus cells. They are highly dopaminergic and produce glial cell line-derived neurotrophic factor. Thus, the mammalian CB is a neurogenic center with a recognizable physiological function in adult life. CB stem cells could be potentially useful for antiparkinsonian cell therapy.	Univ Seville, Hosp Univ Virgen Rocio, Lab Invest Biomed, Seville 41013, Spain	University of Sevilla; Virgen del Rocio University Hospital	Lopez-Barneo, J (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Lab Invest Biomed, Avenida Manuel Siurot S-N, Seville 41013, Spain.	lbarneo@us.es	IBIS, NEUROBIOLOGIA/O-9922-2015; Sáenz, Patricia Ortega/E-8623-2016; Pardal, Ricardo/C-4370-2015; IBIS, FISIOPATOLOGIA/O-9510-2015	Pardal, Ricardo/0000-0003-1085-0714; 				ACHILLES E, 1991, HISTOPATHOLOGY, V18, P453, DOI 10.1111/j.1365-2559.1991.tb00877.x; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ARIASSTELLA J, 1976, HUM PATHOL, V7, P361, DOI 10.1016/S0046-8177(76)80052-4; Arjona V, 2003, NEUROSURGERY, V53, P321, DOI 10.1227/01.NEU.0000073315.88827.72; Astrom K, 2003, HUM GENET, V113, P228, DOI 10.1007/s00439-003-0969-6; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Calof AL, 1998, J NEUROBIOL, V36, P190, DOI 10.1002/(SICI)1097-4695(199808)36:2<190::AID-NEU7>3.0.CO;2-X; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dinger B, 2003, OXYGEN SENSING RESPO, P439; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EDWARDS C, 1971, J PATHOL, V104, P1, DOI 10.1002/path.1711040102; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Espejo EF, 1998, NEURON, V20, P197, DOI 10.1016/S0896-6273(00)80449-3; HEATH D, 1982, J PATHOL, V138, P115, DOI 10.1002/path.1711380203; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kameda Y, 2005, DEV BIOL, V283, P128, DOI 10.1016/j.ydbio.2005.04.004; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; KLIEWER KE, 1989, HUM PATHOL, V20, P29, DOI 10.1016/0046-8177(89)90199-8; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Luquin MR, 1999, NEURON, V22, P743, DOI 10.1016/S0896-6273(00)80733-3; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MCGREGOR KH, 1984, J APPL PHYSIOL, V57, P1430, DOI 10.1152/jappl.1984.57.5.1430; Mejias R, 2006, J NEUROSCI, V26, P4500, DOI 10.1523/JNEUROSCI.0122-06.2006; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nurse CA, 1997, DEV BIOL, V184, P197, DOI 10.1006/dbio.1997.8539; Paciga M, 2001, NEUROREPORT, V12, P3287, DOI 10.1097/00001756-200110290-00028; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pardal R, 2002, NAT NEUROSCI, V5, P197, DOI 10.1038/nn812; ROBERTSON DI, 1980, CANCER-AM CANCER SOC, V46, P2623, DOI 10.1002/1097-0142(19801215)46:12<2623::AID-CNCR2820461215>3.0.CO;2-U; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Toledo-Aral JJ, 2003, J NEUROSCI, V23, P141; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Villadiego J, 2005, J NEUROSCI, V25, P4091, DOI 10.1523/JNEUROSCI.4312-04.2005; Young HM, 1998, DEV BIOL, V202, P67, DOI 10.1006/dbio.1998.8987	50	249	262	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					364	377		10.1016/j.cell.2007.07.043	http://dx.doi.org/10.1016/j.cell.2007.07.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956736	Bronze			2022-12-28	WOS:000250507700025
J	Galbraith, ED; Jaccard, SL; Pedersen, TF; Sigman, DM; Haug, GH; Cook, M; Southon, JR; Francois, R				Galbraith, Eric D.; Jaccard, Samuel L.; Pedersen, Thomas F.; Sigman, Daniel M.; Haug, Gerald H.; Cook, Mea; Southon, John R.; Francois, Roger			Carbon dioxide release from the North Pacific abyss during the last deglaciation	NATURE			English	Article							ATMOSPHERIC CO2 CONCENTRATIONS; SANTA-BARBARA BASIN; DEEP-WATER; AGE CALIBRATION; RADIOCARBON AGE; SOUTHERN-OCEAN; GLACIAL PERIOD; PRODUCTIVITY; CIRCULATION; VENTILATION	Atmospheric carbon dioxide concentrations were significantly lower during glacial periods than during intervening interglacial periods, but the mechanisms responsible for this difference remain uncertain. Many recent explanations call on greater carbon storage in a poorly ventilated deep ocean during glacial periods(1-5), but direct evidence regarding the ventilation and respired carbon content of the glacial deep ocean is sparse and often equivocal(6). Here we present sedimentary geochemical records from sites spanning the deep subarctic Pacific that-together with previously published results(7)-show that a poorly ventilated water mass containing a high concentration of respired carbon dioxide occupied the North Pacific abyss during the Last Glacial Maximum. Despite an inferred increase in deep Southern Ocean ventilation during the first step of the deglaciation (18,000-15,000 years ago)(4,8), we find no evidence for improved ventilation in the abyssal subarctic Pacific until a rapid transition similar to 14,600 years ago: this change was accompanied by an acceleration of export production from the surface waters above but only a small increase in atmospheric carbon dioxide concentration(8). We speculate that these changes were mechanistically linked to a roughly coeval increase in deep water formation in the North Atlantic(9-11), which flushed respired carbon dioxide from northern abyssal waters, but also increased the supply of nutrients to the upper ocean, leading to greater carbon dioxide sequestration at mid-depths and stalling the rise of atmospheric carbon dioxide concentrations. Our findings are qualitatively consistent with hypotheses invoking a deglacial flushing of respired carbon dioxide from an isolated, deep ocean reservoir(1-5,12), but suggest that the reservoir may have been released in stages, as vigorous deep water ventilation switched between North Atlantic and Southern Ocean source regions.	Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; ETH, Inst Geol, Dept Earth Sci, CH-8092 Zurich, Switzerland; Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of British Columbia; University of Victoria; Princeton University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Santa Cruz; University of California System; University of California Irvine	Galbraith, ED (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada.	egalbrai@princeton.edu	Jaccard, Samuel/G-3447-2014; Sigman, Daniel M/A-2649-2008; Galbraith, Eric D./F-9469-2014	Jaccard, Samuel/0000-0002-5793-0896; Sigman, Daniel M/0000-0002-7923-1973; Galbraith, Eric D./0000-0003-4476-4232; Cook, Mea/0000-0003-3786-6353				Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; BOYLE EA, 1988, NATURE, V331, P55, DOI 10.1038/331055a0; Broecker W, 2004, SCIENCE, V306, P1169, DOI 10.1126/science.1102293; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; BRUNELLE BG, 2007, PALEOCEANOGRAPHY, V22; Crusius J, 2004, GEOLOGY, V32, P633, DOI 10.1130/G20508.1; Dezileau L, 2002, CR GEOSCI, V334, P1039, DOI 10.1016/S1631-0713(02)01826-6; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Hughen KA, 2004, RADIOCARBON, V46, P1161, DOI 10.1017/S0033822200033075; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; Ivanochko TS, 2004, QUATERNARY SCI REV, V23, P467, DOI 10.1016/j.quascirev.2003.06.006; Jaccard SL, 2005, SCIENCE, V308, P1003, DOI 10.1126/science.1108696; Keigwin LD, 1998, PALEOCEANOGRAPHY, V13, P323, DOI 10.1029/98PA00874; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Marchitto TM, 2005, EARTH PLANET SC LETT, V231, P317, DOI 10.1016/j.epsl.2004.12.024; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Ortiz JD, 2004, GEOLOGY, V32, P521, DOI 10.1130/G20234.1; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; SARKAR A, 1993, GEOCHIM COSMOCHIM AC, V57, P1009, DOI 10.1016/0016-7037(93)90036-V; Sarnthein M, 2006, GEOLOGY, V34, P141, DOI 10.1130/G22200.1; Schmittner A, 2005, NATURE, V434, P628, DOI 10.1038/nature03476; SHACKLETON NJ, 1988, NATURE, V335, P708, DOI 10.1038/335708a0; Sigman D. M., 2003, TREATISE GEOCHEMISTR, V6, P491, DOI DOI 10.1016/B978-0-08-095975-7.00618-5; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Toggweiler J, 2003, GLOB BIOGEOCHEM CYCL, V17; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Zheng Y, 2000, PALEOCEANOGRAPHY, V15, P528, DOI 10.1029/1999PA000473	39	170	175	5	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					890	U9		10.1038/nature06227	http://dx.doi.org/10.1038/nature06227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943127				2022-12-28	WOS:000250230600043
J	Turnbaugh, PJ; Ley, RE; Hamady, M; Fraser-Liggett, CM; Knight, R; Gordon, JI				Turnbaugh, Peter J.; Ley, Ruth E.; Hamady, Micah; Fraser-Liggett, Claire M.; Knight, Rob; Gordon, Jeffrey I.			The Human Microbiome Project	NATURE			English	Article							GERM-FREE MICE; SYMBIOTIC BACTERIA; ENVIRONMENTAL-SAMPLES; MOLECULAR ANALYSIS; GUT MICROBIOTA; COMMUNITIES; OBESITY; DIVERSITY; ECOLOGY; GENOME	A strategy to understand the microbial components of the human genetic and metabolic landscape and how they contribute to normal physiology and predisposition to disease.	Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland Baltimore; University of Colorado System; University of Colorado Boulder	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu	Ley, Ruth E/M-8542-2014; Knight, Rob/D-1299-2010; ravegnini, gloria/K-1330-2016	Ley, Ruth E/0000-0002-9087-1672; ravegnini, gloria/0000-0002-7774-402X; Turnbaugh, Peter/0000-0002-0888-2875; Knight, Rob/0000-0002-0975-9019; Fraser, Claire/0000-0003-1462-2428	NIDDK NIH HHS [P30 DK056341-07, P30 DK056341-06, P30 DK056341] Funding Source: Medline; NIGMS NIH HHS [T32 GM065103] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AMBRAMSKY Z, 1984, NATURE, V309, P150; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Committee on Metagenomics, 2007, NEW SCI MET REV SECR; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gao HC, 2007, APPL ENVIRON MICROB, V73, P563, DOI 10.1128/AEM.01771-06; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gentry TJ, 2006, MICROB ECOL, V52, P159, DOI 10.1007/s00248-006-9072-6; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gordon JI, 2005, EXTENDING OUR VIEW S; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MAC ARTHUR ROBERT H., 1967; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sidhu H, 2001, J UROLOGY, V166, P1487, DOI 10.1016/S0022-5347(05)65817-X; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WOSTMANN BS, 1982, J NUTR, V112, P552, DOI 10.1093/jn/112.3.552; Wu LY, 2001, APPL ENVIRON MICROB, V67, P5780, DOI 10.1128/AEM.67.12.5780-5790.2001; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999	54	3226	3410	33	1207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					804	810		10.1038/nature06244	http://dx.doi.org/10.1038/nature06244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943116	hybrid, Green Accepted			2022-12-28	WOS:000250230600029
J	Barnes, WJP				Barnes, W. Jon. P.			Biomimetic solutions to sticky problems	SCIENCE			English	Editorial Material							ADHESION; PADS		Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Barnes, WJP (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.	j.barnes@bio.gla.ac.uk						Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Barnes WJP, 2006, J COMP PHYSIOL A, V192, P1179, DOI 10.1007/s00359-006-0146-1; Chung JY, 2005, J R SOC INTERFACE, V2, P55, DOI 10.1098/rsif.2004.0020; Creton C., 2007, MRS B, V32; Daltorio KA, 2007, MRS BULL, V32, P504, DOI 10.1557/mrs2007.85; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135; Ghatak A, 2004, P ROY SOC A-MATH PHY, V460, P2725, DOI 10.1098/rspa.2004.1313; Gorb S, 2000, P ROY SOC B-BIOL SCI, V267, P1239, DOI 10.1098/rspb.2000.1133; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Majumder A, 2007, SCIENCE, V318, P258, DOI 10.1126/science.1145839; Santos D, 2007, IEEE INT CONF ROBOT, P1262, DOI 10.1109/ROBOT.2007.363158	12	46	46	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					203	204		10.1126/science.1149994	http://dx.doi.org/10.1126/science.1149994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932274				2022-12-28	WOS:000250086100022
J	Grundy, WM; Buratti, BJ; Cheng, AF; Emery, JP; Lunsford, A; McKinnon, WB; Moore, JM; Newman, SF; Olkin, CB; Reuter, DC; Schenk, PM; Spencer, JR; Stern, SA; Throop, HB; Weaver, HA				Grundy, W. M.; Buratti, B. J.; Cheng, A. F.; Emery, J. P.; Lunsford, A.; McKinnon, W. B.; Moore, J. M.; Newman, S. F.; Olkin, C. B.; Reuter, D. C.; Schenk, P. M.; Spencer, J. R.; Stern, S. A.; Throop, H. B.; Weaver, H. A.		New Horizons Team	New horizons mapping of Europa and Ganymede	SCIENCE			English	Article							HYDRATED SALT MINERALS; SULFURIC-ACID; VOYAGER PHOTOMETRY; POLAR WANDER; SURFACE; OCEAN	The New Horizons spacecraft observed Jupiter's icy satellites Europa and Ganymede during its flyby in February and March 2007 at visible and infrared wavelengths. Infrared spectral images map H2O ice absorption and hydrated contaminants, bolstering the case for an exogenous source of Europa's "non-ice" surface material and filling large gaps in compositional maps of Ganymede's Jupiter-facing hemisphere. Visual wavelength images of Europa extend knowledge of its global pattern of arcuate troughs and show that its surface scatters light more isotropically than other icy satellites.	Lowell Observ, Flagstaff, AZ 86001 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; NASA, Ames Res Ctr, SETI Inst, Mountain View, CA 94043 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Lunar & Planetary Inst, Houston, TX 77058 USA; NASA Headquarters, Sci Mission Directorate, Washington, DC 20546 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA)	Grundy, WM (corresponding author), Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA.	w.grundy@lowell.edu	Weaver, Harold A/D-9188-2016; Olkin, Catherine/AAF-5160-2019	Weaver, Harold A/0000-0003-0951-7762; Olkin, Catherine/0000-0002-5846-716X; Grundy, Will/0000-0002-8296-6540; Newman, Sarah/0000-0003-3126-5717				Bagenal F., 2004, JUPITER PLANET SATEL; BURATTI B, 1984, ICARUS, V58, P254, DOI 10.1016/0019-1035(84)90042-3; BURATTI B, 1983, ICARUS, V55, P93, DOI 10.1016/0019-1035(83)90053-2; Carlson RW, 2005, ICARUS, V177, P461, DOI 10.1016/j.icarus.2005.03.026; Carlson RW, 2002, ICARUS, V157, P456, DOI 10.1006/icar.2002.6858; Carlson RW, 1999, SCIENCE, V286, P97, DOI 10.1126/science.286.5437.97; CHENG AF, IN PRESS SPACE SCI R; Dalton JB, 2005, ICARUS, V177, P472, DOI 10.1016/j.icarus.2005.02.023; Fanale FP, 2001, J GEOPHYS RES-PLANET, V106, P14595, DOI 10.1029/2000JE001385; Greeley R, 2004, CAMB PLANET, P329; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; Hand KP, 2007, ICARUS, V189, P424, DOI 10.1016/j.icarus.2007.02.002; Hansen GB, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002149; HILLIER J, 1990, SCIENCE, V250, P419, DOI 10.1126/science.250.4979.419; Johnson RE, 2004, CAMB PLANET, P485; JOHNSON TV, 1992, SPACE SCI REV, V60, P3, DOI 10.1007/BF00216848; Leith AC, 1996, ICARUS, V120, P387, DOI 10.1006/icar.1996.0058; McCord TB, 1998, SCIENCE, V280, P1242, DOI 10.1126/science.280.5367.1242; McCord TB, 1999, J GEOPHYS RES-PLANET, V104, P11827, DOI 10.1029/1999JE900005; McCord TB, 2001, SCIENCE, V292, P1523, DOI 10.1126/science.1059916; MCEWEN AS, 1986, J GEOPHYS RES-SOLID, V91, P8077, DOI 10.1029/JB091iB08p08077; REUTER DC, IN PRESS SPACE SCI R; Sarid AR, 2002, ICARUS, V158, P24, DOI 10.1006/icar.2002.6873; Schenk PM, 2004, CAMB PLANET, P427; SCHENK PM, 2005, LUNAR PLANET SCI C, V36, P2081; SCHENK PM, 2007, IC OC FIR SAT OUT SO; STERN SA, IN PRESS SPACE SCI R	27	44	45	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					234	237		10.1126/science.1147623	http://dx.doi.org/10.1126/science.1147623			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932288				2022-12-28	WOS:000250086100036
J	Stolarski, J; Meibom, A; Przenioslo, R; Mazur, M				Stolarski, Jaroslaw; Meibom, Anders; Przenioslo, Radoslaw; Mazur, Maciej			A Cretaceous scleractinian coral with a calcitic skeleton	SCIENCE			English	Article							ANISOTROPIC LATTICE-DISTORTIONS; EVOLUTION; GEOCHEMISTRY; ARAGONITE; SEAWATER; REEF; PH	It has been generally thought that scleractinian corals form purely aragonitic skeletons. We show that a well-preserved fossil coral, Coelosmilia sp. from the Upper Cretaceous (about 70 million years ago), has preserved skeletal structural features identical to those observed in present-day scleractinians. However, the skeleton of Coelosmilia sp. is entirely calcitic. Its fine-scale structure and chemistry indicate that the calcite is primary and did not form from the diagenetic alteration of aragonite. This result implies that corals, like other groups of marine, calcium carbonate-producing organisms, can form skeletons of different carbonate polymorphs.	Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland; Museum Natl Hist Nat, LEME, F-75005 Paris, France; Univ Warsaw, Inst Expt Phys, PL-00681 Warsaw, Poland; Univ Warsaw, Dept Chem, Lab Electrochem, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Museum National d'Histoire Naturelle (MNHN); University of Warsaw; University of Warsaw	Stolarski, J (corresponding author), Polish Acad Sci, Inst Paleobiol, Twarda 51-55, PL-00818 Warsaw, Poland.	stolacy@twarda.pan.pl	Stolarski, Jaroslaw/AAF-7331-2019; Stolarski, Jaroslaw/V-9586-2017	Stolarski, Jaroslaw/0000-0003-0994-6823; Stolarski, Jaroslaw/0000-0003-0994-6823; Przenioslo, Radoslaw/0000-0002-7550-6976; Mazur, Maciej/0000-0002-9197-5553; Meibom, Anders/0000-0002-4542-2819				Allison N, 2005, GEOCHIM COSMOCHIM AC, V69, P3801, DOI 10.1016/j.gca.2005.01.026; BARNES DJ, 1984, J EXP MAR BIOL ECOL, V79, P213, DOI 10.1016/0022-0981(84)90196-5; BOGGILD OB, 1930, D KGL DANSKE VIDENSK, V2, P232; Cairns Stephen D., 1995, New Zealand Oceanographic Institute Memoir, V103, P1; Constanz B., 1990, P201; CORNISH V, 1888, GEOL MAG, V5, P66; Cuif Jean-Pierre, 1998, Palaeontologische Zeitschrift, V72, P257; Cuif JP, 2005, J STRUCT BIOL, V150, P319, DOI 10.1016/j.jsb.2005.03.004; Enders M., 1932, Archiv fuer Naturgeschichte Berlin (NF), V1, P646; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gautret P, 2000, ACTA PALAEONTOL POL, V45, P107; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Meibom A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028657; Meibom A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025968; OLIVER WA, 1980, PALEOBIOLOGY, V6, P146, DOI 10.1017/S0094837300006709; Pokroy B, 2004, NAT MATER, V3, P900, DOI 10.1038/nmat1263; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Ries JB, 2006, GEOLOGY, V34, P525, DOI 10.1130/G22600.1; Rollion-Bard C, 2003, EARTH PLANET SC LETT, V215, P275, DOI 10.1016/S0012-821X(03)00391-1; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Roniewicz Ewa, 1993, Courier Forschungsinstitut Senckenberg, V164, P233; Sinclair DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027183; Sorauf JE, 1999, J PALEONTOL, V73, P1029, DOI 10.1017/S0022336000030961; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stolarski J, 2005, ACTA PALAEONTOL POL, V50, P847; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; Stolarski J, 2007, FACIES, V53, P67, DOI 10.1007/s10347-006-0089-6; Wendt J., 1990, P45; [No title captured]	31	65	69	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					92	94		10.1126/science.1149237	http://dx.doi.org/10.1126/science.1149237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916731				2022-12-28	WOS:000249915400047
J	Birch, M				Birch, Marion			Beyond the surgery - health professionals and global poverty	LANCET			English	Editorial Material									Grayston Ctr, London N1 6HT, England		Birch, M (corresponding author), Grayston Ctr, 28 Charles Sq, London N1 6HT, England.	marionbirch@medact.org						*BRIT MED ASS, 2006, DOCT PUBL CONF DOCT; *COMM SOC DET HLTH, 2007, INT STAT COMM SOC DE, P55; Davies J., 2006, WORLD DISTRIBUTION H; *GLOB HLTH WATCH, 2006, GLOB HLTH WATCH 2005, P12; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Medact, 2002, COLL DAM HLTH ENV CO; PHIPPS S, 2003, IMPACT POVERTY HLTH; ROBERTSON D, 2007, TIMES LOND      0828; STEPHAN A, 2007, NEW STATESMAN   0312; Stott R, 2006, BRIT MED J, V333, P983, DOI 10.1136/bmj.39028.427164.BE; *UK GOV, GLEN 2005 CHAIRM SUM; *UN, 2006, HUM DEV REP 2006; *UNICEF, 2006, STAT WORLDS CHILDR; United Kingdom Home Office, 2007, ENF RUL STRAT ENS EN; Yates Tom, 2007, Med Confl Surviv, V23, P297, DOI 10.1080/13623690701596775	15	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT-NOV	2007	370	9597					1468	1470		10.1016/S0140-6736(07)61617-1	http://dx.doi.org/10.1016/S0140-6736(07)61617-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224ZN	17964337				2022-12-28	WOS:000250487000009
J	Wilson, IB; Landon, BE; Marsden, PV; Hirschhorn, LR; McInnes, K; Ding, L; Cleary, PD				Wilson, Ira B.; Landon, Bruce E.; Marsden, Peter V.; Hirschhorn, Lisa R.; McInnes, Keith; Ding, Lin; Cleary, Paul D.			Correlations among measures of quality in HIV care in the United States: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PAY-FOR-PERFORMANCE; HEALTH-CARE; UPDATED RECOMMENDATIONS; IMPROVEMENT; INFECTION; ADULTS; GUIDELINES; OUTCOMES	Objective To determine whether a selected set of indicators can represent a single overall quality construct. Design Cross sectional study of data abstracted during an evaluation of an initiative to improve quality of care for people with HIV. Setting 69 sites in 30 states. Data sources Medical records of 9020 patients. Main outcome measures Adjusted performance rates at site level for eight measures of quality of care specific to HIV and a site level summary performance score (the number of measures for which the site was in the top quarter of the distribution). Results Of 28 site level correlations between measures, two were greater than 0.40, two were between 0.30 and 0.39, four were between 0.20 and 0.29, and the 20 remaining were all less than 0.20. One site was in the top quarter for seven measures, but no sites were in the top quarter for six or eight of the measures. Across the eight quality measures, sites were in the top quarter no more often than predicted by a chance (binomial) distribution. Conclusions The quality suggested by one measured indicator cannot necessarily be generalised to unmeasured indicators, even if this might be expected for clinical or other reasons.	Tufts Univ, New England Med Ctr, Dept Med, Inst Clin Res & Hlth Care Policy, Boston, MA 02111 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA 02215 USA; Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA	Tufts Medical Center; Tufts University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Yale University	Wilson, IB (corresponding author), Tufts Univ, New England Med Ctr, Dept Med, Inst Clin Res & Hlth Care Policy, Boston, MA 02111 USA.	iwilson@tufts-nemc.org	Cleary, Paul/AAF-7048-2019; Wilson, Ira/F-9190-2016	Wilson, Ira/0000-0002-0246-738X	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR020300] Funding Source: NIH RePORTER; NCRR NIH HHS [K24 RR020300] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Asch SM, 2005, MED CARE, V43, P667, DOI 10.1097/01.mlr.0000167182.72251.a1; Berwick DM, 1998, ANN INTERN MED, V128, P289, DOI 10.7326/0003-4819-128-4-199802150-00008; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Gandhi TK, 2002, MED CARE, V40, P155, DOI 10.1097/00005650-200202000-00010; Homer CJ, 2005, ARCH PEDIAT ADOL MED, V159, P464, DOI 10.1001/archpedi.159.5.464; *I MED COMM QUAL H, 2000, ERR IS HUM BUILD SAF; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kerr EA, 2004, HEALTH AFFAIR, V23, P247, DOI 10.1377/hlthaff.23.3.247; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; Landrum MB, 2000, HLTH SERVICES OUTCOM, V1, P23, DOI [10.1023/A:1010093701870, DOI 10.1023/A:1010093701870]; Masur H, 2002, ANN INTERN MED, V137, P435, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00002; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Palmer RH, 1996, MED CARE, V34, pSS52; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Schneider EC, 2001, MED CARE, V39, P1313, DOI 10.1097/00005650-200112000-00007; Schonlau M, 2005, ANN FAM MED, V3, P200, DOI 10.1370/afm.269; *US DEP HHS, 2004, GUID US ANT AG HIV 1; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; Wilson IB, 2002, MED CARE, V40, P1149, DOI 10.1097/00005650-200212000-00003; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	30	28	28	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2007	335	7629					1085	1088B		10.1136/bmj.39364.520278.55	http://dx.doi.org/10.1136/bmj.39364.520278.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UX	17967826	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000251403000037
J	Lever, A; Mackenzie, I				Lever, Andrew; Mackenzie, Iain			Sepsis: definition, epiderhiology, and diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							C-REACTIVE PROTEIN; UNITED-STATES; ACCURACY; PROCALCITONIN; EPIDEMIOLOGY		Addenbrookes Hosp, John Farman Intens Care Unit, Cambridge, England; Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Mackenzie, I (corresponding author), Addenbrookes Hosp, John Farman Intens Care Unit, Box 17, Cambridge, England.	iain@number2.demon.co.uk						Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Chopin N, 2006, CRIT CARE MED, V34, P1654, DOI 10.1097/01.CCM.0000217471.12799.1C; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Conterno LO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001834.pub2; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Eisen DP, 2006, FEMS IMMUNOL MED MIC, V48, P274, DOI 10.1111/j.1574-695X.2006.00144.x; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mykietiuk A, 2006, EUR J CLIN MICROBIOL, V25, P457, DOI 10.1007/s10096-006-0161-8; Plebani A, 2002, CLIN IMMUNOL, V104, P221, DOI 10.1006/clim.2002.5241; Read RC, 2000, J INFECT DIS, V182, P1557, DOI 10.1086/315889; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Speers David J, 2006, Clin Biochem Rev, V27, P39; Swingler G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001729.pub2; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; Zucol F, 2006, J CLIN MICROBIOL, V44, P2750, DOI 10.1128/JCM.00112-06	26	302	324	1	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2007	335	7625					879	883		10.1136/bmj.39346.495880.AE	http://dx.doi.org/10.1136/bmj.39346.495880.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17962288	Green Published			2022-12-28	WOS:000250631000042
J	Ferrand, Y; Crump, MP; Davis, AP				Ferrand, Yann; Crump, Matthew P.; Davis, Anthony P.			A synthetic lectin analog for biomimetic disaccharide recognition	SCIENCE			English	Article							CARBOHYDRATE-RECOGNITION; RECEPTOR; AFFINITY; BINDING; PROTEINS; NMR	Carbohydrate recognition is biologically important but intrinsically challenging, for both nature and host-guest chemists. Saccharides are complex, subtly variable, and camouflaged by hydroxyl groups that hinder discrimination between substrate and water. We have developed a rational strategy for the biomimetic recognition of carbohydrates with all-equatorial stereochemistry (beta-glucose, analogs, and homologs) and have now applied it to disaccharides such as cellobiose. Our synthetic receptor showed good affinities, not unlike those of some lectins (carbohydrate-binding proteins). Binding was demonstrated by nuclear magnetic resonance, induced circular dichroism, fluorescence spectroscopy, and calorimetry, all methods giving self-consistent results. Selectivity for the target substrates was exceptional; minor changes to disaccharide structure (for instance, cellobiose to lactose) caused almost complete suppression of complex formation.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Davis, AP (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	anthony.davis@bristol.ac.uk	Davis, Anthony/F-2794-2017	Davis, Anthony/0000-0001-5213-624X; Crump, Matthew/0000-0002-7868-5818; Ferrand, Yann/0000-0002-6552-6914	Engineering and Physical Sciences Research Council [EP/D060192/1] Funding Source: researchfish; EPSRC [EP/D060192/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aboitiz N, 2004, CHEMBIOCHEM, V5, P1245, DOI 10.1002/cbic.200400025; Alpturk O, 2006, P NATL ACAD SCI USA, V103, P9756, DOI 10.1073/pnas.0603758103; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; Davis AP, 2005, FUNCTIONAL SYNTHETIC RECEPTORS, P45, DOI 10.1002/352760572X.ch2; Davis AP, 1999, ANGEW CHEM INT EDIT, V38, P2978; Davis AP, 1998, ANGEW CHEM INT EDIT, V37, P2270, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2270::AID-ANIE2270>3.0.CO;2-6; Dwek RA, 2002, CHEM REV, V102, P283, DOI 10.1021/cr010385j; Francesconi O, 2006, ANGEW CHEM INT EDIT, V45, P6693, DOI 10.1002/anie.200602412; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; Hubbard RD, 2001, J AM CHEM SOC, V123, P5810, DOI 10.1021/ja003712y; Klein E, 2005, ANGEW CHEM INT EDIT, V44, P298, DOI 10.1002/anie.200461409; Koning SM, 2001, J BACTERIOL, V183, P4979, DOI 10.1128/JB.183.17.4979-4984.2001; Larsson EA, 2004, J PHYS CHEM A, V108, P3932, DOI 10.1021/jp049714c; Lecollinet G, 2002, ANGEW CHEM INT EDIT, V41, P4093, DOI 10.1002/1521-3773(20021104)41:21<4093::AID-ANIE4093>3.0.CO;2-I; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Lutzen A., 2004, HIGHLIGHTS BIOORGANI, P109; Mazik M, 2006, J ORG CHEM, V71, P2957, DOI 10.1021/jo052479p; Mazik M, 2006, J ORG CHEM, V71, P7854, DOI 10.1021/jo0610309; Nativi C, 2007, J AM CHEM SOC, V129, P4377, DOI 10.1021/ja068754m; Neidlein U, 1996, CHEM COMMUN, P1493, DOI 10.1039/cc9960001493; NEUROHR KJ, 1981, BIOCHEMISTRY-US, V20, P3499, DOI 10.1021/bi00515a030; Ryan TJ, 2002, P NATL ACAD SCI USA, V99, P4863, DOI 10.1073/pnas.062013499; Schmuck C, 2005, ORG LETT, V7, P3517, DOI 10.1021/ol051230r; Striegler S, 2003, CURR ORG CHEM, V7, P81, DOI 10.2174/1385272033373201; Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Waki M, 2006, CHEM-EUR J, V12, P7839, DOI 10.1002/chem.200600315	29	261	263	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					619	622		10.1126/science.1148735	http://dx.doi.org/10.1126/science.1148735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962557				2022-12-28	WOS:000250409200039
J	Bhaskaran, H; Russell, R				Bhaskaran, Hari; Russell, Rick			Kinetic redistribution of native and misfolded RNAs by a DEAD-box chaperone	NATURE			English	Article							GROUP-I INTRON; TETRAHYMENA RIBOZYME; PERIPHERAL ELEMENT; FOLDING LANDSCAPE; STRUCTURED RNA; PROTEIN; HELICASES; SEQUENCE; HELIX; INTERMEDIATE	DExD/H-box proteins are ubiquitously involved in RNA-mediated processes and use ATP to accelerate conformational changes in RNA. However, their mechanisms of action, and what determines which RNA species are targeted, are not well understood. Here we show that the DExD/H-box protein CYT-19, a general RNA chaperone, mediates ATP-dependent unfolding of both the native conformation and a long-lived misfolded conformation of a group I catalytic RNA with efficiencies that depend on the stabilities of the RNA species but not on specific structural features. CYT-19 then allows the RNA to refold, changing the distribution from equilibrium to kinetic control. Because misfolding is favoured kinetically, conditions that allow unfolding of the native RNA yield large increases in the population of misfolded species. Our results suggest that DExD/H-box proteins act with sufficient breadth and efficiency to allow structured RNAs to populate a wider range of conformations than would be present at equilibrium. Thus, RNAs may face selective pressure to stabilize their active conformations relative to inactive ones to avoid significant redistribution by DExD/H-box proteins. Conversely, RNAs whose functions depend on forming multiple conformations may rely on DExD/H-box proteins to increase the populations of less stable conformations, thereby increasing their overall efficiencies.	Univ Texas, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Russell, R (corresponding author), Univ Texas, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	rick_russell@mail.utexas.edu	Russell, Rick/A-9256-2012		NIGMS NIH HHS [R01 GM070456-04, R01 GM070456] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; DELCAMPO M, IN PRESS MOL CELL; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; Grossberger R, 2005, NUCLEIC ACIDS RES, V33, P2280, DOI 10.1093/nar/gki515; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102; JOYCE GF, 1989, NUCLEIC ACIDS RES, V17, P7879, DOI 10.1093/nar/17.19.7879; KARPEL RL, 1982, BIOCHEMISTRY-US, V21, P2102, DOI 10.1021/bi00538a019; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Mahen EM, 2005, MOL CELL, V19, P27, DOI 10.1016/j.molcel.2005.05.025; MOHR G, 1994, NATURE, V370, P147, DOI 10.1038/370147a0; Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Pan J, 2000, J MOL BIOL, V296, P133, DOI 10.1006/jmbi.1999.3439; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Russell R, 2000, NAT STRUCT BIOL, V7, P367; Russell R, 1999, J MOL BIOL, V291, P1155, DOI 10.1006/jmbi.1999.3026; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Russell R, 2007, BIOCHEMISTRY-US, V46, P4951, DOI 10.1021/bi0620149; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; SHUMAN S, 1992, P NATL ACAD SCI USA, V89, P10935, DOI 10.1073/pnas.89.22.10935; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Thirumalai D, 2005, BIOCHEMISTRY-US, V44, P4957, DOI 10.1021/bi047314+; Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Treiber DK, 2001, J MOL BIOL, V305, P11, DOI 10.1006/jmbi.2000.4253; VANDERHORST G, 1991, P NATL ACAD SCI USA, V88, P184, DOI 10.1073/pnas.88.1.184; Yang QS, 2007, J MOL BIOL, V368, P1087, DOI 10.1016/j.jmb.2007.02.071; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008	48	85	88	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1014	U2		10.1038/nature06235	http://dx.doi.org/10.1038/nature06235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960235	Green Accepted			2022-12-28	WOS:000250395000043
J	Yusuf, S; Fallen, E; Harrington, RA; Guyton, RA				Yusuf, Salim; Fallen, Ernest; Harrington, Robert A.; Guyton, Robert A.			Management of stable coronary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STENT IMPLANTATION; ELUTING STENTS; ARTERY-DISEASE; HEART-DISEASE; PREVENTION; OUTCOMES; TRIALS; ANGINA; BYPASS		McMaster Univ, Hamilton, ON, Canada; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC USA	McMaster University; Duke University; Duke University	Yusuf, S (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Yusuf, Salim/0000-0003-4776-5601				Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Bhatt AB, 2006, CURR OPIN CARDIOL, V21, P492, DOI 10.1097/01.hco.0000240588.22086.43; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Corti R, 2004, CLIN CARDIOL, V27, P547, DOI 10.1002/clc.4960271020; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Guyton RA, 2006, ANN THORAC SURG, V81, P1949, DOI 10.1016/j.athoracsur.2006.03.020; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Harrington RA, 2006, J AM COLL CARDIOL, V48, P2592, DOI 10.1016/j.jacc.2006.10.025; Machecourt J, 2007, J AM COLL CARDIOL, V50, P501, DOI 10.1016/j.jacc.2007.04.051; PUSKAS JD, 2007, 43 ANN M SOC THOR SU; Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044	14	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1762	1766						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960017				2022-12-28	WOS:000250355100015
J	McCannon, CJ; Berwick, DM; Massoud, MR				McCannon, C. Joseph; Berwick, Donald M.; Massoud, M. Rashad			The science of large-scale change in global health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; QUALITY		Inst Healthcare Improvement, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	McCannon, CJ (corresponding author), Inst Healthcare Improvement, 20 Univ Ave,7th Floor, Cambridge, MA 02138 USA.	jmccannon@ihi.org						ATTEWELL P, 1992, ORGAN SCI, V3, P1, DOI 10.1287/orsc.3.1.1; BarabuYSi A., 2003, LINKED EVERYTHING IS; BARKER PM, IN PRESS J INFECT DI; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Chowdhury A.M.R., 1996, SIMPLE SOLUTION TEAC; Deming WE, 2000, OUT CRISIS; Dooley K.J., 1996, CHAOS NETWORK, V8, P2; FRASER S, 2000, HLTH MANAGEMENT, P10; Hermida J, 2005, SCALING I CONTINUOUS; Levine Ruth, 2004, MILLIONS SAVED PROVE; MASSOUD MR, 2006, FRAMEWORK SPREAD LOC, P3; McCannon CJ, 2006, BRIT MED J, V332, P1328, DOI 10.1136/bmj.332.7553.1328; Nolan TW, 2007, EXECUTION STRATEGIC; Resar R, 2005, J PEDIATR-US, V147, P727, DOI 10.1016/j.jpeds.2005.09.022; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Senge PM, 2006, 5 DISCIPLINE ART PRA; Stacey R., 1996, COMPLEXITY CREATIVIT; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; TAYLOR C, 2002, JUST LASTING CHANGE; *U RES CO LLC, 2007, QUAL ASS WORKF DEV P; Van de Ven AH, 2004, HDB ORG CHANGE INNOV, P259; Wenger Etienne., 1998, COMMUNITIES PRACTICE, V18th ed; *WHO HTM EIP, 2004, APPR RAP SCAL UP US	24	51	52	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1937	1939		10.1001/jama.298.16.1937	http://dx.doi.org/10.1001/jama.298.16.1937			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954547				2022-12-28	WOS:000250356700028
J	Pandey, P; Sehgal, AR; Riboud, M; Levine, D; Goyal, M				Pandey, Priyanka; Sehgal, Ashwini R.; Riboud, Michelle; Levine, David; Goyal, Madhav			Informing resource-poor populations and the delivery of entitled health and social services in rural india - A cluster randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEVELOPING-COUNTRIES; TEACHER; PROGRAM; ABSENCE	Context A lack of awareness about entitled health and social services may contribute to poor delivery of such services in developing countries, especially among individuals of low socioeconomic status. Objective To determine the impact of informing resource-poor rural populations about entitled services. Design, Setting, and Participants Community-based, cluster randomized controlled trial conducted from May 2004 to May 2005 in 105 randomly selected village clusters in Uttar Pradesh state in India. Households (548 intervention and 497 control) were selected by a systematic sampling design, including both low-caste and mid- to high-caste households. Intervention Four to 6 public meetings were held in each intervention village cluster to disseminate information on entitled health services, entitled education services, and village governance requirements. No intervention took place in control village clusters. Main Outcome Measures Visits by nurse midwife; prenatal examinations, tetanus vaccinations, and prenatal supplements received by pregnant women; vaccinations received by infants; excess school fees charged; occurrence of village council meetings; and development work in villages. Results At baseline, there were no significant differences in self-reported delivery of health and social services. After 1 year, intervention villagers reported better delivery of several services compared with control villagers: in a multivariate analysis, 30% more prenatal examinations (95% confidence interval [CI], 17%-43%; P < . 001), 27% more tetanus vaccinations (95% CI, 12%-41%; P < .001), 24% more prenatal supplements (95% CI, 8%-39%; P = .003), 25% more infant vaccinations (95% CI, 8%-42%; P = .004), and decreased excess school fees of 8 rupees (95% CI, 4-13 rupees; P < .001). In a difference-in-differences analysis, 21% more village council meetings were reported (95% CI, 5%-36%; P = .01). There were no improvements in visits by a nurse midwife or in development work in the villages. Both low-caste and mid- to high-caste intervention households reported significant improvements in service delivery. Conclusions Informing resource-poor rural populations in India about entitled services enhanced the delivery of health and social services among both low- and mid- to high-caste households. Interventions that emphasize educating resource-poor populations about entitled services may improve the delivery of such services.	Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD 21287 USA; World Bank, S Asia Human Dev, Washington, DC 20433 USA; Case Western Reserve Univ, Ctr Reducing Hlth Disparities, Cleveland, OH USA; Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, Cleveland, OH USA	Johns Hopkins University; Johns Hopkins Medicine; The World Bank; Case Western Reserve University; Case Western Reserve University; MetroHealth System	Goyal, M (corresponding author), Johns Hopkins Sch Med, Div Gen Internal Med, 2024 E Monument St 1-500H, Baltimore, MD 21287 USA.	madhav@jhmi.edu						Abbasi K, 1999, BRIT MED J, V318, P1066, DOI 10.1136/bmj.318.7190.1066; [Anonymous], CENSUS OF INDIA 2001; [Anonymous], 2005, ANN STATUS ED REPORT; [Anonymous], 2001, CENS IND 2001; Baqui AH, 2007, INDIAN J PEDIATR, V74, P241, DOI 10.1007/s12098-007-0038-6; Bardhan P, 2005, J PUBLIC ECON, V89, P675, DOI 10.1016/j.jpubcco.2003.01.001; Bardhan P, 2002, J ECON PERSPECT, V16, P185, DOI 10.1257/089533002320951037; *CENS IND, CENS TERMS 2001; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; *COMPTR AUD GEN IN, 2001, REP COMPTR AUD GEN I; *CTR DEM GOV, 1999, HDB FIGHT CORR; *CTR MED STUD TRAN, IND CORR STUD 2005 I, V1; Debroy B., 2003, DISTRICT LEVEL DEPRI; *EXP PAN CONT PREN, 1989, CAR OUT FUT CONT PRE; Flanagin A, 2006, JAMA-J AM MED ASSOC, V296, P2970, DOI 10.1001/jama.296.24.2970; Gaiha R, 1998, ASIAN SURV, V38, P928, DOI 10.1525/as.1998.38.10.01p0391b; *GOV IND MIN SOC J, FREQ ASK QUEST SCHED; *GOV IND NAT COMM, CENTR LIST OTH BACKW; *GOV IND PLANN COM, NAT HUM DEV REP 2001; *GOV IND PLANN COM, POV EST 1999 2000; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hoff KR, 2004, BELIEF SYSTEMS DURAB; *I MED COMM STUD P, 1985, PREV LOW BIRTH WEIGH; International Institute of Population Sciences, NAT FAM HLTH SURV; Kremer M, 2005, J EUR ECON ASSOC, V3, P658, DOI 10.1162/jeea.2005.3.2-3.658; OLKEN BA, MONITORING CORRUPTIO; Reinikka R, 2004, Q J ECON, V119, P679, DOI 10.1162/0033553041382120; Reinikka R., PUBLIC EXPENDITURE T; Sharan M, 2005, INT J GYNECOL OBSTET, V90, P251, DOI 10.1016/j.ijgo.2005.05.008; Transparency International, GLOB CORR REP 2006 C; *UTT PRAD BAS ED O, 2002, UTT PRAD BAS SHIKSH; *WORLD BANK, TEACH SKIPP WORK; *WORLD BANK, TEACH DOCT MISS ACT; *WORLD BANK, 2004, HAV WORLDS POOR FAR; World Bank, 2004, WORLD DEV REP; *WORLD BANK, COUNTR S AS DEC REF	36	59	60	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1867	1875		10.1001/jama.298.16.1867	http://dx.doi.org/10.1001/jama.298.16.1867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223GC	17954538				2022-12-28	WOS:000250356700019
J	Gofflot, F; Chartoire, N; Vasseur, L; Heikkinen, S; Dembele, D; Le Merrer, J; Auwerx, J				Gofflot, Francoise; Chartoire, Nathalie; Vasseur, Laurent; Heikkinen, Sami; Dembele, Doulaye; Le Merrer, Julie; Auwerx, Johan			Systematic gene expression mapping clusters nuclear receptors according to their function in the brain	CELL			English	Article							ESTROGEN-RECEPTORS; MICE LACKING; BODY-WEIGHT; FOOD-INTAKE; MEMORY; MOUSE; HIPPOCAMPUS; ALPHA; RAT; PATTERNS	Nuclear receptors (NRs) compose a large family of transcription factors that operate at the interface between genes and environment, acting as sensors and effectors that translate endocrine and metabolic cues into well-defined gene expression programs. We report here on a systematic quantitative and anatomical expression atlas of the 49 NR genes in 104 regions of the adult mouse brain, organized in the interactive MousePat database. MousePat defines NR expression patterns to cellular resolution, a requirement for functional genomic strategies to understand the function of a highly heterogeneous and complex organ such as the brain. Using MousePat data, NR expression patterns can be clustered into anatomical and regulatory networks that delineate the role of NRs in brain functions, like the control of feeding and learning/ memory. Mining the MousePat resource will improve the understanding of NR function in the brain and elucidate hierarchical networks that control behavior and whole body homeostasis.	Inst Clin Souris, F-67404 Iiikirch, France; Univ Strasbourg 1, INSERM, CNRS, Inst Genet Biol Mol & Cellulaire, F-67404 Iiikirch, France; Univ Kuopio, AI Virtanen Inst & Biol Mol & Cellulaire, Kuopio 70211, Finland	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Eastern Finland	Gofflot, F (corresponding author), Inst Clin Souris, F-67404 Iiikirch, France.	auwerx@igbmc.u-strasbg.fr	Le Merrer, Julie/P-3648-2016; stephan, aline/A-5613-2010; Dembélé, Doulaye/O-6513-2017; Auwerx, Johan/ABE-9307-2021; Heikkinen, Sami P/L-1460-2013	Le Merrer, Julie/0000-0002-8670-4273; Dembélé, Doulaye/0000-0003-3879-6940; Heikkinen, Sami P/0000-0002-6083-2402; Auwerx, Johan/0000-0002-5065-5393				Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Chotteau-Lelievre Anne, 2006, Methods Mol Biol, V326, P61; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; FULTON JOHN F., 1954, QUART BULL NORTHWESTERN UNIV MED SCH, V28, P10; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Herzig U, 2001, NOVART FDN SYMP, V239, P129; Hof PR., 2000, COMP CYTOARCHITECTON; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Jiang X, 2004, J BIOL CHEM, V279, P38480, DOI 10.1074/jbc.M403948200; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Koester SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-212; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-19; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; REEVES AG, 1969, ARCH NEUROL-CHICAGO, V20, P616, DOI 10.1001/archneur.1969.00480120062005; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Vasudevan N, 2005, ENDOCRINE, V26, P25, DOI 10.1385/ENDO:26:1:025; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; WEILAND NG, 1992, ENDOCRINOLOGY, V131, P2697, DOI 10.1210/en.131.6.2697; Werme M, 2000, MOL BRAIN RES, V76, P18, DOI 10.1016/S0169-328X(99)00327-7; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Wilcoxon JS, 2007, BEHAV BRAIN RES, V177, P109, DOI 10.1016/j.bbr.2006.10.030; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zurkovsky L, 2006, NEUROBIOL LEARN MEM, V86, P336, DOI 10.1016/j.nlm.2006.07.008	49	128	137	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					405	418		10.1016/j.cell.2007.09.012	http://dx.doi.org/10.1016/j.cell.2007.09.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956739	Bronze			2022-12-28	WOS:000250507700028
J	Dethlefsen, L; McFall-Ngai, M; Relman, DA				Dethlefsen, Les; McFall-Ngai, Margaret; Relman, David A.			An ecological and evolutionary perspective on human-microbe mutualism and disease	NATURE			English	Review							GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; ESCHERICHIA-COLI; GUT MICROBIOTA; STAPHYLOCOCCUS-EPIDERMIDIS; COMMUNITY STRUCTURE; MOLECULAR ANALYSIS; BACTERIAL BIOTA; ORAL-CAVITY; MOUSE MODEL	The microbial communities of humans are characteristic and complex mixtures of microorganisms that have co-evolved with their human hosts. The species that make up these communities vary between hosts as a result of restricted migration of microorganisms between hosts and strong ecological interactions within hosts, as well as host variability in terms of diet, genotype and colonization history. The shared evolutionary fate of humans and their symbiotic bacteria has selected for mutualistic interactions that are essential for human health, and ecological or genetic changes that uncouple this shared fate can result in disease. In this way, looking to ecological and evolutionary principles might provide new strategies for restoring and maintaining human health.	Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; University of Wisconsin System; University of Wisconsin Madison; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	relman@stanford.edu	Dethlefsen, Les/R-2220-2018	Dethlefsen, Les/0000-0001-9622-1630; Relman, David A./0000-0001-8331-1354	NIH HHS [DP1 OD000964] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Brook I, 2005, OTOLARYNG HEAD NECK, V133, P139, DOI 10.1016/j.otohns.2005.03.012; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Callaghan MJ, 2006, INFECT IMMUN, V74, P5085, DOI 10.1128/IAI.00293-06; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Caufield PW, 2000, INFECT IMMUN, V68, P4018, DOI 10.1128/IAI.68.7.4018-4023.2000; Cheesman SE, 2007, RES MICROBIOL, V158, P2, DOI 10.1016/j.resmic.2006.10.005; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Davidson SK, 2006, APPL ENVIRON MICROB, V72, P769, DOI 10.1128/AEM.72.1.769-775.2006; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Flint HJ, 2004, ADV APPL MICROBIOL, V56, P89, DOI 10.1016/S0065-2164(04)56003-3; Fons Michel, 2000, Microbial Ecology in Health and Disease, V12, P240, DOI 10.1080/089106000750060495; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; FRAUNE I, P NATL ACAD SCI US, V104, P13146; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gordon DM, 1998, MICROBIOL-SGM, V144, P2233, DOI 10.1099/00221287-144-8-2233; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Jernberg C, 2005, APPL ENVIRON MICROB, V71, P501, DOI 10.1128/AEM.71.1.501-506.2005; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P1984, DOI 10.1128/AEM.01833-06; Klaassens ES, 2007, APPL ENVIRON MICROB, V73, P1388, DOI 10.1128/AEM.01921-06; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Mackie RI, 2004, PHYSIOL BIOCHEM ZOOL, V77, P127, DOI 10.1086/383498; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Naylor SW, 2005, INT J MED MICROBIOL, V295, P419, DOI 10.1016/j.ijmm.2005.07.010; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; O'Keefe SJD, 2007, J NUTR, V137, p175S, DOI 10.1093/jn/137.1.175S; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Pool-Zobel B, 2005, MUTAT RES-FUND MOL M, V591, P74, DOI 10.1016/j.mrfmmm.2005.04.020; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Reid G, 2006, WORLD J UROL, V24, P28, DOI 10.1007/s00345-005-0043-1; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Robinson DA, 2006, ANTIMICROB AGENTS CH, V50, P2903, DOI 10.1128/AAC.00325-06; Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Savage DC, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P19, DOI 10.1016/B978-012491543-5/50006-1; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Sjolund M, 2005, EMERG INFECT DIS, V11, P1389; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Swenson W, 2000, P NATL ACAD SCI USA, V97, P9110, DOI 10.1073/pnas.150237597; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Uenishi G, 2007, AM J PRIMATOL, V69, P367, DOI 10.1002/ajp.20351; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; Wilson DS, 1997, ECOLOGY, V78, P2018, DOI 10.2307/2265941; Wilson KH, 2006, ANAEROBE, V12, P249, DOI 10.1016/j.anaerobe.2006.09.002; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	96	1014	1096	6	436	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					811	818		10.1038/nature06245	http://dx.doi.org/10.1038/nature06245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943117	Green Accepted			2022-12-28	WOS:000250230600030
J	Thornton, KA; Levis, M				Thornton, Katherine A.; Levis, Mark			FLT3 mutation and acute myelogenous leukemia with leukostasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA	Johns Hopkins University	Thornton, KA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA.	kthornton@jhmi.edu							0	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1639	1639		10.1056/NEJMicm064764	http://dx.doi.org/10.1056/NEJMicm064764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942876				2022-12-28	WOS:000250200500009
J	Newcomer, JW; Hennekens, CH				Newcomer, John W.; Hennekens, Charles H.			Severe mental illness and risk of cardiovascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CATIE SCHIZOPHRENIA TRIAL; METABOLIC SYNDROME; PREVALENCE; CARE		Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Clin Studies, St Louis, MO 63110 USA; Florida Atlantic Univ, Charles E Schmidt Coll Biomed Sci, Dept Clin Sci & Med Educ, Boca Raton, FL 33431 USA; Florida Atlantic Univ, Ctr Excellence, Boca Raton, FL 33431 USA; Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33152 USA; Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33152 USA; Nova SE Univ, Dept Prevent Med, Ft Lauderdale, FL 33314 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; University of Miami; University of Miami; Nova Southeastern University	Newcomer, JW (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave,Campus Box 8134, St Louis, MO 63110 USA.	newcomerj@wustl.edu	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Newcomer, John/0000-0003-2153-9382	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063985, R01MH072912] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-63985, MH-72912] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1194; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Compton MT, 2006, HARVARD REV PSYCHIAT, V14, P212, DOI 10.1080/10673220600889256; Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P565, DOI 10.1001/archpsyc.58.6.565; Fagiolini A, 2005, BIPOLAR DISORD, V7, P424, DOI 10.1111/j.1399-5618.2005.00234.x; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Frayne SM, 2005, ARCH INTERN MED, V165, P2631, DOI 10.1001/archinte.165.22.2631; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; *I MED, IMPR QUAL HLTH CAR M; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; MORRATO EH, IN PRESS J CLIN PSYC; Nasrallah HA, 2006, SCHIZOPHR RES, V86, P15, DOI 10.1016/j.schres.2006.06.026; *NAT CANC I, MON NAT CANC I, V8; *NAT HEART LUNG BL, CLIN PRACT GUID; Newcomer JW, 2005, CNS DRUGS, V19, P1; Office of the Surgeon General, 2019, SURG GEN ADV MAR US; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SCHINNAR AP, 1990, AM J PSYCHIAT, V147, P1602	24	304	304	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1794	1796		10.1001/jama.298.15.1794	http://dx.doi.org/10.1001/jama.298.15.1794			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940236				2022-12-28	WOS:000250187300023
J	Garrido, PI				Garrido, Paulo Ivo			Women's health and political will	LANCET			English	Editorial Material									Minist Hlth, Maputo, Mozambique		Garrido, PI (corresponding author), Minist Hlth, Maputo, Mozambique.	pigarrido@misau.gov.mz						*DEP INT DEV, 2007, INT HLTH PARTN LAUNC; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; 2007, PARTNERSHIP MATERNAL; GLOBAL CAMPAIGN HLTH	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2007	370	9595					1288	1289		10.1016/S0140-6736(07)61551-7	http://dx.doi.org/10.1016/S0140-6736(07)61551-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933631				2022-12-28	WOS:000250176600006
J	Hill, K; Thomas, K; AbouZahr, C; Walker, N; Say, L; Inoue, M; Suzuki, E				Hill, Kenneth; Thomas, Kevin; AbouZahr, Carla; Walker, Neff; Say, Late; Inoue, Mie; Suzuki, Emi		Maternal Mortality Working G	Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data	LANCET			English	Article							DEATHS	Background Maternal mortality, as a largely avoidable cause of death, is an important focus of international development efforts, and a target for Millennium Development Goal (MDG) 5. However, data weaknesses have made monitoring progress problematic. In 2006, a new maternal mortality working group was established to develop improved estimation methods and make new estimates of maternal mortality for 2005, and to analyse trends in maternal mortality since 1990. Methods We developed and used a range of methods, depending on the type of data available, to produce comparable country, regional, and global estimates of maternal mortality ratios for 2005 and to assess trends between 1990 and 2005. Findings We estimate that there were 535 900 maternal deaths in 2005, corresponding to a maternal mortality ratio of 402 (uncertainty bounds 216-654) deaths per 100 000 livebirths. Most maternal deaths in 2005 were concentrated in sub-Saharan Africa (270 500, 50%) and Asia (240 600, 45%). For all countries with data, there was a decrease of 2.5% per year in the maternal mortality ratio between 1990 and 2005 (p<0.0001); however, there was no evidence of a significant reduction in maternal mortality ratios in sub-Saharan Africa in the same period. Interpretation Although some regions have shown some progress since 1990 in reducing maternal deaths, maternal mortality ratios in sub-Saharan Africa have remained very high, with little evidence of improvement in the past 15 years. To achieve MDG5 targets by 2015 will require sustained and urgent emphasis on improved pregnancy and delivery care throughout the developing world.	Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; Penn State Univ, State Coll, PA USA; Hlth Metr Network, Geneva, Switzerland; Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD USA; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; WHO, Dept Measurement & Hlth Informat, CH-1211 Geneva, Switzerland; World Bank, Washington, DC 20433 USA	Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; World Health Organization; The World Bank	Hill, K (corresponding author), Harvard Ctr Populat & Dev Studies, 9 Bow St, Cambridge, MA 02138 USA.	kenneth_hill@harvard.edu	, lalesay/AAG-1912-2021					[Anonymous], 2002, WORLD MORTALITY 2000; [Anonymous], [No title captured]; ATRASH HK, 1995, OBSTET GYNECOL, V86, P700, DOI 10.1016/0029-7844(95)00200-B; Bouvier-Colle M-H, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P421, DOI 10.1016/S0368-2315(04)96550-7; BOUVIERCOLLE MH, 1991, INT J EPIDEMIOL, V20, P717, DOI 10.1093/ije/20.3.717; *CDCP, 1991, MMWR-MORBID MORTAL W, V40, P469; *CDCP, 1991, MMWR MORBID MORTAL W, V40, P521; *CDCP, 1991, NAT PREGN MORT SURV; Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; *DEP HLTH, 2004, WHY MOTHERS DIE 2000; Gakidou E, 2004, INT J EPIDEMIOL, V33, P710, DOI 10.1093/ije/dyh099; Gissler M, 1997, ACTA OBSTET GYN SCAN, V76, P651, DOI 10.3109/00016349709024605; Health Canada, 2004, SPEC REP MAT MORT SE; Karimian-Teherani D, 2002, ACTA OBSTET GYN SCAN, V81, P323; LEWIS G, 2001, 5 CONF RENQ MAT DEAT; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Schuitemaker N, 1997, OBSTET GYNECOL, V90, P78, DOI 10.1016/S0029-7844(97)00128-2; SHAHIDULLAH M, 1995, STUD FAMILY PLANN, V26, P101, DOI 10.2307/2137935; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; STANTON C, 1997, 4 DHS MACR INT INC; STECKLOV G, 1995, STUD FAMILY PLANN, V26, P33, DOI 10.2307/2138049; Sullivan EA, 2006, MATERNAL DEATHS AUST; Turner Linda A, 2002, Chronic Dis Can, V23, P22; *UN, 2000, 55 SESS UN GEN ASS N; WHO/UNICEF, 1997, SIST METH EST MAT MO; *WHO UNICEF UNFPA, 2004, MAT MORT 2000 EST DE; *WHO UNICEF UNFPA, 2001, MAT MORT 1995 EST DE; *WORLD BANK, 2005, WORLD DEV IND 2005; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; World Health Organization (WHO), 2009, LIF TABL WHO MEMB ST	31	326	337	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1311	1319		10.1016/S0140-6736(07)61572-4	http://dx.doi.org/10.1016/S0140-6736(07)61572-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220SC	17933645				2022-12-28	WOS:000250176600024
J	Lindor, K				Lindor, Keith			Ursodeoxycholic acid for the treatment of primary biliary cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIALS; CHOLESTATIC LIVER-DISEASE; DOUBLE-BLIND; BIOCHEMICAL RESPONSE; SERUM-LIPIDS; MULTICENTER; COLCHICINE; THERAPY; EPIDEMIOLOGY		Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Fiterman Ctr Digest Dis, Rochester, MN 55905 USA	Mayo Clinic	Lindor, K (corresponding author), Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Fiterman Ctr Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.	lindor.keith@mayo.edu						Almasio PL, 2000, ALIMENT PHARM THERAP, V14, P1645, DOI 10.1046/j.1365-2036.2000.00869.x; Angulo P, 1999, J HEPATOL, V30, P830, DOI 10.1016/S0168-8278(99)80136-6; Angulo P, 2001, AM J GASTROENTEROL, V96, P3152; Angulo P, 1999, LIVER, V19, P115, DOI 10.1111/j.1478-3231.1999.tb00020.x; BACH N, 1994, J HEPATOL, V20, P698, DOI 10.1016/S0168-8278(05)80137-0; BALAN V, 1994, MAYO CLIN PROC, V69, P923, DOI 10.1016/S0025-6196(12)61815-1; Battezzati PM, 2001, ALIMENT PHARM THERAP, V15, P1427, DOI 10.1046/j.1365-2036.2001.01018.x; BEUERS U, 1992, HEPATOLOGY, V15, P603, DOI 10.1002/hep.1840150409; CALMUS Y, 1992, GASTROENTEROLOGY, V102, P1371; CHRISTENSEN E, 1985, GASTROENTEROLOGY, V89, P1084, DOI 10.1016/0016-5085(85)90213-6; COMBES B, 1995, HEPATOLOGY, V22, P759, DOI 10.1016/0270-9139(95)90294-5; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; DICKSON ER, 1985, NEW ENGL J MED, V312, P1011, DOI 10.1056/NEJM198504183121602; GERSHWIN ME, 1988, HEPATOLOGY, V8, P147, DOI 10.1002/hep.1840080128; GONG Y, 2005, COCHRANE DB SYST REV, V3; Gong Y, 2007, AM J GASTROENTEROL, V102, P1799, DOI 10.1111/j.1572-0241.2007.01235.x; He XS, 2006, CELL IMMUNOL, V239, P1, DOI 10.1016/j.cellimm.2006.04.006; Heathcote EJ, 1999, LIVER TRANSPLANT SUR, V5, P269, DOI 10.1002/lt.500050419; HEATHCOTE EJ, 1994, HEPATOLOGY, V19, P1149, DOI 10.1002/hep.1840190512; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Irie J, 2006, J EXP MED, V203, P1209, DOI 10.1084/jem.20051911; Jones DEJ, 2003, J HEPATOL, V39, P639, DOI 10.1016/S0168-8278(03)00270-8; Jones DEJ, 1999, J HEPATOL, V30, P402, DOI 10.1016/S0168-8278(99)80097-X; JORGENSEN RA, 1995, GUT, V36, P935, DOI 10.1136/gut.36.6.935; Kaplan MM, 2006, NEW ENGL J MED, V354, P313; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kaplan MM, 2004, HEPATOLOGY, V39, P915, DOI 10.1002/hep.20103; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Koarada S, 2004, J IMMUNOL, V173, P2315, DOI 10.4049/jimmunol.173.4.2315; KRAMS SM, 1989, HEPATOLOGY, V9, P411, DOI 10.1002/hep.1840090311; Lazaridis KN, 2001, J HEPATOL, V35, P134, DOI 10.1016/S0168-8278(01)00092-7; Lazaridis KN, 2007, J CLIN GASTROENTEROL, V41, P494, DOI 10.1097/01.mcg.0000225653.07932.8f; Leuschner Ulrich, 2003, Clin Liver Dis, V7, P741, DOI 10.1016/S1089-3261(03)00101-6; Levy Cynthia, 2003, Clin Liver Dis, V7, P901, DOI 10.1016/S1089-3261(03)00097-7; Lindor KD, 1996, GASTROENTEROLOGY, V110, P1515, DOI 10.1053/gast.1996.v110.pm8613058; LINDOR KD, 1994, GASTROENTEROLOGY, V106, P1284, DOI 10.1016/0016-5085(94)90021-3; LOMBARD M, 1993, GASTROENTEROLOGY, V104, P519, DOI 10.1016/0016-5085(93)90422-9; Longo M, 2002, GUT, V51, P265, DOI 10.1136/gut.51.2.265; MITCHISON HC, 1986, HEPATOLOGY, V6, P1279, DOI 10.1002/hep.1840060609; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Pares A, 2000, J HEPATOL, V32, P561, DOI 10.1016/S0168-8278(00)80216-0; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; Ritzel U, 2002, J HEPATOL, V36, P454, DOI 10.1016/S0168-8278(02)00006-5; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; Shi J, 2006, AM J GASTROENTEROL, V101, P1529, DOI 10.1111/j.1572-0241.2006.00634.x; Siegel JL, 2003, J CLIN GASTROENTEROL, V37, P183, DOI 10.1097/00004836-200308000-00018; Silveira MG, 2007, AM J GASTROENTEROL, V102, P1244, DOI 10.1111/j.1572-0241.2007.01136.x; Talwalkar JA, 2003, LANCET, V362, P53, DOI 10.1016/S0140-6736(03)13808-1; ter Borg PCJ, 2006, AM J GASTROENTEROL, V101, P2044, DOI 10.1111/j.1572-0241.2006.00699.x; Ueno Y, 2007, J GASTROENTEROL, V42, P189, DOI 10.1007/s00535-007-2019-y; Williams CN, 2000, ALIMENT PHARM THER, V14, P1133; Xu LZ, 2003, P NATL ACAD SCI USA, V100, P8454, DOI 10.1073/pnas.1433063100; YOSHIKAWA M, 1992, HEPATOLOGY, V16, P358, DOI 10.1002/hep.1840160213; Zein CO, 2005, HEPATOLOGY, V42, P762, DOI 10.1002/hep.20866	58	73	89	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1524	1529		10.1056/NEJMct074694	http://dx.doi.org/10.1056/NEJMct074694			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928600				2022-12-28	WOS:000250037000009
J	Rabb, H; Colvin, RB; Arnaout, MA; Steinman, TI; Haupert, HD; Haupert, GT; Niles, JL				Rabb, Hamid; Colvin, Robert B.; Arnaout, M. Amin; Steinman, Theodore I.; Haupert, Harris Dr.; Haupert, Garner T.; Niles, John L.			A 41-year-old man with abdominal pain and elevated serum creatinine - Acute tubular injury (acute tubular necrosis) and glomerular podocyte injury, both caused by NSAIDs in association with dehydration.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KIDNEY INJURY; BIOMARKER		Johns Hopkins Univ Hosp, Div Nephrol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rabb, H (corresponding author), Johns Hopkins Univ Hosp, Div Nephrol, Baltimore, MD 21287 USA.							BOHLE A, 1976, KIDNEY INT, V10, pS9; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Cheng HF, 2005, CURR PHARM DESIGN, V11, P1795, DOI 10.2174/1381612053764922; Chien CC, 2004, CONTRIB NEPHROL, V144, P53; Clarkson MR, 2007, BRENNER RECTORS KIDN, P943; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; DUFLOT J, 1993, AM J KIDNEY DIS, V22, P607, DOI 10.1016/S0272-6386(12)80938-3; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FRIEDEWALD J, 2006, CONNS CURRENT THERAP, P876; Glassock RJ, 2003, NEPHROL DIAL TRANSPL, V18, P52, DOI 10.1093/ndt/gfg1060; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Johnson RJ, 2003, COMPREHENSIVE CLIN N; MASSRY SG, 2001, TXB NEPHROLOGY; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; MOLITORIS BA, 2001, ACUTE RENAL FAILURE; Molls RR, 2006, AM J PHYSIOL-RENAL, V290, pF1187, DOI 10.1152/ajprenal.00342.2005; Morgan MD, 2006, J AM SOC NEPHROL, V17, P1224, DOI 10.1681/ASN.2005080882; Muranyi W, 2005, J AM SOC NEPHROL, V16, P3669, DOI 10.1681/ASN.2005050561; ROSE BD, 2007, UPTODATE; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Seo P, 2004, AM J MED, V117, P39, DOI 10.1016/j.amjmed.2004.02.030; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; WARREN GV, 1989, AM J KIDNEY DIS, V13, P127, DOI 10.1016/S0272-6386(89)80130-1	24	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1531	1541		10.1056/NEJMcpc079024	http://dx.doi.org/10.1056/NEJMcpc079024			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928602				2022-12-28	WOS:000250037000013
J	Candille, SI; Kaelin, CB; Cattanach, BM; Yu, B; Thompson, DA; Nix, MA; Kerns, JA; Schmutz, SM; Millhauser, GL; Barsh, GS				Candille, Sophie I.; Kaelin, Christopher B.; Cattanach, Bruce M.; Bin Yu; Thompson, Darren A.; Nix, Matthew A.; Kerns, Julie A.; Schmutz, Sheila M.; Millhauser, Glenn L.; Barsh, Gregory S.			A beta-defensin mutation causes black coat color in domestic dogs	SCIENCE			English	Article							AGOUTI GENE; DENDRITIC CELLS; MOUSE MODEL; PROOPIOMELANOCORTIN; MELANOCORTIN; MICE; PIGMENTATION; EXPRESSION; PEPTIDES; PROTEIN	Genetic analysis of mammalian color variation has provided fundamental insight into human biology and disease. In most vertebrates, two key genes, Agouti and Melanocortin 1 receptor (Mc1r), encode a ligand-receptor system that controls pigment type-switching, but in domestic dogs, a third gene is implicated, the K locus, whose genetic characteristics predict a previously unrecognized component of the melanocortin pathway. We identify the K locus as beta-defensin 103 (CBD103) and show that its protein product binds with high affinity to the Mc1r and has a simple and strong effect on pigment type-switching in domestic dogs and transgenic mice. These results expand the functional role of beta-defensins, a protein family previously implicated in innate immunity, and identify an additional class of ligands for signaling through melanocortin receptors.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; MRC, Mammalian Genet Unit, Harwell OX11 ORD, Oxon, England; Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Biochem, Santa Cruz, CA 95064 USA; Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 5A8, Canada	Stanford University; Stanford University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Saskatchewan	Barsh, GS (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu		Thompson, Darren/0000-0002-3725-7112	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064265] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK064265, R01 DK064265-08] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barsh GS, 2006, PIGMENTARY SYSTEM, P395, DOI DOI 10.1002/9780470987100.CH19; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chen HQ, 2006, PEPTIDES, V27, P931, DOI 10.1016/j.peptides.2005.08.018; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Klungland H, 2003, ANN NY ACAD SCI, V994, P331, DOI 10.1111/j.1749-6632.2003.tb03197.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Little C., 1957, INHERITANCE COAT COL; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; SAMPSON J, 2005, DOG ITS GENOME, P19; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Smart JL, 2003, ANN NY ACAD SCI, V994, P202, DOI 10.1111/j.1749-6632.2003.tb03181.x; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Wright S, 1917, J HERED, V8, P224, DOI 10.1093/oxfordjournals.jhered.a111784; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	36	255	276	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1418	1423		10.1126/science.1147880	http://dx.doi.org/10.1126/science.1147880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	17947548	Green Accepted			2022-12-28	WOS:000251246100037
J	Nowack, KC; Koppens, FHL; Nazarov, YV; Vandersypen, LMK				Nowack, K. C.; Koppens, F. H. L.; Nazarov, Yu. V.; Vandersypen, L. M. K.			Coherent control of a single electron spin with electric fields	SCIENCE			English	Article							MANIPULATION	Manipulation of single spins is essential for spin-based quantum information processing. Electrical control instead of magnetic control is particularly appealing for this purpose, because electric fields are easy to generate locally on-chip. We experimentally realized coherent control of a single-electron spin in a quantum dot using an oscillating electric field generated by a local gate. The electric field induced coherent transitions (Rabi oscillations) between spin-up and spin-down with 90 rotations as fast as similar to 55 nanoseconds. Our analysis indicated that the electrically induced spin transitions were mediated by the spin-orbit interaction. Taken together with the recently demonstrated coherent exchange of two neighboring spins, our results establish the feasibility of fully electrical manipulation of spin qubits.	Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands	Delft University of Technology	Nowack, KC (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	k.c.nowack@tudelft.nl; l.m.k.vandersypen@tudelft.nl	Koppens, Frank/X-4422-2018; Nazarov, Yuli V/F-6511-2011	Koppens, Frank/0000-0001-9764-6120; 				Awschalom DD, 2002, NANOSCI TECHNOL, P147; Baugh J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.096804; Debald S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.226803; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Erlingsson SI, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155327; Golovach VN, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165319; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Kato Y, 2004, NATURE, V427, P50, DOI 10.1038/nature02202; Kato Y, 2003, SCIENCE, V299, P1201, DOI 10.1126/science.1080880; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Khaetskii AV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125316; Klauser D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205302; Koppens FHL, 2007, J APPL PHYS, V101, DOI 10.1063/1.2722734; Koppens FHL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106803; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; LAIRD EA, 2007, CONDENS MATTER; Levitov LS, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115324; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Poole C., 1983, ELECT SPIN RESONANCE, V2nd; Rudner MS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.036602; Salis G, 2001, NATURE, V414, P619, DOI 10.1038/414619a; Schulte M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137601; Simovic B, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2206776; Tokura Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047202; WALLS J, 2007, CONDENS MATTER	30	776	786	7	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1430	1433		10.1126/science.1148092	http://dx.doi.org/10.1126/science.1148092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	17975030	Green Submitted			2022-12-28	WOS:000251246100039
J	Batterham, RL; ffytche, DH; Rosenthal, JM; Zelaya, FO; Barker, GJ; Withers, DJ; Williams, SCR				Batterham, Rachel L.; ffytche, Dominic H.; Rosenthal, J. Miranda; Zelaya, Fernando O.; Barker, Gareth J.; Withers, Dominic J.; Williams, Steven C. R.			PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans	NATURE			English	Article							HUMAN ORBITOFRONTAL CORTEX; FOOD-INTAKE; PEPTIDE-YY; ACUTE HYPOGLYCEMIA; OBESE SUBJECTS; APPETITE; ACTIVATION; SATIATION; CHOCOLATE; REWARD	The ability to maintain adequate nutrient intake is critical for survival. Complex interrelated neuronal circuits have developed in the mammalian brain to regulate many aspects of feeding behaviour, from food-seeking to meal termination. The hypothalamus and brainstem are thought to be the principal homeostatic brain areas responsible for regulating body weight(1,2). However, in the current 'obesogenic' human environment food intake is largely determined by non-homeostatic factors including cognition, emotion and reward, which are primarily processed in corticolimbic and higher cortical brain regions(3). Although the pleasure of eating is modulated by satiety and food deprivation increases the reward value of food, there is currently no adequate neurobiological account of this interaction between homeostatic and higher centres in the regulation of food intake in humans(1,4,5). Here we show, using functional magnetic resonance imaging, that peptide YY3-36 (PYY), a physiological gut-derived satiety signal, modulates neural activity within both corticolimbic and higher-cortical areas as well as homeostatic brain regions. Under conditions of high plasma PYY concentrations, mimicking the fed state, changes in neural activity within the caudolateral orbital frontal cortex predict feeding behaviour independently of meal-related sensory experiences. In contrast, in conditions of low levels of PYY, hypothalamic activation predicts food intake. Thus, the presence of a postprandial satiety factor switches food intake regulation from a homeostatic to a hedonic, corticolimbic area. Our studies give insights into the neural networks in humans that respond to a specific satiety signal to regulate food intake. An increased understanding of how such homeostatic and higher brain functions are integrated may pave the way for the development of new treatment strategies for obesity.	UCL, Dept Med, Ctr Diabet & Endocrinol, London WC1E 6JJ, England; Kings Coll London, Ctr Neuroimaging Sci, Inst Psychiat, London SE5 8AF, England	University of London; University College London; University of London; King's College London	Batterham, RL (corresponding author), UCL, Dept Med, Ctr Diabet & Endocrinol, London WC1E 6JJ, England.	r.batterham@ucl.ac.uk	Barker, Gareth J/C-9616-2009; Williams, Steve C/D-6979-2011; Withers, Dominic J/D-7671-2014; Zelaya, Fernando O/I-3125-2012; ffytche, Dominic/ABD-8214-2021	Barker, Gareth J/0000-0002-5214-7421; Williams, Steve C/0000-0003-4299-1941; Withers, Dominic J/0000-0002-8009-7521; Zelaya, Fernando O/0000-0002-9525-1560; Batterham, Rachel/0000-0002-5477-8585; ffytche, Dominic/0000-0002-4214-9642; opoku, anita/0000-0001-7243-8157	MRC [G108/551] Funding Source: UKRI; Medical Research Council [G108/551] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; Berthoud HR, 2004, APPETITE, V43, P315, DOI 10.1016/j.appet.2004.04.009; Chan JL, 2006, DIABETOLOGIA, V49, P169, DOI 10.1007/s00125-005-0041-2; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; DelParigi A, 2004, INT J OBESITY, V28, P370, DOI 10.1038/sj.ijo.0802558; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Hinton EC, 2004, EUR J NEUROSCI, V20, P1411, DOI 10.1111/j.1460-9568.2004.03589.x; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, NEUROSCIENCE, V126, P807, DOI 10.1016/j.neuroscience.2004.04.035; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Liu YJ, 2000, NATURE, V405, P1058, DOI 10.1038/35016590; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rosenthal JM, 2001, DIABETES, V50, P1618, DOI 10.2337/diabetes.50.7.1618; Rosenthal MJ, 2007, DIABETIC MED, V24, P720, DOI 10.1111/j.1464-5491.2007.02131.x; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; Talairach J., 1988, COPLANAR STEREOTAXIC; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Whitwell JL, 2007, NEUROIMAGE, V35, P207, DOI 10.1016/j.neuroimage.2006.12.006; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992	38	319	327	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					106	+		10.1038/nature06212	http://dx.doi.org/10.1038/nature06212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17934448				2022-12-28	WOS:000250585800046
J	Edwards, AM; Phillips, RA; Watkins, NW; Freeman, MP; Murphy, EJ; Afanasyev, V; Buldyrev, SV; da Luz, MGE; Raposo, EP; Stanley, HE; Viswanathan, GM				Edwards, Andrew M.; Phillips, Richard A.; Watkins, Nicholas W.; Freeman, Mervyn P.; Murphy, Eugene J.; Afanasyev, Vsevolod; Buldyrev, Sergey V.; da Luz, M. G. E.; Raposo, E. P.; Stanley, H. Eugene; Viswanathan, Gandhimohan M.			Revisiting Levy flight search patterns of wandering albatrosses, bumblebees and deer	NATURE			English	Article							ANOMALOUS DIFFUSION; MOVEMENT; BEHAVIOR; SUCCESS; WALKS	The study of animal foraging behaviour is of practical ecological importance(1), and exemplifies the wider scientific problem of optimizing search strategies(2). Levy flights are random walks, the step lengths of which come from probability distributions with heavy power-law tails(3,4), such that clusters of short steps are connected by rare long steps. Levy flights display fractal properties, have no typical scale, and occur in physical(3-5) and chemical(6) systems. An attempt to demonstrate their existence in a natural biological system presented evidence that wandering albatrosses perform Levy flights when searching for prey on the ocean surface(7). This well known finding(2,4,8,9) was followed by similar inferences about the search strategies of deer(10) and bumblebees(10). These pioneering studies have triggered much theoretical work in physics (for example, refs 11, 12), as well as empirical ecological analyses regarding reindeer(13), microzooplankton(14), grey seals(15), spider monkeys(16) and fishing boats(17). Here we analyse a new, high-resolution data set of wandering albatross flights, and find no evidence for Levy flight behaviour. Instead we find that flight times are gamma distributed, with an exponential decay for the longest flights. We re-analyse the original albatross data(7) using additional information, and conclude that the extremely long flights, essential for demonstrating Levy flight behaviour, were spurious. Furthermore, we propose a widely applicable method to test for power-law distributions using likelihood(18) and Akaike weights(19,20). We apply this to the four original deer and bumblebee data sets(10), finding that none exhibits evidence of Levy flights, and that the original graphical approach(10) is insufficient. Such a graphical approach has been adopted to conclude Levy flight movement for other organisms(13-17), and to propose Levy flight analysis as a potential real-time ecosystem monitoring tool(17). Our results question the strength of the empirical evidence for biological Levy flights.	British Antarctic Survey, Cambridge CB3 0ET, England; Boston Univ, Dept Phys, Boston, MA 02215 USA; Yeshiva Univ, Dept Phys, New York, NY 10033 USA; Univ Fed Parana, Dept Fis, BR-81531990 Curitiba, Parana, Brazil; Univ Fed Pernambuco, Dept Fis, Lab Fis Teor & Computac, BR-50670901 Recife, PE, Brazil; Univ Fed Alagoas, Inst Fis, BR-57072970 Maceio, AL, Brazil	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Boston University; Yeshiva University; Universidade Federal do Parana; Universidade Federal de Pernambuco; Universidade Federal de Alagoas	Edwards, AM (corresponding author), British Antarctic Survey, High Cross, Cambridge CB3 0ET, England.	EdwardsAnd@pac.dfo-mpo.gc.ca	Watkins, Nick/GPX-7439-2022; murphy, eugene/GZL-1620-2022; Viswanathan, Gandhimohan M/J-8558-2012; Raposo, Ernesto P./ABA-7215-2020; Watkins, Nicholas Wynn/C-5140-2008; Raposo, Ernesto P/N-2786-2017; Freeman, Mervyn/E-5687-2019; da luz, marcos g e gomes eleuterio/H-7835-2012; Buldyrev, Sergey V/I-3933-2015; edwards, andrew m/E-6900-2010; Viswanathan, Gandhimohan/AAF-3937-2020	Watkins, Nick/0000-0003-4484-6588; Viswanathan, Gandhimohan M/0000-0002-2301-5593; Raposo, Ernesto P./0000-0002-4178-8266; Watkins, Nicholas Wynn/0000-0003-4484-6588; Raposo, Ernesto P/0000-0002-3595-4352; Freeman, Mervyn/0000-0002-8653-8279; da luz, marcos g e gomes eleuterio/0000-0003-3865-2621; Stanley, H./0000-0003-2800-4495; Buldyrev, Sergey/0000-0002-3008-1070	Natural Environment Research Council [bas010021] Funding Source: researchfish; NERC [bas010021] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AFANASYEV V, 1993, NERC TECH, V1, P4; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; BARDOU F, 2002, LEVY STATISTICS LASE; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; ben Avraham D., 2000, DIFFUSION REACTIONS; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Focardi S, 1996, J ANIM ECOL, V65, P606, DOI 10.2307/5740; HEINRICH B, 1979, OECOLOGIA, V40, P235, DOI 10.1007/BF00345321; Hilborn R., 1997, MONOGRAPHS POPULATIO, V28; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Klafter J, 2005, PHYS WORLD, V18, P29; Marell A, 2002, CAN J ZOOL, V80, P854, DOI 10.1139/Z02-061; Metzler R, 2004, J PHYS A-MATH GEN, V37, pR161, DOI 10.1088/0305-4470/37/31/R01; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; OTT A, 1990, PHYS REV LETT, V65, P2201, DOI 10.1103/PhysRevLett.65.2201; Pueyo S, 2006, OIKOS, V112, P392, DOI 10.1111/j.0030-1299.2006.14188.x; Pueyo S, 2006, SCIENCE, V313, DOI 10.1126/science.1129595; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041928; Shlesinger M., 1995, LEVY FLIGHTS RELATED, Ved, DOI [10.1007/3-540-59222-9, DOI 10.1007/3-540-59222-9]; Shlesinger M. F., 1986, On Growth and Form - Fractal and Non-Fractal Patterns in Physics. Proceedings of the NATO Advanced Study Institute, P279; Shlesinger MF, 2006, NATURE, V443, P281, DOI 10.1038/443281a; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sokal R.R., 2012, BIOMETRY; Turchin Peter, 1998; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866	30	628	635	6	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1044	U5		10.1038/nature06199	http://dx.doi.org/10.1038/nature06199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960243	Green Accepted			2022-12-28	WOS:000250395000051
J	Ruchaud, S; Carmena, M; Earnshaw, WC				Ruchaud, Sandrine; Carmena, Mar; Earnshaw, William C.			The chromosomal passenger complex: One for all and all for one	CELL			English	Editorial Material							AURORA-B; SURVIVIN; INCENP; CENTROMERE; REGULATOR; MITOSIS; MIDBODY; SPINDLE	The chromosomal passenger complex - composed of Aurora B kinase and its regulatory subunits INCENP, Survivin, and Borealin - modulates multiple events during mitosis. In this issue, Jeyaprakash al. (2007) report the crystal structure of the regulatory subunit complex and reveal how interactions between these proteins promote the targeting and function of the chromosomal passenger complex during mitosis.	Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Earnshaw, WC (corresponding author), Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	bill.earnshaw@ed.ac.uk	Earnshaw, William/AAY-7438-2020; Ruchaud, Sandrine/AAJ-2179-2021	Earnshaw, William/0000-0002-7191-0621	Wellcome Trust [073915] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; JEYAPRAKASH AA, 2007, CELL; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562	10	74	78	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					230	231		10.1016/j.cell.2007.10.002	http://dx.doi.org/10.1016/j.cell.2007.10.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956723	Bronze			2022-12-28	WOS:000250507700012
J	Frazer, KA; Ballinger, DG; Cox, DR; Hinds, DA; Stuve, LL; Gibbs, RA; Belmont, JW; Boudreau, A; Hardenbol, P; Leal, SM; Pasternak, S; Wheeler, DA; Willis, TD; Yu, FL; Yang, HM; Zeng, CQ; Gao, Y; Hu, HR; Hu, WT; Li, CH; Lin, W; Liu, SQ; Pan, H; Tang, XL; Wang, J; Wang, W; Yu, J; Zhang, B; Zhang, QR; Zhao, HB; Zhao, H; Zhou, J; Gabriel, SB; Barry, R; Blumenstiel, B; Camargo, A; Defelice, M; Faggart, M; Goyette, M; Gupta, S; Moore, J; Nguyen, H; Onofrio, RC; Parkin, M; Roy, J; Stahl, E; Winchester, E; Ziaugra, L; Altshuler, D; Shen, Y; Yao, ZJ; Huang, W; Chu, X; He, YG; Jin, L; Liu, YF; Shen, YY; Sun, WW; Wang, HF; Wang, Y; Wang, Y; Xiong, XY; Xu, L; Waye, MMY; Tsui, SKW; Wong, JTF; Galver, LM; Fan, JB; Gunderson, K; Murray, SS; Oliphant, AR; Chee, MS; Montpetit, A; Chagnon, F; Ferretti, V; Leboeuf, M; Olivier, JF; Phillips, MS; Roumy, S; Sallee, C; Verner, A; Hudson, TJ; Kwok, PY; Cai, DM; Koboldt, DC; Miller, RD; Pawlikowska, L; Taillon-Miller, P; Xiao, M; Tsui, LC; Mak, W; Song, YQ; Tam, PKH; Nakamura, Y; Kawaguchi, T; Kitamoto, T; Morizono, T; Nagashima, A; Ohnishi, Y; Sekine, A; Tanaka, T; Tsunoda, T; Deloukas, P; Bird, CP; Delgado, M; Dermitzakis, ET; Gwilliam, R; Hunt, S; Morrison, J; Powell, D; Stranger, BE; Whittaker, P; Bentley, DR; Daly, MJ; de Bakker, PIW; Barrett, J; Chretien, YR; Maller, J; McCarroll, S; Patterson, N; Pe'er, I; Price, A; Purcell, S; Richter, DJ; Sabeti, P; Saxena, R; Schaffner, SF; Sham, PC; Varilly, P; Altshuler, D; Stein, LD; Krishnan, L; Smith, AV; Tello-Ruiz, MK; Thorisson, GA; Chakravarti, A; Chen, PE; Cutler, DJ; Kashuk, CS; Lin, S; Abecasis, GR; Guan, WH; Li, Y; Munro, HM; Qin, ZHS; Thomas, DJ; McVean, G; Auton, A; Bottolo, L; Cardin, N; Eyheramendy, S; Freeman, C; Marchini, J; Myers, S; Spencer, C; Stephens, M; Donnelly, P; Cardon, LR; Clarke, G; Evans, DM; Morris, AP; Weir, BS; Tsunoda, T; Johnson, TA; Mullikin, JC; Sherry, ST; Feolo, M; Skol, A				Frazer, Kelly A.; Ballinger, Dennis G.; Cox, David R.; Hinds, David A.; Stuve, Laura L.; Gibbs, Richard A.; Belmont, John W.; Boudreau, Andrew; Hardenbol, Paul; Leal, Suzanne M.; Pasternak, Shiran; Wheeler, David A.; Willis, Thomas D.; Yu, Fuli; Yang, Huanming; Zeng, Changqing; Gao, Yang; Hu, Haoran; Hu, Weitao; Li, Chaohua; Lin, Wei; Liu, Siqi; Pan, Hao; Tang, Xiaoli; Wang, Jian; Wang, Wei; Yu, Jun; Zhang, Bo; Zhang, Qingrun; Zhao, Hongbin; Zhao, Hui; Zhou, Jun; Gabriel, Stacey B.; Barry, Rachel; Blumenstiel, Brendan; Camargo, Amy; Defelice, Matthew; Faggart, Maura; Goyette, Mary; Gupta, Supriya; Moore, Jamie; Nguyen, Huy; Onofrio, Robert C.; Parkin, Melissa; Roy, Jessica; Stahl, Erich; Winchester, Ellen; Ziaugra, Liuda; Altshuler, David; Shen, Yan; Yao, Zhijian; Huang, Wei; Chu, Xun; He, Yungang; Jin, Li; Liu, Yangfan; Shen, Yayun; Sun, Weiwei; Wang, Haifeng; Wang, Yi; Wang, Ying; Xiong, Xiaoyan; Xu, Liang; Waye, Mary M. Y.; Tsui, Stephen K. W.; Wong, J. Tze-Fei; Galver, Luana M.; Fan, Jian-Bing; Gunderson, Kevin; Murray, Sarah S.; Oliphant, Arnold R.; Chee, Mark S.; Montpetit, Alexandre; Chagnon, Fanny; Ferretti, Vincent; Leboeuf, Martin; Olivier, Jean-Franccois; Phillips, Michael S.; Roumy, Stephanie; Sallee, Clementine; Verner, Andrei; Hudson, Thomas J.; Kwok, Pui-Yan; Cai, Dongmei; Koboldt, Daniel C.; Miller, Raymond D.; Pawlikowska, Ludmila; Taillon-Miller, Patricia; Xiao, Ming; Tsui, Lap-Chee; Mak, William; Song, You Qiang; Tam, Paul K. H.; Nakamura, Yusuke; Kawaguchi, Takahisa; Kitamoto, Takuya; Morizono, Takashi; Nagashima, Atsushi; Ohnishi, Yozo; Sekine, Akihiro; Tanaka, Toshihiro; Tsunoda, Tatsuhiko; Deloukas, Panos; Bird, Christine P.; Delgado, Marcos; Dermitzakis, Emmanouil T.; Gwilliam, Rhian; Hunt, Sarah; Morrison, Jonathan; Powell, Don; Stranger, Barbara E.; Whittaker, Pamela; Bentley, David R.; Daly, Mark J.; de Bakker, Paul I. W.; Barrett, Jeff; Chretien, Yves R.; Maller, Julian; McCarroll, Steve; Patterson, Nick; Pe'er, Itsik; Price, Alkes; Purcell, Shaun; Richter, Daniel J.; Sabeti, Pardis; Saxena, Richa; Schaffner, Stephen F.; Sham, Pak C.; Varilly, Patrick; Altshuler, David; Stein, Lincoln D.; Krishnan, Lalitha; Smith, Albert Vernon; Tello-Ruiz, Marcela K.; Thorisson, Gudmundur A.; Chakravarti, Aravinda; Chen, Peter E.; Cutler, David J.; Kashuk, Carl S.; Lin, Shin; Abecasis, Goncalo R.; Guan, Weihua; Li, Yun; Munro, Heather M.; Qin, Zhaohui Steve; Thomas, Daryl J.; McVean, Gilean; Auton, Adam; Bottolo, Leonardo; Cardin, Niall; Eyheramendy, Susana; Freeman, Colin; Marchini, Jonathan; Myers, Simon; Spencer, Chris; Stephens, Matthew; Donnelly, Peter; Cardon, Lon R.; Clarke, Geraldine; Evans, David M.; Morris, Andrew P.; Weir, Bruce S.; Tsunoda, Tatsuhiko; Johnson, Todd A.; Mullikin, James C.; Sherry, Stephen T.; Feolo, Michael; Skol, Andrew		Int HapMap Consortium	A second generation human haplotype map of over 3.1 million SNPs	NATURE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; MEIOTIC RECOMBINATION; NATURAL-SELECTION; RECESSIVE TRAITS; TAG SNPS; GENE; HOMOZYGOSITY; SEGMENTS; POLYMORPHISMS	We describe the Phase II HapMap, which characterizes over 3.1 million human single nucleotide polymorphisms (SNPs) genotyped in 270 individuals from four geographically diverse populations and includes 25-35% of common SNP variation in the populations surveyed. The map is estimated to capture untyped common variation with an average maximum r(2) of between 0.9 and 0.96 depending on population. We demonstrate that the current generation of commercial genome-wide genotyping products captures common Phase II SNPs with an average maximum r(2) of up to 0.8 in African and up to 0.95 in non-African populations, and that potential gains in power in association studies can be obtained through imputation. These data also reveal novel aspects of the structure of linkage disequilibrium. We show that 10-30% of pairs of individuals within a population share at least one region of extended genetic identity arising from recent ancestry and that up to 1% of all common variants are untaggable, primarily because they lie within recombination hotspots. We show that recombination rates vary systematically around genes and between genes of different function. Finally, we demonstrate increased differentiation at non-synonymous, compared to synonymous, SNPs, resulting from systematic differences in the strength or efficacy of natural selection between populations.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Scripps Res Inst, La Jolla, CA 92037 USA; Perlegen Sci Inc, Mountain View, CA 94043 USA; Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Affymetrix Inc, Santa Clara, CA 95051 USA; Pacific Biosci, Menlo Pk, CA 94025 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Chinese Acad Sci, Beijing Genom Inst, Beijing 100300, Peoples R China; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Simches Res Ctr, Boston, MA 02114 USA; Chinese Natl Human Genome Ctr, Beijing Econ Technol Dev Area, Beijing 100176, Peoples R China; Chinese Natl Human Genome Ctr, Shanghai 201203, Peoples R China; Fudan Univ, Shanghai 201203, Peoples R China; Chinese Acad Sci, SIBS, Sch Life Sci, MPG Partner Inst Computat Biol, Shanghai 201203, Peoples R China; Chinese Univ Hong Kong, Dept Biochem, Croucher Lab Human Genet, Shatin, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Appl Genom Ctr, Kowloon, Hong Kong, Peoples R China; Illumina, San Diego, CA 92121 USA; Complete Genom Inc, Sunnyvale, CA 94085 USA; Prognosys Biosci Inc, San Diego, CA 92121 USA; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Univ Montreal, Publ Law Res Ctr, Downtown Stn, Montreal, PQ H3C 3J7, Canada; Ontario Inst Canc Res, MaRS Ctr, Toronto, ON M5G 1L7, Canada; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; RIKEN SNP Res Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Dept Oncol, Cambridge CB1 8RN, England; Solexa Ltd, Saffron Walden CB10 1XL, Essex, England; Columbia Univ, New York, NY 10027 USA; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; Int Epidemiol Inst, Rockville, MD 20850 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; NHGRI, US NIH, Bethesda, MD 20892 USA; Natl Lib Med, US NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; Beijing Normal Univ, Beijing 100875, Peoples R China; Hlth Sci Univ Hokkaido, Ishikari, Hokkaido 0610293, Japan; Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 3908621, Japan; UNESCO Bangkok, Bangkok 10110, Thailand; Univ Tsukuba, Eubios Eth Inst, Tsukuba, Ibaraki 3058691, Japan; Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; Univ Ibadan, Coll Med, Ibadan, Oyo State, Nigeria; Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; Univ Utah, Dept Human Genet, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Chinese Acad Social Sci, Inst Philosophy, Ctr Appl Eth, Beijing 100067, Peoples R China; Genet Interest Grp, London N13 0P, England; Kyoto Univ, Inst Res Humanities, Kyoto 6068501, Japan; Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 8528523, Japan; Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; Vanderbilt Univ, Ctr Genet & Hlth Policy, Nashville, TN 37232 USA; Wellcome Trust Res Labs, London NW1 2BE, England; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Chinese Acad Sci, Beijing 100864, Peoples R China; Genome Canada, Ottawa, ON K2P 1P1, Canada; McGill Univ, Off Technol Transfer, Montreal, PQ H3A 2A7, Canada; Genome Quebec, Montreal, PQ H3B 1S6, Canada; Minist Educ Culture Sports Sci & Technol, Chiyoda Ku, Tokyo 1008959, Japan; Minist Sci & Technol, Beijing 100862, Peoples R China; Human Genet Resource Adm China, Beijing 100081, Peoples R China; NHGRI, US NIH, Bethesda, MD 20892 USA; US NIH, Off Behav & Social Sci Res, Bethesda, MD 20892 USA; Novartis Pharmaceut, Biomarker Dev, E Hanover, NJ 07936 USA; US NIH, Off Technol Transfer, Rockville, MD 20852 USA; Univ Maryland, Sch Law, Baltimore, MD 21201 USA; NHGRI, US NIH, Bethesda, MD 20892 USA	University of Oxford; Scripps Research Institute; Baylor College of Medicine; Affymetrix; Cold Spring Harbor Laboratory; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese University of Hong Kong; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Illumina; McGill University; Universite de Montreal; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of California System; University of California San Francisco; Washington University (WUSTL); University of Hong Kong; University of Tokyo; RIKEN; Wellcome Trust Sanger Institute; University of Cambridge; Columbia University; University of Leicester; Johns Hopkins University; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz; University of Chicago; Fred Hutchinson Cancer Center; University of Oxford; Wellcome Centre for Human Genetics; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Chicago; Beijing Normal University; Health Sciences University of Hokkaido; Shinshu University; University of Tsukuba; Howard University; University of Ibadan; Case Western Reserve University; Utah System of Higher Education; University of Utah; Chinese Academy of Social Sciences; Kyoto University; Nagasaki University; University of Oklahoma System; University of Oklahoma - Norman; Vanderbilt University; Washington University (WUSTL); Chinese Academy of Sciences; McGill University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; Novartis; National Institutes of Health (NIH) - USA; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	McVean, G (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	mjdaly@chgr.mgh.harvard.edu; mcvean@stats.ox.ac.uk	Song, You-Qiang/E-5207-2011; de Bakker, Paul IW/B-8730-2009; Wheeler, David A/M-9740-2018; Song, You-qiang/C-4401-2009; Wilson, Richard K./AAF-4139-2019; Schaffner, Stephen F/D-1189-2011; Abecasis, Goncalo R/B-7840-2010; Kwok, Pui-Yan/F-7725-2014; Altshuler, David M/A-4476-2009; Marchini, Jonathan/ABE-9024-2020; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; 郑, 征/C-8514-2011; Saxena, Richa/AAG-7279-2020; Belmont, John W/AAI-2494-2019; Adebamowo, Clement/C-8778-2011; Weir, Bruce S/A-2894-2013; Smith, Albert Vernon/K-5150-2015; Tsui, Stephen Kwok-Wing/E-4385-2015; Johnson, Todd Andrew/ABG-4704-2021; Belmont, John/AAH-6084-2021; Sham, Pak Chung/C-4388-2009; Qin, Zhaohui/Q-3133-2019; Qin, Zhaohui S/E-8196-2011; Dermitzakis, Emmanouil/B-7687-2013; Xiao, Ming/E-7448-2012; Anthropology, MOE KeyLab Fudan/A-9454-2010; Deloukas, Panos/B-2922-2013; Tanaka, Toshihiro/J-9310-2014; Myers, Simon R/A-6792-2015; Tsunoda, Tatsuhiko/K-2061-2014; Evans, David M/H-6325-2013; Ganesh, Dunna Sai/AGX-5170-2022; Johnson, Todd/Q-9944-2019; Daly, Mark J/B-2453-2017; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Thorisson, Gudmundur/E-7359-2010; maller, julian B/A-9323-2009; Weinstock, George M/C-6314-2013; Auton, Adam J/B-1159-2009; Sabeti, Pardis/GQH-8610-2022; Tsui, Lap-chee/A-1081-2010; Varilly, Patrick/C-8118-2013; /C-4405-2009	de Bakker, Paul IW/0000-0001-7735-7858; Wheeler, David A/0000-0002-9056-6299; Wilson, Richard K./0000-0002-1992-1358; Kwok, Pui-Yan/0000-0002-5087-3059; Altshuler, David M/0000-0002-7250-4107; Marchini, Jonathan/0000-0003-0610-8322; Jin, Li/0000-0002-4546-2415; Belmont, John W/0000-0001-7409-3578; Adebamowo, Clement/0000-0002-6571-2880; Smith, Albert Vernon/0000-0003-1942-5845; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Johnson, Todd Andrew/0000-0003-3377-6692; Qin, Zhaohui/0000-0002-1583-146X; Qin, Zhaohui S/0000-0002-1583-146X; Deloukas, Panos/0000-0001-9251-070X; Tanaka, Toshihiro/0000-0001-6201-9784; Myers, Simon R/0000-0002-2585-9626; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Evans, David M/0000-0003-0663-4621; Johnson, Todd/0000-0003-3377-6692; Daly, Mark J/0000-0002-0949-8752; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Thorisson, Gudmundur/0000-0001-5635-1860; Weinstock, George M/0000-0002-2997-4592; Wong, J. Tze-Fei/0000-0001-8539-8537; Richter, Daniel/0000-0002-9238-5571; Saxena, Richa/0000-0003-2233-1065; Song, You-Qiang/0000-0001-9407-2256; Stranger, Barbara/0000-0001-9021-7331; Bottolo, Leonardo/0000-0002-6381-2327; Kato, Kazuto/0000-0001-9006-9551; Macer, Darryl/0000-0001-9335-4235; Hunt, Sarah/0000-0002-8350-1235; He, Yungang/0000-0002-2931-2871; Abecasis, Goncalo/0000-0003-1509-1825; Hudson, Thomas/0000-0002-1376-4849; Phillips, Michael/0000-0003-1040-9080; Wang, Haifeng/0000-0001-5022-0720; Lin, Shin/0000-0003-0118-0413; ajayi, Ikeoluwapo/0000-0001-7719-8746; Kitamoto, Takuya/0000-0002-4008-5497; Donnelly, Peter/0000-0001-9495-3408; Fosker, Christine/0000-0002-3799-9474; Xue, Hong/0000-0002-8133-9828; Varilly, Patrick/0000-0003-4619-8174; Frazer, Kelly/0000-0002-6060-8902; /0000-0001-6231-3035; Chu, Xun/0000-0002-7440-1371; Schaffner, Stephen/0000-0001-6699-3568; Sherry, Stephen/0000-0002-7982-076X; Maller, Julian/0000-0002-1565-9559; Hinds, David/0000-0002-4911-803X; Eyheramendy, Susana/0000-0003-4723-9660; Clayton, Ellen/0000-0002-0308-4110	Wellcome Trust [077011, 077008, 081682, 077046] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Bowcock AM, 2007, NATURE, V447, P645, DOI 10.1038/447645a; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Durham LK, 1997, AM J HUM GENET, V61, P830, DOI 10.1086/514891; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Holloway K, 2006, HUM MOL GENET, V15, P1099, DOI 10.1093/hmg/ddl025; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Lim J, 2006, GENOMICS, V87, P392, DOI 10.1016/j.ygeno.2005.11.002; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McVean G, 2005, PLOS GENET, V1, P413, DOI 10.1371/journal.pgen.0010054; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2006, BIOCHEM SOC T, V34, P526, DOI 10.1042/BST0340526; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Paabo S, 2003, NATURE, V421, P409, DOI 10.1038/nature01400; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Service S, 2007, GENET EPIDEMIOL, V31, P189, DOI 10.1002/gepi.20201; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Smith RA, 1998, BLOOD, V92, P4415, DOI 10.1182/blood.V92.11.4415.423a07_4415_4421; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	57	4157	4305	10	422	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					851	U3		10.1038/nature06258	http://dx.doi.org/10.1038/nature06258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943122	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000250230600036
J	van Doorn, GS; Kirkpatrick, M				van Doorn, G. S.; Kirkpatrick, M.			Turnover of sex chromosomes induced by sexual conflict	NATURE			English	Article							CICHLID FISH; SYMPATRIC SPECIATION; Y-CHROMOSOME; EVOLUTION; SELECTION; GENES; MODEL; MECHANISMS; EXPRESSION; REVERSAL	Sex-determination genes are among the most fluid features of the genome in many groups of animals(1,2). In some taxa the master sex-determining gene moves frequently between chromosomes, whereas in other taxa different genes have been recruited to determine the sex of the zygotes. There is a well developed theory for the origin of stable and highly dimorphic sex chromosomes seen in groups such as the eutherian mammals(3). In contrast, the evolutionary lability of genetic sex determination in other groups remains largely unexplained(1). In this theoretical study, we show that an autosomal gene under sexually antagonistic selection can cause the spread of a new sex-determining gene linked to it. The mechanism can account for the origin of new sex-determining loci, the transposition of an ancestral sex-determining gene to an autosome, and the maintenance of multiple sex-determining factors in species that lack heteromorphic sex chromosomes.	Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA	The Santa Fe Institute; University of Texas System; University of Texas Austin	van Doorn, GS (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	vandoorn@santafe.edu	van Doorn, G. Sander/G-3247-2011	van Doorn, G. Sander/0000-0002-4703-3788				Arnqvist Goran, 2005, pUnpaginated; Bull J.J., 1983, EVOLUTION SEX DETERM; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Ezaz T, 2006, CURR BIOL, V16, pR736, DOI 10.1016/j.cub.2006.08.021; Gnad F, 2006, BIOINFORMATICS, V22, P2577, DOI 10.1093/bioinformatics/btl422; Kallman K.D., 1984, P95; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kozielska M, 2006, J EVOLUTION BIOL, V19, P879, DOI 10.1111/j.1420-9101.2005.01040.x; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Mank JE, 2006, BIOL J LINN SOC, V87, P83, DOI 10.1111/j.1095-8312.2006.00558.x; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Matsuda M, 2005, ANNU REV GENET, V39, P293, DOI 10.1146/annurev.genet.39.110304.095800; Oliver B, 2004, BIOESSAYS, V26, P543, DOI 10.1002/bies.20034; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pomiankowski A, 2004, GENETICS, V166, P1761, DOI 10.1534/genetics.166.4.1761; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1986, EVOLUTION, V40, P633, DOI 10.1111/j.1558-5646.1986.tb00514.x; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Seehausen O, 1999, ECOL LETT, V2, P367; TRAUT W, 1994, GENETICS, V136, P1097; Vuilleumier S, 2007, J EVOLUTION BIOL, V20, P913, DOI 10.1111/j.1420-9101.2007.01311.x; Werren JH, 1998, ANNU REV ECOL SYST, V29, P233, DOI 10.1146/annurev.ecolsys.29.1.233; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	25	249	249	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					909	912		10.1038/nature06178	http://dx.doi.org/10.1038/nature06178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943130				2022-12-28	WOS:000250230600048
J	Winer, EP; Harris, JR; Smith, BL; D'Alessandro, HA; Brachtel, EF; Barbie, DA; Harris, NL				Winer, Eric P.; Harris, Jay R.; Smith, Barbara L.; D'Alessandro, Helen Anne; Brachtel, Elena F.; Barbie, David A.; Harris, Nancy Lee			A 62-year-old woman with a second breast cancer - Invasive ductal carcinoma, and ductal carcinoma in situ, of the right breast, grade 3 of 3, estrogen-receptor-positive and HER2-positive.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIAL COMPARING DOXORUBICIN; ADJUVANT THERAPY; CANCER; TRASTUZUMAB; WOMEN; MAMMOGRAPHY; SURVIVAL; RISK; CYCLOPHOSPHAMIDE; SURVEILLANCE		Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Surg Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Winer, EP (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.							Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; Adjuvant! Online, ADJUVANT ONLINE DECI; Albain K, 2005, BREAST CANC RES TREA, V90, P195; Berry DA, 2000, J CLIN ONCOL, V18, P3471, DOI 10.1200/JCO.2000.18.20.3471; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4 Suppl 1, pS1; CHANG JC, 2004, DIS BREAST, P675; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; Ellis MJ, 2006, J CLIN ONCOL, V24, P3019, DOI 10.1200/JCO.2005.04.3034; HEALEY EA, 1993, J CLIN ONCOL, V11, P1545, DOI 10.1200/JCO.1993.11.8.1545; Hu JCC, 2001, EUR J SURG ONCOL, V27, P335, DOI 10.1053/ejso.2000.1078; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Jones, 2007, J CLIN ONCOL, V25, P1819, DOI 10.1200/JCO.2007.11.9602; Jones SE, 2006, J CLIN ONCOL, V24, P5381, DOI 10.1200/JCO.2006.06.5391; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Partridge A H, 2001, J Natl Cancer Inst Monogr, P135; PARTRIDGE AH, 2003, J NATL CANC I MONOGR, V31, P131; PARTRIDGE AH, 2002, J NATL CANC I MONOGR, V94, P866; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; ROSEN PP, 1989, J CLIN ONCOL, V7, P355, DOI 10.1200/JCO.1989.7.3.355; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; SLAMON D, 2005, 28 ANN SAN ANT BREAS; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091; Wang S, 2000, J CLIN PATHOL, V53, P374, DOI 10.1136/jcp.53.5.374; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	39	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1640	1648		10.1056/NEJMcpc079026	http://dx.doi.org/10.1056/NEJMcpc079026			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942877				2022-12-28	WOS:000250200500011
J	Vandenbroucke, JP; von Elm, E; Altman, DG; Gotzsche, PC; Mulrow, CD; Pocock, SJ; Poole, C; Schlesselman, JJ; Egger, M				Vandenbroucke, Jan P.; von Elm, Erik; Altman, Douglas G.; Gotzsche, Peter C.; Mulrow, Cynthia D.; Pocock, Stuart J.; Poole, Charles; Schlesselman, James J.; Egger, Matthias		STROBE Initiative	Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration	ANNALS OF INTERNAL MEDICINE			English	Article							POPULATION-BASED COHORT; CORONARY-HEART-DISEASE; CONFLICT-OF-INTEREST; MOBILE PHONE USE; RISK-FACTORS; ORAL-CONTRACEPTIVES; SAMPLE-SIZE; STATISTICAL-METHODS; VENOUS THROMBOSIS; REGRESSION-MODELS	Much medical research is observational. The reporting of observational studies is often of insufficient quality. Poor reporting hampers the assessment of the strengths and weaknesses of a study and the generalizability of its results. Taking into account empirical evidence and theoretical considerations, a group of methodologists, researchers, and editors developed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) recommendations to improve the quality of reporting of observational studies. The STROBE Statement consists of a checklist of 22 items, which relate to the title, abstract, introduction, methods, results, and discussion sections of articles. Eighteen items are common to cohort studies, case-control studies, and cross-sectional studies, and 4 are specific to each of the 3 study designs. The STROBE Statement provides guidance to authors about how to improve the reporting of observational studies and facilitates critical appraisal and interpretation of studies by reviewers, journal editors, and readers. This explanatory and elaboration document is intended to enhance the use, understanding, and dissemination of the STROBE Statement. The meaning and rationale for each checklist item are presented. For each item, 1 or several published examples and, where possible, references to relevant empirical studies and methodological literature are provided. Examples of useful flow diagrams are also included. The STROBE Statement, this document, and the associated Web site (www.strobe-statement.org) should be helpful resources to improve reporting of observational research.	Leiden Univ, Med Ctr, Leiden, Netherlands; Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Freiburg, Med Ctr, Freiburg, Germany; Canc Res UK NHS Ctr Stat Med, Oxford, England; Rigshosp, Nord Cochrane Ctr, Copenhagen, Denmark; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; London Sch Hygiene & Trop Med, London, England; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA; Univ Bristol, Bristol, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bern; University of Freiburg; Cancer Research UK; Rigshospitalet; University of Copenhagen; University of Texas System; University of Texas Health San Antonio; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bristol	Egger, M (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	strobe@ispm.unibe.ch	Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716; von Elm, Erik/0000-0002-7412-0406				Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Altman D.G., 2005, ENCY BIOSTATISTICS, P708, DOI DOI 10.1002/0470011815.B2A10012; ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; ALTMAN DG, 1983, BRIT MED J, V286, P1489, DOI 10.1136/bmj.286.6376.1489; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Anderson HR, 2005, EPIDEMIOLOGY, V16, P155, DOI 10.1097/01.ede.0000152528.22746.0f; [Anonymous], 1997, JAMA, V277, P927; Anoop S, 2004, ARCH DIS CHILD, V89, P325, DOI 10.1136/adc.2002.009738; Artama M, 2006, INT J EPIDEMIOL, V35, P280, DOI 10.1093/ije/dyi234; ASPINALL RL, 1995, BRIT MED J, V311, P844, DOI 10.1136/bmj.311.7009.844; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; BECHER H, 1992, STAT MED, V11, P1747, DOI 10.1002/sim.4780111308; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Berglund A, 2000, J CLIN EPIDEMIOL, V53, P1089, DOI 10.1016/S0895-4356(00)00225-0; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brenner H, 1997, EPIDEMIOLOGY, V8, P429, DOI 10.1097/00001648-199707000-00014; CAMBIEN F, 1985, AM J EPIDEMIOL, V122, P434, DOI 10.1093/oxfordjournals.aje.a114124; CAMPBELL DT, 1957, PSYCHOL BULL, V54, P297, DOI 10.1037/h0040950; Canto JG, 2000, NEW ENGL J MED, V342, P1094, DOI 10.1056/NEJM200004133421505; Carlin JB, 2002, J PAEDIATR CHILD H, V38, P300, DOI 10.1046/j.1440-1754.2002.00855.x; CERHAN JR, 1993, ANN INTERN MED, V119, P8, DOI 10.7326/0003-4819-119-1-199307010-00002; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Clayton D., 1993, STAT MODELS EPIDEMIO, P249; CNATTINGIUS S, 1995, CANCER EPIDEM BIOMAR, V4, P441; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; COLE P, 1971, BRIT J PREV SOC MED, V25, P242; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; CORNFIELD J, 1959, J NATL CANCER I, V22, P173; COSTANZA MC, 1995, PREV MED, V24, P425, DOI 10.1006/pmed.1995.1069; COX DR, 1957, J AM STAT ASSOC, V52, P543, DOI 10.2307/2281704; Craig SL, 1999, AM J CLIN ONCOL-CANC, V22, P51, DOI 10.1097/00000421-199902000-00013; Custer B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-152; DALES LG, 1978, INT J EPIDEMIOL, V7, P373, DOI 10.1093/ije/7.4.373; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; Devine OJ, 1998, STAT MED, V17, P1375, DOI 10.1002/(SICI)1097-0258(19980630)17:12<1375::AID-SIM857>3.0.CO;2-D; Docherty M, 1999, BRIT MED J, V318, P1224; Doll R, 2004, BMJ-BRIT MED J, V328, P1529, DOI 10.1136/bmj.328.7455.1529; DOLL R, 2004, BMJ-BRIT MED J, V328, P1533, DOI DOI 10.1136/BMJ.328.7455.1529; DRESCHER K, 1990, STAT MED, V9, P765, DOI 10.1002/sim.4780090706; Dunn NR, 2001, CONTRACEPTION, V63, P65, DOI 10.1016/S0010-7824(01)00172-X; Dunne MP, 1997, INT J EPIDEMIOL, V26, P844, DOI 10.1093/ije/26.4.844; Ebrahim S, 2004, INT J EPIDEMIOL, V33, P1165, DOI 10.1093/ije/dyh368; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Empana JP, 2003, EUR HEART J, V24, P1903, DOI 10.1016/j.ehj.2003.09.002; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; FEINSTEIN AR, 1986, J CHRON DIS, V39, P495, DOI 10.1016/0021-9681(86)90194-3; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Forand Steven P, 2004, Environ Health, V3, P7, DOI 10.1186/1476-069X-3-7; Freeman LEB, 2004, AM J EPIDEMIOL, V160, P679, DOI 10.1093/aje/kwh267; FULLER WA, 1978, J AM STAT ASSOC, V73, P99, DOI 10.2307/2286529; Funai EF, 2001, GYNECOL OBSTET INVES, V51, P8, DOI 10.1159/000052882; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Gefeller O, 1998, EUR J EPIDEMIOL, V14, P321, DOI 10.1023/A:1007497104800; Gissler M, 1996, EUR J OBSTET GYN R B, V69, P73, DOI 10.1016/0301-2115(95)02517-0; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V274, P219, DOI 10.1001/jama.274.3.219; Glasziou P, 2004, BMJ-BRIT MED J, V328, P39, DOI 10.1136/bmj.328.7430.39; Goodman KJ, 2005, INT J EPIDEMIOL, V34, P1348, DOI 10.1093/ije/dyi152; GOTZSCHE PC, 2007, SEARCHING NONRANDOMI; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; GREENBERG RS, 1985, EPIDEMIOL REV, V7, P22, DOI 10.1093/oxfordjournals.epirev.a036284; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P450, DOI 10.1097/00001648-199507000-00025; Greenland S, 2003, J AM STAT ASSOC, V98, P47, DOI 10.1198/01621450338861905; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Greenland S, 1998, MODERN EPIDEMIOLOGY, P401; Greenland S., 1998, MODERN EPIDEMIOLOGY, P343; Greenland S., 1998, MODERN EPIDEMIOLOGY; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Hartley J, 1996, J INFORM SCI, V22, P27, DOI 10.1177/016555159602200103; Hay AD, 2003, FAM PRACT, V20, P696, DOI 10.1093/fampra/cmg613; HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69; Hepworth SJ, 2006, BMJ-BRIT MED J, V332, P883, DOI 10.1136/bmj.38720.687975.55; Hess Dean R, 2004, Respir Care, V49, P1238; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hills M., 1993, STAT MODELS EPIDEMIO, P271; HORTON R, 1995, BRIT MED J, V310, P985, DOI 10.1136/bmj.310.6985.985; Horton R, 2002, JAMA-J AM MED ASSOC, V287, P2775, DOI 10.1001/jama.287.21.2775; HOSMER DW, 1991, AM J PUBLIC HEALTH, V81, P1630, DOI 10.2105/AJPH.81.12.1630; Huss A, 2007, ENVIRON HEALTH PERSP, V115, P1, DOI 10.1289/ehp.9149; Il'yasova D, 2005, CANCER CAUSE CONTROL, V16, P383, DOI 10.1007/s10552-004-5025-x; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Jenicek M, 1999, CLIN CASE REPORTING, P117; JICK H, 1978, AM J EPIDEMIOL, V107, P1; Johannes CB, 1997, AM J EPIDEMIOL, V146, P429, DOI 10.1093/oxfordjournals.aje.a009296; JOHNSON ES, 1990, J OCCUP ENVIRON MED, V32, P250, DOI 10.1097/00043764-199003000-00013; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Kemmeren JM, 2004, BLOOD, V103, P927, DOI 10.1182/blood-2003-04-1285; KengeyaKayondo JF, 1996, INT J EPIDEMIOL, V25, P1077, DOI 10.1093/ije/25.5.1077; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Kushi LH, 1999, AM J EPIDEMIOL, V149, P21, DOI 10.1093/oxfordjournals.aje.a009723; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Langholz B, 2001, BIOELECTROMAGNETICS, pS19, DOI 10.1002/1521-186X(2001)22:5+<::AID-BEM1021>3.0.CO;2-I; Lash TL, 2003, EPIDEMIOLOGY, V14, P451, DOI 10.1097/01.EDE.0000071419.41011.cf; Last J.M., 2000, DICT EPIDEMIOLOGY, Vthird; Lee GM, 2002, EPIDEMIOLOGY, V13, P21, DOI 10.1097/00001648-200201000-00005; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lilienfeld AM, 1976, FDN EPIDEMIOLOGY; Linn S, 2007, ANN EPIDEMIOL, V17, P142, DOI 10.1016/j.annepidem.2006.08.004; Lipsitz SR, 1999, STAT MED, V18, P2435, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2435::AID-SIM267>3.0.CO;2-B; Little RJ, 2002, STAT ANAL MISSING DA, P19; LOHR SL, 1999, DESIGN EFFECTS SAMPL; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Lukanova A, 2006, CANCER EPIDEM BIOMAR, V15, P401, DOI 10.1158/1055-9965.EPI-05-0836; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, P81; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Maldonado G, 1999, ANN EPIDEMIOL, V9, P17; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Martinelli I, 2003, ARCH INTERN MED, V163, P2771, DOI 10.1001/archinte.163.22.2771; Mastrangelo G, 2004, ENVIRON HEALTH PERSP, V112, P1188, DOI 10.1289/ehp.6972; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; McEvoy SP, 2005, BRIT MED J, V331, P428, DOI 10.1136/bmj.38537.397512.55; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Metzkor-Cotter E, 2003, CLIN INFECT DIS, V37, P1149, DOI 10.1086/378738; Miettinen O. S., 1985, THEORETICAL EPIDEMIO, P64; Mihailovic A, 2005, CAN J SURG, V48, P148; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 1998, JAMA-J AM MED ASSOC, V279, P1489, DOI 10.1001/jama.279.18.1489; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Mullner M, 2002, ANN INTERN MED, V136, P122, DOI 10.7326/0003-4819-136-2-200201150-00009; Murphy E.A., 1976, LOGIC MED; Nakayama T, 1998, LANCET, V351, P1179, DOI 10.1016/S0140-6736(05)79123-6; Olsen J, 1999, AM J EPIDEMIOL, V149, P290; Olson SH, 2002, EPIDEMIOLOGY, V13, P123, DOI 10.1097/00001648-200203000-00004; Olson SH, 2001, AM J EPIDEMIOL, V154, P574, DOI 10.1093/aje/154.6.574; Osella AR, 2000, INT J EPIDEMIOL, V29, P922, DOI 10.1093/ije/29.5.922; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Perneger TV, 2004, INT J QUAL HEALTH C, V16, P191, DOI 10.1093/intqhc/mzh053; PHILLIPS AN, 1992, STAT MED, V11, P953, DOI 10.1002/sim.4780110712; PHILLIPS AN, 1991, J CLIN EPIDEMIOL, V44, P1223, DOI 10.1016/0895-4356(91)90155-3; Phillips CV, 2001, INT J EPIDEMIOL, V30, P771, DOI 10.1093/ije/30.4.771; Phillips CV, 2003, EPIDEMIOLOGY, V14, P459, DOI 10.1097/01.ede.0000072106.65262.ae; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Pocock SJ, 2004, BMJ-BRIT MED J, V329, P883, DOI 10.1136/bmj.38250.571088.55; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Poole C, 2003, INT J EPIDEMIOL, V32, P534, DOI 10.1093/ije/dyg197; Purandare N, 2006, BMJ-BRIT MED J, V332, P1119, DOI 10.1136/bmj.38814.696493.AE; Qiu CX, 2004, EPIDEMIOLOGY, V15, P687, DOI 10.1097/01.ede.0000142147.49297.9d; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Rigby AS, 1998, DISABIL REHABIL, V20, P405, DOI 10.3109/09638289809166102; Robins JM, 2001, EPIDEMIOLOGY, V12, P313, DOI 10.1097/00001648-200105000-00011; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Rogler LH, 2001, J NERV MENT DIS, V189, P182, DOI 10.1097/00005053-200103000-00007; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rothman K, 2002, EPIDEMIOLOGY INTRO, V1, P168; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, P44; Rothman K. J., 1998, MODERN EPIDEMIOLOGY, P147; Rothman K. J., 1998, MODERN EPIDEMIOLOGY, P120; Rothman K. J., 1998, MODERN EPIDEMIOLOGY, P74; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Rothman KJ, 1986, MODERN EPIDEMIOLOGY, P311; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P93; Rotnitzky A, 1997, STAT MED, V16, P81, DOI 10.1002/(SICI)1097-0258(19970115)16:1<81::AID-SIM473>3.0.CO;2-0; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Rubin DB, 1987, MULTIPLE IMPUTATION; Rushton L, 2000, OCCUP ENVIRON MED, V57, P1, DOI 10.1136/oem.57.1.1; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002; Sagiv SK, 2007, EPIDEMIOLOGY, V18, P120, DOI 10.1097/01.ede.0000249769.15001.7c; Salo PM, 2006, J ALLERGY CLIN IMMUN, V118, P892, DOI 10.1016/j.jaci.2006.07.037; Sandler DP, 2002, EPIDEMIOLOGY, V13, P117, DOI 10.1097/00001648-200203000-00001; SARACCI R, 1980, AM J EPIDEMIOL, V112, P465, DOI 10.1093/oxfordjournals.aje.a113014; SASIENI P, 1992, STAT MED, V11, P617, DOI 10.1002/sim.4780110506; Scales CD, 2005, J UROLOGY, V174, P1374, DOI 10.1097/01.ju.0000173640.91654.b5; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P235; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5; Schuz J, 1999, INT J EPIDEMIOL, V28, P631, DOI 10.1093/ije/28.4.631; Schuz J, 2003, PAEDIATR PERINAT EP, V17, P106, DOI 10.1046/j.1365-3016.2003.00460.x; Schwartz LM, 2006, BMJ-BRIT MED J, V333, P1248, DOI 10.1136/bmj.38985.564317.7C; Slama R, 2005, REV EPIDEMIOL SANTE, V53, p2S65; Slattery Martha L., 1995, Annals of Epidemiology, V5, P245, DOI 10.1016/1047-2797(94)00113-8; Smeeth L, 2004, LANCET, V364, P963, DOI 10.1016/S0140-6736(04)17020-7; SMITH GD, 1990, J EPIDEMIOL COMMUN H, V44, P257, DOI 10.1136/jech.44.4.257; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sturmer T, 2002, AM J EPIDEMIOL, V155, P593, DOI 10.1093/aje/155.7.593; Szklo M, 2000, EPIDEMIOLOGY BASICS, P408; Szklo M.F., 2000, EPIDEMIOLOGY BASICS, P40; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; Tanis BC, 2001, NEW ENGL J MED, V345, P1787, DOI 10.1056/NEJMoa003216; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Temple R, 1999, JAMA-J AM MED ASSOC, V281, P841, DOI 10.1001/jama.281.9.841; THOMPSON WD, 1994, EPIDEMIOL REV, V16, P33, DOI 10.1093/oxfordjournals.epirev.a036143; TIBSHIRANI R, 1982, CLIN INVEST MED, V5, P63; Tiihonen J, 2006, BRIT MED J, V333, P224, DOI 10.1136/bmj.38881.382755.2F; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Uter W, 2001, STAT METHODS MED RES, V10, P231, DOI 10.1191/096228001680195175; VACH W, 1991, AM J EPIDEMIOL, V134, P895, DOI 10.1093/oxfordjournals.aje.a116164; VANDENBROUCKE JP, 1991, BRIT MED J, V302, P249, DOI 10.1136/bmj.302.6771.249; Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330, DOI 10.7326/0003-4819-134-4-200102200-00017; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Vineis P, 2003, SOZ PRAVENTIV MED, V48, P80, DOI 10.1007/s00038-003-1029-7; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Walker M, 2004, INT J EPIDEMIOL, V33, P1185, DOI 10.1093/ije/dyh295; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; *WHO, 2007, BOD MASS IND; Wieland S, 2005, J CLIN EPIDEMIOL, V58, P560, DOI 10.1016/j.jclinepi.2004.11.018; Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356; Yadon ZE, 2003, AM J TROP MED HYG, V68, P519, DOI 10.4269/ajtmh.2003.68.519; ZHAO LP, 1992, AM J EPIDEMIOL, V136, P464, DOI 10.1093/oxfordjournals.aje.a116520	236	1458	1488	1	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					W163	W194		10.7326/0003-4819-147-8-200710160-00010-w1	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00010-w1			32	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938389	Green Published, Green Accepted			2022-12-28	WOS:000250437100017
J	Demaret, P; Detaille, T				Demaret, Pierre; Detaille, Thierry			Torch on a baby's tummy	LANCET			English	Editorial Material									Univ Catholique Louvain, Clin Univ St Luc, Paediat Intens Care Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Demaret, P (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Paediat Intens Care Unit, Ave Hippocrate 10, B-1200 Brussels, Belgium.	pietdem@yahoo.fr	Demaret, Pierre/M-9128-2016	Demaret, Pierre/0000-0001-5866-6399					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1346	1346		10.1016/S0140-6736(07)61576-1	http://dx.doi.org/10.1016/S0140-6736(07)61576-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220SC	17933649				2022-12-28	WOS:000250176600028
J	James, J; Thomas, P; Kerr, D				James, Janet; Thomas, Peter; Kerr, David			Preventing childhood obesity: two year follow-up results from the Christchurch obesity prevention programme in schools (CHOPPS)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOFT DRINK CONSUMPTION; INTERVENTIONS; CHILDREN; WEIGHT	Objective To assess the long term effects of an obesity prevention programme in schools. Design Longitudinal results after a cluster randomised controlled trial. Setting Schools in southwest England. Participants Of the original sample of 644 children aged 7-11, 511 children were tracked and measurements were obtained from 434 children three years after baseline. Intervention The intervention was conducted over one school year, with four sessions of focused education promoting a healthy diet and discouraging the consumption of carbonated drinks. Main outcome measures Anthropometric measures of height, weight, and waist circumference. Body mass index (BMI) converted to z score (SD scores) and to centile values with growth reference curves. Waist circumference was also converted to z scores (SD scores). Results At three years after baseline the age and sex specific BMI z scores (SD scores) had increased in the control group by 0.10 (SD 0.53) but decreased in the intervention group by -0.01 (SD 0.58), with a mean difference of 0.10 (95% confidence interval -0.00 to 0.21, P=0.06). The prevalence of overweight increased in both the intervention and control group at three years and the significant difference between the groups seen at 12 months was no longer evident. The BMI increased in the control group by 2.14 (SD 1.64) and the intervention group by 1.88 (SD 1.71), with mean difference of 0.26 (-0.07 to 0.58, P=0.12). The waist circumference increased in both groups after three years with a mean difference of 0.09 (-0.06 to 0.26, P=0.25). Conclusions These longitudinal results show that after a simple year tong intervention the difference in prevalence of overweight in children seen at 12 months was not sustained at three years.	Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England; Bournemouth Univ, Bournemouth Diabet & Endocrine Ctr, Poole BH12 5BB, Dorset, England; Bournemouth Univ, Ctr Postgrad Med Res & Educ, Poole BH12 5BB, Dorset, England; Poole Hosp, Dorset Res & Dev Support Unit, Poole, Dorset, England	Bournemouth University; Bournemouth University; Poole Hospital	James, J (corresponding author), Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England.	janet.james@rbch.nhs.uk	James, Janet/F-9995-2019	James, Janet/0000-0002-9308-6362; Thomas, Peter/0000-0003-2478-4324				[Anonymous], 2006, OB PREV ID ASS MAN O; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; JEBB S, 2007, HLTH LIVING SOCIAL M; JOTANGIA D, 2005, OBESITY CHILDREN 11; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Mrdjenovic G, 2003, J PEDIATR-US, V142, P604, DOI 10.1067/mpd.2003.200; Rush E, 2006, ASIA PAC J CLIN NUTR, V15, P242; Sharma M, 2006, OBES REV, V7, P261, DOI 10.1111/j.1467-789X.2006.00227.x; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Tam CS, 2006, INT J OBESITY, V30, P1091, DOI 10.1038/sj.ijo.0803328; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210; WHO, 2003, WHO TECH REP SER, V916, P1; World Health Organization, 2006, GLOB STRAT DIET PHYS; Zaninotto P., 2006, FORECASTING OBESITY	21	97	99	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2007	335	7623					762	+		10.1136/bmj.39342.571806.55	http://dx.doi.org/10.1136/bmj.39342.571806.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17923721	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000250418600035
J	Sand, M; Bechara, FG				Sand, Michael; Bechara, Falk G.			RETRACTED: A growing, bleeding, violet mole (Retracted article. See vol. 371, pg. 288, 2008)	LANCET			English	Editorial Material; Retracted Publication							ENDOMETRIOSIS		Ruhr Univ Bochum, Acad Teaching Hosp, Augusta Krankenanstalt, Dept Gen & Visceral Surg, D-44791 Bochum, Germany; Ruhr Univ Bochum, Dept Dermatol & Allergol, D-44791 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Sand, M (corresponding author), Ruhr Univ Bochum, Acad Teaching Hosp, Augusta Krankenanstalt, Dept Gen & Visceral Surg, Bergstr 26, D-44791 Bochum, Germany.	michael.sand@ruhr-uni-bochum.de						BERGQVIST A, 1993, GYNECOL ENDOCRINOL, V7, P207, DOI 10.3109/09513599309152504; FRANKLIN RR, 1990, PROG CLIN BIOL RES, V323, P289; Kondi-Pafiti A, 2004, Clin Exp Obstet Gynecol, V31, P302; PURVIS RS, 1994, J DERMATOL SURG ONC, V20, P693, DOI 10.1111/j.1524-4725.1994.tb00456.x; von Stemm AMR, 1999, J EUR ACAD DERMATOL, V12, P30, DOI 10.1016/S0926-9959(98)00099-3	5	2	2	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1392	1392		10.1016/S0140-6736(07)61582-7	http://dx.doi.org/10.1016/S0140-6736(07)61582-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220SC	17933655				2022-12-28	WOS:000250176600034
J	Tomson, T; Hiilesmaa, V				Tomson, Torbjorn; Hiilesmaa, Vilho			Pregnancy plus - Epilepsy in pregnancy	BRITISH MEDICAL JOURNAL			English	Article							ANTIEPILEPTIC DRUGS; MAJOR MALFORMATIONS; IN-UTERO; CONGENITAL-MALFORMATIONS; PLASMA-CONCENTRATIONS; PRENATAL EXPOSURE; SEIZURE CONTROL; BIRTH-DEFECTS; WOMEN; LAMOTRIGINE		Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; Univ Helsinki, Dept Obstet & Gynaecol, Helsinki 00029, Finland	Karolinska Institutet; University of Helsinki	Tomson, T (corresponding author), Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	torbjorn.tomson@karolinska.se						Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; Adab N, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858]; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; BARDY AH, 1987, ACTA NEUROL SCAND, V75, P356, DOI 10.1111/j.1600-0404.1987.tb05459.x; Breen DP, 2006, BRIT MED J, V333, P615, DOI 10.1136/bmj.38961.437639.BE; Christensen J, 2006, NEUROLOGY, V67, P1497, DOI 10.1212/01.wnl.0000240047.11166.0e; Crawford P, 2005, EPILEPSIA, V46, P117, DOI 10.1111/j.1528-1167.2005.00323.x; Cunnington M, 2007, EPILEPSIA, V48, P1207, DOI 10.1111/j.1528-1167.2007.01021.x; de Haan GJ, 2004, NEUROLOGY, V63, P571, DOI 10.1212/01.WNL.0000133213.10244.FD; Eriksson K, 2005, EPILEPSY RES, V65, P189, DOI 10.1016/j.eplepsyres.2005.06.001; Fried S, 2004, DRUG SAFETY, V27, P197, DOI 10.2165/00002018-200427030-00004; Gaily E, 2004, NEUROLOGY, V62, P28, DOI 10.1212/WNL.62.1.28; GJERDE IO, 1988, ACTA NEUROL SCAND, V78, P198, DOI 10.1111/j.1600-0404.1988.tb03646.x; Hernandez-Diaz S, 2007, BIRTH DEFECTS RES A, V79, P357; HIILESMAA VK, 1985, AM J OBSTET GYNECOL, V152, P499, DOI 10.1016/0002-9378(85)90615-5; HIILESMAA VK, 1992, NEUROLOGY, V42, P8; Holmes LB, 2006, BIRTH DEFECTS RES A, V76, P318; Holmes LB, 2004, ARCH NEUROL-CHICAGO, V61, P673, DOI 10.1001/archneur.61.5.673; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Kaaja E, 2003, NEUROLOGY, V60, P575, DOI 10.1212/01.WNL.0000044157.28073.DC; Kalviainen R, 2006, NEUROLOGY, V67, pS59, DOI 10.1212/WNL.67.12_suppl_4.S59; Kaneko S, 1999, EPILEPSY RES, V33, P145, DOI 10.1016/S0920-1211(98)00084-9; Katz O, 2006, J MATERN-FETAL NEO M, V19, P21, DOI 10.1080/14767050500434096; Kooper AJA, 2007, PRENATAL DIAG, V27, P29, DOI 10.1002/pd.1614; Lipka K, 2003, ACTA ANAESTH SCAND, V47, P616, DOI 10.1034/j.1399-6576.2003.00115.x; Mazzucchelli I, 2006, EPILEPSIA, V47, P504, DOI 10.1111/j.1528-1167.2006.00459.x; Moore JL, 2005, EPILEPSY BEHAV, V7, P172, DOI 10.1016/j.yebeh.2005.05.020; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Pennell PB, 2004, NEUROLOGY, V62, P292, DOI 10.1212/01.WNL.0000103286.47129.F8; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Petrenaite V, 2005, EPILEPSY RES, V65, P185, DOI 10.1016/j.eplepsyres.2005.06.004; Richmond JR, 2004, AM J OBSTET GYNECOL, V190, P371, DOI 10.1016/j.ajog.2003.09.020; Sabers A, 1998, ACTA NEUROL SCAND, V97, P164; Samren EB, 1999, ANN NEUROL, V46, P739; STOKES T, 2004, CLIN GUIDELINES EVID; Tomson T, 2006, NEUROLOGY, V66, P354; Tomson T, 2005, THER DRUG MONIT, V27, P718, DOI 10.1097/01.ftd.0000179843.63515.8f; Tomson T, 2005, CURR OPIN NEUROL, V18, P135, DOI 10.1097/01.wco.0000162854.67767.06; Tomson T, 2004, EPILEPSIA, V45, P1171, DOI 10.1111/j.0013-9580.2004.15104.x; TOMSON T, 1994, EPILEPSIA, V35, P122, DOI 10.1111/j.1528-1157.1994.tb02921.x; Tomson T, 2007, CLIN PHARMACOKINET, V46, P209, DOI 10.2165/00003088-200746030-00002; Tran TA, 2002, NEUROLOGY, V59, P251, DOI 10.1212/WNL.59.2.251; Vajda FJ, 2004, J CLIN NEUROSCI, V11, P854, DOI 10.1016/j.jocn.2004.05.003; Viinikainen K, 2006, EPILEPSIA, V47, P186, DOI 10.1111/j.1528-1167.2006.00386.x; Vinten J, 2005, NEUROLOGY, V64, P949, DOI 10.1212/01.WNL.0000154514.82948.69; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Wyszynski DF, 2005, NEUROLOGY, V64, P961, DOI 10.1212/01.WNL.0000154516.43630.C5	47	40	44	3	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 13	2007	335	7623					769	773		10.1136/bmj.39266.473113.BE	http://dx.doi.org/10.1136/bmj.39266.473113.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17932208	Green Published			2022-12-28	WOS:000250418600037
J	Calvert, P				Calvert, Paul			Printing cells	SCIENCE			English	Editorial Material							LIVING CELLS; TISSUE; CONSTRUCTS		Univ Massachusetts Dartmouth, Dept Mat & Text, N Dartmouth, MA 02747 USA	University of Massachusetts System; University Massachusetts Dartmouth	Calvert, P (corresponding author), Univ Massachusetts Dartmouth, Dept Mat & Text, N Dartmouth, MA 02747 USA.	pcalvert@umassd.edu						Baca HK, 2006, SCIENCE, V313, P337, DOI 10.1126/science.1126590; Boland T, 2007, MAT SCI ENG C-BIO S, V27, P372, DOI 10.1016/j.msec.2006.05.047; Boland T, 2007, ADV MATER PROCESS, V165, P51; Mironov V, 2007, J MATER CHEM, V17, P2054, DOI 10.1039/b617903g; Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658; Nakamura M, 2006, DIGITAL FABRICATION 2006, FINAL PROGRAM AND PROCEEDINGS, P89; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Ringeisen Bradley R., 2006, Biotechnology Journal, V1, P930, DOI 10.1002/biot.200600058; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Saunders R, 2005, MATER RES SOC SYMP P, V845, P57; Saunders R, 2004, MATER RES SOC SYMP P, V1, P95; Smith CM, 2004, TISSUE ENG, V10, P1566, DOI 10.1089/1076327042500274; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011	13	179	194	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					208	209		10.1126/science.1144212	http://dx.doi.org/10.1126/science.1144212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932278				2022-12-28	WOS:000250086100026
J	Retherford, KD; Spencer, JR; Stern, SA; Saur, J; Strobel, DF; Steffl, AJ; Gladstone, GR; Weaver, HA; Cheng, AF; Parker, JW; Slater, DC; Versteeg, MH; Davis, MW; Bagenal, F; Throop, HB; Lopes, RMC; Reuter, DC; Lunsford, A; Conard, SJ; Young, LA; Moore, JM				Retherford, K. D.; Spencer, J. R.; Stern, S. A.; Saur, J.; Strobel, D. F.; Steffl, A. J.; Gladstone, G. R.; Weaver, H. A.; Cheng, A. F.; Parker, J. Wm.; Slater, D. C.; Versteeg, M. H.; Davis, M. W.; Bagenal, F.; Throop, H. B.; Lopes, R. M. C.; Reuter, D. C.; Lunsford, A.; Conard, S. J.; Young, L. A.; Moore, J. M.			Io's atmospheric response to eclipse: UV Aurorae observations	SCIENCE			English	Article							SO2; MAGNETOSPHERE; SPECTROSCOPY; SUBLIMATION; MORPHOLOGY; EMISSIONS	The New Horizons (NH) spacecraft observed Io's aurora in eclipse on four occasions during spring 2007. NH Alice ultraviolet spectroscopy and concurrent Hubble Space Telescope ultraviolet imaging in eclipse investigate the relative contribution of volcanoes to Io's atmosphere and its interaction with Jupiter's magnetosphere. Auroral brightness and morphology variations after eclipse ingress and egress reveal changes in the relative contribution of sublimation and volcanic sources to the atmosphere. Brightnesses viewed at different geometries are best explained by a dramatic difference between the dayside and nightside atmospheric density. Far-ultraviolet aurora morphology reveals the influence of plumes on Io's electrodynamic interaction with Jupiter's magnetosphere. Comparisons to detailed simulations of Io's aurora indicate that volcanoes supply 1 to 3% of the dayside atmosphere.	SW Res Inst, San Antonio, TX 78228 USA; SW Res Inst, Boulder, CO 80302 USA; NASA Headquarters, Washington, DC 20546 USA; Univ Cologne, D-50923 Cologne, Germany; Johns Hopkins Univ, Baltimore, MD 21218 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Colorado, Boulder, CO 80302 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Southwest Research Institute; National Aeronautics & Space Administration (NASA); University of Cologne; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Retherford, KD (corresponding author), SW Res Inst, 6220 Culebra Rd, San Antonio, TX 78228 USA.	KRetherford@swri.edu	Weaver, Harold A/D-9188-2016; Strobel, Darrell5/AAO-6643-2021; Davis, Michael/AAK-3433-2021; Lopes, Rosaly M.C./D-1608-2016; Saur, Joachim/V-6780-2019	Weaver, Harold A/0000-0003-0951-7762; Strobel, Darrell5/0000-0002-0944-8675; Davis, Michael/0000-0003-4338-1635; Lopes, Rosaly M.C./0000-0002-7928-3167; Saur, Joachim/0000-0003-1413-1231; Parker, Joel/0000-0002-3672-0603				Bagenal F, 2007, J ATMOS SOL-TERR PHY, V69, P387, DOI 10.1016/j.jastp.2006.08.012; Bouchez AH, 2000, ICARUS, V148, P316, DOI 10.1006/icar.2000.6518; CLARKE JT, 1994, J GEOPHYS RES-PLANET, V99, P8387, DOI 10.1029/93JE02547; COOK AF, 1981, SCIENCE, V211, P1419, DOI 10.1126/science.211.4489.1419; de Pater I, 2002, ICARUS, V156, P296, DOI 10.1006/icar.2001.6787; FEAGA L, 2005, THESIS J HOPKINS U; Feldman PD, 2000, GEOPHYS RES LETT, V27, P1787, DOI 10.1029/1999GL011067; Ford H, 2003, P SOC PHOTO-OPT INS, V4854, P81, DOI 10.1117/12.460040; Geissler P, 2004, ICARUS, V172, P127, DOI 10.1016/j.icarus.2004.01.008; Geissler PE, 1999, SCIENCE, V285, P870, DOI 10.1126/science.285.5429.870; Geissler PE, 2001, J GEOPHYS RES-SPACE, V106, P26137, DOI 10.1029/2000JA002511; Jessup KL, 2004, ICARUS, V169, P197, DOI 10.1016/j.icarus.2003.11.015; LELLOUCH E, 2008, LO GGALILEO, P231; Neubauer FM, 1999, J GEOPHYS RES-PLANET, V104, P3863, DOI 10.1029/1998JE900031; Neubauer FM, 1998, J GEOPHYS RES-PLANET, V103, P19843, DOI 10.1029/97JE03370; PEARL J, 1979, NATURE, V280, P755, DOI 10.1038/280755a0; Retherford KD, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009710; Retherford KD, 2000, J GEOPHYS RES-SPACE, V105, P27157, DOI 10.1029/2000JA002500; RETHERFORD KD, 2002, THESIS J HOPKINS U; RETHERFORD KD, 2007, MAGN OUT PLAN M SAN; Roesler FL, 1999, SCIENCE, V283, P353, DOI 10.1126/science.283.5400.353; Saur J, 2000, GEOPHYS RES LETT, V27, P2893, DOI 10.1029/2000GL003824; Saur J, 2004, ICARUS, V171, P411, DOI 10.1016/j.icarus.2004.05.010; SINTON WM, 1988, ICARUS, V75, P207, DOI 10.1016/0019-1035(88)90002-4; Spencer JR, 2007, SCIENCE, V318, P240, DOI 10.1126/science.1147621; Spencer JR, 2005, ICARUS, V176, P283, DOI 10.1016/j.icarus.2005.01.019; Spencer JR, 2000, SCIENCE, V288, P1198, DOI 10.1126/science.288.5469.1198; STERN SA, 2005, P SOC PHOTO-OPT INS, V5906, P358; Strobel DF, 2001, ASTROPHYS SPACE SCI, V277, P271, DOI 10.1023/A:1012261209678	29	29	29	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					237	240		10.1126/science.1147594	http://dx.doi.org/10.1126/science.1147594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932289				2022-12-28	WOS:000250086100037
J	Sethna, JP				Sethna, James P.			Crackling wires	SCIENCE			English	Editorial Material							NOISE		Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA	Cornell University	Sethna, JP (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	sethna@lassp.cornell.edu						BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Csikor FF, 2007, SCIENCE, V318, P251, DOI 10.1126/science.1143719; Fisher DS, 1998, PHYS REP, V301, P113, DOI 10.1016/S0370-1573(98)00008-8; Kardar M, 1998, PHYS REP, V301, P85, DOI 10.1016/S0370-1573(98)00007-6; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675	6	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					207	208		10.1126/science.1148507	http://dx.doi.org/10.1126/science.1148507			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932277				2022-12-28	WOS:000250086100025
J	Volkov, I; Banavar, JR; Hubbell, SP; Maritan, A				Volkov, Igor; Banavar, Jayanth R.; Hubbell, Stephen P.; Maritan, Amos			Patterns of relative species abundance in rainforests and coral reefs	NATURE			English	Article							NEUTRAL BIODIVERSITY THEORY; DENSITY-DEPENDENCE; POPULATION; DIVERSITY	A formidable many-body problem in ecology is to understand the complex of factors controlling patterns of relative species abundance (RSA) in communities of interacting species. Unlike many problems in physics, the nature of the interactions in ecological communities is not completely known. Although most contemporary theories in ecology start with the basic premise that species interact, here we show that a theory in which all interspecific interactions are turned off leads to analytical results that are in agreement with RSA data from tropical forests and coral reefs. The assumption of non-interacting species leads to a sampling theory for the RSA that yields a simple approximation at large scales to the exact theory. Our results show that one can make significant theoretical progress in ecology by assuming that the effective interactions among species are weak in the stationary states in species-rich communities such as tropical forests and coral reefs.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; Smithsonian Trop Res Inst, APO, AA 34002 USA; Univ Padua, Dipartimento Fis G Galilei, CNISM, I-35131 Padua, Italy; Ist Nazl Fis Nucl, I-35131 Padua, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN)	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	banavar@psu.edu; maritan@pd.infn.it	Volkov, Igor/GVT-6571-2022	Maritan, Amos/0000-0002-3535-7873				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2006, SCIENCE, V313, DOI 10.1126/science.1129115; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dewdney AK, 1998, THEOR POPUL BIOL, V54, P294, DOI 10.1006/tpbi.1997.1370; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Etienne RS, 2007, J THEOR BIOL, V248, P522, DOI 10.1016/j.jtbi.2007.06.010; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2006, ECOL LETT, V9, P500, DOI 10.1111/j.1461-0248.2006.00907.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Etienne RS, 2004, ECOL LETT, V7, P170, DOI 10.1111/j.1461-0248.2004.00572.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hubbell Stephen P., 2001, V32, pi; KENDALL DG, 1949, J R STAT SOC B, V11, P230; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Maxwell J.C., 2003, SCI PAPERS JC MAXWEL, V1; PIELOU E C, 1969, P286; Press W., 1992, NUMERICAL RECIPES, V2nd; Rannala B, 1996, THEOR POPUL BIOL, V50, P91, DOI 10.1006/tpbi.1996.0024; Rao C. R., 1971, STATISTICAL ECOLOGY, V1, P131; Van der Waals J.D., 2004, CONTINUITY GASEOUS L; van Kampen N.G., 2001, STOCHASTIC PROCESSES; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883	29	205	209	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					45	49		10.1038/nature06197	http://dx.doi.org/10.1038/nature06197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972874				2022-12-28	WOS:000250585800033
J	Greenhalgh, T; Kristjansson, E; Robinson, V				Greenhalgh, Trisha; Kristjansson, Elizabeth; Robinson, Vivian			Realist review to understand the efficacy of school feeding programmes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE-MINERAL ACCRETION; AGED 10-12 YEARS; BREAKFAST PROGRAM; MILK INTERVENTION; NATIONAL EVALUATION; GIRLS; GROWTH; TRIAL; MASS; CHILDREN		UCL, Dept Primary Care & Populat Sci, London N19 5LW, England; Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of London; University College London; University of Ottawa; University of Ottawa	Greenhalgh, T (corresponding author), UCL, Dept Primary Care & Populat Sci, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088; Welch, Vivian/0000-0002-5238-7097				AGARWAL D K, 1989, Indian Journal of Medical Research Section B, V90, P163; [Anonymous], 2004, REALIST SYNTHESIS IN; BAILEY K V, 1962, Trop Geogr Med, V14, P129; BAKER IA, 1980, J EPIDEMIOL COMMUN H, V34, P31, DOI 10.1136/jech.34.1.31; Bro RT, 1996, J EDUC RES, V90, P111, DOI 10.1080/00220671.1996.9944452; BRO RT, 1994, CHILD FAM BEHAV THER, V16, P1, DOI 10.1300/J019v16n03_01; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; CHANDLER AMK, 1995, J NUTR, V125, P894; Chang Susan M., 1996, Food and Nutrition Bulletin, V17, P248; DEVADAS RP, 1979, INDIAN J NUTR DIET, V16, P335; Dixon-Woods M, 2007, QUAL RES, V7, P375, DOI DOI 10.1177/1468794107078517; Du XQ, 2005, BRIT J NUTR, V94, P1038, DOI 10.1079/BJN20051584; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Grillenberger M, 2003, J NUTR, V133, p3957S, DOI 10.1093/jn/133.11.3957S; Jacoby Enrique, 1996, Food and Nutrition Bulletin, V17, P54; Jacoby ER, 1998, AM J CLIN NUTR, V67, p795S, DOI 10.1093/ajcn/67.4.795S; Kristjansson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004676.pub2; LIEBERMAN HM, 1976, J AM DIET ASSOC, V68, P132; MANN HCC, 1926, DIETS BOYS SCH AGE; Murphy SP, 2003, J NUTR, V133, p3950S, DOI 10.1093/jn/133.11.3950S; Neumann CG, 2003, J NUTR, V133, p3941S, DOI 10.1093/jn/133.11.3941S; Orr JB, 1928, LANCET, V1, P202; PAIGE DM, 1976, PEDIATRICS, V58, P697; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; POWELL C, 1983, HUM NUTR-CLIN NUTR, V37, P381; Powell CA, 1998, AM J CLIN NUTR, V68, P873, DOI 10.1093/ajcn/68.4.873; Shemilt I, 2004, CHILD CARE HLTH DEV, V30, P413, DOI 10.1111/j.1365-2214.2004.00453.x; Shemilt I, 2004, CHILD CARE HLTH DEV, V30, P429, DOI 10.1111/j.1365-2214.2004.00454.x; Siekmann JH, 2003, J NUTR, V133, p3972S, DOI 10.1093/jn/133.11.3972S; Simeon DT, 1998, AM J CLIN NUTR, V67, p790S, DOI 10.1093/ajcn/67.4.790S; TISDALL FF, 1951, CAN MED ASSOC J, V64, P477; Whaley SE, 2003, J NUTR, V133, p3965S, DOI 10.1093/jn/133.11.3965S; Zhu K, 2006, AM J CLIN NUTR, V83, P714, DOI 10.1093/ajcn.83.3.714; Zhu K, 2005, AM J CLIN NUTR, V81, P1168; Zhu K, 2004, BRIT J NUTR, V92, P985, DOI 10.1079/BJN20041278	35	125	127	1	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2007	335	7625					858	861		10.1136/bmj.39359.525174.AD	http://dx.doi.org/10.1136/bmj.39359.525174.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17954518	Green Published			2022-12-28	WOS:000250631000036
J	Heath, I				Heath, Iona			Something rotten	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dst.pipex.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2007	335	7625					855	855		10.1136/bmj.39367.395694.4E	http://dx.doi.org/10.1136/bmj.39367.395694.4E			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227BA	17962285	Green Published			2022-12-28	WOS:000250631000034
J	Walter, KM; Edwards, ME; Grosse, G; Zimov, SA; Chapin, FS				Walter, K. M.; Edwards, M. E.; Grosse, G.; Zimov, S. A.; Chapin, F. S., III			Thermokarst lakes as a source of atmospheric CH4 during the last deglaciation	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; METHANE SOURCE; GREENLAND; ANTARCTICA; PEATLANDS; GRADIENT; SIBERIA; RECORD; END; CO2	Polar ice-core records suggest that an arctic or boreal source was responsible for more than 30% of the large increase in global atmospheric methane (CH4) concentration during deglacial climate warming; however, specific sources of that CH4 are still debated. Here we present an estimate of past CH4 flux during deglaciation from bubbling from thermokarst (thaw) lakes. Based on high rates of CH4 bubbling from contemporary arctic thermokarst lakes, high CH4 production potentials of organic matter from Pleistocene-aged frozen sediments, and estimates of the changing extent of these deposits as thermokarst lakes developed during deglaciation, we find that CH4 bubbling from newly forming thermokarst lakes comprised 33 to 87% of the high-latitude increase in atmospheric methane concentration and, in turn, contributed to the climate warming at the Pleistocene-Holocene transition.	Univ Alaska, Water & Environm Res Ctr, Fairbanks, AK 99775 USA; Univ Alaska, Int Arctic Res Ctr, Fairbanks, AK 99775 USA; Univ Alaska, Coll Nat Sci, Fairbanks, AK 99775 USA; Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA; Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Moscow 117901, Russia; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; University of Alaska System; University of Alaska Fairbanks	Walter, KM (corresponding author), Univ Alaska, Water & Environm Res Ctr, Fairbanks, AK 99775 USA.	ftkmw1@uaf.edu	Zimov, Sergey/K-3009-2018; Chapin, F Stuart/AAZ-3931-2020; Grosse, Guido/F-5018-2011	Chapin, F Stuart/0000-0002-2558-9910; Grosse, Guido/0000-0001-5895-2141; Zimov, Sergey/0000-0002-0053-6599	Natural Environment Research Council [NE/D001846/1] Funding Source: researchfish; NERC [NE/D001846/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson P. M., 2002, LATE QUATERNARY VEGE; Anderson PM, 2004, DEV QUA SCI, V1, P427; Blunier T, 2000, SCIENCE, V288, P68, DOI 10.1126/science.288.5463.68; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Czudek T., 1970, QUATERNARY RES, V1, P103, DOI [10.1016/0033-5894(70)90013-X, DOI 10.1016/0033-5894(70)90013-X]; Dallenbach A, 2000, GEOPHYS RES LETT, V27, P1005, DOI 10.1029/1999GL010873; Grosse G, 2007, GEOMORPHOLOGY, V86, P25, DOI 10.1016/j.geomorph.2006.08.005; Hinkel KM, 2003, ARCT ANTARCT ALP RES, V35, P291, DOI 10.1657/1523-0430(2003)035[0291:SEAACS]2.0.CO;2; Hopkins DM, 1988, P 5 INT C PERM, V1, P790; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Kennett JP, 2003, METHANE HYDRATES QUA; KOKOROWSKI H, COMMUNICATION; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Romanovskii NN, 2000, PERMAFROST PERIGLAC, V11, P137, DOI 10.1002/1099-1530(200004/06)11:2<137::AID-PPP345>3.3.CO;2-C; Sazonova TS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003680; Schaefer H, 2006, SCIENCE, V313, P1109, DOI 10.1126/science.1126562; Semiletov IP, 1999, J ATMOS SCI, V56, P286, DOI 10.1175/1520-0469(1999)056<0286:ASASOC>2.0.CO;2; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Sher AV, 2005, QUATERNARY SCI REV, V24, P533, DOI 10.1016/j.quascirev.2004.09.007; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Thorpe RB, 1996, J GEOPHYS RES-ATMOS, V101, P28627, DOI 10.1029/96JD02547; TOMIRDIARO SV, 1980, LESSOVOLEDOVAYA FORM; TOMIRDIARO SV, 1982, PALEOECOLOGY BERINGI, P29; Velichko AA, 2002, QUATERN INT, V91, P75, DOI 10.1016/S1040-6182(01)00104-5; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Zhuang Q, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002239; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800; ZIMOV SA, 2006, GEOPHYS RES LETT, V33, DOI DOI 10.1029/2006GL027484; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	33	226	238	8	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					633	636		10.1126/science.1142924	http://dx.doi.org/10.1126/science.1142924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962561				2022-12-28	WOS:000250409200043
J	Goldacre, B				Goldacre, Ben			Beware of mentioning psychosocial factors	BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-BACK-PAIN					ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728				Buchbinder R, 2001, MED J AUSTRALIA, V175, P456, DOI 10.5694/j.1326-5377.2001.tb143675.x; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430	3	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 20	2007	335	7624					801	801		10.1136/bmj.39370.657130.59	http://dx.doi.org/10.1136/bmj.39370.657130.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227AX	17947783	Green Published			2022-12-28	WOS:000250630700028
J	Djamei, A; Pitzschke, A; Nakagami, H; Rajh, I; Hirt, H				Djamei, Armin; Pitzschke, Andrea; Nakagami, Hirofumi; Rajh, Iva; Hirt, Heribert			Trojan horse strategy in Agrobacterium transformation: Abusing MAPK defense signaling	SCIENCE			English	Article							INNATE IMMUNITY; PROTEIN; TRANSLOCATION; RECOGNITION; INFECTION; VIP1	Nuclear import of transfer DNA (T-DNA) is a central event in Agrobacterium transformation of plant cells and is thought to occur by the hijacking of certain host cell proteins. The T-DNA-associated virulence protein VirE2 mediates this process by binding to the nuclear import machinery via the host cell factor VIP1, whose role in plants has been so far unknown. Here we show that VIP1 is a transcription factor that is a direct target of the Agrobacterium-induced mitogen-activated protein kinase (MAPK) MPK3. Upon phosphorylation by MPK3, VIP1 relocalizes from the cytoplasm to the nucleus and regulates the expression of the PR1 pathogenesis-related gene. MAPK-dependent phosphorylation of VIP1 is necessary for VIP1-mediated Agrobacterium T-DNA transfer, indicating that Agrobacterium abuses the MAPK-targeted VIP1 defense signaling pathway for nuclear delivery of the T-DNA complex as a Trojan horse.	Univ Vienna, Dept Plant Mol Biol, Max F Perutz Labs, A-1030 Vienna, Austria; URGV, Plant Genom Lab, F-91057 Evry, France	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); UDICE-French Research Universities; Universite Paris Saclay	Djamei, A (corresponding author), Max Planck Inst Terr Mikrobiol, Dept Organism Interact, Karl Von Frisch Str, D-35043 Marburg, Germany.		Hirt, Heribert/A-2061-2013; Nakagami, Hirofumi/A-4122-2011; Djamei, Armin/AAL-8909-2021	Nakagami, Hirofumi/0000-0003-2569-7062; Djamei, Armin/0000-0002-8087-9566; Pitzschke, Andrea/0000-0002-3451-1429				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Li JX, 2005, P NATL ACAD SCI USA, V102, P5733, DOI 10.1073/pnas.0404118102; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Tzfira T, 2002, P NATL ACAD SCI USA, V99, P10435, DOI 10.1073/pnas.162304099; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979	13	197	217	8	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					453	456		10.1126/science.1148110	http://dx.doi.org/10.1126/science.1148110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947581				2022-12-28	WOS:000250230400048
J	Levy, O; Appelbaum, L; Leggat, W; Gothlif, Y; Hayward, DC; Miller, DJ; Hoegh-Guldberg, O				Levy, O.; Appelbaum, L.; Leggat, W.; Gothlif, Y.; Hayward, D. C.; Miller, D. J.; Hoegh-Guldberg, O.			Light-responsive cryptochromes from a simple multicellular animal, the coral Acropora millepora	SCIENCE			English	Article							PHOTORECEPTORS; BLUE	Hundreds of species of reef-building corals spawn synchronously over a few nights each year, and moonlight regulates this spawning event. However, the molecular elements underpinning the detection of moonlight remain unknown. Here we report the presence of an ancient family of blue-light-sensing photoreceptors, cryptochromes, in the reef-building coral Acropora millepora. In addition to being cryptochrome genes from one of the earliest-diverging eumetazoan phyla, cry1 and cry2 were expressed preferentially in light. Consistent with potential roles in the synchronization of fundamentally important behaviors such as mass spawning, cry2 expression increased on full moon nights versus new moon nights. Our results demonstrate phylogenetically broad roles of these ancient circadian clock-related molecules in the animal kingdom.	Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia; Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; Tel Aviv Univ, Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; Australian Natl Univ, Res Sch Biol Sci, ARC, Ctr Mol Genet Dev, Canberra, ACT 2601, Australia; James Cook Univ N Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of Queensland; Howard Hughes Medical Institute; Stanford University; Tel Aviv University; Australian National University; James Cook University	Levy, O (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia.		Leggat, William/C-4532-2012; Hoegh-Guldberg, Ove/ABA-5420-2020; Leggat, Bill/AAJ-8929-2020; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Leggat, Bill/0000-0003-4148-2555; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Gothilf, Yoav/0000-0002-6054-4128; Hayward, David/0000-0003-2937-2425				BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BABCOCK RC, 1994, CORAL REEFS, V13, P161, DOI 10.1007/BF00301193; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309, DOI 10.4319/lo.2002.47.1.0309; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hayward DC, 2001, DEV GENES EVOL, V211, P10; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Levy O, 2006, J EXP MAR BIOL ECOL, V328, P35, DOI 10.1016/j.jembe.2005.06.018; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; MARSHALL SM, 1933, NAT HIST, V3, P219; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007	21	187	189	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					467	470		10.1126/science.1145432	http://dx.doi.org/10.1126/science.1145432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947585				2022-12-28	WOS:000250230400052
J	Pichichero, ME; Casey, JR				Pichichero, Michael E.; Casey, Janet R.			Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE OTITIS-MEDIA; RESISTANT STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; ANTIMICROBIAL RESISTANCE; NASOPHARYNGEAL CARRIAGE; NONVACCINE SEROTYPES; INVASIVE DISEASE; ANTIBIOTIC-RESISTANCE; IMPACT; ERA	Context Concern has been raised about the possible emergence of a bacterial strain that is untreatable by US Food and Drug Administration (FDA)-approved antibiotics and that causes acute otitis media (AOM) in children. Objective To monitor continuing shifts in the strains of Streptococcus pneumoniae that cause AOM, with particular attention to capsular serotypes and antibiotic susceptibility, following the introduction of a pneumococcal 7-valent conjugate vaccine (PCV7). Design, Setting, and Patients Prospective cohort study using tympanocentesis to identify S pneumoniae strains that caused AOM in children receiving PCV7 between September 2003 and June 2006. All children were from a Rochester, New York, pediatric practice. Main Outcome Measure Determination of serotypes and antibiotic susceptibility of S pneumoniae causing AOM. Results Among 1816 children in whom AOM was diagnosed, tympanocentesis was performed in 212, yielding 59 cases of Spneumoniae infection. One strain of Spneumoniae belonging to serotype 19A was a new genotype and was resistant to all antibiotics approved by the FDA for use in children with AOM. This strain was identified in 9 cases (2 in 2003-2004, 2 in 2004-2005, and 5 in 2005-2006). Four children infected with this strain had been unsuccessfully treated with 2 or more antibiotics, including high-dose amoxicillin or amoxicillin-clavulanate and 3 injections of ceftriaxone; 3 had recurrent AOM; and for 2 others, the infection was their first in life. The first 4 cases required tympanostomy tube insertion after additional unsuccessful antibiotic therapies. Levofloxacin was used in the subsequent 5 cases, with resolution of infection without surgery. Conclusion In the years following introduction of PCV7, a strain of S pneumoniae has emerged in the United States as an otopathogen that is resistant to all FDA-approved antibiotics for treatment of AOM in children.	Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Legacy Pediat, Rochester, NY USA	University of Rochester	Pichichero, ME (corresponding author), Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	michael_pichichero@urmc.rochester.edu	Pichichero, Michael E/AID-7886-2022					Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; BLOCK SL, 2006, LANCET, V367, P740; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Clinical and Laboratory Standards Institute, 2006, PERF STAND ANT SUS S; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1060, DOI 10.1097/00006454-199711000-00011; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P1, DOI 10.1097/00006454-199901000-00002; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; Finkelstein JA, 2003, PEDIATRICS, V112, P862, DOI 10.1542/peds.112.4.862; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Garbutt J, 2006, PEDIATRICS, V117, pE1087, DOI 10.1542/peds.2005-2651; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hanage WP, 2007, J INFECT DIS, V195, P347, DOI 10.1086/510249; Harrison CJ, 2003, PEDIATR INFECT DIS J, V22, pS120, DOI 10.1097/00006454-200308001-00003; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Herz AM, 2006, PEDIATR INFECT DIS J, V25, P293, DOI 10.1097/01.inf.0000207485.39112.bf; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Joloba ML, 2001, CLIN INFECT DIS, V33, P1489, DOI 10.1086/323027; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mandell LA, 2002, CLIN INFECT DIS, V35, P721, DOI 10.1086/341900; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McEllistrem MC, 2003, J INFECT DIS, V188, P1679, DOI 10.1086/379665; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Millar EV, 2006, CLIN INFECT DIS, V43, P8, DOI 10.1086/504802; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Palmu AAI, 2004, PEDIATR INFECT DIS J, V23, P732, DOI 10.1097/01.inf.0000133049.30299.5d; Pelton SI, 2002, PEDIATR INFECT DIS J, V21, P599, DOI 10.1097/00006454-200206000-00036; Pelton SI, 2004, PEDIATR INFECT DIS J, V23, P1015, DOI 10.1097/01.inf.0000143645.58215.f0; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Pichichero ME, 2005, CLIN INFECT DIS, V41, P470, DOI 10.1086/431584; Pichichero ME, 1998, JAMA-J AM MED ASSOC, V279, P1748, DOI 10.1001/jama.279.21.1748; Pichichero ME, 2000, ANN OTO RHINOL LARYN, V109, P2, DOI 10.1177/00034894001090S801; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P3491, DOI 10.1128/AAC.48.9.3491-3497.2004; Poehling KA, 2007, PEDIATRICS, V119, P707, DOI 10.1542/peds.2006-2138; Porat N, 2004, J INFECT DIS, V190, P2154, DOI 10.1086/425908; Powell KR, 2006, PEDIATRICS, V118, P1287, DOI 10.1542/peds.2006-1722; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Temime L, 2004, ANTIMICROB AGENTS CH, V48, P2206, DOI 10.1128/AAC.48.6.2206-2213.2004; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2	51	248	256	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1772	1778		10.1001/jama.298.15.1772	http://dx.doi.org/10.1001/jama.298.15.1772			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940232	Bronze			2022-12-28	WOS:000250187300020
J	Chowdhury, ME; Botlero, R; Koblinsky, M; Saha, SK; Dieltiens, G; Ronsmans, C				Chowdhury, Mahbub Elahi; Botlero, Roslin; Koblinsky, Marge; Saha, Sajal Kumar; Dieltiens, Greet; Ronsmans, Carine			Determinants of reduction in maternal mortality in Matlab, Bangladesh: a 30-year cohort study	LANCET			English	Article							EMERGENCY OBSTETRIC CARE; HEALTH; ABORTION	Background Research on the effectiveness of strategies to reduce maternal mortality is scarce. We aimed to assess the contribution of intervention strategies, such as skilled attendance at birth, to the recorded reduction in maternal mortality in Matlab, Bangladesh. We examined and compared trends in maternal mortality in two adjacent areas over 30 years, by separate analyses of causes of death, underlying sociodemographic determinants, and areas and time periods in which interventions differed. Methods We analysed survey data that was routinely collected between 1976 and 2005 for about 200 000 inhabitants of Matlab, in Bangladesh, in adjacent areas served by either the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) or by the government. We used logistic regression to assess time trends in maternal mortality. We separately analysed deaths due to direct obstetric causes, abortion-related causes, and other causes. Findings Maternal mortality fell by 68% in the ICDDR,B service area and by 54% in the government service area over 30 years. Maternal mortality remained stable between 1976 and 1989 (crude annual OR 1.00 [0.98-1.01]) but decreased substantially after 1989 (OR 0.95 [0.93-0.97]). The speed of decline was faster after the skilled-attendance strategy was introduced in the ICDDR,B service area in 1990 (p=0.09). Abortion-related mortality fell sharply from 1990 onwards (OR 0.91 [0.86-0.95]). Educational differentials for mortality were substantial; the OR for more than 8 years of schooling compared with no schooling was 0.30 (0.21-0.44) for maternal mortality and 0.09 (0.02-0.37) for abortion mortality. Interpretation The fall in maternal mortality over 30 years occurred despite a low uptake of skilled attendance at birth. Part of the decline was due to a fall in abortion-related deaths and better access to emergency obstetric care; midwives might also have contributed by facilitating access to emergency care. Investment in midwives, emergency obstetric care, and safe pregnancy termination by manual vacuum aspiration have clearly been important. However, additional policies, such as those that bring about expansion of female education, better financial access for the poor, and poverty reduction, are essential to sustain the successes achieved to date.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Dis Epidemiol Unit, London WC1E 7HT, England; Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; Inst Trop Med, B-2000 Antwerp, Belgium	University of London; London School of Hygiene & Tropical Medicine; International Centre for Diarrhoeal Disease Research (ICDDR); Institute of Tropical Medicine (ITM)	Ronsmans, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	carine.ronsmans@lshtm.ac.uk						Ahmed MK, 2005, TROP MED INT HEALTH, V10, P198, DOI 10.1111/j.1365-3156.2004.01362.x; Ahmed SM, 2003, HEALTH POLICY PLANN, V18, P306, DOI 10.1093/heapol/czg037; Bhuiya A, 2001, J HEALTH POPUL NUTR, V19, P281; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; De Brouwere V, 2001, STUDIES HLTH SERVICE, V17, P1; DIELTIENS G, 2005, 25 GEN C INT UN SCI; FAUVEAU V, 1991, LANCET, V338, P1183, DOI 10.1016/0140-6736(91)92041-Y; Fauveau V., 1994, MATLAB WOMEN CHILDRE; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gill Z, 2004, INT J GYNECOL OBSTET, V85, P213, DOI 10.1016/j.ijgo.2004.01.004; Goodburn EA, 2000, HEALTH POLICY PLANN, V15, P394, DOI 10.1093/heapol/15.4.394; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; HILL K, 2003, NATL I POPULATION RE; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; *ICDDRB, 2007, HLTH DEM SURV SYST M, V39; *ICDDRB, 2004, HLTH DEM SURV SYST M; Islam MT, 2006, REPROD HEALTH MATTER, V14, P61, DOI 10.1016/S0968-8080(06)27229-X; KOENIG MA, 1988, STUD FAMILY PLANN, V19, P69, DOI 10.2307/1966492; MARSTON C, 2004, EFFECTS CONTRACEPTIO; *MIN FIN, 2006, PEOPL REP BANGL BANG; *NAT I POP RES TRA, 2005, BANGL DEM HLTH SURV; Rahman M, 2001, LANCET, V358, P1051, DOI 10.1016/S0140-6736(01)06182-7; Ronsmans C, 1998, STUD FAMILY PLANN, V29, P282, DOI 10.2307/172274; Ronsmans C, 1997, LANCET, V350, P1810, DOI 10.1016/S0140-6736(97)08012-4; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; RUZICKA LT, 1978, DEMOGRAPHIC SURVEILL; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400	31	92	93	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1320	1328		10.1016/S0140-6736(07)61573-6	http://dx.doi.org/10.1016/S0140-6736(07)61573-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933646				2022-12-28	WOS:000250176600025
J	McComas, DJ; Allegrini, F; Bagenal, F; Crary, F; Ebert, RW; Elliott, H; Stern, A; Valek, P				McComas, D. J.; Allegrini, F.; Bagenal, F.; Crary, F.; Ebert, R. W.; Elliott, H.; Stern, A.; Valek, P.			Diverse plasma Populations and structures in Jupiter's magnetotail	SCIENCE			English	Article							HOT PLASMA; MAGNETOSPHERE	Jupiter's magnetotail is the largest cohesive structure in the solar system and marks the loss of vast numbers of heavy ions from the Jupiter system. The New Horizons spacecraft traversed the magnetotail to distances exceeding 2500 jovian radii (R-J) and revealed a remarkable diversity of plasma populations and structures throughout its length. Ions evolve from a hot plasma disk distribution at similar to 100 R-J to slower, persistent flows down the tail that become increasingly variable in flux and mean energy. The plasma is highly structured-exhibiting sharp breaks, smooth variations, and apparent plasmoids-and contains ions from both Io and Jupiter's ionosphere with intense bursts of H+ and H-3(+). Quasi-periodic changes were seen in flux at similar to 450 and similar to 1500 R-J with a 10-hour period. Other variations in flow speed at similar to 600 to 1000 R-J with a 3- to 4-day period may be attributable to plasmoids moving down the tail.	SW Res Inst, San Antonio, TX 78238 USA; Univ Texas, Dept Phys & Astron, San Antonio, TX 78249 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; NASA Headquarters, Sci Mission Directorate, Washington, DC 20546 USA	Southwest Research Institute; University of Texas System; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA)	McComas, DJ (corresponding author), SW Res Inst, 6220 Culebra Rd, San Antonio, TX 78238 USA.	dmccomas@swri.edu	McComas, David J/H-6202-2011	McComas, David J/0000-0001-6160-1158; Allegrini, Frederic/0000-0003-0696-4380; Valek, Philip/0000-0002-2318-8750				Bagenal F, 2007, J ATMOS SOL-TERR PHY, V69, P387, DOI 10.1016/j.jastp.2006.08.012; Delamere PA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009706; Fukazawa K, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011874; Hill T. W., 1983, PHYSICS JOVIAN MAGNE, P353, DOI DOI 10.1017/CBO9780511564574.012; Khurana KK, 2004, CAMB PLANET, P593; Kivelson MG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011176; Krimigis S. M., 1983, PHYSICS JOVIAN MAGNE, P106, DOI [10.1029/CBO9780511564574.005, DOI 10.1017/CBO9780511564574.006]; KRIMIGIS SM, 1981, J GEOPHYS RES-SPACE, V86, P8227, DOI 10.1029/JA086iA10p08227; Kronberg EA, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011994; Krupp N, 2004, CAMB PLANET, P617; Krupp N, 1998, GEOPHYS RES LETT, V25, P1249, DOI 10.1029/98GL00863; MCCOMAS DJ, 1993, J GEOPHYS RES-SPACE, V98, P13453, DOI 10.1029/93JA00726; McNutt RL, 2007, SCIENCE, V318, P220, DOI 10.1126/science.1148025; NAGY AF, 1986, J GEOPHYS RES, V91, P351, DOI 10.1029/JA091iA01p00351; SITTLER EC, 1987, J GEOPHYS RES, V92, P9943, DOI 10.1029/JA092iA09p09943; Thomas N, 2004, CAMB PLANET, P561; Vasyliunas V.M., 1983, PHYS JOVIAN MAGNETOS, P395, DOI [10.1017/CBO9780511564574.013, DOI 10.1017/CBO9780511564574.013, 10.1017/cbo9780511564574.013]; Yelle RV, 2004, CAMB PLANET, P185	18	73	73	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					217	220		10.1126/science.1147393	http://dx.doi.org/10.1126/science.1147393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932282				2022-12-28	WOS:000250086100030
J	Stuchell-Brereton, MD; Skalicky, JJ; Kieffer, C; Karren, MA; Ghaffarian, S; Sundquist, WI				Stuchell-Brereton, Melissa D.; Skalicky, Jack J.; Kieffer, Collin; Karren, Mary Anne; Ghaffarian, Sanaz; Sundquist, Wesley I.			ESCRT-III recognition by VPS4 ATPases	NATURE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; PROTEIN INTERACTIONS; MIT DOMAIN; SACCHAROMYCES-CEREVISIAE; MEMBRANE-TRAFFICKING; MAMMALIAN-CELLS; COMPLEX; MACHINERY; AMSH; IDENTIFICATION	The ESCRT (endosomal sorting complex required for transport) pathway is required for terminal membrane fission events in several important biological processes, including endosomal intraluminal vesicle formation(1,2), HIV budding(3) and cytokinesis(4). VPS4 ATPases perform a key function in this pathway by recognizing membrane-associated ESCRT-III assemblies and catalysing their disassembly(5-7), possibly in conjunction with membrane fission. Here we show that the microtubule interacting and transport (MIT) domains of human VPS4A and VPS4B bind conserved sequence motifs located at the carboxy termini of the CHMP1-3 class of ESCRT-III proteins. Structures of VPS4A MIT-CHMP1A and VPS4B MIT-CHMP2B complexes reveal that the C-terminal CHMP motif forms an amphipathic helix that binds in a groove between the last two helices of the tetratricopeptide-like repeat (TPR) of the VPS4 MIT domain, but in the opposite orientation to that of a canonical TPR interaction. Distinct pockets in the MIT domain bind three conserved leucine residues of the CHMP motif, and mutations that inhibit these interactions block VPS4 recruitment, impair endosomal protein sorting and relieve dominant-negative VPS4 inhibition of HIV budding. Thus, our studies reveal how the VPS4 ATPases recognize their CHMP substrates to facilitate the membrane fission events required for the release of viruses, endosomal vesicles and daughter cells.	Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Dept Biochem, Room 4100,15 N Med Dr E, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu			NIAID NIH HHS [R01 AI051174] Funding Source: Medline; NIGMS NIH HHS [P50 GM082545] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Howard TL, 2001, J CELL SCI, V114, P2395; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Phillips SA, 2001, J BIOL CHEM, V276, P5074, DOI 10.1074/jbc.M004671200; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	30	242	246	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					740	744		10.1038/nature06172	http://dx.doi.org/10.1038/nature06172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928862				2022-12-28	WOS:000250045000048
J	Butler, D				Butler, Declan			France lays plans for a green future	NATURE			English	News Item																		2007, NATURE, V447, P518	1	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					518	518		10.1038/449518a	http://dx.doi.org/10.1038/449518a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17972363	Bronze			2022-12-28	WOS:000249893500009
J	Buyske, J				Buyske, Jo			Natural orifice transluminal endoscopic surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Sch Med, Penn Presbyterian Med Ctr, Dept Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Presbyterian Medical Center	Buyske, J (corresponding author), Univ Penn, Sch Med, Penn Presbyterian Med Ctr, Dept Surg, 39th & Market St, Philadelphia, PA 19104 USA.	jo.buyske@uphs.upenn.edu						Kalloo AN, 2004, GASTROINTEST ENDOSC, V60, P114, DOI 10.1016/S0016-5107(04)01309-4; Marescaux J, 2007, ARCH SURG-CHICAGO, V142, P823, DOI 10.1001/archsurg.142.9.823; Mouret P, 1996, Ann Acad Med Singap, V25, P744; Rattner D, 2006, SURG ENDOSC, V20, P711, DOI 10.1007/s00464-006-0263-5; Rattner D, 2006, SURG ENDOSC, V20, P329, DOI 10.1007/s00464-005-3006-0; REDDY N, 2004, 45 ANN C SOC GASTR E	6	9	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1560	1561		10.1001/jama.298.13.1560	http://dx.doi.org/10.1001/jama.298.13.1560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17915355				2022-12-28	WOS:000249860500029
J	Strander, B; Andersson-Ellstrom, A; Milsom, I; Sparen, P				Strander, Bjorn; Andersson-Ellstrom, Agneta; Milsom, Ian; Sparen, Par			Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA; DIAGNOSIS; HPV; ADENOCARCINOMA; TRENDS; WOMEN	Objective To study the long term risk of invasive cancer of the cervix or vagina after treatment for cervical intraepithelial neoplasia grade 3. Design Prospective cohort study. Setting Swedish cancer registry. Participants All women in Sweden with severe dysplasia or cervical carcinoma in situ (equivalent to cervical intraepithelial neoplasia grade 3) treated during 1958-2002 (n=132 493) contributing 2 315 724 woman years. Main outcome measures Standardised incidence ratios with risk of cancer in the Swedish general female population as reference and relative risks in multivariable log-linear regression model with internal references. Results Women with previous cervical intraelpithelial neoplasia grade 3 had an increased risk of invasive cervical cancer compared with the general female population (standardised incidence ratio 2.34 95% confidence interval 2.18 to 2.50). The increased risk showed a decreasing trend with time since diagnosis for women treated later than 1970 but the risk was still increased after 25 years. An effect of age was found with an accentuated increase in risk for women aged more than 50. The excess risk for cervical cancer associated with previous cervical intraepithelial neoplasia grade 3 has steadily increased since 1958. For vaginal cancer the standardised incidence ratio was 6.82 (5.61 to 8.21) but this decreased to 2.65 after 25 years. Adjustments in the multivariable log-linear regression model did not substantially alter these results. Conclusions Women previously treated for cervical intraepithelial neoplasia grade 3 are at an increased risk of developing invasive cervical cancer and vaginal cancer. This risk has increased since the 1960s and is accentuated in women aged more than 50. The risk is still increased 25 years after treatment.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Gothenburg Univ, Dept Obstet & Gynecol, Sahlgrens Acad, SU, SE-41685 Ostra Sjukhuset, Sweden	Karolinska Institutet; University of Gothenburg	Strander, B (corresponding author), Sahlgrens Univ Hosp, Ctr Oncol, SE-41345 Gothenburg, Sweden.	bjorn.strander@oc.gu.se	Strander, Björn/AAB-2609-2021	Strander, Björn/0000-0001-8369-7955; Sparen, Par/0000-0002-5184-8971				Andersson-Ellstrom A, 2000, ACTA OBSTET GYN SCAN, V79, P221, DOI 10.1034/j.1600-0412.2000.079003221.x; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Edgren G, 2007, LANCET ONCOL, V8, P311, DOI 10.1016/S1470-2045(07)70043-8; *HARG, 1997, ATT FOR CERV SAMT VA; Hellman K, 2004, INT J GYNECOL CANCER, V14, P491, DOI 10.1111/j.1048-891x.2004.014310.x; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; KOLSTAD P, 1976, OBSTET GYNECOL, V48, P125; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; *NAT BOARD HLTH WE, 1998, GYN CELLPR FORSL SCR; National Board of Health and Welfare, 1998, SWED HOSP DISCH REG; PETTERSSON F, 1985, INT J EPIDEMIOL, V14, P521, DOI 10.1093/ije/14.4.521; PETTERSSON F, 1989, RADIOTHER ONCOL, V16, P115, DOI 10.1016/0167-8140(89)90028-5; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; STRANDER B, 2004, SVENSK GYNEKOLOGI UN; Strander B, 2007, EUR J CANCER, V43, P1849, DOI 10.1016/j.ejca.2007.05.016; The National Board of Health and Welfare; Centre for Epidemiology, 2005, CANC INC SWED 2003; Zielinski GD, 2004, OBSTET GYNECOL SURV, V59, P543, DOI 10.1097/00006254-200407000-00024	21	105	118	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2007	335	7629					1077	+		10.1136/bmj.39363.471806.BE	http://dx.doi.org/10.1136/bmj.39363.471806.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UX	17959735	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000251403000035
J	Iglehart, JK				Iglehart, John K.			The Fate of SCHIP - Surrogate marker for health care ideology?	NEW ENGLAND JOURNAL OF MEDICINE			English	News Item																		HOLAHAN J, 2007, WHAT HAPPENED INSURA; MANN C, 2007, MOVING BACKWARD NEW; Reischauer RD, 2007, NEW ENGL J MED, V356, P1393, DOI 10.1056/NEJMp078034; Smith Devyn, COMMUNICATION	4	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2104	2107		10.1056/NEJMp0706881	http://dx.doi.org/10.1056/NEJMp0706881			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	17947389				2022-12-28	WOS:000251076500002
J	Qian, B; Raman, S; Das, R; Bradley, P; McCoy, AJ; Read, RJ; Baker, D				Qian, Bin; Raman, Srivatsan; Das, Rhiju; Bradley, Philip; McCoy, Airlie J.; Read, Randy J.; Baker, David			High-resolution structure prediction and the crystallographic phase problem	NATURE			English	Article							PROTEIN-STRUCTURE PREDICTION; STRUCTURE REFINEMENT; MOLECULAR-REPLACEMENT; MASS-SPECTROMETRY; STRUCTURE MODELS; NMR STRUCTURES; X-RAY; ALIGNMENT; IDENTIFICATION; INFORMATION	The energy-based refinement of low-resolution protein structure models to atomic-level accuracy is a major challenge for computational structural biology. Here we describe a new approach to refining protein structure models that focuses sampling in regions most likely to contain errors while allowing the whole structure to relax in a physically realistic all-atom force field. In applications to models produced using nuclear magnetic resonance data and to comparative models based on distant structural homologues, the method can significantly improve the accuracy of the structures in terms of both the backbone conformations and the placement of core side chains. Furthermore, the resulting models satisfy a particularly stringent test: they provide significantly better solutions to the X-ray crystallographic phase problem in molecular replacement trials. Finally, we show that all-atom refinement can produce de novo protein structure predictions that reach the high accuracy required for molecular replacement without any experimental phase information and in the absence of templates suitable for molecular replacement from the Protein Data Bank. These results suggest that the combination of high-resolution structure prediction with state-of-the-art phasing tools may be unexpectedly powerful in phasing crystallographic data for which molecular replacement is hindered by the absence of sufficiently accurate previous models.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Cambridge	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Read, Randy J/L-1418-2013	Baker, David/0000-0001-7896-6217; Read, Randy J/0000-0001-8273-0047; Das, Rhiju/0000-0001-7497-0972	Wellcome Trust [050211] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bonneau R, 2001, PROTEINS, V43, P1, DOI 10.1002/1097-0134(20010401)43:1<1::AID-PROT1012>3.0.CO;2-A; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chen CL, 2000, J MOL CATAL B-ENZYM, V8, P213, DOI 10.1016/S1381-1177(99)00059-4; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; DAS R, 2007, PROTEINS        0925, DOI DOI 10.1002/PROT.21636; Dauter Z, 2002, CURR OPIN STRUC BIOL, V12, P674, DOI 10.1016/S0959-440X(02)00372-X; Doreleijers JF, 1998, J MOL BIOL, V281, P149, DOI 10.1006/jmbi.1998.1808; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Garbuzynskiy SO, 2005, PROTEINS, V60, P139, DOI 10.1002/prot.20491; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Giorgetti A, 2005, BIOINFORMATICS, V21, P72, DOI 10.1093/bioinformatics/bti1112; Glover F., 1997, TABU SEARCH; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leaver-Fay A, 2005, LECT NOTES COMPUT SC, V3692, P389; Lee J, 1999, P NATL ACAD SCI USA, V96, P2025, DOI 10.1073/pnas.96.5.2025; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Moult J, 2005, PROTEINS, V61, P3, DOI 10.1002/prot.20716; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petsko GA, 2000, GENOME BIOL, VI; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Plewczynski D, 2004, ACTA BIOCHIM POL, V51, P161; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; ROSSMANN MG, 1995, CURR OPIN STRUC BIOL, V5, P650, DOI 10.1016/0959-440X(95)80058-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Strop P, 2007, ACTA CRYSTALLOGR D, V63, P188, DOI 10.1107/S0907444906045793; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Wales DJ, 1999, SCIENCE, V285, P1368, DOI 10.1126/science.285.5432.1368; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	50	250	282	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					259	264		10.1038/nature06249	http://dx.doi.org/10.1038/nature06249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17934447	Green Accepted			2022-12-28	WOS:000250746200052
J	Chalasani, SH; Chronis, N; Tsunozaki, M; Gray, JM; Ramot, D; Goodman, MB; Bargmann, CI				Chalasani, Sreekanth H.; Chronis, Nikos; Tsunozaki, Makoto; Gray, Jesse M.; Ramot, Daniel; Goodman, Miriam B.; Bargmann, Cornelia I.			Dissecting a circuit for olfactory behaviour in Caenorhabditis elegans	NATURE			English	Article							GLR-1 GLUTAMATE-RECEPTOR; GATED CHLORIDE CHANNEL; STEP-RESPONSE ANALYSIS; C-ELEGANS; NEURAL ACTIVITY; NERVOUS-SYSTEM; NEURONS ENCODE; THERMOTAXIS; CHEMOTAXIS; EXPRESSION	Although many properties of the nervous system are shared among animals and systems, it is not known whether different neuronal circuits use common strategies to guide behaviour. Here we characterize information processing by Caenorhabditis elegans olfactory neurons (AWC) and interneurons (AIB and AIY) that control food- and odour-evoked behaviours. Using calcium imaging and mutations that affect specific neuronal connections, we show that AWC neurons are activated by odour removal and activate the AIB interneurons through AMPA-type glutamate receptors. The level of calcium in AIB interneurons is elevated for several minutes after odour removal, a neuronal correlate to the prolonged behavioural response to odour withdrawal. The AWC neuron inhibits AIY interneurons through glutamate-gated chloride channels; odour presentation relieves this inhibition and results in activation of AIY interneurons. The opposite regulation of AIY and AIB interneurons generates a coordinated behavioural response. Information processing by this circuit resembles information flow from vertebrate photoreceptors to 'OFF' bipolar and 'ON' bipolar neurons, indicating a conserved or convergent strategy for sensory information processing.	Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; Stanford Univ, Program Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Rockefeller University; Stanford University; Stanford University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@rockefeller.edu	CHRONIS, NIKOS/AAJ-5084-2021	CHRONIS, NIKOS/0000-0003-3830-1979; Bargmann, Cornelia/0000-0002-8484-0618; Goodman, Miriam B./0000-0002-5810-1272	NINDS NIH HHS [R01 NS047715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bargmann C. I., 2006, WORMBOOK; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chou JH, 2001, GENETICS, V157, P211; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; DAVIS RE, 1989, J NEUROSCI, V9, P415; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dillon J, 2006, BIOCHEM SOC T, V34, P942, DOI 10.1042/BST0340942; DUSENBERY DB, 1980, J COMP PHYSIOL, V136, P327, DOI 10.1007/BF00657352; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GRANT GB, 1995, J NEUROSCI, V15, P3852; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Horoszok L, 2001, BRIT J PHARMACOL, V132, P1247, DOI 10.1038/sj.bjp.0703937; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Miller AC, 2005, J NEUROSCI, V25, P3369, DOI 10.1523/JNEUROSCI.5133-04.2005; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Ryu WS, 2002, J NEUROSCI, V22, P5727; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Zariwala HA, 2003, J NEUROSCI, V23, P4369; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	50	400	413	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					63	+		10.1038/nature06292	http://dx.doi.org/10.1038/nature06292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972877				2022-12-28	WOS:000250585800036
J	Chen, KY; Cong, B; Wing, R; Vrebalov, J; Tanksley, SD				Chen, Kai-Yi; Cong, Bin; Wing, Rod; Vrebalov, Julia; Tanksley, Steven D.			Changes in regulation of a transcription factor lead to autogamy in cultivated tomatoes	SCIENCE			English	Article							LYCOPERSICON; BACKCROSS; PLANTS; QTL	We report the cloning of Style2.1, the major quantitative trait locus responsible for a key floral attribute (style length) associated with the evolution of self-pollination in cultivated tomatoes. The gene encodes a putative transcription factor that regulates cell elongation in developing styles. The transition from cross-pollination to self-pollination was accompanied, not by a change in the STYLE2.1 protein, but rather by a mutation in the Style2.1 promoter that results in a down-regulation of Style2.1 expression during flower development.	Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Univ Arizona, Dept Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; Cornell Univ, USDA ARS, Plant Soil Nutr Lab, Ithaca, NY 14853 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; University of Arizona; Cornell University; United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research	Tanksley, SD (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA.	sdt4@cornell.edu	Wing, Rod A/Z-2885-2019	Wing, Rod A/0000-0001-6633-6226; CHEN, KAI-YI/0000-0002-6211-0198				Barrett S.C.H., 1990, BIOL APPROACHES EVOL, P229, DOI DOI 10.1016/B978-0-12-402960-6.50019-6; Bernacchi D, 1997, GENETICS, V147, P861; Brown A. H. D., 1989, Isozymes in plant biology., P73; Chen KY, 2004, GENETICS, V168, P1563, DOI 10.1534/genetics.103.022558; Fulton TM, 1997, THEOR APPL GENET, V95, P881, DOI 10.1007/s001220050639; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P621; Rick C. M., 1979, The biology and taxonomy of the Solanaceae, P667; Rick C.M., 1988, PLANT EVOLUTIONARY B, P133, DOI DOI 10.1007/978-94-009-1207-6_6; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; Smyth DR, 2005, PLANT CELL, V17, P330, DOI 10.1105/tpc.104.030353; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249	14	104	110	5	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					643	645		10.1126/science.1148428	http://dx.doi.org/10.1126/science.1148428			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962563				2022-12-28	WOS:000250409200046
J	Fryxell, JM; Mosser, A; Sinclair, ARE; Packer, C				Fryxell, John M.; Mosser, Anna; Sinclair, Anthony R. E.; Packer, Craig			Group formation stabilizes predator-prey dynamics	NATURE			English	Article							FUNCTIONAL-RESPONSES; POPULATION-DYNAMICS; SPATIAL SCALE; LIONS; FOOD	Theoretical ecology is largely founded on the principle of mass action, in which uncoordinated populations of predators and prey move in a random and well-mixed fashion across a featureless landscape. The conceptual core of this body of theory is the functional response, predicting the rate of prey consumption by individual predators as a function of predator and/or prey densities(1-5). This assumption is seriously violated in many ecosystems in which predators and/or prey form social groups. Here we develop a new set of group-dependent functional responses to consider the ecological implications of sociality and apply the model to the Serengeti ecosystem. All of the prey species typically captured by Serengeti lions (Panthera leo) are gregarious, exhibiting nonlinear relationships between prey-group density and population density. The observed patterns of group formation profoundly reduce food intake rates below the levels expected under random mixing, having as strong an impact on intake rates as the seasonal migratory behaviour of the herbivores. A dynamical system model parameterized for the Serengeti ecosystem (using wildebeest (Connochaetes taurinus) as a well-studied example) shows that grouping strongly stabilizes interactions between lions and wildebeest. Our results suggest that social groups rather than individuals are the basic building blocks around which predator-prey interactions should be modelled and that group formation may provide the underlying stability of many ecosystems.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of Guelph; University of Minnesota System; University of Minnesota Twin Cities; University of British Columbia	Fryxell, JM (corresponding author), Univ Guelph, Dept Integrat Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	jfryxell@uoguelph.ca						Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; CANTRELL RS, 1991, J MATH BIOL, V29, P315, DOI 10.1007/BF00167155; Cosner C, 1999, THEOR POPUL BIOL, V56, P65, DOI 10.1006/tpbi.1999.1414; Donalson DD, 1999, ECOLOGY, V80, P2492, DOI 10.1890/0012-9658(1999)080[2492:PDASSE]2.0.CO;2; ELLIOTT JP, 1977, CAN J ZOOL, V55, P1811, DOI 10.1139/z77-235; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; GRINNELL J, 1995, ANIM BEHAV, V49, P95, DOI 10.1016/0003-3472(95)80157-X; Hastings A., 1997, POPULATION BIOL CONC; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hosseini PR, 2003, AM NAT, V161, P567, DOI 10.1086/368293; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Keeling MJ, 2000, SCIENCE, V290, P1758, DOI 10.1126/science.290.5497.1758; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Nachman G, 2006, J ANIM ECOL, V75, P948, DOI 10.1111/j.1365-2656.2006.01114.x; Nisbet RM, 1998, ECOL LETT, V1, P34, DOI 10.1046/j.1461-0248.1998.00011.x; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Pascual M, 2001, ECOLOGY, V82, P2357, DOI 10.1890/0012-9658(2001)082[2357:ODASST]2.0.CO;2; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; SCHEEL D, 1993, BEHAV ECOL, V4, P90, DOI 10.1093/beheco/4.1.90; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Yodzis P., 1989, INTRO THEORETICAL EC	29	154	156	0	143	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1041	U4		10.1038/nature06177	http://dx.doi.org/10.1038/nature06177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960242				2022-12-28	WOS:000250395000050
J	Goldston, D				Goldston, David			Spending stalemate	NATURE			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					962	962		10.1038/449962a	http://dx.doi.org/10.1038/449962a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960207				2022-12-28	WOS:000250395000012
J	Towbin, JA				Towbin, Jeffrey A.			Scarring in the heart - A reversible phenomenon?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FIBROSIS		Baylor Coll Med, Dept Pediat, Pediat Cardiol Sect, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat, Pediat Cardiol Sect, Houston, TX 77030 USA.		Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X				Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	4	26	29	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1767	1768		10.1056/NEJMcibr075397	http://dx.doi.org/10.1056/NEJMcibr075397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960018				2022-12-28	WOS:000250355100016
J	Reddy, M; Gill, SS; Kalkar, SR; Wu, W; Anderson, PJ; Rochon, PA				Reddy, Madhuri; Gill, Sudeep S.; Kalkar, Sunila R.; Wu, Wei; Anderson, Peter J.; Rochon, Paula A.			Oral drug therapy for multiple neglected tropical diseases - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TRANSMITTED HELMINTH INFECTIONS; INTESTINAL NEMATODE INFECTIONS; RANDOMIZED CONTROLLED-TRIALS; WUCHERERIA-BANCROFTI; TRICHURIS-TRICHIURA; PYRANTEL PAMOATE; CLINICAL-TRIALS; ALBENDAZOLE; MEBENDAZOLE; EFFICACY	Context The neglected tropical diseases include 13 conditions that occur in areas of extreme poverty and are poverty promoting. The neglected tropical diseases produce a disease burden almost as great as that associated with human immunodeficiency virus/AIDS, tuberculosis, or malaria, yet are virtually unknown by health care workers in North America, because they occur almost exclusively in the poorest regions of the world. Seven of the most prevalent diseases have existing oral drug treatments. Identifying treatments that are effective against more than 1 disease could facilitate efficient and inexpensive treatment. Objectives To systematically review the evidence for drug treatments and to increase awareness that neglected tropical diseases exist and that treatments are available. Data Sources and Study Selection Using a MEDLINE search ( 1966 through June 2007), randomized controlled trials (RCTs) were reviewed that examined simultaneous treatment of 2 or more of the 7 most prevalent neglected tropical diseases using oral drug therapy. Data Synthesis Twenty-nine RCTs were identified, of which 3 targeted 4 diseases simultaneously, 20 targeted 3 diseases, and 6 targeted 2 diseases. Trials were published between 1972 and 2005 and baseline prevalence of individual diseases varied among RCTs. Albendazole plus diethylcarbamazine significantly reduced prevalence of elephantiasis (16.7% to 5.3%), hookworm (10.3% to 1.9%), roundworm (34.5% to 2.3%), and whipworm (55.5% to 40.3%). Albendazole plus ivermectin significantly reduced prevalence of elephantiasis (12.6% to 4.6%), hookworm (7.8% to 0%), roundworm (33.5% to 6.1%), and whipworm (42.7% to 8.9%). Levamisole plus mebendazole significantly reduced prevalence of hookworm (94.0% to 71.8%), roundworm (62.0% to 1.4%), and whipworm (93.1% to 74.5%). Pyrantel-oxantel significantly reduced hookworm (93.4% to 85.2%), roundworm (22.8% to 1.4%), and whipworm (86.8% to 59.5%), while albendazole alone significantly reduced prevalence of hookworm (8.1% to 1.3%), roundworm (28.4% to 0.9%), and whipworm (51.9% to 31.9%). No RCT examined treatment of river blindness or trachoma as part of an intervention to target 2 or more neglected tropical diseases. Adverse events were generally inadequately reported. Conclusions At least 2 of the most prevalent neglected tropical diseases can be treated simultaneously with existing oral drug treatments, facilitating effective and efficient treatment. Increasing awareness about neglected tropical diseases, their global impact, and the availability of oral drug treatments is an essential step in controlling these diseases.	Hebrew Rehabil Ctr, Dept Med, Boston, MA 02131 USA; Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON K7L 3N6, Canada; Univ Toronto, Baycrest Kunin Lunenfeld Appl Res Unit, Dept Med, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; Queens University - Canada; Queens University - Canada; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Reddy, M (corresponding author), Hebrew Rehabil Ctr, Dept Med, 1200 Ctr St, Boston, MA 02131 USA.	madhurireddy@hrca.harvard.edu	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151; Wu, Wei/0000-0002-9633-4122				Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343; Albonico M, 2002, T ROY SOC TROP MED H, V96, P685, DOI 10.1016/S0035-9203(02)90352-4; ALBONICO M, 1995, T ROY SOC TROP MED H, V89, P538, DOI 10.1016/0035-9203(95)90101-9; ALBONICO M, 1994, T ROY SOC TROP MED H, V88, P585, DOI 10.1016/0035-9203(94)90174-0; Albonico M, 1999, INT J EPIDEMIOL, V28, P591, DOI 10.1093/ije/28.3.591; [Anonymous], CONTR NEGL TROP DIS; *B M GAT FDN, LEAD GLOB HLTH ORG R; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Barry M, 2007, NEW ENGL J MED, V356, P2561, DOI 10.1056/NEJMp078089; BARTOLONI A, 1993, TROP GEOGR MED, V45, P114; Beach MJ, 1999, AM J TROP MED HYG, V60, P479, DOI 10.4269/ajtmh.1999.60.479; BEHNKE JM, 1994, J HELMINTHOL, V68, P187, DOI 10.1017/S0022149X00014334; Belizario VY, 2003, B WORLD HEALTH ORGAN, V81, P35; Beller EM, 2002, MED J AUSTRALIA, V177, P565, DOI 10.5694/j.1326-5377.2002.tb04955.x; Bundy D. A. P., 1992, World Health Statistics Quarterly, V45, P168; Canning D, 2006, T ROY SOC TROP MED H, V100, P499, DOI 10.1016/j.trstmh.2006.02.001; CHAN M, WHO GLOB PARTN M NEG; Charoenlarp Pricha, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P712; Chirac P, 2006, LANCET, V367, P1560, DOI 10.1016/S0140-6736(06)68672-8; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Egger M, 2003, Health Technol Assess, V7, P1; EHRENBERG JP, BMC PUBLIC HLTH, V5; FARAHMANDIAN I, 1977, CHEMOTHERAPY, V23, P98, DOI 10.1159/000221977; Fenwick A, 2005, LANCET, V365, P1029, DOI 10.1016/s0140-6736(05)71134-x; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Fox LM, 2005, AM J TROP MED HYG, V73, P115, DOI 10.4269/ajtmh.2005.73.115; Gebski VJ, 2001, MED J AUSTRALIA, V175, P272, DOI 10.5694/j.1326-5377.2001.tb143565.x; *GLOB NETW NEGL TR, CONTR NTDS; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006; HALL A, 1994, T ROY SOC TROP MED H, V88, P110, DOI 10.1016/0035-9203(94)90525-8; HOANG TK, 1993, MED PARAZITOL MOSK, V2, P27; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hopkins DR, 2005, AM J TROP MED HYG, V73, P669, DOI 10.4269/ajtmh.2005.73.669; Hotez P, 2005, LANCET, V365, P2089, DOI 10.1016/S0140-6736(05)66730-X; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JANCLOES MF, 1979, TROP GEOGR MED, V31, P111; Jongsuksuntigul Praphasri, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P724; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 2002, JAMA-J AM MED ASSOC, V288, P2407; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; KRISTOF ND, 2007, NY TIMES        0702; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Legesse M, 2004, East Afr Med J, V81, P134; Legesse M, 2002, ETHIOPIAN MED J, V40, P335; Lietman TM, 2006, LANCET, V367, P395, DOI 10.1016/S0140-6736(06)68134-8; LUCAS AO, 1972, ANN TROP MED PARASIT, V66, P391, DOI 10.1080/00034983.1972.11686840; Marti H, 1996, AM J TROP MED HYG, V55, P477, DOI 10.4269/ajtmh.1996.55.477; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Montori VM, 2001, CAN MED ASSOC J, V165, P1339; Muchiri EM, 2001, J PARASITOL, V87, P413, DOI 10.1645/0022-3395(2001)087[0413:ACSODA]2.0.CO;2; Olds GR, 1999, J INFECT DIS, V179, P996, DOI 10.1086/314686; Ortiz JJ, 2002, T ROY SOC TROP MED H, V96, P193, DOI 10.1016/S0035-9203(02)90301-9; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; PENE P, 1982, AM J TROP MED HYG, V31, P263, DOI 10.4269/ajtmh.1982.31.263; PENE P, 1981, B SOC PATHOL EXOT, V74, P590; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Rahman Wahab A., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P765; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; ROSSIGNOL JF, 1983, T ROY SOC TROP MED H, V77, P707, DOI 10.1016/0035-9203(83)90211-0; Sachs J. D., 2005, END POVERTY EC POSSI; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Sachs Jeffrey D, 2007, Sci Am, V296, p33A; Savioli L, 2003, AM J OBSTET GYNECOL, V188, P5, DOI 10.1067/mob.2003.78; *SCHIST CONTR IN, INT MASS TREATM NEGL; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SIMEON DT, 1995, J NUTR, V125, P1875, DOI 10.1093/jn/125.7.1875; SINNIAH B, 1981, ANN TROP MED PARASIT, V75, P315, DOI 10.1080/00034983.1981.11687445; Sorensen Eigil, 1996, Ceylon Medical Journal, V41, P42; SRIDHARAN R, LEPROSY; STEPHENSON LS, 1989, AM J TROP MED HYG, V41, P436, DOI 10.4269/ajtmh.1989.41.436; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Utzinger J, 2006, PLOS MED, V3, P585, DOI 10.1371/journal.pmed.0030112; Verhagen AP, 2001, J CLIN EPIDEMIOL, V54, P651, DOI 10.1016/S0895-4356(00)00360-7; WESCHE D, 1994, PAPUA NEW GUINEA MED, V37, P7; WESCHE D, 1994, PAPUA NEW GUINEA MED, V37, P12; WHO, TRACH; *WHO, GOAL 6 COMM DIS PREV; *WHO, 1994, WHO INF CONS HOOKW I; *WHO, 2002, WHO INF CONS US PRAZ; WHO, AFR TRYP SLEEP SICKN; *WHO DEP CONTR NEG, NEGL TROP DIS HIDD S; World Health Organization, PREV CHEM HUM HELM; Xia Z H, 1992, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V10, P279; Yamey G, 2007, BMJ-BRIT MED J, V335, P269, DOI 10.1136/bmj.39281.645035.80; Yang YP, 2004, PROG SAFETY SCI TECH, V4, P285; Zu L Q, 1992, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V10, P95; 2007, LANCET, V369, P1404	97	75	76	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1911	1924		10.1001/jama.298.16.1911	http://dx.doi.org/10.1001/jama.298.16.1911			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954542				2022-12-28	WOS:000250356700023
J	Bolnick, DA; Fullwiley, D; Duster, T; Cooper, RS; Fujimura, JH; Kahn, J; Kaufman, JS; Marks, J; Morning, A; Nelson, A; Ossorio, P; Reardon, J; Reverby, SM; TallBear, K				Bolnick, Deborah A.; Fullwiley, Duana; Duster, Troy; Cooper, Richard S.; Fujimura, Joan H.; Kahn, Jonathan; Kaufman, Jay S.; Marks, Jonathan; Morning, Ann; Nelson, Alondra; Ossorio, Pilar; Reardon, Jenny; Reverby, Susan M.; TallBear, Kimberly			The science and business of genetic ancestry testing	SCIENCE			English	Editorial Material									Univ Texas, Dept Anthropol, Austin, TX 78712 USA; Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Harvard Univ, Dept African & African Amer Studies, Cambridge, MA 02138 USA; NYU, Dept Sociol, New York, NY 10003 USA; Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA; Loyola Univ, Chicago Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ Wisconsin, Dept Sociol, Madison, WI 53706 USA; Hamline Univ Sch Law, St Paul, MN USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Dept Anthropol, Charlotte, NC 28223 USA; Yale Univ, Dept Sociol, New Haven, CT USA; Yale Univ, Dept African Amer Studies, New Haven, CT USA; Univ Wisconsin, Sch Law, Madison, WI 53706 USA; Univ Calif Santa Cruz, Dept Sociol, Santa Cruz, CA 95064 USA; Wellesley Coll, Dept Womens Studies, Wellesley, MA 02181 USA; Arizona State Univ, Dept Amer Indian Studies, Tempe, AZ USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; Harvard University; Harvard University; New York University; University of California System; University of California Berkeley; Loyola University Chicago; University of Wisconsin System; University of Wisconsin Madison; Mitchell Hamline School of Law; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte; Yale University; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Cruz; Wellesley College; Arizona State University; Arizona State University-Tempe; University of California System; University of California Berkeley	Bolnick, DA (corresponding author), Univ Texas, Dept Anthropol, Austin, TX 78712 USA.	deborah.bolnick@mail.utexas.edu		Nelson, Alondra/0000-0003-0383-1806; Morning, Ann/0000-0003-2798-6984; Kaufman, Jay/0000-0003-1606-401X				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Enoch Mary-Anne, 2006, J Psychopharmacol, V20, P19, DOI 10.1177/1359786806066041; HAMBLIN M, 2002, AM J HUM GENET, V66, P1669; HARMON A, 2006, NY TIMES        0412, pA1; Harris P., 2007, OBSERVER LONDON 0715, P22; HOERNER B, 2005, WIRED, P13; Hudson K, 2007, AM J HUM GENET, V81, P635, DOI 10.1086/521634; Mourant AE., 1976, DISTRIBUTION HUMAN B; Reardon Jenny, 2004, RACE FINISH IDENTITY; Rotimi Charles N, 2003, Dev World Bioeth, V3, P151, DOI 10.1046/j.1471-8731.2003.00071.x; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Simons J, 2007, FORTUNE, V155, P37; *TAK MED PROD, 2003, MOTH GEN JOURN; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Weiss KM, 2005, EVOL ANTHROPOL, V14, P165, DOI 10.1002/evan.20079; Wolinsky H, 2006, EMBO REP, V7, P1072, DOI 10.1038/sj.embor.7400843; YANG A, 2007, CHANCE, V20, P32	17	179	182	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					399	400		10.1126/science.1150098	http://dx.doi.org/10.1126/science.1150098			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947567				2022-12-28	WOS:000250230400028
J	von Elm, E; Altman, DG; Egger, M; Pocock, SJ; Gotzsche, PF; Vandenbroucke, JP				von Elm, Erik; Altman, Douglas G.; Egger, Matthias; Pocock, Stuart J.; Gotzsche, Peter F.; Vandenbroucke, Jan P.		STROBE Initiative	The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-RESEARCH; QUALITY; CONSORT; EXTENSION; INTERVENTIONS; HARMS; NEED	Much biomedical research is observational. The reporting of such research is often inadequate, which hampers the assessment of its strengths and weaknesses and of a study's generalizability. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Initiative developed recommendations on what should be included in an accurate and complete report of an observational study. We defined the scope of the recommendations to cover 3 main study designs: cohort, case-control, and crosssectional studies. We convened a 2-day workshop in September 2004, with methodologists, researchers, and journal editors, to draft a checklist of items. This list was subsequently revised during several meetings of the coordinating group and in e-mail discussions with the larger group of STROBE contributors, taking into account empirical evidence and methodological considerations. The workshop and the subsequent iterative process of consultation and revision resulted in a checklist of 22 items (the STROBE Statement) that relate to the title, abstract, introduction, methods, results, and discussion sections of articles. Eighteen items are common to all 3 study designs and 4 are specific for cohort, case-control, or crosssectional studies. A detailed Explanation and Elaboration document is published separately and is freely available at www.annals.org and on the Web sites of PLoS Medicine and Epidemiology. We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies.	Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Oxford, Ctr Stat Med, Oxford, England; Univ Bristol, Bristol, Avon, England; Univ London, London Sch Hyg & Trop Med, London, England; Nord Cochrane Ctr, Copenhagen, Denmark; Leiden Univ Hosp, Leiden, Netherlands	University of Bern; University of Oxford; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC)	von Elm, E (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	strobe@ispm.unibe.ch	Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716; von Elm, Erik/0000-0002-7412-0406				Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Black N, 1996, BRIT MED J, V312, P1215; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasziou P, 2004, BMJ-BRIT MED J, V328, P39, DOI 10.1136/bmj.328.7430.39; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lee W, 2007, BRIT J PSYCHIAT, V190, P204, DOI 10.1192/bjp.bp.106.027250; Moher D, 2004, CAN MED ASSOC J, V171, P349, DOI 10.1503/cmaj.1040031; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Ormerod AD, 2001, BRIT J DERMATOL, V145, P378, DOI 10.1046/j.1365-2133.2001.04404.x; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Pocock SJ, 2004, BMJ-BRIT MED J, V329, P883, DOI 10.1136/bmj.38250.571088.55; *REG LIA GROUP, 1981, AM EPIDEMIOL, V114, P609; RENNIE D, 2006, JAMA-J AM MED ASSOC, V2001, P285; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Schriger DL, 2005, ANN EMERG MED, V45, P437, DOI 10.1016/j.annemergmed.2004.09.022; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; VANDENBROUCKE JP, 2007, IN PRESS EPIDEMIOLOG	28	1796	1804	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					573	577		10.7326/0003-4819-147-8-200710160-00010	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938396	Green Published, Green Accepted			2022-12-28	WOS:000250437100007
J	Sedgh, G; Henshaw, S; Singh, S; Ahman, E; Shah, IH				Sedgh, Gilda; Henshaw, Stanley; Singh, Susheela; Ahman, Elisabeth; Shah, Iqbal H.			Induced abortion: estimated rates and trends worldwide	LANCET			English	Article							CONTRACEPTION; PHILIPPINES; LEVEL	Background Information on incidence of induced abortion is crucial for identifying policy and programmatic needs aimed at reducing unintended pregnancy. Because unsafe abortion is a cause of maternal morbidity and mortality, measures of its incidence are also important for monitoring progress towards Millennium Development Goal 5. We present new worldwide estimates of abortion rates and trends and discuss their implications for policies and programmes to reduce unintended pregnancy and unsafe abortion and to increase access to safe abortion. Methods The worldwide and regional incidences of safe abortions in 2003 were calculated by use of reports from official national reporting systems, nationally representative surveys, and published studies. Unsafe abortion rates in 2003 were estimated from hospital data, surveys, and other published studies. Demographic techniques were applied to estimate numbers of abortions and to calculate rates and ratios for 2003. UN estimates of female populations and livebirths were the source for denominators for rates and ratios, respectively. Regions are defined according to UN classifications. Trends in abortion rates and incidences between 1995 and 2003 are presented. Findings An estimated 42 million abortions were induced in 2003, compared with 46 million in 1995. The induced abortion rate in 2003 was 29 per 1000 women aged 15-44 years, down from 35 in 1995. Abortion rates were lowest in western Europe (12 per 1000 women). Rates were 17 per 1000 women in northern Europe, 18 per 1000 women in southern Europe, and 21 per 1000 women in northern America (USA and Canada). In 2003, 48% of all abortions worldwide were unsafe, and more than 97% of all unsafe abortions were in developing countries. There were 31 abortions for every 100 livebirths worldwide in 2003, and this ratio was highest in eastern Europe (105 for every 100 livebirths). Interpretation Overall abortion rates are similar in the developing and developed world, but unsafe abortion is concentrated in developing countries. Ensuring that the need for contraception is met and that all abortions are safe win reduce maternal mortality substantially and protect maternal health.	Alan Guttmacher Inst, New York, NY 10038 USA; WHO, CH-1211 Geneva, Switzerland	World Health Organization	Sedgh, G (corresponding author), Alan Guttmacher Inst, New York, NY 10038 USA.	gsedgh@guttmacher.org						Agadjanian V, 2002, STUD FAMILY PLANN, V33, P237, DOI 10.1111/j.1728-4465.2002.00237.x; [Anonymous], 2003, ADDING IT BENEFITS I; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; *DEP MAK PREGN SAF, 2006, WHO ANN REP 2005; Duggal R, 2004, SUMMARY KEY FINDINGS; FERRANDO D, 2001, PATHFINDER INT FLORA; GOLDBERG H, 2005, INT UN SCI STUD POP; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, P44, DOI 10.2307/2991902; HENSHAW SK, 2006, CLIN GUIDE MED SURG, P11; Jewkes R, 2005, BJOG-INT J OBSTET GY, V112, P355, DOI 10.1111/j.1471-0528.2004.00422.x; Juarez F, 2005, INT FAM PLAN PERSPEC, V31, P140, DOI 10.1363/3114005; Leridon H., 1977, HUMAN FERTILITY BASI; LLOVET JJ, 1998, REPROD HEALTH MATTER, V6, P55; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; Sedgh G., 2007, WOMEN UNMET NEED CON; Sedgh G, 2007, INT FAM PLAN PERSPEC, V33, P106, DOI 10.1363/3310607; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P100, DOI 10.2307/2950765; Singh S, 1994, INT FAM PLAN PERSPEC, V20, P4, DOI [10.2307/2133331, DOI 10.2307/2133331]; SINGH S, 2003, SOCIOCULTURAL POLITI, P15; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; *UN DEP EC SOC AFF, 2005, POP DIV WORLD POP PR; *UN POP DIV, 2002, WORLD CONTR US 2001; *UN POP FUND U AB, 2004, MAT MORT UPD 2004 DE; United Nations Population Division, 2006, WORLD CONTR US 2005; WESTOFF CF, 2001, 1 DHS ORC MACR; WESTOFF CF, 2005, 8 DHS PRINC U ORC MA; WESTOFF CF, 2006, 14 DHS MACR INT; WESTOFF CF, 1995, 16 DHS MACR INT; WESTOFF CF, 1991, 5 DHS I RES DEV MACR; *WHO, 2003, UNS AB GLOB REG EST; World Health Organization, 2004, UNS AB GLOB REG EST; World Health Organization, 1992, WHOMSM925; World Health Organization, 2003, SAF AB TECHN POL GUI; [No title captured]	36	306	320	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1338	1345		10.1016/S0140-6736(07)61575-X	http://dx.doi.org/10.1016/S0140-6736(07)61575-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933648				2022-12-28	WOS:000250176600027
J	Myers, MD; Ayers, MA; Baron, JS; Beauchemin, PR; Gallagher, KT; Goldhaber, MB; Hutchinson, DR; LaBaugh, JW; Sayre, RG; Schwarzbach, SE; Schweig, ES; Thormodsgard, J; van Riper, C; Wilde, W				Myers, M. D.; Ayers, M. A.; Baron, J. S.; Beauchemin, P. R.; Gallagher, K. T.; Goldhaber, M. B.; Hutchinson, D. R.; LaBaugh, J. W.; Sayre, R. G.; Schwarzbach, S. E.; Schweig, E. S.; Thormodsgard, J.; van Riper, C., III; Wilde, W.			Sustainability - USGS goals for the coming decade	SCIENCE			English	Editorial Material									US Geol Survey, Natl Ctr, Reston, VA 20192 USA	United States Department of the Interior; United States Geological Survey	Goldhaber, MB (corresponding author), US Geol Survey, Natl Ctr, Reston, VA 20192 USA.	mgold@usgs.gov	Baron, Jill/C-5270-2016	Baron, Jill/0000-0002-5902-6251				Bales RC, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004387; Dettinger M, 2006, CLIMATIC CHANGE, V76, P149, DOI 10.1007/s10584-005-9001-6; USGS, 2007, 1309 USGS; *USGS, 1982, 878A USGS	4	6	6	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					200	201		10.1126/science.1147228	http://dx.doi.org/10.1126/science.1147228			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932272				2022-12-28	WOS:000250086100020
J	Mangione-Smith, R; DeCristofaro, AH; Setodji, CM; Keesey, J; Klein, DJ; Adams, JL; Schuster, MA; McGlynn, EA				Mangione-Smith, Rita; DeCristofaro, Alison H.; Setodji, Claude M.; Keesey, Joan; Klein, David J.; Adams, John L.; Schuster, Mark A.; McGlynn, Elizabeth A.			The quality of ambulatory care delivered to children in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							URINARY-TRACT-INFECTION; YOUNG-CHILDREN; MEDICAL-RECORDS; FEBRILE INFANTS; MANAGED CARE; ASTHMA; CONSISTENCY; PREVALENCE; PREVENTION; EMERGENCY	Background Little is known about the magnitude of deficits in the quality of care delivered to children, since comprehensive studies have been lacking. Methods We assessed the extent to which care processes recommended for pediatric outpatients are delivered. Quality indicators were developed with the use of the RAND-UCLA modified Delphi method. Parents of 1536 children who were randomly selected from 12 metropolitan areas provided written informed consent to obtain medical records from all providers who had seen the children during the 2-year period before the date of study recruitment. Trained nurses abstracted these medical records. Composite quality scores were calculated by dividing the number of times indicated care was documented as having been ordered or delivered by the number of times a care process was indicated. Results On average, according to data in the medical records, children in the study received 46.5% (95% confidence interval [CI], 44.5 to 48.4) of the indicated care. They received 67.6% (95% CI, 63.9 to 71.3) of the indicated care for acute medical problems, 53.4% (95% CI, 50.0 to 56.8) of the indicated care for chronic medical conditions, and 40.7% (95% CI, 38.1 to 43.4) of the indicated preventive care. Quality varied according to the clinical area, with the rate of adherence to indicated care ranging from 92.0% (95% CI, 89.9 to 94.1) for upper respiratory tract infections to 34.5% (95% CI, 31.0 to 37.9) for preventive services for adolescents. Conclusions Deficits in the quality of care provided to children appear to be similar in magnitude to those previously reported for adults. Strategies to reduce these apparent deficits are needed.	Univ Washington, Inst Child Hlth, Dept Pediat, Seattle, WA 98115 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; RAND Corp, Santa Monica, CA USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Hlth Serv, Los Angeles, CA 90024 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mangione-Smith, R (corresponding author), Univ Washington, Inst Child Hlth, Dept Pediat, 6200 NE 74th St,Suite 210, Seattle, WA 98115 USA.	ritams@u.washington.edu	Adams, John/ABE-6170-2021					Adams RJ, 2001, PEDIATRICS, V107, P706, DOI 10.1542/peds.107.4.706; Adams RJ, 2001, ARCH PEDIAT ADOL MED, V155, P501, DOI 10.1001/archpedi.155.4.501; *AG HEALTHC RES QU, 2007, NAT HEALTHC QUAL REP; Baker JW, 1999, PEDIATRICS, V103, P414, DOI 10.1542/peds.103.2.414; Battleman DS, 2001, ACAD EMERG MED, V8, P709, DOI 10.1111/j.1553-2712.2001.tb00189.x; Bergman DA, 1999, PEDIATRICS, V103, P843; Bethell C, 2004, PEDIATRICS, V113, P1973; Brook RH., 1994, RAND UCLA APPROPRIAT; Caione P, 2004, BJU INT, V93, P1309, DOI 10.1111/j.1464-410X.04866.x; *CDCP, 2004, CHLAM CDC FACT SHEET; Centers of Disease Control and Prevention, 2000, SEX TRANSM DIS SURV; Christakis DA, 2001, AMBUL PEDIATR, V1, P99, DOI 10.1367/1539-4409(2001)001<0099:CAQOCF>2.0.CO;2; Diette GB, 2001, J PEDIATR-US, V138, P59, DOI 10.1067/mpd.2001.109600; Finkelstein JA, 2002, ARCH PEDIAT ADOL MED, V156, P562, DOI 10.1001/archpedi.156.6.562; Gest KL, 2000, PEDIATRICS, V106, P879; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; *I MED, 1999, TO ERR IS HUM BUILD; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kravitz RL, 1997, HEALTH POLICY, V42, P135, DOI 10.1016/S0168-8510(97)00064-X; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; McDermott MF, 2006, ACAD EMERG MED, V13, P345, DOI 10.1197/j.aem.2005.09.006; McGlynn E, 2000, QUALITY CARE CHILDRE; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MCGLYNN EAD, 2007, QUALITY CARE CHILDRE; *NAT COMM QUAL ASS, 2005, 33 NAT COMM QUAL ASS; ROBERTS KB, 1983, J PEDIATR-US, V103, P864, DOI 10.1016/S0022-3476(83)80702-1; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Shafer MAB, 2002, JAMA-J AM MED ASSOC, V288, P2846, DOI 10.1001/jama.288.22.2846; Shekelle PG, 1998, INT J TECHNOL ASSESS, V14, P707, DOI 10.1017/S0266462300012022; Stange KC, 1998, MED CARE, V36, P851, DOI 10.1097/00005650-199806000-00009; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; *US BUR CENS, 2001, CURR POP SURV; Warman KL, 2001, PEDIATRICS, V108, P277, DOI 10.1542/peds.108.2.277; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; ZUCKERMAN AE, 1975, PEDIATRICS, V56, P407; Zuckerman B, 2004, PEDIATRICS, V114, P1522, DOI 10.1542/peds.2004-0635; [No title captured], DOI DOI 10.2307/2529310	40	434	436	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1515	1523		10.1056/NEJMsa064637	http://dx.doi.org/10.1056/NEJMsa064637			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928599	Bronze			2022-12-28	WOS:000250037000008
J	Ballinger, AB; Anggiansah, C				Ballinger, Anne B.; Anggiansah, Clive			Colorectal cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONTRAST BARIUM ENEMA; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COLON-CANCER; COLONOSCOPY; EXPERIENCE; SURVIVAL; EUROPE		Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England		Ballinger, AB (corresponding author), Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England.	anne.ballinger@homerton.nhs.uk						Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Bosworth HB, 2006, AM J MED, V119, P791, DOI 10.1016/j.amjmed.2006.02.013; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Collins PD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000279.pub3; Dunlop MG, 2002, GUT, V51, pV17, DOI 10.1136/gut.51.suppl_5.v17; Ganeshan A, 2007, AGE AGEING, V36, P48, DOI 10.1093/ageing/afl116; Gatta G, 2000, GUT, V47, P533, DOI 10.1136/gut.47.4.533; Gill S, 2007, MAYO CLIN PROC, V82, P114; Gluecker TM, 2003, RADIOLOGY, V227, P378, DOI 10.1148/radiol.2272020293; Goddard AF, 2005, GUIDELINES MANAGEMEN; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Kealey SM, 2004, CLIN RADIOL, V59, P44, DOI 10.1016/j.crad.2003.08.001; Leslie A, 2002, CLIN RADIOL, V57, P184, DOI 10.1053/crad.2001.0832; MCDONALD S, 2001, AUST NZ J SURG, V71, P627; Mulhall BP, 2005, ANN INTERN MED, V142, P635, DOI 10.7326/0003-4819-142-8-200504190-00013; Niv Y, 2002, GUT, V50, P33, DOI 10.1136/gut.50.1.33; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; *OFF NAT STAT, 2004, CANC STAT REG REG CA; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Quinn M, 2001, CANC TRENDS ENGLAND; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; ROCKEY DC, 1993, NEW ENGL J MED, V329, P1691, DOI 10.1056/NEJM199312023292303; Rockey DC, 2005, LANCET, V365, P305; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	26	51	56	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2007	335	7622					715	718		10.1136/bmj.39321.527384.BE	http://dx.doi.org/10.1136/bmj.39321.527384.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916855	Green Published			2022-12-28	WOS:000250156800034
J	Tielsch, JM; Khatry, SK; Stoltzfus, RJ; Katz, J; LeClerq, SC; Adhikari, R; Mullany, LC; Black, R; Shresta, S				Tielsch, James M.; Khatry, Subarna K.; Stoltzfus, Rebecca J.; Katz, Joanne; LeClerq, Steven C.; Adhikari, Ramesh; Mullany, Luke C.; Black, Robert; Shresta, Shardaram			Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial	LANCET			English	Article							DOUBLE-BLIND; RESPIRATORY-INFECTIONS; BANGLADESHI CHILDREN; PERSISTENT DIARRHEA; IRON SUPPLEMENTATION; DEVELOPING-COUNTRIES; NEONATAL-MORTALITY; PRESCHOOL-CHILDREN; POOLED ANALYSIS; VITAMIN-A	Background Zinc supplementation can reduce subsequent morbidity in children recovering from diarrhoea and respiratory illness in developing countries. However, whether routine supplementation would decrease morbidity and mortality in populations with zinc deficiency is unclear. We assessed the effect of daily zinc supplementation on children in southern Nepal. Methods We did a community-based, cluster-randomised, double-masked, placebo-controlled, 2x2 factorial trial in children aged 1-35 months. Treatment groups were placebo, iron and folic acid, zinc, and iron and folic acid with zinc, with daily doses of 12.5 mg iron, 50 mu g folic acid, and 10 mg zinc. Study staff gave children tablets on 2 days each week and left tablets with caregivers for other days. All children received vitamin A supplementation twice per year. Results of the iron arm of the trial have been reported previously. Between October, 2001, and January, 2006, 41276 children were enrolled into the placebo (n=20 308) or zinc (n=20 968) groups and were followed-up for 60 636.3 person-years. The primary outcome was child mortality, and analyses were by intention to treat. Daily reports of signs and symptoms of common morbidities in stratified random subsamples of children were assessed every week for 12 months. This study is registered at ClinicalTrials.gov, number NCT00109551. Findings 2505 children refused to continue the trial and 3219 children were lost to follow-up. There was no significant difference in mortality between the zinc and placebo groups (316 vs 333 deaths; hazard ratio 0.92, 95% Cl 0.75-1.12). Zinc had no effect on mortality in children younger than 12 months (181 vs 168 deaths; 1.04, 0.83-1.31); mortality was lower, but not statistically significantly so, in older children receiving zinc (135 vs 165; 0.80, 0.60-1.06). The frequency and duration of diarrhoea, persistent diarrhoea, dysentery, and acute lower respiratory infections did not differ between the groups. Interpretation Total mortality of children receiving zinc supplementation was not significantly different from that of children receiving placebo. Further data are needed from other populations with endemic zinc deficiency to confirm the potential age-specific effects reported in this study.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Nepal Nutr Intervent Project Sarlahi, Kathmandu, Nepal; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Tribhuvan Univ, Inst Med, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Tielsch, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Room W5009, Baltimore, MD 21205 USA.	jtielsch@jhsph.edu		Black, Robert/0000-0001-9926-7984; Tielsch, James/0000-0002-1151-060X; Katz, Joanne/0000-0002-5997-7823	NICHD NIH HHS [R01 HD038753, R01 HD038753-04, HD 38753] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038753] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baqui AH, 2003, J NUTR, V133, P4150, DOI 10.1093/jn/133.12.4150; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Berger J, 2006, EUR J CLIN NUTR, V60, P443, DOI 10.1038/sj.ejcn.1602336; Bhandari N, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e86; Bhandari N, 2002, BRIT MED J, V324, P1358, DOI 10.1136/bmj.324.7350.1358; Bhutta ZA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e42; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; *CENTR BUR STAT, 2004, NEP LIV STAND SURV 2, V2; *FAO WHO EXP CONS, 2002, HUM VIT MIN REQ REP; Fishman SM, 2004, COMP QUANTIFICATION, P39; Gardner JMM, 1998, EUR J CLIN NUTR, V52, P34, DOI 10.1038/sj.ejcn.1600509; Gupta DN, 2003, ACTA PAEDIATR, V92, P531, DOI 10.1080/08035250310002722; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lira PIC, 1998, AM J CLIN NUTR, V68, p418S, DOI 10.1093/ajcn/68.2.418S; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Murray C.J.L., 2004, COMP QUANTIFICATION, V1, P257, DOI DOI 10.1007/S12263-011-0248-4; Ninh NX, 1996, AM J CLIN NUTR, V63, P514, DOI 10.1093/ajcn/63.4.514; Osendarp SJM, 2002, AM J CLIN NUTR, V76, P1401, DOI 10.1093/ajcn/76.6.1401; Otten J. J., 2006, DIET REFERENCE INTAK; Penny ME, 1999, J PEDIATR-US, V135, P208, DOI 10.1016/S0022-3476(99)70024-7; Rahman MM, 2001, BMJ-BRIT MED J, V323, P314, DOI 10.1136/bmj.323.7308.314; Rice AL., 2004, COMP QUANTIFICATION, V1, P0211; Richard SA, 2006, AM J TROP MED HYG, V75, P126, DOI 10.4269/ajtmh.2006.75.1.0750126; Rosado JL, 1997, AM J CLIN NUTR, V65, P13, DOI 10.1093/ajcn/65.1.13; Roy SK, 1998, ACTA PAEDIATR, V87, P1235, DOI 10.1080/080352598750030898; Roy SK, 1997, ARCH DIS CHILD, V77, P196, DOI 10.1136/adc.77.3.196; Ruel MT, 1997, PEDIATRICS, V99, P808, DOI 10.1542/peds.99.6.808; Sazawal S, 1998, PEDIATRICS, V102, P1, DOI 10.1542/peds.102.1.1; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; Sazawal S, 2001, PEDIATRICS, V108, P1280, DOI 10.1542/peds.108.6.1280; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Sempertegui F, 1996, EUR J CLIN NUTR, V50, P42; Shankar AH, 2000, AM J TROP MED HYG, V62, P663, DOI 10.4269/ajtmh.2000.62.663; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; *UN ADM COORD COMM, 2000, 4 UNACCSCN; Van Zweeden AB, 2001, BRIT MED J, V322, P1, DOI DOI 10.1136/BMJ.322.7277.1.PUBMED:11141128	45	100	100	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1230	1239		10.1016/S0140-6736(07)61539-6	http://dx.doi.org/10.1016/S0140-6736(07)61539-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920918	Green Accepted			2022-12-28	WOS:000250091900023
J	Blow, N				Blow, Nathan			Genomics: The personal side of genomics	NATURE			English	Editorial Material																		Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068	6	24	35	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					627	632		10.1038/449627a	http://dx.doi.org/10.1038/449627a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914399				2022-12-28	WOS:000249893500051
J	Callaway, E				Callaway, Ewen			Dogs help sniff out genes	NATURE			English	News Item																		HILLBERTZ N, 2007, NATURE GENET; KARLSSON E, 2007, NATURE GENET; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338	3	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					514	514		10.1038/449514b	http://dx.doi.org/10.1038/449514b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17972361	Bronze			2022-12-28	WOS:000249893500005
J	Garattini, S; Bertele, V				Garattini, Silvio; Bertele, Vittorio			Non-inferiority trials are unethical because they disregard patients' interests	LANCET			English	Article							ISSUES		Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bertele, V (corresponding author), Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy.	bertele@marionegri.it	Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297				[Anonymous], 1990, LANCET, V336, P65; Barbui C, 2000, EUR PSYCHIAT, V15, P268, DOI 10.1016/S0924-9338(00)00233-9; Bertele V, 1999, HEART, V81, P675, DOI 10.1136/hrt.81.6.675; BERTELE V, EQUIVOCAL EQUIVALENC; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Garattini S, 2003, BMJ-BRIT MED J, V326, P1199, DOI 10.1136/bmj.326.7400.1199; Hung HMJ, 2005, BIOMETRICAL J, V47, P28, DOI 10.1002/bimj.200410084; Hung HMJ, 2003, STAT MED, V22, P213, DOI 10.1002/sim.1315; HUNT D, 1992, LANCET, V339, P753; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; Siegel JP, 2000, AM HEART J, V139, pS166, DOI 10.1016/S0002-8703(00)90066-8; Snapinn Steven M, 2004, J Biopharm Stat, V14, P263, DOI 10.1081/BIP-120037178; Splawinski J, 2004, SCI ENG ETHICS, V10, P73, DOI 10.1007/s11948-004-0065-x; Tebbe U, 1998, J AM COLL CARDIOL, V31, P487, DOI 10.1016/S0735-1097(97)00553-6; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; 2006, SCRIP WORLD PHA 0918, P27	17	132	135	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1875	1877		10.1016/S0140-6736(07)61604-3	http://dx.doi.org/10.1016/S0140-6736(07)61604-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240LI	17959239				2022-12-28	WOS:000251588700035
J	Ingmundson, A; Delprato, A; Lambright, DG; Roy, CR				Ingmundson, Alyssa; Delprato, Anna; Lambright, David G.; Roy, Craig R.			Legionella pneumophila proteins that regulate Rab1 membrane cycling	NATURE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; GDP DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; DISPLACEMENT FACTOR; IDENTIFICATION; SYSTEM; MECHANISM; EFFECTORS; GTPASES	Rab1 is a GTPase that regulates the transport of endoplasmic-reticulum-derived vesicles in eukaryotic cells. The intracellular pathogen Legionella pneumophila subverts Rab1 function to create a vacuole that supports bacterial replication by a mechanism that is not well understood. Here we describe L. pneumophila proteins that control Rab1 activity directly. We show that a region in the DrrA (defect in Rab1 recruitment A) protein required for recruitment of Rab1 to membranes functions as a guanine nucleotide dissociation inhibitor displacement factor. A second region of the DrrA protein stimulated Rab1 activation by functioning as a guanine nucleotide exchange factor. The LepB protein was found to inactivate Rab1 by stimulating GTP hydrolysis, indicating that LepB has GTPase-activating protein activity that regulates removal of Rab proteins from membranes. Thus, L. pneumophila encodes proteins that regulate three distinct biochemical reactions critical for Rab GTPase membrane cycling to redirect Rab1 to the pathogen-occupied vacuole and to control Rab1 function.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT 06536 USA; UMASS Med Sch, Program Mol Med, Worcester, MA 01605 USA; UMASS Med Sch, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	Yale University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Roy, CR (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu		Roy, Craig/0000-0003-4490-440X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041699] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041699-13, R01 AI041699] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Amor JC, 2005, J BIOL CHEM, V280, P1392, DOI 10.1074/jbc.M410820200; ARAKI S, 1990, J BIOL CHEM, V265, P13007; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Kagan JC, 2005, METHOD ENZYMOL, V403, P71, DOI 10.1016/S0076-6879(05)03007-7; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	34	249	256	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					365	U1		10.1038/nature06336	http://dx.doi.org/10.1038/nature06336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17952054				2022-12-28	WOS:000250918600043
J	Sharot, T; Riccardi, AM; Raio, CM; Phelps, EA				Sharot, Tali; Riccardi, Alison M.; Raio, Candace M.; Phelps, Elizabeth A.			Neural mechanisms mediating optimism bias	NATURE			English	Article							FUTURE LIFE EVENTS; PREFRONTAL CORTEX; CINGULATE CORTEX; AMYGDALA; SELF; EMOTION; ANXIETY; MEMORY; HEALTH	Humans expect positive events in the future even when there is no evidence to support such expectations. For example, people expect to live longer and be healthier than average(1), they underestimate their likelihood of getting a divorce(1), and overestimate their prospects for success on the job market(2). We examined how the brain generates this pervasive optimism bias. Here we report that this tendency was related specifically to enhanced activation in the amygdala and in the rostral anterior cingulate cortex when imagining positive future events relative to negative ones, suggesting a key role for areas involved in monitoring emotional salience in mediating the optimism bias. These are the same regions that show irregularities in depression(3), which has been related to pessimism(4). Across individuals, activity in the rostral anterior cingulate cortex was correlated with trait optimism. The current study highlights how the brain may generate the tendency to engage in the projection of positive future events, suggesting that the effective integration and regulation of emotional and autobiographical information supports the projection of positive future events in healthy individuals, and is related to optimism.	NYU, Dept Psychol, New York, NY 10003 USA; UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	New York University; University of London; University College London	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu	Raio, Candace/GON-5368-2022					Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cunningham WA, 2005, COGN AFFECT BEHAV NE, V5, P202, DOI 10.3758/CABN.5.2.202; D'Argembeau A, 2004, EMOTION, V4, P173, DOI 10.1037/1528-3542.4.2.173; DREVETS WC, 1997, NATURE, V386, P827; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; HOCH S, 1984, J EXP PSYCHOL, V11, P719; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Lovallo D, 2003, HARVARD BUS REV, V81, P56; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Sharot T, 2007, P NATL ACAD SCI USA, V104, P389, DOI 10.1073/pnas.0609230103; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Strunk DR, 2006, BEHAV RES THER, V44, P861, DOI 10.1016/j.brat.2005.07.001; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816	27	421	437	1	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					102	+		10.1038/nature06280	http://dx.doi.org/10.1038/nature06280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17960136				2022-12-28	WOS:000250585800045
J	Allen, MR; Frame, DJ				Allen, Myles R.; Frame, David J.			Call off the quest	SCIENCE			English	Editorial Material							CLIMATE SENSITIVITY		Univ Oxford, Dept Phys, Oxford OX1 3PU, England; Univ Oxford, Ctr Environm, Oxford OX1 3QY, England	University of Oxford; University of Oxford	Allen, MR (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.	myles.allen@physics.ox.ac.uk; dframe@atm.ox.ac.uk	Frame, Dave/A-8918-2014; Frame, Dave/R-6169-2016; Allen, Myles R/A-5172-2012	Frame, Dave/0000-0002-0949-3994; 				Boer GJ, 2003, CLIM DYNAM, V21, P167, DOI 10.1007/s00382-003-0323-7; Charney J., 1979, CARBON DIOXIDE CLIMA; Frame DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025801; Frame DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022241; RODWELL M, 2007, Q J R METEOROL SOC, V113, P118; Roe GH, 2007, SCIENCE, V318, P629, DOI 10.1126/science.1144735; Sanderson BM, 2008, CLIM DYNAM, V30, P175, DOI 10.1007/s00382-007-0280-7; Senior CA, 2000, GEOPHYS RES LETT, V27, P2685, DOI 10.1029/2000GL011373; Solomon S., 2007, PHYS SCI BASIS WORKI; Yohe G, 2004, SCIENCE, V306, P416, DOI 10.1126/science.1101170	10	78	78	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					582	583		10.1126/science.1149988	http://dx.doi.org/10.1126/science.1149988			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962547				2022-12-28	WOS:000250409200029
J	Kolodkin-Gal, I; Hazan, R; Gaathon, A; Carmeli, S; Engelberg-Kulka, H				Kolodkin-Gal, Ilana; Hazan, Ronen; Gaathon, Ariel; Carmeli, Shmuel; Engelberg-Kulka, Hanna			A linear pentapeptide is a quorum-sensing factor required for mazEF-mediated cell death in Escherichia coli	SCIENCE			English	Article							STAPHYLOCOCCUS-AUREUS; STRESSFUL CONDITIONS; BACTERIA; TOXIN; COMMUNICATION; CANNIBALISM; PROKARYOTES; MODULE	mazEF is a toxin-antitoxin module located on many bacterial chromosomes, including those of pathogens. Here, we report that Escherichia coli mazEF-mediated cell death is a population phenomenon requiring a quorum-sensing molecule that we call the extracellular death factor (EDF). Structural analysis revealed that EDF is a linear pentapeptide, Asn-Asn-Trp-Asn-Asn. Each of the five amino acids of EDF is important for its activity.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Core Res Facil, IL-91120 Jerusalem, Israel; Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University	Engelberg-Kulka, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel.	hanita@cc.huji.ac.il	Hazan, Ronen/ABI-1067-2020; Carmeli, shmuel/N-1273-2018; Hazan, Ronen/R-8384-2016; Gal, Ilana Kolodkin/AFE-8494-2022	Hazan, Ronen/0000-0001-9967-730X; Carmeli, shmuel/0000-0002-9641-9943; Hazan, Ronen/0000-0001-9967-730X; Gal, Ilana Kolodkin/0000-0002-8464-5660	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hochman A, 1997, CRIT REV MICROBIOL, V23, P207, DOI 10.3109/10408419709115136; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Okada M, 2005, NAT CHEM BIOL, V1, P23, DOI 10.1038/nchembio709; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PUCHER GEORGE W., 1940, INDUST AND ENGINEER CHEM ANALYT ED, V12, P27, DOI 10.1021/ac50141a008; Reitzer L.J., 1996, ESCHERICHIA COLI SAL, P391; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	27	193	212	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					652	655		10.1126/science.1147248	http://dx.doi.org/10.1126/science.1147248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962566				2022-12-28	WOS:000250409200049
J	Dean, N; Shuaib, A				Dean, Naeenn; Shuaib, Ashfaq			Transient ischaemic attacks: unstable, treatable, neglected	LANCET			English	Editorial Material							STROKE; CLOPIDOGREL; PREVENTION; ASPIRIN; THERAPY; TRIAL; RISK		Royal Alexandra Hosp, Edmonton, AB, Canada; Univ Alberta, Dept Med, Edmonton, AB T6B 2B7, Canada	Royal Alexandra Hospital; University of Alberta	Shuaib, A (corresponding author), Royal Alexandra Hosp, Edmonton, AB, Canada.	Ashfaq.shuaib@ualberta.ca						Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Hackam DG, 2007, STROKE, V38, P1881, DOI 10.1161/STROKEAHA.106.475525; Heuschmann PU, 2004, JAMA-J AM MED ASSOC, V292, P1831, DOI 10.1001/jama.292.15.1831; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KENNEDY J, 2007, CEREBROVASC DIS, V23, P56; LAVALLEE PC, 2007, LANCET NEUROL; Mackay J, 2004, ATLAS HEART DIS STRO; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Rothwell PM, 2006, LANCET NEUROL, V5, P323, DOI 10.1016/S1474-4422(06)70408-2; Rothwell PM, 2004, STROKE, V35, P2855, DOI 10.1161/01.STR.0000147040.20446.f6; ROTHWELL PM, 2007, LANCET; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74	13	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2007	370	9596					1398	1400		10.1016/S0140-6736(07)61449-4	http://dx.doi.org/10.1016/S0140-6736(07)61449-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17928045				2022-12-28	WOS:000250386000006
J	Kobrynski, LJ; Sullivan, KE				Kobrynski, Lisa J.; Sullivan, Kathleen E.			Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes	LANCET			English	Review							CARDIO-FACIAL SYNDROME; CONOTRUNCAL HEART-DEFECTS; IN-SITU HYBRIDIZATION; LIVE VIRAL VACCINES; T-CELL PRODUCTION; SYNDROME/VELOCARDIOFACIAL SYNDROME; DIGEORGE/VELOCARDIOFACIAL SYNDROME; VELOPHARYNGEAL INSUFFICIENCY; THYMUS TRANSPLANTATION; MICRODELETION SYNDROME	Velocardiofacial syndrome, DiGeorge syndrome, and some other clinical syndromes have in common a high frequency of hemizygous deletions of chromosome 22q11.2. This deletion syndrome is very common, affecting nearly one in 3000 children. Here, we focus on recent advances in cardiac assessment, speech, immunology, and pathophysiology of velocardiofacial syndrome. The complex medical care of patients needs a multidisciplinary approach, and every patient has his own unique clinical features that need a tailored approach. Patients with chromosome 22q11.2 deletion syndrome might have high level of functioning, but most often need interventions to improve the function of many organ systems.	Childrens Hosp Philadelphia, Dept Pediat, Div Allergy & Immunol, Philadelphia, PA 19104 USA; Emory Univ, Sch Med, Dept Pediat, Allergy & Immunol Sect, Atlanta, GA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Emory University	Sullivan, KE (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Allergy & Immunol, 34th & Civic Ctr Blvd,Abramson Room 1216, Philadelphia, PA 19104 USA.	suilivak@mail.med.upenn.edu		Sullivan, Kathleen/0000-0003-4018-1646				Anaclerio Silvia, 2004, Ital Heart J, V5, P624; Antshel KM, 2006, J AM ACAD CHILD PSY, V45, P596, DOI 10.1097/01.chi.0000205703.25453.5a; Azzari C, 2005, VACCINE, V23, P1668, DOI 10.1016/j.vaccine.2004.10.005; BALE PM, 1993, PEDIATR PATHOL, V13, P181, DOI 10.3109/15513819309048205; Barnea-Goraly N, 2005, COGNITIVE BRAIN RES, V25, P735, DOI 10.1016/j.cogbrainres.2005.09.013; Barnea-Goraly N, 2003, AM J PSYCHIAT, V160, P1863, DOI 10.1176/appi.ajp.160.10.1863; Bartsch O, 2003, AM J MED GENET A, V117A, P1, DOI 10.1002/ajmg.a.10914; BASTIAN J, 1989, J PEDIATR-US, V115, P391, DOI 10.1016/S0022-3476(89)80837-6; Baumer A, 2004, J MED GENET, V41, P413, DOI 10.1136/jmg.2003.016352; Becker DB, 2004, PLAST RECONSTR SURG, V114, P1367, DOI 10.1097/01.PRS.0000138591.F1; Berend SA, 2000, AM J MED GENET, V91, P313, DOI 10.1002/(SICI)1096-8628(20000410)91:4<313::AID-AJMG13>3.3.CO;2-L; Bish JP, 2006, NEUROSCI LETT, V399, P245, DOI 10.1016/j.neulet.2006.02.001; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Boudjemline Y, 2001, J PEDIATR-US, V138, P520, DOI 10.1067/mpd.2001.112174; Bowers DC, 1998, LANCET, V352, P1983, DOI 10.1016/S0140-6736(98)00094-4; Campbell LE, 2006, BRAIN, V129, P1218, DOI 10.1093/brain/awl066; Cancrini C, 2005, J CLIN IMMUNOL, V25, P265, DOI 10.1007/s10875-005-4085-3; Chen YF, 2006, GENOMICS, V87, P290, DOI 10.1016/j.ygeno.2005.10.002; Chinen J, 2003, J ALLERGY CLIN IMMUN, V111, P573, DOI 10.1067/mai.2003.165; Cipollone D, 2006, CARDIOVASC PATHOL, V15, P194, DOI 10.1016/j.carpath.2006.04.004; Coberly S, 1996, PEDIATR PATHOL LAB M, V16, P823, DOI 10.1080/107710496175435; Collard HR, 1999, CLIN IMMUNOL, V91, P156, DOI 10.1006/clim.1999.4691; Devriendt K, 1998, J MED GENET, V35, P789, DOI 10.1136/jmg.35.9.789-a; Digilio MC, 1997, AM J MED GENET, V73, P95; Digilio MC, 1999, BRIT J AUDIOL, V33, P329, DOI 10.3109/03005369909090116; DIGILIO MC, 1995, AM J MED GENET, V55, P513, DOI 10.1002/ajmg.1320550427; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Fernandez L, 2005, CLIN GENET, V68, P373, DOI 10.1111/j.1399-0004.2005.00493.x; Finocchi A, 2006, PEDIATR ALLERGY IMMU, V17, P382, DOI 10.1111/j.1399-3038.2006.00409.x; FIREMAN P, 1965, J PEDIATR-US, V67, P907; Fokstuen S, 1998, CLIN GENET, V53, P63, DOI 10.1034/j.1399-0004.1998.531530113.x; Formankova R, 2005, BLOOD, V106, p446B; Frohn-Mulder IME, 1999, GENET COUNSEL, V10, P35; Gennery AR, 2002, ARCH DIS CHILD, V86, P422, DOI 10.1136/adc.86.6.422; Gerdes M, 1999, AM J MED GENET, V85, P127, DOI 10.1002/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F; Gerdes M, 2001, GENET MED, V3, P40, DOI 10.1097/00125817-200101000-00009; GOLDINGKUSHNER KJ, 1985, J CRAN GENET DEV BIO, V5, P259; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; GOLDSOBEL AB, 1987, J PEDIATR-US, V111, P40, DOI 10.1016/S0022-3476(87)80339-6; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; Gothelf D, 2007, INT J NEUROPSYCHOPH, V10, P301, DOI 10.1017/S1461145706006699; Hou JW, 1997, J FORMOS MED ASSOC, V96, P419; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Iserin L, 1998, EUR J PEDIATR, V157, P881, DOI 10.1007/s004310050959; Ivins S, 2005, DEV BIOL, V285, P554, DOI 10.1016/j.ydbio.2005.06.026; Jawad AF, 2001, J PEDIATR-US, V139, P715, DOI 10.1067/mpd.2001.118534; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Jiang LH, 2005, INT J CARDIOL, V105, P216, DOI 10.1016/j.ijcard.2005.01.012; JUNKER AK, 1995, J PEDIATR-US, V127, P231, DOI 10.1016/S0022-3476(95)70300-4; Kanaya Y, 2006, CLIN EXP IMMUNOL, V144, P85, DOI 10.1111/j.1365-2249.2006.03038.x; Katzman PJ, 2005, PEDIATR DEVEL PATHOL, V8, P557, DOI 10.1007/s10024-005-0056-1; Kelly RG, 2004, HUM MOL GENET, V13, P2829, DOI 10.1093/hmg/ddh304; Khositseth A, 2005, PEDIATR CARDIOL, V26, P570, DOI 10.1007/s00246-004-0775-5; Kitsiou-Tzeli S, 2004, IN VIVO, V18, P603; Kok LL, 1996, AUST NZ J OPHTHALMOL, V24, P53, DOI 10.1111/j.1442-9071.1996.tb00995.x; Kornfeld SJ, 2000, J ALLERGY CLIN IMMUN, V105, P983, DOI 10.1067/mai.2000.105527; Lajiness-O'Neill R, 2006, ARCH CLIN NEUROPSYCH, V21, P175, DOI 10.1016/j.acn.2005.09.001; Lawrence S, 2003, J PEDIATR-US, V143, P277, DOI 10.1067/S0022-3476(03)00248-8; LeanaCox J, 1996, AM J MED GENET, V65, P309, DOI 10.1002/(SICI)1096-8628(19961111)65:4<309::AID-AJMG12>3.0.CO;2-Y; Lin LZ, 2006, DEV BIOL, V295, P756, DOI 10.1016/j.ydbio.2006.03.053; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; LINSAY EA, 2001, NATURE, V410, P97; Losken A, 2006, PLAST RECONSTR SURG, V117, P1493, DOI 10.1097/01.prs.0000206377.14083.ce; Losken A, 2003, PLAST RECONSTR SURG, V112, P1755, DOI 10.1097/01.PRS.0000090720.33554.8B; Maeda J, 2006, DEV DYNAM, V235, P701, DOI 10.1002/dvdy.20686; Mahadevan NR, 2004, DEV GENES EVOL, V214, P559, DOI 10.1007/s00427-004-0433-1; Mansour A M, 1987, J Pediatr Ophthalmol Strabismus, V24, P263; Markert ML, 2005, CLIN IMMUNOL, V116, P294; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Markert ML, 2003, BLOOD, V102, P1121, DOI 10.1182/blood-2002-08-2545; McDonald-McGinn DM, 1999, GENET COUNSEL, V10, P11; McDonald-McGinn DM, 2006, AM J MED GENET A, V140A, P906, DOI 10.1002/ajmg.a.31199; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Michielon G, 2006, ANN THORAC SURG, V81, P968, DOI 10.1016/j.athoracsur.2005.09.033; MONTCEL STD, 1996, J MED GENET, V33, P719; Moss EM, 1999, J PEDIATR-US, V134, P193, DOI 10.1016/S0022-3476(99)70415-4; MOTZKIN B, 1993, J PEDIATR-US, V123, P406, DOI 10.1016/S0022-3476(05)81740-8; Moylett EH, 2004, CLIN IMMUNOL, V112, P106, DOI 10.1016/j.clim.2004.02.008; Munoz S, 2001, REV MED CHILE, V129, P515; Murphy KC, 1998, BRIT J PSYCHIAT, V172, P180, DOI 10.1192/bjp.172.2.180; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Niklasson L, 2005, DEV MED CHILD NEUROL, V47, P803, DOI 10.1017/S0012162205001702; NOVAK RW, 1994, AM J MED GENET, V50, P311, DOI 10.1002/ajmg.1320500402; Nowotschin S, 2006, DEVELOPMENT, V133, P1565, DOI 10.1242/dev.02309; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Parissis D, 2005, J NEUROL, V252, P989, DOI 10.1007/s00415-005-0788-x; Paylor R, 2001, HUM MOL GENET, V10, P2645, DOI 10.1093/hmg/10.23.2645; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Perez EE, 2003, PEDIATRICS, V112, pE325, DOI 10.1542/peds.112.4.e325; Pierdominici M, 2003, CLIN EXP IMMUNOL, V132, P323, DOI 10.1046/j.1365-2249.2003.02134.x; Piliero LM, 2004, BLOOD, V103, P1020, DOI 10.1182/blood-2003-08-2824; Rasmussen SA, 1996, AM J MED GENET, V64, P546, DOI 10.1002/(SICI)1096-8628(19960906)64:4<546::AID-AJMG4>3.0.CO;2-N; Roberts C, 2005, DEV DYNAM, V232, P928, DOI 10.1002/dvdy.20268; Rommel N, 1999, GENET COUNSEL, V10, P71; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; SCHUBERT MS, 1992, ANN ALLERGY, V69, P231; Sediva A, 2005, MED SCI MONITOR, V11, pCR182; Shah SS, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e94; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; Simon TJ, 2005, CORTEX, V41, P145, DOI 10.1016/S0010-9452(08)70889-X; Simon TJ, 2005, NEUROIMAGE, V25, P169, DOI 10.1016/j.neuroimage.2004.11.018; Smith CA, 1998, CLIN DIAGN LAB IMMUN, V5, P415, DOI 10.1128/CDLI.5.3.415-417.1998; Solot CB, 2001, GENET MED, V3, P67, DOI 10.1097/00125817-200101000-00015; Solot CB, 2000, J COMMUN DISORD, V33, P187, DOI 10.1016/S0021-9924(00)00018-6; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Stewart TL, 1999, TERATOLOGY, V59, P20, DOI 10.1002/(SICI)1096-9926(199901)59:1<20::AID-TERA6>3.0.CO;2-S; Sullivan JC, 2002, HYPERTENSION, V40, P430; Sullivan KE, 1998, CLIN IMMUNOL IMMUNOP, V86, P141, DOI 10.1006/clin.1997.4463; Sullivan KE, 2002, CLIN DIAGN LAB IMMUN, V9, P1129, DOI 10.1128/CDLI.9.5.1129-1131.2002; Sullivan KE, 1999, CLIN DIAGN LAB IMMUN, V6, P906, DOI 10.1128/CDLI.6.6.906-911.1999; Swillen A, 1999, GENET COUNSEL, V10, P79; Swillen A, 1997, J MED GENET, V34, P453, DOI 10.1136/jmg.34.6.453; Taddei I, 2001, P NATL ACAD SCI USA, V98, P11428, DOI 10.1073/pnas.201127298; Theodoropoulos Demetrios S, 2003, Clin Med Res, V1, P43; Trost D, 1999, DEUT MED WOCHENSCHR, V124, P3, DOI 10.1055/s-2008-1062601; van Amelsvoort T, 2004, ARCH GEN PSYCHIAT, V61, P1085, DOI 10.1001/archpsyc.61.11.1085; Van Esch H, 1999, GENET COUNSEL, V10, P59; VANESCH H, 2003, GENET COUNSEL, V1, P43; Vantrappen G, 1999, GENET COUNSEL, V10, P3; Vorstman JAS, 2006, HUM MUTAT, V27, P814, DOI 10.1002/humu.20330; Wang PP, 2000, DEV MED CHILD NEUROL, V42, P422, DOI 10.1017/S0012162200000785; WELLER E, 1999, PSYCHIAT DIAGNOSES C; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; Worthington S, 1998, J PAEDIATR CHILD H, V34, P438, DOI 10.1046/j.1440-1754.1998.00262.x; Xu HS, 2005, DEVELOPMENT, V132, P4387, DOI 10.1242/dev.02018; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yan WL, 1998, AM J MED GENET, V81, P41, DOI 10.1002/(SICI)1096-8628(19980207)81:1<41::AID-AJMG8>3.0.CO;2-Q; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086; Zou D, 2006, DEV BIOL, V298, P430, DOI 10.1016/j.ydbio.2006.06.049; Zou D, 2006, DEV BIOL, V293, P499, DOI 10.1016/j.ydbio.2005.12.015	135	380	409	0	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1443	1452		10.1016/S0140-6736(07)61601-8	http://dx.doi.org/10.1016/S0140-6736(07)61601-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950858				2022-12-28	WOS:000250386000021
J	Walker, RG; Strippoli, GFM				Walker, Rowan G.; Strippoli, Giovanni F. M.			A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate	LANCET			English	Editorial Material							CHRONIC KIDNEY-DISEASE; DARBEPOETIN-ALPHA; HEMOGLOBIN LEVELS; ERYTHROPOIETIN; METAANALYSIS		Royal Melbourne Hosp, Melbourne, Vic, Australia; Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia; Univ Sydney, Sch Publ Hlth, Cochrane Renal Grp, Sydney, NSW 2006, Australia; Mario Negri Sud Consortium, Chieti, Italy	Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; Monash University; University of Sydney; Consorzio Mario Negri Sud	Walker, RG (corresponding author), Royal Melbourne Hosp, Melbourne, Vic, Australia.	rowan.walker@mh.org.au		Strippoli, Giovanni/0000-0002-6936-0616				Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Fishbane S, 2005, KIDNEY INT, V68, P1337, DOI 10.1111/j.1523-1755.2005.00532.x; Jadoul M, 2004, NEPHROL DIAL TRANSPL, V19, P898, DOI 10.1093/ndt/gfh021; Jamal NM, 2006, J INT MED RES, V34, P42, DOI 10.1177/147323000603400105; *KDIGO, 2007, CLIN PRACT GUID; Levin NW, 2007, LANCET, V370, P1415, DOI 10.1016/S0140-6736(07)61599-2; Macdougall IC, 2006, CLIN J AM SOC NEPHRO, V1, P1211, DOI 10.2215/CJN.00730306; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P66, DOI 10.1093/ndt/17.suppl_5.66; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Ross SD, 2003, CLIN THER, V25, P1786, DOI 10.1016/S0149-2918(03)80170-4; Strippoli GFM, 2005, AM J KIDNEY DIS, V46, P970, DOI 10.1053/j.ajkd.2005.09.009; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P3154, DOI 10.1097/01.ASN.0000145436.09176.A7; Walker R, 2007, NEPHROLOGY, V12, P448, DOI 10.1111/j.1440-1797.2007.00802.x; West RM, 2007, J AM SOC NEPHROL, V18, P2371, DOI 10.1681/ASN.2006050436	14	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2007	370	9596					1395	1396		10.1016/S0140-6736(07)61586-4	http://dx.doi.org/10.1016/S0140-6736(07)61586-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950848				2022-12-28	WOS:000250386000004
J	Reynolds, T				Reynolds, Toby			From small things	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE		Univ London, London SW17 0RE, England	University of London	Reynolds, T (corresponding author), Univ London, London SW17 0RE, England.	Toby.reynolds@gmail.com						McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606	4	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 13	2007	335	7623					747	748		10.1136/bmj.39328.503785.AD	http://dx.doi.org/10.1136/bmj.39328.503785.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17932203	Green Published			2022-12-28	WOS:000250418600025
J	Krupp, N				Krupp, Norbert			New surprises in the largest magnetosphere of our solar system	SCIENCE			English	Editorial Material								En route to its ultimate rendezvous with Pluto, the New Horizons spacecraft passed through the magnetic and plasma environment of Jupiter in February 2007. Onboard instruments collected high-resolution images, spectroscopic data, and information about charged particles. The results have revealed unusual structure and variation in Jupiter's plasma and large plasmoids that travel down the magnetotail. Data on Jupiter's aurora provide details of the interaction with the solar wind, and a major volcanic eruption from the moon Io was observed during the encounter.	Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany	Max Planck Society	Krupp, N (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	krupp@mps.mpg.de						Gladstone GR, 2007, SCIENCE, V318, P229, DOI 10.1126/science.1147613; McComas DJ, 2007, SCIENCE, V318, P217, DOI 10.1126/science.1147393; McNutt RL, 2007, SCIENCE, V318, P220, DOI 10.1126/science.1148025; Spencer JR, 2007, SCIENCE, V318, P240, DOI 10.1126/science.1147621	4	4	4	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					216	217		10.1126/science.1150448	http://dx.doi.org/10.1126/science.1150448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932281				2022-12-28	WOS:000250086100029
J	Reuter, DC; Simon-Miller, AA; Lunsford, A; Baines, KH; Cheng, AF; Jennings, DE; Olkin, CB; Spencer, JR; Stern, SA; Weaver, HA; Young, LA				Reuter, D. C.; Simon-Miller, A. A.; Lunsford, A.; Baines, K. H.; Cheng, A. F.; Jennings, D. E.; Olkin, C. B.; Spencer, J. R.; Stern, S. A.; Weaver, H. A.; Young, L. A.			Jupiter cloud composition, stratification, convection, and wave motion: A view from new horizons	SCIENCE			English	Article							ATMOSPHERE; IDENTIFICATION; SATELLITES; PROBE	Several observations of Jupiter's atmosphere made by instruments on the New Horizons spacecraft have implications for the stability and dynamics of Jupiter's weather layer. Mesoscale waves, first seen by Voyager, have been observed at a spatial resolution of 11 to 45 kilometers. These waves have a 300-kilometer wavelength and phase velocities greater than the local zonal flow by 100 meters per second, much higher than predicted by models. Additionally, infrared spectral measurements over five successive Jupiter rotations at spatial resolutions of 200 to 140 kilometers have shown the development of transient ammonia ice clouds (lifetimes of 40 hours or less) in regions of strong atmospheric upwelling. Both of these phenomena serve as probes of atmospheric dynamics below the visible cloud tops.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; NASA Headquarters, Sci Mission Directorate, Washington, DC 20546 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA)	Reuter, DC (corresponding author), NASA, Goddard Space Flight Ctr, Code 693, Greenbelt, MD 20771 USA.	dennis.c.reuter@nasa.gov	Olkin, Catherine/AAF-5160-2019; Jennings, Donald/D-7978-2012; Weaver, Harold A/D-9188-2016; Simon, Amy/C-8020-2012	Olkin, Catherine/0000-0002-5846-716X; Weaver, Harold A/0000-0003-0951-7762; Simon, Amy/0000-0003-4641-6186				Atreya SK, 2005, PLANET SPACE SCI, V53, P498, DOI 10.1016/j.pss.2004.04.002; Baines KH, 2007, SCIENCE, V318, P226, DOI 10.1126/science.1147912; Baines KH, 2002, ICARUS, V159, P74, DOI 10.1006/icar.2002.6901; Belton MJS, 1996, SCIENCE, V274, P377, DOI 10.1126/science.274.5286.377; Bosak T, 2002, ICARUS, V158, P401, DOI 10.1006/icar.2002.6886; Brooke TY, 1998, ICARUS, V136, P1, DOI 10.1006/icar.1998.6013; CHENG AF, IN PRESS SPACE SCI R; CONARD S, 2005, P SOC PHOTO-OPT INS, V5906, P409; FLASAR FM, 1986, J ATMOS SCI, V43, P2683, DOI 10.1175/1520-0469(1986)043<2683:MWAAPO>2.0.CO;2; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; REUTER D, 2005, P SOC PHOTO-OPT INS, V5906, P433; REUTER DC, IN PRESS SPACE SCI R; WEIDENSCHILLING SJ, 1973, ICARUS, V20, P465, DOI 10.1016/0019-1035(73)90019-5; Wong MH, 2004, PLANET SPACE SCI, V52, P385, DOI 10.1016/j.pss.2003.06.005	14	45	48	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					223	225		10.1126/science.1147618	http://dx.doi.org/10.1126/science.1147618			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932284				2022-12-28	WOS:000250086100032
J	Bisgaard, H; Hermansen, MN; Buchvald, F; Loland, L; Halkjaer, LB; Bonnelykke, K; Brasholt, M; Heltberg, A; Vissing, NH; Thorsen, SV; Stage, M; Pipper, CB				Bisgaard, Hans; Hermansen, Mette Northman; Buchvald, Frederik; Loland, Lotte; Halkjaer, Liselotte Brydensholt; Bonnelykke, Klaus; Brasholt, Martin; Heltberg, Andreas; Vissing, Nadja Hawwa; Thorsen, Sannie Vester; Stage, Malene; Pipper, Christian Bressen			Childhood asthma after bacterial colonization of the airway in neonates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOWER RESPIRATORY INFLAMMATION; YOUNG-CHILDREN; BIRTH COHORT; INFANTS; LIFE; IGE; SENSITIZATION; ASSOCIATION; AGE	Background Pathological features of the airway in young children with severe recurrent wheeze suggest an association between bacterial colonization and the initiating events of early asthma. We conducted a study to investigate a possible association between bacterial colonization of the hypopharynx in asymptomatic neonates and later development of recurrent wheeze, asthma, and allergy during the first 5 years of life. Methods The subjects were children from the Copenhagen Prospective Study on Asthma in Childhood birth cohort who were born to mothers with asthma. Aspirates from the hypopharyngeal region of asymptomatic 1-month-old infants were cultured for Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus. Wheeze was monitored prospectively on diary cards during the first 5 years of life. Blood eosinophil count and total IgE and specific IgE were measured at 4 years of age. Lung function was measured and asthma was diagnosed at 5 years of age. Results Hypopharyngeal samples were cultured from 321 neonates at 1 month of age. Twenty-one percent of the infants were colonized with S. pneumoniae, M. catarrhalis, H. influenzae, or a combination of these organisms; colonization with one or more of these organisms, but not colonization with S. aureus, was significantly associated with persistent wheeze (hazard ratio, 2.40; 95% confidence interval [CI], 1.45 to 3.99), acute severe exacerbation of wheeze (hazard ratio, 2.99; 95% CI, 1.66 to 5.39), and hospitalization for wheeze (hazard ratio, 3.85; 95% CI, 1.90 to 7.79). Blood eosinophil counts and total IgE at 4 years of age were significantly increased in children colonized neonatally with S. pneumoniae, M. catarrhalis, H. influenzae, or a combination of these organisms, but specific IgE was not significantly affected. The prevalence of asthma and the reversibility of airway resistance after beta(2)-agonist administration at 5 years of age were significantly increased in the children colonized neonatally with these organisms as compared with the children without such colonization (33% vs. 10% and 23% vs. 18%, respectively). Conclusions Neonates colonized in the hypopharyngeal region with S. pneumoniae, H. influenzae, or M. catarrhalis, or with a combination of these organisms, are at increased risk for recurrent wheeze and asthma early in life.	Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, DK-2900 Copenhagen, Denmark	University of Copenhagen	Bisgaard, H (corresponding author), Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Niels Andersens Vej 65, DK-2900 Copenhagen, Denmark.	bisgaard@copsac.dk	Bisgaard, Hans/N-4761-2016; Thorsen, Sannie Vester/AAF-1308-2020; Kronow, Joern/B-1054-2011	Bisgaard, Hans/0000-0003-4131-7592; Thorsen, Sannie Vester/0000-0002-8778-9053; Pipper, Christian Bressen/0000-0003-0261-616X; Bonnelykke, Klaus/0000-0003-2003-1018; Heltberg, Andreas Sondergaard/0000-0002-7822-9302				ANIANSSON G, 1992, J INFECT DIS, V165, pS38, DOI 10.1093/infdis/165-Supplement_1-S38; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bisgaard H, 2005, CHEST, V128, P355, DOI 10.1378/chest.128.1.355; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; BISGAARD H, 1995, ARCH DIS CHILD, V73, P226, DOI 10.1136/adc.73.3.226; Bisgaard H, 1995, EUR RESPIR J, V8, P2067, DOI 10.1183/09031936.95.08122067; Bisgaard H, 2001, AM J RESP CRIT CARE, V163, P1290, DOI 10.1164/ajrccm.163.6.ed1801b; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Karakoc F, 2002, CLIN EXP ALLERGY, V32, P51, DOI 10.1046/j.0022-0477.2001.01273.x; Kocevar VS, 2004, CHEST, V125, P1680, DOI 10.1378/chest.125.5.1680; Krawiec ME, 2001, AM J RESP CRIT CARE, V163, P1338, DOI 10.1164/ajrccm.163.6.2005116; Le Bourgeois M, 2002, CHEST, V122, P791, DOI 10.1378/chest.122.3.791; Loland L, 2006, CHEST, V129, P669, DOI 10.1378/chest.129.3.669; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Nielsen KG, 2001, AM J RESP CRIT CARE, V164, P554, DOI 10.1164/ajrccm.164.4.2006119; *NIT, 2002, NIH PUBL; Paganelli R, 1998, ALLERGY, V53, P763; Rhodes HL, 2001, J ALLERGY CLIN IMMUN, V108, P720, DOI 10.1067/mai.2001.119151; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Sherrill DL, 1999, J ALLERGY CLIN IMMUN, V104, P28, DOI 10.1016/S0091-6749(99)70110-7; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68	23	704	739	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1487	1495		10.1056/NEJMoa052632	http://dx.doi.org/10.1056/NEJMoa052632			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928596				2022-12-28	WOS:000250037000005
J	Gearhart, J; Pashos, EE; Prasad, MK				Gearhart, John; Pashos, Evanthia E.; Prasad, Megana K.			Pluripotency redux - Advances in stem-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FIBROBLASTS		Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Gearhart, J (corresponding author), Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA.							Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MEISSNER A, IN PRESS NAT BIOTECH; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944	5	94	104	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1469	1472		10.1056/NEJMp078126	http://dx.doi.org/10.1056/NEJMp078126			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928593				2022-12-28	WOS:000250037000002
J	Okie, S				Okie, Susan			The employer as health coach	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROMOTION; PROGRAMS; IMPACT											ABELSON R, 2005, NY TIMES        1029; Aldana SG, 2001, AM J HEALTH PROMOT, V15, P296, DOI 10.4278/0890-1171-15.5.296; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Pelletier KR, 2001, AM J HEALTH PROMOT, V16, P107, DOI 10.4278/0890-1171-16.2.107; *WATS WYATT WORLDW, 2007, 12 ANN NAT BUS GROUP	5	45	45	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1465	1469		10.1056/NEJMp078152	http://dx.doi.org/10.1056/NEJMp078152			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	218TE	17928592				2022-12-28	WOS:000250037000001
J	Ludwig, RJ; Kaufman, R				Ludwig, Ralf J.; Kaufman, Roland			How shingles can be beached	LANCET			English	Editorial Material									Univ Frankfurt, Dept Dermatol, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Ludwig, RJ (corresponding author), Univ Frankfurt, Dept Dermatol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	r.ludwig@em.uni-frankfurt.de	Ludwig, Ralf J/A-2629-2008; Ludwig, Ralf/F-3996-2018	Ludwig, Ralf J/0000-0002-1394-1737; Ludwig, Ralf/0000-0002-1394-1737					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2007	370	9594					1240	1240		10.1016/S0140-6736(07)61540-2	http://dx.doi.org/10.1016/S0140-6736(07)61540-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920919				2022-12-28	WOS:000250091900024
J	Ledford, H				Ledford, Heidi			Minimum telomere length defined for healthy cells	NATURE			English	News Item																			0	1	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					515	515		10.1038/449515a	http://dx.doi.org/10.1038/449515a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17972362	Bronze			2022-12-28	WOS:000249893500006
J	Porco, TC; Getz, WM				Porco, Travis C.; Getz, Wayne M.			Controlling extensively drug-resistant tuberculosis	LANCET			English	Editorial Material							EMERGENCE		Univ Calif San Francisco, Francis I Proctor Fdn Ophthalm Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Environm Sci & Policy Management, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Porco, TC (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Ophthalm Res, San Francisco, CA 94143 USA.	travis.porco@ucsf.edu	Getz, Wayne/I-4521-2013	Getz, Wayne/0000-0001-8784-9354				[Anonymous], 2007, GLOB TUB CONTR SURV; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mann Thomas, 1996, MAGIC MOUNTAIN; Oliver Paul, 1997, CONVERSATION BLUES; Porco TC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-157; RICH ML, 2006, REICHMAN HERSHFIELDS, P417; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; [Stop TB Partnership World Health Organization], 2006, GLOB PLAN STOP TB 20; World Health Organization, 2007, GLOB MDR TB XDR TB R; WORLD HEALTH ORGANIZATION, 2007, WHO GUID HUM RIGHTS	13	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2007	370	9597					1464	1465		10.1016/S0140-6736(07)61614-6	http://dx.doi.org/10.1016/S0140-6736(07)61614-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964334				2022-12-28	WOS:000250487000006
J	Jepsen, K; Solum, D; Zhou, TY; McEvilly, RJ; Kim, HJ; Glass, CK; Hermanson, O; Rosenfeld, MG				Jepsen, Kristen; Solum, Derek; Zhou, Tianyuan; McEvilly, Robert J.; Kim, Hyun-Jung; Glass, Christopher K.; Hermanson, Ola; Rosenfeld, Michael G.			SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron	NATURE			English	Article							DOMAIN-CONTAINING PROTEINS; MAMMALIAN TELENCEPHALON; REGULATED TRANSCRIPTION; HISTONE DEMETHYLATION; CO-REPRESSOR; DIFFERENTIATION; COREPRESSOR; METHYLATION; NOTCH; EXPRESSION	A series of transcription factors critical for maintenance of the neural stem cell state have been identified(1-3), but the role of functionally important corepressors(4-7) in maintenance of the neural stem cell state and early neurogenesis remains unclear. Previous studies have characterized the expression of both SMRT ( also known as NCoR2, nuclear receptor co-repressor 2) and NCoR in a variety of developmental systems(8); however, the specific role of the SMRT corepressor in neurogenesis is still to be determined. Here we report a critical role for SMRT in forebrain development and in maintenance of the neural stem cell state. Analysis of a series of markers in SMRT-gene-deleted mice revealed the functional requirement of SMRT in the actions of both retinoic-acid-dependent and Notch-dependent forebrain development. In isolated cortical progenitor cells, SMRT was critical for preventing retinoic-acid-receptor- dependent induction of differentiation along a neuronal pathway in the absence of any ligand. Our data reveal that SMRT represses expression of the jumonji-domain containing gene JMJD3, a direct retinoic-acid-receptor target that functions as a histone H3 trimethyl K27 demethylase and which is capable of activating specific components of the neurogenic program.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Karolinska Inst, Dept Neurosci, Ctr Excellence Dev Biol, SE-17177 Stockholm, Sweden	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet	Jepsen, K (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kjepsen@ucsd.edu	, Ola/AAF-5126-2021; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Hermanson, Ola/0000-0001-9320-7921				AGGER K, 2007, NATURE          0822; Akiyama H, 2003, J BIOL CHEM, V278, P10752, DOI 10.1074/jbc.M209856200; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cohen RN, 2000, MOL ENDOCRINOL, V14, P900, DOI 10.1210/me.14.6.900; DESANTAF, 2007, CELL, V130, P1083; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; LAN F, 2007, NATURE          0912; LEE ER, 2007, STEM CELLS      0524; LEEMG, 2007, SCI EXPRESS     0830; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nishihara E, 2004, MOL NEUROBIOL, V30, P307, DOI 10.1385/MN:30:3:307; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433	35	318	332	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					415	U8		10.1038/nature06270	http://dx.doi.org/10.1038/nature06270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17928865				2022-12-28	WOS:000250918600054
J	Mackenzie, I; Lever, A				Mackenzie, Iain; Lever, Andrew			Management of sepsis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTENSIVE INSULIN THERAPY; QUALITY-OF-LIFE; ANTIMICROBIAL THERAPY; PULMONARY-ARTERY; SEPTIC SHOCK; ILL PATIENTS; SURVIVORS		Addenbrookes Hosp, John Farman Intens Care Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Mackenzie, I (corresponding author), Addenbrookes Hosp, John Farman Intens Care Unit, Box 17, Cambridge CB2 2QQ, England.	iain@number2.demon.co.uk						Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; ALEJANDRIA MM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001090; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bertolini G, 2003, INTENS CARE MED, V29, P834, DOI 10.1007/s00134-003-1711-5; Finfer S, 2004, NEW ENGL J MED, V350, P2247; *GEORG I, 2005, NORM INT CAR EV SURV; Granja C, 2004, CRIT CARE, V8, pR91, DOI 10.1186/cc2818; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Ibrahim EH, 2002, JPEN-PARENTER ENTER, V26, P174, DOI 10.1177/0148607102026003174; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lanone S, 2005, INTENS CARE MED, V31, P1611, DOI 10.1007/s00134-005-2748-4; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Pildal J, 2004, CLIN INFECT DIS, V39, P38, DOI 10.1086/421089; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Venkataraman R, 2003, CRIT CARE, V7, P139, DOI 10.1186/cc1889; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213	31	27	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2007	335	7626					929	932		10.1136/bmj.39346.696620.AE	http://dx.doi.org/10.1136/bmj.39346.696620.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17974689	Green Published			2022-12-28	WOS:000250848300034
J	Masse, K; Bhamra, S; Eason, R; Dale, N; Jones, EA				Masse, Karine; Bhamra, Surinder; Eason, Robert; Dale, Nicholas; Jones, Elizabeth A.			Purine-mediated signalling triggers eye development	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; VERTEBRATE EYE; GROWTH-FACTOR; HOMEOBOX GENE; PINEAL-GLAND; XENOPUS; ATP; EXPRESSION; TISSUE; PROLIFERATION	A conserved network of eye field transcription factors (EFTFs) underlies the development of the eye in vertebrates and invertebrates(1). To direct eye development, Pax6, a key gene in this network(2,3), interacts with genes encoding other EFTFs such as Rx1 and Six3 (refs 4-6). However, the mechanisms that control expression of the EFTFs remain unclear(7). Here we show that purine-mediated signalling triggers both EFTF expression and eye development in Xenopus laevis. Overexpression of ectonucleoside triphosphate diphosphohydrolase 2 (E-NTPDase2)(8), an ectoenzyme that converts ATP to ADP(9), caused ectopic eye-like structures, with occasional complete duplication of the eye, and increased expression of Pax6, Rx1 and Six3. In contrast, down-regulation of endogenous E-NTPDase2 decreased Rx1 and Pax6 expression. E-NTPDase2 therefore acts upstream of these EFTFs. To test whether ADP (the product of E-NTPDase2) might act to trigger eye development through P2Y1 receptors, selective in Xenopus for ADP(10,11), we simultaneously knocked down expression of the genes encoding E-NTPDase2 and the P2Y1 receptor. This could prevent the expression of Rx1 and Pax6 and eye formation completely. We next measured ATP release(12-14) in the presumptive eye field, demonstrating a transient release of ATP at a time that could plausibly trigger (once converted to ADP) expression of the EFTFs. This surprising role for transient purine-mediated signalling in eye development may be widely conserved, because alterations to the locus of E-NTPDase2 on human chromosome 9 cause severe head and eye defects, including microphthalmia(15-18). Our results suggest a new mechanism for the initiation of eye development.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Dale, N (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	n.e.dale@warwick.ac.uk; elizabeth.jones@warwick.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLDERDICE PW, 1983, AM J HUM GENET, V35, P1005; Barnett MW, 1998, DEV GROWTH DIFFER, V40, P47; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Braun N, 2003, EUR J NEUROSCI, V17, P1355, DOI 10.1046/j.1460-9568.2003.02567.x; Brown P, 2002, J PHYSIOL-LONDON, V540, P843; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Cheng AWM, 2003, NEUROREPORT, V14, P351, DOI 10.1097/01.wnr.0000058033.29600.a3; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Chow RL, 1999, DEVELOPMENT, V126, P4213; Collignon J, 1996, DEVELOPMENT, V122, P509; Esteve P, 2006, CURR OPIN NEUROBIOL, V16, P13, DOI 10.1016/j.conb.2006.01.001; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Haldin CE, 2003, INT J DEV BIOL, V47, P253; Hampshire DJ, 2006, EUR J HUM GENET, V14, P543, DOI 10.1038/sj.ejhg.5201577; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Li HS, 1997, DEVELOPMENT, V124, P603; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Masse K, 2006, GENOMICS, V87, P366, DOI 10.1016/j.ygeno.2005.11.003; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Neas KR, 2005, AM J MED GENET A, V132A, P425, DOI 10.1002/ajmg.a.30496; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Yatsenko SA, 2005, J MED GENET, V42, P328, DOI 10.1136/jmg.2004.028258; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	33	96	97	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1058	U6		10.1038/nature06189	http://dx.doi.org/10.1038/nature06189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960245	Bronze			2022-12-28	WOS:000250395000054
J	Northen, TR; Yanes, O; Northen, MT; Marrinucci, D; Uritboonthai, W; Apon, J; Golledge, SL; Nordstrom, A; Siuzdak, G				Northen, Trent R.; Yanes, Oscar; Northen, Michael T.; Marrinucci, Dena; Uritboonthai, Winnie; Apon, Junefredo; Golledge, Stephen L.; Nordstrom, Anders; Siuzdak, Gary			Clathrate nanostructures for mass spectrometry	NATURE			English	Article							SECONDARY-ION MS; DESORPTION-IONIZATION; ELECTROSPRAY-IONIZATION; LARGE BIOMOLECULES; TISSUE-SECTIONS; SEPARATION; PROTEINS; DRUGS; BLOOD; SIMS	The ability of mass spectrometry to generate intact biomolecular ions efficiently in the gas phase has led to its widespread application in metabolomics(1), proteomics(2), biological imaging(3), biomarker discovery(4) and clinical assays (namely neonatal screens(5)). Matrix-assisted laser desorption/ionization(6,7) (MALDI) and electrospray ionization(8) have been at the forefront of these developments. However, matrix application complicates the use of MALDI for cellular, tissue, biofluid and microarray analysis and can limit the spatial resolution because of the matrix crystal size(9) (typically more than 10 mu m), sensitivity and detection of small compounds (less than 500 Da). Secondary-ion mass spectrometry(10) has extremely high lateral resolution (100 nm) and has found biological applications(11,12) although the energetic desorption/ionization is a limitation owing to molecular fragmentation. Here we introduce nanostructure- initiator mass spectrometry (NIMS), a tool for spatially defined mass analysis. NIMS uses 'initiator' molecules trapped in nanostructured surfaces or 'clathrates' to release and ionize intact molecules adsorbed on the surface. This surface responds to both ion and laser irradiation. The lateral resolution (ion-NIMS about 150 nm), sensitivity, matrix-free and reduced fragmentation of NIMS allows direct characterization of peptide microarrays, direct mass analysis of single cells, tissue imaging, and direct characterization of blood and urine.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Scripps Ctr Mass Spectrometry, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; Univ Oregon, CAMCOR Surface Anal Facil, Eugene, OR 97403 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California Santa Barbara; University of Oregon	Siuzdak, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	siuzdak@scripps.edu	Northen, Trent/K-3139-2012; Yanes, Oscar/N-3630-2016	Yanes, Oscar/0000-0003-3695-7157; Siuzdak, Gary/0000-0002-4749-0014; Northen, Trent/0000-0001-8404-3259				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Benninghoven A, 1987, SECONDARY ION MASS S, P1; Caldwell RL, 2005, MOL CELL PROTEOMICS, V4, P394, DOI 10.1074/mcp.R500006-MCP200; CHACE DH, 1993, CLIN CHEM, V39, P66; Chaurand P, 1999, ANAL CHEM, V71, P5263, DOI 10.1021/ac990781q; Chaurand P, 2006, J PROTEOME RES, V5, P2889, DOI 10.1021/pr060346u; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Fiedler GM, 2007, CLIN CHEM, V53, P421, DOI 10.1373/clinchem.2006.077834; GRADE H, 1978, J AM CHEM SOC, V100, P5615, DOI 10.1021/ja00486a006; Hao CY, 2007, ANAL BIOANAL CHEM, V387, P1247, DOI 10.1007/s00216-006-0956-6; Hashimoto H, 2004, APPL SURF SCI, V231, P385, DOI 10.1016/j.apsusc.2004.03.106; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kraemer T, 2007, ANAL BIOANAL CHEM, V388, P1415, DOI 10.1007/s00216-007-1271-6; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Maurer HH, 2004, CLIN CHEM LAB MED, V42, P1310, DOI 10.1515/CCLM.2004.250; McLean JA, 2005, J AM CHEM SOC, V127, P5304, DOI 10.1021/ja043907w; Ostrowski SG, 2005, ANAL CHEM, V77, P6190, DOI 10.1021/ac0508189; OVERBERG A, 1990, RAPID COMMUN MASS SP, V4, P293, DOI 10.1002/rcm.1290040808; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Want EJ, 2005, CHEMBIOCHEM, V6, P1941, DOI 10.1002/cbic.200500151; Wei J, 1999, NATURE, V399, P243, DOI 10.1038/20400; Winograd N, 2005, ANAL CHEM, V77, p142A, DOI 10.1021/ac053355f; Wiseman JM, 2006, ANGEW CHEM INT EDIT, V45, P7188, DOI 10.1002/anie.200602449; Wu KJ, 1996, ANAL CHEM, V68, P873, DOI 10.1021/ac950717i; Xu JYY, 2003, ANAL CHEM, V75, P6155, DOI 10.1021/ac034220h	28	385	407	2	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1033	U3		10.1038/nature06195	http://dx.doi.org/10.1038/nature06195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960240				2022-12-28	WOS:000250395000048
J	Rivenbark, AG; Strahl, BD				Rivenbark, Ashley G.; Strahl, Brian D.			Unlocking cell fate	SCIENCE			English	Editorial Material							ARGININE METHYLATION; HISTONE; DEMETHYLIMINATION		Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Rivenbark, AG (corresponding author), Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259				AGGER K, 2007, NATURE; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; DESANTA F, 2007, CELL; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lan F., 2007, NATURE; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400	11	12	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					403	404		10.1126/science.1150321	http://dx.doi.org/10.1126/science.1150321			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947570				2022-12-28	WOS:000250230400031
J	Soma, A; Onodera, A; Sugahara, J; Kanai, A; Yachie, N; Tomita, M; Kawamura, F; Sekine, Y				Soma, Akiko; Onodera, Akinori; Sugahara, Junichi; Kanai, Akio; Yachie, Nozomu; Tomita, Masaru; Kawamura, Fujio; Sekine, Yasuhiko			Permuted tRNA genes expressed via a circular RNA intermediate in Cyanidioschyzon merolae	SCIENCE			English	Article							MODEL SYSTEM; MITOCHONDRIA; SEQUENCE; PLASTIDS; PROGRAM; SPLIT	A computational analysis of the nuclear genome of a red alga, Cyanidioschyzon merolae, identified 11 transfer RNA (tRNA) genes in which the 3' half of the tRNA lies upstream of the 5' half in the genome. We verified that these genes are expressed and produce mature tRNAs that are aminoacylated. Analysis of tRNA-processing intermediates for these genes indicates an unusual processing pathway in which the termini of the tRNA precursor are ligated, resulting in formation of a characteristic circular RNA intermediate that is then processed at the acceptor stem to generate the correct termini.	Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Tokyo 1718501, Japan; Keio Univ, Inst Adv Biosci, Tsuruoka 9970017, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2528520, Japan; Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa 2528520, Japan; Rikkyo St Pauls Univ, Res Informat Ctr Extremophile, Tokyo 1718501, Japan	Rikkyo University; Keio University; Keio University; Keio University; Rikkyo University	Sekine, Y (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Tokyo 1718501, Japan.	ysekine@rikkyo.ac.jp	Kanai, Akio/C-4921-2014; Soma, Akiko/K-6592-2017	Kanai, Akio/0000-0002-6362-2419; Soma, Akiko/0000-0002-2809-7604				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; ALTMAN S, 1993, FASEB J, V7, P7, DOI 10.1096/fasebj.7.1.7916700; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; HEINONEN TY, 1987, J BIOL CHEM, V262, P2879; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Kuroiwa T, 1998, BIOESSAYS, V20, P344, DOI 10.1002/(SICI)1521-1878(199804)20:4<344::AID-BIES11>3.3.CO;2-L; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; PAN T, 1993, GENE, V125, P111, DOI 10.1016/0378-1119(93)90317-V; Randau L, 2005, NATURE, V433, P537, DOI 10.1038/nature03233; Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Sugahara Junichi, 2006, In Silico Biology, V6, P411; Sugahara J, 2007, RNA, V13, P671, DOI 10.1261/rna.309507; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P2025, DOI 10.1093/nar/30.9.2025	18	77	84	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					450	453		10.1126/science.1145718	http://dx.doi.org/10.1126/science.1145718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947580				2022-12-28	WOS:000250230400047
J	Winckler, B; Schafer, DA				Winckler, Bettina; Schafer, Dorothy A.			Cordon-Bleu: A new taste in actin nucleation	CELL			English	Editorial Material							GENE	Polymerization of actin filaments powers many dynamic cellular events and is directed by a small group of actin nucleators. In this issue, Ahuja et al. (2007) identify and characterize a new actin nucleator called cordon-bleu (Cobl) that may drive morphogenesis of the central nervous system during development.	Univ Virginia, Dept Neurosci, Charlottesville, VA 22093 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22093 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22093 USA	University of Virginia; University of Virginia; University of Virginia	Winckler, B (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22093 USA.	bw5h@virginia.edu; das9w@virginia.edu						AHUJA R, 2007, CELL; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Carroll EA, 2003, DEV BIOL, V262, P16, DOI 10.1016/S0012-1606(03)00323-3; DOMINGUEZ R, 2007, ANN NY ACAD SCI  APR; Ehlers MD, 2007, NEURON, V55, P686, DOI 10.1016/j.neuron.2007.08.009; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241	10	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					236	238		10.1016/j.cell.2007.10.003	http://dx.doi.org/10.1016/j.cell.2007.10.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956726	Bronze			2022-12-28	WOS:000250507700015
J	Medzhitov, R				Medzhitov, Ruslan			Recognition of microorganisms and activation of the immune response	NATURE			English	Review							TOLL-LIKE RECEPTORS; HELPER T-CELLS; INNATE IMMUNITY; RIG-I; PATTERN-RECOGNITION; ANTIVIRAL RESPONSES; ADAPTIVE IMMUNITY; DENDRITIC CELLS; GENE INDUCTION; DISEASE	The mammalian immune system has innate and adaptive components, which cooperate to protect the host against microbial infections. The innate immune system consists of functionally distinct 'modules' that evolved to provide different forms of protection against pathogens. It senses pathogens through pattern-recognition receptors, which trigger the activation of antimicrobial defences and stimulate the adaptive immune response. The adaptive immune system, in turn, activates innate effector mechanisms in an antigen-specific manner. The connections between the various immune components are not fully understood, but recent progress brings us closer to an integrated view of the immune system and its function in host defence.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, TAC S-669,300 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Endo Y, 2006, IMMUNOBIOLOGY, V211, P283, DOI 10.1016/j.imbio.2006.01.003; Ewald P, 1996, EVOLUTION INFECT DIS; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Glimcher LH, 2000, GENE DEV, V14, P1693; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hansen TH, 2007, NAT IMMUNOL, V8, P563, DOI 10.1038/ni1475; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liu PT, 2007, TRENDS MOL MED, V13, P117, DOI 10.1016/j.molmed.2007.01.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Reinhardt RL, 2006, CURR OPIN IMMUNOL, V18, P271, DOI 10.1016/j.coi.2006.03.003; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stetson DB, 2004, ADV IMMUNOL, V83, P163; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	65	1836	1947	7	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					819	826		10.1038/nature06246	http://dx.doi.org/10.1038/nature06246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943118				2022-12-28	WOS:000250230600031
J	Mataka, E				Mataka, Elizabeth			Maternal health and HIV: bridging the gap	LANCET			English	Editorial Material									Zambia Natl AIDS Network, Lusaka 10101, Zambia		Mataka, E (corresponding author), Zambia Natl AIDS Network, Lusaka 10101, Zambia.	liznmataka@zamnet.zm						Bell E, 2007, REPROD HEALTH MATTER, V15, P113, DOI 10.1016/S0968-8080(07)29029-9; Graham W, 2003, WORKSH HIV AIDS AD M; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; *INT AIDS SOC, 2002, WOM BARC MUJ AD INT; MBORINGACHA D, 2006, 2006 HIV AIDS IMPL M; McIntyre J, 2005, REPROD HEALTH MATTER, V13, P129, DOI 10.1016/S0968-8080(05)25184-4; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosenfield A, 2001, AM J PUBLIC HEALTH, V91, P703, DOI 10.2105/AJPH.91.5.703; *UNAIDS WHO, 2006, DEC 2006 AIDS EP UPD	10	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1290	1291		10.1016/S0140-6736(07)61552-9	http://dx.doi.org/10.1016/S0140-6736(07)61552-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933632				2022-12-28	WOS:000250176600007
J	Reinhardt, UE				Reinhardt, Uwe E.			The US muddle over a child's right to health care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	reinhard@princeton.edu						Reinhardt UE, 1997, JAMA-J AM MED ASSOC, V278, P1446, DOI 10.1001/jama.278.17.1446	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 13	2007	335	7623					749	749		10.1136/bmj.39360.488576.59	http://dx.doi.org/10.1136/bmj.39360.488576.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224AX	17932204	Green Published			2022-12-28	WOS:000250418600026
J	Cheng, KK; Chalmers, I; Sheldon, TA				Cheng, K. K.; Chalmers, Iain; Sheldon, Trevor A.			Adding fluoride to water supplies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRINKING-WATER; RISK		Univ Birmingham, Birmingham B15 2TT, W Midlands, England; James Lind Lib, Oxford OX2 7LG, England; Univ York, York YO10 5DD, N Yorkshire, England	University of Birmingham; University of York - UK	Cheng, KK (corresponding author), Univ Birmingham, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	k.k.cheng@bham.ac.uk	Cheng, Kar/AAL-8899-2021; Sheldon, Trevor/AAK-7088-2021	Cheng, Kar/0000-0002-1516-1857; Sheldon, Trevor/0000-0002-7479-5913				*CDC, 2002, FLUOR STAT 2002 STAT; COCHRANE AL, 1971, BRIT MED BULL, V27, P3, DOI 10.1093/oxfordjournals.bmb.a070810; CONNETT P, 2004, 50 REASONS OPPOSE FL; Council of Europa, 1997, CONV PROT HUM RIGHTS; *DRINK WAT INSP, 2006, FLUOR DRINK WAT; General Medical Council (UK), 1998, SEEK PAT CONS ETH CO; *GES SOZ KANT BAS, 2003, P975485GES SOZ KANT; Hillier S, 2000, LANCET, V355, P265, DOI 10.1016/S0140-6736(99)07161-5; JAUNCEY, 1983, OPINION LORD JAUNCEY; JOWELL T, 1998, HOUSE COMMONS OFFICI; Locker D, 2000, COMMUNITY DENT ORAL, V28, P161, DOI 10.1034/j.1600-0528.2000.280301.x; MAGUIRE A, 2004, BIOAVAILABILITY FLUO; Marinho V C, 2003, Cochrane Database Syst Rev, pCD002278, DOI 10.1002/14651858.CD002278; Medical Research Council, 2002, WORK GROUP REP WAT F; Murray JJ, 1991, FLUORIDES CARIES PRE, V3; *NHS CTR REV DISS, 2000, SYST REV PUBL WAT FL; Rose G., 1993, STRATEGY PREVENTIVE; Scottish Intercollegiate Guidelines Network, 2005, PREV MAN DENT DEC PR; WARNER, 2004, HOUSE LORDS OFFICIAL; Whelton HP, 2004, COMMUNITY DENT ORAL, V32, P9, DOI 10.1111/j.1600-0528.2004.00134.x; Wilson P, 2006, EVID POLICY, V2, P321; World Health Organization, WHO OR HLTH COUNTR A; Yang CY, 2000, ENVIRON RES, V82, P189, DOI 10.1006/enrs.1999.4018	23	43	46	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2007	335	7622					699	702		10.1136/bmj.39318.562951.BE	http://dx.doi.org/10.1136/bmj.39318.562951.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916854	Green Published			2022-12-28	WOS:000250156800030
J	Khanna, KM; McNamara, JT; Lefrancois, L				Khanna, Kamal M.; McNamara, Jeffery T.; Lefrancois, Leo			In situ imaging of the endogenous CD8 T cell response to infection	SCIENCE			English	Article							CLONAL EXPANSION; SPLEEN; NAIVE; DIFFERENTIATION; EXPRESSION; MIGRATION	Mounting a protective immune response is critically dependent on the orchestrated movement of cells within lymphoid organs. We report here the visualization, using major histocompatability complex class I tetramers, of the CD8-positive (CD8) T cell response in the spleens of mice to Listeria monocytogenes infection. A multistage pathway was revealed that included initial activation at the borders of the B and T cell zones followed by cluster formation with antigen-presenting cells leading to CD8 T cell exit to the red pulp via bridging channels. Strikingly, many memory CD8 T cells localized to the B cell zones and, when challenged, underwent rapid migration to the T cell zones where proliferation occurred, followed by egress via bridging channels in parallel with the primary response. Thus, the ability to track endogenous immune responses has uncovered both distinct and overlapping mechanisms and anatomical locations driving primary and secondary immune responses.	Univ Connecticut, Dept Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Dept Immunol, Farmington, CT 06030 USA.	Llefranc@neuron.uchc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, P01AI056172] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041576, R01 AI041576-06, AI56172, P01 AI056172, AI41576, P01 AI056172-05] Funding Source: Medline; PHS HHS [DRG-1886-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BOPUSSO P, 2003, NAT IMMUNOL, V4, P579; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Klonowski KD, 2006, J IMMUNOL, V177, P6738, DOI 10.4049/jimmunol.177.10.6738; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MITCHELL J, 1973, IMMUNOLOGY, V24, P93; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Potsch C, 1999, EUR J IMMUNOL, V29, P3562, DOI 10.1002/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Unsoeld H, 2004, J IMMUNOL, V173, P3013, DOI 10.4049/jimmunol.173.5.3013; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; VANEWIJK W, 1980, CELL TISSUE RES, V212, P497, DOI 10.1007/BF00236513	20	93	93	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					116	120		10.1126/science.1146291	http://dx.doi.org/10.1126/science.1146291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916739	Green Accepted			2022-12-28	WOS:000249915400055
J	Lalueza-Fox, C; Rompler, H; Caramelli, D; Staubert, C; Catalano, G; Hughes, D; Rohland, N; Pilli, E; Longo, L; Condemi, S; de la Rasilla, M; Fortea, J; Rosas, A; Stoneking, M; Schoneberg, T; Bertranpetit, J; Hofreiter, M				Lalueza-Fox, Carles; Roempler, Holger; Caramelli, David; Staubert, Claudia; Catalano, Giulio; Hughes, David; Rohland, Nadin; Pilli, Elena; Longo, Laura; Condemi, Silvana; de la Rasilla, Marco; Fortea, Javier; Rosas, Antonio; Stoneking, Mark; Schoeneberg, Torsten; Bertranpetit, Jaume; Hofreiter, Michael			A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals	SCIENCE			English	Article							MC1R; SKIN; VARIANTS; HAIR; DNA	The melanocortin 1 receptor (MC1R) regulates pigmentation in humans and other vertebrates. Variants of MC1R with reduced function are associated with pale skin color and red hair in humans of primarily European origin. We amplified and sequenced a fragment of the MC1R gene (mc1r) from two Neanderthal remains. Both specimens have a mutation that was not found in similar to 3700 modern humans analyzed. Functional analyses show that this variant reduces MC1R activity to a level that alters hair and/or skin pigmentation in humans. The impaired activity of this variant suggests that Neanderthals varied in pigmentation levels, potentially on the scale observed in modern humans. Our data suggest that inactive MC1R variants evolved independently in both modern humans and Neanderthals.	Univ Barcelona, Dept Biol Anim, E-08007 Barcelona, Spain; Univ Leipzig, Fac Med, Dept Mol Biochem, D-7010 Leipzig, Germany; Univ Florence, Dept Anim Biol & Genet, Lab Anthropol, I-50121 Florence, Italy; Univ Pompeu Fabra, Unitat Biol Evolut, Barcelona, Spain; Univ Siena, Dipartimento Sci Ambientali, I-53100 Siena, Italy; CNRS, UMR 6578, Unite Anthropol, Marseille, France; Univ Oviedo, Area Prehist, Oviedo, Spain; CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Barcelona; Leipzig University; University of Florence; Pompeu Fabra University; University of Siena; Centre National de la Recherche Scientifique (CNRS); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Max Planck Society; Harvard University	Lalueza-Fox, C (corresponding author), Univ Barcelona, Dept Biol Anim, E-08007 Barcelona, Spain.	clalueza@ub.edu; hofreite@eva.mpg.de	Stäubert, Claudia/I-7397-2015; Longo, Laura/G-2797-2011; Catalano, Giulio/AAT-2749-2020; LALUEZA-FOX, CARLES/AAG-5341-2020; Condemi, Silvana/ABE-2701-2021; Hughes, David/E-7190-2015; Bertranpetit, Jaume/F-8550-2012; Rosas, Antonio/D-9742-2016; Hofreiter, Michael/A-3996-2017	Stäubert, Claudia/0000-0003-0721-8507; Longo, Laura/0000-0001-6562-3047; Catalano, Giulio/0000-0002-2564-5775; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Condemi, Silvana/0000-0002-6516-0879; Hughes, David/0000-0002-9644-8998; Bertranpetit, Jaume/0000-0003-0100-0590; Rosas, Antonio/0000-0002-5829-9952; Pilli, Elena/0000-0002-3150-5082; Hofreiter, Michael/0000-0003-0441-4705; de la RASILLA, Marco/0000-0002-5505-0625; Caramelli, David/0000-0001-6468-1675				Beaumont KA, 2005, HUM MOL GENET, V14, P2145, DOI 10.1093/hmg/ddi219; Cann HM, 2002, SCIENCE, V296, P261; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rana BK, 1999, GENETICS, V151, P1547; Rees JL, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.2000.130303.x; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Sanchez-Laorden L, 2006, CELL MOL BIOL, V52, P39, DOI 10.1170/T706; Santos N. M. D., 2006, J BIOL CHEM, V281, P12896; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021	27	203	213	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1453	1455		10.1126/science.1147417	http://dx.doi.org/10.1126/science.1147417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	17962522				2022-12-28	WOS:000251246100046
J	Benton, R; Vannice, KS; Vosshall, LB				Benton, Richard; Vannice, Kirsten S.; Vosshall, Leslie B.			An essential role for a CD36-related receptor in pheromone detection in Drosophila	NATURE			English	Article							OLFACTORY NEURONS; SEX-PHEROMONE; CD36 FAMILY; FLY BRAIN; MELANOGASTER; RESPONSES; PROTEIN; REVEALS; ACETATE; SYSTEM	The CD36 family of transmembrane receptors is present across metazoans and has been implicated biochemically in lipid binding and transport(1). Several CD36 proteins function in the immune system as scavenger receptors for bacterial pathogens and seem to act as cofactors for Toll-like receptors by facilitating recognition of bacterially derived lipids(2-4). Here we show that a Drosophila melanogaster CD36 homologue, Sensory neuron membrane protein (SNMP), is expressed in a population of olfactory sensory neurons (OSNs) implicated in pheromone detection. SNMP is essential for the electrophysiological responses of OSNs expressing the receptor OR67d to (Z)-11-octadecenyl acetate (cis-vaccenyl acetate, cVA), a volatile male-specific fatty-acid-derived pheromone that regulates sexual and social aggregation behaviours(5-8). SNMP is also required for the activation of the moth pheromone receptor HR13 by its lipid-derived pheromone ligand (Z)-11-hexadecenal(9), but is dispensable for the responses of the conventional odorant receptor OR22a to its short hydrocarbon fruit ester ligands. Finally, we show that SNMP is required for responses of OR67d to cVA when ectopically expressed in OSNs not normally activated by pheromones. Because mammalian CD36 binds fatty acids(10), we suggest that SNMP acts in concert with odorant receptors to capture pheromone molecules on the surface of olfactory dendrites. Our work identifies an unanticipated cofactor for odorant receptors that is likely to have a widespread role in insect pheromone detection. Moreover, these results define a unifying model for CD36 function, coupling recognition of lipid-based extracellular ligands to signalling receptors in both pheromonal communication and pathogen recognition through the innate immune system.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA	Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099				BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; BRAND AH, 1993, DEVELOPMENT, V118, P401; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ge Yimin, 2005, Lab Hematol, V11, P31, DOI 10.1532/LH96.04056; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Kim MS, 1998, GENETICS, V150, P711; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Rebeiz M, 2004, DEV BIOL, V271, P431, DOI 10.1016/j.ydbio.2004.04.011; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rozen S, 2000, Methods Mol Biol, V132, P365; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	39	373	407	7	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					289	U13		10.1038/nature06328	http://dx.doi.org/10.1038/nature06328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17943085				2022-12-28	WOS:000250746200059
J	Dorling, D; Mitchell, R; Pearce, J				Dorling, Danny; Mitchell, Richard; Pearce, Jamie			The global impact of income inequality on health by age: an observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION HEALTH; UNITED-STATES; MORTALITY	Objectives To explore whether the apparent impact of income inequality on health, which has been shown for wealthier nations, is replicated worldwide, and whether the impact varies by age. Design Observational study. Setting 126 countries of the world for which complete data on income inequality and mortality by age and sex were available around the year 2002 (including 94.4% of world human population). Data sources Data on mortality were from the World Health Organization and income data were taken from the annual reports of the United Nations Development Programme. Main outcome measures Mortality in 5-year age bands for each sex by income inequality and income level. Results At ages 15-29 and 25-39 variations in income inequality seem more closely correlated with mortality worldwide than do variations in material wealth. This relation is especially strong among the poorest countries in Africa. Mortality is higher for a given level of overall income in more unequal nations. Conclusions Income inequality seems to have an influence worldwide, especially for younger adults. Social inequality seems to have a universal negative impact on health.	Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; Univ Glasgow, Glasgow G12 8RZ, Lanark, Scotland; Univ Canterbury, Dept Geog, GeoHlth Lab, Christchurch 8020, New Zealand	University of Sheffield; University of Glasgow; University of Canterbury	Dorling, D (corresponding author), Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England.	Daniel.dorling@sheffield.ac.uk	Mitchell, Rich JL/E-8056-2011	Pearce, Jamie/0000-0002-0994-7140				[Anonymous], 2004, BOTSW HUM DEV REP; Babones SJ, 2005, J WORLD SYST RES, V11, P29, DOI 10.5195/JWSR.2005.392; Brodish PH, 2000, SOUTHERN MED J, V93, P386; Chiang TL, 1999, BMJ-BRIT MED J, V319, P1162, DOI 10.1136/bmj.319.7218.1162; Daly MC, 1998, MILBANK Q, V76, P315, DOI 10.1111/1468-0009.00094; Davey Smith G., 2003, HLTH INEQUALITIES LI; DULEEP HO, 1995, SOC SECUR BULL, V58, P34; Hales S, 1999, LANCET, V354, P2047, DOI 10.1016/S0140-6736(99)03763-0; Kaplan GA, 1996, BRIT MED J, V312, P999; Lobmayer P, 2002, J EPIDEMIOL COMMUN H, V56, P183, DOI 10.1136/jech.56.3.183; Lopez ADAO, 2001, 40 GPE WHO; Lynch J, 2004, MILBANK Q, V82, P355, DOI 10.1111/j.0887-378X.2004.00312.x; Lynch J, 2001, LANCET, V358, P194, DOI 10.1016/S0140-6736(01)05407-1; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Marmot M., 2004, STATUS SYNDROME, DOI 10.1111/J.1740-9713.2004.00058.X; Mcisaac SJ, 1997, EUR J PUBLIC HEALTH, V7, P45, DOI 10.1093/eurpub/7.1.45; Mitchell R., 2000, INEQUALITIES LIFE DE; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; Ross NA, 2000, BRIT MED J, V320, P898, DOI 10.1136/bmj.320.7239.898; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; WEATHERBY NL, 1983, DEMOGRAPHY, V20, P27, DOI 10.2307/2060899; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036	22	53	53	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2007	335	7625					873	875		10.1136/bmj.39349.507315.DE	http://dx.doi.org/10.1136/bmj.39349.507315.DE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227BA	17954512	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000250631000040
J	Patterson, PH				Patterson, Paul H.			Maternal effects on schizophrenia risk	SCIENCE			English	Editorial Material							TWINS; INFECTION; PREGNANCY; AUTISM; LEADS		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Patterson, PH (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	php@caltech.edu						Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; DAVIS JO, 1995, SCHIZOPHRENIA BULL, V21, P357, DOI 10.1093/schbul/21.3.357; Derom CA, 2006, TWIN RES HUM GENET, V9, P733, DOI 10.1375/183242706779462723; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Hyman SL, 2006, INT REV RES MENT RET, V30, P171; Jacobs N, 2001, BEHAV GENET, V31, P209, DOI 10.1023/A:1010257512183; Meyer U., 2007, MOL PSYCHIAT; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Monteiro J, 1998, AM J HUM GENET, V63, P339, DOI 10.1086/301978; Phung DT, 2002, AM J OBSTET GYNECOL, V186, P1041, DOI 10.1067/mob.2002.122449; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Rosa A, 2002, SCHIZOPHRENIA BULL, V28, P697, DOI 10.1093/oxfordjournals.schbul.a006973; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; TORREY EF, 1992, SCHIZOPHRENIA BULL, V18, P159, DOI 10.1093/schbul/18.2.159; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	17	131	140	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					576	577		10.1126/science.1150196	http://dx.doi.org/10.1126/science.1150196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962542				2022-12-28	WOS:000250409200024
J	Green, PHR; Cellier, C				Green, Peter H. R.; Cellier, Christophe			Medical progress: Celiac disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GLUTEN-FREE DIET; T-CELL LYMPHOMA; ANTITISSUE TRANSGLUTAMINASE ANTIBODY; BREAST-FEEDING PROTECTS; TISSUE TRANSGLUTAMINASE; FOLLOW-UP; REFRACTORY SPRUE; VILLOUS ATROPHY; ENDOSCOPIC MARKERS; CLINICAL-FEATURES		Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Paris 05, Assistance Publ Hop Paris, INSERM,European Georges Pompidou Hosp, U793,Dept Gastroenterol, Paris, France	Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Green, PHR (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, 180 Ft Washington Ave,Rm 956, New York, NY 10032 USA.	pg11@columbia.edu		christophe, Cellier/0000-0003-0784-2318				Abrams JA, 2004, DIGEST DIS SCI, V49, P546, DOI 10.1023/B:DDAS.0000026296.02308.00; Abrams JA, 2006, CLIN GASTROENTEROL H, V4, P726, DOI 10.1016/j.cgh.2006.02.010; Al-Toma A, 2007, BLOOD, V109, P2243, DOI 10.1182/blood-2006-08-042820; Al-Toma A, 2006, CLIN GASTROENTEROL H, V4, P1322, DOI 10.1016/j.cgh.2006.07.007; Askling J, 2002, GASTROENTEROLOGY, V123, P1428, DOI 10.1053/gast.2002.36585; Bagdi E, 1999, BLOOD, V94, P260, DOI 10.1182/blood.V94.1.260.413k40_260_264; Bai D, 2005, SCAND J GASTROENTERO, V40, P183, DOI 10.1080/00365520510011498; BARDELLA MT, 1994, ARCH DIS CHILD, V70, P211, DOI 10.1136/adc.70.3.211; Bettendorf M, 2006, J PEDIATR ENDOCR MET, V19, P149; Bevan S, 1999, J MED GENET, V36, P687; Bingley PJ, 2004, BRIT MED J, V328, P322, DOI 10.1136/bmj.328.7435.322; Bonamico M, 2004, J PEDIATR GASTR NUTR, V38, P204, DOI 10.1097/00005176-200402000-00019; Carbonnel F, 1998, BLOOD, V92, P3879, DOI 10.1182/blood.V92.10.3879.422k34_3879_3886; Carlsson A, 2006, SCAND J GASTROENTERO, V41, P553, DOI 10.1080/00365520500352600; Catassi C, 1999, LANCET, V354, P647, DOI 10.1016/S0140-6736(99)02609-4; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 1999, GASTROINTEST ENDOSC, V50, P613, DOI 10.1016/S0016-5107(99)80007-8; Cellier C, 2000, LANCET, V355, P806, DOI 10.1016/S0140-6736(99)04855-2; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Ciacci C, 2001, DIGEST DIS SCI, V46, P2206, DOI 10.1023/A:1011919100259; COLLINS JR, 1964, NEW ENGL J MED, V271, P1153, DOI 10.1056/NEJM196411262712208; Culliford A, 2005, GASTROINTEST ENDOSC, V62, P55, DOI 10.1016/S0016-5107(05)01566-X; D'Amico MA, 2005, CLIN PEDIATR, V44, P249, DOI 10.1177/000992280504400309; Daum S, 2001, GUT, V49, P804, DOI 10.1136/gut.49.6.804; de Serre NPM, 2000, HISTOPATHOLOGY, V37, P70, DOI 10.1046/j.1365-2559.2000.00926.x; Dickey W, 2000, SCAND J GASTROENTERO, V35, P181; Dickey W, 1996, J CLIN GASTROENTEROL, V23, P21, DOI 10.1097/00004836-199607000-00007; Dickey W, 2001, AM J GASTROENTEROL, V96, P2126, DOI 10.1016/S0002-9270(01)02510-2; Dickey W, 2006, AM J GASTROENTEROL, V101, P2356, DOI 10.1111/j.1572-0241.2006.00750.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Fabiani E, 2000, J PEDIATR-US, V136, P841, DOI 10.1016/S0022-3476(00)35904-2; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Gale J, 2000, J CLIN ONCOL, V18, P795, DOI 10.1200/JCO.2000.18.4.795; Gillett HR, 2002, GASTROENTEROLOGY, V122, P800, DOI 10.1053/gast.2002.31874; Goerres MS, 2003, ALIMENT PHARM THER, V18, P487, DOI 10.1046/j.1365-2036.2003.01687.x; Goh C, 2007, POSTGRAD MED J, V83, P132, DOI 10.1136/pgmj.2006.049189; Gomez JC, 2001, AM J GASTROENTEROL, V96, P2700, DOI 10.1111/j.1572-0241.2001.04124.x; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Green PHR, 2000, GASTROINTEST ENDOSC, V51, P60, DOI 10.1016/S0016-5107(00)70389-0; Green PHR, 2004, GUT, V53, P774; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hallert C, 2002, ALIMENT PHARM THER, V16, P1333, DOI 10.1046/j.1365-2036.2002.01283.x; Howdle PD, 2003, QJM-INT J MED, V96, P345, DOI 10.1093/qjmed/hcg058; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Ivarsson A, 2005, BEST PRACT RES CL GA, V19, P425, DOI 10.1016/j.bpg.2005.02.005; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Johnson TC, 2004, CLIN GASTROENTEROL H, V2, P888, DOI 10.1016/S1542-3565(04)00390-8; Kaukinen K, 2002, AM J GASTROENTEROL, V97, P695, DOI 10.1111/j.1572-0241.2002.05471.x; KUMAR PJ, 1988, ARCH DIS CHILD, V63, P916, DOI 10.1136/adc.63.8.916; Lee SK, 2005, CURR OPIN GASTROEN, V21, P589, DOI 10.1097/01.mog.0000174218.00333.19; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Lenhardt A, 2004, DIGEST LIVER DIS, V36, P730, DOI 10.1016/j.dld.2004.06.017; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Maurino E, 2002, AM J GASTROENTEROL, V97, P2595; Memeo L, 2005, MODERN PATHOL, V18, P1134, DOI 10.1038/modpathol.3800404; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meyer D, 2001, AM J GASTROENTEROL, V96, P112; Mohamed BM, 2006, DIGEST DIS SCI, V51, P1862, DOI 10.1007/s10620-005-9038-4; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Molberg O, 1998, NAT MED, V4, P974, DOI 10.1038/nm0898-974b; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; OMahony S, 1996, ALIMENT PHARM THERAP, V10, P671, DOI 10.1046/j.1365-2036.1996.66237000.x; Oxentenko AS, 2002, AM J GASTROENTEROL, V97, P933; Peraaho M, 2004, SCAND J GASTROENTERO, V39, P27, DOI 10.1080/00365520310007783; Persson LA, 2002, ADV EXP MED BIOL, V503, P115; Raivio T, 2006, ALIMENT PHARM THER, V24, P147, DOI 10.1111/j.1365-2036.2006.02957.x; Rampertab SD, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.044; Rampertab SD, 2003, GUT, V52, P1211, DOI 10.1136/gut.52.8.1211; Ravelli A, 2005, AM J GASTROENTEROL, V100, P177, DOI 10.1111/j.1572-0241.2005.40669.x; Rongey C, 2006, DIGEST DIS SCI, V51, P1082, DOI 10.1007/s10620-006-8013-z; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; SATEGNAGUIDETTI C, 1993, J CLIN GASTROENTEROL, V17, P123, DOI 10.1097/00004836-199309000-00007; Shahbazkhani B, 2003, EUR J GASTROEN HEPAT, V15, P475, DOI 10.1097/01.meg.0000059118.41030.96; Shamaly H, 2007, J PEDIATR GASTR NUTR, V44, P583, DOI 10.1097/MPG.0b013e3180320679; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Smedby KE, 2005, GUT, V54, P54, DOI 10.1136/gut.2003.032094; Sollid LM, 2005, CLIN GASTROENTEROL H, V3, P843, DOI 10.1016/S1542-3565(05)00532-X; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sood Ajit, 2003, Indian J Gastroenterol, V22, P124; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Sugai E, 2006, CLIN GASTROENTEROL H, V4, P1112, DOI 10.1016/j.cgh.2006.05.004; Tatar G, 2004, DIGEST DIS SCI, V49, P1479, DOI 10.1023/B:DDAS.0000042250.59327.91; Thompson T, 2003, J AM DIET ASSOC, V103, P376, DOI 10.1053/jada.2003.50044; TRIER JS, 1978, GASTROENTEROLOGY, V75, P307; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; Tursi A, 2003, J CLIN GASTROENTEROL, V36, P219, DOI 10.1097/00004836-200303000-00007; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Verkarre V, 2003, GUT, V52, P205, DOI 10.1136/gut.52.2.205; Viljamaa M, 2005, SCAND J GASTROENTERO, V40, P437, DOI 10.1080/00365520510012181; Vivas S, 2006, NEW ENGL J MED, V355, P856; Vivas S, 2006, NEW ENGL J MED, V354, P2514, DOI 10.1056/NEJMc053129; Wahab PJ, 2000, ALIMENT PHARM THER, V14, P767; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Wong RCW, 2002, J CLIN PATHOL, V55, P488, DOI 10.1136/jcp.55.7.488	110	1281	1337	3	283	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1731	1743		10.1056/NEJMra071600	http://dx.doi.org/10.1056/NEJMra071600			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960014				2022-12-28	WOS:000250355100008
J	Jadzinsky, PD; Calero, G; Ackerson, CJ; Bushnell, DA; Kornberg, RD				Jadzinsky, Pablo D.; Calero, Guillermo; Ackerson, Christopher J.; Bushnell, David A.; Kornberg, Roger D.			Structure of a thiol monolayer-protected gold nanoparticle at 1.1 angstrom resolution	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; CLUSTER COMPOUNDS; METAL-CLUSTERS; SIZE; NANOCLUSTERS; PARTICLES; MOLECULES; CATALYSIS; HYDROGEN; GROWTH	Structural information on nanometer-sized gold particles has been limited, due in part to the problem of preparing homogeneous material. Here we report the crystallization and x-ray structure determination of a p-mercaptobenzoic acid (p-MBA)-protected gold nanoparticle, which comprises 102 gold atoms and 44 p-MBAs. The central gold atoms are packed in a Marks decahedron, surrounded by additional layers of gold atoms in unanticipated geometries. The p-MBAs interact not only with the gold but also with one another, forming a rigid surface layer. The particles are chiral, with the two enantiomers alternating in the crystal lattice. The discrete nature of the particle may be explained by the closing of a 58-electron shell.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Ackerson, Chris/AAY-5797-2021		NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NIAID NIH HHS [AI21144] Funding Source: Medline; NIGMS NIH HHS [Y1-GM-1104] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aiken JD, 1999, J MOL CATAL A-CHEM, V145, P1, DOI 10.1016/S1381-1169(99)00098-9; Ascencio JA, 1998, SURF SCI, V396, P349, DOI 10.1016/S0039-6028(97)00689-4; Bau R, 1998, J AM CHEM SOC, V120, P9380, DOI 10.1021/ja9819763; Boal AK, 2000, J AM CHEM SOC, V122, P734, DOI 10.1021/ja993900s; BRUST M, 1995, J CHEM SOC CHEM COMM, P1655, DOI 10.1039/c39950001655; Brust M., 2004, COLLOIDS COLLOID ASS, P96; Cleveland CL, 1997, PHYS REV LETT, V79, P1873, DOI 10.1103/PhysRevLett.79.1873; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; DEHEER WA, 1993, REV MOD PHYS, V65, P611, DOI 10.1103/RevModPhys.65.611; Duan GL, 2001, MOL PHYS, V99, P1689, DOI 10.1080/00268970110063917; Garzon IL, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.073403; Hakkinen H, 2006, J PHYS CHEM B, V110, P9927, DOI 10.1021/jp0619787; Hasan M, 2002, J AM CHEM SOC, V124, P1132, DOI 10.1021/ja0120577; Herlert A, 2000, J ELECTRON SPECTROSC, V106, P179, DOI 10.1016/S0368-2048(99)00075-4; Hicks JF, 1999, ANAL CHEM, V71, P3703, DOI 10.1021/ac990432w; Hostetler MJ, 1998, LANGMUIR, V14, P17, DOI 10.1021/la970588w; Ingram RS, 1997, J AM CHEM SOC, V119, P9175, DOI 10.1021/ja971734n; MARKS LD, 1994, REP PROG PHYS, V57, P603, DOI 10.1088/0034-4885/57/6/002; MARTIN TP, 1991, J PHYS CHEM-US, V95, P6421, DOI 10.1021/j100170a009; Martin TP, 1996, PHYS REP, V273, P199, DOI 10.1016/0370-1573(95)00083-6; Mednikov EG, 2007, J AM CHEM SOC, V129, P11619, DOI 10.1021/ja073945q; Peterson RR, 2005, ANAL CHEM, V77, P4348, DOI 10.1021/ac0502495; Prasad BLV, 2002, LANGMUIR, V18, P7515, DOI 10.1021/la020181d; Schaaff TG, 1998, J PHYS CHEM B, V102, P10643, DOI 10.1021/jp9830528; Schaaff TG, 1999, J PHYS CHEM B, V103, P9394, DOI 10.1021/jp993229d; Schaaff TG, 2000, J PHYS CHEM B, V104, P2630, DOI 10.1021/jp993691y; Shichibu Y, 2007, J PHYS CHEM C, V111, P7845, DOI 10.1021/jp073101t; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Teo B. K., 1993, Journal of Cluster Science, V4, P471, DOI 10.1007/BF00703738; Teo BK, 2001, J CLUST SCI, V12, P349, DOI 10.1023/A:1016603903142; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Vericat C, 2005, PHYS CHEM CHEM PHYS, V7, P3258, DOI 10.1039/b505903h; Wan LJ, 2000, J PHYS CHEM B, V104, P3563, DOI 10.1021/jp993328r; Wang SH, 2004, J AM CHEM SOC, V126, P7438, DOI 10.1021/ja031822+; Whetten RL, 1999, ACCOUNTS CHEM RES, V32, P397, DOI 10.1021/ar970239t; Wilcoxon JP, 2004, J AM CHEM SOC, V126, P6402, DOI 10.1021/ja031622y; Yacaman MJ, 2001, J VAC SCI TECHNOL B, V19, P1091, DOI 10.1116/1.1387089	37	2030	2041	41	1101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					430	433		10.1126/science.1148624	http://dx.doi.org/10.1126/science.1148624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947577				2022-12-28	WOS:000250230400040
J	Menetrey, J; Llinas, P; Mukherjea, M; Sweeney, HL; Houdusse, A				Menetrey, Julie; Llinas, Paola; Mukherjea, Monalisa; Sweeney, H. Lee; Houdusse, Anne			The structural basis for the large powerstroke of myosin VI	CELL			English	Article							MOTOR DOMAIN; CRYSTAL-STRUCTURE; POWER STROKE; NUCLEOTIDE-BINDING; ACTIN-FILAMENTS; MECHANISM; COMPLEX; PROTEIN; REVEAL; STATE	Due to a unique addition to the lever arm-positioning region (converter), class VI myosins move in the opposite direction (toward the minus end of actin filaments) compared to other characterized myosin classes. However, the large size of the myosin VI lever arm swing (powerstroke) cannot be explained by our current view of the structural transitions that occur within the myosin motor. We have solved the crystal structure of a fragment of the myosin VI motor in the structural state that represents the starting point for movement on actin; the pre-powerstroke state. Unexpectedly, the converter itself rearranges to achieve a conformation that has not been seen for other myosins. This results in a much larger powerstroke than is achievable without the converter rearrangement. Moreover, it provides a new mechanism that could be exploited to increase the powerstroke of yet to be characterized plus- end- directed myosin classes.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Inst Curie, CNRS, UMR 144, Paris 05, France	University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Sweeney, HL (corresponding author), Univ Penn, Sch Med, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	lsweeney@mail.med.upenn.edu; anne.houdusse@curie.fr	Sweeney, H Lee/F-1862-2010; Ménétrey, Julie/AAM-6408-2021	houdusse, anne/0000-0002-8566-0336				Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Koppole S, 2006, J MOL BIOL, V361, P604, DOI 10.1016/j.jmb.2006.06.022; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Robblee JP, 2005, BIOCHEMISTRY-US, V44, P10238, DOI 10.1021/bi050232g; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010	34	62	62	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					300	308		10.1016/j.cell.2007.08.027	http://dx.doi.org/10.1016/j.cell.2007.08.027			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956731	Bronze			2022-12-28	WOS:000250507700020
J	Stites, EC; Trampont, PC; Ma, Z; Ravichandran, KS				Stites, Edward C.; Trampont, Paul C.; Ma, Zhong; Ravichandran, Kodi S.			Network analysis of oncogenic Ras activation in cancer	SCIENCE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SIGNALING PATHWAYS; PROTEINS; GTP; BINDING; CELLS; GAP	To investigate the unregulated Ras activation associated with cancer, we developed and validated a mathematical model of Ras signaling. The model-based predictions and associated experiments help explain why only one of two classes of activating Ras point mutations with in vitro transformation potential is commonly found in cancers. Model-based analysis of these mutants uncovered a systems-level process that contributes to total Ras activation in cells. This predicted behavior was supported by experimental observations. We also used the model to identify a strategy in which a drug could cause stronger inhibition on the cancerous Ras network than on the wild-type network. This system-level analysis of the oncogenic Ras network provides new insights and potential therapeutic strategies.	Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Med Scientist Training Program, Charlottesville, VA 22908 USA; Univ Virginia, Interdisciplinary Program Biophys, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Dodson, Peter/A-9544-2009	Trampont, Paul/0000-0002-3643-8472	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI055432] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bollag G, 1996, J BIOL CHEM, V271, P32491, DOI 10.1074/jbc.271.51.32491; Bornheimer SJ, 2004, P NATL ACAD SCI USA, V101, P15899, DOI 10.1073/pnas.0407009101; BOS JL, 1989, CANCER RES, V49, P4682; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; ECCLESTON JF, 1991, BIOCHEM SOC T, V19, P432, DOI 10.1042/bst0190432; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Markevich N. I., 2004, Systems Biology, V1, P104, DOI 10.1049/sb:20045003; PATEL G, 1992, ONCOGENE, V7, P283; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0	21	83	85	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					463	467		10.1126/science.1144642	http://dx.doi.org/10.1126/science.1144642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947584				2022-12-28	WOS:000250230400051
J	Orosz, JA; McClintock, JE; Narayan, R; Bailyn, CD; Hartman, JD; Macri, L; Liu, JF; Pietsch, W; Remillard, RA; Shporer, A; Mazeh, T				Orosz, Jerome A.; McClintock, Jeffrey E.; Narayan, Ramesh; Bailyn, Charles D.; Hartman, Joel D.; Macri, Lucas; Liu, Jiefeng; Pietsch, Wolfgang; Remillard, Ronald A.; Shporer, Avi; Mazeh, Tsevi			A 15.65-solar-mass black hole in an eclipsing binary in the nearby spiral galaxy M 33	NATURE			English	Article							MODEL ATMOSPHERES; MASS; GRIDS; STAR	Stellar-mass black holes are found in X-ray-emitting binary systems, where their mass can be determined from the dynamics of their companion stars(1-3). Models of stellar evolution have difficulty producing black holes in close binaries with masses more than ten times that of the Sun (> 10M(circle dot); ref. 4), which is consistent with the fact that the most massive stellar black holes known so far(2,3) all have masses within one standard deviation of 10M(circle dot). Here we report a mass of (15.65 +/- 1.45) M-circle dot for the black hole in the recently discovered system M 33 X-7, which is located in the nearby galaxy Messier 33 (M 33) and is the only known black hole that is in an eclipsing binary(5). To produce such a massive black hole, the progenitor star must have retained much of its outer envelope until after helium fusion in the core was completed(4). On the other hand, in order for the black hole to be in its present 3.45-day orbit about its (70.0 +/- 6.9) M-circle dot companion, there must have been a 'common envelope' phase of evolution in which a significant amount of mass was lost from the system(6). We find that the common envelope phase could not have occurred in M 33 X-7 unless the amount of mass lost from the progenitor during its evolution was an order of magnitude less than what is usually assumed in evolutionary models of massive stars(7-9).	San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Yale Univ, Dept Astron, New Haven, CT 06520 USA; Natl Opt Astron Observ, Tucson, AZ 85719 USA; Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; Tel Aviv Univ, Wise Observ, IL-69978 Tel Aviv, Israel	California State University System; San Diego State University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Yale University; National Optical Astronomy Observatory; Max Planck Society; Massachusetts Institute of Technology (MIT); Tel Aviv University	Orosz, JA (corresponding author), San Diego State Univ, Dept Astron, 5500 Campanile Dr, San Diego, CA 92182 USA.	orosz@sciences.sdsu.edu	Shporer, Avi/Y-2777-2019	Shporer, Avi/0000-0002-1836-3120; Narayan, Ramesh/0000-0002-1919-2730; Macri, Lucas/0000-0002-1775-4859; Hartman, Joel/0000-0001-8732-6166				Alard C, 2000, ASTRON ASTROPHYS SUP, V144, P363, DOI 10.1051/aas:2000214; Brown GE, 2001, NEW ASTRON, V6, P457, DOI 10.1016/S1384-1076(01)00077-X; Charles P. A., 2006, COMPACT STELLAR XRAY, P215; GEIS DR, 2003, P IAU S, V212, P91; Greiner J, 2001, NATURE, V414, P522, DOI 10.1038/35107019; Harlaftis ET, 2004, ASTRON ASTROPHYS, V414, pL13, DOI 10.1051/0004-6361:20031754; Heap SR, 2006, ASTROPHYS J, V638, P409, DOI 10.1086/498635; HUMPHREYS RM, 1980, ASTROPHYS J SUPPL S, V44, P319, DOI 10.1086/190696; Lanz T, 2003, ASTROPHYS J SUPPL S, V146, P417, DOI 10.1086/374373; Lucy LB, 2003, ASTRON J, V125, P2266, DOI 10.1086/368144; Ma J, 2001, ASTRON J, V122, P1796, DOI 10.1086/323098; MEYNET G, 1994, ASTRON ASTROPHYS SUP, V103, P97; Neil ET, 2007, ASTROPHYS J, V657, P409, DOI 10.1086/510287; Orosz JA, 2000, ASTRON ASTROPHYS, V364, P265; OROSZ JA, 2003, IAU S, V212, P365; Pietsch W, 2006, ASTROPHYS J, V646, P420, DOI 10.1086/504704; Pietsch W, 2004, ASTRON ASTROPHYS, V413, P879, DOI 10.1051/0004-6361:20034081; Podsiadlowski P, 2003, MON NOT R ASTRON SOC, V341, P385, DOI 10.1046/j.1365-8711.2003.06464.x; Reynolds AP, 1997, MON NOT R ASTRON SOC, V288, P43, DOI 10.1093/mnras/288.1.43; SCHALLER G, 1992, ASTRON ASTROPHYS SUP, V96, P269; Shporer A, 2007, ASTRON ASTROPHYS, V462, P1091, DOI 10.1051/0004-6361:20066354; Tauris T.M., 2006, COMPACT STELLAR XRAY, P623; Vazquez GA, 2007, ASTROPHYS J, V663, P995, DOI 10.1086/518589	25	149	150	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					872	875		10.1038/nature06218	http://dx.doi.org/10.1038/nature06218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943124	Green Submitted, Green Accepted			2022-12-28	WOS:000250230600039
J	Gaidos, E; Haghighipour, N; Agol, E; Latham, D; Raymond, S; Rayner, J				Gaidos, Eric; Haghighipour, Nader; Agol, Eric; Latham, David; Raymond, Sean; Rayner, John			New worlds on the horizon: Earth-sized planets close to other stars	SCIENCE			English	Review							NEPTUNE-MASS PLANETS; M-CIRCLE-PLUS; TERRESTRIAL PLANETS; HABITABLE ZONES; SUPER-EARTHS; MIGRATION; SYSTEM; DISKS; PROTOPLANET; TRANSITS	The search for habitable planets like Earth around other stars fulfills an ancient imperative to understand our origins and place in the cosmos. The past decade has seen the discovery of hundreds of planets, but nearly all are gas giants like Jupiter and Saturn. Recent advances in instrumentation and new missions are extending searches to planets the size of Earth but closer to their host stars. There are several possible ways such planets could form, and future observations will soon test those theories. Many of these planets we discover may be quite unlike Earth in their surface temperature and composition, but their study will nonetheless inform us about the process of planet formation and the frequency of Earth-like planets around other stars.	Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; NASA, Ames Res Ctr, Astrobiol Inst, Moffett Field, CA 94035 USA; Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Colorado, Ctr Astrophys & Space Astron, Boulder, CO 80309 USA	University of Hawaii System; University of Hawaii Manoa; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Hawaii System; University of Hawaii Manoa; University of Washington; University of Washington Seattle; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Colorado System; University of Colorado Boulder	Gaidos, E (corresponding author), Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA.	gaidos@hawaii.edu	Agol, Eric/B-8775-2013	Agol, Eric/0000-0002-0802-9145; Gaidos, Eric/0000-0002-5258-6846; Raymond, Sean/0000-0001-8974-0758; Rayner, John/0000-0002-3165-159X				Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Agol E, 2007, MON NOT R ASTRON SOC, V374, P941, DOI 10.1111/j.1365-2966.2006.11213.x; Alibert Y, 2006, ASTRON ASTROPHYS, V455, pL25, DOI 10.1051/0004-6361:20065697; Borde P, 2003, ASTRON ASTROPHYS, V405, P1137, DOI 10.1051/0004-6361:20030675; Catanzarite J, 2006, PUBL ASTRON SOC PAC, V118, P1322, DOI 10.1086/504442; Eisner JA, 2006, ASTROPHYS J, V641, P1162, DOI 10.1086/500637; Gaidos E, 2005, ASTROBIOLOGY, V5, P100, DOI 10.1089/ast.2005.5.100; Gaidos EJ, 2000, ICARUS, V145, P637, DOI 10.1006/icar.2000.6407; Gillon M, 2005, ASTRON ASTROPHYS, V442, P731, DOI 10.1051/0004-6361:20053030; GILLON M, IN PRESS ASTRON ASTR; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Lee MH, 2002, ASTROPHYS J, V567, P596, DOI 10.1086/338504; Leger A, 2004, ICARUS, V169, P499, DOI 10.1016/j.icarus.2004.01.001; LISSAUER JJ, 1993, ANNU REV ASTRON ASTR, V31, P129, DOI 10.1146/annurev.aa.31.090193.001021; Raymond SN, 2006, SCIENCE, V313, P1413, DOI 10.1126/science.1130461; Raymond SN, 2005, ASTROPHYS J, V632, P670, DOI 10.1086/433179; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Rivera EJ, 2005, ASTROPHYS J, V634, P625, DOI 10.1086/491669; Scalo J, 2007, ASTROBIOLOGY, V7, P85, DOI 10.1089/ast.2006.0000; SEAGER S, IN PRESS ASTROPHYS; SELSIS F, IN PRESS ICARUS; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; VALENCIA D, IN PRESS ASTROPHYS J; Wright JT, 2005, PUBL ASTRON SOC PAC, V117, P657, DOI 10.1086/430369; Zhou JL, 2005, ASTROPHYS J, V631, pL85, DOI 10.1086/497094; [No title captured]	39	29	29	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					210	213		10.1126/science.1144358	http://dx.doi.org/10.1126/science.1144358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932279	Green Submitted			2022-12-28	WOS:000250086100027
J	Kollberg, G; Tulinius, M; Gilljam, T; Ostman-Smith, I; Forsander, G; Jotorp, P; Oldfors, A; Holme, E				Kollberg, Gittan; Tulinius, Mar; Gilljam, Thomas; Ostman-Smith, Ingegerd; Forsander, Gun; Jotorp, Peter; Oldfors, Anders; Holme, Elisabeth			Brief report: Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	10th International Congress of the World-Muscle-Society	SEP 28-OCT 10, 2005	Iguassu Falls, BRAZIL	World Muscle Soc			GLYCOGEN-SYNTHASE; TOLERANCE; DEPLETION; LIVER; MICE	Storage of glycogen is essential for glucose homeostasis and for energy supply during bursts of activity and sustained muscle work. We describe three siblings with profound muscle and heart glycogen deficiency caused by a homozygous stop mutation (R462 -> ter) in the muscle glycogen synthase gene. The oldest brother died from sudden cardiac arrest at the age of 10.5 years. Two years later, an 11-year-old brother showed muscle fatigability, hypertrophic cardiomyopathy, and an abnormal heart rate and blood pressure while exercising; a 2-year-old sister had no symptoms. In muscle-biopsy specimens obtained from the two younger siblings, there was lack of glycogen, predominance of oxidative fibers, and mitochondrial proliferation. Glucose tolerance was normal.	Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Pediat, S-41345 Gothenburg, Sweden; Vasteras Hosp, Dept Pediat, Vasteras, Sweden	Sahlgrenska University Hospital; Sahlgrenska University Hospital; Vasteras Central Hospital	Holme, E (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem, S-41345 Gothenburg, Sweden.	elisabeth.holme@clinchem.gu.se		Oldfors, Anders/0000-0002-5758-7397				BALDWIN KM, 1973, AM J PHYSIOL, V225, P1045, DOI 10.1152/ajplegacy.1973.225.5.1045; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Maquat LE, 2005, J CELL SCI, V118, P3213; Michelson-Kerman M, 2003, J CHILD NEUROL, V18, P876, DOI 10.1177/088307380301801208; Orho M, 1998, J CLIN INVEST, V102, P507, DOI 10.1172/JCI2890; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Shulman RG, 2001, P NATL ACAD SCI USA, V98, P457, DOI 10.1073/pnas.98.2.457; Shulman RG, 2001, P NATL ACAD SCI USA, V98, P6417, DOI 10.1073/pnas.101129298; TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6; VARDI P, 1991, DIABETOLOGIA, V34, P93, DOI 10.1007/BF00500379; VESTERGAARD H, 1994, AM J PHYSIOL, V266, pE92, DOI 10.1152/ajpendo.1994.266.1.E92; Vissing J, 2003, NEW ENGL J MED, V349, P2503, DOI 10.1056/NEJMoa031836	17	77	78	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1507	1514		10.1056/NEJMoa066691	http://dx.doi.org/10.1056/NEJMoa066691			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	218TE	17928598				2022-12-28	WOS:000250037000007
J	Palumbo, A; Boccadoro, M				Palumbo, Antonio; Boccadoro, Mario			A new standard of care for elderly patients with myeloma	LANCET			English	Editorial Material							MULTIPLE-MYELOMA; PLUS THALIDOMIDE; PREDNISONE; MELPHALAN		Univ Turin, Azienda Osped San Giovanni Battista, Div Ematol, I-10126 Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Palumbo, A (corresponding author), Univ Turin, Azienda Osped San Giovanni Battista, Div Ematol, I-10126 Turin, Italy.	appalumbo@yahoo.com		Boccadoro, Mario/0000-0001-8130-5209				Anderson KC, 2007, EXP HEMATOL, V35, P155, DOI 10.1016/j.exphem.2007.01.024; [Anonymous], 1998, J Clin Oncol, V16, P3832; El Accaoui RN, 2007, THROMB HAEMOSTASIS, V97, P1031, DOI 10.1160/TH06-09-0494; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Ghobrial IM, 2007, EXPERT OPIN EMERG DR, V12, P155, DOI 10.1517/14728214.12.1.155; Hulin C, 2007, J CLIN ONCOL, V25, p441s; LUDWIG H, 2007, HEMATOLOGICA, V92, pS166; Morgan GJ, 2006, LANCET ONCOL, V7, P316, DOI 10.1016/S1470-2045(06)70657-X; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4	9	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1191	1192		10.1016/S0140-6736(07)61522-0	http://dx.doi.org/10.1016/S0140-6736(07)61522-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920906				2022-12-28	WOS:000250091900004
J	Biai, S; Rodrigues, A; Gomes, M; Ribeiro, I; Sodemann, M; Alves, F; Aaby, P				Biai, Sidu; Rodrigues, Amabelia; Gomes, Melba; Ribeiro, Isabela; Sodemann, Morten; Alves, Fernanda; Aaby, Peter			Reduced in-hospital mortality after improved management of children under 5 years admitted to hospital with malaria: randomised trial	BRITISH MEDICAL JOURNAL			English	Article							CHILDHOOD MORTALITY; GUINEA-BISSAU; CARE; HEALTH; QUALITY; EQUITY; KENYA	Objective To test whether strict implementation of a standardised protocol for the management of malaria and provision of a financial incentive for health workers reduced mortality. Design Randomised controlled intervention trial. Setting Paediatric ward at the national hospital in Guinea-Bissau. All children admitted to hospital with severe malaria received free drug kits. Participants 951 children aged 3 months to 5 years admitted to hospital with a diagnosis of malaria randomised to normal or intervention wards. Interventions Before the start of the study, all personnel were trained in the use of the standardised guidelines for the management of malaria, including strict follow-up procedures. Nurses and doctors were randomised to work on intervention or control wards. Personnel in the intervention ward received a small financial incentive ($50; 25; pound (sic)35/month) and their compliance with standard case management was closely monitored. Main outcome measures In-hospital mortality and cumulative mortality within 4 weeks of hospital admission. Results In-hospital mortality was 5% for the intervention group and 10% in the control group (risk ratio 0.48, 95% confidence interval 0.29 to 0.79). The effect may have been stronger in patients with positive malaria slides (0.36, 0.16 to 0.80). Cumulative mortality 4 weeks after discharge was also lower in the intervention group (0.61, 0.40 to 0.95). Conclusions Supervising healthcare workers to adhere to a standardised treatment protocol was associated with greatly reduced in-hospitat mortality. Financial incentives may be important for the dedication and compliance of staff members.	INDEPTH Network, Projecto Saude Bandim, Bissau 1004, Guinea Bissau; WHO, CH-1211 Geneva 27, Switzerland; WHO, Bissau 1011, Guinea Bissau	World Health Organization; World Health Organization	Biai, S (corresponding author), INDEPTH Network, Projecto Saude Bandim, Bissau 1004, Guinea Bissau.	sidubiai@hotmail.com		Sodemann, Morten/0000-0001-8992-2500; Aaby, Peter/0000-0001-8331-1389				Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; CHAWLA V, 1988, E AFR MED J, V65, P238; Ferrinho Paulo, 2004, Hum Resour Health, V2, P14, DOI 10.1186/1478-4491-2-14; Jan S, 2005, B WORLD HEALTH ORGAN, V83, P771; MENGE I, 1995, E AFR MED J, V72, P165; NABISWA AK, 1994, E AFR MED J, V71, P9; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyes H, 1997, HEALTH POLICY PLANN, V12, P214, DOI 10.1093/heapol/12.3.214; RODRIGUES A, IN PRESS TROP MED IN; Roenen C, 1997, TROP MED INT HEALTH, V2, P127, DOI 10.1046/j.1365-3156.1997.d01-240.x; Sodemann M, 2004, ACTA PAEDIATR, V93, P959, DOI [10.1080/08035250410025564, 10.1111/j.1651-2227.2004.tb02696.x]; Sodemann M, 1997, B WORLD HEALTH ORGAN, V75, P205; VanLerberghe W, 1997, TROP MED INT HEALTH, V2, P799, DOI 10.1046/j.1365-3156.1997.d01-382.x; VEIRUM JE, 1991, IN PRESS ACTA PAEDIA; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Zucker JR, 1996, AM J TROP MED HYG, V55, P655, DOI 10.4269/ajtmh.1996.55.655	18	38	38	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2007	335	7625					862	865		10.1136/bmj.39345.467813.80	http://dx.doi.org/10.1136/bmj.39345.467813.80			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227BA	17954513	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000250631000037
J	Schmerr, N; Garnero, EJ				Schmerr, Nicholas; Garnero, Edward J.			Upper mantle discontinuity topography from thermal and chemical heterogeneity	SCIENCE			English	Article							TRANSITION-ZONE; SYSTEM MG2SIO4-FE2SIO4; SPINEL TRANSITIONS; SEISMIC EVIDENCE; CONSTRAINTS; STACKING; WATER; SS	Using high-resolution stacks of precursors to the seismic phase SS, we investigated seismic discontinuities associated with mineralogical phase changes approximately 410 and 660 kilometers (km) deep within Earth beneath South America and the surrounding oceans. Detailed maps of phase boundary topography revealed deep 410- and 660-km discontinuities in the down-dip direction of subduction, inconsistent with purely isochemical olivine phase transformation in response to lowered temperatures. Mechanisms invoking chemical heterogeneity within the mantle transition zone were explored to explain this feature. In some regions, multiple reflections from the discontinuities were detected, consistent with partial melt near 410-km depth and/or additional phase changes near 660-km depth. Thus, the origin of upper mantle heterogeneity has both chemical and thermal contributions and is associated with deeply rooted tectonic processes.	Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Schmerr, N (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Box 871404, Tempe, AZ 85287 USA.	nschmer@asu.edu	Schmerr, Nicholas/D-7338-2012	Schmerr, Nicholas/0000-0002-3256-1262				Akaogi M, 2002, PHYS EARTH PLANET IN, V132, P303, DOI 10.1016/S0031-9201(02)00075-4; AKAOGI M, 1989, J GEOPHYS RES-SOLID, V94, P15671, DOI 10.1029/JB094iB11p15671; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; BINA CR, 1987, J GEOPHYS RES-SOLID, V92, P4853, DOI 10.1029/JB092iB06p04853; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Collier JD, 2001, GEOPHYS J INT, V147, P319, DOI 10.1046/j.1365-246X.2001.00532.x; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Deuss A, 2006, SCIENCE, V311, P198, DOI 10.1126/science.1120020; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Fei Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002562; FEI Y, 1999, GEOCHEM SOC SPEC PUB, V6, P189; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P2673, DOI 10.1029/97JB03212; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P21165, DOI 10.1029/98JB00595; Gossler J, 1996, EARTH PLANET SC LETT, V138, P1, DOI 10.1016/0012-821X(95)00215-X; Gu YJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000489; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Karato S, 2006, REV MINERAL GEOCHEM, V62, P343, DOI 10.2138/rmg.2006.62.15; Leahy GM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004631; Lebedev S, 2002, SCIENCE, V296, P1300, DOI 10.1126/science.1069407; Li X, 2000, EARTH PLANET SC LETT, V183, P527, DOI 10.1016/S0012-821X(00)00294-6; Liu KH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002208; Schmerr N, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004197; SHEARER PM, 1991, J GEOPHYS RES-SOL EA, V96, P18147, DOI 10.1029/91JB01592; SHEARER PM, 1992, NATURE, V355, P791, DOI 10.1038/355791a0; Simmons NA, 2000, NATURE, V405, P559, DOI 10.1038/35014589; Smyth JR, 2006, GEOPHYS MONOGR SER, V168, P1, DOI 10.1029/168GM02; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P14835, DOI 10.1029/97JB00550; Zheng YC, 2007, SCIENCE, V316, P855, DOI 10.1126/science.1138074	30	82	85	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					623	626		10.1126/science.1145962	http://dx.doi.org/10.1126/science.1145962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962558				2022-12-28	WOS:000250409200040
J	Cavalieri, AL; Muller, N; Uphues, T; Yakovlev, VS; Baltuska, A; Horvath, B; Schmidt, B; Blumel, L; Holzwarth, R; Hendel, S; Drescher, M; Kleineberg, U; Echenique, PM; Kienberger, R; Krausz, F; Heinzmann, U				Cavalieri, A. L.; Mueller, N.; Uphues, Th.; Yakovlev, V. S.; Baltuska, A.; Horvath, B.; Schmidt, B.; Bluemel, L.; Holzwarth, R.; Hendel, S.; Drescher, M.; Kleineberg, U.; Echenique, P. M.; Kienberger, R.; Krausz, F.; Heinzmann, U.			Attosecond spectroscopy in condensed matter	NATURE			English	Article							ELECTRON DYNAMICS; PHOTOEMISSION	Comprehensive knowledge of the dynamic behaviour of electrons in condensed-matter systems is pertinent to the development of many modern technologies, such as semiconductor and molecular electronics, optoelectronics, information processing and photo-voltaics. Yet it remains challenging to probe electronic processes, many of which take place in the attosecond (1 as = 10(-18) s) regime. In contrast, atomic motion occurs on the femtosecond (1 fs = 10(-15) s) timescale and has been mapped in solids in real time(1,2) using femtosecond X-ray sources(3). Here we extend the attosecond techniques(4,5) previously used to study isolated atoms in the gas phase to observe electron motion in condensed-matter systems and on surfaces in real time. We demonstrate our ability to obtain direct time-domain access to charge dynamics with attosecond resolution by probing photoelectron emission from single-crystal tungsten. Our data reveal a delay of approximately 100 attoseconds between the emission of photoelectrons that originate from localized core states of the metal, and those that are freed from delocalized conduction-band states. These results illustrate that attosecond metrology constitutes a powerful tool for exploring not only gas-phase systems, but also fundamental electronic processes occurring on the attosecond timescale in condensed-matter systems and on surfaces.	Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Univ Bielefeld, Fak Phys, D-33615 Bielefeld, Germany; Univ Munich, Dept Phys, D-85748 Garching, Germany; Vienna Univ Technol, Inst Photon, A-1040 Vienna, Austria; Menlo Syst GmbH, D-82152 Martinsried, Germany; Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; Univ Basque Country, Ctr Mixto, CSIC, Dpto Fis Mat, San Sebastian 20018, Spain; DIPC, San Sebastian 20018, Spain	Max Planck Society; University of Bielefeld; University of Munich; Technische Universitat Wien; Menlo Systems GmbH; University of Hamburg; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country	Cavalieri, AL (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	adrian.cavalieri@mpq.mpg.de; krausz@lmu.de; uheinzm@physik.uni-bielefeld.de	Uphues, Thorsten/D-1373-2014; Heinzmann, Ulrich/A-6248-2012; Echenique, Pedro Miguel/AAB-3348-2019; Baltuska, ANDRIUS/ABE-2033-2020; Yakovlev, Vladislav S/C-4091-2015	Uphues, Thorsten/0000-0003-3423-4510; Yakovlev, Vladislav S/0000-0002-0648-9375; Baltuska, Andrius/0000-0002-5267-0626; Kienberger, Reinhard/0000-0001-8781-3685				Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; BERGLUND CN, 1964, PHYS REV A-GEN PHYS, V136, P1044, DOI 10.1103/PhysRev.136.A1044; Borisov AG, 2004, CHEM PHYS LETT, V393, P132, DOI 10.1016/j.cplett.2004.06.026; Bruhwiler PA, 2002, REV MOD PHYS, V74, P703, DOI 10.1103/RevModPhys.74.703; Cavalleri A, 2006, NATURE, V442, P664, DOI 10.1038/nature05041; Einstein A, 1905, ANN PHYS-BERLIN, V17, P132; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; GLOVER TE, 1994, PHYS REV LETT, V73, P78, DOI 10.1103/PhysRevLett.73.78; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; HAIGHT R, 1994, REV SCI INSTRUM, V65, P1853, DOI 10.1063/1.1144834; HAIGHT R, 1995, SURF SCI REP, V21, P277, DOI 10.1016/0167-5729(95)00002-X; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Hofer U, 1997, SCIENCE, V277, P1480, DOI 10.1126/science.277.5331.1480; Huber R, 2001, NATURE, V414, P286, DOI 10.1038/35104522; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kitzler M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173904; Miaja-Avila L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113604; Petek H, 1997, PROG SURF SCI, V56, P239, DOI 10.1016/S0079-6816(98)00002-1; Pfeifer T, 2006, REP PROG PHYS, V69, P443, DOI 10.1088/0034-4885/69/2/R04; Quere F, 2005, J MOD OPTIC, V52, P339, DOI 10.1080/09500340412331307942; Reis DA, 2007, TOP APPL PHYS, V108, P371; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; SCHINS JM, 1994, PHYS REV LETT, V73, P2180, DOI 10.1103/PhysRevLett.73.2180; SIEGBAHN K, 1974, J ELECTRON SPECTROSC, V5, P3, DOI 10.1016/0368-2048(74)85005-X; Siffalovic P, 2001, REV SCI INSTRUM, V72, P30, DOI 10.1063/1.1329904; TANUMA S, 1991, SURF INTERFACE ANAL, V17, P911, DOI 10.1002/sia.740171304; Wonisch A, 2006, APPL OPTICS, V45, P4147, DOI 10.1364/AO.45.004147; Yakovlev VS, 2005, J MOD OPTIC, V52, P395, DOI 10.1080/09500340412331283642; YEN R, 1982, APPL PHYS LETT, V40, P185, DOI 10.1063/1.93002	30	790	801	11	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1029	1032		10.1038/nature06229	http://dx.doi.org/10.1038/nature06229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960239				2022-12-28	WOS:000250395000047
J	Oberlander, J				Oberlander, Jonathan			Learning from failure in health care reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.							BROWN LD, 1994, HEALTH AFFAIR, V13, P175, DOI 10.1377/hlthaff.13.2.175; Hacker J. S., 1997, ROAD NOWHERE GENESIS; JOHNSON H, 1996, SYSTEM AM WAY POLITI; STARR P, 1995, AM PROSPECT, V6, P20; ZELMAN WA, 1994, HEALTH AFFAIR, V13, P9, DOI 10.1377/hlthaff.13.1.9	5	31	31	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1677	1679		10.1056/NEJMp078201	http://dx.doi.org/10.1056/NEJMp078201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223FN	17960009				2022-12-28	WOS:000250355100001
J	Rosenberg, AA				Rosenberg, Andrew A.			Fishing for certainty	NATURE			English	Editorial Material									Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Rosenberg, AA (corresponding author), Univ New Hampshire, Inst Study Earth Oceans & Space, Morse Hall 142, Durham, NH 03824 USA.								0	26	27	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					989	989		10.1038/449989a	http://dx.doi.org/10.1038/449989a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960225	Bronze			2022-12-28	WOS:000250395000033
J	Carbia-Nagashima, A; Gerez, J; Perez-Castro, C; Paez-Pereda, M; Silberstein, S; Stalla, GK; Holsboer, F; Arzt, E				Carbia-Nagashima, Alberto; Gerez, Juan; Perez-Castro, Carolina; Paez-Pereda, Marcelo; Silberstein, Susana; Stalla, Guenter K.; Holsboer, Florian; Arzt, Eduardo			RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1 alpha during hypoxia	CELL			English	Article							E3 LIGASE ACTIVITY; KAPPA-B; CHAIN FORMATION; UBIQUITIN; COMPLEX; CANCER; UBC9; EXPRESSION; INDUCTION; PATHWAY	SUMO conjugation to proteins is involved in the regulation of diverse cellular functions. We have identified a protein, RWD-containing sumoylation enhancer ( RSUME), that enhances overall SUMO-1, -2, and -3 conjugation by interacting with the SUMO conjugase Ubc9. RSUME increases noncovalent binding of SUMO-1 to Ubc9 and enhances Ubc9 thioester formation and SUMO polymerization. RSUME enhances the sumoylation of IkB in vitro and in cultured cells, leading to an inhibition of NF-kB transcriptional activity. RSUME is induced by hypoxia and enhances the sumoylation of HIF-1 alpha, promoting its stabilization and transcriptional activity during hypoxia. Disruption of the RWD domain structure of RSUME demonstrates that this domain is critical for RSUME action. Together, these findings point to a central role of RSUME in the regulation of sumoylation and, hence, several critical regulatory pathways in mammalian cells.	Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina; IFIBYNE CONICET, Buenos Aires, DF, Argentina; Max Planck Inst Psychiat, D-80804 Munich, Germany; Affectis Pharmaceut, D-80804 Munich, Germany	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society	Arzt, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, C1428EHA, Buenos Aires, DF, Argentina.	earzt@fbmc.fcen.uba.ar		Paez-Pereda, Marcelo/0000-0001-6029-0706				ARZT E, 1992, J CLIN INVEST, V90, P1944, DOI 10.1172/JCI116072; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bae SK, 2006, FEBS LETT, V580, P4105, DOI 10.1016/j.febslet.2006.06.052; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Castro CP, 2003, ENDOCRINOLOGY, V144, P693, DOI 10.1210/en.2002-220891; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Richard DE, 1999, BIOCHEM BIOPH RES CO, V266, P718, DOI 10.1006/bbrc.1999.1889; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7	44	235	263	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					309	323		10.1016/j.cell.2007.07.044	http://dx.doi.org/10.1016/j.cell.2007.07.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956732	Bronze, Green Published			2022-12-28	WOS:000250507700021
J	Sanai, N; Berger, MS; Garcia-Verdugo, JM; Alvarez-Buylla, A				Sanai, Nader; Berger, Mitchel S.; Garcia-Verdugo, Jose Manuel; Alvarez-Buylla, Arturo			Comment on "Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension"	SCIENCE			English	Editorial Material							ADULT HUMAN BRAIN; SUBVENTRICULAR ZONE; STEM-CELLS; NEURONS	Curtis et al. (Research Articles, 2 March 2007, p. 1243) claimed discovery of a human neuronal migratory stream to the olfactory bulb along a putative lateral ventricular extension. However, high levels of proliferation reported with proliferating cell nuclear antigen were not confirmed using different markers, neuronal chain migration was not demonstrated, and no serial reconstruction shows a true ventricular extension.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Valencia, Inst Cavanilles Biodivers & Biol Evolut, Valencia 46071, Spain; Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Valencia; University of California System; University of California San Francisco	Sanai, N (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,Room M779, San Francisco, CA 94143 USA.	sanain@neurosurg.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925				Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Bernier PJ, 2000, NEUROSCI RES, V37, P67, DOI 10.1016/S0168-0102(00)00102-4; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Humphrey T, 1940, J COMP NEUROL, V73, P431, DOI 10.1002/cne.900730305; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082	14	95	96	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849								10.1126/science.1145011	http://dx.doi.org/10.1126/science.1145011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947566				2022-12-28	WOS:000250230400024
J	Bhavsar, AP; Guttman, JA; Finlay, BB				Bhavsar, Amit P.; Guttman, Julian A.; Finlay, B. Brett			Manipulation of host-cell pathways by bacterial pathogens	NATURE			English	Review							ENTEROPATHOGENIC ESCHERICHIA-COLI; NF-KAPPA-B; TYPHIMURIUM-CONTAINING VACUOLES; ACTIN PEDESTAL FORMATION; III SECRETION EFFECTORS; SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; SHIGELLA-FLEXNERI; KINASE ACTIVATION; PROTEIN COMPLEX	Bacterial pathogens operate by attacking crucial intracellular pathways in their hosts. These pathogens usually target more than one intracellular pathway and often interact at several points in each of these pathways to commandeer them fully. Although different bacterial pathogens tend to exploit similar pathway components in the host, the way in which they 'hijack' host cells usually differs. Knowledge of how pathogens target distinct cytoskeletal components and immune-cell signalling pathways is rapidly advancing, together with the understanding of bacterial virulence at a molecular level. Studying how these bacterial pathogens subvert host-cell pathways is central to understanding infectious disease.	Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, 301-2185 E Mall, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca		Bhavsar, Amit/0000-0003-3336-9288				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Autenrieth SE, 2007, CELL MICROBIOL, V9, P425, DOI 10.1111/j.1462-5822.2006.00800.x; Batchelor M, 2004, EMBO REP, V5, P104, DOI 10.1038/sj.embor.7400038; Benabdillah R, 2004, MICROB PATHOGENESIS, V36, P247, DOI 10.1016/j.micpath.2003.12.006; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Cantarelli VV, 2002, INFECT IMMUN, V70, P2206, DOI 10.1128/IAI.70.4.2206-2209.2002; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gao LY, 2000, MICROBES INFECT, V2, P1705, DOI 10.1016/S1286-4579(00)01326-5; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; Goosney DL, 2001, INFECT IMMUN, V69, P3315, DOI 10.1128/IAI.69.5.3315-3322.2001; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Hanajima-Ozawa M, 2007, INFECT IMMUN, V75, P565, DOI 10.1128/IAI.01479-06; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Shaner NC, 2005, CELL MOTIL CYTOSKEL, V60, P104, DOI 10.1002/cm.20047; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Toyotome T, 2001, J BIOL CHEM, V276, P32071, DOI 10.1074/jbc.M101882200; Unsworth KE, 2007, CELL MICROBIOL, V9, P438, DOI 10.1111/j.1462-5822.2006.00801.x; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Yoshida S, 2002, EMBO J, V21, P2923, DOI 10.1093/emboj/cdf319; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	75	388	402	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					827	834		10.1038/nature06247	http://dx.doi.org/10.1038/nature06247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943119				2022-12-28	WOS:000250230600032
J	Shapiro, J				Shapiro, Jerry			Hair loss in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANDROGENETIC ALOPECIA; FINASTERIDE TREATMENT; POSTMENOPAUSAL WOMEN; DIFFUSE ALOPECIA; IRON-DEFICIENCY; SERUM FERRITIN; FEMALE; MINOXIDIL; TRICHOTILLOMANIA; PREVALENCE		Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada; Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; NYU, Dept Dermatol, New York, NY 10016 USA	University of British Columbia; Vancouver Coastal Health Research Institute; New York University	Shapiro, J (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, 835 W 10th Ave, Vancouver, BC V5Z 4E8, Canada.							Avram MR, 2002, DERMATOL SURG, V28, P894, DOI 10.1046/j.1524-4725.2002.02068.x; Birch MP, 2002, CLIN EXP DERMATOL, V27, P387; Birch MP, 2001, BRIT J DERMATOL, V144, P297, DOI 10.1046/j.1365-2133.2001.04018.x; DEVILLEZ RL, 1994, ARCH DERMATOL, V130, P303, DOI 10.1001/archderm.130.3.303; Dougherty DD, 2006, J CLIN PSYCHIAT, V67, P1086, DOI 10.4088/JCP.v67n0711; Drake LA, 1996, J AM ACAD DERMATOL, V35, P465; FUTTERWEIT W, 1988, J AM ACAD DERMATOL, V19, P831, DOI 10.1016/S0190-9622(88)70241-8; HARD S, 1963, ACTA DERM-VENEREOL, V43, P562; Hull SPM, 2003, BRIT J DERMATOL, V149, P692, DOI 10.1046/j.1365-2133.2003.05535.x; Iorizzo M, 2006, ARCH DERMATOL, V142, P298, DOI 10.1001/archderm.142.3.298; Kantor J, 2003, J INVEST DERMATOL, V121, P985, DOI 10.1046/j.1523-1747.2003.12540.x; KASICK JM, 1983, CLEVELAND CLIN Q, V50, P111, DOI 10.3949/ccjm.50.2.111; LITT JZ, 2006, LITTS DRUG ERUPTION; Lucky AW, 2004, J AM ACAD DERMATOL, V50, P541, DOI 10.1016/j.jaad.2003.06.014; LUDWIG E, 1977, ARCH DERMATOL, V113, P109; Madani S, 2000, J AM ACAD DERMATOL, V42, P549, DOI 10.1016/S0190-9622(00)90164-6; MILLER JA, 1982, BRIT J DERMATOL, V106, P331, DOI 10.1111/j.1365-2133.1982.tb01732.x; Olsen EA, 2005, J AM ACAD DERMATOL, V52, P301, DOI 10.1016/j.jaad.2004.04.008; Olsen EA, 2001, J AM ACAD DERMATOL, V45, pS70, DOI 10.1067/mjd.2001.117426; Price VH, 2000, J AM ACAD DERMATOL, V43, P768, DOI 10.1067/mjd.2000.107953; Ross EK, 2005, J AM ACAD DERMATOL, V53, P496; RUSHTON DH, 1990, BRIT J DERMATOL, V123, P187, DOI 10.1111/j.1365-2133.1990.tb01846.x; Sinclair R, 2005, BRIT J DERMATOL, V152, P466, DOI 10.1111/J.1365-2133.2005.06218.X; Sinclair R, 2002, BRIT J DERMATOL, V147, P982, DOI 10.1046/j.1365-2133.2002.04997.x; SWEDO SE, 1993, NEW ENGL J MED, V329, P141, DOI 10.1056/NEJM199307083290220; Trost LB, 2006, J AM ACAD DERMATOL, V54, P824, DOI 10.1016/j.jaad.2005.11.1104; Trueb RM, 2004, DERMATOLOGY, V209, P202, DOI 10.1159/000079890; Unger WP, 2003, J AM ACAD DERMATOL, V49, P853, DOI 10.1016/S0190-9622(03)01568-8; Vexiau P, 2002, BRIT J DERMATOL, V146, P992, DOI 10.1046/j.1365-2133.2002.04798.x; Whiting DA, 1996, J AM ACAD DERMATOL, V35, P899, DOI 10.1016/S0190-9622(96)90113-9	30	69	74	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1620	1630		10.1056/NEJMcp072110	http://dx.doi.org/10.1056/NEJMcp072110			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942874				2022-12-28	WOS:000250200500007
J	Tian, BZ; Zheng, XL; Kempa, TJ; Fang, Y; Yu, NF; Yu, GH; Huang, JL; Lieber, CM				Tian, Bozhi; Zheng, Xiaolin; Kempa, Thomas J.; Fang, Ying; Yu, Nanfang; Yu, Guihua; Huang, Jinlin; Lieber, Charles M.			Coaxial silicon nanowires as solar cells and nanoelectronic power sources	NATURE			English	Article							PERFORMANCE; ELECTRONICS; FABRICATION; TRANSISTORS; CIRCUITS	Solar cells are attractive candidates for clean and renewable power(1,2); with miniaturization, they might also serve as integrated power sources for nanoelectronic systems. The use of nanostructures or nanostructured materials represents a general approach to reduce both cost and size and to improve efficiency in photovoltaics(1-9). Nanoparticles, nanorods and nanowires have been used to improve charge collection efficiency in polymer-blend(4) and dye-sensitized solar cells(5,6), to demonstrate carrier multiplication(7), and to enable low-temperature processing of photovoltaic devices(3-6). Moreover, recent theoretical studies have indicated that coaxial nanowire structures could improve carrier collection and overall efficiency with respect to single-crystal bulk semiconductors of the same materials(8,9). However, solar cells based on hybrid nanoarchitectures suffer from relatively low efficiencies and poor stabilities(1). In addition, previous studies have not yet addressed their use as photovoltaic power elements in nanoelectronics. Here we report the realization of p-type/intrinsic/n-type (p-i-n) coaxial silicon nanowire solar cells. Under one solar equivalent (1-sun) illumination, the p-i-n silicon nanowire elements yield a maximum power output of up to 200 pW per nanowire device and an apparent energy conversion efficiency of up to 3.4 per cent, with stable and improved efficiencies achievable at high-flux illuminations. Furthermore, we show that individual and interconnected silicon nanowire photovoltaic elements can serve as robust power sources to drive functional nanoelectronic sensors and logic gates. These coaxial silicon nanowire photovoltaic elements provide a new nanoscale test bed for studies of photoinduced energy/charge transport and artificial photosynthesis(10), and might find general usage as elements for powering ultralow-power electronics(11) and diverse nanosystems(12,13).	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Funde, Adinath M./D-8169-2012; Yu, Nanfang/AAA-2634-2020; Zheng, Xiaolin/F-5231-2011	Kempa, Thomas/0000-0002-1672-8325; Zheng, Xiaolin/0000-0002-8889-7873				Aberle AG, 2000, PROG PHOTOVOLTAICS, V8, P473, DOI 10.1002/1099-159X(200009/10)8:5<473::AID-PIP337>3.0.CO;2-D; Avouris P, 2006, MATER TODAY, V9, P46, DOI 10.1016/S1369-7021(06)71653-4; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Baxter JB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861510; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Green MA, 2003, PROG PHOTOVOLTAICS, V11, P333, DOI 10.1002/pip.496; Green MA, 2007, PROG PHOTOVOLTAICS, V15, P35, DOI 10.1002/pip.741; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Hayden O, 2006, NAT MATER, V5, P352, DOI 10.1038/nmat1635; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Javey A, 2007, NANO LETT, V7, P773, DOI 10.1021/nl063056l; Karpov VG, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364136; Kayes BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1901835; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Lewis R, 2005, PROF ENG, V18, P21; Luque A., 2011, HDB PHOTOVOLTAIC SCI, DOI 10.1002/0470014008; Luque A, 2007, MRS BULL, V32, P236, DOI 10.1557/mrs2007.28; Patolsky F, 2006, NAT PROTOC, V1, P1711, DOI 10.1038/nprot.2006.227; Shah AV, 2004, PROG PHOTOVOLTAICS, V12, P113, DOI 10.1002/pip.533; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Wurfel P, 2005, PHYSICS OF SOLAR CELLS: FROM PRINCIPLES TO NEW CONCEPTS, P1; Zhang Y, 2007, NANO LETT, V7, P1264, DOI 10.1021/nl070174f; Zheng GF, 2004, ADV MATER, V16, P1890, DOI 10.1002/adma.200400472	30	2557	2612	28	1576	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					885	U8		10.1038/nature06181	http://dx.doi.org/10.1038/nature06181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943126				2022-12-28	WOS:000250230600042
J	Kels, CG				Kels, Charles Grant			The family man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kels@post.harvard.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1742	1742		10.1001/jama.298.15.1742	http://dx.doi.org/10.1001/jama.298.15.1742			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940221				2022-12-28	WOS:000250187300001
J	Schlechte, JA				Schlechte, Janet A.			Update in Endocrinology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SUBCLINICAL HYPOTHYROIDISM; RISK-FACTOR; ISLET TRANSPLANTATION; DIABETES-MELLITUS; DOUBLE-BLIND; PREVENTION; WOMEN		Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Schlechte, JA (corresponding author), Univ Iowa, Dept Internal Med, 200 Hawkins Dr,157 MRF, Iowa City, IA 52242 USA.	janet-schlechte@uiowa.edu		Schlechte, Janet/0000-0002-4089-0445				Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; CARR D, 1988, CLIN ENDOCRINOL, V28, P325, DOI 10.1111/j.1365-2265.1988.tb01219.x; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; [Food and Nutrition Board Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 1997, DIET REF INT CALC PH, DOI 10.17226/5776; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Meier C, 2001, J CLIN ENDOCR METAB, V86, P4860, DOI 10.1210/jc.86.10.4860; NYSTROM E, 1988, CLIN ENDOCRINOL, V29, P63, DOI 10.1111/j.1365-2265.1988.tb00250.x; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Poppe K, 2003, HUM REPROD UPDATE, V9, P149, DOI 10.1093/humupd/dmg012; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Sambrook PN, 2003, J BONE MINER RES, V18, P919, DOI 10.1359/jbmr.2003.18.5.919; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228	17	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					563	572		10.7326/0003-4819-147-8-200710160-00009	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938395				2022-12-28	WOS:000250437100006
J	Meselson, M; Mark Welch, D				Meselson, Matthew; Mark Welch, David			Stable heterozygosity?	SCIENCE			English	Editorial Material									Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA	Harvard University; Marine Biological Laboratory - Woods Hole	Meselson, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	msm@wjh.harvard.edu						Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211	4	6	6	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					202	203		10.1126/science.1150197	http://dx.doi.org/10.1126/science.1150197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932273				2022-12-28	WOS:000250086100021
J	Pouchkina-Stantcheva, NN; McGee, BM; Boschetti, C; Tolleter, D; Chakrabortee, S; Popova, AV; Meersman, F; Macherel, D; Hincha, DK; Tunnacliffe, A				Pouchkina-Stantcheva, Natalia N.; McGee, Brian M.; Boschetti, Chiara; Tolleter, Dimitri; Chakrabortee, Sohini; Popova, Antoaneta V.; Meersman, Filip; Macherel, David; Hincha, Dirk K.; Tunnacliffe, Alan			Functional divergence of former alleles in an ancient asexual invertebrate	SCIENCE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; BDELLOID ROTIFERS; SELECTION; GENE; SEX; PHOSPHATIDYLCHOLINE; DEHYDRATION; EFFICACY	Theory suggests it should be difficult for asexual organisms to adapt to a changing environment because genetic diversity can only arise from mutations accumulating within direct antecedents and not through sexual exchange. In an asexual microinvertebrate, the bdelloid rotifer, we have observed a mechanism by which such organisms could acquire the diversity needed for adaptation. Gene copies most likely representing former alleles have diverged in function so that the proteins they encode play complementary roles in survival of dry conditions. One protein prevents desiccation-sensitive enzymes from aggregating during drying, whereas its counterpart does not have this activity, but is able to associate with phospholipid bilayers and is potentially involved in maintenance of membrane integrity. The functional divergence of former alleles observed here suggests that adoption of asexual reproduction could itself be an evolutionary mechanism for the generation of diversity.	Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England; Univ Angers, INH, INRA, UMR Physiol Mol Semences 1191, F-49045 Angers, France; Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers; Max Planck Society; University of Cambridge	Tunnacliffe, A (corresponding author), Univ Cambridge, Inst Biotechnol, Tennis Court Rd, Cambridge CB2 1QT, England.	at10004@biotech.cam.ac.uk	Macherel, David/B-2084-2012; tolleter, dimitri/AAB-4166-2020	Macherel, David/0000-0002-3352-2185; tolleter, dimitri/0000-0003-1214-3140; Tunnacliffe, Alan/0000-0001-8570-125X; Chakrabortee, Sohini/0000-0001-8488-6416; Popova, Antoaneta/0000-0002-8120-7083				Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Birky CW, 2004, P NATL ACAD SCI USA, V101, P2651, DOI 10.1073/pnas.0308453101; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Burt A, 2000, EVOLUTION, V54, P337; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Cacela C, 2006, BIOPHYS J, V90, P2831, DOI 10.1529/biophysj.105.074427; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Hincha DK, 2000, EUR J BIOCHEM, V267, P535, DOI 10.1046/j.1432-1327.2000.01028.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x; Ricci C, 1998, HYDROBIOLOGIA, V387, P321, DOI 10.1023/A:1017086425934; Sanchez-Ballesta MT, 2004, J AGR FOOD CHEM, V52, P1950, DOI 10.1021/jf035216+; Spring J, 2002, NAT GENET, V31, P128, DOI 10.1038/ng0602-128; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Welch DBM, 2004, P NATL ACAD SCI USA, V101, P1622, DOI 10.1073/pnas.2136686100; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Welch JLM, 1998, HYDROBIOLOGIA, V387, P403; Welch JLM, 2004, P NATL ACAD SCI USA, V101, P1618, DOI 10.1073/pnas.0307677100; White M.J.D., 1978, MODES SPECIATION; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; WONG PTT, 1988, CHEM PHYS LIPIDS, V46, P213, DOI 10.1016/0009-3084(88)90024-2	31	107	108	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					268	271		10.1126/science.1144363	http://dx.doi.org/10.1126/science.1144363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932297				2022-12-28	WOS:000250086100046
J	Farquhar, J; Peters, M; Johnston, DT; Strauss, H; Masterson, A; Wiechert, U; Kaufman, AJ				Farquhar, James; Peters, Marc; Johnston, David T.; Strauss, Harald; Masterson, Andrew; Wiechert, Uwe; Kaufman, Alan J.			Isotopic evidence for Mesoarchaean anoxia and changing atmospheric sulphur chemistry	NATURE			English	Article							MASS-INDEPENDENT FRACTIONATION; MULTIPLE-SULFUR; EVOLUTION; SULFIDES; MICROPROBE; SEDIMENTS; RECORDS; CYCLE	The evolution of the Earth's atmosphere is marked by a transition from an early atmosphere with very low oxygen content to one with an oxygen content within a few per cent of the present atmospheric level. Placing time constraints on this transition is of interest because it identifies the time when oxidative weathering became efficient, when ocean chemistry was transformed by delivery of oxygen and sulphate, and when a large part of Earth's ecology changed from anaerobic to aerobic(1). The observation of non-mass-dependent sulphur isotope ratios in sedimentary rocks more than similar to 2.45 billion years (2.45 Gyr) old and the disappearance of this signal in younger sediments is taken as one of the strongest lines of evidence for the transition from an anoxic to an oxic atmosphere around 2.45 Gyr ago(1-5). Detailed examination of the sulphur isotope record before 2.45 Gyr ago also reveals early and late periods of large amplitude non-mass-dependent signals bracketing an intervening period when the signal was attenuated(5-9). Until recently, this record has been too sparse to allow interpretation, but collection of new data has prompted some workers(8) to argue that the Mesoarchaean interval (3.2-2.8 Gyr ago) lacks a non-mass-dependent signal, and records the effects of earlier and possibly permanent oxygenation of the Earth's atmosphere. Here we focus on the Mesoarchaean interval, and demonstrate preservation of a non-mass-dependent signal that differs from that of preceding and following periods in the Archaean. Our findings point to the persistence of an anoxic early atmosphere, and identify variability within the isotope record that suggests changes in pre-2.45-Gyr-ago atmospheric pathways for non-mass-dependent chemistry and in the ultraviolet transparency of an evolving early atmosphere.	Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Maryland, ESSIC, College Pk, MD 20742 USA; Univ Munster, Geol Palaontol Inst & Museum, D-48149 Munster, Germany; Free Univ Berlin, Dept Earth Sci, D-12249 Berlin, Germany	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Munster; Free University of Berlin	Farquhar, J (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	jfarquha@geol.umd.edu	Johnston, David/A-9796-2010	Masterson, Andrew/0000-0002-3422-2985; Johnston, David/0000-0002-2487-1084				Baroni M, 2007, SCIENCE, V315, P84, DOI 10.1126/science.1131754; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Cates NL, 2006, GEOCHIM COSMOCHIM AC, V70, P4229, DOI 10.1016/j.gca.2006.05.014; Farquhar J, 2005, GEOL SOC SPEC PUBL, V248, P167, DOI 10.1144/GSL.SP.2005.248.01.09; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2001, SCIENCE, V292, pU6; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Gao X., 1991, GEOCHIM COSMOCHIM AC, V55, P2671, DOI DOI 10.1016/0016-7037(91)90381-E; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Hu GX, 2003, GEOCHIM COSMOCHIM AC, V67, P3101, DOI 10.1016/S0016-7037(02)00929-8; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Johnston DT, 2006, GEOCHIM COSMOCHIM AC, V70, P5723, DOI 10.1016/j.gca.2006.08.001; Johnston DT, 2005, SCIENCE, V310, P1477, DOI 10.1126/science.1117824; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kasting JF, 2006, PHILOS T R SOC B, V361, P917, DOI 10.1098/rstb.2006.1839; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Ono S, 2007, GEOCHIM COSMOCHIM AC, V71, P1170, DOI 10.1016/j.gca.2006.11.017; Ono S, 2006, S AFR J GEOL, V109, P97, DOI 10.2113/gssajg.109.1-2.97; Papineau D, 2005, GEOCHIM COSMOCHIM AC, V69, P5033, DOI 10.1016/j.gca.2005.07.005; Papineau D., 2006, GEOBIOLOGY, V4, P227; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; ROMERO AB, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003GL018134; Thiemens MH, 2006, ANNU REV EARTH PL SC, V34, P217, DOI 10.1146/annurev.earth.34.031405.125026; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Whitehouse MJ, 2005, CHEM GEOL, V222, P112, DOI 10.1016/j.chemgeo.2005.06.004; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	32	220	234	1	96	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					706	U5		10.1038/nature06202	http://dx.doi.org/10.1038/nature06202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928857				2022-12-28	WOS:000250045000040
J	Magos, A				Magos, Adam			Does hysterectomy cause urinary incontinence?	LANCET			English	Editorial Material							WOMEN; RISK		Royal Free Hosp, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Magos, A (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.	a.magos@medsch.ucl.ac.uk						Altman D, 2007, LANCET, V370, P1494, DOI 10.1016/S0140-6736(07)61635-3; Altman Daniel, 2003, Int Urogynecol J Pelvic Floor Dysfunct, V14, P418, DOI 10.1007/s00192-003-1097-5; Babalola EO, 2007, AM J OBSTET GYNECOL, V196, P214, DOI 10.1016/j.ajog.2006.10.390; Brown JS, 2000, LANCET, V356, P535, DOI 10.1016/S0140-6736(00)02577-0; de Tayrac R, 2007, EUR J OBSTET GYN R B, V130, P258, DOI 10.1016/j.ejogrb.2006.01.032; Engh MAE, 2006, ACTA OBSTET GYN SCAN, V85, P614, DOI 10.1080/00016340600555942; Gustafsson C, 2006, UROLOGY, V68, P769, DOI 10.1016/j.urology.2006.04.001; *HES ONL, MAIN OP SUMM; Melville JL, 2005, ARCH INTERN MED, V165, P537, DOI 10.1001/archinte.165.5.537; Swithinbank LV, 1999, BRIT J GEN PRACT, V49, P897; Thakar R, 2002, NEW ENGL J MED, V347, P1318, DOI 10.1056/NEJMoa013336; Thakar R, 2004, BJOG-INT J OBSTET GY, V111, P20, DOI 10.1111/j.1471-0528.2004.00461.x	12	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1462	1463		10.1016/S0140-6736(07)61613-4	http://dx.doi.org/10.1016/S0140-6736(07)61613-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964333				2022-12-28	WOS:000250487000005
J	Mansouri, FA; Buckley, MJ; Tanaka, K				Mansouri, Farshad A.; Buckley, Mark J.; Tanaka, Keiji			Mnemonic function of the dorsolateral prefrontal cortex in conflict-induced behavioral adjustment	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; TASK; PERFORMANCE; INTERFERENCE; INFORMATION; MECHANISMS; CORTICES; MONKEYS	Our cognitive abilities in performing tasks are influenced by experienced competition/ conflict between behavioral choices. To determine the role of the anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC) in the conflict detection-resolution process, we conducted complementary lesion and single-cell recording studies in monkeys that were resolving a conflict between two rules. We observed conflict-induced behavioral adjustment that persisted after lesions within the ACC but disappeared after lesions within the DLPFC. In the DLPFC, activity was modulated in some cells by the current conflict level and in other cells by the conflict experienced in the previous trial. These results show that the DLPFC, but not the ACC, is essential for the conflict-induced behavioral adjustment and suggest that encoding and maintenance of information about experienced conflict is mediated by the DLPFC.	RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	RIKEN; University of Oxford; Saitama University	Mansouri, FA (corresponding author), RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan.	farshad@postman.riken.jp	Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427				Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; GOLDMAN PS, 1971, J COMP PHYSIOL PSYCH, V77, P212, DOI 10.1037/h0031649; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Heaton R.K., 1993, WISCONSIN CARD SORTI; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lauwereyns J, 2000, J EXP PSYCHOL ANIM B, V26, P352, DOI 10.1037/0097-7403.26.3.352; Levy R, 1999, J NEUROSCI, V19, P5149; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Mansouri FA, 2002, BEHAV BRAIN RES, V136, P415, DOI 10.1016/S0166-4328(02)00182-1; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837	27	132	133	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					987	990		10.1126/science.1146384	http://dx.doi.org/10.1126/science.1146384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17962523				2022-12-28	WOS:000250788500047
J	Rutz, C; Bluff, LA; Weir, AAS; Kacelnik, A				Rutz, Christian; Bluff, Lucas A.; Weir, Alex A. S.; Kacelnik, Alex			Video cameras on wild birds	SCIENCE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Rutz, C (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	christian.rutz@zoo.ox.ac.uk	Weir, Alex/B-4664-2008	Rutz, Christian/0000-0001-5187-7417	Biotechnology and Biological Sciences Research Council [BB/C517392/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bluff LA, 2007, COMP COGN BEHAV REV, V2, P1; Hunt G.R., 2006, ACTA ZOOL SINICA, V52, P622	2	74	76	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					765	765		10.1126/science.1146788	http://dx.doi.org/10.1126/science.1146788			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17916693				2022-12-28	WOS:000250583900032
J	Huf, G; Coutinho, ESF; Adams, CE				Huf, Gisele; Coutinho, E. S. F.; Adams, C. E.			Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VIOLENT	Objective To determine whether haloperidol alone results in swifter and safer tranquillisation and sedation than haloperidol plus promethazine. Design Pragmatic randomised open trial (January-July 2004). Setting Psychiatric emergency room, Rio de Janeiro, Brazil. Participants 316 patients who needed urgent intramuscular sedation because of agitation, dangerous behaviour, or both. Interventions Open treatment with intramuscular haloperidol 5-10 mg or intramuscular haloperidol 5-10 mg plus intramuscular promethazine up to 50 mg; doses were at the discretion of the prescribing clinician. Main outcome measures The primary outcome was proportion tranquil or asleep by 20 minutes. Secondary outcomes were asleep by 20 minutes; tranquil or asleep by 40, 60, and 120 minutes; physically restrained or given additional drugs within 2 hours; severe adverse events; another episode of agitation or aggression; additional visit from the doctor during the subsequent 24 hours; overall antipsychotic load in the first 24 hours; and still in hospital after 2 weeks. Results Primary outcome data were available for 311 (98.4%) people, 77% of whom were thought to have a psychotic illness. Patients allocated haloperidol plus promethazine were more likely to be tranquil or asleep by 20 minutes than those who received intramuscular haloperidol alone (relative risk 1.30, 95% confidence interval 1.10 to 1.55; number needed to treat 6, 95% confidence interval 4 to 16; P=0.002). No differences were found after 20 minutes. However, 10 cases of acute dystonia occurred, all in the haloperidol alone group. Conclusions Haloperidol plus promethazine is a better option than haloperidol alone in terms of speed of onset of action and safety. Enough data are now available to change guidelines that continue to recommend treatments that leave people exposed to longer periods of aggression than necessary and patients vulnerable to distressing and unsafe adverse effects.	Fundacao Oswaldo Cruz, Natl Inst Qual Control Hlth, BR-21040900 Rio De Janeiro, Brazil; Fundacao Oswaldo Cruz, FIOCRUZ, Natl Sch Publ Hlth, ENSP, BR-21040900 Rio De Janeiro, Brazil; Univ Nottingham, Div Psychiat, Nottingham NG7 2RD, England	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Nottingham	Huf, G (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Qual Control Hlth, Av Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.	gisete@ensp.fiocruz.br	huf, gisele/F-1121-2013; Coutinho, Evandro S/E-2408-2011	huf, gisele/0000-0002-3560-343X; Coutinho, Evandro/0000-0002-4649-7353				Alexander J, 2004, BRIT J PSYCHIAT, V185, P63, DOI 10.1192/bjp.185.1.63; Allen MH, 2001, POSTGRAD MED, V110, P1; Belgamwar RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003729.pub2; Binder RL, 1999, PSYCHIATR SERV, V50, P1553, DOI 10.1176/ps.50.12.1553; CASEY D, 1988, PSYCHOPHARMACOLOGY C; Cunnane J., 1994, PSYCHIAT B, V18, P138; Gillies D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003079.pub2; Huf G, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005146; Huf G, 2003, BMJ-BRIT MED J, V327, P708; Huf G, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-4; Kaplan HI., 1994, KAPLAN SADOCKS SYNOP; McAllister-Williams RH, 2002, BRIT J PSYCHIAT, V180, P485, DOI 10.1192/bjp.180.6.485; *NICE, 2005, 25 NICE; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PILOWSKY LS, 1992, BRIT J PSYCHIAT, V160, P831, DOI 10.1192/bjp.160.6.831; van Harten PN, 1999, BMJ-BRIT MED J, V319, P623, DOI 10.1136/bmj.319.7210.623; Volz A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006391; *WHO EX BOARD, 2001, EB108INFDOC2 WHO EX	18	69	72	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2007	335	7625					869	B872		10.1136/bmj.39339.448819.AE	http://dx.doi.org/10.1136/bmj.39339.448819.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17954515	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000250631000039
J	Lim, RYH; Fahrenkrog, B; Koser, J; Schwarz-Herion, K; Deng, J; Aebi, U				Lim, Roderick Y. H.; Fahrenkrog, Birthe; Koeser, Joachim; Schwarz-Herion, Kyrill; Deng, Jie; Aebi, Ueli			Nanomechanical basis of selective gating by the nuclear pore complex	SCIENCE			English	Article							PHENYLALANINE-GLYCINE NUCLEOPORINS; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN IMPORT; BINDING-DYNAMICS; REPEAT REGIONS; MECHANISM; PERMEABILITY; SPECTROSCOPY; TOPOLOGY; CYCLE	The nuclear pore complex regulates cargo transport between the cytoplasm and the nucleus. We set out to correlate the governing biochemical interactions to the nanoscopic responses of the phenylalanine-glycine (FG)-rich nucleoporin domains, which are involved in attenuating or promoting cargo translocation. We found that binding interactions with the transport receptor karyopherin-beta 1 caused the FG domains of the human nucleoporin Nup153 to collapse into compact molecular conformations. This effect was reversed by the action of Ran guanosine triphosphate, which returned the FG domains into a polymer brush-like, entropic barrier conformation. Similar effects were observed in Xenopus oocyte nuclei in situ. Thus, the reversible collapse of the FG domains may play an important role in regulating nucleocytoplasmic transport.	Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; Inst Mat Res & Engn, Singapore 117602, Singapore	University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE)	Lim, RYH (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	roderick.lim@unibas.ch; birthe.fahrenkrog@unibas.ch	Fahrenkrog, Birthe/D-5840-2011	Fahrenkrog, Birthe/0000-0003-4080-9413; Lim, Roderick/0000-0001-5015-6087				Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	29	235	235	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					640	643		10.1126/science.1145980	http://dx.doi.org/10.1126/science.1145980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17916694				2022-12-28	WOS:000250409200045
J	Tang, C; Schwieters, CD; Clore, GM				Tang, Chun; Schwieters, Charles D.; Clore, G. Marius			Open-to-closed transition in apo maltose-binding protein observed by paramagnetic NMR	NATURE			English	Article							DIPOLAR COUPLINGS; ACTIVE-TRANSPORT; MACROMOLECULES; SPECTROSCOPY; DYNAMICS; REFINEMENT; RECEPTOR; DATABASE; DOMAINS; MOTIONS	Large-scale domain rearrangements in proteins have long been recognized to have a critical function in ligand binding and recognition, catalysis and regulation(1-5). Crystal structures have provided a static picture of the apo (usually open) and holo usually closed) states. The general question arises as to whether the apo state exists as a single species in which the closed state is energetically inaccessible and interdomain rearrangement is induced by ligand or substrate binding, or whether the predominantly open form already coexists in rapid equilibrium with a minor closed species. The maltose-binding protein (MBP), a member of the bacterial periplasmic binding protein family(6), provides a model system for investigating this problem because it has been the subject of extensive studies by crystallography(7,8), NMR9-11 and other biophysical techniques(11-13). Here we show that although paramagnetic relaxation enhancement (PRE) data for the sugar-bound form are consistent with the crystal structure of holo MBP, the PRE data for the apo state are indicative of a rapidly exchanging mixture (ns to mu s regime) of a predominantly (similar to 95%) open form (represented by the apo crystal structure) and a minor (similar to 5%) partially closed species. Using ensemble simulated annealing refinement against the PRE data we are able to determine a [r(-6)] ensemble average structure of the minor apo species and show that it is distinct from the sugar-bound state.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; NIH, Div Computat Biosci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Tang, Chun/0000-0001-6477-6500	CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090, Z01CT000090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029023, ZIADK029023, Z01DK029043, Z01DK029042] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J MAGN RESON, V154, P329, DOI 10.1006/jmre.2001.2489; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280; Hall JA, 1997, J BIOL CHEM, V272, P17615, DOI 10.1074/jbc.272.28.17615; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PERUVSHIN K, 1997, P NATL ACAD SCI USA, V94, P12366; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SKYNNIKOV NR, 2000, J MOL BIOL, V295, P1265; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; Zhang YH, 1999, P NATL ACAD SCI USA, V96, P939, DOI 10.1073/pnas.96.3.939; Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790	35	325	330	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1078	U12		10.1038/nature06232	http://dx.doi.org/10.1038/nature06232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960247				2022-12-28	WOS:000250395000058
J	Brown, H				Brown, Hannah			Who cares for baby?	BRITISH MEDICAL JOURNAL			English	Article								Divisions between maternal and child health services in the developing world, first reported 20 years ago, left services for newborns overlooked. Today, neonatal mortality is still unacceptably high. Hannah Brown reports on initiatives trying to bridge the gap.				Hannah@two-cultures.com						*H KELL INT, 2002, OV NUTR SECT SERV CA; ROSENFIELD A, 1985, LANCET, V2, P83; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; World Health Organization, WORLD HLTH REP 2005	4	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2007	335	7624					798	800		10.1136/bmj.39365.579016.94	http://dx.doi.org/10.1136/bmj.39365.579016.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AX	17947782	Green Published			2022-12-28	WOS:000250630700027
J	Loosemore, M; Knowles, CH; Whyte, GP				Loosemore, Mike; Knowles, Charles H.; Whyte, Greg P.			Amateur boxing and risk of chronic traumatic brain injury: systematic review of observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CENTRAL-NERVOUS-SYSTEM; MEDICAL ASPECTS; BOXERS; EPIDEMIOLOGY; SPORT; CT	Objective To evaluate the risk of chronic traumatic brain injury from amateur boxing. Setting Secondary research performed by combination of sport physicians and clinical academics. Design, data sources, and methods Systematic review of observational studies in which chronic traumatic brain injury was defined as any abnormality on clinical neurological examination, psychometric testing, neuroimaging studies, and electroencephalography. Studies were identified through database (1950 to date) and bibliographic searches without language restrictions. Two reviewers extracted study characteristics, quality, and data, with adherence to a protocol developed from a widely recommended method for systematic review of observational studies (MOOSE). Results 36 papers had relevant extractable data (from a detailed evaluation of 93 studies of 943 identified from the initial search). Quality of evidence was generally poor. The best quality studies were those with a cohort design and those that used psychometric tests. These yielded the most negative results: only four of 17 (24%) better quality studies found any indication of chronic traumatic brain injury in a minority of boxers studied. Conclusion There is no strong evidence to associate chronic traumatic brain injury with amateur boxing.	Northwick Pk Hosp & Clin Res Ctr, English Inst Sport, Olympic Med Inst, London Reg, Harrow HA1 3UJ, Middx, England; Royal London Hosp, Ctr Acad Surg, Barts & London NHS Trust, London E1 1BB, England; Royal London Hosp, Ctr Acad Surg, Homerton Univ NHS Fdn Trust, London E1 1BB, England; Liverpool John Moores Univ, Sport & Exercise Sci Res Inst, Liverpool L3 5UX, Merseyside, England	Imperial College London; Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital; Liverpool John Moores University	Loosemore, M (corresponding author), Northwick Pk Hosp & Clin Res Ctr, English Inst Sport, Olympic Med Inst, London Reg, Harrow HA1 3UJ, Middx, England.	mike.loosemore@eis2win.co.uk						BLONSTEIN JL, 1966, P ROY SOC MED, V59, P649, DOI 10.1177/003591576605900733; *BMA BOARD SCI WOR, 2007, 2 BMA BOARD SCI WORK; BOGDANOFF B, 1989, NEUROLOGY, V87, P535; British Medical Association, 1993, BOX DEB; BUTLER RJ, 1994, BRIT J SPORT MED, V4, P28; Cabanis E A, 1986, Acta Radiol Suppl, V369, P365; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Finch C, 2002, AUST NZ J PUBL HEAL, V26, P462, DOI 10.1111/j.1467-842X.2002.tb00348.x; GIBBS FA, 1958, ATLAS ELECTROENCEPHA, V1, P324; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; KHAN K, 2001, UNDERTAKING SYSTEMAT; KHAN KS, 2001, 4 CRD U YORK NHS CTR; MACPHERSON P, 1988, NEURORADIOLOGY, V30, P506, DOI 10.1007/BF00339691; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWSDLEY C, 1963, LANCET, V2, P795; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157-a; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moseley IF, 2000, NEURORADIOLOGY, V42, P1, DOI 10.1007/s002340050001; PHILLIPS J, 1982, LANCET, V1, P1310; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; SPILLANE JD, 1962, BRIT MED J, P1205; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Toth C, 2005, SPORTS MED, V35, P685, DOI 10.2165/00007256-200535080-00003; UNTERHARNSCHEIDT F, 1971, FORTSCHR NEUROL P I, V39, P109; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; ZAZYM T, 2006, BRIT J SPORT MED, V40, P670	31	61	62	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2007	335	7624					809	812		10.1136/bmj.39342.690220.55	http://dx.doi.org/10.1136/bmj.39342.690220.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AX	17916811	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000250630700037
J	von Elm, E				von Elm, Erik			Research integrity: collaboration and research needed	LANCET			English	Editorial Material							HWANG		Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Med Ctr Freiburg, Dept Med Biometry & Stat, German Cochrane Ctr, Freiburg, Germany	University of Bern; University of Freiburg	von Elm, E (corresponding author), Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.	vonelm@ispm.unibe.ch		von Elm, Erik/0000-0002-7412-0406				Anderson MS, 2007, ACAD MED, V82, P853, DOI 10.1097/ACM.0b013e31812f764c; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; European Science Foundation, 2007, ESF ORI 1 WORLD C RE; Gerber P, 2006, MED J AUSTRALIA, V184, P632, DOI 10.5694/j.1326-5377.2006.tb00420.x; Gottweis H, 2006, NAT BIOTECHNOL, V24, P141, DOI 10.1038/nbt0206-141; Martinson BC, 2007, NATURE, V449, P141, DOI 10.1038/449141a; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123	8	3	3	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2007	370	9596					1403	1404		10.1016/S0140-6736(07)61590-6	http://dx.doi.org/10.1016/S0140-6736(07)61590-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950852				2022-12-28	WOS:000250386000009
J	Ahuja, R; Pinyol, R; Reichenbach, N; Custer, L; Klingensmith, J; Kessels, MM; Qualmann, B				Ahuja, Rashmi; Pinyol, Roser; Reichenbach, Nicole; Custer, Laura; Klingensmith, John; Kessels, Michael M.; Qualmann, Britta			Cordon-bleu is an actin nucleation factor and controls neuronal morphology	CELL			English	Article							ARP2/3 COMPLEX; N-WASP; CYTOSKELETAL DYNAMICS; STRUCTURAL BASIS; MECHANISM; DOMAIN; CYTOCHALASIN; ENDOCYTOSIS; REGULATOR; NETWORKS	Despite the wealth of different actin structures formed, only two actin nucleation factors are well established in vertebrates: the Arp2/3 complex and formins. Here, we describe a further nucleator, cordon-bleu (Cobl). Cobl is a brainenriched protein using three Wiskott-Aldrich syndrome protein homology 2 (WH2) domains for actin binding. Cobl promotes nonbundled, unbranched filaments. Filament formation relies on barbed-end growth and requires all three Cobl WH2 domains and the extended linker L2. We suggest that the nucleation power of Cobl is based on the assembly of three actin monomers in cross-filament orientation. Cobl localizes to sites of high actin dynamics and modulates cell morphology. In neurons, induction of both neurites and neurite branching is dramatically increased by Cobl expression effects that critically depend on Cobl's actin nucleation ability. Correspondingly, Cobl depletion results in decreased dendritic arborization. Thus, Cobl is an actin nucleator controlling neuronal morphology and development.	Leibniz Inst Neurobiol, Res Grp Membrane Trafficking & Cytoskeleton, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; Leibniz Inst Neurobiol, Res Grp Cell Biol, D-39118 Magdeburg, Germany; Univ Jena, Inst Biochem 1, D-07740 Jena, Germany; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Friedrich Schiller University of Jena; Duke University	Kessels, MM (corresponding author), Leibniz Inst Neurobiol, Res Grp Membrane Trafficking & Cytoskeleton, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany.	kessels@ifn-magdeburg.de; qualmann@ifn-magdeburg.de	Pinyol, Roser/AAA-4404-2019	Pinyol, Roser/0000-0002-0288-6314	NICHD NIH HHS [P01 HD039948-020001, P01 HD039948] Funding Source: Medline; NIDCR NIH HHS [R01 DE013674, R01 DE013674-06] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013674] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Carroll EA, 2003, DEV BIOL, V262, P16, DOI 10.1016/S0012-1606(03)00323-3; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Du JY, 1998, BIOCHEMISTRY-US, V37, P13276, DOI 10.1021/bi981117r; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2002, INT REV CYTOL, V220, P93; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; VARTIAINEN MK, 2004, CURR OPIN CELL BIOL, V43, P81; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	34	183	186	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					337	350		10.1016/j.cell.2007.08.030	http://dx.doi.org/10.1016/j.cell.2007.08.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956734	Bronze, Green Accepted			2022-12-28	WOS:000250507700023
J	Lamborg, C				Lamborg, Carl			A new twist for mercury	SCIENCE			English	Editorial Material							MASS-INDEPENDENT FRACTIONATION; HG ISOTOPES		Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Lamborg, C (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	clamborg@whoi.edu						Barling J, 2001, EARTH PLANET SC LETT, V193, P447, DOI 10.1016/S0012-821X(01)00514-3; Beard BL, 1999, SCIENCE, V285, P1889, DOI 10.1126/science.285.5435.1889; Bergquist BA, 2007, SCIENCE, V318, P417, DOI 10.1126/science.1148050; Fitzgerald WF, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P107; Fitzgerald WF, 2004, GEOCHIM COSMOCHIM AC, V68, P1961, DOI 10.1016/j.gca.2003.11.014; Jackson TA, 2006, GEOCHIM COSMOCHIM AC, V70, pA284, DOI 10.1016/j.gca.2006.06.577; Kritee K, 2007, ENVIRON SCI TECHNOL, V41, P1889, DOI 10.1021/es062019t; Selin NE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007450; Thiemens MH, 2006, ANNU REV EARTH PL SC, V34, P217, DOI 10.1146/annurev.earth.34.031405.125026	9	3	3	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					402	403		10.1126/science.1149935	http://dx.doi.org/10.1126/science.1149935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947569				2022-12-28	WOS:000250230400030
J	Sacchetti, B; Funari, A; Michienzi, S; Di Cesare, S; Piersanti, S; Saggio, I; Tagliafico, E; Ferrari, S; Robey, PG; Riminucci, M; Bianco, P				Sacchetti, Benedetto; Funari, Alessia; Michienzi, Stefano; Di Cesare, Silvia; Piersanti, Stefania; Saggio, Isabella; Tagliafico, Enrico; Ferrari, Stefano; Robey, Pamela Gehron; Riminucci, Mara; Bianco, Paolo			Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment	CELL			English	Article							MESENCHYMAL STEM-CELLS; TYROSINE KINASE GENES; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; TIE2 RECEPTOR; GROWTH-FACTOR; IN-VITRO; EXPRESSION; ANGIOPOIETIN-1	The identity of cells that establish the hematopoietic microenvironment (HME) in human bone marrow ( BM), and of clonogenic skeletal progenitors found in BM stroma, has long remained elusive. We show that MCAM/CD146 expressing, subendothelial cells in human BM stroma are capable of transferring, upon transplantation, the HME to heterotopic sites, coincident with the establishment of identical subendothelial cells within a miniature bone organ. Establishment of subendothelial stromal cells in developing heterotopic BM in vivo occurs via specific, dynamic interactions with developing sinusoids. Subendothelial stromal cells residing on the sinusoidal wall are major producers of Angiopoietin-1-(a pivotal molecule of the HSC `` niche'' involved in vascular remodeling). Our data reveal the functional relationships between establishment of the HME in vivo, establishment of skeletal progenitors in BM sinusoids, and angiogenesis.	Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; Univ Roma La Sapienza, Dept Genet & Mol Biol, I-00161 Rome, Italy; Biomed Sci Pk San Raffaele, I-00128 Rome, Italy; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; CNR, Inst Mol Biol & Pathol, Rome, Italy; Univ Modena, Dept Biochem, I-59100 Modena, Italy; Natl Inst Dental & Craniofacial Res, NIH, Craniofacial & Skeletal Dis Branch, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	Sapienza University Rome; Sapienza University Rome; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Universita di Modena e Reggio Emilia; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bianco, P (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy.	p.bianco@flashnet.it	DI CESARE, SILVIA/AAB-5754-2020; sacchetti, benedetto/A-3314-2009; Tagliafico, Enrico/C-9079-2009; Riminucci, Mara/AAC-3906-2022; Saggio, Isabella/H-2417-2015; Robey, Pamela Gehron/H-1429-2011; FUNARI, ALESSIA/A-3298-2009	DI CESARE, SILVIA/0000-0002-9912-7997; Tagliafico, Enrico/0000-0003-0981-2542; Robey, Pamela Gehron/0000-0002-5316-5576; saggio, isabella/0000-0002-9497-7415	Telethon [GGP04263] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000380] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; BIANCO P, 1993, HISTOCHEMISTRY, V100, P93, DOI 10.1007/BF00572894; Bianco Paolo, 2015, Development, V142, P1023, DOI 10.1242/dev.102210; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Deschaseaux F, 2000, J CELL PHYSIOL, V184, P319, DOI 10.1002/1097-4652(200009)184:3<319::AID-JCP5>3.0.CO;2-N; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; FRIEDENSTEIN A J, 1990, P353; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; MANIATIS A, 1971, BLOOD-J HEMATOL, V38, P569, DOI 10.1182/blood.V38.5.569.569; Miura Y, 1998, CELL TRANSPLANT, V7, P453, DOI 10.1016/S0963-6897(98)00033-5; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; OWEN M, 1988, CIBA F SYMP, V136, P42; Pickl WF, 1997, J IMMUNOL, V158, P2107; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; SIMMONS PJ, 1991, BLOOD, V78, P55; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; TAVASSOLI M, 1983, AM J HEMATOL, V15, P195, DOI 10.1002/ajh.2830150211; Vogel W, 2003, HAEMATOLOGICA, V88, P126; WEISS L, 1976, ANAT RECORD, V186, P161, DOI 10.1002/ar.1091860204; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; Zannettino ACW, 2003, J CELL BIOCHEM, V89, P56, DOI 10.1002/jcb.10481; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	48	1583	1641	3	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					324	336		10.1016/j.cell.2007.08.025	http://dx.doi.org/10.1016/j.cell.2007.08.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956733	Bronze			2022-12-28	WOS:000250507700022
J	Whetten, RL; Price, RC				Whetten, Robert L.; Price, Ryan C.			Nano-golden order	SCIENCE			English	Editorial Material									Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Whetten, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	whetten@chemistry.gatech.edu						BAGLEY BG, 1970, NATURE, V225, P1040, DOI 10.1038/2251040a0; Ball P, 2005, NEW SCI, V186, P30; BATES PA, 1985, ACTA CRYSTALLOGR C, V41, P862, DOI 10.1107/S0108270185005777; Billinge SJL, 2007, SCIENCE, V316, P561, DOI 10.1126/science.1135080; Hakkinen H, 2006, J PHYS CHEM B, V110, P9927, DOI 10.1021/jp0619787; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Mednikov EG, 2007, J AM CHEM SOC, V129, P11619, DOI 10.1021/ja073945q; Price RC, 2005, J AM CHEM SOC, V127, P13750, DOI 10.1021/ja053968+; Pyykko P, 2004, ANGEW CHEM INT EDIT, V43, P4412, DOI 10.1002/anie.200300624; SCHMIDBAUR H, 1999, GOLD PROGR CHEM BIOC, pCH10; SCHROTER I, 1991, CHEM BER, V124, P2161, DOI 10.1002/cber.19911241003; SERVICE RF, 2002, SCIENCE, V295; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Whetten RL, 1996, ADV MATER, V8, P428, DOI 10.1002/adma.19960080513	15	161	163	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					407	408		10.1126/science.1150176	http://dx.doi.org/10.1126/science.1150176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947573				2022-12-28	WOS:000250230400034
J	Blaser, MJ; Kirschner, D				Blaser, Martin J.; Kirschner, Denise			The equilibria that allow bacterial persistence in human hosts	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; HELICOBACTER-PYLORI CAGA; GASTRIC EPITHELIAL-CELLS; COMPLETE GENOME SEQUENCE; HUMAN IMMUNE-RESPONSE; REGULATORY T-CELLS; TYPHOID-FEVER; DYNAMICS; COLONIZATION; PATHOGEN	We propose that microbes that have developed persistent relationships with human hosts have evolved cross-signalling mechanisms that permit homeostasis that conforms to Nash equilibria and, more specifically, to evolutionarily stable strategies. This implies that a group of highly diverse organisms has evolved within the changing contexts of variation in effective human population size and lifespan, shaping the equilibria achieved, and creating relationships resembling climax communities. We propose that such ecosystems contain nested communities in which equilibrium at one level contributes to homeostasis at another. The model can aid prediction of equilibrium states in the context of further change: widespread immunodeficiency, changing population densities, or extinctions.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	New York University; New York University; University of Michigan System; University of Michigan	Blaser, MJ (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	martin.blaser@med.nyu.edu						ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Aras RA, 2003, P NATL ACAD SCI USA, V100, P13579, DOI 10.1073/pnas.1735481100; Aras RA, 2003, J EXP MED, V198, P1349, DOI 10.1084/jem.20030381; Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; BARNARD AJ, 2004, HUNTER GATHERERS HIS, P278; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; BELLWOOD P, 2001, 1 FARMERS ORIGINS AG, P360; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser MJ, 2007, PLOS MED, V4, P53, DOI 10.1371/journal.pmed.0040007; Blaser MJ, 2006, EMBO REP, V7, P956, DOI 10.1038/sj.embor.7400812; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; BLEDZKASAREK M, 2006, APMIS, V144, P589; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BONHOEFFER S, 1994, P NATL ACAD SCI USA, V91, P8062, DOI 10.1073/pnas.91.17.8062; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Clark-Curtiss JE, 2003, ANNU REV MICROBIOL, V57, P517, DOI 10.1146/annurev.micro.57.030502.090903; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dietz K., 1982, Life Sciences Research Report, P87; Dominguez-Bello MG, 2005, J INFECT DIS, V191, P646, DOI 10.1086/426946; ESPERSEN F, 1982, ACTA PATH MICRO IM C, V90, P293; Falk PG, 2000, TRENDS MICROBIOL, V8, P321, DOI 10.1016/S0966-842X(00)01780-7; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; FENNER F, 1965, MYXOMATOSIS; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; FOX JG, 1993, GASTROENTEROLOGY, V104, P86, DOI 10.1016/0016-5085(93)90839-5; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gammack D, 2004, J MATH BIOL, V48, P218, DOI 10.1007/s00285-003-0232-8; Ganguli S, 2005, MATH BIOSCI ENG, V2, P535; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; GLICKMAN M, 2003, CELL, V104, P477; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; HOPESIMPSON RE, 1952, LANCET, V2, P549, DOI DOI 10.1016/S0140-6736(52)91357-3; HORNICK RB, 1970, NEW ENGL J MED, V283, P686, DOI 10.1056/NEJM197009242831306; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kim SY, 2006, CELL MICROBIOL, V8, P97, DOI 10.1111/j.1462-5822.2005.00603.x; Kirschner D, 2005, TRENDS MICROBIOL, V13, P206, DOI 10.1016/j.tim.2005.03.005; KIRSCHNER DE, 1995, J THEOR BIOL, V176, P281, DOI 10.1006/jtbi.1995.0198; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Law R, 1998, P ROY SOC B-BIOL SCI, V265, P1245, DOI 10.1098/rspb.1998.0426; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LEVINE SM, IN PRESS FASEB J; Lewis D.H., 1985, P29; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; MARGULIS L, 1993, SYMBIOSIS CELL EVOLU, P163; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; McGowan CC, 2003, MOL MICROBIOL, V48, P1225, DOI 10.1046/j.1365-2958.2003.03500.x; MIMS CA, 1995, MIMS PATHOGENESIS IN, P168; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Murphy BM, 2002, MATH BIOSCI, V180, P161, DOI 10.1016/S0025-5564(02)00133-5; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Neumann J. V., 1944, THEORY GAMES EC BEHA; NOWAK M, 2000, MATH PRINCIPLES IMMU; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; O'Brien DP, 2006, J BIOL CHEM, V281, P13317, DOI 10.1074/jbc.M601805200; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parsonnet J, 1999, JAMA-J AM MED ASSOC, V282, P2240, DOI 10.1001/jama.282.23.2240; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Putsep K, 1999, NATURE, V398, P671, DOI 10.1038/19439; Raymond J, 2004, EMERG INFECT DIS, V10, P1816, DOI 10.3201/eid1010.040042; ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436; ROSEBURY T, 1962, MICROORGANISMS INDIG, P1; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; SINNOTT CR, 1987, LANCET, V1, P976; SMITH BD, 1995, EMERGENCE AGR, P231; SMITH J, 2001, P ROY SOC LOND B BIO, V261, P61; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1976, AM SCI, V64, P41; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Webb GF, 2002, P NATL ACAD SCI USA, V99, P3135, DOI 10.1073/pnas.042685799; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Wirth HP, 2006, FASEB J, V20, P1534, DOI 10.1096/fj.05-5529fje; Wodarz D, 2000, PHILOS T R SOC B, V355, P1059, DOI 10.1098/rstb.2000.0643; Wodarz D, 2000, EUR J IMMUNOL, V30, P2704, DOI 10.1002/1521-4141(200009)30:9<2704::AID-IMMU2704>3.0.CO;2-0; Yokoyama K, 2005, P NATL ACAD SCI USA, V102, P9661, DOI 10.1073/pnas.0502529102; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	97	159	168	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					843	849		10.1038/nature06198	http://dx.doi.org/10.1038/nature06198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943121	Bronze, Green Published			2022-12-28	WOS:000250230600035
J	Garber, AM; McClellan, MB				Garber, Alan M.; McClellan, Mark B.			Satisfaction guaranteed - "Payment by results" for biologic agents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BORTEZOMIB; MYELOMA		Ctr Hlth Care Evaluat, Palo Alto, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; Brookings Inst, Engelberg Ctr Hlth Care Reform, Washington, DC 20036 USA; Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Brookings Institution; American Enterprise Institute for Public Policy Research	Garber, AM (corresponding author), Ctr Hlth Care Evaluat, Palo Alto, CA USA.		Garber, Alan M/F-1476-2010					Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Institute of Medicine, 2007, REW PROV PERF AL INC; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288	4	38	38	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1575	1577		10.1056/NEJMp078204	http://dx.doi.org/10.1056/NEJMp078204			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942870	Green Published			2022-12-28	WOS:000250200500002
J	Cuk, M				Cuk, Matija			Excitation of lunar eccentricity by planetary resonances	SCIENCE			English	Article							EVOLUTION; SYSTEM; ORIGIN; ORBIT		Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Cuk, M (corresponding author), Univ British Columbia, Dept Phys & Astron, 6224 Agr Rd, Vancouver, BC V6T 1Z1, Canada.			Cuk, Matija/0000-0003-1226-7960				Bills BG, 1999, GEOPHYS RES LETT, V26, P3045, DOI 10.1029/1999GL008348; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Garrick-Bethell I, 2006, SCIENCE, V313, P652, DOI 10.1126/science.1128237; GOLDREIC.P, 1966, REV GEOPHYS, V4, P411, DOI 10.1029/RG004i004p00411; GOLDREICH P, 1963, MON NOT R ASTRON SOC, V126, P257, DOI 10.1093/mnras/126.3.257; KAULA WM, 1976, LUNAR SCI, V7, P440; Touma J, 1998, ASTRON J, V115, P1653, DOI 10.1086/300312; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516; WILLIAMS JG, 2006, 37 M AM ASTR SOC DIV	12	11	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					244	244		10.1126/science.1146984	http://dx.doi.org/10.1126/science.1146984			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932291				2022-12-28	WOS:000250086100039
J	Park, HB; Jung, CH; Lee, YM; Hill, AJ; Pas, SJ; Mudie, ST; Van Wagner, E; Freeman, BD; Cookson, DJ				Park, Ho Bum; Jung, Chul Ho; Lee, Young Moo; Hill, Anita J.; Pas, Steven J.; Mudie, Stephen T.; Van Wagner, Elizabeth; Freeman, Benny D.; Cookson, David J.			Polymers with cavities tuned for fast selective transport of small molecules and ions	SCIENCE			English	Article							GAS SEPARATION MEMBRANES; INTRINSIC MICROPOROSITY; FREE-VOLUME; SYSTEMS	Within a polymer film, free-volume elements such as pores and channels typically have a wide range of sizes and topologies. This broad range of free-volume element sizes compromises a polymer's ability to perform molecular separations. We demonstrated free-volume structures in dense vitreous polymers that enable outstanding molecular and ionic transport and separation performance that surpasses the limits of conventional polymers. The unusual microstructure in these materials can be systematically tailored by thermally driven segment rearrangement. Free-volume topologies can be tailored by controlling the degree of rearrangement, flexibility of the original chain, and judicious inclusion of small templating molecules. This rational tailoring of free-volume element architecture provides a route for preparing high-performance polymers for molecular-scale separations.	Hanyang Univ, Sch Chem Engn, Seoul 133791, South Korea; Univ Texas, Ctr Energy & Environm Resources, Austin, TX 78758 USA; Univ Texas, Dept Chem Engn, Austin, TX 78758 USA; CSIRO, S Clayton, Vic 3169, Australia; Australian Synchrotron Res Program, Argonne, IL 60439 USA	Hanyang University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lee, YM (corresponding author), Hanyang Univ, Sch Chem Engn, Seoul 133791, South Korea.	ymlee@hanyang.ac.kr	Pas, Steven/F-6516-2013; Lee, Young Moo/G-5920-2015; Hill, Anita J/B-9231-2011; Freeman, Benny/G-5405-2016; Park, Ho Bum/C-2941-2016	Lee, Young Moo/0000-0002-5047-3143; Hill, Anita J/0000-0003-1574-243X; Freeman, Benny/0000-0003-2779-7788; Park, Ho Bum/0000-0002-8003-9698				Asensio JA, 2005, FUEL CELLS, V5, P336, DOI 10.1002/fuce.200400081; Barsema JN, 2004, J MEMBRANE SCI, V238, P93, DOI 10.1016/j.memsci.2004.03.024; Bos A, 1999, J MEMBRANE SCI, V155, P67, DOI 10.1016/S0376-7388(98)00299-3; Budd PM, 2005, J MATER CHEM, V15, P1977, DOI 10.1039/b417402j; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Freeman BD, 1999, MACROMOLECULES, V32, P375, DOI 10.1021/ma9814548; GREGG SJ, 1982, ADSORPTION SURFACE; Hickner MA, 2004, CHEM REV, V104, P4587, DOI 10.1021/cr020711a; Ilinitch OM, 1999, MICROPOR MESOPOR MAT, V31, P97, DOI 10.1016/S1387-1811(99)00060-8; Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218; KARDASH IY, 1967, VYSOKOMOL SOYED B, V9, P873; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; LIGHTFOOT P, 1993, SCIENCE, V262, P883, DOI 10.1126/science.262.5135.883; Lin HQ, 2006, SCIENCE, V311, P639, DOI 10.1126/science.1118079; Lin HQ, 2006, ADV MATER, V18, P39, DOI 10.1002/adma.200501409; MEIER IK, 1994, J MEMBRANE SCI, V94, P195, DOI 10.1016/0376-7388(93)E0174-I; Nagai K, 2001, PROG POLYM SCI, V26, P721, DOI 10.1016/S0079-6700(01)00008-9; Park HB, 2005, ADV MATER, V17, P477, DOI 10.1002/adma.200400944; Park HB, 2002, CHEM MATER, V14, P3034, DOI 10.1021/cm020216v; Pinnau I, 1996, J MEMBRANE SCI, V116, P199, DOI 10.1016/0376-7388(96)00041-5; ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J; Sing KSW, 2004, ADSORPT SCI TECHNOL, V22, P773, DOI 10.1260/0263617053499032; Steel KM, 2003, CARBON, V41, P253, DOI 10.1016/S0008-6223(02)00309-3; Stern S.A., 1997, U.S. patent, Patent No. [5,591,250, 5591250]; Tullos GL, 1999, MACROMOLECULES, V32, P3598, DOI 10.1021/ma981579c; Vasudevan VJ, 1996, MACROMOLECULES, V29, P637, DOI 10.1021/ma951133l; VIETH WR, 1976, J MEMBRANE SCI, V1, P177, DOI 10.1016/S0376-7388(00)82267-X; VISSER T, 2007, J MEMBR SCI; WELSH WJ, 1981, MACROMOLECULES, V14, P947, DOI 10.1021/ma50005a011; Wilks BR, 2003, J POLYM SCI POL PHYS, V41, P2185, DOI 10.1002/polb.10576; Yampolskii Y.P., 2006, MAT SCI MEMBRANES GA	32	753	798	27	523	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					254	258		10.1126/science.1146744	http://dx.doi.org/10.1126/science.1146744			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932294				2022-12-28	WOS:000250086100042
J	Ford, I; Murray, H; Packard, CJ; Shepherd, J; Macfarlane, PW; Cobbe, SM				Ford, Ian; Murray, Heather; Packard, Chris J.; Shepherd, James; Macfarlane, Peter W.; Cobbe, Stuart M.		W Scotland Coronary Preventio	Long-term follow-up of the West of Scotland Coronary Prevention Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER-RISK; PRAVASTATIN; ATHEROSCLEROSIS; PROGRESSION; REGRESSION; MORTALITY; STATINS; DISEASE; MEN	Background The West of Scotland Coronary Prevention Study was a randomized clinical trial comparing pravastatin with placebo in men with hypercholesterolemia who did not have a history of myocardial infarction, with an average follow-up of approximately 5 years. The combined outcome of death from definite coronary heart disease or definite nonfatal myocardial infarction was reduced from 7.9 to 5.5% (P<0.001) in the treatment group. Extended follow-up data were obtained for approximately 10 years after completion of the trial. Methods For the survivors of the trial, all deaths, hospitalizations and deaths due to coronary events and stroke, and incident cancers and deaths from cancer were tracked with the use of a national computerized record-linkage system. The results were analyzed with time-to-event analyses and use of Cox proportional-hazards models. Results Five years after the trial ended, 38.7% of the original statin group and 35.2% of the original placebo group were being treated with a statin. In the period approximately 10 years after completion of the trial, the risk of death from coronary heart disease or nonfatal myocardial infarction was 10.3% in the placebo group and 8.6% in the pravastatin group (P=0.02); over the entire follow-up period, the rate was 15.5% in the placebo group and 11.8% in the pravastatin group (P<0.001). Similar percentage reductions were seen in the combined rate of death from coronary heart disease and hospitalization for coronary events for both periods. The rate of death from cardiovascular causes was reduced (P=0.01), as was the rate of death from any cause (P=0.03), over the entire follow-up period. There were no excess deaths from noncardiovascular causes or excess fatal or incident cancers. Conclusions In this analysis, 5 years of treatment with pravastatin was associated with a significant reduction in coronary events for a subsequent 10 years in men with hypercholesterolemia who did not have a history of myocardial infarction.	Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Ford, I (corresponding author), Univ Glasgow, Robertson Ctr Biostat, Boyd Orr Bldg, Glasgow G12 8QQ, Lanark, Scotland.		Murray, Heather/GQY-8016-2022; Ford, Ian/ABE-6145-2020					[Anonymous], 1995, J Clin Epidemiol, V48, P1441; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; CROUSE JR, 1995, AM J CARDIOL, V75, P455, DOI 10.1016/S0002-9149(99)80580-3; CROUSE JR, 1995, AM J CARDIOL, V75, P862; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; LORD I, 1992, J CLIN EPIDEMIOL, V45, P849, DOI 10.1016/0895-4356(92)90068-X; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; PEDERSEN TR, 1994, LANCET, V344, P1383; PITT B, 1995, J AM COLL CARDIOL, V26, P1133, DOI 10.1016/0735-1097(95)00301-0; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Shannon J, 2005, AM J EPIDEMIOL, V162, P318, DOI 10.1093/aje/kwi203; SHEPHERD J, 1995, AM J CARDIOL, V76, P485; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Simes RJ, 2002, LANCET, V359, P1379; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	20	328	336	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1477	1486		10.1056/NEJMoa065994	http://dx.doi.org/10.1056/NEJMoa065994			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928595	Bronze			2022-12-28	WOS:000250037000004
J	Frumkin, H; Hess, J; Vindigni, S				Frumkin, Howard; Hess, Jeremy; Vindigni, Stephen			Peak petroleum and public health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPACT		US Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; US Ctr Dis Control & Prevent, Agcy Tox Subst & Dis Registry, Atlanta, GA 30333 USA; Emory Med Sch, Dept Emergency Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Frumkin, H (corresponding author), US Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, 1600 Clifton Rd,Mailstop E-28, Atlanta, GA 30333 USA.	hfrumkin@cdc.gov		Frumkin, Howard/0000-0001-7079-3534				BAILEY DM, 1980, PUBLIC HEALTH REP, V95, P58; Brown L.R., 1970, SEEDS CHANGE GREEN R; CAMPBELL C., 2004, COMING OIL CRISIS; *CIT PORTL PEAK OI, 2007, DESC OIL PEAK NAV TR; CLARK GB, 1981, PUBLIC HEALTH REP, V96, P111; Deffeyes K., 2003, HUBBERTS PEAK IMPEND; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Haines A, 2000, BRIT MED J, V321, P1168, DOI 10.1136/bmj.321.7270.1168; Hirsch R.L., 2005, PEAKING WORLD OIL PR; HUBBERT MK, NUCL ENERY FOSSIL FU; *INT EN AG, WORLD EN OUTL 2004; JERARDO A, 2003, IMPORT SHARE US FOOD; Klare Michael T., 2004, BLOOD OIL DANGERS CO; KLINE AB, 1975, PUBLIC HEALTH REP, V90, P3; Kunstler J.H., 2005, LONG EMERGENCY; MCKEE M, 2006, 134 ANN M AM PUBL HL; MILLER L, 1972, MENTAL HLTH RAPID SO; Pirog R., 2003, CHECKING FOOD ODOMET; POLAN M, 2006, OMNIVORES DILEMMA NA; Roberts, 2005, DEEP SEA LIFE EDGE A; ROBERTS I, 1992, BRIT MED J, V305, P283, DOI 10.1136/bmj.305.6848.283; VIDAL J, 2005, GUARDIAN        0421; WALD M, 1981, NY TIMES        0302, P1; 2006, PREVENTING ADVERSE E	24	24	24	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1688	1690		10.1001/jama.298.14.1688	http://dx.doi.org/10.1001/jama.298.14.1688			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925522				2022-12-28	WOS:000250009400026
J	Ellis, J; Hotta, A; Rastegar, M				Ellis, James; Hotta, Akitsu; Rastegar, Mojgan			Retrovirus silencing by an epigenetic TRIM	CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; VARIEGATION; MUTATION	Embryonic cells silence transcription by retroviruses, but how do they recognize virus DNA? In this issue, Wolf and Goff ( 2007) report that a TRIM28 corepressor complex binds to the retrovirus primer binding site. Epigenetic silencing of retrovirus transcription is accomplished by "writing" a dimethyl mark on lysine 9 of histone H3 that is read by the heterochromatin protein HP gamma.	SickKids Hosp, Dev & Stem Cell Biol Program, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Ellis, J (corresponding author), SickKids Hosp, Dev & Stem Cell Biol Program, Toronto, ON, Canada.	jellis@sickkids.ca	Rastegar, Mojgan/T-9394-2019; Ellis, James/F-4789-2011	Rastegar, Mojgan/0000-0003-3619-6116; Ellis, James/0000-0002-4400-0091; Hotta, Akitsu/0000-0002-2619-7441				BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ramunas J, 2007, MOL THER, V15, P810, DOI 10.1038/sj.mt.6300073; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; WOLF D, 2007, CELL; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007	11	20	24	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					13	14		10.1016/j.cell.2007.09.029	http://dx.doi.org/10.1016/j.cell.2007.09.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923079	Bronze			2022-12-28	WOS:000249934700002
J	Jacob, L; Lum, L				Jacob, Leni; Lum, Lawrence			Deconstructing the hedgehog pathway in development and disease	SCIENCE			English	Editorial Material							SIGNAL-TRANSDUCTION; CELL; DIVERGENCE; DROSOPHILA; NETWORK; COMPLEX; IHOG; SMO	The Hedgehog (Hh) family of secreted signaling proteins is a master regulator of cell fate determination in metazoans, contributing to both pattern formation during embryonic development and postembryonic tissue homeostasis. In a universally used mode of action, graded distribution of Hh protein induces differential cell fate in a dose-dependent manner in cells that receive Hh. Though much of this pathway has been elucidated from genetically based studies in model organisms, such as Drosophila and mice, the importance of Hh-mediated signaling in humans is clearly evident from malformations and a broad range of cancers that arise when the pathway is corrupted.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lum, L (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	lawrence.lum@utsouthwestern.edu			NIGMS NIH HHS [R01 GM076398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Claret S, 2007, CURR BIOL, V17, P1326, DOI 10.1016/j.cub.2007.06.059; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jacob L., 2007, SCI STKE, V2007, pcm7; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040	16	52	65	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					66	68		10.1126/science.1147314	http://dx.doi.org/10.1126/science.1147314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916724	Green Accepted			2022-12-28	WOS:000249915400038
J	Muller, B; Sheen, J				Mueller, Bruno; Sheen, Jen			Advances in cytokinin signaling	SCIENCE			English	Editorial Material							RESPONSE REGULATORS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; TRANSDUCTION; DIFFERENTIATION; RECEPTOR; PATHWAY; AHK3; ARR2		Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu	Mueller, Bruno/E-9888-2017	Mueller, Bruno/0000-0003-2664-7219				Amasino R, 2005, PLANT PHYSIOL, V138, P1177, DOI 10.1104/pp.104.900160; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mahonen AP, 2006, CURR BIOL, V16, P1116, DOI 10.1016/j.cub.2006.04.030; Mizuno T, 2004, CURR OPIN PLANT BIOL, V7, P499, DOI 10.1016/j.pbi.2004.07.015; MULLER B, 2007, SCI STKE; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Yokoyama A, 2007, PLANT CELL PHYSIOL, V48, P84, DOI 10.1093/pcp/pcl040	19	133	140	5	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					68	69		10.1126/science.1145461	http://dx.doi.org/10.1126/science.1145461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916725				2022-12-28	WOS:000249915400039
J	Kojevnikov, A				Kojevnikov, Alexei			Russian science: The little ball made science bigger	NATURE			English	Editorial Material									Univ British Columbia, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Kojevnikov, A (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z1, Canada.		Kojevnikov, Alexei/K-9084-2017; Kojevnikov, Alexei/AAH-8556-2020						0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					542	542		10.1038/449542a	http://dx.doi.org/10.1038/449542a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914379				2022-12-28	WOS:000249893500026
J	Britton, J; Edwards, R				Britton, John; Edwards, Richard			Tobacco smoking, harm reduction, and nicotine product regulation	LANCET			English	Editorial Material							SMOKELESS TOBACCO; MYOCARDIAL-INFARCTION; CONTROL PROGRAM; HEALTH-RISKS; IMPACT; SNUS; CESSATION; PANCREAS; CANCER; PANEL		[Britton, John] Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England; [Edwards, Richard] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Otago	Britton, J (corresponding author), Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Clin Sci Bldg, Nottingham NG5 1PB, England.	j.britton@virgin.net	Edwards, Richard/O-4771-2017	Edwards, Richard/0000-0003-2264-9823				Anderson JE, 2002, CHEST, V121, P932, DOI 10.1378/chest.121.3.932; Balfour DJK, 2004, NICOTINE TOB RES, V6, P899, DOI 10.1080/14622200412331324965; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351; Boffetta P, 2005, INT J CANCER, V114, P992, DOI 10.1002/ijc.20811; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; BROADSTOCK M, 2007, SYSTEMATIC REV HLTH; Critchley JA, 2003, THORAX, V58, P435, DOI 10.1136/thorax.58.5.435; *CTR EP RES, 2006, 2005 REP AD HLTH NEW; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Gartner CE, 2007, LANCET, V369, P2010, DOI 10.1016/S0140-6736(07)60677-1; Gentry CL, 2002, CNS NEUROL DISORD-DR, V1, P359, DOI 10.2174/1568007023339184; *HLTH CAN, LONG TERM TRENDS PRE; Hubbard R, 2005, TOB CONTROL, V14, P416, DOI 10.1136/tc.2005.011387; JARVIS MJ, 1999, SOCIAL PATTERNING IN; Joseph AM, 1996, NEW ENGL J MED, V335, P1792, DOI 10.1056/NEJM199612123352402; KOZLOWSKI LT, 2002, NICOTINE TOB RES S2, V4; Lader D., 2007, SMOKING RELATED BEHA; Levy DT, 2006, ADDICT BEHAV, V31, P1190, DOI 10.1016/j.addbeh.2005.09.010; Levy DT, 2004, CANCER EPIDEM BIOMAR, V13, P2035; Luo J, 2007, LANCET, V369, P2015, DOI 10.1016/S0140-6736(07)60678-3; Nelson DE, 2006, AM J PUBLIC HEALTH, V96, P897, DOI 10.2105/AJPH.2004.061580; Peto R., 2001, CRITICAL ISSUES GLOB, P154, DOI DOI 10.4314/NMP.V55I6.45441; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; Ramstrom LM, 2006, TOB CONTROL, V15, P210, DOI 10.1136/tc.2005.014969; Rodu B, 2002, J INTERN MED, V252, P398, DOI 10.1046/j.1365-2796.2002.01057.x; Roth HD, 2005, INHAL TOXICOL, V17, P741, DOI 10.1080/08958370500224698; *ROYAL COLL PHYS, 2000, NIC ADD BRIT REP TOB; *ROYAL COLL PHYS T, 2007, HARM RED NIC ADD; Royal College of Physicians, 1962, SMOKING HLTH REPORT; Siahpush M, 2006, TOB CONTROL, V15, P65, DOI 10.1136/tc.2005.013276; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987; *WHO, 2006, TOB DEADL FORM DISG; Wisborg K, 2000, OBSTET GYNECOL, V96, P967, DOI 10.1016/S0029-7844(00)01071-1; *WORLD BANK, TOB CONTR GLANC; World Bank, 1999, CURB EP GOV EC TOB C; World Health Organization, 2003, WHO FRAM CONV TOB CO	40	46	47	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					441	445		10.1016/S0140-6736(07)61482-2	http://dx.doi.org/10.1016/S0140-6736(07)61482-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	260ED	17920116				2022-12-28	WOS:000252992700033
J	Hawkes, N				Hawkes, Nigel			The NHS stifles the entrepreneur in us all - Managers in the NHS do not innovate because there is nothing in it for them	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2007	335	7626					913	913		10.1136/bmj.39381.648681.47	http://dx.doi.org/10.1136/bmj.39381.648681.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230AS	17974686	Green Published			2022-12-28	WOS:000250848300028
J	Posner, MR; Hershock, DM; Blajman, CR; Mickiewicz, E; Winquist, E; Gorbounova, V; Tjulandin, S; Shin, DM; Cullen, K; Ervin, TJ; Murphy, BA; Raez, LE; Cohen, RB; Spaulding, M; Tishler, RB; Roth, B; Viroglio, RD; Venkatesan, V; Romanov, I; Agarwala, S; Harter, KW; Dugan, M; Cmelak, A; Markoe, AM; Read, PW; Steinbrenner, L; Colevas, AD; Norris, CM; Haddad, RI				Posner, Marshall R.; Hershock, Diane M.; Blajman, Cesar R.; Mickiewicz, Elizabeth; Winquist, Eric; Gorbounova, Vera; Tjulandin, Sergei; Shin, Dong M.; Cullen, Kevin; Ervin, Thomas J.; Murphy, Barbara A.; Raez, Luis E.; Cohen, Roger B.; Spaulding, Monica; Tishler, Roy B.; Roth, Berta; del Carmen Viroglio, Rosana; Venkatesan, Varagur; Romanov, Ilya; Agarwala, Sanjiv; Harter, K. William; Dugan, Matthew; Cmelak, Anthony; Markoe, Arnold M.; Read, Paul W.; Steinbrenner, Lynn; Colevas, A. Dimitrios; Norris, Charles M., Jr.; Haddad, Robert I.		Tax 324 Study Grp	Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; PHASE-III TRIAL; INDUCTION CHEMOTHERAPY; RADIATION-THERAPY; I-II; RANDOMIZED-TRIAL; ACTIVE-DRUG; RADIOTHERAPY; PRESERVATION; CARBOPLATIN	Background A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and fluorouracil (PF), followed by chemoradiotherapy. Methods We randomly assigned 501 patients (all of whom had stage III or IV disease with no distant metastases and tumors considered to be unresectable or were candidates for organ preservation) to receive either TPF or PF induction chemotherapy, followed by chemoradiotherapy with weekly carboplatin therapy and radiotherapy for 5 days per week. The primary end point was overall survival. Results With a minimum of 2 years of follow-up (greater/equal 3 years for 69% of patients), significantly more patients survived in the TPF group than in the PF group (hazard ratio for death, 0.70; P=0.006). Estimates of overall survival at 3 years were 62% in the TPF group and 48% in the PF group; the median overall survival was 71 months and 30 months, respectively (P=0.006). There was better locoregional control in the TPF group than in the PF group (P=0.04), but the incidence of distant metastases in the two groups did not differ significantly (P=0.14). Rates of neutropenia and febrile neutropenia were higher in the TPF group; chemotherapy was more frequently delayed because of hematologic adverse events in the PF group. Conclusions Patients with squamous-cell carcinoma of the head and neck who received docetaxel plus cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy had a significantly longer survival than did patients who received cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy.	Dana Farber Canc Inst, Boston, MA 02115 USA; Sanofi Aventis, Malvern, PA USA; Hosp Iturraspe, Buenos Aires, Santa Fe, Argentina; Inst Angel H Roffo, Buenos Aires, DF, Argentina; London Reg Canc Ctr, London, ON N6A 4L6, Canada; Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia; Emory Winship Canc Inst, Atlanta, GA USA; Univ Maryland, Greenbaum Canc Ctr, Baltimore, MD 21201 USA; Maine Ctr Canc Med & Blood Disorders, Scarborough, ME USA; Vanderbilt Univ, Nashville, TN USA; Metro Nashville Gen Hosp, Nashville, TN USA; Univ Miami, Sylvester Canc Ctr, Miami, FL 33152 USA; Univ Virginia, Charlottesville, VA USA; Vet Affairs Western New York Healthcare Syst, Buffalo, NY USA; Univ Pittsburgh, Pittsburgh, PA USA; Vincent T Lombardi Canc Res Ctr, Washington, DC USA	Harvard University; Dana-Farber Cancer Institute; Sanofi-Aventis; Western University (University of Western Ontario); Russian Academy of Medical Sciences; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; University of Miami; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Posner, MR (corresponding author), Dana Farber Canc Inst, 44 Binney St,SW 430, Boston, MA 02115 USA.	marshall_posner@dfci.harvard.edu	colevas, alexander/AAP-2415-2021; Tjulandin, Sergei/Y-5069-2018; Ray, Dana M/C-3470-2013; Shin, Dong Moon/G-9649-2013; Raez, Luis/AAL-8829-2020; Romanov, Ilya/O-8613-2017	Shin, Dong Moon/0000-0002-8245-4174; Raez, Luis/0000-0003-2669-5771; Romanov, Ilya/0000-0002-5421-5985; Haddad, Robert/0000-0003-1413-0079				Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Bensadoun RJ, 2006, INT J RADIAT ONCOL, V64, P983, DOI 10.1016/j.ijrobp.2005.09.041; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; BERNIER J, 2006, J CLIN ONCOL S, V24, P18; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; CATIMEL G, 1994, ANN ONCOL, V5, P533, DOI 10.1093/oxfordjournals.annonc.a058908; Chitapanarux I, 2007, EUR J CANCER, V43, P1399, DOI 10.1016/j.ejca.2007.03.022; Colevas AD, 1999, J CLIN ONCOL, V17, P3503, DOI 10.1200/JCO.1999.17.11.3503; Colevas AD, 2002, AM J CLIN ONCOL-CANC, V25, P153, DOI 10.1097/00000421-200204000-00010; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; Domenge C, 2000, BRIT J CANCER, V83, P1594, DOI 10.1054/bjoc.2000.1512; DOUPLE EB, 1985, CANCER TREAT REV, V12, P111, DOI 10.1016/0305-7372(85)90026-X; Dreyfuss AI, 1996, J CLIN ONCOL, V14, P1672, DOI 10.1200/JCO.1996.14.5.1672; FLEMING ID, 1998, AJCC CANC STAGING HD; Forastiere AA, 2006, J CLIN ONCOL, V24, p284S; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Haddad R, 2003, CANCER, V97, P412, DOI 10.1002/cncr.11063; JACOBS MC, 1989, INT J RADIAT ONCOL, V17, P361, DOI 10.1016/0360-3016(89)90451-3; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jeremic B, 2004, J CLIN ONCOL, V22, P3540, DOI 10.1200/JCO.2004.10.076; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Lefebvre JL, 2004, J CLIN ONCOL, V22, p495S; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Posner MR, 2001, J CLIN ONCOL, V19, P1096, DOI 10.1200/JCO.2001.19.4.1096; Posner MR, 2004, SEMIN ONCOL, V31, P778, DOI 10.1053/j.seminoncol.2004.09.007; Schrijvers D, 2004, ANN ONCOL, V15, P638, DOI 10.1093/annonc/mdh145; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028	30	1191	1260	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1705	1715		10.1056/NEJMoa070956	http://dx.doi.org/10.1056/NEJMoa070956			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960013				2022-12-28	WOS:000250355100006
J	Meshik, A; Mabry, J; Hohenberg, C; Marrocchi, Y; Pravdivtseva, O; Burnett, D; Olinger, C; Wiens, R; Reisenfeld, D; Allton, J; McNamara, K; Stansbery, E; Jurewicz, AJG				Meshik, Alex; Mabry, Jennifer; Hohenberg, Charles; Marrocchi, Yves; Pravdivtseva, Olga; Burnett, Donald; Olinger, Chad; Wiens, Roger; Reisenfeld, Dan; Allton, Judith; McNamara, Karen; Stansbery, Eileen; Jurewicz, Amy J. G.			Constraints on neon and argon isotopic fractionation in solar wind	SCIENCE			English	Article							GENESIS; ABUNDANCES; ORIGIN; OXYGEN; MATTER; GASES; HE	To evaluate the isotopic composition of the solar nebula from which the planets formed, the relation between isotopes measured in the solar wind and on the Sun's surface needs to be known. The Genesis Discovery mission returned independent samples of three types of solar wind produced by different solar processes that provide a check on possible isotopic variations, or fractionation, between the solar-wind and solar-surface material. At a high level of precision, we observed no significant inter-regime differences in Ne-20/Ne-22 or Ar-36/Ar-38 values. For Ne-20/Ne-22, the difference between low- and high-speed wind components is 0.24 +/- 0.37%; for Ar-36/Ar-38, it is 0.11 +/- 0.26%. Our measured Ar-36/Ar-38 ratio in the solar wind of 5.501 +/- 0.005 is 3.42 +/- 0.09% higher than that of the terrestrial atmosphere, which may reflect atmospheric losses early in Earth's history.	Washington Univ, Dept Phys, St Louis, MO 63130 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Montana, Dept Phys & Astron, Missoula, MT 59812 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Arizona State Univ, Ctr Meteorite Studies, Tempe, AZ 85287 USA	Washington University (WUSTL); California Institute of Technology; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Arizona State University; Arizona State University-Tempe	Meshik, A (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	am@physics.wustl.edu	Reisenfeld, Daniel/F-7614-2015	Pravdivtseva, Olga/0000-0003-4259-0291; Jurewicz, Amy/0000-0002-3282-5782				Basu S, 2004, ASTROPHYS J, V606, pL85, DOI 10.1086/421110; BENKERT JP, 1993, J GEOPHYS RES-PLANET, V98, P13147, DOI 10.1029/93JE01460; Bodmer P, 1998, ASTRON ASTROPHYS, V337, P921; Burnett DS, 2003, SPACE SCI REV, V105, P509, DOI 10.1023/A:1024425810605; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; CERUTTI H, 1974, THESIS U BERN; CLAYTON RN, 1972, EARTH PLANET SC LETT, V13, P455, DOI 10.1016/0012-821X(72)90125-2; Clayton RN, 2005, TREATISE GEOCHEM, V1, P129; Geiss J, 2004, SPACE SCI REV, V110, P307, DOI 10.1023/B:SPAC.0000023409.54469.40; Geiss J, 2003, SPACE SCI REV, V106, P3, DOI 10.1023/A:1024651232758; GEISS J, 1995, SPACE SCI REV, V72, P49, DOI 10.1007/BF00768753; GEISS J, 1970, SOL PHYS, V12, P458, DOI 10.1007/BF00148028; Grimberg A, 2006, SCIENCE, V314, P1133, DOI 10.1126/science.1133568; HEBER VS, 2007, LUNAR PLANET SCI C, V38; Hohenberg CM, 2002, METEORIT PLANET SCI, V37, P257, DOI 10.1111/j.1945-5100.2002.tb01108.x; Mabry J. C., 2007, LUNAR PLANET SCI C; McSween H.Y., 2006, METEORITES EARLY SOL, P499; Neugebauer M, 2003, SPACE SCI REV, V105, P661, DOI 10.1023/A:1024478129261; NIER AO, 1950, PHYS REV, V77, P789, DOI 10.1103/PhysRev.77.789; Ozima M, 1998, GEOCHIM COSMOCHIM AC, V62, P301, DOI 10.1016/S0016-7037(97)00339-6; Palma RL, 2002, GEOCHIM COSMOCHIM AC, V66, P2929, DOI 10.1016/S0016-7037(02)00853-0; Palme H, 2005, TREATISE GEOCHEM, V1, P41; Pepin RO, 2006, EARTH PLANET SC LETT, V252, P1, DOI 10.1016/j.epsl.2006.09.014; Reisenfeld DB, 2003, AIP CONF PROC, V679, P632, DOI 10.1063/1.1618674; von Steiger R, 2001, SPACE SCI REV, V97, P123, DOI 10.1023/A:1011886414964; VONSTEIGER R, 1989, ASTRON ASTROPHYS, V225, P222; Weygand JM, 2001, GEOCHIM COSMOCHIM AC, V65, P4589, DOI 10.1016/S0016-7037(01)00740-2	27	48	49	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					433	435		10.1126/science.1145528	http://dx.doi.org/10.1126/science.1145528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947578				2022-12-28	WOS:000250230400041
J	Nallamothu, BK; Bradley, EH; Krumholz, HM				Nallamothu, Brahmajee K.; Bradley, Elizabeth H.; Krumholz, Harlan M.			Current concepts - Time to treatment in primary percutaneous coronary intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE-MYOCARDIAL-INFARCTION; TO-BALLOON TIME; PRIMARY ANGIOPLASTY; REPERFUSION THERAPY; ON-SITE; THROMBOLYTIC THERAPY; FIBRINOLYTIC THERAPY; NATIONAL-REGISTRY; US HOSPITALS; MORTALITY		Ann Arbor Vet Affairs Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Dis, Ann Arbor, MI USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, Cardiovasc Med Sect, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), 333 Cedar St,Rm 1-456 SHM,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072575] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL072575] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antman EM, 2007, CIRCULATION, V115, pE411, DOI 10.1161/CIRCULATIONAHA.107.183508; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antman EM, 2005, CIRCULATION, V111, P2013; Antoniucci D, 2002, AM J CARDIOL, V89, P1248, DOI 10.1016/S0002-9149(02)02320-2; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Armstrong PW, 2006, EUR HEART J, V27, P1530, DOI 10.1093/eurheartj/ehl088; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P3212; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Betriu A, 2005, AM J CARDIOL, V95, P100, DOI 10.1016/j.amjcard.2004.08.069; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Brodie BR, 2006, AM HEART J, V151, P1231, DOI 10.1016/j.ahj.2005.07.016; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2003, AM HEART J, V145, P708, DOI 10.1067/mhj.2003.9; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; CHRISTIAN TF, 1992, CIRCULATION, V86, P81, DOI 10.1161/01.CIR.86.1.81; Curtis JP, 2006, J AM COLL CARDIOL, V47, P1544, DOI 10.1016/j.jacc.2005.10.077; Dalby M, 2003, CIRCULATION, V108, P1809, DOI 10.1161/01.CIR.0000091088.63921.8C; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Department of Health & Human Services, HOSP COMP QUAL TOOL; Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, 1994, LANCET, V343, P311; Garvey JL, 2006, J AM COLL CARDIOL, V47, P485, DOI 10.1016/j.jacc.2005.08.072; Giugliano RP, 2003, CIRCULATION, V108, P2828, DOI 10.1161/01.CIR.0000106684.71725.98; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; Henry TD, 2005, AM HEART J, V150, P373, DOI 10.1016/j.ahj.2005.01.059; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Jacoby Jeanne, 2005, J Invasive Cardiol, V17, P154; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kalla K, 2006, CIRCULATION, V113, P2398, DOI 10.1161/CIRCULATIONAHA.105.586198; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8; Keeley EC, 2006, LANCET, V367, P1656; Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503; Kent D M, 2001, Eff Clin Pract, V4, P214; KIM CB, 1993, CIRCULATION, V88, P2426, DOI 10.1161/01.CIR.88.5.2426; Kloner RA, 1998, CIRCULATION, V97, P1042, DOI 10.1161/01.CIR.97.11.1042; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; McNamara RL, 2006, J AM COLL CARDIOL, V47, P45, DOI 10.1016/j.jacc.2005.04.071; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2004, AM J CARDIOL, V94, P772, DOI 10.1016/j.amjcard.2004.05.064; O'Neill WW, 2005, J AM COLL CARDIOL, V45, p225A; PAOLASSO E, 1993, LANCET, V342, P767; Pinto DS, 2006, CIRCULATION, V114, P2019, DOI 10.1161/CIRCULATIONAHA.106.638353; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Schomig A, 2006, EUR HEART J, V27, P1900, DOI 10.1093/eurheartj/ehl174; Stenestrand U, 2006, JAMA-J AM MED ASSOC, V296, P1749, DOI 10.1001/jama.296.14.1749; Swor R, 2006, PREHOSP EMERG CARE, V10, P374, DOI 10.1080/10903120600725876; Thatcher Jackson L, 2003, J Invasive Cardiol, V15, P693; Thune JJ, 2005, CIRCULATION, V112, P2017, DOI 10.1161/CIRCULATIONAHA.105.558676; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Van de Werf FJ, 2006, CIRCULATION, V114, P2002, DOI 10.1161/CIRCULATIONAHA.106.658252; Ward MR, 2001, AM J CARDIOL, V87, P336, DOI 10.1016/S0002-9149(00)01370-9; Wharton TP, 2005, CIRCULATION, V112, P3509, DOI 10.1161/CIRCULATIONAHA.104.478362; Wharton TP, 2004, J AM COLL CARDIOL, V43, P1943, DOI 10.1016/j.jacc.2004.03.013; Wijeysundera HC, 2007, J AM COLL CARDIOL, V49, P422, DOI 10.1016/j.jacc.2006.09.033; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	68	206	223	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1631	1638		10.1056/NEJMra065985	http://dx.doi.org/10.1056/NEJMra065985			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942875				2022-12-28	WOS:000250200500008
J	Wodchis, WP; Ross, JS; Detsky, AS				Wodchis, Walter P.; Ross, Joseph S.; Detsky, Allan S.			Is P4P really FFS?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PAY-FOR-PERFORMANCE; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE; QUALITY; IMPROVE; PLAN		Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto Rehabil Inst, Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto Rehabil Inst, Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; Mt Sinai Sch Med, Dept Med, New York, NY USA; James J Peters Vet Adm Med Ctr, Hlth Serv Res & Dev Targeted Res Enhancement Prog, Bronx, NY USA; James J Peters Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 427, Toronto, ON M5G 1X5, Canada.	allan.detsky@uhn.on.ca	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; wodchis, walter/0000-0003-2494-7031; Ross, Joseph/0000-0002-9218-3320				Beich J, 2006, MED CARE RES REV, V63, p96S, DOI 10.1177/1077558705283641; Bell CM, 2007, CAN MED ASSOC J, V176, P1717, DOI 10.1503/cmaj.070472; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P799, DOI 10.1001/jama.298.7.799; ENTHOVEN AC, 1978, NEW ENGL J MED, V298, P650, DOI 10.1056/NEJM197803232981204; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2006, REW PROV PERF AL INC; Millett C, 2007, CAN MED ASSOC J, V176, P1705, DOI 10.1503/cmaj.061556; Newhouse JP, 1993, FREE ALL LESSONS RAN; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; ROEMER MI, 1959, HGOSP MONOGRAPH SERI, V6; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740	16	24	24	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1797	1799		10.1001/jama.298.15.1797	http://dx.doi.org/10.1001/jama.298.15.1797			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940237				2022-12-28	WOS:000250187300024
J	Cotgrove, A; Timimi, S				Cotgrove, Andrew; Timimi, Sami			Should young people be given antidepressants?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Lincolnshire Partnership NHS Trust, Sleaford NG34 8QA, Lincs, England		Cotgrove, A (corresponding author), Lincolnshire Partnership NHS Trust, Sleaford NG34 8QA, Lincs, England.	andy.cotgrove@cwpnt.nhs.uk; stimimi@talk21.com							0	7	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 13	2007	335	7623					750	751		10.1136/bmj.39316.399931.94	http://dx.doi.org/10.1136/bmj.39316.399931.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17932205	Green Published			2022-12-28	WOS:000250418600027
J	Gill, K; Pande, R; Malhotra, A				Gill, Kirrin; Pande, Rohini; Malhotra, Anju			Women deliver for development	LANCET			English	Review							REDUCING MATERNAL MORTALITY; HEALTH-CARE UTILIZATION; HIV-INFECTION; PERINATAL-MORTALITY; PROSPECTIVE COHORT; COST-EFFECTIVENESS; DOMESTIC VIOLENCE; RURAL BANGLADESH; DEVELOPING-WORLD; NEONATAL DEATHS	There is a large amount of research into maternal health as a health issue, but maternal health as a development issue has been less explored. This Review analyses the evidence from the past 20 years on the links between maternal health and development to examine maternal health within a development framework. We note that although existing evidence suggests that these links are strong, further research is needed to definitively substantiate how and to what extent maternal health and development affect each other. Further, we find that progress and investment in maternal health have lagged far behind estimates of what is needed to achieve the Millennium Development Goals.	Int Ctr Res Women, Washington, DC 20036 USA		Pande, R (corresponding author), Int Ctr Res Women, 1120 20th St NW,Suite 500N, Washington, DC 20036 USA.	rpande@icrw.org		Malhotra, Anju/0000-0001-9653-2754				AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Ahmad H, 2001, CHEST, V120, P666, DOI 10.1378/chest.120.2.666; AHMAN E, 2003, GLOBAL BURDEN UNSAFE; AHMED S, 1997, SIMULTANEITY MATERNA; Ahmed Y, 1999, INT J TUBERC LUNG D, V3, P675; AINSWORTH M, 1994, WORLD BANK RES OBSER, V9, P203, DOI 10.1093/wbro/9.2.203; AINSWORTH M, 1998, COPING AIDS EC IMPAC, pCH9; Allendorf K, 2007, STUD FAMILY PLANN, V38, P35, DOI 10.1111/j.1728-4465.2007.00114.x; Alliegro MB, 1997, ARCH INTERN MED, V157, P2585, DOI 10.1001/archinte.157.22.2585; [Anonymous], 1998, HLTH DIMENSIONS SEX; [Anonymous], 2003, ADDING IT BENEFITS I; Anson O, 2004, HEALTH POLICY, V70, P197, DOI 10.1016/j.healthpol.2004.03.001; Ashford L., 2002, HIDDEN SUFFERING DIS; Bacchus L, 2004, EUR J OBSTET GYN R B, V113, P6, DOI 10.1016/S0301-2115(03)00326-9; Barua A, 2001, REPROD HEALTH MATTER, V9, P53, DOI 10.1016/S0968-8080(01)90008-4; Becker S, 2006, SOC SCI MED, V62, P2313, DOI 10.1016/j.socscimed.2005.10.006; Beegle K, 2001, STUD FAMILY PLANN, V32, P130, DOI 10.1111/j.1728-4465.2001.00130.x; BEHRMAN JR, 1989, J HUM RESOUR, V24, P644, DOI 10.2307/145999; Berer M, 1999, SAFE MOTHERHOOD INIT, P198; Bhatia JC., 1995, HLTH TRANSITION REV, V5, P127; BLEDSOE CH, 1988, SOC SCI MED, V27, P627, DOI 10.1016/0277-9536(88)90011-1; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bloom DE., 2001, EFFECT HLTH EC GROWT; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; BRETTLE RP, 1995, AIDS, V9, P1177, DOI 10.1097/00002030-199510000-00010; CHEN LC, 1974, STUD FAMILY PLANN, V5, P334, DOI 10.2307/1965185; Collin SM, 2006, AIDS CARE, V18, P812, DOI 10.1080/09540120500465061; Conteh L, 2001, COSTS SCALING PRIORI; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; DANEL I, 2003, REDUCING MATERNAL MO, P51; Danel I, 2000, MATERNAL MORTALITY R; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Defo BK, 1997, SOC SCI MED, V44, P1023, DOI 10.1016/S0277-9536(96)00228-6; *DEP INT DEV, 2007, DFIDS MAT HLTH STRAT; El Kady D, 2005, OBSTET GYNECOL, V105, P357, DOI 10.1097/01.AOG.0000151109.46641.03; Ellsberg M., 2005, RES VIOLENCE WOMEN P; Elo I T, 1992, Health Transit Rev, V2, P49; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; FORTNEY JA, 1987, STUD FAMILY PLANN, V18, P109, DOI 10.2307/1966702; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; GERTLER P, 2003, LOSING PRESENCE PRES; Gilborn LZ, 2002, WESTERN J MED, V176, P12, DOI 10.1136/ewjm.176.1.12; GOVINDASAMY P, 2000, WOMEN POVERTY DEMOGR, P263; Graham WJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P499; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Greener R, 2004, MACROECONOMICS OF HIV/AIDS, P167; GREENWOOD AM, 1987, B WORLD HEALTH ORGAN, V65, P635; GUARCELLO L, 2004, INFLUECE ORPHANHOOD; Gwatkin D. R., 2005, REACHING POOR HLTH N; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Haacker M, 2004, MACROECONOMICS OF HIV/AIDS, P41; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hilton M.J., 2021, RAKIURA DUNE RESTORA; Hotchkiss DR, 2005, POPUL RES POLICY REV, V24, P543, DOI 10.1007/s11113-005-4852-0; HUTTON G, 2006, MOVING UNIVERSAL COV; Islam MK, 2006, COSTS MATERNAL NEWBO; Jowett M, 2000, HEALTH POLICY, V53, P201, DOI 10.1016/S0168-8510(00)00089-0; Kaye DK, 2006, TROP MED INT HEALTH, V11, P1576, DOI 10.1111/j.1365-3156.2006.01711.x; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Kishor S., 2004, PROFILING DOMESTIC V; KISHOR S, 2003, 2003 ANN M POP ASS A; KOENIG MA, 1988, STUD FAMILY PLANN, V19, P69, DOI 10.2307/1966492; Kusiako T, 2000, B WORLD HEALTH ORGAN, V78, P621; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; LEROY V, 1994, AIDS, V8, P983, DOI 10.1097/00002030-199407000-00017; LEVINE RA, 1991, POPUL DEV REV, V17, P459, DOI 10.2307/1971950; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; LopezCasasnovas G, 2005, HEALTH AND ECONOMIC GROWTH: FINDINGS AND POLICY IMPLICATIONS, P1; MALHOTRA A, 2002, MEASURING WOMENS ENP; MARSTON C, 2004, EFFECTS CONTRACPTION; Matsumura M., 2001, ASIA PAC POPULAT J, V16, P23, DOI DOI 10.18356/E8A4C9ED-EN; Matthews Z., 2005, FOCUS GENDER COLLECT; McFarlane J, 1996, NURS RES, V45, P37, DOI 10.1097/00006199-199601000-00007; McIntyre J, 2005, REPROD HEALTH MATTER, V13, P129, DOI 10.1016/S0968-8080(05)25184-4; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Miles-Doan R, 1998, STUD FAMILY PLANN, V29, P69, DOI 10.2307/172182; MURRAY JL, 1998, HLTH DIMENSIONS SEX; Nanda P, 1999, HEALTH ECON, V8, P415, DOI 10.1002/(SICI)1099-1050(199908)8:5<415::AID-HEC450>3.0.CO;2-L; Nyamukapa C, 2005, SOC SCI MED, V60, P2155, DOI 10.1016/j.socscimed.2004.10.005; OBERMEYER CM, 1991, STUD FAMILY PLANN, V22, P177, DOI 10.2307/1966644; Oleke C, 2007, AIDS CARE, V19, P361, DOI 10.1080/09540120600677987; Pallitto CC, 2004, DOMESTIC VIOLENCE MA; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; *PRB IMMP, 2007, EC FIN TOOLS ASS SAF; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Reed HE, 2000, CONS MAT MORB MAT MO; Rodrigues M, 2003, SOC SCI MED, V57, P1797, DOI 10.1016/S0277-9536(03)00062-5; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Roy NC, 2001, J HEALTH POPUL NUTR, V19, P291; Royston E, 1989, PREVENTING MATERNAL; Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017; Save the Children, 2006, STAT WORLDS MOTH 200; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Shiffman J, 2002, HEALTH POLICY PLANN, V17, P225, DOI 10.1093/heapol/17.3.225; Shiffman J, 2000, STUD FAMILY PLANN, V31, P274, DOI 10.1111/j.1728-4465.2000.00274.x; SOMMERFELT AE, REDUCE WORKSH 2003 A; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; Strong MA, 1992, HLTH TRANSITION REV, V2, P215; Stuchbery M, 1998, SOC PSYCH PSYCH EPID, V33, P483, DOI 10.1007/s001270050083; Taguchi N, 2003, TROP MED INT HEALTH, V8, P847, DOI 10.1046/j.1365-3156.2003.01101.x; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; TINKER A, 1994, WOMENS HLTH NUTR MAK; Tinker A, 1993, MAKING MOTHERHOOD SA; UN, 2007, MILL DEV GOALS REP; *UN, 2002, REP INT C FIN DEV IN; UN Millennium Project, 2005, TAK ACT ACH GEND EQ; *UNAIDS, 2006, AIDS EP UPD 2006; USAID, 2001, USAID C BUDG JUST FY; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; Weiner R, 2003, B WORLD HEALTH ORGAN, V81, P561; WHO, 2004, MAT MORT 2000 EST DE; WHO & UNICEF, 2003, ANT CAR DEV COUNTR P; WINIKOFF B, 1987, STUD FAMILY PLANN, V18, P128, DOI 10.2307/1966808; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organisation, 1999, RED MAT MORT JOINT W; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2006, SKILL ATT BIRTH 2006; World Health Organization, 2004, UNS AB GLOB REG EST; World Health Organization, 1997, COV MAT CAR LIST AV; World Health Organization, 2001, MAT MORT 1995 EST DE; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2002, REV GLOB BURD DIS 20	134	68	69	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1347	1357		10.1016/S0140-6736(07)61577-3	http://dx.doi.org/10.1016/S0140-6736(07)61577-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933650				2022-12-28	WOS:000250176600029
J	Petignat, P; Roy, M				Petignat, Patrick; Roy, Michel			Diagnosis and management of cervical cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GYNECOLOGIC-ONCOLOGY-GROUP; CONCURRENT CHEMOTHERAPY; RADIATION-THERAPY; PELVIC RADIATION; RANDOMIZED-TRIAL; RADICAL SURGERY; CARCINOMA; CISPLATIN; EXTRAPERITONEAL; RADIOTHERAPY		Univ Hosp Geneva, Senol & Gynaecol Oncol Unit, CH-1211 Geneva 14, Switzerland; Univ Laval, CHUQ, Gynecol Oncol Serv, Quebec City, PQ, Canada	University of Geneva; Laval University	Petignat, P (corresponding author), Univ Hosp Geneva, Senol & Gynaecol Oncol Unit, CH-1211 Geneva 14, Switzerland.	patrick.petignat@hcuge.ch		Petignat, Patrick/0000-0002-6835-533X				Bekkers RLM, 2002, INT J GYNECOL CANCER, V12, P485, DOI 10.1046/j.1525-1438.2002.01131.x; CREASMAN WT, 1995, GYNECOL ONCOL, V58, P157, DOI 10.1006/gyno.1995.1203; Dreyer G, 2005, BEST PRACT RES CL OB, V19, P631, DOI 10.1016/j.bpobgyn.2005.03.003; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Hricak H, 2005, J CLIN ONCOL, V23, P9329, DOI 10.1200/JCO.2005.02.0354; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; LAGASSE LD, 1980, GYNECOL ONCOL, V9, P90, DOI 10.1016/0090-8258(80)90013-X; Lai CH, 2003, GYNECOL ONCOL, V89, P160, DOI 10.1016/S0090-8258(03)00064-7; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; *MED PRACT ETH COM, 1998, PRACT GUID CERV CANC, V12, P134; Monk BJ, 2005, J CLIN ONCOL, V23, P4617, DOI 10.1200/JCO.2005.10.522; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Narayan K, 2005, INT J GYNECOL CANCER, V15, P573, DOI 10.1111/j.1525-1438.2005.00128.x; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Plante M, 2005, GYNECOL ONCOL, V99, pS143, DOI 10.1016/j.ygyno.2005.07.067; Plante M, 2003, GYNECOL ONCOL, V91, P494, DOI 10.1016/j.ygyno.2003.08.024; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Rotman M, 2006, INT J RADIAT ONCOL, V65, P169, DOI 10.1016/j.ijrobp.2005.10.019; Sironi S, 2006, RADIOLOGY, V238, P272, DOI 10.1148/radiol.2381041799; Sonoda Y, 2004, GYNECOL ONCOL, V95, P534, DOI 10.1016/j.ygyno.2004.07.060; Vasilev SA, 1996, GYNECOL ONCOL, V61, P315, DOI 10.1006/gyno.1996.0149; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WEISER EB, 1989, GYNECOL ONCOL, V33, P283, DOI 10.1016/0090-8258(89)90513-1; Whitney CW, 1999, J CLIN ONCOL, V17, P1339, DOI 10.1200/JCO.1999.17.5.1339; WHO, 2006, COMPR CERV CANC CONT	25	125	130	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2007	335	7623					765	768		10.1136/bmj.39337.615197.80	http://dx.doi.org/10.1136/bmj.39337.615197.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17932207	Green Published			2022-12-28	WOS:000250418600036
J	Willett, KM; Gillett, NP; Jones, PD; Thorne, PW				Willett, Katharine M.; Gillett, Nathan P.; Jones, Philip D.; Thorne, Peter W.			Attribution of observed surface humidity changes to human influence	NATURE			English	Article							RELATIVE-HUMIDITY; WATER-VAPOR; TEMPERATURE; TRENDS; CLIMATOLOGY; MODEL; VARIABILITY; ICOADS; CYCLE	Water vapour is the most important contributor to the natural greenhouse effect, and the amount of water vapour in the atmosphere is expected to increase under conditions of greenhouse-gas-induced warming, leading to a significant feedback on anthropogenic climate change(1-3). Theoretical and modelling studies predict that relative humidity will remain approximately constant at the global scale as the climate warms, leading to an increase in specific humidity(1,4,5). Although significant increases in surface specific humidity have been identified in several regions(6-9), and on the global scale in non-homogenized data(10), it has not been shown whether these changes are due to natural or human influences on climate. Here we use a new quality-controlled and homogenized gridded observational data set of surface humidity, with output from a coupled climate model, to identify and explore the causes of changes in surface specific humidity over the late twentieth century. We identify a significant global-scale increase in surface specific humidity that is attributable mainly to human influence. Specific humidity is found to have increased in response to rising temperatures, with relative humidity remaining approximately constant. These changes may have important implications, because atmospheric humidity is a key variable in determining the geographical distribution(11-13) and maximum intensity(14) of precipitation, the potential maximum intensity of tropical cyclones(15), and human heat stress(16), and has important effects on the biosphere(17) and surface hydrology(17,18).	Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; Met Off, Hadley Ctr, Exeter EX1 3PB, Devon, England	University of East Anglia; Met Office - UK; Hadley Centre	Gillett, NP (corresponding author), Univ E Anglia, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England.	n.gillett@uea.ac.uk	Thorne, Peter W/R-6823-2017; Thorne, Peter/F-2225-2014; Jones, Philip Douglas/C-8718-2009	Thorne, Peter W/0000-0003-0485-9798; Thorne, Peter/0000-0003-0485-9798; Jones, Philip Douglas/0000-0001-5032-5493				Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Allen MR, 2003, CLIM DYNAM, V21, P477, DOI 10.1007/s00382-003-0313-9; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Alley R, 2007, CLIMATE CHANGE 2007; Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; Dai A, 2006, J CLIMATE, V19, P3589, DOI 10.1175/JCLI3816.1; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020111; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Holland GJ, 1997, J ATMOS SCI, V54, P2519, DOI 10.1175/1520-0469(1997)054<2519:TMPIOT>2.0.CO;2; Ishii M, 2005, INT J CLIMATOL, V25, P865, DOI 10.1002/joc.1169; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Jones PD, 2001, J GEOPHYS RES-ATMOS, V106, P3371, DOI 10.1029/2000JD900564; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Lott N., 2001, 200101 NAT CLIM DAT; MCCARTHY MP, 2006, 71 HADL CTR; Peixoto JP, 1996, J CLIMATE, V9, P3443, DOI 10.1175/1520-0442(1996)009<3443:TCORHI>2.0.CO;2; Philipona R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018765; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Robinson PJ, 2000, INT J CLIMATOL, V20, P985, DOI 10.1002/1097-0088(200007)20:9<985::AID-JOC513>3.0.CO;2-W; Santer BD, 2007, P NATL ACAD SCI USA, V104, P15248, DOI 10.1073/pnas.0702872104; Sherwood SC, 2006, J CLIMATE, V19, P6278, DOI 10.1175/JCLI3979.1; STEADMAN RG, 1984, J CLIM APPL METEOROL, V23, P1674, DOI 10.1175/1520-0450(1984)023<1674:AUSOAT>2.0.CO;2; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4; Wang JXL, 2001, J CLIMATE, V14, P2833, DOI 10.1175/1520-0442(2001)014<2833:LTCCAT>2.0.CO;2; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; WILLETT KM, 2007, THESIS U E ANGLIA; Worley SJ, 2005, INT J CLIMATOL, V25, P823, DOI 10.1002/joc.1166; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; ZRNELL N, 2001, CLIMATE CHANGE 2001, P191	36	249	264	5	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					710	U6		10.1038/nature06207	http://dx.doi.org/10.1038/nature06207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928858	Green Accepted			2022-12-28	WOS:000250045000041
J	Lecuyer, E; Yoshida, H; Parthasarathy, N; Alm, C; Babak, T; Cerovina, T; Hughes, TR; Tomancak, P; Krause, HM				Lecuyer, Eric; Yoshida, Hideki; Parthasarathy, Neela; Alm, Christina; Babak, Tomas; Cerovina, Tanja; Hughes, Timothy R.; Tomancak, Pavel; Krause, Henry M.			Global analysis of mRNA localization reveals a prominent role in organizing cellular architecture and function	CELL			English	Article							GENE-EXPRESSION; ASYMMETRIC LOCALIZATION; DEPENDENT LOCALIZATION; TRANSPOSABLE ELEMENTS; DEVELOPMENTAL CONTROL; APICAL LOCALIZATION; DROSOPHILA; PROTEIN; ORGANIZATION; COMPLEX	Although subcellular mRNA trafficking has been demonstrated as a mechanism to control protein distribution, it is generally believed that most protein localization occurs subsequent to translation. To address this point, we developed and employed a high-resolution fluorescent in situ hybridization procedure to comprehensively evaluate mRNA localization dynamics during early Drosophila embryogenesis. Surprisingly, of the 3370 genes analyzed, 71% of those expressed encode subcellularly localized mRNAs. Dozens of new and striking localization patterns were observed, implying an equivalent variety of localization mechanisms. Tight correlations between mRNA distribution and subsequent protein localization and function, indicate major roles for mRNA localization in nucleating localized cellular machineries. A searchable web resource documenting mRNA expression and localization dynamics has been established and will serve as an invaluable tool for dissecting localization mechanisms and for predicting gene functions and interactions.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M4X 1K9, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M4X 1K9, Canada; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M4X 1K9, Canada; Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Toronto; University of Toronto; University of Toronto; Max Planck Society	Krause, HM (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 100 Coll St, Toronto, ON M4X 1K9, Canada.	h.krause@utoronto.ca	Tomancak, Pavel/C-2109-2009	Tomancak, Pavel/0000-0002-2222-9370; Krause, Henry/0000-0002-6182-7074; Babak, Tomas/0000-0003-0879-0134				Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Alliegro MC, 2006, P NATL ACAD SCI USA, V103, P9034, DOI 10.1073/pnas.0602859103; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; DOSSANTOS G, 2007, IN PRESS DEV; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; Dubowy J, 1998, MECH DEVELOP, V70, P193, DOI 10.1016/S0925-4773(97)00185-8; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Erdmann VA, 2001, CELL MOL LIFE SCI, V58, P960, DOI 10.1007/PL00000913; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hughes JR, 2004, CURR BIOL, V14, P1950, DOI 10.1016/j.cub.2004.10.022; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Parthasarathy N., 2007, METHOD MOL BIOL, P289; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rothwell WF, 1998, DEVELOPMENT, V125, P1295; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Tadros W, 2007, DEV CELL, V12, P847, DOI 10.1016/j.devcel.2007.05.009; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Van Doren M, 1998, CURR BIOL, V8, P243; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5	70	660	674	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					174	187		10.1016/j.cell.2007.08.003	http://dx.doi.org/10.1016/j.cell.2007.08.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923096	Bronze			2022-12-28	WOS:000249934700020
J	Podsiadlo, P; Kaushik, AK; Arruda, EM; Waas, AM; Shim, BS; Xu, JD; Nandivada, H; Pumplin, BG; Lahann, J; Ramamoorthy, A; Kotov, NA				Podsiadlo, Paul; Kaushik, Amit K.; Arruda, Ellen M.; Waas, Anthony M.; Shim, Bong Sup; Xu, Jiadi; Nandivada, Himabindu; Pumplin, Benjamin G.; Lahann, Joerg; Ramamoorthy, Ayyalusamy; Kotov, Nicholas A.			Ultrastrong and stiff layered polymer nanocomposites	SCIENCE			English	Article							MECHANICAL-PROPERTIES; CARBON NANOTUBES; SILICATE NANOCOMPOSITES; ELASTIC PROPERTIES; COMPOSITES; STRENGTH; FIBERS; MONTMORILLONITE; WHISKERS; MODULUS	Nanoscale building blocks are individually exceptionally strong because they are close to ideal, defect-free materials. It is, however, difficult to retain the ideal properties in macroscale composites. Bottom-up assembly of a clay/polymer nanocomposite allowed for the preparation of a homogeneous, optically transparent material with planar orientation of the alumosilicate nanosheets. The stiffness and tensile strength of these multilayer composites are one order of magnitude greater than those of analogous nanocomposites at a processing temperature that is much lower than those of ceramic or polymer materials with similar characteristics. A high level of ordering of the nanoscale building blocks, combined with dense covalent and hydrogen bonding and stiffening of the polymer chains, leads to highly effective load transfer between nanosheets and the polymer.	Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Program Macromol Sci & Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kotov, NA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	kotov@umich.edu	Kotov, Nicholas/AAZ-4204-2021; Xu, jiadi/E-3163-2010; Kaushik, Amit/F-2655-2012; Lahann, Joerg/J-7663-2013; Arruda, Ellen M/C-3579-2009; Shim, Bong Sup/A-1348-2019	Kotov, Nicholas/0000-0002-6864-5804; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900; Shim, Bong Sup/0000-0003-3205-6191; Xu, Jiadi/0000-0001-9698-5622				Bergstrom JS, 1999, RUBBER CHEM TECHNOL, V72, P633, DOI 10.5254/1.3538823; Bonapasta AA, 2000, CHEM MATER, V12, P738; BRAUN D, 1980, COLLOID POLYM SCI, V258, P795, DOI 10.1007/BF01566233; Breuer O, 2004, POLYM COMPOSITE, V25, P630, DOI 10.1002/pc.20058; Cheng M, 2005, J ENG MATER-T ASME, V127, P197, DOI 10.1115/1.1857937; Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; Guan Y, 2006, J PHYS CHEM B, V110, P13484, DOI 10.1021/jp061548g; Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760; HINDELEH AM, 1989, POLYM COMMUN, V30, P184; Jiang CY, 2006, ADV MATER, V18, P829, DOI 10.1002/adma.200502444; KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370; Lagaly G, 1999, APPL CLAY SCI, V15, P1; Mack JJ, 2005, ADV MATER, V17, P77, DOI 10.1002/adma.200400133; Mamedov A, 2000, LANGMUIR, V16, P3941, DOI 10.1021/la990957j; Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747; Manevitch OL, 2004, J PHYS CHEM B, V108, P1428, DOI 10.1021/jp0302818; Nagy M., 1976, PROGR COLLOID POLYM, V60, P138; Olek M, 2004, NANO LETT, V4, P1889, DOI 10.1021/nl04895Qw; Podsiadlo P, 2007, NANO LETT, V7, P1224, DOI [10.1021/nl0700649, 10.1021/nI0700649]; Podsiadlo P, 2007, ADV MATER, V19, P949, DOI 10.1002/adma.200602706; Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Sturcova A, 2005, BIOMACROMOLECULES, V6, P1055, DOI 10.1021/bm049291k; Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Van Lier G, 2000, CHEM PHYS LETT, V326, P181, DOI 10.1016/S0009-2614(00)00764-8; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Yue CY, 2000, COMPOS SCI TECHNOL, V60, P421, DOI 10.1016/S0266-3538(99)00137-2	31	1304	1341	44	1207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					80	83		10.1126/science.1143176	http://dx.doi.org/10.1126/science.1143176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916728				2022-12-28	WOS:000249915400043
J	Blard, PH; Lave, J; Pik, R; Wagnon, P; Bourles, D				Blard, P.-H.; Lave, J.; Pik, R.; Wagnon, P.; Bourles, D.			Persistence of full glacial conditions in the central Pacific until 15,000 years ago	NATURE			English	Article							SUBTROPICAL NORTH PACIFIC; COSMOGENIC NUCLIDES; PRODUCTION-RATES; MASS-BALANCE; SECULAR VARIATION; MAXIMUM; CLIMATE; SURFACE; RECORD; HAWAII	The magnitude of atmospheric cooling during the Last Glacial Maximum and the timing of the transition into the current interglacial period remain poorly constrained in tropical regions, partly because of a lack of suitable climate records(1). Glacial moraines provide a method of reconstructing past temperatures, but they are relatively rare in the tropics. Here we present a reconstruction of atmospheric temperatures in the central Pacific during the last deglaciation on the basis of cosmogenic He-3 ages of moraines and numerical modelling of the ice cap on Mauna Kea volcano, Hawaii-the only highland in the central Pacific on which moraines that formed during the last glacial period are preserved(2). Our reconstruction indicates that the Last Glacial Maximum occurred between 19,000 and 16,000 years ago in this region and that temperatures at high elevations were about 7 degrees C lower than today during this interval. Glacial retreat began about 16,000 years ago, but temperatures were still about 6.5 degrees C lower than today until 15,000 years ago. When combined with estimates of sea surface temperatures in the central Pacific Ocean(3), our reconstruction indicates that the lapse rate during the Last Glacial Maximum was higher than at present, which is consistent with the proposal that the atmosphere was drier at that time(1,4). Furthermore, the persistence of full glacial conditions until 15,000 years ago is consistent with the relatively late and abrupt transition to warmer temperatures in Greenland(5), indicating that there may have been an atmospheric teleconnection between the central Pacific and North Atlantic regions during the last deglaciation.	Aix Marseille Univ, CNRS, Ctr Europeen Rech & Enseignement Geosci Environm, F-13545 Aix En Provence, France; CNRS, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Univ Grenoble 1, CNRS, Lab Geodynam Chaines Alpines, F-38400 Grenoble, France; Inst Rech Dev Great Ice, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut de Recherche pour le Developpement (IRD)	Blard, PH (corresponding author), CALTECH, Div Geol & Planetary Sci, MC 100-23,1200 E Calif Blvd, Pasadena, CA 91125 USA.	blard@gps.caltech.edu	BLARD, Pierre-Henri/ABB-9401-2021	Blard, Pierre-Henri/0000-0002-8455-8014; Bourles, Didier/0000-0001-5991-6126				Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Blard PH, 2006, EARTH PLANET SC LETT, V247, P222, DOI 10.1016/j.epsl.2006.05.012; CARCAILLET JT, 2004, GEOCHEM GEOPHYS GEOS, V5; Dorn R.I., 1991, NATL GEOGR RES EXPLO, V7, P456; Dunai TJ, 2001, EARTH PLANET SC LETT, V193, P197, DOI 10.1016/S0012-821X(01)00503-9; Dunne J, 1999, GEOMORPHOLOGY, V27, P3, DOI 10.1016/S0169-555X(98)00086-5; Farrera I, 1999, CLIM DYNAM, V15, P823, DOI 10.1007/s003820050317; FRANCOU B, 2003, J GEOPHYS RES ATMOS, V108; Gosse JC, 2001, QUATERNARY SCI REV, V20, P1475, DOI 10.1016/S0277-3791(00)00171-2; Harper JT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017329; Hill TM, 2006, QUATERNARY SCI REV, V25, P2835, DOI 10.1016/j.quascirev.2006.03.012; Hock R, 2003, J HYDROL, V282, P104, DOI 10.1016/S0022-1694(03)00257-9; Hock R, 1999, J GLACIOL, V45, P101, DOI 10.3189/S0022143000003087; Hostetler SW, 2000, SCIENCE, V290, P1747, DOI 10.1126/science.290.5497.1747; Hotchkiss S, 1999, QUATERNARY RES, V52, P115, DOI 10.1006/qres.1999.2052; JOHANNESSON T, 1995, J GLACIOL, V41, P345, DOI 10.3189/S0022143000016221; JOHNSEN SJ, 1972, NATURE, V235, P429, DOI 10.1038/235429a0; Kageyama M, 2005, QUATERN INT, V138, P202, DOI 10.1016/j.quaint.2005.02.013; Kiefer T, 2005, QUATERNARY SCI REV, V24, P1063, DOI 10.1016/j.quascirev.2004.02.021; Kitoh A, 2001, GEOPHYS RES LETT, V28, P2221, DOI 10.1029/2000GL012271; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lee KE, 2001, PALEOCEANOGRAPHY, V16, P268, DOI 10.1029/1999PA000493; Lee KE, 1999, NATURE, V397, P512, DOI 10.1038/17357; LEJEUNE Y, IN PRESS J HYDROMETE; LUDWIG KR, 1991, GEOLOGY, V19, P171, DOI 10.1130/0091-7613(1991)019<0171:CSROHD>2.3.CO;2; Masarik J, 2003, EARTH PLANET SC LETT, V216, P201, DOI 10.1016/S0012-821X(03)00476-X; Mikolajewicz U, 1997, NATURE, V387, P384, DOI 10.1038/387384a0; *NOAA, 2007, RAD DAT ACC; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; PENG L, 1992, J GEOPHYS RES-SOL EA, V97, P4407, DOI 10.1029/91JB03074; Porter SC, 2005, QUATERN INT, V138, P118, DOI 10.1016/j.quaint.2005.02.009; PORTER SC, 1979, QUATERNARY RES, V12, P161, DOI 10.1016/0033-5894(79)90055-3; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Schaefer JM, 2006, SCIENCE, V312, P1510, DOI 10.1126/science.1122872; Schuler TV, 2005, ANN GLACIOL, V42, P395, DOI 10.3189/172756405781812998; SICART JE, 2005, J GEOPHYS RES ATMOS, V110; Smith JA, 2005, SCIENCE, V308, P678, DOI 10.1126/science.1107075; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; TRULL TW, 1993, GEOCHIM COSMOCHIM AC, V57, P1313, DOI 10.1016/0016-7037(93)90068-8; Vazquez-Selem L., 1998, 15 BIENN M AM QUAT A, V1998, P174; Wolfe E.W., 1997, GEOL SURV PROF PAPER	41	53	53	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					591	U10		10.1038/nature06142	http://dx.doi.org/10.1038/nature06142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914394				2022-12-28	WOS:000249893500043
J	Levy, S; Lahoud, E; Shomroni, I; Steinhauer, J				Levy, S.; Lahoud, E.; Shomroni, I.; Steinhauer, J.			The a.c. and d.c. Josephson effects in a Bose-Einstein condensate	NATURE			English	Article							QUANTUM INTERFERENCE; RELATIVE PHASE; DOUBLE-WELL; OSCILLATIONS	The alternating- and direct-current (a.c. and d.c.) Josephson effects were first discovered in a system of two superconductors, the macroscopic wavefunctions of which are weakly coupled via a tunnelling barrier(1,2). In the a.c. Josephson effect(1-7), a constant chemical potential difference (voltage) is applied, which causes an oscillating current to flow through the barrier. Because the frequency is proportional to the chemical potential difference only, the a.c. Josephson effect serves as a voltage standard(2). In the d.c. Josephson effect, a small constant current is applied, resulting in a constant supercurrent flowing through the barrier(4,5,8). In a sense, the particles do not 'feel' the presence of the tall tunnelling barrier, and flow freely through it with no driving potential. Bose-Einstein condensates should also support Josephson effects(9); however, while plasma oscillations have been seen(10) in a single Bose-Einstein condensate Josephson junction, the a.c. Josephson effect remains elusive. Here we observe the a.c. and d.c. Josephson effects in a single Bose-Einstein condensate Josephson junction. The d.c. Josephson effect has been observed previously only in superconducting systems(11); in our study, it is evident when we measure the chemical potential-current relation of the Bose-Einstein condensate Josephson junction(4,11). Our system constitutes a trapped-atom interferometer(12,13) with continuous readout(14), which operates on the basis of the a.c. Josephson effect. In addition, the measured chemical potential-current relation shows that the device is suitable for use as an analogue of the superconducting quantum interference device, which would sense rotation(2,15).	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Steinhauer, J (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	jeffs@physics.technion.ac.il	Shomroni, Itay/AAD-3160-2020					Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; ANDERSON PW, 1963, PHYS REV LETT, V10, P230, DOI 10.1103/PhysRevLett.10.230; Andrews MR, 1996, SCIENCE, V273, P84, DOI 10.1126/science.273.5271.84; BARONE A, 1982, PHYSICS APPLICATIONS, pCH1; Cataliotti FS, 2001, SCIENCE, V293, P843, DOI 10.1126/science.1062612; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Dalfovo F, 1996, PHYS REV A, V54, P4213, DOI 10.1103/PhysRevA.54.4213; Esslinger T, 1998, PHYS REV A, V58, pR2664, DOI 10.1103/PhysRevA.58.R2664; FEYNMAN RP, 1965, FEYNMAN LECT PHYS, V3, pCH21; Giovanazzi S, 2000, PHYS REV LETT, V84, P4521, DOI 10.1103/PhysRevLett.84.4521; Greiner M, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.031401; Gustavson TL, 1997, PHYS REV LETT, V78, P2046, DOI 10.1103/PhysRevLett.78.2046; Hall DS, 1998, PHYS REV LETT, V81, P1543, DOI 10.1103/PhysRevLett.81.1543; JAVANAINEN J, 1986, PHYS REV LETT, V57, P3164, DOI 10.1103/PhysRevLett.57.3164; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Leggett AJ, 2001, REV MOD PHYS, V73, P307, DOI 10.1103/RevModPhys.73.307; LIKHAREV K, 1986, DYNAMICS JOSEPHSON J, pCH1; Marino I, 1999, PHYS REV A, V60, P487, DOI 10.1103/PhysRevA.60.487; Meier F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.033610; PACKARD RE, 1992, PHYS REV B, V46, P3540, DOI 10.1103/PhysRevB.46.3540; Pereverzev SV, 1997, NATURE, V388, P449, DOI 10.1038/41277; Pitaevskii L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.180402; Raghavan S, 1999, PHYS REV A, V59, P620, DOI 10.1103/PhysRevA.59.620; Ruostekoski J, 1998, PHYS REV A, V58, pR50, DOI 10.1103/PhysRevA.58.R50; Saba M, 2005, SCIENCE, V307, P1945, DOI 10.1126/science.1108801; Sakellari E, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.033612; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; SHIN Y, 2001, PHYS REV LETT, V92; Simmonds RW, 2001, NATURE, V412, P55, DOI 10.1038/35083518; Smerzi A, 1997, PHYS REV LETT, V79, P4950, DOI 10.1103/PhysRevLett.79.4950; Zapata I, 1998, PHYS REV A, V57, pR28, DOI 10.1103/PhysRevA.57.R28	32	412	416	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					579	U8		10.1038/nature06186	http://dx.doi.org/10.1038/nature06186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914391				2022-12-28	WOS:000249893500040
J	Chopdat, N; Menezes, CN; John, MA; Mahomed, N; Grobusch, MP				Chopdat, Nazeer; Menezes, Colin Nigel; John, Melanie-Anne; Mahomed, Nasreen; Grobusch, Martin Peter			A gardener who coughed up blood	LANCET			English	Editorial Material							ECHINOCOCCOSIS		Helen Joseph Hosp, Dept Internal Med, Infect Dis Unit, ZA-2006 Johannesburg, South Africa; Helen Joseph Hosp, Dept Radiol, ZA-2006 Johannesburg, South Africa; Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; Helen Joseph Hosp, Natl Hlth Lab Serv, Div Clin & Infect Dis, Infect Dis Unit, ZA-2006 Johannesburg, South Africa; Helen Joseph Hosp, Sch Pathol, ZA-2006 Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service	Menezes, CN (corresponding author), Helen Joseph Hosp, Dept Internal Med, Infect Dis Unit, Perth Rd, ZA-2006 Johannesburg, South Africa.	menezesc@medicine.wits.ac.za		Menezes, Colin/0000-0003-3838-5359				McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Morar R, 2003, EUR RESPIR J, V21, P1069, DOI 10.1183/09031936.03.00108403; Sailer M, 1997, J PEDIATR-US, V130, P320, DOI 10.1016/S0022-3476(97)70364-0	3	13	13	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT-NOV	2007	370	9597					1520	1520		10.1016/S0140-6736(07)61637-7	http://dx.doi.org/10.1016/S0140-6736(07)61637-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964353				2022-12-28	WOS:000250487000029
J	Gonnermann, HM; Mukhopadhyay, S				Gonnermann, Helge M.; Mukhopadhyay, Sujoy			Non-equilibrium degassing and a primordial source for helium in ocean-island volcanism	NATURE			English	Article							RARE-GAS SYSTEMATICS; MIDOCEAN RIDGE; UPPER-MANTLE; LOIHI SEAMOUNT; EARTHS MANTLE; POPPING ROCK; NOBLE-GASES; BASALTS; GEOCHEMISTRY; CONSTRAINTS	Radioactive decay of uranium and thorium produces He-4, whereas He-3 in the Earth's mantle is not produced by radioactive decay and was only incorporated during accretion-that is, it is primordial(1). He-3/He-4 ratios in many ocean-island basalts (OIBs) that erupt at hotspot volcanoes, such as Hawaii and Iceland, can be up to sixfold higher than in mid-ocean ridge basalts (MORBs). This is inferred to be the result of outgassing by melt production at mid-ocean ridges in conjunction with radiogenic ingrowth of He-4, which has led to a volatile-depleted upper mantle (MORB source) with low He-3 concentrations and low He-3/He-4 ratios(2-6). Consequently, high He-3/He-4 ratios in OIBs are conventionally viewed as evidence for an undegassed, primitive mantle source, which is sampled by hot, buoyantly upwelling deep-mantle plumes(3,6,7). However, this conventional model provides no viable explanation of why helium concentrations and elemental ratios of He/Ne and He/Ar in OIBs are an order of magnitude lower than in MORBs. This has been described as the 'helium concentration paradox'(8) and has contributed to a long-standing controversy about the structure and dynamics of the Earth's mantle. Here we show that the helium concentration paradox, as well as the full range of noble-gas concentrations observed in MORB and OIB glasses, can self-consistently be explained by disequilibrium open-system degassing of the erupting magma. We show that a higher CO2 content in OIBs than in MORBs leads to more extensive degassing of helium in OIB magmas and that noble gases in OIB lavas can be derived from a largely undegassed primitive mantle source.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Gonnermann, HM (corresponding author), Univ Hawaii, SOEST, Dept Geol & Geophys, Honolulu, HI 96822 USA.	helge@hawaii.edu	Gonnermann, Helge M/B-1054-2012					ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; Anderson DL, 1998, P NATL ACAD SCI USA, V95, P9087, DOI 10.1073/pnas.95.16.9087; Anderson DL, 1998, P NATL ACAD SCI USA, V95, P4822, DOI 10.1073/pnas.95.9.4822; Aubaud C, 2004, EARTH PLANET SC LETT, V222, P391, DOI 10.1016/j.epsl.2004.03.001; Ballentine CJ, 2002, PHILOS T ROY SOC A, V360, P2611, DOI 10.1098/rsta.2002.1083; BURNARD P, 2003, GEOCHEM GEOPHYS GEOS, V4; CARROLL MR, 1993, GEOCHIM COSMOCHIM AC, V57, P5039, DOI 10.1016/0016-7037(93)90606-W; Dixon JE, 1997, AM MINERAL, V82, P368; Dixon JE, 2001, J PETROL, V42, P627, DOI 10.1093/petrology/42.3.627; FISHER DE, 1985, NATURE, V316, P716, DOI 10.1038/316716a0; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; HART R, 1979, NATURE, V278, P156, DOI 10.1038/278156a0; Head JW, 1996, J GEOPHYS RES-SOL EA, V101, P28265, DOI 10.1029/96JB02275; Helffrich GR, 2001, NATURE, V412, P501, DOI 10.1038/35087500; Hilton DR, 2000, EARTH PLANET SC LETT, V183, P43, DOI 10.1016/S0012-821X(00)00253-3; Hilton DR, 1998, NATURE, V396, P359, DOI 10.1038/24603; Holloway JR, 1998, CHEM GEOL, V147, P89, DOI 10.1016/S0009-2541(97)00174-5; Honda M, 1999, GEOCHIM COSMOCHIM AC, V63, P2863, DOI 10.1016/S0016-7037(99)00206-9; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; Honda M, 1998, GEOPHYS RES LETT, V25, P1951, DOI 10.1029/98GL01329; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; KELLOGG LH, 1990, EARTH PLANET SC LETT, V99, P276, DOI 10.1016/0012-821X(90)90116-F; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Lensky NG, 2004, J VOLCANOL GEOTH RES, V129, P7, DOI 10.1016/S0377-0273(03)00229-4; Moreira M, 1998, SCIENCE, V279, P1178, DOI 10.1126/science.279.5354.1178; Moreira M, 2000, EARTH PLANET SC LETT, V176, P375, DOI 10.1016/S0012-821X(00)00010-8; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; ONIONS RK, 1983, NATURE, V306, P429, DOI 10.1038/306429a0; Paonita A, 2007, GEOCHIM COSMOCHIM AC, V71, P1747, DOI 10.1016/j.gca.2006.12.019; Porcelli D, 2002, REV MINERAL GEOCHEM, V47, P411, DOI 10.2138/rmg.2002.47.11; Resing JA, 2004, EARTH PLANET SC LETT, V226, P449, DOI 10.1016/j.epsl.2004.07.028; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; SARDA P, 1990, EARTH PLANET SC LETT, V97, P268, DOI 10.1016/0012-821X(90)90047-2	33	76	76	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1037	1040		10.1038/nature06240	http://dx.doi.org/10.1038/nature06240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960241				2022-12-28	WOS:000250395000049
J	Pronyk, PM; Hargreaves, JR; Morduch, J				Pronyk, Paul M.; Hargreaves, James R.; Morduch, Jonathan			Microfinance programs and better health - Prospects for sub-Saharan Africa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RURAL BANGLADESH; CREDIT PROGRAMS; EMPOWERMENT; POVERTY		Univ Witwatersrand, Sch Publ Hlth, Rural AIDS & Dev Act Res Programme, ZA-1360 Acomhoek, South Africa; London Sch Hyg & Trop Med, London WC1, England; NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10003 USA	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; New York University	Pronyk, PM (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Rural AIDS & Dev Act Res Programme, POB 2, ZA-1360 Acomhoek, South Africa.	pronyk@agincourt.co.za		Hargreaves, James/0000-0002-3509-3572	ESRC [ES/E003818/1] Funding Source: UKRI; Economic and Social Research Council [ES/E003818/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Armendaritz de Aghion B, 2005, EC MICROFINANCE; BANJEREE A, 2005, HDB EC GROWTH A, V1; Barnes C., 2001, IMPACT 3 MICROFINANC; CHESTON S, 2002, PATHWAYS OUT POVERTY, P167; Daley-Harris S, 2006, STATE MICROCREDIT SU; DUNFORD C, 2002, PATHWAYS OUT POVERTY, P75; ENGELS F, 1848, CONDITIONS WORKING C; GOLDBERG N, 2005, GRAMEEN FDN US PUBLI; Kabeer N, 2001, WORLD DEV, V29, P63, DOI 10.1016/S0305-750X(00)00081-4; Khandker, 1998, FIGHTING POVERTY MIC; Khandker SR, 2005, WORLD BANK ECON REV, V19, P263, DOI 10.1093/wber/lhi008; KIM JC, AM J PUBLIC HLTH; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; McKenzie DJ, 2006, ECON DEV CULT CHANGE, V55, P3, DOI 10.1086/505725; OTERO M, MICROFINANCE NEXT DE; Pitt MM, 2003, INT ECON REV, V44, P87, DOI 10.1111/1468-2354.t01-1-00063; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Sachs JD, 2005, END POVERTY; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P65, DOI 10.2307/2138085; SIMANOWITZ A, 2002, PATHWAYS OUT POVERTY, P1; UNICEF, 2003, STAT WORLDS CHILDR 2; United Nations, MILL DEV GOALS REP; Walt G, 2001, POVERTY INEQUITY HLT; World Bank, 2007, GLOB MON REP 2007; Wright GAN, 2000, MICROFINANCE SYSTEMS	25	42	42	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1925	1927		10.1001/jama.298.16.1925	http://dx.doi.org/10.1001/jama.298.16.1925			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954543				2022-12-28	WOS:000250356700024
J	Brissett, NC; Pitcher, RS; Juarez, R; Picher, AJ; Green, AJ; Dafforn, TR; Fox, GC; Blanco, L; Doherty, AJ				Brissett, Nigel C.; Pitcher, Robert S.; Juarez, Raquel; Picher, Angel J.; Green, Andrew J.; Dafforn, Timothy R.; Fox, Gavin C.; Blanco, Luis; Doherty, Aidan J.			Structure of a NHEJ polymerase-mediated DNA synaptic complex	SCIENCE			English	Article							LIGASE-D; BACTERIAL-DNA; COMPONENT; MYCOBACTERIA; PROTEINS; INSIGHTS; PRIMASE; KU	Nonhomologous end joining (NHEJ) is a critical DNA double-strand break (DSB) repair pathway required to maintain genome stability. Many prokaryotes possess a minimalist NHEJ apparatus required to repair DSBs during stationary phase, composed of two conserved core proteins, Ku and ligase D (LigD). The crystal structure of Mycobacterium tuberculosis polymerase domain of LigD mediating the synapsis of two noncomplementary DNA ends revealed a variety of interactions, including microhomology base pairing, mismatched and flipped-out bases, and 3' termini forming hairpin-like ends. Biochemical and biophysical studies confirmed that polymerase-induced end synapsis also occurs in solution. We propose that this DNA synaptic structure reflects an intermediate bridging stage of the NHEJ process, before end processing and ligation, with both the polymerase and the DNA sequence playing pivotal roles in determining the sequential order of synapsis and remodeling before end joining.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; Univ Birmingham, Dept Biosci, Birmingham B15 2TT, W Midlands, England; European Synchrotron Radiat Facil, Grenoble 9, France	University of Sussex; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Birmingham; European Synchrotron Radiation Facility (ESRF)	Blanco, L (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	lblanco@cbm.uam.es; ajd21@sussex.ac.uk	Blanco, Luis/I-1848-2015; Dafforn, Tim/A-9072-2015	Doherty, Aidan/0000-0002-6370-1109; Dafforn, Tim/0000-0003-2257-6679; Brissett, Nigel/0000-0003-3645-6408; Green, Andrew/0000-0002-1077-7417	Biotechnology and Biological Sciences Research Council [BB/D522746/1] Funding Source: Medline; Medical Research Council [G120/738] Funding Source: Medline; MRC [G120/738] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Garcia-Diaz M, 2006, CELL, V124, P331, DOI [10.1016/j.cell.2005.10.039, 10.1016/j.cel.2005.10.039]; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Juarez R, 2006, NUCLEIC ACIDS RES, V34, P4572, DOI 10.1093/nar/gkl457; Krejci L, 2003, PROG NUCLEIC ACID RE, V74, P159, DOI 10.1016/S0079-6603(03)01013-4; Lao-Sirieix SH, 2005, TRENDS GENET, V21, P568, DOI 10.1016/j.tig.2005.07.010; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Pitcher RS, 2006, MOL CELL, V23, P743, DOI 10.1016/j.molcel.2006.07.009; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Pitcher RS, 2005, CELL CYCLE, V4, P675, DOI 10.4161/cc.4.5.1676; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Yakovleva L, 2006, J BIOL CHEM, V281, P25026, DOI 10.1074/jbc.M603302200; Zhu H, 2006, P NATL ACAD SCI USA, V103, P1711, DOI 10.1073/pnas.0509083103; Zhu H, 2006, J BIOL CHEM, V281, P13873, DOI 10.1074/jbc.M600055200	20	64	68	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					456	459		10.1126/science.1145112	http://dx.doi.org/10.1126/science.1145112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947582				2022-12-28	WOS:000250230400049
J	Chang, BS; Chen, Y; Zhao, YM; Bruick, RK				Chang, Bingsheng; Chen, Yue; Zhao, Yingming; Bruick, Richard K.			JMJD6 is a histone arginine demethylase	SCIENCE			English	Article							HYPOXIA-INDUCIBLE FACTOR; DOMAIN-CONTAINING PROTEINS; PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; METHYLATION; FAMILY; HYDROXYLASE; CLEARANCE; ENGULFMENT	Arginine methylation occurs on a number of proteins involved in a variety of cellular functions. Histone tails are known to be mono- and dimethylated on multiple arginine residues where they influence chromatin remodeling and gene expression. To date, no enzyme has been shown to reverse these regulatory modifications. We demonstrate that the Jumonji domain-containing 6 protein (JMJD6) is a JmjC-containing iron- and 2-oxoglutarate-dependent dioxygenase that demethylates histone H3 at arginine 2 (H3R2) and histone H4 at arginine 3 (H4R3) in both biochemical and cell-based assays. These findings may help explain the many developmental defects observed in the JMJD6(-/-) knockout mice.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu	Hu, Ruogu/B-2203-2008		NATIONAL CANCER INSTITUTE [R21CA107943, R33CA107943, R01CA115962] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NCI NIH HHS [CA107943, CA115962] Funding Source: Medline; NCRR NIH HHS [C06-RR15437-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802	28	473	493	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					444	447		10.1126/science.1145801	http://dx.doi.org/10.1126/science.1145801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947579				2022-12-28	WOS:000250230400045
J	Kaiser, CR				Kaiser, Christian R.			Simmering, not boiling	SCIENCE			English	Editorial Material							COOLING FLOWS; CLUSTERS		Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England	University of Southampton	Kaiser, CR (corresponding author), Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England.	crk@soton.ac.uk						Birzan L, 2004, ASTROPHYS J, V607, P800, DOI 10.1086/383519; Bruggen M, 2002, NATURE, V418, P301, DOI 10.1038/nature00857; Churazov E, 2001, ASTROPHYS J, V554, P261, DOI 10.1086/321357; Donahue M, 2006, ASTROPHYS J, V643, P730, DOI 10.1086/503270; FABIAN AC, 1994, ANNU REV ASTRON ASTR, V32, P277, DOI 10.1146/annurev.aa.32.090194.001425; Hatch NA, 2007, MON NOT R ASTRON SOC, V380, P33, DOI 10.1111/j.1365-2966.2007.12009.x; Heinz S, 2006, MON NOT R ASTRON SOC, V373, pL65, DOI 10.1111/j.1745-3933.2006.00243.x; Kaiser CR, 2003, MON NOT R ASTRON SOC, V338, P837, DOI 10.1046/j.1365-8711.2003.06131.x; MCNAMARA BR, 1989, ASTRON J, V98, P2018, DOI 10.1086/115275; Peterson JR, 2001, ASTRON ASTROPHYS, V365, pL104, DOI 10.1051/0004-6361:20000021; Sanders JS, 2006, MON NOT R ASTRON SOC, V371, P1483, DOI 10.1111/j.1365-2966.2006.10779.x; Wu KKS, 2000, MON NOT R ASTRON SOC, V318, P889, DOI 10.1046/j.1365-8711.2000.03828.x	13	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					404	405		10.1126/science.1148788	http://dx.doi.org/10.1126/science.1148788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947571				2022-12-28	WOS:000250230400032
J	Marande, W; Burger, G				Marande, William; Burger, Gertraud			Mitochondrial DNA as a genomic jigsaw puzzle	SCIENCE			English	Article							RNA; PROTISTS		Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada	Universite de Montreal	Burger, G (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada.	Gertraud.Burger@UMontreal.ca						BONEN L, 1993, FASEB J, V7, P40, DOI 10.1096/fasebj.7.1.8422973; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Simpson AGB, 2004, MOL PHYLOGENET EVOL, V30, P201, DOI 10.1016/S1055-7903(03)00177-5; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006	6	98	102	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					415	415		10.1126/science.1148033	http://dx.doi.org/10.1126/science.1148033			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947575				2022-12-28	WOS:000250230400036
J	Kumar, P; Yuan, XH; Kumar, MR; Kind, R; Li, XQ; Chadha, RK				Kumar, Prakash; Yuan, Xiaohui; Kumar, M. Ravi; Kind, Rainer; Li, Xueqing; Chadha, R. K.			The rapid drift of the Indian tectonic plate	NATURE			English	Article							LITHOSPHERE-ASTHENOSPHERE BOUNDARY; UPPER-MANTLE; PALEOMAGNETIC CONSTRAINTS; RECEIVER FUNCTIONS; BENEATH; ANTARCTICA; AUSTRALIA; CRATONS; BREAKUP; AFRICA	The breakup of the supercontinent Gondwanaland into Africa, Antarctica, Australia and India about 140 million years ago, and consequently the opening of the Indian Ocean, is thought to have been caused by heating of the lithosphere from below by a large plume whose relicts are now the Marion, Kerguelen and Reunion plumes. Plate reconstructions based on palaeomagnetic data suggest that the Indian plate attained a very high speed (18-20 cm yr(-1) during the late Cretaceous period) subsequent to its breakup from Gondwanaland, and then slowed to similar to 5 cm yr(-1) after the continental collision with Asia similar to 50 Myr ago(1,2). The Australian and African plates moved comparatively less distance and at much lower speeds of 2-4 cm yr(-1) (refs 3-5). Antarctica remained almost stationary. This mobility makes India unique among the fragments of Gondwanaland. Here we propose that when the fragments of Gondwanaland were separated by the plume, the penetration of their lithospheric roots into the asthenosphere were important in determining their speed. We estimated the thickness of the lithospheric plates of the different fragments of Gondwanaland around the Indian Ocean by using the shear-wave receiver function technique. We found that the fragment of Gondwanaland with clearly the thinnest lithosphere is India. The lithospheric roots in South Africa, Australia and Antarctica are between 180 and 300 km deep, whereas the Indian lithosphere extends only about 100 km deep. We infer that the plume that partitioned Gondwanaland may have also melted the lower half of the Indian lithosphere, thus permitting faster motion due to ridge push or slab pull.	Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Natl Geophys Res Inst, Hyderabad 500007, Andhra Pradesh, India; Free Univ Berlin, D-12249 Berlin, Germany	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Geophysical Research Institute (NGRI); Free University of Berlin	Kind, R (corresponding author), Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany.	kind@gfz-potsdam.de	Yuan, Xiaohui/G-5149-2010	Yuan, Xiaohui/0000-0002-2891-1354				ANDERSON DL, 1995, REV GEOPHYS, V33, P125, DOI 10.1029/94RG02785; Angus DA, 2006, GEOPHYS J INT, V166, P1335, DOI 10.1111/j.1365-246X.2006.03070.x; Artemieva IM, 2006, TECTONOPHYSICS, V416, P245, DOI 10.1016/j.tecto.2005.11.022; Barrell J, 1914, J GEOL, V22, P655, DOI 10.1086/622181; CANDE SC, 1982, EARTH PLANET SC LETT, V58, P151, DOI 10.1016/0012-821X(82)90190-X; Coffin MF, 2002, J PETROL, V43, P1121, DOI 10.1093/petrology/43.7.1121; Frederiksen AW, 2000, GEOPHYS J INT, V141, P401, DOI 10.1046/j.1365-246x.2000.00090.x; Gaherty JB, 1999, PHYS EARTH PLANET IN, V110, P21, DOI 10.1016/S0031-9201(98)00132-0; Gaina C, 2007, GEOPHYS J INT, V170, P151, DOI 10.1111/j.1365-246X.2007.03450.x; GURNIS M, 1994, GEOLOGY, V22, P1023, DOI 10.1130/0091-7613(1994)022<1023:RDOLCD>2.3.CO;2; Gutenberg B, 1959, PHYS EARTHS INTERIOR; Ingle S, 2004, CHEM GEOL, V209, P83, DOI 10.1016/j.chemgeo.2004.04.023; JACOBY WR, 1985, LANDOLTBORNSTEIN N B, V2, P298; James DE, 2001, GEOPHYS RES LETT, V28, P2485, DOI 10.1029/2000GL012578; Jordan W P Jr, 1975, Contact Dermatitis, V1, P13, DOI 10.1111/j.1600-0536.1975.tb05304.x; JURDY DM, 1984, J GEOPHYS RES, V89, P9927, DOI 10.1029/JB089iB12p09927; KLOOTWIJK CT, 1992, GEOLOGY, V20, P395, DOI 10.1130/0091-7613(1992)020<0395:AEIACP>2.3.CO;2; KUMAR A, 1993, PRECAMBRIAN RES, V62, P227, DOI 10.1016/0301-9268(93)90023-U; Kumar P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022291; Kumar P, 2005, EARTH PLANET SC LETT, V236, P249, DOI 10.1016/j.epsl.2005.05.029; Kumar P, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003930; Landes M, 2007, EARTH PLANET SC LETT, V255, P32, DOI 10.1016/j.epsl.2006.12.003; Li X, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015411; Li XQ, 2004, NATURE, V427, P827, DOI 10.1038/nature02349; Li XQ, 2007, GEOPHYS J INT, V170, P700, DOI [10.1111/j.1365-246X.2007.03428.x, 10.1111/J.1365-246X.2007.03428.x]; Mezger K, 1999, PRECAMBRIAN RES, V94, P251, DOI 10.1016/S0301-9268(98)00118-1; Mitra S, 2006, B SEISMOL SOC AM, V96, P1551, DOI 10.1785/0120050116; Pandey OP, 1999, J GEOL, V107, P683, DOI 10.1086/314373; POLET J, 1995, GEOLOGY, V23, P205, DOI 10.1130/0091-7613(1995)023<0205:DEOCAI>2.3.CO;2; Priestley K, 2006, EARTH PLANET SC LETT, V244, P285, DOI 10.1016/j.epsl.2006.01.008; Ritsema J, 1998, J GEOPHYS RES-SOL EA, V103, P21201, DOI 10.1029/98JB01274; Sodoudi F, 2006, GEOPHYS J INT, V166, P1363, DOI 10.1111/j.1365-246X.2006.03080.x; VEEVERS JJ, 1986, EARTH PLANET SC LETT, V77, P91, DOI 10.1016/0012-821X(86)90135-4	33	316	333	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					894	897		10.1038/nature06214	http://dx.doi.org/10.1038/nature06214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943128	Green Submitted			2022-12-28	WOS:000250230600044
J	Pedersen, IM; Cheng, G; Wieland, S; Volinia, S; Croce, CM; Chisari, FV; David, M				Pedersen, Irene M.; Cheng, Guofeng; Wieland, Stefan; Volinia, Stefano; Croce, Carlo M.; Chisari, Francis V.; David, Michael			Interferon modulation of cellular microRNAs as an antiviral mechanism	NATURE			English	Article							HEPATITIS-C VIRUS; GENOTYPE 2A; REPLICATION; INFECTION; GENES; CELLS	RNA interference through non-coding microRNAs (miRNAs) represents a vital component of the innate antiviral immune response in plants and invertebrate animals; however, a role for cellular miRNAs in the defence against viral infection in mammalian organisms has thus far remained elusive(1). Here we show that interferon beta (IFN beta) rapidly modulates the expression of numerous cellular miRNAs, and that eight of these IFN beta-induced miRNAs have sequence-predicted targets within the hepatitis C virus (HCV) genomic RNA. The introduction of synthetic miRNA-mimics corresponding to these IFN beta-induced miRNAs reproduces the antiviral effects of IFN beta on HCV replication and infection, whereas neutralization of these antiviral miRNAs with anti-miRNAs reduces the antiviral effects of IFN beta against HCV. In addition, we demonstrate that IFN beta treatment leads to a significant reduction in the expression of the liver-specific miR-122, an miRNA that has been previously shown to be essential for HCV replication(2). Therefore, our findings strongly support the notion that mammalian organisms too, through the interferon system, use cellular miRNAs to combat viral infections.	Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; Scripps Res Inst, Div Expt Pathol, La Jolla, CA 92037 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University System of Ohio; Ohio State University	David, M (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	midavid@ucsd.edu	Volinia, Stefano/AAA-9264-2019; Chisari, Francis V/A-3086-2008; Young, Richard A/F-6495-2012; Volinia, Stefano/A-3029-2010	Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Chisari, Francis/0000-0002-4832-1044	NIDDK NIH HHS [R01 DK078857, R01 DK078857-02, R01 DK078857-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078857] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; LARNER AC, 1984, P NATL ACAD SCI-BIOL, V81, P6733, DOI 10.1073/pnas.81.21.6733; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889; Zamore PD, 2004, CURR BIOL, V14, pR198, DOI 10.1016/j.cub.2004.02.021; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	26	712	805	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					919	U13		10.1038/nature06205	http://dx.doi.org/10.1038/nature06205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943132	Green Accepted			2022-12-28	WOS:000250230600050
J	Chowdhury, AMR				Chowdhury, A. Mushtaque R.			Rethinking interventions for women's health	LANCET			English	Editorial Material							BANGLADESH		BRAC Univ, James P Grant Sch Publ Hlth, Dhaka 1212, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC University	Chowdhury, AMR (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka 1212, Bangladesh.	Mushtaque.arc@brac.net						Bhuiya A, 2002, SOC SCI MED, V55, P1553, DOI 10.1016/S0277-9536(01)00287-8; BHUIYA A, 2001, CHALLENGING INEQUITI, P227; Chowdhury A.M.R., 2003, INT REV EDUC, V49, P601, DOI DOI 10.1023/B:REVI.0000006929.59667.16; Chowdhury AMR, 2004, J INT DEV, V16, P369, DOI DOI 10.1002/JID.1083; CHOWDHURY AMR, 2007, TACKLING SOCIAL DETE, P1; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; *GOV BANGL, 2004, UNL POT NAT STRAT AC; Pitchforth E, 2006, QUAL SAF HEALTH CARE, V15, P214, DOI 10.1136/qshc.2005.017285; STANDING H, IN PRESS SOC SCI MED	9	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1292	1293		10.1016/S0140-6736(07)61554-2	http://dx.doi.org/10.1016/S0140-6736(07)61554-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933634				2022-12-28	WOS:000250176600009
J	Obaid, TA				Obaid, Thoraya Ahmed			No woman should die giving life	LANCET			English	Editorial Material									UN Populat Fund, New York, NY 10017 USA	United Nations Population Fund	Obaid, TA (corresponding author), UN Populat Fund, New York, NY 10017 USA.	obaid@unfpa.org						BERNSTEIN S, PUBLIC DECISIONS PRI; *UN SECR, 2007, REP SECR GEN WORK OR; *WHO UNICEF UNFPA, 2007, MAT MORT 2005 EST DE; 1994, INT C POP DEV IPCD C	4	17	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2007	370	9595					1287	1288		10.1016/S0140-6736(07)61550-5	http://dx.doi.org/10.1016/S0140-6736(07)61550-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220SC	17933630				2022-12-28	WOS:000250176600005
J	Showalter, MR; Cheng, AF; Weaver, HA; Stern, SA; Spencer, JR; Throop, HB; Birath, EM; Rose, D; Moore, JM				Showalter, Mark R.; Cheng, Andrew F.; Weaver, Harold A.; Stern, S. Alan; Spencer, John R.; Throop, Henry B.; Birath, Emma M.; Rose, Debi; Moore, Jeffrey M.			Clump detections and limits on moons in Jupiter's ring system	SCIENCE			English	Article							CASSINI; GALILEO; SATELLITES; ACCRETION; ORBITS	The dusty jovian ring system must be replenished continuously from embedded source bodies. The New Horizons spacecraft has performed a comprehensive search for kilometer-sized moons within the system, which might have revealed the larger members of this population. No new moons were found, however, indicating a sharp cutoff in the population of jovian bodies smaller than 8-kilometer-radius Adrastea. However, the search revealed two families of clumps in the main ring: one close pair and one cluster of three to five. All orbit within a brighter ringlet just interior to Adrastea. Their properties are very different from those of the few other clumpy rings known; the origin and nonrandom distribution of these features remain unexplained, but resonant confinement by Metis may play a role.	Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; NASA Headquarters, Washington, DC 20546 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; SW Res Inst, Boulder, CO 80302 USA; Synthsys D, Superior, CO 80027 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Showalter, MR (corresponding author), Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA.	mshowalter@seti.org	Weaver, Harold A/D-9188-2016	Weaver, Harold A/0000-0003-0951-7762				Barbara JM, 2002, ICARUS, V160, P161, DOI 10.1006/icar.2002.6962; Brooks SM, 2004, ICARUS, V170, P35, DOI 10.1016/j.icarus.2004.03.003; Burns J.A., 1984, IAU COLLO Q 75 PLANE, P200; Burns JA, 2004, CAMB PLANET, P241; BURNS JA, 1980, ICARUS, V44, P339, DOI 10.1016/0019-1035(80)90029-9; CANUP RM, 1995, ICARUS, V113, P331, DOI 10.1006/icar.1995.1026; Charnoz S, 2005, SCIENCE, V310, P1300, DOI 10.1126/science.1119387; de Pater I, 1999, ICARUS, V138, P214, DOI 10.1006/icar.1998.6068; de Pater I, 2007, SCIENCE, V317, P1888, DOI 10.1126/science.1148103; Hedman MM, 2007, ICARUS, V188, P89, DOI 10.1016/j.icarus.2006.11.017; Namouni F, 2002, NATURE, V417, P45, DOI 10.1038/417045a; Ockert-Bell ME, 1999, ICARUS, V138, P188, DOI 10.1006/icar.1998.6072; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; PORCO CC, 1990, B AM ASTRON SOC, V1043; PORCO CC, 2007, 8857 INT ASTR UN; PORCO CC, 2005, 8242 INT ASTR UN; Showalter MR, 2004, ICARUS, V171, P356, DOI 10.1016/j.icarus.2004.05.006; Showalter MR, 1998, SCIENCE, V282, P1099, DOI 10.1126/science.282.5391.1099; SHOWALTER MR, 1987, ICARUS, V69, P458, DOI 10.1016/0019-1035(87)90018-2; SHOWALTER MR, 2003, B AM ASTRON SOC, V35; Spitale JN, 2006, ASTRON J, V132, P692, DOI 10.1086/505206; Throop HB, 2004, ICARUS, V172, P59, DOI 10.1016/j.icarus.2003.12.020	22	19	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					232	234		10.1126/science.1147647	http://dx.doi.org/10.1126/science.1147647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932287				2022-12-28	WOS:000250086100035
J	Landon, BE; Schneider, EC; Normand, SLT; Scholle, SH; Pawlson, LG; Epstein, AM				Landon, Bruce E.; Schneider, Eric C.; Normand, Sharon-Lise T.; Scholle, Sarah Hudson; Pawlson, L. Gregory; Epstein, Arnold M.			Quality of care in Medicaid managed care and commercial health plans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE	Context In contrast to the commercially insured population, the proportion of Medicaid beneficiaries enrolling in health maintenance organizations continues to increase. Objective To compare quality of care within and between the Medicaid and commercial populations in 3 types of managed care plans: Medicaid-only plans (serving predominantly Medicaid enrollees), commercial-only plans (serving predominantly commercial enrollees), and Medicaid/commercial plans (serving substantial numbers of both types of enrollees). Design, Setting, and Participants All 383 health plans that reported quality-of-care data to the National Committee for Quality Assurance for 2002 and 2003, including 204 commercial-only plans, 142 Medicaid/commercial plans (plans reported data for the Medicaid and commercial populations separately); and 37 Medicaid-only plans. Main Outcome Measures Eleven quality indicators from the Healthcare Effectiveness Data and Information Set (HEDIS) applicable to the Medicaid population. Results Among Medicaid enrollees, performance on the 11 measures observed in this study were comparable for Medicaid-only plans and Medicaid/commercial plans. Similarly, among commercial enrollees, there was virtually no difference in performance between health plans that served only the commercial population and those that also served the Medicaid population. Overall across all health plan types, the performance for the commercial population exceeded the performance for the Medicaid population on all measures except 1, ranging from a difference of 4.9% for controlling hypertension (58.4% for commercial vs 53.5% for Medicaid; P=.002) to 24.5% for rates of appropriate postpartum care (77.2% for commercial vs 52.7% for Medicaid; P=.001). Differences of similar magnitude were observed for commercial and Medicaid populations treated within the same health plan. Conclusions Medicaid managed care enrollees receive lower-quality care than that received by commercial managed care enrollees. There were no differences in quality of care for the Medicaid population between Medicaid-only plans and commercial plans that also served the Medicaid population.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Gen Med, Sect Hlth Serv & Policy Res, Boston, MA 02115 USA; Natl Comm Qual Assurance, Washington, DC USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	Landon@hcp.med.harvard.edu		Normand, Sharon-Lise/0000-0001-7027-4769; Schneider, Eric/0000-0002-1132-5084				*AG HEALTHC RES QU, AHRQ NAT HEALTHC DIS; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; *CDCP, WHAT COMPL CAN RES U; Chernew ME, 2004, HEALTH AFFAIR, V23, P91, DOI 10.1377/hlthaff.23.2.91; *CTR DIS CONTR PRE, 1997, MMWR-MORBID MORTAL W, V46, P193; *CTR MED MED SERV, MED MAN CAR OV; Epstein AM, 1997, JAMA-J AM MED ASSOC, V278, P1617, DOI 10.1001/jama.278.19.1617; *KAIS FAM FDN, TRENDS IND CHANG HLT; Landon BE, 1998, JAMA-J AM MED ASSOC, V279, P211, DOI 10.1001/jama.279.3.211; Landon BE, 2004, HEALTH AFFAIR, V23, P245, DOI 10.1377/hlthaff.23.4.245; Landon BE, 2004, JAMA-J AM MED ASSOC, V291, P1744, DOI 10.1001/jama.291.14.1744; Landon BE, 1999, JAMA-J AM MED ASSOC, V282, P1769, DOI 10.1001/jama.282.18.1769; Landon Bruce E, 2002, Jt Comm J Qual Improv, V28, P72; McCormick D, 2002, JAMA-J AM MED ASSOC, V288, P1484, DOI 10.1001/jama.288.12.1484; Miller RH, 1997, HEALTH AFFAIR, V16, P7, DOI 10.1377/hlthaff.16.5.7; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; *NAT COMM QUAL ASS, HEDIS 2003; National Committee for Quality Assurance, STAT HLTH CAR QUAL 2; Scanlon DP, 2006, MED CARE RES REV, V63, p56S, DOI 10.1177/1077558706293835; Scanlon DP, 2006, MED CARE RES REV, V63, p37S, DOI 10.1177/1077558706293834; Scanlon DP, 2005, MED CARE, V43, P338, DOI 10.1097/01.mlr.0000156863.61808.cb; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Thomas CP, 2003, J SUBST ABUSE TREAT, V24, P1, DOI 10.1016/S0740-5472(02)00319-7; Thompson JW, 2003, JAMA-J AM MED ASSOC, V290, P1486, DOI 10.1001/jama.290.11.1486; Zaslavsky AM, 2005, INT J QUAL HEALTH C, V17, P67, DOI 10.1093/intqhc/mzi005; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002; 2004, COMPETITIVE EDGE HMO	27	46	46	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1674	1681		10.1001/jama.298.14.1674	http://dx.doi.org/10.1001/jama.298.14.1674			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	218IO	17925519	Bronze			2022-12-28	WOS:000250009400023
J	Richards, T				Richards, Tessa			Border crossing - An age old problem	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 6	2007	335	7622					698	698		10.1136/bmj.39356.408102.59	http://dx.doi.org/10.1136/bmj.39356.408102.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916853	Green Published			2022-12-28	WOS:000250156800029
J	Araki, H; Cooper, B; Blouin, MS				Araki, Hitoshi; Cooper, Becky; Blouin, Michael S.			Genetic effects of captive breeding cause a rapid, cumulative fitness decline in the wild	SCIENCE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; REPRODUCTIVE SUCCESS; STEELHEAD TROUT; HATCHERY; DOMESTICATION; POPULATION; PROGRAMS; SIZE	Captive breeding is used to supplement populations of many species that are declining in the wild. The suitability of and long-term species survival from such programs remain largely untested, however. We measured lifetime reproductive success of the first two generations of steelhead trout that were reared in captivity and bred in the wild after they were released. By reconstructing a three-generation pedigree with microsatellite markers, we show that genetic effects of domestication reduce subsequent reproductive capabilities by similar to 40% per captive-reared generation when fish are moved to natural environments. These results suggest that even a few generations of domestication may have negative effects on natural reproduction in the wild and that the repeated use of captive-reared parents to supplement wild populations should be carefully reconsidered.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University	Araki, H (corresponding author), Oregon State Univ, Dept Zool, 3029 Cordley Hall, Corvallis, OR 97331 USA.	arakih@science.oregonstate.edu						Araki H, 2005, MOL ECOL, V14, P4097, DOI 10.1111/j.1365-294X.2005.02689.x; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; Augerot X, 2005, ATLAS PACIFIC SALMON; BEREJIKIAN B, 2004, NNMFSNWFSC61; Berejikian BA, 1997, ICES J MAR SCI, V54, P1040, DOI 10.1016/S1054-3139(97)80008-2; CUENCO ML, 1993, NATO ADV SCI INST SE, V248, P269; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fleming Ian A., 2001, Nordic Journal of Freshwater Research, V75, P71; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fritts AL, 2007, CAN J FISH AQUAT SCI, V64, P813, DOI 10.1139/F07-057; Goodman D, 2005, CAN J FISH AQUAT SCI, V62, P374, DOI 10.1139/F04-187; HEARD WR, 1995, 154 NMFS NOAA N PAC; Heath DD, 2003, SCIENCE, V299, P1738, DOI 10.1126/science.1079707; Hercus MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2105, DOI 10.1098/rspb.2000.1256; Kyneb A, 2006, ECOL ENTOMOL, V31, P322, DOI 10.1111/j.1365-2311.2006.00775.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; *NW FISH SCI CTR, 2004, M HELD AUG 20 SEPT 2; Olney PJS., 1994, CREATIVE CONSERVATIO; Pearsons TN, 2007, CAN J FISH AQUAT SCI, V64, P803, DOI 10.1139/F07-058; REISENBICHLER RR, 1977, J FISH RES BOARD CAN, V34, P123, DOI 10.1139/f77-015; REZNICK D, 1981, EVOLUTION, V35, P941, DOI [10.2307/2407865, 10.1111/j.1558-5646.1981.tb04960.x]; Williams R.N., 2006, RETURN RIVER RESTORI	24	616	646	5	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					100	103		10.1126/science.1145621	http://dx.doi.org/10.1126/science.1145621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916734				2022-12-28	WOS:000249915400050
J	Bignami, GF				Bignami, Giovanni F.			Sputnik and satellite astronomy	SCIENCE			English	Editorial Material									Univ Pavia, Ist Studi Super, I-27100 Pavia, Italy	University of Pavia	Bignami, GF (corresponding author), Univ Pavia, Ist Studi Super, Via Palestro 3, I-27100 Pavia, Italy.	gfb@lambrate.inaf.it		Bignami, Giovanni/0000-0001-9582-2450				[No title captured]	1	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					53	54		10.1126/science.1149322	http://dx.doi.org/10.1126/science.1149322			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916716				2022-12-28	WOS:000249915400030
J	Meister, G				Meister, Gunter			miRNAs get an early start on translational silencing	CELL			English	Review							PROTEIN-SYNTHESIS; HUMAN-CELLS; CAENORHABDITIS-ELEGANS; LET-7 MICRORNA; MESSENGER-RNAS; INITIATION; REPRESSION	MicroRNAs (miRNAs) control gene expression by regulating mRNA stability and translation. Using cell-free in vitro systems, several labs have recently reported insights into the molecular mechanisms underlying miRNA-guided translational repression (Kiriakidou et al., 2007; Mathonnet et al., 2007; Thermann and Hentze, 2007; Wakiyama et al., 2007). These new findings indicate that miRNAs inhibit translation at early steps of initiation.	Max Planck Inst Biochem, Lab RNA Biol, Munich Ctr Integrated Prot Sci, CiPSM, D-82152 Martinsried, Germany	Max Planck Society	Meister, G (corresponding author), Max Planck Inst Biochem, Lab RNA Biol, Munich Ctr Integrated Prot Sci, CiPSM, Am Klopferspitz 18, D-82152 Martinsried, Germany.	meister@biochem.mpg.de						Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; MATHONNET G, 2007, SCI             0726; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	21	173	184	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					25	28		10.1016/j.cell.2007.09.021	http://dx.doi.org/10.1016/j.cell.2007.09.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923084	Bronze			2022-12-28	WOS:000249934700007
J	Astafiev, O; Inomata, K; Niskanen, AO; Yamamoto, T; Pashkin, YA; Nakamura, Y; Tsai, JS				Astafiev, O.; Inomata, K.; Niskanen, A. O.; Yamamoto, T.; Pashkin, Yu. A.; Nakamura, Y.; Tsai, J. S.			Single artificial-atom lasing	NATURE			English	Article							CAVITY QUANTUM ELECTRODYNAMICS; JOSEPHSON; PHOTON; CIRCUIT; SYSTEM; STATES; LASER; DOT	Solid-state superconducting circuits(1-3) are versatile systems in which quantum states can be engineered and controlled. Recent progress in this area has opened up exciting possibilities for exploring fundamental physics as well as applications in quantum information technology; in a series of experiments(4-8) it was shown that such circuits can be exploited to generate quantum optical phenomena, by designing superconducting elements as artificial atoms that are coupled coherently to the photon field of a resonator. Here we demonstrate a lasing effect with a single artificial atom-a Josephson-junction charge qubit(9)-embedded in a superconducting resonator. We make use of one of the properties of solid-state artificial atoms, namely that they are strongly and controllably coupled to the resonator modes. The device is essentially different from existing lasers and masers; one and the same artificial atom excited by current injection produces many photons.	NEC Corp Ltd, Nano Elect Res Labs, Tsukuba, Ibaraki 3058501, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; CREST JST, Kawaguchi, Saitama 3320012, Japan; VTT, Tech Res Ctr Finland, Espoo 02044, Finland	NEC Corporation; RIKEN; Japan Science & Technology Agency (JST); VTT Technical Research Center Finland	Astafiev, O (corresponding author), NEC Corp Ltd, Nano Elect Res Labs, Tsukuba, Ibaraki 3058501, Japan.	astf@zb.jp.nec.com	Astafiev, Oleg/L-9771-2013; Pashkin, Yuri/M-8540-2015; Inomata, Kunihiro/L-3275-2018; Niskanen, Antti/A-5957-2013; Nakamura, Yasunobu/H-1300-2012; Tsai, Jaw-Shen/I-7813-2012	Pashkin, Yuri/0000-0003-4767-8217; Inomata, Kunihiro/0000-0002-1151-4512; Nakamura, Yasunobu/0000-0003-0424-630X; 				AVERIN DV, 1989, JETP LETT+, V50, P367; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; FULTON TA, 1989, PHYS REV LETT, V63, P1307, DOI 10.1103/PhysRevLett.63.1307; HAUSS J, 2007, SINGLE QUBIT LASING; HOUCK AA, 2007, GENERATING SINGLE MI; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; McKeever J, 2003, NATURE, V425, P268, DOI 10.1038/nature01974; MU Y, 1992, PHYS REV A, V46, P5944, DOI 10.1103/PhysRevA.46.5944; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; RICE PR, 1994, PHYS REV A, V50, P4318, DOI 10.1103/PhysRevA.50.4318; Rodrigues DA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.067204; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Siegman A. E., 1986, LASER; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walther H, 2006, REP PROG PHYS, V69, P1325, DOI 10.1088/0034-4885/69/5/R02; Wendin G., 2006, HDB THEORETICAL COMP, V3, P223; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; You JQ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104516	23	262	264	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					588	590		10.1038/nature06141	http://dx.doi.org/10.1038/nature06141			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914393	Green Submitted			2022-12-28	WOS:000249893500042
J	Karnoub, AE; Dash, AB; Vo, AP; Sullivan, A; Brooks, MW; Bell, GW; Richardson, AL; Polyak, K; Tubo, R; Weinberg, RA				Karnoub, Antoine E.; Dash, Ajeeta B.; Vo, Annie P.; Sullivan, Andrew; Brooks, Mary W.; Bell, George W.; Richardson, Andrea L.; Polyak, Kornelia; Tubo, Ross; Weinberg, Robert A.			Mesenchymal stem cells within tumour stroma promote breast cancer metastasis	NATURE			English	Article							EXPRESSION; PROGRESSION; CARCINOMA; DELIVERY; GROWTH; RANTES; MICROENVIRONMENT; CHEMOKINES; VEHICLES; REVEALS	Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Genzyme Corp, Framingham, MA 01701 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Sanofi-Aventis; Genzyme Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Thomson, Axel/A-7893-2013		NCI NIH HHS [R01 CA116235-01A1, R01 CA116235-03, P50 CA089393-070014, R01 CA116235, P50 CA089393, R01 CA116235-02, P50 CA089393-060014, P50 CA089393-080014] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089393, R01CA116235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Azenshtein E, 2002, CANCER RES, V62, P1093; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hall B., 2007, V180, P263; Hillyer P, 2005, IMMUNOL CELL BIOL, V83, P375, DOI 10.1111/j.1440-1711.2005.01345.x; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lodie TA, 2002, TISSUE ENG, V8, P739, DOI 10.1089/10763270260424105; Luboshits G, 1999, CANCER RES, V59, P4681; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; Mira E, 2001, EMBO REP, V2, P151, DOI 10.1093/embo-reports/kve027; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Palani A, 2006, J MED CHEM, V49, P2851, DOI 10.1021/jm060009x; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson SC, 2003, CANCER RES, V63, P8360; Studeny M, 2002, CANCER RES, V62, P3603; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Young HE, 2001, ANAT RECORD, V263, P350, DOI 10.1002/ar.1112; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128	36	2393	2536	9	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					557	U4		10.1038/nature06188	http://dx.doi.org/10.1038/nature06188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914389				2022-12-28	WOS:000249893500036
J	Ronco, G; Segnan, N				Ronco, Guglielmo; Segnan, Nereo			HPV testing for primary cervical cancer screening	LANCET			English	Editorial Material							LIQUID-BASED CYTOLOGY; HUMAN-PAPILLOMAVIRUS; WOMEN; RECRUITMENT		CPO Piemonte, Canc Epidemiol Unit, I-10123 Turin, Italy	Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte	Ronco, G (corresponding author), CPO Piemonte, Canc Epidemiol Unit, I-10123 Turin, Italy.	guglielmo.ronco@cpo.it		Segnan, Nereo/0000-0002-4730-5384				Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; IARC Working Group on the Evaluation of Cancer Preventive Strategies, 2005, IARC HDB CANC PREV; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kotaniemi-Talonen L, 2005, BRIT J CANCER, V93, P862, DOI 10.1038/sj.bjc.6602799; Mayrand MH, 2006, INT J CANCER, V119, P615, DOI 10.1002/ijc.21897; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7	13	25	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1740	1742		10.1016/S0140-6736(07)61480-9	http://dx.doi.org/10.1016/S0140-6736(07)61480-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	17919717				2022-12-28	WOS:000251140500005
J	Azzalin, CM; Reichenbach, P; Khoriauli, L; Giulotto, E; Lingner, J				Azzalin, Claus M.; Reichenbach, Patrick; Khoriauli, Lela; Giulotto, Elena; Lingner, Joachim			Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends	SCIENCE			English	Article							HUMAN-CELLS; PROTEIN; YEAST; DECAY; SENESCENCE; EXPRESSION; PATHWAYS; UPF1	Telomeres, the DNA-protein complexes located at the end of linear eukaryotic chromosomes, are essential for chromosome stability. Until now, telomeres have been considered to be transcriptionally silent. We demonstrate that mammalian telomeres are transcribed into telomeric repeat-containing RNA (TERRA). TERRA molecules are heterogeneous in length, are transcribed from several subtelomeric loci toward chromosome ends, and localize to telomeres. We also show that suppressors with morphogenetic defects in genitalia (SMG) proteins, which are effectors of nonsense-mediated messenger RNA decay, are enriched at telomeres in vivo, negatively regulate TERRA association with chromatin, and protect chromosome ends from telomere loss. Thus, telomeres are actively transcribed into TERRA, and SMG factors represent a molecular link between TERRA regulation and the maintenance of telomere integrity.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; Natl Ctr Competence Res, CH-1211 Geneva, Switzerland; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Pavia	Lingner, J (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	joachim.lingner@isrec.ch	azzalin, claus M/K-3898-2015	azzalin, claus M/0000-0002-9396-1980; GIULOTTO, ELENA/0000-0002-4705-2049; Lingner, Joachim/0000-0002-2853-5803				Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; REDON S, 2007, IN PRESS NUCL R 1016; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; SANDELL LL, 1994, P NATL ACAD SCI US, V91; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006	27	890	925	0	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					798	801		10.1126/science.1147182	http://dx.doi.org/10.1126/science.1147182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17916692				2022-12-28	WOS:000250583900041
J	Rothwell, PM; Giles, MF; Chandratheva, A; Marquardt, L; Geraghty, O; Redgrave, JNE; Lovelock, CE; Binney, LE; Bull, LM; Cthbertson, FC; Welch, SJV; Bosch, S; Carasco-Alexander, F; Silver, LE; Gutnikov, SA; Mehta, Z				Rothwell, Peter M.; Giles, Matthew F.; Chandratheva, Arvind; Marquardt, Lars; Geraghty, Olivia; Redgrave, Jessica N. E.; Lovelock, Caroline E.; Binney, Lucy E.; Bull, Linda M.; Cthbertson, Fiona C.; Welch, Sarah J. V.; Bosch, Shelley; Carasco-Alexander, Faye; Silver, Louise E.; Gutnikov, Sergei A.; Mehta, Ziyah		EXPRESS Study	Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison	LANCET			English	Article							SYMPTOMATIC CAROTID STENOSIS; RANDOMIZED CONTROLLED-TRIALS; ACUTE CORONARY SYNDROMES; SHORT-TERM PROGNOSIS; HIGH EARLY RISK; VASCULAR EVENTS; CASE-FATALITY; ABCD SCORE; ENDARTERECTOMY; INDIVIDUALS	Background The risk of recurrent stroke is up to 10% in the week after a transient ischaemic attack (TIA) or minor stroke. Modelling studies suggest that urgent use of existing preventive treatments could reduce the risk by 80-90%, but in the absence of evidence many health-care systems make little provision. Our aim was to determine the effect of more rapid treatment after TIA and minor stroke in patients who are not admitted direct to hospital. Methods We did a prospective before (phase 1: April 1, 2002, to Sept 30, 2004) versus after (phase 2: Oct 1, 2004, to March 31, 2007) study of the effect on process of care and outcome of more urgent assessment and immediate treatment in clinic, rather than subsequent initiation in primary care, in all patients with TIA or minor stroke not admitted direct to hospital. The study was nested within a rigorous population-based incidence study of all TIA and stroke (Oxford Vascular Study; OXVASC), such that case ascertainment, investigation, and follow-up were complete and identical in both periods. The primary outcome was the risk of stroke within 90 days of first seeking medical attention, with independent blinded (to study period) audit of all events. Findings Of the 1278 patients in OXVASC who presented with TIA or stroke (634 in phase 1 and 644 in phase 2), 607 were referred or presented direct to hospital, 620 were referred for outpatient assessment, and 51 were not referred to secondary care. 95% (n=591) of all outpatient referrals were to the study clinic. Baseline characteristics and delays in seeking medical attention were similar in both periods, but median delay to assessment in the study clinic fell from 3 (IQR 2-5) days in phase 1 to less than 1 (0-3) day in phase 2 (p<0.0001), and median delay to first prescription of treatment fell from 20 (8-53) days to 1 (0-3) day (p<0.0001). The 90-day risk of recurrent stroke in the patients referred to the study clinic was 10.3% (32/310 patients) in phase 1 and 2.1% (6/281 patients) in phase 2 (adjusted hazard ratio 0.20, 95% CI 0.08-0.49; p=0.0001); there was no significant change in risk in patients treated elsewhere. The reduction in risk was independent of age and sex, and early treatment did not increase the risk of intracerebral haemorrhage or other bleeding. Interpretation Early initiation of existing treatments after TIA or minor stroke was associated with an 80% reduction in the risk of early recurrent stroke. Further follow-up is required to determine long-term outcome, but these results have immediate implications for service provision and public education about TIA and minor stroke.	Radcliffe Infirm, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HA, England	Radcliffe Infirmary; University of Oxford	Rothwell, PM (corresponding author), Radcliffe Infirm, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Woodstock Rd, Oxford OX2 6HA, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	MRC [G0500987] Funding Source: UKRI; Medical Research Council [G0500987] Funding Source: Medline; The Dunhill Medical Trust [OSRP2/1006] Funding Source: Medline; Department of Health [RP-PG-0606-1146] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Dunhill Medical Trust(Dunhill Medical Trust); Department of Health		Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Correia M, 2006, STROKE, V37, P50, DOI 10.1161/01.STR.0000195209.26543.8f; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; Coull AJ, 2004, STROKE, V35, P1925, DOI 10.1161/01.STR.0000133129.58126.67; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Cucchiara BL, 2006, STROKE, V37, P1710, DOI 10.1161/01.STR.0000227195.46336.93; *CXAPRIE STEER COM, 1996, LANCET, V348, P1329; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Giles MF, 2006, STROKE, V37, P1254, DOI 10.1161/01.STR.0000217388.57851.62; GILES MF, 2007, AGE AGEING; Gladstone DJ, 2004, CAN MED ASSOC J, V170, P1099, DOI 10.1503/cmaj.1031349; GLASZIOU P, 2007, BMJ-BRIT MED J, V344, P349; Goldstein LB, 2000, ARCH INTERN MED, V160, P2941, DOI 10.1001/archinte.160.19.2941; Gubitz G, 1999, CEREBROVASC DIS, V9, P210, DOI 10.1159/000015957; Hackam DG, 2007, STROKE, V38, P1881, DOI 10.1161/STROKEAHA.106.475525; Halkes PHA, 2006, LANCET, V367, P1665; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; Johnston SC, 1999, EUR NEUROL, V42, P105, DOI 10.1159/000069419; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; LAVALLEE PC, 2007, CEREBROVASC DIS, V23, P16; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; LOVETT JK, 2002, CEREBROVASC DIS, V13, P45; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; Mouradian MS, 2002, STROKE, V33, P1656, DOI 10.1161/01.STR.0000017877.62543.14; National Audit Office, 2004, RED BRAIN DAM FAST A; Ovbiagele B, 2004, STROKE, V35, P2879, DOI 10.1161/01.STR.0000147967.49567.d6; Potts M, 2006, BMJ-BRIT MED J, V333, P701, DOI 10.1136/bmj.333.7570.701; Reimer WJMSO, 2006, STROKE, V37, P1844, DOI 10.1161/01.STR.0000226463.17988.a3; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2006, LANCET NEUROL, V5, P323, DOI 10.1016/S1474-4422(06)70408-2; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Rothwell PM, 2005, NEUROLOGY, V64, P817, DOI 10.1212/01.WNL.0000152985.32732.EE; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Rothwell PM, 2001, STROKE, V32, P328; *ROYAL COLL PHYS I, 2004, NAT CLIN GUID STROK, P134; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Sandercock P, 1997, LANCET, V349, P1569; Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.0000075777.18006.89; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Tsivgoulis G, 2006, STROKE, V37, P2892, DOI 10.1161/01.STR.0000249007.12256.4a; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Widjaja E, 2005, J NEUROL NEUROSUR PS, V76, P145, DOI 10.1136/jnnp.2004.042747; Yusuf S, 2001, NEW ENGL J MED, V345, P494	58	840	875	1	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1432	1442		10.1016/S0140-6736(07)61448-2	http://dx.doi.org/10.1016/S0140-6736(07)61448-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17928046				2022-12-28	WOS:000250386000020
J	Lieberman, E; Michel, JB; Jackson, J; Tang, T; Nowak, MA				Lieberman, Erez; Michel, Jean-Baptiste; Jackson, Joe; Tang, Tina; Nowak, Martin A.			Quantifying the evolutionary dynamics of language	NATURE			English	Article								Human language is based on grammatical rules(1-4). Cultural evolution allows these rules to change over time(5). Rules compete with each other: as new rules rise to prominence, old ones die away. To quantify the dynamics of language evolution, we studied the regularization of English verbs over the past 1,200 years. Although an elaborate system of productive conjugations existed in English's proto-Germanic ancestor, Modern English uses the dental suffix, '-ed', to signify past tense(6). Here we describe the emergence of this linguistic rule amidst the evolutionary decay of its exceptions, known to us as irregular verbs. We have generated a data set of verbs whose conjugations have been evolving for more than a millennium, tracking inflectional changes to 177 Old-English irregular verbs. Of these irregular verbs, 145 remained irregular in Middle English and 98 are still irregular today. We study how the rate of regularization depends on the frequency of word usage. The half-life of an irregular verb scales as the square root of its usage frequency: a verb that is 100 times less frequent regularizes 10 times as fast. Our study provides a quantitative analysis of the regularization process by which ancestral forms gradually yield to an emerging linguistic rule.	Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Dept Math, Cambridge, MA 02138 USA; Harvard Univ, Dept Appl Math, Cambridge, MA 02138 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lieberman, E (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Dept Math, Cambridge, MA 02138 USA.	erez@erez.com	Aiden, Erez Lieberman/A-2908-2010; Nowak, Martin A/A-6977-2008; tang, tina/GRX-7859-2022; Michel, Jean-Baptiste/AAH-9336-2020		NIGMS NIH HHS [R01 GM078986-02, R01 GM078986] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrams DM, 2003, NATURE, V424, P900, DOI 10.1038/424900a; [Anonymous], 2001, FREQUENCY EMERGENCE, DOI DOI 10.1075/TSL.45.11C0R; Bybee J.L., 1985, TYPOLOGICAL STUDIES, V9; Bybee J, 2006, LANGUAGE, V82, P711, DOI 10.1353/lan.2006.0186; Chomsky Noam, 1993, SYNTAX INT HDB CONT, P506; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; CLARK R, 1993, LINGUIST INQ, V24, P299; DOUGHERTY RC, 1994, NATURAL LANGUAGE CO; GLUSHKO M, 2003, P 19 SCAND C LING, V31, P30; GREENBERG JH, 1966, CURRENT TRENDS LINGU, P61; HARE M, 1995, COGNITION, V56, P61, DOI 10.1016/0010-0277(94)00655-5; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hooper J., 1976, CURRENT PROGR HIST L, P95; Kroch A., 1989, J LANGUAGE VARIATION, V1, P199, DOI [DOI 10.1017/S0954394500000168, 10.1017/S0954394500000168]; KROCH A, 1994, 30 REG M CHIC LING S, V2, P180; Kroch Anthony, 2000, PENN HELSINKI PARSED; Labov W, 2007, LANGUAGE, V83, P344, DOI 10.1353/lan.2007.0082; Lightfoot D, 1999, DEV LANGUAGE ACQUISI; Marcus GF, 1995, COGNITIVE PSYCHOL, V29, P189, DOI 10.1006/cogp.1995.1015; MILLER GA, 1957, AM J PSYCHOL, V70, P311, DOI 10.2307/1419346; NIYOGI P, 2000, COMPUTATIONAL NATURE; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Pinker S, 2000, LANDFALL, V8, P87; Pinker S., 1999, WORDS RULES INGREDIE; Stabler EP, 2003, THEOR COMPUT SCI, V293, P345, DOI 10.1016/S0304-3975(01)00351-6; VANDERWOUDEN T, 1988, 3 INT EURALEX C, P363; Yang C. D., 2002, KNOWLEDGE LEARNING N; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	28	225	231	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					713	716		10.1038/nature06137	http://dx.doi.org/10.1038/nature06137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218VV	17928859	Green Accepted, Green Submitted			2022-12-28	WOS:000250045000042
J	Van Aken, BB; Rivera, JP; Schmid, H; Fiebig, M				Van Aken, Bas B.; Rivera, Jean-Pierre; Schmid, Hans; Fiebig, Manfred			Observation of ferrotoroidic domains	NATURE			English	Article							LICOPO4	Domains are of unparalleled technological importance as they are used for information storage and for electronic, magnetic and optical switches. They are an essential property of any ferroic material. Three forms of ferroic order are widely known: ferromagnetism, a spontaneous magnetization; ferroelectricity, a spontaneous polarization; and ferroelasticity, a spontaneous strain. It is currently debated whether to include an ordered arrangement of magnetic vortices as a fourth form of ferroic order, termed ferrotoroidicity. Although there are reasons to expect this form of order from the point of view of thermodynamics(1), a crucial hallmark of the ferroic state-that is, ferrotoroidic domains has not hitherto been observed. Here ferrotoroidic domains are spatially resolved by optical second harmonic generation in LiCoPO4, where they coexist with independent antiferromagnetic domains. Their space- and time-asymmetric nature relates ferrotoroidics to multiferroics with magnetoelectric phase control(2-5) and to other systems in which space and time asymmetry leads to possibilities for future applications.	Max Born Inst, D-12489 Berlin, Germany; Univ Bonn, HISKP, D-53115 Bonn, Germany; Univ Geneva, Dept Inorgan Analyt & Appl Chem, CH-1211 Geneva 4, Switzerland	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; University of Bonn; University of Geneva	Fiebig, M (corresponding author), Max Born Inst, Max Born Str 2A, D-12489 Berlin, Germany.	fiebig@hiskp.uni-bonn.de	van Aken, Bas/C-6673-2008	Van Aken, Bas/0000-0003-1532-2216				Arima TH, 2005, J PHYS SOC JPN, V74, P1419, DOI 10.1143/JPSJ.74.1419; ASCHER E, 1966, HELV PHYS ACTA, V39, P40; Ascher E., 1974, International Journal of Magnetism, V5, P287; ASCHER E, 1966, J APPL PHYS, V37, P1404, DOI 10.1063/1.1708493; Bauer E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.027003; DUBOVIK VM, 1990, PHYS REP, V187, P145, DOI 10.1016/0370-1573(90)90042-Z; EDERER C, 2007, MODERN THEORY TOROID; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Fiebig M, 2005, J OPT SOC AM B, V22, P96, DOI 10.1364/JOSAB.22.000096; Fiebig M, 2004, OPT LETT, V29, P41, DOI 10.1364/OL.29.000041; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Figotin A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.165210; GINZBURG VL, 1984, SOLID STATE COMMUN, V50, P339, DOI 10.1016/0038-1098(84)90381-8; Gorbatsevich A. A., 1994, Ferroelectrics, V161, P321, DOI 10.1080/00150199408213381; Hur N, 2004, NATURE, V429, P392, DOI 10.1038/nature02572; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kharchenko NF, 2001, LOW TEMP PHYS+, V27, P895, DOI 10.1063/1.1414584; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kornev I, 2000, PHYS REV B, V62, P12247, DOI 10.1103/PhysRevB.62.12247; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Mostovoy M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067601; NEWNHAM RE, 1965, J AM CERAM SOC, V48, P547, DOI 10.1111/j.1151-2916.1965.tb14666.x; Popov YF, 1998, J EXP THEOR PHYS+, V87, P146, DOI 10.1134/1.558635; Rivera J.-P., 1994, Ferroelectrics, V161, P147, DOI 10.1080/00150199408213364; Sannikov DG, 1998, FERROELECTRICS, V219, P813, DOI 10.1080/00150199808213514; SANTORO RP, 1966, J PHYS CHEM SOLIDS, V27, P1192, DOI 10.1016/0022-3697(66)90097-7; Vaknin D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.224414; Withers RL, 2001, FERROELECTRICS, V250, P47, DOI 10.1080/00150190108225030	28	272	272	4	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					702	705		10.1038/nature06139	http://dx.doi.org/10.1038/nature06139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928856				2022-12-28	WOS:000250045000039
J	Aboa-Eboule, C; Brisson, C; Maunsell, E; Masse, B; Bourbonnais, R; Vezina, M; Milot, A; Theroux, P; Dagenais, GR				Aboa-Eboule, Corine; Brisson, Chantal; Maunsell, Elizabeth; Masse, Benoit; Bourbonnais, Renee; Vezina, Michel; Milot, Alain; Theroux, Pierre; Dagenais, Gilles R.			Job strain and risk of acute recurrent coronary heart disease events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTERIZED RECORD LINKAGE; ACUTE MYOCARDIAL-INFARCTION; MORTALITY DATA-BASE; CARDIOVASCULAR-DISEASE; SOCIAL SUPPORT; WHITEHALL-II; CONTENT QUESTIONNAIRE; SECONDARY PREVENTION; PROSPECTIVE COHORT; DECISION LATITUDE	Context There is evidence that job strain increases the risk of a first coronary heart disease (CHD) event. However, little is known about its association with the risk of recurrent CHD events after a first myocardial infarction (MI). Objective To determine whether job strain increases the risk of recurrent CHD events. Design, Setting, and Patients Prospective cohort study of 972 men and women aged 35 to 59 years who returned to work after a first MI and were then followed up between February 10, 1996, and June 22, 2005. Patients were interviewed at baseline (on average, 6 weeks after their return to work), then after 2 and 6 years subsequently. Job strain, a combination of high psychological demands and low decision latitude, was evaluated in 4 quadrants: high strain (high demands and low latitude), active (high demands and high latitude), passive (low demands and low latitude), and low strain. A chronic job strain variable was constructed based on the first 2 interviews, and patients were divided into those exposed to high strain at both interviews and those unexposed to high strain at 1 or both interviews. The survival analyses were presented separately for 2 periods: before 2.2 years and at 2.2 years and beyond. Main Outcome Measure The outcome was a composite of fatal CHD, nonfatal MI, and unstable angina. Results The outcome was documented in 206 patients. In the unadjusted analysis, chronic job strain was associated with recurrent CHD in the second period after 2.2 years of follow-up (hazard ratio [HR], 2.20; 95% CI, 1.32-3.66; respective event rates for patients exposed and unexposed to chronic job strain, 6.18 and 2.81 per 100 person-years). Chronic job strain remained an independent predictor of recurrent CHD in a multivariate model adjusted for 26 potentially confounding factors (HR, 2.00; 95% CI, 1.08-3.72). Conclusion Chronic job strain after a first MI was associated with an increased risk of recurrent CHD.	Univ Quebec, Ctr Hosp, Unite Rech Sante Populat, Quebec City, PQ G1S 4L8, Canada; Univ Laval, Unite Rech Sante Populat, Quebec City, PQ G1K 7P4, Canada; Inst Cardiol Quebec, Quebec City, PQ, Canada; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Inst Cardiol, Montreal, PQ, Canada	Laval University; University of Quebec; Laval University; Laval University; Fred Hutchinson Cancer Center; Universite de Montreal; Institut de Cardiologie de Montreal	Brisson, C (corresponding author), Univ Quebec, Ctr Hosp, Unite Rech Sante Populat, 1050 Chemin Ste Foy, Quebec City, PQ G1S 4L8, Canada.	cbrisson@uresp.ulaval.ca		Masse, Benoit/0000-0002-4944-8098				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; ALFREDSSON L, 1985, INT J EPIDEMIOL, V14, P378, DOI 10.1093/ije/14.3.378; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; AUDET N, 1998, CAHIER TECHNIQUE MET, V2, P215; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; BIRKETT NJ, 1992, AM J EPIDEMIOL, V136, P356, DOI 10.1093/oxfordjournals.aje.a116500; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Brisson C, 1998, WORK STRESS, V12, P322, DOI 10.1080/02678379808256870; Cohn JN, 2006, AM J CARDIOL, V97, p4F, DOI 10.1016/j.amjcard.2006.03.004; Collins SM, 2005, AM J IND MED, V48, P182, DOI 10.1002/ajim.20204; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; De Lange AH, 2004, WORK STRESS, V18, P149, DOI 10.1080/02678370412331270860; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; Deelstra JT, 2003, J APPL PSYCHOL, V88, P324, DOI 10.1037/0021-9010.88.2.324; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Eaker ED, 2004, AM J EPIDEMIOL, V159, P950, DOI 10.1093/aje/kwh127; FAUCETT JA, 1991, PAIN, V44, P35, DOI 10.1016/0304-3959(91)90144-M; GOLDBERG MS, 1993, CAN J PUBLIC HEALTH, V84, P201; HAAN MN, 1988, ANN CLIN RES, V20, P143; Hammar N, 1998, OCCUP ENVIRON MED, V55, P548, DOI 10.1136/oem.55.8.548; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P382; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; ILFELD FW, 1976, PSYCHOL REP, V39, P1215, DOI 10.2466/pr0.1976.39.3f.1215; JOHNSON DR, 1983, AM SOCIOL REV, V48, P398, DOI 10.2307/2095231; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Johnson JV, 1996, AM J PUBLIC HEALTH, V86, P324, DOI 10.2105/AJPH.86.3.324; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Karasek R., 1990, HLTH WORK STRESS PRO; Karasek R., 1985, JOB CONTENT QUESTION; KARASEK RA, 1983, VALIDATION SURVEY IN; Kivimaki M, 2006, PSYCHOSOM MED, V68, P398, DOI 10.1097/01.psy.0000221252.84351.e2; KOMITZER M, 2006, EUR J CARDIVOASC PRE, V13, P695; KORNOWSKI R, 1993, AM J CARDIOL, V72, P883, DOI 10.1016/0002-9149(93)91100-V; Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349, DOI 10.5271/sjweh.1386; Larocque B, 1998, REV EPIDEMIOL SANTE, V46, P371; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Monfared AAT, 2006, PHARMACOEPIDEM DR S, V15, P19, DOI 10.1002/pds.1131; Netterstrom B, 2006, EUR J CARDIOV PREV R, V13, P414, DOI 10.1097/00149831-200606000-00018; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008; Paquet M, 2005, J ADV NURS, V51, P567, DOI 10.1111/j.1365-2648.2005.03544.x; Pilote L, 2004, CAN J CARDIOL, V20, P61; REED DM, 1989, AM J EPIDEMIOL, V129, P495, DOI 10.1093/oxfordjournals.aje.a115160; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; SHANNON HS, 1989, CAN J PUBLIC HEALTH, V80, P54; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; TAYLOR GJ, 1990, CAN J PSYCHIAT, V35, P290, DOI 10.1177/070674379003500402; THEORELL T, 1991, INT J CARDIOL, V30, P61, DOI 10.1016/0167-5273(91)90125-9	56	132	134	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1652	1660		10.1001/jama.298.14.1652	http://dx.doi.org/10.1001/jama.298.14.1652			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925517	Bronze			2022-12-28	WOS:000250009400021
J	Semenza, GL				Semenza, Gregg L.			Life with oxygen	SCIENCE			English	Editorial Material							GENE-EXPRESSION; HYPOXIA; HIF-1-ALPHA; HIF; FAMILY	The survival of all metazoan organisms is dependent on the regulation of O-2 delivery and utilization to maintain a balance between the generation of energy and production of potentially toxic oxidants. Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis and has essential roles in metazoan development, physiology, and disease pathogenesis. Remarkable progress has been made in delineating the molecular mechanisms whereby changes in cellular oxygenation are transduced to the nucleus as changes in gene transcription through the activity of HIF-1. Pharmacologic agents that activate or inhibit the hypoxia signal transduction pathway may be useful therapies for ischemic and neoplastic disorders, respectively, which are the major causes of mortality in industrialized societies.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Broadway Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu						Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Peet Daniel, 2006, Novartis Found Symp, V272, P37; REED MJ, 2004, SCI AGING KNOWLEDGE, pPE7; Semenza G. L., 2007, SCI STKE, pcm8; Severinghaus JW, 2003, ADV EXP MED BIOL, V543, P7; Tomita M, 2007, BIOCHEM J, V406, P317, DOI 10.1042/BJ20070286; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	17	505	529	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					62	64		10.1126/science.1147949	http://dx.doi.org/10.1126/science.1147949			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916722				2022-12-28	WOS:000249915400036
J	Nam, MS; Ardavan, A; Blundell, SJ; Schlueter, JA				Nam, Moon-Sun; Ardavan, Arzhang; Blundell, Stephen J.; Schlueter, John A.			Fluctuating superconductivity in organic molecular metals close to the Mott transition	NATURE			English	Article							UPPER CRITICAL-FIELD; PENETRATION DEPTH; CRITICAL-TEMPERATURE; KAPPA-(BEDT-TTF)(2)CU(NCS)(2); DEPENDENCE; INSULATOR; PHYSICS; STATE	On cooling through the transition temperature T-c of a conventional superconductor, an energy gap develops as the normal-state charge carriers form Cooper pairs; these pairs form a phase-coherent condensate that exhibits the well-known signatures of superconductivity: zero resistivity and the expulsion of magnetic flux (the Meissner effect(1)). However, in many unconventional superconductors, the formation of the energy gap is not coincident with the formation of the phase-coherent super-fluid. Instead, at temperatures above the critical temperature a range of unusual properties, collectively known as 'pseudogap phenomena', are observed(2). Here we argue that a key pseudogap phenomenon-fluctuating superconductivity occurring substantially above the transition temperature-could be induced by the proximity of a Mott-insulating state. The Mott-insulating state in the kappa-(BEDT-TTF)(2)X organic molecular metals(3-5) can be tuned, without doping, through superconductivity into a normal metallic state as a function of the parameter t/U, where t is the tight-binding transfer integral characterizing the metallic bandwidth and U is the on-site Coulomb repulsion. By exploiting a particularly sensitive probe of superconducting fluctuations, the vortex-Nernst effect, we find that a fluctuating regime develops as t/U decreases and the role of Coulomb correlations increases.	Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	University of Oxford; United States Department of Energy (DOE); Argonne National Laboratory	Ardavan, A (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	arzhang.ardavan@physics.ox.ac.uk	Ardavan, Arzhang/AAY-9214-2020		Engineering and Physical Sciences Research Council [GR/T27341/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Analytis JG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177002; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Carrington A, 1999, PHYS REV LETT, V83, P4172, DOI 10.1103/PhysRevLett.83.4172; CAULFIELD J, 1994, J PHYS-CONDENS MAT, V6, P2911, DOI 10.1088/0953-8984/6/15/013; DONIACH S, 1981, PHYS REV B, V24, P5063, DOI 10.1103/PhysRevB.24.5063; Gan JY, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014508; Ishiguro T., 2006, ORGANIC SUPERCONDUCT; Kagawa F, 2005, NATURE, V436, P534, DOI 10.1038/nature038O6; Kanoda K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.051007; LANG M, 1992, PHYS REV B, V46, P5822, DOI 10.1103/PhysRevB.46.5822; Larkin MI, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.144514; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lefebvre S, 2000, PHYS REV LETT, V85, P5420, DOI 10.1103/PhysRevLett.85.5420; Logvenov GY, 1996, PHYSICA C, V264, P261, DOI 10.1016/0921-4534(96)00243-2; MAYAFFRE H, 1994, EUROPHYS LETT, V28, P205, DOI 10.1209/0295-5075/28/3/009; McKenzie RH, 1997, SCIENCE, V278, P820, DOI 10.1126/science.278.5339.820; Nam MS, 1999, J PHYS-CONDENS MAT, V11, pL477, DOI 10.1088/0953-8984/11/43/102; Pourret A, 2006, NAT PHYS, V2, P683, DOI 10.1038/nphys413; Powell BJ, 2006, J PHYS-CONDENS MAT, V18, pR827, DOI 10.1088/0953-8984/18/45/R03; Powell BJ, 2004, J PHYS-CONDENS MAT, V16, pL367, DOI 10.1088/0953-8984/16/30/L03; Powell BJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047004; Pratt FL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.097006; Sasaki T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224513; SONDHEIMER EH, 1948, PROC R SOC LON SER-A, V193, P484, DOI 10.1098/rspa.1948.0058; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Tinkham M., 2004, INTRO SUPERCONDUCTIV, V2nd; Ussishkin I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.287001; Wang YY, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.257003; Wang YY, 2003, SCIENCE, V299, P86, DOI 10.1126/science.1078422; WILLIAMS JM, 1990, INORG CHEM, V29, P3272, DOI 10.1021/ic00343a003; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016	33	66	66	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					584	587		10.1038/nature06182	http://dx.doi.org/10.1038/nature06182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914392				2022-12-28	WOS:000249893500041
J	Sartori, AA; Lukas, C; Coates, J; Mistrik, M; Fu, S; Bartek, J; Baer, R; Lukas, J; Jackson, SP				Sartori, Alessandro A.; Lukas, Claudia; Coates, Julia; Mistrik, Martin; Fu, Shuang; Bartek, Jiri; Baer, Richard; Lukas, Jiri; Jackson, Stephen P.			Human CtIP promotes DNA end resection	NATURE			English	Article							DOUBLE-STRAND BREAKS; BUDDING YEAST SAE2; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; MRE11 COMPLEX; CELL-CYCLE; CHECKPOINT CONTROL; PROTEIN-KINASES; BINDING PROTEIN	In the S and G2 phases of the cell cycle, DNA double-strand breaks (DSBs) are processed into single-stranded DNA, triggering ATR-dependent checkpoint signalling and DSB repair by homologous recombination. Previous work has implicated the MRE11 complex in such DSB-processing events. Here, we show that the human CtIP (RBBP8) protein confers resistance to DSB-inducing agents and is recruited to DSBs exclusively in the S and G2 cell-cycle phases. Moreover, we reveal that CtIP is required for DSB resection, and thereby for recruitment of replication protein A (RPA) and the protein kinase ATR to DSBs, and for the ensuing ATR activation. Furthermore, we establish that CtIP physically and functionally interacts with the MRE11 complex, and that both CtIP and MRE11 are required for efficient homologous recombination. Finally, we reveal that CtIP has sequence homology with Sae2, which is involved in MRE11-dependent DSB processing in yeast. These findings establish evolutionarily conserved roles for CtIP-like proteins in controlling DSB resection, checkpoint signalling and homologous recombination.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; Columbia Univ, Dept Pathol, Inst Canc Genet, New York, NY 10032 USA	University of Cambridge; University of Cambridge; Danish Cancer Society; Danish Cancer Society; Columbia University	Sartori, AA (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Sartori, Alessandro/AAK-7840-2021; Bartek, Jiri/G-5870-2014; Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Sartori, Alessandro/0000-0003-2770-0333; Jackson, Stephen Philip/0000-0001-9317-7937; Lukas, Jiri/0000-0001-9087-506X; Lukas, Claudia/0000-0001-7169-6883; Mistrik, Martin/0000-0002-2321-0348	NATIONAL CANCER INSTITUTE [P01CA097403] Funding Source: NIH RePORTER; Cancer Research UK [A5290] Funding Source: Medline; NCI NIH HHS [P01 CA097403] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; DARPA P, 1990, CANCER RES, V50, P6919; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lavin MF, 2004, DNA REPAIR, V3, P1515, DOI 10.1016/j.dnarep.2004.07.001; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; McKee AHZ, 1997, GENETICS, V146, P797; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Prinz S, 1997, GENETICS, V146, P781; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Rattray AJ, 2001, GENETICS, V158, P109; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Vilkki S, 2002, J MED GENET, V39, P785, DOI 10.1136/jmg.39.11.785; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wu GK, 2006, CELL CYCLE, V5, P1592, DOI 10.4161/cc.5.15.3127; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	962	979	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					509	U6		10.1038/nature06337	http://dx.doi.org/10.1038/nature06337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	17965729	Green Accepted			2022-12-28	WOS:000251158500038
J	Lam, SKH; Owen, A				Lam, Simon K. H.; Owen, Andrew			Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; HEART-FAILURE PATIENTS; COST-EFFECTIVENESS; CARDIOVERTER-DEFIBRILLATORS; SYSTOLIC DYSFUNCTION; PROPHYLACTIC USE; MORTALITY; PREVENTION; STIMULATION; GUIDELINES	Objective To review the evidence base from randomised controlled trials of combined cardiac resynchronisation therapy and implantable cardioverter defibrillator therapy in left ventricular impairment and symptomatic heart failure. Design Bayesian network meta-analysis. Data sources Medline, Embase, and Cochrane databases up to June 2006. Review methods Two reviewers independently assessed trial eligibility and quality. Included trials compared cardiac resynchronisation therapy, implantable cardioverter defibrillator therapy, combined resynchronisation and defibriltator therapy, and medical therapy atone, in patients with impaired left ventricular systolic function. Bayesian random effects network models were used to examine overall number of deaths. Results 12 studies including 1636 events in 8307 patients were identified. Combined cardiac resynchronisation and implantable cardioverter defibrillator therapy reduced the number of deaths by one third compared with medical therapy alone (odds ratio 0.57, 95% credible interval 0.40 to 0.80) but did not further improve survival when compared with defibrillator therapy (0.82, 0.57 to 1.18) or resynchronisation therapy (0.85, 0.60 to 1.22) alone. Conclusion Evidence from randomised controlled trials is insufficient to show the superiority of combined cardiac resynchronisation and implantable cardioiverter defibrillator therapy over cardiac resynchronisation therapy alone in patients with left ventricular impairment.	Natl Heart & Lung Inst, London SW3 6LY, England; Kent & Canterbury Hosp, Dept Cardiol, Canterbury, Kent, England	Imperial College London; University of Kent	Lam, SKH (corresponding author), Chi Lin Med Ctr, Kowloon, Hong Kong, Peoples R China.	simon.lam@medsci.oxon.org		Lam, Simon/0000-0001-7658-2551				Abdulla J, 2006, CARDIOLOGY, V106, P249, DOI 10.1159/000093234; *ACC AHA ESC, 2006, CIRCULATION, V114, P1088; Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Auricchio A, 2002, J AM COLL CARDIOL, V39, P2026, DOI 10.1016/S0735-1097(02)01895-8; Auricchio A, 2003, J AM COLL CARDIOL, V42, P2109, DOI 10.1016/j.jacc.2003.04.003; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; Bryant J, 2004, HEALTH TECHNOL ASSES, V8, P1; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Calvert MJ, 2005, EUR HEART J, V26, P2681, DOI 10.1093/eurheartj/ehi662; Chow AWC, 2003, BMJ-BRIT MED J, V326, P1073, DOI 10.1136/bmj.326.7398.1073; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Deeks J J, 2003, Health Technol Assess, V7, piii; DEEKS JJ, 2006, COCHRANE LIB; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desai AS, 2004, JAMA-J AM MED ASSOC, V292, P2874, DOI 10.1001/jama.292.23.2874; Doshi RN, 2005, J CARDIOVASC ELECTR, V16, P1160, DOI 10.1111/j.1540-8167.2005.50062.x; Ermis C, 2004, J CARDIOVASC ELECTR, V15, P862, DOI 10.1046/j.1540-8167.2004.04044.x; Ezekowitz JA, 2003, ANN INTERN MED, V138, P445, DOI 10.7326/0003-4819-138-6-200303180-00007; *FDA, 2002, SUMM SAF EFF INSYNC; *FDA, 2001, AMENDMENT PMA, V1; Feldman AM, 2005, J AM COLL CARDIOL, V46, P2311, DOI 10.1016/j.jacc.2005.08.033; Freemantle N, 2006, EUR J HEART FAIL, V8, P433, DOI 10.1016/j.ejheart.2005.11.014; Garrigue S, 2002, HEART, V87, P529, DOI 10.1136/heart.87.6.529; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Hartling L, 2005, ANN INTERN MED, V142, P1100, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00010; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kindermann M, 2006, J AM COLL CARDIOL, V47, P1927, DOI 10.1016/j.jacc.2005.12.056; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; LECLERCQ C, 2003, PACE, V26, P983; Lee DS, 2003, J AM COLL CARDIOL, V41, P1573, DOI 10.1016/S0735-1097(03)00253-5; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; McAlister FA, 2004, ANN INTERN MED, V141, P381, DOI 10.7326/0003-4819-141-5-200409070-00101; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P34, DOI 10.1111/j.1542-474X.2005.00073.x; Nanthakumar K, 2004, J AM COLL CARDIOL, V44, P2166, DOI 10.1016/j.jacc.2004.08.054; *NAT I HLTH CLIN E, 2006, TECHN APPRA 95; *NAT I HLTH CLIN E, 2006, TECHN APPR 95; *NIH, 2006, NCT00251251 NIH; *NIH, 2000, NCT00251251 NIH; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Salukhe TV, 2004, INT J CARDIOL, V93, P101, DOI 10.1016/j.ijcard.2003.10.002; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sutton A J, 1998, Health Technol Assess, V2, P1; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; *US FDA, SUMM SAF EFF ST JUD; WHITEHEAD A, 2002, METAANALYSIS CONTROL, P259; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07	53	86	88	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2007	335	7626					925	928B		10.1136/bmj.39343.511389.BE	http://dx.doi.org/10.1136/bmj.39343.511389.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17932160	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000250848300033
J	Majeed, A; Lester, H; Bindman, A				Majeed, Azeem; Lester, Helen; Bindman, Andrew			Improving the quality of care with performance indicators	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNITED-STATES; PHYSICIANS		Imperial Coll, Fac Med, Dept Primary Care & Social Med, London W6 8RP, England; Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA	Imperial College London; University of Manchester; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Majeed, A (corresponding author), Imperial Coll, Fac Med, Dept Primary Care & Social Med, London W6 8RP, England.	a.majeed@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858				Bindman AB, 2007, BMJ-BRIT MED J, V334, P1261, DOI 10.1136/bmj.39203.658970.55; Goldfield N, 2003, BRIT MED J, V326, P744, DOI 10.1136/bmj.326.7392.744; HEATH I, IN PRESS BMJ; Institute of Medicine, IOM DEF QUAL; Institute of Medicine, 2001, CROSSING QUALITY CHA; Lester H, 2007, FAM MED, V39, P96; MAJEED FA, 1995, BRIT MED J, V311, P209, DOI 10.1136/bmj.311.6999.209; Marshall M, 2003, MEASURING GEN PRACTI; Marshall M, 2002, QUALITY INDICATORS G; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294	11	26	27	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2007	335	7626					916	918		10.1136/bmj.39337.539120.AD	http://dx.doi.org/10.1136/bmj.39337.539120.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230AS	17974688	Green Published			2022-12-28	WOS:000250848300030
J	Mason, S; Knowles, E; Colwell, B; Dixon, S; Wardrope, J; Gorringe, R; Snooks, H; Perrin, J; Nicholl, J				Mason, Suzanne; Knowles, Emma; Colwell, Brigitte; Dixon, Simon; Wardrope, Jim; Gorringe, Robert; Snooks, Helen; Perrin, Julie; Nicholl, Jon			Effectiveness of paramedic practitioners in attending 999 calls from elderly people in the community: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY CARE; PATIENT; ATTITUDES; TREAT	Objective To evaluate the benefits of paramedic practitioners assessing and, when possible, treating older people in the community after minor injury or illness. Paramedic practitioners have been trained with extended skills to assess, treat, and discharge older patients with minor acute conditions in the community. Design Cluster randomised controlled trial involving 56 clusters. Weeks were randomised to the paramedic practitioner service being active (intervention) or inactive (control) when the standard 999 service was available. Setting A large urban area in England. Participants 3018 patients aged over 60 who called the emergency services (n=1549 intervention, n=1469 control). Main outcome measures Emergency department attendance or hospital admission between 0 and 28 days; interval from time of call to time of discharge; patients' satisfaction with the service received. Results Overall, patients in the intervention group were less likely to attend an emergency department (relative risk 0.72, 95% confidence interval 0.68 to 0.75) or require hospital admission within 28 days (0.87, 0.81 to 0.94) and experienced a shorter total episode time (235 v 278 minutes, 95% confidence interval for difference -60 minutes to -25 minutes). Patients in the intervention group were more likely to report being highly satisfied with their healthcare episode (relative risk 1.16, 1.09 to 1.23). There was no significant difference in 28 day mortality (0.87, 0.63 to 1.21). Conclusions Paramedics with extended skills can provide a clinically effective alternative to standard ambulance transfer and treatment in an emergency department for older patients with acute minor conditions. Trial registration ISRCTN27796329.	Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Sheffield Teaching Hosp Trust, Dept Emergency Med, Sheffield S5 7AU, S Yorkshire, England; S Yorkshire Ambulance Serv, Rotherham S60 2BQ, S Yorkshire, England; Swansea Univ, Sch Med, Ctr Hlth Informat Res & Evaluat, Swansea SA2 8PP, W Glam, Wales	University of Sheffield; University of Sheffield; Swansea University	Mason, S (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.	s.mason@sheffield.ac.uk	Snooks, Helen A/N-2165-2014; Nicholl, Jon/B-8257-2008	Snooks, Helen A/0000-0003-0173-8843; Mason, Suzanne/0000-0002-1701-0577; Dixon, Simon/0000-0001-7394-7009				Campbell M. J., 2006, STAT SQUARE 2; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; CASTILLO PA, 1993, CLIN GERIATR MED, V9, P491, DOI 10.1016/S0749-0690(18)30388-4; Department of Health, 2001, NHS PLAN; Department of Health, 2005, TAK HLTH CAR PAT TRA; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Hale D, 2000, Prehosp Emerg Care, V4, P245, DOI 10.1080/10903120090941272; HALE D, 2000, PREHOSP EMERG CARE, V4, P2415; Kamper M, 2001, Prehosp Emerg Care, V5, P371, DOI 10.1080/10903120190939535; Lerner EB, 2003, AM J EMERG MED, V21, P115, DOI 10.1053/ajem.2003.50014; Marks PJ, 2002, EMERG MED J, V19, P449, DOI 10.1136/emj.19.5.449; Mason S, 2006, EMERG MED J, V23, P435, DOI 10.1136/emj.2005.027300; Mason S, 2003, EMERG MED J, V20, P196, DOI 10.1136/emj.20.2.196; O'Meara P, 2003, EMERG MED J, V20, P199, DOI 10.1136/emj.20.2.199; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Snooks H, 2004, QUAL SAF HEALTH CARE, V13, P435, DOI 10.1136/qshc.2003.007658; Snooks H, 2002, BRIT MED J, V325, P330, DOI 10.1136/bmj.325.7359.330; SNOOKS H, 2001, DEV IMPACT EMERGENCY; Squires JP, 2004, EMERG MED J, V21, P724, DOI 10.1136/emj.2004.016923; *STATACORP, 2003, STAT SOFTW REL 8 0; Sun BC, 2000, ANN EMERG MED, V35, P426, DOI 10.1067/mem.2000.104195; WOLFORD R, 1996, PREHOSP DIS MED, V109, pS36; WOLFORDRW, 1996, PREHOSP DISASTER MED, V109, pS36; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	24	84	84	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2007	335	7626					919	922		10.1136/bmj.39343.649097.55	http://dx.doi.org/10.1136/bmj.39343.649097.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17916813	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000250848300031
J	Moore, RG; Zhang, JD; Nascimento, VB; Jin, R; Guo, JD; Wang, GT; Fang, Z; Mandrus, D; Plummer, EW				Moore, R. G.; Zhang, Jiandi; Nascimento, V. B.; Jin, R.; Guo, Jiandong; Wang, G. T.; Fang, Z.; Mandrus, D.; Plummer, E. W.			A surface-tailored, purely electronic, Mott metal-to-insulator transition	SCIENCE			English	Article							PEROVSKITE	Mott transitions, which are metal-insulator transitions (MITs) driven by electron-electron interactions, are usually accompanied in bulk by structural phase transitions. In the layered perovskite Ca1.9Sr0.1RuO4, such a first-order Mott MIT occurs in the bulk at a temperature of 154 kelvin on cooling. In contrast, at the surface, an unusual inherent Mott MIT is observed at 130 kelvin, also on cooling but without a simultaneous lattice distortion. The broken translational symmetry at the surface causes a compressional stress that results in a 150% increase in the buckling of the Ca/Sr-O surface plane as compared to the bulk. The Ca/Sr ions are pulled toward the bulk, which stabilizes a phase more amenable to a Mott insulator ground state than does the bulk structure and also energetically prohibits the structural transition that accompanies the bulk MIT.	Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; Florida Int Univ, Dept Phys, Miami, FL 33199 USA; Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; Chinese Acad Sci, Inst Phys, Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; State University System of Florida; Florida International University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Chinese Academy of Sciences; Institute of Physics, CAS	Moore, RG (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.		Guo, Jiandong/AAG-7728-2020; Fang, Zhong/D-4132-2009; Mandrus, David/H-3090-2014; Moore, Rob/CAG-8039-2022; Guo, Jiandong/F-2081-2015; Nascimento, Von/AAU-2753-2021	Guo, Jiandong/0000-0002-7893-022X; Moore, Rob/0000-0002-1608-5411; Guo, Jiandong/0000-0002-7893-022X; Wang, Guangtao/0000-0001-5331-3754; Nascimento, Von Braun/0000-0003-0027-6261				Anderson P.W., 1984, BASIC NOTIONS CONDEN, DOI 10.4324/9780429494116; Fang Z, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045116; Fang Z, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.020509; Feng D., 2005, INTRO CONDENSED MATT; Friedt O, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.174432; Heifets E, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235417; Hove M.A., 1986, LOW ENERGY ELECT DIF; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Ismail, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035407; Jung JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.056403; Kotliar G, 2004, PHYS TODAY, V57, P53, DOI 10.1063/1.1712502; Kotliar G, 2000, PHYS REV LETT, V84, P5180, DOI 10.1103/PhysRevLett.84.5180; Liebsch A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216403; Liebsch A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.096401; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Moore RG, 2004, PHYS STATUS SOLIDI B, V241, P2363, DOI 10.1002/pssb.200404874; Mott N.F, 1974, METAL INSULATOR TRAN; MOTT NF, 1949, P PHYS SOC LOND A, V62, P416, DOI 10.1088/0370-1298/62/7/303; Nakatsuji S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137202; Nakatsuji S, 2000, PHYS REV LETT, V84, P2666, DOI 10.1103/PhysRevLett.84.2666; NAKATSUJI S, 2003, PHYS REV LETT, V93; Nascimento VB, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035408; ONODA S, ARXIVCONDMAT0408297; PATTOFF M, 2002, ADV SOLID STATE PHYS, V42, P121; Peierls R.F., 1955, QUANTUM THEORY SOLID; PENDRY JB, 1980, J PHYS C SOLID STATE, V13, P937, DOI 10.1088/0022-3719/13/5/024; Piskunov S, 2005, SURF SCI, V575, P75, DOI 10.1016/j.susc.2004.11.008; Plummer EW, 2002, SURF SCI, V500, P1, DOI 10.1016/S0039-6028(01)01565-5; Potthoff M, 1999, PHYS REV B, V59, P2549, DOI 10.1103/PhysRevB.59.2549; Puchkov AV, 1998, PHYS REV LETT, V81, P2747, DOI 10.1103/PhysRevLett.81.2747	30	66	73	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					615	619		10.1126/science.1145374	http://dx.doi.org/10.1126/science.1145374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962556				2022-12-28	WOS:000250409200038
J	Leng, SX; Finucane, T; Boult, L; Zheng, L; Greenough, WB				Leng, Sean X.; Finucane, Thomas; Boult, Lisa; Zheng, Larry; Greenough, William B., III			Inadvertent self-healing in desperate times	LANCET			English	Editorial Material							PRESSURE ULCERS		Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA	Johns Hopkins University	Leng, SX (corresponding author), Johns Hopkins Univ, Sch Med, 5505 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	sieng@jhmi.edu			NIA NIH HHS [R21 AG024235-01, R21 AG024235-02, R21 AG024235] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R21AG024235] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bates-Jensen BM, 2001, ANN INTERN MED, V135, P744, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00014; Byrne DW, 1996, SPINAL CORD, V34, P255, DOI 10.1038/sc.1996.46; Horan FT, 2005, J BONE JOINT SURG BR, V87B, P104, DOI 10.1302/0301-620X.87B1; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5	4	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1458	1458		10.1016/S0140-6736(07)61603-1	http://dx.doi.org/10.1016/S0140-6736(07)61603-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950859				2022-12-28	WOS:000250386000023
J	Sullivan, FM; Swan, IRC; Donnan, PT; Morrison, JM; Smith, BH; McKinstry, B; Davenport, RJ; Vale, LD; Clarkson, JE; Hammersley, V; Hayavi, S; McAteer, A; Stewart, K; Daly, F				Sullivan, Frank M.; Swan, Iain R. C.; Donnan, Peter T.; Morrison, Jillian M.; Smith, Blair H.; McKinstry, Brian; Davenport, Richard J.; Vale, Luke D.; Clarkson, Janet E.; Hammersley, Victoria; Hayavi, Sima; McAteer, Anne; Stewart, Ken; Daly, Fergus			Early treatment with prednisolone or acyclovir in Bell's palsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-SIMPLEX-VIRUS; HOUSE-BRACKMANN; VALACYCLOVIR; EPIDEMIOLOGY; MULTICENTER; STEROIDS	Background Corticosteroids and antiviral agents are widely used to treat the early stages of idiopathic facial paralysis (i.e., Bell's palsy), but their effectiveness is uncertain. Methods We conducted a double-blind, placebo-controlled, randomized, factorial trial involving patients with Bell's palsy who were recruited within 72 hours after the onset of symptoms. Patients were randomly assigned to receive 10 days of treatment with prednisolone, acyclovir, both agents, or placebo. The primary outcome was recovery of facial function, as rated on the House-Brackmann scale. Secondary outcomes included quality of life, appearance, and pain. Results Final outcomes were assessed for 496 of 551 patients who underwent randomization. At 3 months, the proportions of patients who had recovered facial function were 83.0% in the prednisolone group as compared with 63.6% among patients who did not receive prednisolone (P<0.001) and 71.2% in the acyclovir group as compared with 75.7% among patients who did not receive acyclovir (adjusted P=0.50). After 9 months, these proportions were 94.4% for prednisolone and 81.6% for no prednisolone (P<0.001) and 85.4% for acyclovir and 90.8% for no acyclovir (adjusted P=0.10). For patients treated with both drugs, the proportions were 79.7% at 3 months (P<0.001) and 92.7% at 9 months (P<0.001). There were no clinically significant differences between the treatment groups in secondary outcomes. There were no serious adverse events in any group. Conclusions In patients with Bell's palsy, early treatment with prednisolone significantly improves the chances of complete recovery at 3 and 9 months. There is no evidence of a benefit of acyclovir given alone or an additional benefit of acyclovir in combination with prednisolone.	Univ Dundee, Scottish Sch Primary Care, Dundee DD2 4BF, Scotland; Univ Dundee, Dent Hlth Serv Res Unit, Dundee DD2 4BF, Scotland; Univ Glasgow, Dept Otolaryngol, Glasgow, Lanark, Scotland; Univ Glasgow, Div Community Based Sci, Glasgow, Lanark, Scotland; Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen, Scotland; Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; Univ Edinburgh, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; St Johns Hosp, Natl Hlth Serv Lothian, Livingston, Scotland	University of Dundee; University of Dundee; University of Glasgow; University of Glasgow; University of Aberdeen; University of Aberdeen; University of Edinburgh	Sullivan, FM (corresponding author), Univ Dundee, Scottish Sch Primary Care, Mackenzie Bldg,Kirsty Semple Way, Dundee DD2 4BF, Scotland.	f.m.sullivan@chs.dundee.ac.uk	Sullivan, Frank/L-8286-2019; Hug, Balthasar L./G-1568-2010; Smith, Blair H/G-2834-2012; Sullivan, Frank m/A-7767-2009	Sullivan, Frank/0000-0002-6623-4964; Smith, Blair H/0000-0002-5362-9430; Clarkson, Jan/0000-0001-5940-2926; Donnan, Peter/0000-0001-7828-0610; Vale, Luke/0000-0001-8574-8429; McKinstry, Brian/0000-0001-9581-0468	Chief Scientist Office [HERU1, HERU2] Funding Source: Medline	Chief Scientist Office		ADOUR KK, 1975, JAMA-J AM MED ASSOC, V233, P527, DOI 10.1001/jama.233.6.527; Allen D, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001869.PUB2; Cave JA, 2004, BMJ-BRIT MED J, V329, P1103, DOI 10.1136/bmj.329.7474.1103-a; Coulson SE, 2005, OTOLARYNG HEAD NECK, V132, P543, DOI 10.1016/j.otohns.2005.01.027; CROXSON G, 1990, AM J OTOL, V11, P240; De Diego-Sastre JI, 2005, REV NEUROLOGIA, V41, P287, DOI 10.33588/rn.4105.2004593; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Gilden DH, 2004, NEW ENGL J MED, V351, P1323, DOI 10.1056/NEJMcp041120; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; Harris DL, 2001, BRIT J PLAST SURG, V54, P216, DOI 10.1054/bjps.2001.3559; Hato N, 2003, OTOL NEUROTOL, V24, P948, DOI 10.1097/00129492-200311000-00022; Hato N, 2007, OTOL NEUROTOL, V28, P408, DOI 10.1097/01.mao.0000265190.29969.12; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Kawaguchi K, 2007, LARYNGOSCOPE, V117, P147, DOI 10.1097/01.mlg.0000248737.65607.9e; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; McKinstry B, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-15; Neely JG, 1996, AM J OTOL, V17, P340; Peitersen E, 2002, ACTA OTO-LARYNGOL, V122, P4, DOI 10.1080/000164802320401694; Preisser JS, 2002, STAT MED, V21, P3035, DOI 10.1002/sim.1241; Ross BG, 1996, OTOLARYNG HEAD NECK, V114, P380, DOI 10.1016/S0194-5998(96)70206-1; Rowlands S, 2002, EUR J NEUROL, V9, P63, DOI 10.1046/j.1468-1331.2002.00343.x; SALINAS RA, 2004, COCHRANE DATABASE SY, V0004; Stjernquist-Desatnik A, 2006, ANN OTO RHINOL LARYN, V115, P306, DOI 10.1177/000348940611500410; Theil D, 2001, BRAIN PATHOL, V11, P408, DOI 10.1111/j.1750-3639.2001.tb00408.x; Williamson IG, 1996, BRIT J GEN PRACT, V46, P743; SCOTTISH BELLS PALSY	26	391	413	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1598	1607		10.1056/NEJMoa072006	http://dx.doi.org/10.1056/NEJMoa072006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942873	Bronze			2022-12-28	WOS:000250200500005
J	Hindin, MJ				Hindin, Michelle J.			Contraception, safe abortion, and maternal morbidity	LANCET			English	Editorial Material							MORTALITY; HEALTH; DEATH		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hindin, MJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	mhindin@jhsph.edu		Hindin, Michelle/0000-0001-9941-7639				Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; DaVanzo J, 2007, BJOG-INT J OBSTET GY, V114, P1079, DOI 10.1111/j.1471-0528.2007.01338.x; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; Geller SE, 2004, AM J OBSTET GYNECOL, V191, P939, DOI 10.1016/j.ajog.2004.05.099; Geller SE, 2007, AM J OBSTET GYNECOL, V196, P57, DOI 10.1016/j.ajog.2006.07.052; Graham WJ, 2007, AM J PUBLIC HEALTH, V97, P978, DOI 10.2105/AJPH.2005.073692; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; *MEAS DHS STAT, 2007, ORC MACR; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; SINGH S, 2004, ADDING IT BENEFITS I; *UN DEV PROGR, 2007, MILL DEV GOALS MDGS; World Health Organization, 2005, WORLD HLTH REP 2005	15	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1294	1295		10.1016/S0140-6736(07)61555-4	http://dx.doi.org/10.1016/S0140-6736(07)61555-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933635				2022-12-28	WOS:000250176600010
J	Yazbeck, AS				Yazbeck, Abdo S.			Challenges in measuring maternal mortality	LANCET			English	Editorial Material									World Bank, World Bank Inst, Hlth & AIDS Program, Washington, DC 20433 USA	The World Bank	Yazbeck, AS (corresponding author), World Bank, World Bank Inst, Hlth & AIDS Program, 1818 H St NW, Washington, DC 20433 USA.	Ayazbeck@worldbank.org						Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; *OFF PRIM MIN, 2007, WORLDS MAJ DIS CONQ; SOLHOLM R, 2007, NORWAY POST     0727; Wagstaff A, 2004, MILLENNIUM DEV GOALS; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0; Yazbeck AS, 2004, REPROD HEALTH MATTER, V12, P25, DOI 10.1016/S0968-8080(04)24145-3	6	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2007	370	9595					1291	1292		10.1016/S0140-6736(07)61553-0	http://dx.doi.org/10.1016/S0140-6736(07)61553-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933633				2022-12-28	WOS:000250176600008
J	Makous, W				Makous, Walter			Comment on "Emergence of novel color vision in mice engineered to express a human cone photopigment"	SCIENCE			English	Editorial Material							AFTERIMAGES		Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Rochester	Makous, W (corresponding author), Univ Rochester, Ctr Visual Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	walt@cvs.rochester.edu	Makous, Walter L/A-1200-2007					DRYSDALE AE, 1975, VISION RES, V15, P813, DOI 10.1016/0042-6989(75)90259-X; Fender D.H., 1955, OPT ACTA, V2, P128, DOI [10.1080/713821035, DOI 10.1080/713821035]; Helmholtz Hermann von, 1962, HELMHOLTZS TREATISE; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; MACLEOD DIA, 1974, SCIENCE, V185, P1171, DOI 10.1126/science.185.4157.1171; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Steinman R M, 1990, Rev Oculomot Res, V4, P115; WILLIAMS DR, 1979, VISION RES, V19, P867, DOI 10.1016/0042-6989(79)90020-8	8	12	15	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848								10.1126/science.1146084	http://dx.doi.org/10.1126/science.1146084			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932271				2022-12-28	WOS:000250086100016
J	Kroll, J; Dhillon, SS; Marcadet, X; Calligaro, M; Sirtori, C; Unterrainer, K				Kroell, Josef; Dhillon, Sukhdeep S.; Marcadet, Xavier; Calligaro, Michel; Sirtori, Carlo; Unterrainer, Karl			Phase-resolved measurements of stimulated emission in a laser	NATURE			English	Article							WAVE-GUIDES; QUANTUM; POWER	Lasers are usually described by their output frequency and intensity. However, laser operation is an inherently nonlinear process. Knowledge about the dynamic behaviour of lasers is thus of great importance for detailed understanding of laser operation and for improvement in performance for applications. Of particular interest is the time domain within the coherence time of the optical transition. This time is determined by the oscillation period of the laser radiation and thus is very short. Rigorous quantum mechanical models(1,2) predict interesting effects like quantum beats, lasing without inversion, and photon echo processes. As these models are based on quantum coherence and interference, knowledge of the phase within the optical cycle is of particular interest. Laser radiation has so far been measured using intensity detectors, which are sensitive to the square of the electric field. Therefore information about the sign and phase of the laser radiation is lost. Here we use an electro-optic detection scheme to measure the amplitude and phase of stimulated radiation, and correlate this radiation directly with an input probing pulse. We have applied this technique to semiconductor quantum cascade lasers, which are coherent sources operating at frequencies between the optical (> 100 THz) and electronic (< 0.5 THz) ranges(3). In addition to the phase information, we can also determine the spectral gain, the bias dependence of this gain, and obtain an insight into the evolution of the laser field.	Vienna Univ Technol, Photon Inst, A-1040 Vienna, Austria; Univ Paris 07, F-75251 Paris 05, France; Ecole Normale Super, F-75231 Paris 05, France; Alcatel Thales 3 5 Lab, F-91767 Palaiseau, France	Technische Universitat Wien; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Alcatel-Lucent	Unterrainer, K (corresponding author), Vienna Univ Technol, Photon Inst, Gusshausstr 25-29, A-1040 Vienna, Austria.	karl.unterrainer@tuwien.ac.at	Unterrainer, Karl/J-4248-2016	Unterrainer, Karl/0000-0003-1970-9071; Darmo, Juraj/0000-0002-5525-1283; Sirtori, Carlo/0000-0003-1817-4554				Alton J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866639; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Barbieri S, 2004, APPL PHYS LETT, V85, P1674, DOI 10.1063/1.1784874; BENNETT WR, 1962, PHYS REV, V126, P580, DOI 10.1103/PhysRev.126.580; CROWE JW, 1966, IEEE J QUANTUM ELECT, VQE 2, P283, DOI 10.1109/JQE.1966.1074049; Diels J. C., 1996, ULTRASHORT LASER PUL; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; FAIST J, 2000, INTERSUBBAND TRANSIT, V2, P1; HAKEN H, 1975, REV MOD PHYS, V47, P67, DOI 10.1103/RevModPhys.47.67; Huber R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161314; Huber R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017402; Huber R, 2001, NATURE, V414, P286, DOI 10.1038/35104522; Kohen S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1855394; Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a; KROLL J, IN PRESS APPL PHYS L; Nuss M. C., 1998, MILLIMETER SUBMILLIM; OSGOOD RM, 1970, IEEE J QUANTUM ELECT, VQE 6, P145, DOI 10.1109/JQE.1970.1076425; RIGROD WW, 1963, J APPL PHYS, V34, P2602, DOI 10.1063/1.1729777; SCULLY MO, 1967, PHYS REV, V159, P208, DOI 10.1103/PhysRev.159.208; Taflove A., 1995, COMPUTATIONAL ELECTR; Walther C, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404598; Wu Q, 1996, APPL PHYS LETT, V68, P1604, DOI 10.1063/1.115665; ZHANG XC, 1990, APPL PHYS LETT, V56, P1011, DOI 10.1063/1.102601; ZIOLKOWSKI RW, 1995, PHYS REV A, V52, P3082, DOI 10.1103/PhysRevA.52.3082	24	153	154	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					698	U4		10.1038/nature06208	http://dx.doi.org/10.1038/nature06208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928855	Green Submitted			2022-12-28	WOS:000250045000038
J	Patterson, W				Patterson, Walt			Fifty years of hopes and fears	NATURE			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					664	664		10.1038/449664a	http://dx.doi.org/10.1038/449664a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218VV	17928846				2022-12-28	WOS:000250045000027
J	Larson, RG				Larson, Ronald G.			Going with the flow	SCIENCE			English	Editorial Material							DNA; DYNAMICS; ELASTICITY		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Larson, RG (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	rlarson@umich.edu						Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chen YL, 2005, MACROMOLECULES, V38, P6680, DOI 10.1021/ma050238d; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fang L, 2005, J RHEOL, V49, P127, DOI 10.1122/1.1822930; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; Robertson RM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126001; Schroeder CM, 2003, SCIENCE, V301, P1515, DOI 10.1126/science.1086070; Shaqfeh ESG, 2005, J NON-NEWTON FLUID, V130, P1, DOI 10.1016/j.jnnfm.2005.05.011; Weihs D, 2006, BIOPHYS J, V91, P4296, DOI 10.1529/biophysj.106.081109; Zhou Q, 2006, MACROMOLECULES, V39, P6737, DOI 10.1021/ma060670a	16	12	13	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					57	58		10.1126/science.1142441	http://dx.doi.org/10.1126/science.1142441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916719				2022-12-28	WOS:000249915400033
J	Saether, SA; Saetre, GP; Borge, T; Wiley, C; Svedin, N; Andersson, G; Veen, T; Haavie, J; Servedio, MR; Bures, S; Kral, M; Hjernquist, MB; Gustafsson, L; Traff, J; Qvarnstrom, A				Saether, Stein A.; Saetre, Glenn-Peter; Borge, Thomas; Wiley, Chris; Svedin, Nina; Andersson, Gunilla; Veen, Thor; Haavie, Jon; Servedio, Maria R.; Bures, Stanislav; Kral, Miroslav; Hjernquist, Marten B.; Gustafsson, Lars; Traeff, Johan; Qvarnstroem, Anna			Sex chromosome-linked species recognition and evolution of reproductive isolation in flycatchers	SCIENCE			English	Article							SPECIATION; REINFORCEMENT; SELECTION; RECOMBINATION; INHERITANCE; DIVERGENCE; EXPRESSION; GENETICS; LINKAGE; MALES	Interbreeding between species (hybridization) typically produces unfit offspring. Reduced hybridization should therefore be favored by natural selection. However, this is difficult to accomplish because hybridization also sets the stage for genetic recombination to dissociate species-specific traits from the preferences for them. Here we show that this association is maintained by physical linkage (on the same chromosome) in two hybridizing Ficedula flycatchers. By analyzing the mating patterns of female hybrids and cross-fostered offspring, we demonstrate that species recognition is inherited on the Z chromosome, which is also the known location of species-specific male plumage traits and genes causing low hybrid fitness. Limited recombination on the Z chromosome maintains associations of Z-linked genes despite hybridization, suggesting that the sex chromosomes may be a hotspot for adaptive speciation.	Netherlands Inst Ecol, Dept Anim Populat Biol, NL-6666 ZG Heteren, Netherlands; Uppsala Univ, EBC, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; Uppsala Univ, EBC, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Groningen, Ctr Ecol & Evolutionary Studies, Theoret Biol Grp, NL-9751 NN Haren, Netherlands; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Palacky Univ, Ornithol Lab, Olomouc 77146, Czech Republic; Forestry Commiss, Dlouha Loucka 78386, Czech Republic	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Uppsala University; University of Oslo; Uppsala University; Cornell University; University of Groningen; University of North Carolina; University of North Carolina Chapel Hill; Palacky University Olomouc	Saether, SA (corresponding author), Netherlands Inst Ecol, Dept Anim Populat Biol, POB 40, NL-6666 ZG Heteren, Netherlands.	s.a.sather@bio.uio.no	Gustafsson, Lars/A-7634-2012; Svedin, Nina/D-9369-2016; Servedio, Maria R/A-9743-2008; Gustafsson, Lars/O-8056-2019	Gustafsson, Lars/0000-0001-6566-2863; Svedin, Nina/0000-0002-6224-4655; Servedio, Maria R/0000-0002-3965-4445; Gustafsson, Lars/0000-0001-6566-2863; Qvarnstrom, Anna/0000-0002-1178-4053				Coyne J.A., 2004, SPECIATION; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Grant PR, 1997, BIOL J LINN SOC, V60, P317; GRULA JW, 1980, EVOLUTION, V34, P688, DOI 10.1111/j.1558-5646.1980.tb04007.x; Hall DW, 2006, EVOLUTION, V60, P908; Irwin DE, 1999, HEREDITY, V82, P347, DOI 10.1038/sj.hdy.6885270; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Kaiser VB, 2006, EVOLUTION, V60, P1945, DOI 10.1111/j.0014-3820.2006.tb00537.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; KIRKPATRICK M, 2000, AM NAT, V159, P865; Lemmon AR, 2006, GENETICS, V173, P1145, DOI 10.1534/genetics.105.048199; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Ortiz-Barrientos D, 2005, SCIENCE, V310, P1467, DOI 10.1126/science.1121260; Ortiz-Barrientos D, 2002, GENETICA, V116, P167, DOI 10.1023/A:1021296829109; Reeve HK, 2003, P NATL ACAD SCI USA, V100, P1089, DOI 10.1073/pnas.0337427100; Ritchie MG, 1998, ENDLESS FORMS, P291; Saetre GP, 1997, J AVIAN BIOL, V28, P259, DOI 10.2307/3676978; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 1997, NATURE, V387, P589; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Servedio MR, 2000, EVOLUTION, V54, P21, DOI 10.1111/j.0014-3820.2000.tb00003.x; Servedio MR, 2003, P ROY SOC B-BIOL SCI, V270, P1473, DOI 10.1098/rspb.2003.2391; SERVEDIO MR, IN PRESS EVOL ECOL; ten Cate C, 1999, ADV STUD BEHAV, V28, P1; TRICKETT AJ, 1994, HEREDITY, V73, P339, DOI 10.1038/hdy.1994.180; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000	28	186	187	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					95	97		10.1126/science.1141506	http://dx.doi.org/10.1126/science.1141506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916732				2022-12-28	WOS:000249915400048
J	Swigut, T; Wysocka, J				Swigut, Tomek; Wysocka, Joanna			H3K27 demethylases, at long last	CELL			English	Review							HISTONE H3; METHYLATION; LYSINE-4	Methylation of lysine 27 on histone H3 ( H3K27me) by the Polycomb complex (PRC2) proteins is associated with gene silencing in many developmental processes. A cluster of recent papers ( Agger et al., 2007; De Santa et al., 2007; Lan et al., 2007; Lee et al., 2007) identify the JmjC-domain proteins UTX and JMJD3 as H3K27-specific demethylases that remove this methyl mark, enabling the activation of genes involved in animal body patterning and the inflammatory response.	Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu		Swigut, Tomek/0000-0002-7649-6781				AGGER K, 2007, NATURE          0822, DOI DOI 10.1038/NATURE06145; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; DESANTA F, 2007, CELL            0905, DOI DOI 10.1016/J.CELL.2007.08.019; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; LAN F, 2007, NATURE          0912, DOI DOI 10.1038/NATURE06192; Mikkelsen TS, 2007, NATURE; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944	17	230	247	5	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					29	32		10.1016/j.cell.2007.09.026	http://dx.doi.org/10.1016/j.cell.2007.09.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923085	Bronze			2022-12-28	WOS:000249934700008
J	Saltykov, BG				Saltykov, Boris G.			Russian science: Breaking up is hard to do	NATURE			English	Editorial Material									Russian House Int Sci & Technol Cooperat, Moscow, Russia		Saltykov, BG (corresponding author), Russian House Int Sci & Technol Cooperat, Briusov Per 11, Moscow, Russia.							KOUZMINOV Y, 2003, NEW EC CHANCE RUSSIA; *STAT U HIGH SCH E, 2007, SCI IND 2007	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					536	537		10.1038/449536a	http://dx.doi.org/10.1038/449536a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914373				2022-12-28	WOS:000249893500023
J	Soberon, M; Pardo-Lopez, L; Lopez, I; Gomez, I; Tabashnik, BE; Bravo, A				Soberon, Mario; Pardo-Lopez, Liliana; Lopez, Idalia; Gomez, Isabel; Tabashnik, Bruce E.; Bravo, Alejandra			Engineering modified Bt toxins to counter insect resistance	SCIENCE			English	Article							THURINGIENSIS CRY1AB TOXIN; BACILLUS-THURINGIENSIS; PINK-BOLLWORM; HELIOTHIS-VIRESCENS; PORE FORMATION; DOMAIN-II; BINDING; RECEPTOR; OLIGOMERIZATION; LEPIDOPTERA	The evolution of insect resistance threatens the effectiveness of Bacillus thuringiensis (Bt) toxins that are widely used in sprays and transgenic crops. Resistance to Bt toxins in some insects is linked with mutations that disrupt a toxin-binding cadherin protein. We show that susceptibility to the Bt toxin Cry1Ab was reduced by cadherin gene silencing with RNA interference in Manduca sexta, confirming cadherin's role in Bt toxicity. Native Cry1A toxins required cadherin to form oligomers, but modified Cry1A toxins lacking one alpha-helix did not. The modified toxins killed cadherin-silenced M. sexta and Bt-resistant Pectinophora gossypiella that had cadherin deletion mutations. Our findings suggest that cadherin promotes Bt toxicity by facilitating toxin oligomerization and demonstrate that the modified Bt toxins may be useful against pests resistant to standard Bt toxins.	Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico; Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Universidad Nacional Autonoma de Mexico; University of Arizona	Soberon, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Apartado Postal 510-3, Cuernavaca 62250, Morelos, Mexico.	mario@ibt.unam.mx; bravo@ibt.unam.mx	Fernández-López, Sara/B-5573-2015; de la Parra, Maria Alejandra Bravo/R-6740-2017	Fernández-López, Sara/0000-0003-2496-4333; Bravo, Alejandra/0000-0002-7573-7475; Pardo Lopez, Liliana/0000-0002-8927-1733	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER; NIAID NIH HHS [1R01 AI066014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aronson AI, 1999, APPL ENVIRON MICROB, V65, P2503; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Jackson RE, 2007, J ECON ENTOMOL, V100, P180, DOI 10.1603/0022-0493(2007)100[180:CROCHV]2.0.CO;2; JAMES C, 2006, ISAAA BRIEFS, V35, P1; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Likitvivatanavong S, 2006, ARCH BIOCHEM BIOPHYS, V445, P46, DOI 10.1016/j.abb.2005.11.007; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Munoz-Garay C, 2006, J MEMBRANE BIOL, V212, P61, DOI 10.1007/s00232-006-0003-8; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tigue NJ, 2001, APPL ENVIRON MICROB, V67, P5715, DOI 10.1128/AEM.67.12.5715-5720.2001; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	28	177	208	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1640	1642		10.1126/science.1146453	http://dx.doi.org/10.1126/science.1146453			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	17975031				2022-12-28	WOS:000251421700050
J	Miyanishi, M; Tada, K; Koike, M; Uchiyama, Y; Kitamura, T; Nagata, S				Miyanishi, Masanori; Tada, Kazutoshi; Koike, Masato; Uchiyama, Yasuo; Kitamura, Toshio; Nagata, Shigekazu			Identification of Tim4 as a phosphatidylserine receptor	NATURE			English	Article							APOPTOTIC CELLS; IMMUNOGLOBULIN-DOMAIN; DNA-DEGRADATION; GENE FAMILY; ANNEXIN-V; T-CELLS; B-CELLS; MACROPHAGES; EXPRESSION; CLEARANCE	In programmed cell death, a large number of cells undergo apoptosis, and are engulfed by macrophages to avoid the release of noxious materials from the dying cells(1,2). In definitive erythropoiesis, nuclei are expelled from erythroid precursor cells and are engulfed by macrophages. Phosphatidylserine is exposed on the surface of apoptotic cells(3) and on the nuclei expelled from erythroid precursor cells(4); it works as an 'eat me' signal for phagocytes(5,6). Phosphatidylserine is also expressed on the surface of exosomes involved in intercellular signalling(7). Here we established a library of hamster monoclonal antibodies against mouse peritoneal macrophages, and found an antibody that strongly inhibited the phosphatidylserine-dependent engulfment of apoptotic cells. The antigen recognized by the antibody was identified by expression cloning as a type I transmembrane protein called Tim4 (T-cell immunoglobulin- and mucin-domain-containing molecule; also known as Timd4)(8). Tim4 was expressed in Mac1(+) cells in various mouse tissues, including spleen, lymph nodes and fetal liver. Tim4 bound apoptotic cells by recognizing phosphatidylserine via its immunoglobulin domain. The expression of Tim4 in fibroblasts enhanced their ability to engulf apoptotic cells. When the anti-Tim4 monoclonal antibody was administered into mice, the engulfment of apoptotic cells by thymic macrophages was significantly blocked, and the mice developed autoantibodies. Among the other Tim family members, Tim1, but neither Tim2 nor Tim3, specifically bound phosphatidylserine. Tim1- or Tim4-expressing Ba/F3 B cells were bound by exosomes via phosphatidylserine, and exosomes stimulated the interaction between Tim1 and Tim4. These results indicate that Tim4 and Tim1 are phosphatidylserine receptors for the engulfment of apoptotic cells, and may also be involved in intercellular signalling in which exosomes are involved.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Osaka Univ, Sch Med, Dept Genet, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Cell Biol & Neurosci, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Kyoto 6068501, Japan	Kyoto University; Osaka University; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Koike, Masato/F-9584-2010; Nagata, Shigekazu/AAG-3203-2019; Kitamura, Toshio/AAA-2071-2021	Koike, Masato/0000-0002-3174-5684; Nagata, Shigekazu/0000-0001-9758-8426; 				Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Gielen AW, 2005, J NEUROIMMUNOL, V164, P93, DOI 10.1016/j.jneuroim.2005.04.004; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hu B, 2000, J IMMUNOL, V165, P2124, DOI 10.4049/jimmunol.165.4.2124; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; TANAKA Y, 1983, J BIOL CHEM, V258, P1335; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	30	786	824	7	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					435	439		10.1038/nature06307	http://dx.doi.org/10.1038/nature06307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17960135	Green Submitted, Bronze			2022-12-28	WOS:000250918600058
J	Petersen, I; Johnson, AM; Islam, A; Duckworth, G; Livermore, DM; Hayward, AC				Petersen, I.; Johnson, A. M.; Islam, A.; Duckworth, G.; Livermore, D. M.; Hayward, A. C.			Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITAL ADMISSIONS; ACUTE BRONCHITIS; THERAPY; COUGH	Objective To determine the extent to which antibiotics reduce the risk of serious complications after common respiratory tract infections. Design Retrospective cohort study. Setting UK primary care practices contributing to the general practice research database. Data source 3.36 million episodes of respiratory tract infection. Main outcome measures Risk of serious complications in treated and untreated patients in the month after diagnosis: mastoiditis after otitis media, quinsy after sore throat, and pneumonia after upper respiratory tract infection and chest infection. Number of patients needed to treat to prevent one complication. Results Serious complications were rare after upper respiratory tract infections, sore throat, and otitis media, and the number needed to treat was over 4000. The risk of pneumonia after chest infection was high, particularly in elderly people, and was substantially reduced by antibiotic use, with a number needed to treat of 39 forthrose aged >= 65 and 96-119 in younger age groups. Conclusion Antibiotics are not justified to reduce the risk of serious complications for upper respiratory tract infection, sore throat, or otitis media. Antibiotics substantially reduce the risk of pneumonia after chest infection, particularly in elderly people in whom the risk is highest.	UCL, Dept Primary Care & Populat Sci, UCL Ctr Infect Dis Epidemiol, London NW3 2PQ, England; Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England	University of London; University College London; Health Protection Agency	Hayward, AC (corresponding author), UCL, Dept Primary Care & Populat Sci, UCL Ctr Infect Dis Epidemiol, London NW3 2PQ, England.	a.hayward@pcps.ucl.ac.uk	Petersen, Irene/I-2751-2012; Franzeck, Fabian C/B-5055-2011; Hayward, Andrew C/C-3268-2013; Petersen, Irene/C-5702-2009	Hayward, Andrew C/0000-0002-3549-6232; Petersen, Irene/0000-0002-0037-7524; Johnson, Anne/0000-0003-1330-7100	Medical Research Council [G0601726] Funding Source: Medline; MRC [G0601726] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arroll B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub2; Ashworth M, 2004, J PUBLIC HEALTH-UK, V26, P268, DOI 10.1093/pubmed/fdh160; BENNIKE T, 1951, ACTA MED SCAND, V139, P253; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Carstairs V., 1991, DEPRIVATION HLTH SCO; *DEP HLTH, 1999, ANT DONT WEAR ME OUT; Fahey T, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000245.PUB2; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; Little P, 2002, BRIT J GEN PRACT, V52, P187; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Mainous AG, 2006, J ROY SOC MED, V99, P358, DOI 10.1258/jrsm.99.7.358; Majeed A, 2004, BRIT MED J, V329, P879, DOI 10.1136/bmj.329.7471.879; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; *NAT PRESCR CTR, 2006, MEREC B, V17; Perry J, 1978, OXMIS PROBLEM CODES; Pratter MR, 2006, CHEST, V129, p72S, DOI 10.1378/chest.129.1_suppl.72S; Sanders S, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000219.PUB2; Sharland M, 2005, BMJ-BRIT MED J, V331, P328, DOI 10.1136/bmj.38503.706887.AE1; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Standing Medical Advisory Committee: Sub-group on Antimicrobial Resistance, 1998, PATH LEAST RES; Venekamp RP, 2015, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000219.PUB4, 10.1002/14651858.CD000219.pub4]	23	185	186	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					982	984A		10.1136/bmj.39345.405243.BE	http://dx.doi.org/10.1136/bmj.39345.405243.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17947744	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000250990400044
J	Tonks, A				Tonks, Alison			Lyme wars	BMJ-BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Tonks, A (corresponding author), BMJ, London WC1H 9JR, England.	atonks@bmj.com						[Anonymous], 2005, MMWR; Cameron Daniel, 2004, Expert Rev Anti Infect Ther, V2, pS1; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; *CT DEP PUBL HLTH, 2007, LYM DIS; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; MASUR H, 2007, COMMUNICATION   0807; SMITH P, STATE LEGISLATION LI; *STAT CT ATT GEN O, 2004, VERB P PUBL HEAR STA; Tibbles CD, 2007, JAMA-J AM MED ASSOC, V297, P2617, DOI 10.1001/jama.297.23.2617; Wormser GP, 2006, NEW ENGL J MED, V354, P2794, DOI 10.1056/NEJMcp061181; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; 2007, IDSA NEWS, V17	13	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2007	335	7626					910	912		10.1136/bmj.39363.530961.AD	http://dx.doi.org/10.1136/bmj.39363.530961.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17974685	Green Published			2022-12-28	WOS:000250848300027
J	Victor, JC; Monto, AS; Surdina, TY; Suleimenova, SZ; Vaughan, G; Nainan, OV; Favorov, MO; Margolis, HS; Bell, BP				Victor, John C.; Monto, Arnold S.; Surdina, Tatiyana Y.; Suleimenova, Saida Z.; Vaughan, Gilberto; Nainan, Omana V.; Favorov, Michael O.; Margolis, Harold S.; Bell, Beth P.			Hepatitis A vaccine versus immune globulin for postexposure prophylaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FECAL EXCRETION; SERUM GLOBULIN; INFECTIOUS-HEPATITIS; GAMMA-GLOBULIN; VIRUS; TRANSMISSION; PREVENTION; EFFICACY; OUTBREAK; SIZE	Background Hepatitis A vaccine administered to persons after exposure to the hepatitis A virus has not been compared directly with immune globulin, which is known to be highly effective in preventing hepatitis A when given within 2 weeks after exposure to the virus. Methods We randomly assigned household and day-care contacts, 2 to 40 years of age, in Almaty, Kazakhstan, to receive one standard age-appropriate dose of hepatitis A vaccine or immune globulin within 14 days after exposure to patients with hepatitis A. Instances of laboratory-confirmed, symptomatic hepatitis A infection occurring between 15 and 56 days after exposure were then assessed during active follow-up of all susceptible contacts. Results Of 4524 contacts who underwent randomization, 1414 (31%) were susceptible to hepatitis A virus and 1090 were eligible for the per-protocol analysis. Among these contacts, 568 received hepatitis A vaccine and 522 received immune globulin. Most contacts were children (average age, 12 years), and most received prophylaxis during the second week after exposure (average interval after exposure, 10 days). The baseline characteristics of the contacts were similar in the two groups. Symptomatic infection with hepatitis A virus was confirmed in 25 contacts receiving vaccine (4.4%) and in 17 contacts receiving immune globulin (3.3%) (relative risk, 1.35; 95% confidence interval, 0.70 to 2.67). Conclusions Low rates of hepatitis A in both groups indicate that hepatitis A vaccine and immune globulin provided good protection after exposure. Although the study's prespecified criterion for noninferiority was met, the slightly higher rates of hepatitis A among vaccine recipients may indicate a true modest difference in efficacy and might be clinically meaningful in some settings. Vaccine has other advantages, including long-term protection, and it may be a reasonable alternative to immune globulin for postexposure prophylaxis in many situations.	Univ Michigan, Ann Arbor, MI 48109 USA; Kazakhstan Minist Hlth, Alma Ata, Kazakhstan; Ctr Dis Control & Prevent, Atlanta, GA USA	University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA	Victor, JC (corresponding author), Program Appropriate Technol Hlth, 1455 NW Leary Way, Seattle, WA 98107 USA.	cvictor@path.org		Victor, John/0000-0002-7970-6588				*ACIP, IN PRESS MMWR MORB M; ASHLEY A, 1954, NEW ENGL J MED, V250, P412, DOI 10.1056/NEJM195403112501003; Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518; BLACKWELDER WC, 1998, ENCY BIOSTATISTICS, P1367; Bower WA, 2000, J INFECT DIS, V182, P12, DOI 10.1086/315701; BROOKS BF, 1953, NEW ENGL J MED, V249, P58, DOI 10.1056/NEJM195307092490202; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Crowcroft N S, 2001, Commun Dis Public Health, V4, P213; DHONDT E, 1995, J INFECT DIS, V171, pS40, DOI 10.1093/infdis/171.Supplement_1.S40; Fiore Anthony E., 2006, Morbidity and Mortality Weekly Report, V55, P1; HADLER SC, 1980, NEW ENGL J MED, V302, P1222, DOI 10.1056/NEJM198005293022203; HSIA DYY, 1954, NEW ENGL J MED, V250, P417, DOI 10.1056/NEJM195403112501004; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; KLUGE T, 1963, ACTA MED SCAND, V174, P469; LANDRIGAN PJ, 1973, JAMA-J AM MED ASSOC, V223, P74, DOI 10.1001/jama.223.1.74; LEDNAR WM, 1985, AM J EPIDEMIOL, V122, P226, DOI 10.1093/oxfordjournals.aje.a114093; MOSLEY JW, 1968, AM J EPIDEMIOL, V87, P539, DOI 10.1093/oxfordjournals.aje.a120845; National Advisory Committee on Immunization (NACI), 2000, CAN COMMUN DIS REP, V26, P12; RAKELA J, 1977, J INFECT DIS, V135, P933, DOI 10.1093/infdis/135.6.933; Rein DB, 2007, PEDIATRICS, V119, pE12, DOI 10.1542/peds.2006-1573; ROBERTSON BH, 1994, J MED VIROL, V43, P249, DOI 10.1002/jmv.1890430310; ROSENBLUM LS, 1991, J INFECT DIS, V164, P476, DOI 10.1093/infdis/164.3.476; Sagliocca L, 2005, VACCINE, V23, P910, DOI 10.1016/j.vaccine.2004.07.035; Sagliocca L, 1999, LANCET, V353, P1136, DOI 10.1016/S0140-6736(98)08139-2; SHOUVAL D, 1993, VACCINE, V11, pS9, DOI 10.1016/0264-410X(93)90151-M; SILVERBE.M, 1970, AM J DIS CHILD, V119, P117, DOI 10.1001/archpedi.1970.02100050119005; SKINHOJ P, 1981, SCAND J GASTROENTERO, V16, P1057, DOI 10.3109/00365528109181028; Sonder GJB, 2004, AM J PUBLIC HEALTH, V94, P1620, DOI 10.2105/AJPH.94.9.1620; STOKES J, 1945, JAMA-J AM MED ASSOC, V127, P144, DOI 10.1001/jama.1945.02860030016004; Taliani G, 2003, VACCINE, V21, P2234, DOI 10.1016/S0264-410X(03)00138-5; TASSOPOULOS NC, 1986, J INFECT DIS, V154, P231, DOI 10.1093/infdis/154.2.231; Victor JC, 2006, EPIDEMIOL INFECT, V134, P492, DOI 10.1017/S0950268805005194; Victor JC, 2006, AM J EPIDEMIOL, V163, P204, DOI 10.1093/aje/kwj029; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P45	37	122	127	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1685	1694		10.1056/NEJMoa070546	http://dx.doi.org/10.1056/NEJMoa070546			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17947390				2022-12-28	WOS:000250355100004
J	Currey, B; Quamruzzaman, Q; Rahman, M				Currey, Bruce; Quamruzzaman, Quazi; Rahman, Mahmuder			Can the WHO Ministerial Forum lead to the eradication of TB?	LANCET			English	Editorial Material							TUBERCULOSIS		Dhaka Community Hosp, Dhaka 1217, Bangladesh		Currey, B (corresponding author), Dhaka Community Hosp, Dhaka 1217, Bangladesh.	scurrey@agni.com						Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P741; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; *COUNC EUR UN, 2005, JOINT STAT COUNC REP; DECOLOMBANI P, 2003, EUROPEAN FRAMEWORK D; ENARSON DA, 2005, B WORLD HEALTH ORGAN, V85, P395; FABER KNUD, 1938, ADA TUBERC SCAND, V12, P287; *OP SOC I, 2007, UNT POT ENG CIV SOC; Rook GAW, 2007, J INFECT DIS, V196, P191, DOI 10.1086/518937; Schwartzman K, 2002, CAN MED ASSOC J, V166, P759; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; THORSON A, 2003, RETURN WHITE PLAGUE, P54; *WHO REG OFF EUR, 2007, WHO EUR MIN FOR ALL; 2007, BBC NEWS        0730	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1401	1403		10.1016/S0140-6736(07)61589-X	http://dx.doi.org/10.1016/S0140-6736(07)61589-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950851				2022-12-28	WOS:000250386000008
J	Jeyaprakash, AA; Klein, UR; Lindner, D; Ebert, J; Nigg, EA; Conti, E				Jeyaprakash, A. Arockia; Klein, Ulf R.; Lindner, Doris; Ebert, Judith; Nigg, Erich A.; Conti, Elena			Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together	CELL			English	Article							AURORA-B KINASE; SPLICE VARIANTS; CENTRAL SPINDLE; PROTEIN; CENTROMERE; PHOSPHORYLATION; ACTIVATION; REQUIRES; MITOSIS; BIR-1	The chromosomal passenger complex (CPC) is a key regulator of chromosome segregation and cytokinesis. CPC functions are connected to its localization. The complex first localizes to centromeres and later associates with the central spindle and midbody. Survivin, Borealin, and INCENP are the three components of the CPC that regulate the activity and localization of its enzymatic component, the kinase Aurora B. We determined the 1.4 A resolution crystal structure of the regulatory core of the CPC, revealing that Borealin and INCENP associate with the helical domain of Survivin to form a tight three-helical bundle. We used siRNA rescue experiments with structure-based mutants to explore the requirements for CPC localization. We show that the intertwined structural interactions of the core components lead to functional interdependence. Association of the core `` passenger'' proteins creates a single structural unit, whose composite molecular surface presents conserved residues essential for central spindle and midbody localization.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Conti, E (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	conti@embl.de	Arulanandam, Arockia Jeyaprakash/Y-5885-2019	Arulanandam, Arockia Jeyaprakash/0000-0002-1889-8635; Conti, Elena/0000-0003-1254-5588; nigg, erich/0000-0003-4835-5719				Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Cao LH, 2006, BIOCHEM BIOPH RES CO, V346, P400, DOI 10.1016/j.bbrc.2006.05.131; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser AG, 1999, CURR BIOL, V9, P292, DOI 10.1016/S0960-9822(99)80137-7; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Gorbsky GJ, 2004, CURR BIOL, V14, pR346, DOI 10.1016/j.cub.2004.04.022; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lens SMA, 2006, MOL BIOL CELL, V17, P1897, DOI 10.1091/mbc.E05-08-0727; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Lens SMA, 2003, CELL CYCLE, V2, P507, DOI 10.4161/cc.2.6.559; Li F, 2005, BRIT J CANCER, V92, P212, DOI 10.1038/sj.bjc.6602340; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Song ZY, 2004, MOL BIOL CELL, V15, P1287, DOI 10.1091/mbc.E03-07-0512; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Tanaka TU, 2005, PHILOS T R SOC B, V360, P581, DOI 10.1098/rstb.2004.1612; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	48	242	258	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					271	285		10.1016/j.cell.2007.07.045	http://dx.doi.org/10.1016/j.cell.2007.07.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956729	Green Accepted, Bronze			2022-12-28	WOS:000250507700018
J	Kokovay, E; Temple, S				Kokovay, Erzsebet; Temple, Sally			Taking neural crest stem cells to new heights	CELL			English	Editorial Material							ASTROCYTES	The carotid body is an organ of the peripheral nervous system that senses oxygen concentration in the blood and responds to changes by regulating breathing. Pardal et al. ( 2007) now report the discovery of carotid body stem cells, which proliferate in response to hypoxia and generate neurons that secrete dopamine. This new source of adult stem cells may be useful in therapies for treating Parkinson's disease.	New York Stem Cell Inst, Rensselaer, NY 12114 USA; Albany Med Coll, Ctr Neurosci & Neuropharmacol, Albany, NY 12208 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA	The New York Stem Cell Foundation; Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Temple, S (corresponding author), New York Stem Cell Inst, Rensselaer, NY 12114 USA.	sallytemple@nynsci.org						Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Espejo EF, 1998, NEURON, V20, P197, DOI 10.1016/S0896-6273(00)80449-3; FERNANDES KJ, 2007, PHILOS T R SOC LON B; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Minguez-Castellanos A, 2007, J NEUROL NEUROSUR PS, V78, P825, DOI 10.1136/jnnp.2006.106021; PARDAL R, 2007, CELL; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003	9	9	10	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					234	236		10.1016/j.cell.2007.10.006	http://dx.doi.org/10.1016/j.cell.2007.10.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956725	Bronze			2022-12-28	WOS:000250507700014
J	Naucler, P; Ryd, W; Tornberg, S; Strand, A; Wadell, G; Elfgren, K; Radberg, T; Strander, B; Forslund, O; Hansson, B; Rylander, E; Dillner, J				Naucler, Pontus; Ryd, Walter; Tornberg, Sven; Strand, Anders; Wadell, Goran; Elfgren, Kristina; Radberg, Thomas; Strander, Bjorn; Forslund, Ola; Hansson, Bengt-Goran; Rylander, Eva; Dillner, Joakim			Human papillomavirus and papanicolaou tests to screen for cervical cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIGH-RISK HPV; LIQUID-BASED CYTOLOGY; YOUNG-WOMEN; POPULATION; RECRUITMENT; PERSISTENCE; PREVALENCE; NEOPLASIA; INFECTION	Background Screening for cervical cancer based on testing for human papillomavirus (HPV) increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia, but whether this gain represents overdiagnosis or protection against future high-grade cervical epithelial neoplasia or cervical cancer is unknown. Methods In a population-based screening program in Sweden, 12,527 women 32 to 38 years of age were randomly assigned at a 1:1 ratio to have an HPV test plus a Papanicolaou (Pap) test (intervention group) or a Pap test alone (control group). Women with a positive HPV test and a normal Pap test result were offered a second HPV test at least 1 year later, and those who were found to be persistently infected with the same high-risk type of HPV were then offered colposcopy with cervical biopsy. A similar number of double-blinded Pap smears and colposcopies with biopsy were performed in randomly selected women in the control group. Comprehensive registry data were used to follow the women for a mean of 4.1 years. The relative rates of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected at enrollment and at subsequent screening examinations were calculated. Results At enrollment, the proportion of women in the intervention group who were found to have lesions of grade 2 or 3 cervical intraepithelial neoplasia or cancer was 51% greater (95% confidence interval [CI], 13 to 102) than the proportion of women in the control group who were found to have such lesions. At subsequent screening examinations, the proportion of women in the intervention group who were found to have grade 2 or 3 lesions or cancer was 42% less (95% CI, 4 to 64) and the proportion with grade 3 lesions or cancer was 47% less (95% CI, 2 to 71) than the proportions of control women who were found to have such lesions. Women with persistent HPV infection remained at high risk for grade 2 or 3 lesions or cancer after referral for colposcopy. Conclusions The addition of an HPV test to the Pap test to screen women in their mid-30s for cervical cancer reduces the incidence of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected by subsequent screening examinations.	Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, S-20502 Malmo, Sweden; Sahlgrens Univ Hosp, Dept Pathol & Clin Cytol, Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; Sahlgrens Univ Hosp, Ctr Oncol, Gothenburg, Sweden; Karolinska Univ Hosp, Canc Screening Unit, Ctr Oncol, Stockholm, Sweden; Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; Karolinska Inst, Danderyd Hosp, Div Gynecol, Stockholm, Sweden; Univ Hosp, Dept Med Dermatol & Venereol, Uppsala, Sweden; Univ No Sweden, Dept Virol, Umea, Sweden	Lund University; Skane University Hospital; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital	Dillner, J (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, S-20502 Malmo, Sweden.		Strander, Björn/AAB-2609-2021	Strander, Björn/0000-0001-8369-7955				ARBYN M, 2007, EUROPEAN GUIDELINES; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Bulkmans NWJ, 2005, BRIT J CANCER, V92, P1800, DOI 10.1038/sj.bjc.6602541; CLAVEL C, 2004, BRIT J CANCER, V90, P183; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Day NE, 2005, BREAST CANCER RES, V7, P228, DOI 10.1186/bcr1321; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; EVANDER M, 1995, J INFECT DIS, V171, P1026, DOI 10.1093/infdis/171.4.1026; Forslund O, 2002, J MED VIROL, V66, P535, DOI 10.1002/jmv.2178; Forslund O, 2002, J MED VIROL, V67, P467; HAGMAR B, 1995, ACTA CYTOL, V39, P741; Hoyer H, 2005, INT J CANCER, V116, P136, DOI 10.1002/ijc.20955; HUSMAN AMD, 1995, J MED VIROL, V46, P97, DOI 10.1002/jmv.1890460203; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Koss L. G, 1979, DIAGNOSTIC CYTOLOGY; Kotaniemi-Talonen L, 2005, BRIT J CANCER, V93, P862, DOI 10.1038/sj.bjc.6602799; Mayrand MH, 2006, INT J CANCER, V119, P615, DOI 10.1002/ijc.21897; *NAT BOARD HLTH WE, 2007, CANC INC SWED 2005; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8	29	593	617	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1589	1597		10.1056/NEJMoa073204	http://dx.doi.org/10.1056/NEJMoa073204			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942872				2022-12-28	WOS:000250200500004
J	Felson, DT; Niu, J; McClennan, C; Sack, B; Aliabadi, P; Hunter, DJ; Guermazi, A; Englund, M				Felson, David T.; Niu, Jingbo; McClennan, Christine; Sack, Burton; Aliabadi, Piran; Hunter, David J.; Guermazi, Ali; Englund, Martin			Knee buckling: Prevalence, risk factors, and associated limitations in function	ANNALS OF INTERNAL MEDICINE			English	Article							RADIOGRAPHIC OSTEOARTHRITIS; INSTABILITY; PAIN; RELIABILITY; ARTHRITIS; VALIDITY; FALLS; VIEW; HIP	Background: Knee buckling is common in persons with advanced knee osteoarthritis and after orthopedic procedures. Its prevalence in the community is unknown. Objective: To examine the prevalence of knee buckling in the community, its associated risk factors, and its relation to functional limitation. Design: Cross-sectional, population -based study. Setting: The Framingham Osteoarthritis Study. Participants: 2351 men and women age 36 to 94 years (median, 63.5 years). Measurements: Participants were asked whether they had experienced knee buckling or "giving way" and whether it led to falling. They were also asked about knee pain and limitations in function by using the Short Form-12 and Western Ontario and McMaster Universities Osteoarthritis Index, had isometric tests of quadriceps strength, and underwent weight-bearing radiography and magnetic resonance imaging of the knee. Radiographs were scored for osteoarthritis by using the Kellgren-Lawrence scale, and magnetic resonance images were read for anterior cruciate ligament tears. The relationship of buckling to functional limitation was examined by using logistic regression that adjusted for age, sex, body mass index, and knee pain severity. Results: Two hundred seventy-eight participants (11.8%) experienced at least 1 episode of knee buckling within the past 3 months; of these persons, 217 (78.1 %) experienced more than 1 episode and 35 (12.6%) fell during an episode. Buckling was independently associated with the presence of knee pain and with quadriceps weakness. Over half of those with buckling had no osteoarthritis on radiography. Persons with knee buckling had worse physical function than those without buckling, even after adjustment for severity of knee pain and weakness. For example, 46.9% of participants with buckling and 21.7% of those without buckling reported limitations in their work (adjusted odds ratio, 2.0 [95% Cl, 1.5 to 2.71). Limitation: Causal inferences are limited because of the study's cross-sectional design. Conclusion: In adults, knee buckling is common and is associated with functional loss.	Boston Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02118 USA; Boston Univ, Med Ctr, Boston, MA USA	Boston University; Harvard University; Brigham & Women's Hospital; Boston University	Felson, DT (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Unit, Suite 200,650 Albany St, Boston, MA 02118 USA.	jendez@bu.edu	Englund, Martin/J-7245-2012; Hunter, David J/A-4622-2010	Englund, Martin/0000-0003-3320-2437; Hunter, David J/0000-0003-3197-752X; Sack, Burton/0000-0002-8458-1062; Niu, Jingbo/0000-0002-6170-1965; Felson, David/0000-0002-2668-2447	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195] Funding Source: Medline; NIAMS NIH HHS [AR47785] Funding Source: Medline; NIA NIH HHS [AG18393] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arden NK, 2006, ARTHRIT RHEUM-ARTHR, V55, P610, DOI 10.1002/art.22088; Arden NK, 1999, ARTHRITIS RHEUM, V42, P1378, DOI 10.1002/1529-0131(199907)42:7<1378::AID-ANR11>3.0.CO;2-I; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BRANDT KD, 2005, HARRISONS ONLINE; Cummings JR, 2005, SEMIN MUSCULOSKEL R, V9, P5, DOI 10.1055/s-2005-867100; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Felson DT, 1997, OSTEOARTHR CARTILAGE, V5, P241, DOI 10.1016/S1063-4584(97)80020-9; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2004, J RHEUMATOL, V31, P2; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Fitzgerald GK, 2004, ARTHRIT RHEUM-ARTHR, V51, P941, DOI 10.1002/art.20825; Fitzgerald GK, 2002, PHYS THER, V82, P372, DOI 10.1093/ptj/82.4.372; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Houck J, 2003, J ORTHOP SPORT PHYS, V33, P273, DOI 10.2519/jospt.2003.33.5.273; Hurst NP, 1998, BRIT J RHEUMATOL, V37, P862; KALUNIAN KC, 2007, UPTODATE ONLINE VERS; Karlson Elizabeth W., 1995, Annals of Epidemiology, V5, P297, DOI 10.1016/1047-2797(94)00096-C; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; LaValley MP, 2005, ARTHRITIS RHEUM-US, V52, P3542, DOI 10.1002/art.21374; Neyret P, 2002, KNEE, V9, P3, DOI 10.1016/S0968-0160(01)00136-3; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams GN, 2005, J BIOMECH, V38, P685, DOI 10.1016/j.jbiomech.2004.04.004; Yercan HS, 2005, KNEE, V12, P336, DOI 10.1016/j.knee.2005.01.005	24	117	118	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					534	540		10.7326/0003-4819-147-8-200710160-00005	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938391				2022-12-28	WOS:000250437100002
J	Owen, PJD; Baghomian, A; Lazarus, JH; Godkin, AJ				Owen, P. J. D.; Baghomian, A.; Lazarus, J. H.; Godkin, A. J.			Lesson of the week - An unusual cause of jaundice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERTHYROIDISM		Univ Wales Hosp, Ctr Endocrine & Diabet Sci, Cardiff, Wales; Glan Clwyd Gen Hosp, Dept Gastroenterol, Rhyl, Wales; Univ Wales Hosp, Dept Integrated Med, Cardiff, Wales	Cardiff University; Cardiff University	Owen, PJD (corresponding author), Univ Wales Hosp, Ctr Endocrine & Diabet Sci, Cardiff, Wales.	pennyowen74@yahoo.co.uk	Lazarus, John H/H-5108-2017	Lazarus, John H/0000-0001-8852-704X; Godkin, Andrew/0000-0002-1910-7567				Biscoveanu M, 2000, Endocr Pract, V6, P367; COOPER DS, 1996, THYROID; CROWE JP, 1980, GASTROENTEROLOGY, V78, P1437; FONG TL, 1992, J CLIN GASTROENTEROL, V14, P240, DOI 10.1097/00004836-199204000-00010; Hasan MK, 2004, AM J MED SCI, V328, P348, DOI 10.1016/S0002-9629(15)33945-8; HUANG MJ, 1995, J GASTROEN HEPATOL, V10, P344, DOI 10.1111/j.1440-1746.1995.tb01106.x; Nobili V, 2005, THYROID, V15, P1193, DOI 10.1089/thy.2005.15.1193; Ohshima T, 1990, Nihon Hoigaku Zasshi, V44, P365; TADA H, 1994, ENDOCR J, V41, P541, DOI 10.1507/endocrj.41.541; Upadhyay G, 2004, HEPATOLOGY, V39, P1120, DOI 10.1002/hep.20085; Venditti P, 2006, J EXP BIOL, V209, P817, DOI 10.1242/jeb.02045; Williams KV, 1997, J CLIN ENDOCR METAB, V82, P1727, DOI 10.1210/jc.82.6.1727	12	9	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2007	335	7623					773	774		10.1136/bmj.39247.452141.BE	http://dx.doi.org/10.1136/bmj.39247.452141.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17932209	Green Published			2022-12-28	WOS:000250418600038
J	Wu, J; Brown, SHJ; von Daake, S; Taylor, SS				Wu, Jian; Brown, Simon H. J.; von Daake, Sventja; Taylor, Susan S.			PKA type IIa holoenzyme reveals a combinatorial strategy for isoform diversity	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CAMP BINDING DOMAIN; REGULATORY SUBUNIT; CATALYTIC-SUBUNIT; CRYSTAL-STRUCTURE; RI-ALPHA; I-ALPHA; MECHANISM; MODULE	The catalytic (C) subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) is inhibited by two classes of regulatory subunits, RI and RII. The RII subunits are substrates as well as inhibitors and do not require adenosine triphosphate (ATP) to form holoenzyme, which distinguishes them from RI subunits. To understand the molecular basis for isoform diversity, we solved the crystal structure of an RII alpha holoenzyme and compared it to the RI alpha holoenzyme. Unphosphorylated RII alpha(90-400), a deletion mutant, undergoes major conformational changes as both of the cAMP-binding domains wrap around the C subunit's large lobe. The hallmark of this conformational reorganization is the helix switch in domain A. The C subunit is in an open conformation, and its carboxyl-terminal tail is disordered. This structure demonstrates the conserved and isoform-specific features of RI and RII and the importance of ATP, and also provides a new paradigm for designing isoform-specific activators or antagonists for PKA.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	staylor@ucsd.edu	Brown, Simon/A-3261-2009	Brown, Simon/0000-0003-3997-4614	NCI NIH HHS [T32-CA009524] Funding Source: Medline; NIGMS NIH HHS [GM34921, R01 GM034921-23, R01 GM034921] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; ERLICHMAN J, 1974, J BIOL CHEM, V249, P5000; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; GILL GN, 1971, P NATL ACAD SCI USA, V68, P786, DOI 10.1073/pnas.68.4.786; Heller WT, 2004, J BIOL CHEM, V279, P19084, DOI 10.1074/jbc.M313405200; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; Huang LJS, 1998, J BIOL CHEM, V273, P26739, DOI 10.1074/jbc.273.41.26739; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Li F, 2000, BIOCHEMISTRY-US, V39, P15626, DOI 10.1021/bi002196l; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Vigil D, 2005, J BIOL CHEM, V280, P35521, DOI 10.1074/jbc.M506769200; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	23	89	93	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					274	279		10.1126/science.1146447	http://dx.doi.org/10.1126/science.1146447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932298	Green Accepted			2022-12-28	WOS:000250086100048
J	Hittinger, CT; Carroll, SB				Hittinger, Chris Todd; Carroll, Sean B.			Gene duplication and the adaptive evolution of a classic genetic switch	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; TRANSCRIPTIONAL INDUCER; GENOME DUPLICATION; GAL GENES; EXPRESSION; DIVERGENCE; GALACTOKINASE; ELEMENTS; PROTEIN	How gene duplication and divergence contribute to genetic novelty and adaptation has been of intense interest, but experimental evidence has been limited. The genetic switch controlling the yeast galactose use pathway includes two paralogous genes in Saccharomyces cerevisiae that encode a co-inducer (GAL3) and a galactokinase (GAL1). These paralogues arose from a single bifunctional ancestral gene as is still present in Kluyveromyces lactis. To determine which evolutionary processes shaped the evolution of the two paralogues, here we assess the effects of precise replacement of coding and non-coding sequences on organismal fitness. We suggest that duplication of the ancestral bifunctional gene allowed for the resolution of an adaptive conflict between the transcriptional regulation of the two gene functions. After duplication, previously disfavoured binding site configurations evolved that divided the regulation of the ancestral gene into two specialized genes, one of which ultimately became one of the most tightly regulated genes in the genome.	Univ Wisconsin, Howard Hughes Med Inst, Genet Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Hittinger, CT (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Genet Lab, 1525 Linden Dr, Madison, WI 53706 USA.	cthittinger@wustl.edu						BAJWA W, 1988, MOL CELL BIOL, V8, P3439, DOI 10.1128/MCB.8.8.3439; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Brachmann CB, 1998, YEAST, V14, P115; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Force A, 1999, GENETICS, V151, P1531; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HARTL DL, 1997, PRINCIPLES POPULATIO, V216; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; IRWIN DM, 1992, ANIM GENET, V23, P193, DOI 10.1111/j.1365-2052.1992.tb00131.x; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; MEYER J, 1991, MOL CELL BIOL, V11, P5454, DOI 10.1128/MCB.11.11.5454; Ohno S., 1970, EVOLUTION GENE DUPLI; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Piatigorsky J., 2007, GENE SHARING EVOLUTI; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Ptashne M, 2001, GENES SIGNALS; Rubio-Texeira M, 2005, FEMS YEAST RES, V5, P1115, DOI 10.1016/j.femsyr.2005.05.003; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Tumpel S, 2006, P NATL ACAD SCI USA, V103, P5419, DOI 10.1073/pnas.0600993103; van Hoof A, 2005, GENETICS, V171, P1455, DOI 10.1534/genetics.105.044057; Wagner A, 2002, MOL BIOL EVOL, V19, P1760, DOI 10.1093/oxfordjournals.molbev.a003998; WEBSTER TD, 1988, NUCLEIC ACIDS RES, V16, P8011, DOI 10.1093/nar/16.16.8011; Weinreich DM, 2005, EVOLUTION, V59, P1165; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yano KI, 1997, P NATL ACAD SCI USA, V94, P1721, DOI 10.1073/pnas.94.5.1721; Yokoyama S, 2002, GENE, V300, P69, DOI 10.1016/S0378-1119(02)00845-4; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852	50	295	303	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					677	U1		10.1038/nature06151	http://dx.doi.org/10.1038/nature06151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928853				2022-12-28	WOS:000250045000034
J	Boggia, J; Li, Y; Thijs, L; Hansen, TW; Kikuya, M; Bjorklund-Bodegard, K; Richart, T; Ohkuba, T; Kuznetsova, T; Torp-Pedersen, C; Lind, L; Ibsen, H; Imaiji, Y; Wang, JG; Sandoya, E; O'Brien, E; Staessen, JA				Boggia, Jose; Li, Yan; Thijs, Lutgarde; Hansen, Tine W.; Kikuya, Masahiro; Bjorklund-Bodegard, Kristina; Richart, Tom; Ohkuba, Tkayashi; Kuznetsova, Tatiana; Torp-Pedersen, Christian; Lind, Lars; Ibsen, Hans; Imaiji, Yutaka; Wang, Jiguang; Sandoya, Edgardp; O'Brien, Eoin; Staessen, Jan A.		ICADO Investigators	Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study	LANCET			English	Article							CARDIOVASCULAR RISK; REFERENCE VALUES; WHITE-COAT; HYPERTENSION; MORTALITY; ASSOCIATION; SLEEP; REPRODUCIBILITY; PREDICTORS; EXCRETION	Background Few studies have formally compared the predictive value of the blood pressure at night over and beyond the daytime value. We investigated the prognostic significance of the ambulatory blood pressure during night and day and of the night-to-day blood pressure ratio. Methods We did 24-h blood pressure monitoring in 7458 people (mean age 56.8 years [SD 13.9]) enrolled in prospective population studies in Denmark, Belgium, Japan, Sweden, Uruguay, and China. We calculated multivariate-adjusted hazard ratios for daytime and night-time blood pressure and the systolic night-to-day ratio, while adjusting for cohort and cardiovascular risk factors. Findings Median follow-up was 9.6 years (5th to 95th percentile 2.5-13.7). Adjusted for daytime blood pressure, night-time blood pressure predicted total (n=983; p<0.0001), cardiovascular (n=387; p<0.01), and non-cardiovascular (n=560; p<0.001) mortality. Conversely, adjusted for night-time blood pressure, daytime blood pressure predicted only non-cardiovascular mortality (p<0.05), with lower blood pressure levels being associated with increased risk. Both daytime and night-time blood pressure consistently predicted all cardiovascular events (n=943; p<0.05) and stroke (n=420; p<0.01). Adjusted for night-time blood pressure, daytime blood pressure lost prognostic significance only for cardiac events (n=525; p >= 0.07). Adjusted for the 24-h blood pressure, night-to-day ratio predicted mortality, but not fatal combined with non-fatal events. Antohypertensive drug treatment removed the significant association between cardiovascular events and the daytime blood pressure. Participants with systolic night-to-day ratio value of 1 or more were older, at higher risk of death, and died at an older age than those whose night-to-day ratio was normal (>= 0.80 to <0.90). Interpretation In contrast to commonly held views, daytime blood pressure adjusted for night-time blood pressure predicts fatal combined with non-fatal cardiovascular events, except in treated patients, in whom antihypertensive drugs might reduce blood pressure during the day, but not at night. The increased mortality in patients with higher night-time than daytime blood pressure probably indicates reverse causality. Our findings support recording the ambulatory blood pressure during the whole day.	Univ Louvain, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, B-3000 Louvain, Belgium; Univ Republica, Hosp Clin, Dept Fisiopatol, Montevideo, Uruguay; Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Ctr Epidemiol Studies & Clin Trials, Shanghai 200030, Peoples R China; Res Ctr Prevent & Hlth, Copenhagen, Denmark; Tohoku Univ, Grad Sch Pharmaceut Sci & Med, Sendai, Miyagi 980, Japan; Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, Uppsala, Sweden; Copenhagen Univ Hosp, Copenhagen, Denmark; Asociac Espanola Primera Socorros Mutuos, Montevideo, Uruguay; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	Universidad de la Republica, Uruguay; Shanghai Jiao Tong University; Tohoku University; Uppsala University; University of Copenhagen; University College Dublin	Staessen, JA (corresponding author), Univ Louvain, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, Campus Gasthuisberg,Herestr 49,Box 702, B-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Hansen, Thomas/GWZ-2858-2022; Kikuya, Masahiro/X-5662-2018; Wang, Ji Guang/AAP-4045-2021; Staessen, Jan A/A-1065-2011; Kuznetsova, Tatiana/I-6882-2013; Kuznetsova, Tatiana/ABI-5662-2020; Torp-Pedersen, Christian/E-5931-2013	Kikuya, Masahiro/0000-0002-3080-6107; Wang, Ji Guang/0000-0001-8511-1524; Staessen, Jan A/0000-0002-3026-1637; Kuznetsova, Tatiana/0000-0003-3564-7405; Kuznetsova, Tatiana/0000-0003-4293-4576; Sandoya, Edgardo/0000-0003-4125-3293; Boggia de Izaguirre, Jose Gabriel/0000-0002-1564-8534; Hansen, Tine/0000-0003-2274-0352; Thijs, Lutgarde/0000-0002-8108-2356				Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262; Casiglia E, 2005, INT HEART J, V46, P489, DOI 10.1536/ihj.46.489; Celis H, 2002, BLOOD PRESSURE, V11, P352, DOI 10.1080/080370502321095311; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Davidson MB, 2006, ARCH INTERN MED, V166, P846, DOI 10.1001/archinte.166.8.846; Dodt C, 1997, HYPERTENSION, V30, P71, DOI 10.1161/01.HYP.30.1.71; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fagard R, 1996, J HYPERTENS, V14, P557, DOI 10.1097/00004872-199605000-00003; Franklin SS, 2001, CIRCULATION, V103, P1245; GROPPELLI A, 1992, HYPERTENSION, V20, P227, DOI 10.1161/01.HYP.20.2.227; Hansen TW, 2006, AM J HYPERTENS, V19, P243, DOI 10.1016/j.amjhyper.2005.09.018; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Hermida RC, 2003, HYPERTENSION, V42, P283, DOI 10.1161/01.HYP.0000084855.32823.DA; IMAI Y, 1993, HYPERTENSION, V22, P900, DOI 10.1161/01.HYP.22.6.900; IMAI Y, 1990, AM J HYPERTENS, V3, P293, DOI 10.1093/ajh/3.4.293; IMAI Y, 1992, AM J HYPERTENS, V5, P719, DOI 10.1093/ajh/5.10.719; Ingelsson E, 2006, JAMA-J AM MED ASSOC, V295, P2859, DOI 10.1001/jama.295.24.2859; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Kikuya M, 2007, CIRCULATION, V115, P2145, DOI 10.1161/CIRCULATIONAHA.106.662254; Kuznetsova T, 2000, BLOOD PRESS MONIT, V5, P291, DOI 10.1097/00126097-200010000-00007; Li Y, 2005, HYPERTENSION, V46, P527, DOI 10.1161/01.HYP.0000174988.81829.72; Li Y, 2005, BLOOD PRESS MONIT, V10, P125, DOI 10.1097/00126097-200506000-00003; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Mochizuki Y, 1998, AM J HYPERTENS, V11, P403, DOI 10.1016/S0895-7061(97)00497-4; O'Brien, 1996, Blood Press Monit, V1, P55; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; OBRIEN E, 1991, J HYPERTENS, V9, P355, DOI 10.1097/00004872-199104000-00007; OBRIEN E, 1988, LANCET, V2, P397; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Ohkubo T, 1998, HYPERTENSION, V32, P255, DOI 10.1161/01.HYP.32.2.255; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Omboni S, 1998, J HYPERTENS, V16, P733, DOI 10.1097/00004872-199816060-00003; Parati G, 2000, J HYPERTENS, V18, P1725, DOI 10.1097/00004872-200018120-00004; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Sachdeva A, 2006, HYPERTENSION, V48, P527, DOI 10.1161/01.HYP.0000240268.37379.7c; Scarpelli PT, 2000, J NEPHROL, V13, P197; Schettini C, 1999, HYPERTENSION, V34, P818, DOI 10.1161/01.HYP.34.4.818; Schwartz GL, 2007, HYPERTENSION, V49, P1228, DOI 10.1161/HYPERTENSIONAHA.106.078691; Shiburi CP, 2006, AM J HYPERTENS, V19, P40, DOI 10.1016/j.amjhyper.2005.06.018; Staessen, 1996, Blood Press Monit, V1, P13; STAESSEN J, 1992, AM J HYPERTENS, V5, P386, DOI 10.1093/ajh/5.6.386; STAESSEN JA, 1993, J HYPERTENS, V11, P443, DOI 10.1097/00004872-199304000-00016; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Staessen JA, 1997, HYPERTENSION, V29, P30, DOI 10.1161/01.HYP.29.1.30; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; TAYLOR R, 1993, J HYPERTENS, V11, P1275; Thijs L, 2007, BLOOD PRESS MONIT, V12, P255, DOI 10.1097/MBP.0b013e3280f813bc; Vaile JC, 1996, J HYPERTENS, V14, P1427, DOI 10.1097/00004872-199612000-00007; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Weinehall L, 2002, J HYPERTENS, V20, P2081, DOI 10.1097/00004872-200210000-00029; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	54	654	673	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1219	1229		10.1016/S0140-6736(07)61538-4	http://dx.doi.org/10.1016/S0140-6736(07)61538-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920917	Green Accepted			2022-12-28	WOS:000250091900022
J	Facon, T; Mary, JY; Hulin, C; Benbouker, L; Attal, M; Pegourie, B; Renaud, M; Guillerm, JLHG; Ahletaix, C; Dib, M; Voillat, L; Maisonneuve, H; Troncy, J; Dervaux, W; Monconduit, M; Martin, C; Casassus, P; Jaubert, J; Jardel, H; Doyen, C; Kolb, B; Anglaret, B; Grosbois, B; Yakoub-Agha, I; Mathiot, C; Avet-Loiseau, H				Facon, Thierry; Mary, Jean Yves; Hulin, Cyrille; Benbouker, Lofti; Attal, Michel; Pegourie, Brigitte; Renaud, Marc; Guillerm, Jean Luc Harousseau Gaelle; Ahletaix, Carine; Dib, Mamoun; Voillat, Laurent; Maisonneuve, Herve; Troncy, Jacques; Dervaux, Weronique; Monconduit, Mathieu; Martin, Claude; Casassus, Philippe; Jaubert, Jerome; Jardel, Henry; Doyen, Chantal; Kolb, Brigitte; Anglaret, Bruno; Grosbois, Bernard; Yakoub-Agha, Ibrahim; Mathiot, Claire; Avet-Loiseau, Herve		Intergroupe Francophone Mye	Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial	LANCET			English	Article							REQUIRING PROLONGED OBSERVATION; STAGING SYSTEM; IMPROVES SURVIVAL; CHEMOTHERAPY; DEXAMETHASONE; DESIGN	Background In multiple myeloma, combination chemotherapy with melphalan plus prednisone is still regarded as the standard of care in elderly patients. We assessed whether the addition of thalidomide to this combination, or reduced-intensity stem cell transplantation, would improve survival. Methods Between May 22, 2000, and Aug 8, 2005, 447 previously untreated patients with multiple myeloma, who were aged between 65 and 75 years, were randomly assigned to receive either melphalan and prednisone (MP; n=196), melphalan and prednisone plus thalidomide (MPT, n=125), or reduced-intensity stem cell transplantation using melphalan 100 mg/m(2) (MEL100; n=126). The primary endpoint was overall survival. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00367185. Findings After a median follow-up of 51.5 months (IQR 34.4-63.2), median overall survival times were 33.2 months (13.8-54.8) for MP, 51.6 months (26.6-not reached) for MPT, and 38.3 months (13.0-61.6) for MEL100. The MPT regimen was associated with a significantly better overall survival than was the MP regimen (hazard ratio 0.59, 95% CI 0.46-0.81, p=0.0006) or MEL100 regimen (0.69, 0.49-0.96, p=0.027). No difference was seen for MEL100 versus MP (0.86, 0.65-1.15, p=0.32). Interpretation The results of our trial provide strong evidence to indicate that the use of thalidomide in combination with melphalan and prednisone should, at present, be the reference treatment for previously untreated elderly patients with multiple myeloma.	CHU Lille, Serv Hematol, F-59037 Lille, France; Univ Paris 07, Hop St Louis, INSERM, U717, Paris, France; CHU, Serv Hematol, Nancy, France; CHU, Serv Hematol, Tours, France; CHU, Serv Hematol, Toulouse, France; CHU, Serv Hematol, Grenoble, France; CHU, Serv Hematol, Poitiers, France; CHU, Serv Hematol, Nantes, France; CHU, Serv Hematol, Brest, France; CHU, Serv Hematol, Clermont Ferrand, France; CHU, Serv Hematol, Angers, France; CHU, Serv Hematol, Besancon, France; CH, Serv Hematol, La Roche, Yon, France; CHU, Hop Edouard Herriot, Serv Hematol, Lyon, France; CH, Serv Hematol, Metz, France; Ctr Henri Becquerel, Serv Hematol, F-76038 Rouen, France; CH, Serv Hematol, Annecy, France; CHU, Serv Hematol, Bobigny, France; CHU, Serv Hematol, St Etienne, France; CH, Serv Hematol, Vannes, France; UCL, Serv Hematol, Yvoir, Belgium; CHU, Serv Hematol, Reims, France; CH, Serv Hematol, Valence, France; CHU, Serv Hematol, Rennes, France; Inst Curie, Hematol Lab, Paris, France; CHU, Hematol Lab, Nantes, France	Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; CHU Tours; CHU de Toulouse; CHU Grenoble Alpes; CHU Poitiers; Nantes Universite; CHU de Nantes; CHU Brest; Universite de Bretagne Occidentale; CHU Clermont Ferrand; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Franche-Comte; CHU Besancon; CHU Lyon; CHR Metz-Thionville; UNICANCER; Centre Henri Becquerel; Centre Hospitalier Annecy Genevois; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; CHU de St Etienne; Universite Catholique Louvain; CHU de Reims; CHU Rennes; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Nantes Universite; CHU de Nantes	Facon, T (corresponding author), CHU Lille, Hop Claude Huriez, Serv Malad Sang, Rue Michel Polonovski, F-59037 Lille, France.	t-facon@chru-lille.fr	Avet-Loiseau, Herve/P-8872-2014; Yakoub-Agha, Ibrahim/R-7872-2018	Avet-Loiseau, Herve/0000-0002-3050-0140; Yakoub-Agha, Ibrahim/0000-0003-4524-8782				ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; [Anonymous], 1998, J Clin Oncol, V16, P3832; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Byar DP., 1988, CANC CLIN TRIALS MET, P423; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Facon T, 2006, BLOOD, V107, P1292, DOI 10.1182/blood-2005-04-1588; Facon T, 2001, BLOOD, V97, P1566, DOI 10.1182/blood.V97.6.1566; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Hulin C, 2007, J CLIN ONCOL, V25, p441s; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Mateos MV, 2006, BLOOD, V108, P2165, DOI 10.1182/blood-2006-04-019778; Palumbo A, 2004, BLOOD, V104, P3052, DOI 10.1182/blood-2004-02-0408; Palumbo A, 1999, BLOOD, V94, P1248, DOI 10.1182/blood.V94.4.1248.416k09_1248_1253; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2007, J CLIN ONCOL, V25, P4459, DOI 10.1200/JCO.2007.12.3463; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102	25	677	696	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1209	1218		10.1016/S0140-6736(07)61537-2	http://dx.doi.org/10.1016/S0140-6736(07)61537-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920916				2022-12-28	WOS:000250091900021
J	Watkinson, A; Nicholson, A				Watkinson, A.; Nicholson, A.			Rational imaging - Uterine artery embolisation to treat uterine fibroids	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGERY		Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; Peninsula Med Sch, Exeter EX2 5DW, Devon, England; St James Hosp, Leeds Teaching Hosp, Leeds LS9 7TF, W Yorkshire, England	University of Exeter; University of Exeter; Saint James's University Hospital; University of Leeds	Watkinson, A (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	Anthony.Watkinson@rdeft.nhs.uk						Edwards RD, 2007, NEW ENGL J MED, V356, P360; Glomset O, 2006, ACTA RADIOL, V47, P179, DOI 10.1080/02841850500447211; Gupta JK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005073.pub2; Hehenkamp WJK, 2005, AM J OBSTET GYNECOL, V193, P1618, DOI 10.1016/j.ajog.2005.05.017; Mara M, 2006, EUR J OBSTET GYN R B, V126, P226, DOI 10.1016/j.ejogrb.2005.10.008; *NAT I HLTH CLIN E, 2007, CG44 NICE; RAVINA JH, 1995, PRESSE MED, V24, P1754; *ROYAL COLL OBST G, 2000, CLIN REC US UT ART E; Spies JB, 2005, OBSTET GYNECOL, V106, P1309, DOI 10.1097/01.AOG.0000188386.53878.49; Stewart EA, 2006, FERTIL STERIL, V85, P22, DOI 10.1016/j.fertnstert.2005.04.072; WALKER WJ, 2003, BJOG, V110, P1139	11	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2007	335	7622					720	722		10.1136/bmj.39251.440069.AD	http://dx.doi.org/10.1136/bmj.39251.440069.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916857	Green Published			2022-12-28	WOS:000250156800036
J	Hobert, O				Hobert, Oliver			miRNAs play a tune	CELL			English	Editorial Material							C-ELEGANS; LIN-14	Two new studies describe functionally relevant interactions between microRNAs ( miRNAs) and their targets in the immune system and the brain ( Xiao et al., 2007; Karres et al., 2007). Furthermore, these studies illustrate the involvement of miRNAs in tuning the expression of target genes to physiologically relevant levels.	Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Hobert, O (corresponding author), Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854				Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; CARTHEW RW, 2001, GENOMIC REGULATOR SY; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; HOBERT O, 2007, QUANT BIOL, V71, P181; KARRES JS, 2007, CELL; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; XIAO C, 2007, CELL	8	62	67	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					22	24		10.1016/j.cell.2007.09.031	http://dx.doi.org/10.1016/j.cell.2007.09.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923083	Bronze			2022-12-28	WOS:000249934700006
J	Junt, T; Moseman, EA; Iannacone, M; Massberg, S; Lang, PA; Boes, M; Fink, K; Henrickson, SE; Shayakhmetov, DM; Di Paolo, NC; Van Rooijen, N; Mempel, TR; Whelan, SP; von Andrian, UH				Junt, Tobias; Moseman, E. Ashley; Iannacone, Matteo; Massberg, Steffen; Lang, Philipp A.; Boes, Marianne; Fink, Katja; Henrickson, Sarah E.; Shayakhmetov, Dmitry M.; Di Paolo, Nelson C.; Van Rooijen, Nico; Mempel, Thorsten R.; Whelan, Sean P.; von Andrian, Ulrich H.			Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells	NATURE			English	Article							IMMUNE-RESPONSES; DENDRITIC CELLS; MICE; LYMPHOCYTES; COMPLEMENT; RECEPTORS	Lymph nodes prevent the systemic dissemination of pathogens such as viruses that infect peripheral tissues after penetrating the body's surface barriers. They are also the staging ground of adaptive immune responses to pathogen-derived antigens(1,2). It is unclear how virus particles are cleared from afferent lymph and presented to cognate B cells to induce antibody responses. Here we identify a population of CD11b(+)CD169(+)MHCII(+) macrophages on the floor of the subcapsular sinus (SCS) and in the medulla of lymph nodes that capture viral particles within minutes after subcutaneous injection. Macrophages in the SCS translocated surface-bound viral particles across the SCS floor and presented them to migrating B cells in the underlying follicles. Selective depletion of these macrophages compromised local viral retention, exacerbated viraemia of the host, and impaired local B-cell activation. These findings indicate that CD169(+) macrophages have a dual physiological function. They act as innate 'flypaper' by preventing the systemic spread of lymph-borne pathogens and as critical gatekeepers at the lymph-tissue interface that facilitate the recognition of particulate antigens by B cells and initiate humoral immune responses.	Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; Ist Sci San Raffaele, Immunopathogenesis Liver Infect Unit, I-20132 Milan, Italy; Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Novartis Inst Trop Dis, Singapore 138670, Singapore; Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Vrije Univ Amsterdam, VUMC, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Brigham & Women's Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich; University Zurich Hospital; Novartis; University of Washington; University of Washington Seattle; Vrije Universiteit Amsterdam; Harvard University; Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	uva@hms.harvard.edu	Iannacone, Matteo/I-8507-2018; Fink, Katja/AAI-1881-2021; Van Rooijen, Nico/Z-1578-2019; Junt, Tobias/AAE-4389-2021; von Andrian, Ulrich H/A-5775-2008; Massberg, Steffen/AAN-6054-2021	Iannacone, Matteo/0000-0002-9370-2671; Fink, Katja/0000-0002-3571-0390; Whelan, Sean/0000-0003-1564-8590; Henrickson, Sarah/0000-0001-5569-4132; Boes, Marianne/0000-0003-2590-1692	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI059371, R01 AI059371-03] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; CLARK SL, 1962, AM J ANAT, V110, P217, DOI 10.1002/aja.1001100303; DANG LH, 1991, J IMMUNOL, V146, P3273; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Leopold PL, 1998, HUM GENE THER, V9, P367, DOI 10.1089/hum.1998.9.3-367; Ludewig B, 2000, EUR J IMMUNOL, V30, P185, DOI 10.1002/1521-4141(200001)30:1<185::AID-IMMU185>3.3.CO;2-C; Mead DG, 2000, ANN NY ACAD SCI, V916, P437, DOI 10.1111/j.1749-6632.2000.tb05323.x; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Roost HP, 1996, J IMMUNOL METHODS, V189, P233, DOI 10.1016/0022-1759(95)00252-9; Rossbacher J, 2003, J EXP MED, V198, P591, DOI 10.1084/jem.20022042; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vascotto F, 2007, CURR OPIN IMMUNOL, V19, P93, DOI 10.1016/j.coi.2006.11.011; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	29	592	613	4	50	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					110	+		10.1038/nature06287	http://dx.doi.org/10.1038/nature06287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17934446				2022-12-28	WOS:000250585800047
J	Livet, J; Weissman, TA; Kang, HN; Draft, RW; Lu, J; Bennis, RA; Sanes, JR; Lichtman, JW				Livet, Jean; Weissman, Tamily A.; Kang, Hyuno; Draft, Ryan W.; Lu, Ju; Bennis, Robyn A.; Sanes, Joshua R.; Lichtman, Jeff W.			Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system	NATURE			English	Article							CRE RECOMBINASE; SYNAPTIC COMPETITION; MONOMERIC RED; IN-VIVO; CELLS; MICE; NEURONS; CHROMOSOMES; ASTROCYTES; MICROSCOPY	Detailed analysis of neuronal network architecture requires the development of new methods. Here we present strategies to visualize synaptic circuits by genetically labelling neurons with multiple, distinct colours. In Brainbow transgenes, Cre/lox recombination is used to create a stochastic choice of expression between three or more fluorescent proteins (XFPs). Integration of tandem Brainbow copies in transgenic mice yielded combinatorial XFP expression, and thus many colours, thereby providing a way to distinguish adjacent neurons and visualize other cellular interactions. As a demonstration, we reconstructed hundreds of neighbouring axons and multiple synaptic contacts in one small volume of a cerebellar lobe exhibiting approximately 90 colours. The expression in some lines also allowed us to map glial territories and follow glial cells and neurons over time in vivo. The ability of the Brainbow system to label uniquely many individual cells within a population may facilitate the analysis of neuronal circuitry on a large scale.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lichtman, JW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jeff@mcb.harvard.edu	livet, jean/C-2766-2012	livet, jean/0000-0003-3079-4908; Weissman, Tamily/0000-0001-9361-6071				Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Lam KP, 1998, P NATL ACAD SCI USA, V95, P13171, DOI 10.1073/pnas.95.22.13171; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Palay S.L., 1974, CEREBELLAR CORTEX; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	41	1245	1285	7	342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					56	+		10.1038/nature06293	http://dx.doi.org/10.1038/nature06293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972876				2022-12-28	WOS:000250585800035
J	Delbanco, T; Bell, SK				Delbanco, Tom; Bell, Sigall K.			Guilty, afraid, and alone - Struggling with medical error	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Delbanco, T (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Bender Flauren Fagadau, 2007, Virtual Mentor, V9, P300, DOI 10.1001/virtualmentor.2007.9.4.hlaw1-0704; DELBANCO T, 2006, WHEN THINGS GO WRONG; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; Gallagher TH, 2007, NEW ENGL J MED, V356, P2713, DOI 10.1056/NEJMra070568; Leape LL, 2006, THINGS GO WRONG RESP	5	110	111	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1682	1683		10.1056/NEJMp078104	http://dx.doi.org/10.1056/NEJMp078104			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223FN	17960011				2022-12-28	WOS:000250355100003
J	von Elm, E; Altman, DG; Pocock, SJ; Gotzsche, PC; Vandenbroucke, JP				von Elm, Erik; Altman, Douglas G.; Pocock, Stuart J.; Gotzsche, Peter C.; Vandenbroucke, Jan P.		STROBE Initiative	Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Oxford, Ctr Stat Med, Oxford, England; Univ London, London Sch Hyg & Trop Med, London, England; Nord Cochrane Ctr, Copenhagen, Denmark; Leiden Univ Hosp, Dept Clin Epidemiol, Leiden, Netherlands	University of Bern; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC)	von Elm, E (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	strobe@ispm.unibe.ch	Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716; von Elm, Erik/0000-0002-7412-0406; Egger, Matthias/0000-0001-7462-5132					0	1370	1405	10	54	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2007	335	7624					806	808						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227AX	17947786				2022-12-28	WOS:000250630700036
J	Obita, T; Saksena, S; Ghazi-Tabatabai, S; Gill, DJ; Perisic, O; Emr, SD; Williams, RL				Obita, Takayuki; Saksena, Suraj; Ghazi-Tabatabai, Sara; Gill, David J.; Perisic, Olga; Emr, Scott D.; Williams, Roger L.			Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4	NATURE			English	Article							LATE-BUDDING DOMAINS; PROTEIN INTERACTIONS; MIT DOMAIN; ENDOSOMAL CARGO; COMPLEX; TRAFFICKING; MACHINERY; COMPONENTS; INTERACTS; RELEASE	The AAA+ ATPases are essential for various activities such as membrane trafficking, organelle biogenesis, DNA replication, intracellular locomotion, cytoskeletal remodelling, protein folding and proteolysis(1). The AAA ATPase Vps4, which is central to endosomal traffic to lysosomes(2,3), retroviral budding(4) and cytokinesis(5), dissociates ESCRT complexes (the endosomal sorting complexes required for transport) from membranes(6-15). Here we show that, of the six ESCRT-III-related subunits in yeast, only Vps2 and Did2 bind the MIT (microtubule interacting and transport) domain of Vps4, and that the carboxy-terminal 30 residues of the subunits are both necessary and sufficient for interaction. We determined the crystal structure of the Vps2 C terminus in a complex with the Vps4 MIT domain, explaining the basis for selective ESCRT-III recognition. MIT helices alpha 2 and alpha 3 recognize a (D/E) xxLxxRLxxL(K/R) motif, and mutations within this motif cause sorting defects in yeast. Our crystal structure of the amino-terminal domain of an archaeal AAA ATPase of unknown function shows that it is closely related to the MIT domain of Vps4. The archaeal ATPase interacts with an archaeal ESCRT-III-like protein even though these organisms have no endomembrane system, suggesting that the Vps4/ESCRT-III partnership is a relic of a function that pre-dates the divergence of eukaryotes and Archaea.	MRC, Mol Biol Lab, MRC Ctr, Cambridge CB2 0QH, England; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Cornell Univ, Inst Cell & Mol Biol, Ithaca, NY 14853 USA	MRC Laboratory Molecular Biology; Cornell University; Cornell University; University of Texas System; University of Texas Austin	Williams, RL (corresponding author), MRC, Mol Biol Lab, MRC Ctr, Cambridge CB2 0QH, England.	rlw@mrc-lmb.cam.ac.uk	Gill, David/H-7691-2013	Gill, David/0000-0002-0937-9737; Perisic, Olga/0000-0002-3842-2896; Williams, Roger/0000-0001-7754-4207	Medical Research Council [MC_U105184308] Funding Source: Medline; MRC [MC_U105184308] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; FIELD MC, 2007, ORIGINS EVOLUTION EU, P84; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Howard TL, 2001, J CELL SCI, V114, P2395; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Vajjhala PR, 2007, FEBS J, V274, P1894, DOI 10.1111/j.1742-4658.2007.05736.x; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	30	238	246	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					735	U11		10.1038/nature06171	http://dx.doi.org/10.1038/nature06171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928861				2022-12-28	WOS:000250045000047
J	Burke, W; Psaty, BM				Burke, Wylie; Psaty, Bruce M.			Personalized medicine in the era of genomics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WIDE ASSOCIATION; RISK; BREAST; SUSCEPTIBILITY; VARIANT; PHARMACOGENETICS; ALLELES; DISEASE; GENES		Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA; Univ Washington, Ctr Genom & Healthcare Equal, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Grp Hlth, Hlth Serv Ctr Hlth Studies, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Burke, W (corresponding author), Univ Washington, Dept Med Hist & Eth, Box 257120, Seattle, WA 98195 USA.	wbuk@u.washington.edu			NHGRI NIH HHS [P50HG003374] Funding Source: Medline; NHLBI NIH HHS [HL74745, HL43201, HL085251, HL080295, HL087652, HL60739, HL68639] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL085251, R01HL074745, R01HL043201, R01HL080295, U01HL080295, R01HL068639, R01HL060739] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003374] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Bowersox J, 2001, PEDIATRICS, V108, P972; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Guttmacher AE, 2003, NEW ENGL J MED, V349, P996, DOI 10.1056/NEJMe038132; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Marteau TM, 2006, SOC SCI MED, V62, P1360, DOI 10.1016/j.socscimed.2005.08.005; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Rockhill B, 2000, EPIDEMIOL REV, V22, P176, DOI 10.1093/oxfordjournals.epirev.a018017; Roses AD, 2004, NAT REV GENET, V5, P645, DOI 10.1038/nrg1432; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wilkinson JM, 2003, AM J HEALTH PROMOT, V18, P157, DOI 10.4278/0890-1171-18.2.157; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	25	151	157	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1682	1684		10.1001/jama.298.14.1682	http://dx.doi.org/10.1001/jama.298.14.1682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925520				2022-12-28	WOS:000250009400024
J	Prabhu, PR; Cherian, JV; Varghese, SJ; Revathy, MS; Jayanthi, V				Prabhu, P. Rajesh; Cherian, Jijo Velliyapillil; Varghese, S. Joye; Revathy, M. S.; Jayanthi, V.			Seizure and prominent abdominal veins	LANCET			English	Editorial Material							BUDD-CHIARI-SYNDROME		Stanley Med Coll, Dept Gastroenterol, Madras 600001, Tamil Nadu, India		Prabhu, PR (corresponding author), Stanley Med Coll, Dept Gastroenterol, Madras 600001, Tamil Nadu, India.	p.rajeshprabhu@gmail.com		Varghese, Joy/0000-0003-3107-4216				Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; MCDERMOTT WV, 1984, AM J SURG, V147, P463, DOI 10.1016/0002-9610(84)90006-0; Menon KVN, 2004, NEW ENGL J MED, V350, P578, DOI 10.1056/NEJMra020282	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2007	370	9594					1282	1282		10.1016/S0140-6736(07)61541-4	http://dx.doi.org/10.1016/S0140-6736(07)61541-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920920				2022-12-28	WOS:000250091900028
J	Garrett, WS; Lord, GM; Punit, S; Lugo-Villarino, G; Mazmanian, SK; Ito, S; Glickman, JN; Glimcher, LH				Garrett, Wendy S.; Lord, Graham M.; Punit, Shivesh; Lugo-Villarino, Geanncarlo; Mazmanian, Sarkis K.; Ito, Susumu; Glickman, Jonathan N.; Glimcher, Laurie H.			Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system	CELL			English	Article							COLONIC DENDRITIC CELLS; ACTIVATION; RESPONSES; CURE	Inflammatory bowel disease (IBD) has been attributed to overexuberant host immunity or the emergence of harmful intestinal flora. The transcription factor T-bet orchestrates inflammatory genetic programs in both adaptive and innate immunity. We describe a profound and unexpected function for T-bet in influencing the behavior of host inflammatory activity and commensal bacteria. T-bet deficiency in the innate immune system results in spontaneous and communicable ulcerative colitis in the absence of adaptive immunity and increased susceptibility to colitis in immunologically intact hosts. T-bet controls the response of the mucosal immune system to commensal bacteria by regulating TNF-alpha production in colonic dendritic cells, critical for colonic epithelial barrier maintenance. Loss of T-bet influences bacterial populations to become colitogenic, and this colitis is communicable to genetically intact hosts. These findings reveal a novel function for T-bet as a peacekeeper of host-commensal relationships and provide new perspectives on the pathophysiology of IBD.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London SE1 9RT, England; Kings Coll London, London WC2R 2LS, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; California Institute of Technology; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lord, GM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	graham.lord@kcl.ac.uk; lglimche@hsph.harvard.edu	Lord, Graham M/B-3797-2011; Abraham, Sabu/E-1144-2019; Lugo, Geanncarlo/H-4674-2019; Mazmanian, Sarkis/ABD-7729-2021; Eckhardt, Erik/G-1567-2010	Abraham, Sabu/0000-0002-0916-5827; Lugo, Geanncarlo/0000-0003-4620-8491; Mazmanian, Sarkis/0000-0003-2713-1513; Garrett, Wendy/0000-0002-5092-0150; Lord, Graham/0000-0003-2069-4743	Medical Research Council [G108/380] Funding Source: Medline; NCI NIH HHS [R01 CA112663-06, CA112663, R01 CA112663, R01 CA112663-07] Funding Source: Medline; NIAID NIH HHS [AI56296, P01 AI056296-010001, P01 AI056296-01, P01 AI056296-04, P01 AI056296-02, P01 AI056296-03, P01 AI056296, P01 AI056296-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056296] Funding Source: NIH RePORTER; MRC [G108/380] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baumgart DC, 1998, CELL IMMUNOL, V187, P52, DOI 10.1006/cimm.1998.1307; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; CAMERINI V, 1993, J IMMUNOL, V151, P1765; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Dorfman DM, 2003, AM J CLIN PATHOL, V120, P866, DOI 10.1309/J3CTLTTJEVUY4YL0; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Lan JG, 2005, WORLD J GASTROENTERO, V11, P3375, DOI 10.3748/wjg.v11.i22.3375; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; Maloy KJ, 2005, IMMUNOL LETT, V97, P189, DOI 10.1016/j.imlet.2005.01.004; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Niess JH, 2006, CURR OPIN GASTROEN, V22, P354, DOI 10.1097/01.mog.0000231807.03149.54; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rigby RJ, 2005, CLIN EXP IMMUNOL, V139, P245, DOI 10.1111/j.1365-2249.2004.02674.x; Rogler G, 2001, SCAND J GASTROENTERO, V36, P389, DOI 10.1080/003655201300051216; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shen C, 2006, INFLAMM BOWEL DIS, V12, P22, DOI 10.1097/01.MIB.0000194185.69800.07; Silva MA, 2004, INFLAMM BOWEL DIS, V10, P504, DOI 10.1097/00054725-200409000-00003; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tannock GW, 2007, SEMIN IMMUNOL, V19, P94, DOI 10.1016/j.smim.2006.09.001; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Weigmann B, 2002, GUT, V51, P301, DOI 10.1136/gut.51.3.301; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	36	690	733	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					33	45		10.1016/j.cell.2007.08.017	http://dx.doi.org/10.1016/j.cell.2007.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923086	Green Accepted, Bronze			2022-12-28	WOS:000249934700009
J	Bogle, R; Wilkins, M				Bogle, Richard; Wilkins, Martin			Treating acute myocardial infarction: something in the wind?	LANCET			English	Editorial Material							ATRIAL-NATRIURETIC-PEPTIDE; NITRIC-OXIDE SYNTHASE; REPERFUSION; NICORANDIL; ISCHEMIA		Imperial Coll London, Hammersmith Hosp, London W12 0HS, England	Imperial College London	Bogle, R (corresponding author), Imperial Coll London, Hammersmith Hosp, London W12 0HS, England.	m.wilkins@imperial.ac.uk	Wilkins, Martin/ABH-1140-2021	Wilkins, Martin/0000-0003-3926-1171; Bogle, Richard/0000-0002-8300-3367				Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1897, DOI 10.1006/jmcc.2001.1462; Burley DS, 2007, BRIT J PHARMACOL, V152, P855, DOI 10.1038/sj.bjp.0707409; D'Souza SP, 2003, AM J PHYSIOL-HEART C, V284, pH1592, DOI 10.1152/ajpheart.00902.2002; Hayashi M, 2001, J AM COLL CARDIOL, V37, P1820, DOI 10.1016/S0735-1097(01)01233-5; Ishii H, 2007, AM J CARDIOL, V99, P1203, DOI 10.1016/j.amjcard.2006.12.034; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; Okawa H, 2003, MOL CELL BIOCHEM, V248, P171, DOI 10.1023/A:1024148621505; Ren BH, 2007, CLIN CHIM ACTA, V377, P83, DOI 10.1016/j.cca.2006.08.027; Richards AM, 2007, HYPERTENSION, V50, P25, DOI 10.1161/HYPERTENSIONAHA.106.069153; Shanmuganathan S, 2005, AM J PHYSIOL-HEART C, V289, pH237, DOI 10.1152/ajpheart.01192.2004; TOPOL EJ, 2007, NEW ENGL J MED, V353, P113	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1461	1462		10.1016/S0140-6736(07)61612-2	http://dx.doi.org/10.1016/S0140-6736(07)61612-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964332				2022-12-28	WOS:000250487000004
J	Zhao, Y; Tong, C; Jiang, J				Zhao, Yun; Tong, Chao; Jiang, Jin			Hedgehog regulates smoothened activity by inducing a conformational switch	NATURE			English	Review							PROTEIN-KINASE-A; SIGNAL-TRANSDUCTION; SONIC-HEDGEHOG; CUBITUS-INTERRUPTUS; ANIMAL DEVELOPMENT; PRIMARY CILIUM; DROSOPHILA; PHOSPHORYLATION; RECEPTOR; ENCODES	Hedgehog (HH) morphogen is essential for metazoan development. The seven-transmembrane protein smoothened (SMO) transduces the HH signal across the plasma membrane, but how SMO is activated remains poorly understood. In Drosophila melanogaster, HH induces phosphorylation at multiple Ser/Thr residues in the SMO carboxy-terminal cytoplasmic tail, leading to its cell surface accumulation and activation. Here we provide evidence that phosphorylation activates SMO by inducing a conformational switch. This occurs by antagonizing multiple Arg clusters in the SMO cytoplasmic tail. The Arg clusters inhibit SMO by blocking its cell surface expression and keeping it in an inactive conformation that is maintained by intramolecular electrostatic interactions. HH-induced phosphorylation disrupts the interaction, and induces a conformational switch and dimerization of SMO cytoplasmic tails, which is essential for pathway activation. Increasing the number of mutations in the Arg clusters progressively activates SMO. Hence, by employing multiple Arg clusters as inhibitory elements counteracted by differential phosphorylation, SMO acts as a rheostat to translate graded HH signals into distinct responses.	Univ Texas, SW Med Ctr, Dept Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, J (corresponding author), Univ Texas, SW Med Ctr, Dept Dev Biol, Dallas, TX 75390 USA.	jin.jiang@utsouthwestern.edu		Tong, Chao/0000-0001-6521-5465	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067045, R01GM061269] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067045, R01 GM061269] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Centonze VE, 2003, METHOD ENZYMOL, V360, P542; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	37	218	230	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					252	U4		10.1038/nature06225	http://dx.doi.org/10.1038/nature06225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17960137	Bronze			2022-12-28	WOS:000250746200051
J	Van Oost, K; Quine, TA; Govers, G; De Gryze, S; Six, J; Harden, JW; Ritchie, JC; McCarty, GW; Heckrath, G; Kosmas, C; Giraldez, JV; da Silva, JRM; Merckx, R				Van Oost, K.; Quine, T. A.; Govers, G.; De Gryze, S.; Six, J.; Harden, J. W.; Ritchie, J. C.; McCarty, G. W.; Heckrath, G.; Kosmas, C.; Giraldez, J. V.; da Silva, J. R. Marques; Merckx, R.			The impact of agricultural soil erosion on the global carbon cycle	SCIENCE			English	Article							ORGANIC-CARBON; LAND-USE; BALANCE; SEQUESTRATION; 20TH-CENTURY; DEPOSITION; SEDIMENTS; DYNAMICS; REALITY; MATTER	Agricultural soil erosion is thought to perturb the global carbon cycle, but estimates of its effect range from a source of 1 petagram per year(-1) to a sink of the same magnitude. By using caesium-137 and carbon inventory measurements from a large-scale survey, we found consistent evidence for an erosion-induced sink of atmospheric carbon equivalent to approximately 26% of the carbon transported by erosion. Based on this relationship, we estimated a global carbon sink of 0.12 (range 0.06 to 0.27) petagrams of carbon per year(-1) resulting from erosion in the world's agricultural landscapes. Our analysis directly challenges the view that agricultural erosion represents an important source or sink for atmospheric CO2.	Katholieke Univ Leuven, Phys & Reg Geog Res Grp, B-3001 Heverlee, Belgium; Univ Exeter, Dept Geog, Exeter EX4 4RJ, Devon, England; Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; US Geol Survey, Menlo Pk, CA 94025 USA; USDA ARS, Hydrol & Remote Sensing Lab, Beltsville, MD 20705 USA; Univ Aarhus, Dept Agroecol & Environm, Res Ctr Foulum, DK-8830 Tjele, Denmark; Agr Univ Athens, Lab Soils & Agr Chem, Athens 11855, Greece; Univ Cordoba, Dept Agron, E-14080 Cordoba, Spain; Univ Evora, Dept Rural Engn, Inst Ciencias Agr Mediterran, Evora, Portugal; Katholieke Univ Leuven, Div Soil & Water Management, B-3001 Heverlee, Belgium	KU Leuven; University of Exeter; University of California System; University of California Davis; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); Aarhus University; Agricultural University of Athens; Universidad de Cordoba; University of Evora; KU Leuven	Van Oost, K (corresponding author), Catholic Univ Louvain, Dept Geog, B-1048 Louvain, Belgium.	kristof.vanoost@uclouvain.be	six, johan/J-5228-2015; Giraldez, Juan V/H-9638-2015; Van Oost, Kristof/B-6941-2008; Heckrath, Goswin J/F-2964-2016; Quine, Timothy A/B-2984-2010; Govers, Gerard/A-8298-2008	six, johan/0000-0001-9336-4185; Giraldez, Juan V/0000-0003-3987-3805; Govers, Gerard/0000-0001-9884-4778; Quine, Timothy/0000-0002-5143-5157; Marques da Silva, Jose Rafael/0000-0003-0305-8147; Harden, Jennifer W/0000-0002-6570-8259; Heckrath, Goswin/0000-0001-7879-9404; Merckx, Roel/0000-0001-6440-5363				Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Bakker MM, 2004, CATENA, V57, P55, DOI 10.1016/j.catena.2003.07.002; Berhe AA, 2007, BIOSCIENCE, V57, P337, DOI 10.1641/B570408; Boardman J, 1998, J SOIL WATER CONSERV, V53, P46; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; Harden JW, 1999, GLOBAL BIOGEOCHEM CY, V13, P885, DOI 10.1029/1999GB900061; HARRISON K, 1993, GLOBAL BIOGEOCHEM CY, V7, P69, DOI 10.1029/92GB02938; Ito A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029342; Jacinthe PA, 2001, LAND DEGRAD DEV, V12, P329, DOI 10.1002/ldr.454; Lal R, 2004, SCIENCE, V304, P393, DOI 10.1126/science.1093079; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Liu SG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002010; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; McCarty GW, 2002, ENVIRON POLLUT, V116, P423, DOI 10.1016/S0269-7491(01)00219-6; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Plante AF, 2006, EUR J SOIL SCI, V57, P456, DOI 10.1111/j.1365-2389.2006.00792.x; Quine TA, 2007, GLOBAL CHANGE BIOL, V13, P2610, DOI 10.1111/j.1365-2486.2007.01457.x; RITCHIE JC, 1989, WATER RESOUR BULL, V25, P301; Rosenbloom NA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000077; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Smith SV, 2005, ECOL APPL, V15, P1929, DOI 10.1890/05-0073; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Trimble SW, 2000, SCIENCE, V289, P248, DOI 10.1126/science.289.5477.248; TRUMBORE SE, 1993, GLOBAL BIOGEOCHEM CY, V7, P275, DOI 10.1029/93GB00468; Van Oost K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002471; YOO K, 2005, GLOBAL BIOGEOCHEM CY, V19, P917	29	650	670	45	589	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					626	629		10.1126/science.1145724	http://dx.doi.org/10.1126/science.1145724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962559	Green Published			2022-12-28	WOS:000250409200041
J	Galinha, C; Hofhuis, H; Luijten, M; Willemsen, V; Blilou, I; Heidstra, R; Scheres, B				Galinha, Carla; Hofhuis, Hugo; Luijten, Marijn; Willemsen, Viola; Blilou, Ikram; Heidstra, Renze; Scheres, Ben			PLETHORA proteins as dose-dependent master regulators of Arabidopsis root development	NATURE			English	Article							STEM-CELLS; GENE; EMBRYO; TRANSFORMATION; REGENERATION; EXPRESSION; GRADIENTS; ENCODES	Factors with a graded distribution can program fields of cells in a dose-dependent manner(1,2), but no evidence has hitherto surfaced for such mechanisms in plants. In the Arabidopsis thaliana root, two PLETHORA (PLT) genes encoding AP2-domain transcription factors have been shown to maintain the activity of stem cells(3). Here we show that a clade of four PLT homologues is necessary for root formation. Promoter activity and protein fusions of PLT homologues display gradient distributions with maxima in the stem cell area. PLT activities are largely additive and dosage dependent. High levels of PLT activity promote stem cell identity and maintenance; lower levels promote mitotic activity of stem cell daughters; and further reduction in levels is required for cell differentiation. Our findings indicate that PLT protein dosage is translated into distinct cellular responses.	Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University	Scheres, B (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands.	b.scheres@uu.nl		Scheres, Ben/0000-0001-5400-9578; hofhuis, hugo/0000-0001-7882-7380; Blilou, Ikram/0000-0001-8003-3782				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790	24	556	598	2	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1053	1057		10.1038/nature06206	http://dx.doi.org/10.1038/nature06206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960244	Green Published			2022-12-28	WOS:000250395000053
J	Bailey, S; Eliason, WK; Steitz, TA				Bailey, Scott; Eliason, William K.; Steitz, Thomas A.			Structure of hexameric DnaB helicase and its complex with a domain of DnaG primase	SCIENCE			English	Article							ESCHERICHIA-COLI DNAB; SINGLE-STRANDED-DNA; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; REPLICATION-FORK; BACILLUS-STEAROTHERMOPHILUS; PRIMER SYNTHESIS; PROTEIN HEXAMER; GENE-4 HELICASE; LINKER REGION	The complex between the DnaB helicase and the DnaG primase unwinds duplex DNA at the eubacterial replication fork and synthesizes the Okazaki RNA primers. The crystal structures of hexameric DnaB and its complex with the helicase binding domain (HBD) of DnaG reveal that within the hexamer the two domains of DnaB pack with strikingly different symmetries to form a distinct two-layered ring structure. Each of three bound HBDs stabilizes the DnaB hexamer in a conformation that may increase its processivity. Three positive, conserved electrostatic patches on the N-terminal domain of DnaB may also serve as a binding site for DNA and thereby guide the DNA to a DnaG active site.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Bailey, Scott/N-7248-2019; Steitz, Thomas A./C-6559-2009		NIGMS NIH HHS [GM57510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; BISWAS SB, 1994, BIOCHEMISTRY-US, V33, P11307, DOI 10.1021/bi00203a028; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; MAURER R, 1988, J BACTERIOL, V170, P3682, DOI 10.1128/jb.170.8.3682-3688.1988; Mesa P, 2006, J MOL BIOL, V357, P1077, DOI 10.1016/j.jmb.2005.12.027; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; NAKAYAMA N, 1984, J BIOL CHEM, V259, P88; Nunez-Ramirez R, 2006, J MOL BIOL, V357, P1063, DOI 10.1016/j.jmb.2006.01.091; Oakley AJ, 2005, J BIOL CHEM, V280, P11495, DOI 10.1074/jbc.M412645200; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Stordal L, 1996, J BACTERIOL, V178, P4620, DOI 10.1128/jb.178.15.4620-4627.1996; Syson K, 2005, STRUCTURE, V13, P609, DOI 10.1016/j.str.2005.01.022; Thirlway J, 2006, J BACTERIOL, V188, P1534, DOI 10.1128/JB.188.4.1534-1539.2006; Thirlway J, 2004, NUCLEIC ACIDS RES, V32, P2977, DOI 10.1093/nar/gkh628; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Tougu K, 1996, J BIOL CHEM, V271, P21391, DOI 10.1074/jbc.271.35.21391; WU CA, 1992, J BIOL CHEM, V267, P4030; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8	32	161	163	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					459	463		10.1126/science.1147353	http://dx.doi.org/10.1126/science.1147353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947583				2022-12-28	WOS:000250230400050
J	Wilan, K				Wilan, Ken			From bench to business and back again	CELL			English	Editorial Material																			0	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					211	213		10.1016/j.cell.2007.10.010	http://dx.doi.org/10.1016/j.cell.2007.10.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956718	Bronze			2022-12-28	WOS:000250507700007
J	Conner, JC; Bebarta, VS				Conner, Johnathan C.; Bebarta, Vikhyat S.			White phosphorus dermal burns	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Patriot Clin, Tampa, FL 33621 USA		Conner, JC (corresponding author), Patriot Clin, Tampa, FL 33621 USA.	jcconnermd@verizon.net	Bebarta, Vikhyat S/L-9537-2015; Bebarta, Vikhyat S/M-1513-2015						0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1530	1530		10.1056/NEJMicm061897	http://dx.doi.org/10.1056/NEJMicm061897			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928601				2022-12-28	WOS:000250037000011
J	Wigzell, H				Wigzell, Hans			Science & politics: When ministers are well primed	NATURE			English	Editorial Material									Karolinska Inst, S-17177 Stockholm, Sweden; Ehime Univ, Matsuyama, Ehime 790, Japan; Univ Baltimore, Baltimore, MD 21201 USA	Karolinska Institutet; Ehime University; University System of Maryland; University of Baltimore	Wigzell, H (corresponding author), Karolinska Inst, S-17177 Stockholm, Sweden.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					663	663		10.1038/449663a	http://dx.doi.org/10.1038/449663a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218VV	17928845				2022-12-28	WOS:000250045000026
J	Johnson, BA; Rosenthal, N; Capece, JA; Wiegand, F; Mao, L; Beyers, K; McKay, A; Ait-Daoud, N; Anton, RF; Ciraulo, DA; Kranzler, HR; Mann, K; O'Malley, SS; Swift, RM				Johnson, Bankole A.; Rosenthal, Norman; Capece, Julie A.; Wiegand, Frank; Mao, Lian; Beyers, Karen; McKay, Amy; Ait-Daoud, Nassima; Anton, Raymond F.; Ciraulo, Domenic A.; Kranzler, Henry R.; Mann, Karl; O'Malley, Stephanie S.; Swift, Robert M.		Topiramate Alcoholism Adv; Topiramate Alcoholism Study	Topiramate for treating alcohol dependence - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL TOPIRAMATE; GABA	Context Hypothetically, topiramate can improve drinking outcomes among alcohol-dependent individuals by reducing alcohol's reinforcing effects through facilitation of gamma-aminobutyric acid function and inhibition of glutaminergic pathways in the corti-comesolimbic system. Objective To determine if topiramate is a safe and efficacious treatment for alcohol dependence. Design, Setting, and Participants Double-blind, randomized, placebo-controlled, 14-week trial of 371 men and women aged 18 to 65 years diagnosed with alcohol dependence, conducted between January 27, 2004, and August 4, 2006, at 17 US sites. Interventions Up to 300 mg/d of topiramate (n=183) or placebo (n=188), along with a weekly compliance enhancement intervention. Main Outcome Measures Primary efficacy variable was self-reported percentage of heavy drinking days. Secondary outcomes included other self-reported drinking measures (percentage of days abstinent and drinks per drinking day) along with the laboratory measure of alcohol consumption (plasma gamma-glutamyltransferase). Results Treating all dropouts as relapse to baseline, topiramate was more efficacious than placebo at reducing the percentage of heavy drinking days from baseline to week 14 (mean difference, 8.44%; 95% confidence interval, 3.07%-13.80%; P=.002). Prespecified mixed-model analysis also showed that topiramate compared with placebo decreased the percentage of heavy drinking days ( mean difference, 16.19%; 95% confidence interval, 10.79%-21.60%; P<.001) and all other drinking outcomes (P<.001 for all comparisons). Adverse events that were more common with topiramate vs placebo, respectively, included paresthesia (50.8% vs 10.6%), taste perversion (23.0% vs 4.8%), anorexia (19.7% vs 6.9%), and difficulty with concentration (14.8% vs 3.2%). Conclusion Topiramate is a promising treatment for alcohol dependence.	Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA; Ortho McNeil Janssen Sci Affairs LLC, Raritan, NJ USA; Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; Boston Univ, Div Psychiat, Boston, MA 02215 USA; Univ Connecticut, Dept Psychiat, Farmington, CT 06107 USA; Univ Heidelberg, Dept Addict Behav & Addict Med, D-6800 Mannheim, Germany	University of Virginia; Johnson & Johnson; Johnson & Johnson USA; Medical University of South Carolina; Boston University; University of Connecticut; Ruprecht Karls University Heidelberg	Johnson, BA (corresponding author), Univ Virginia, Dept Psychiat & Neurobehav Sci, POB 800623, Charlottesville, VA 22908 USA.	bankolejohnson@virginia.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450; Ciraulo, Domenic/0000-0001-7706-8765				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; EDWARDS G, 1977, J STUD ALCOHOL, V38, P1004, DOI 10.15288/jsa.1977.38.1004; FAWCETT J, 1987, PSYCHOPHARMACOL BULL, V23, P309; First M. B., 1997, STRUCTURED CLIN INTE; Johnson B.A., 2003, HDB CLIN ALCOHOLISM, P282; Johnson BA, 2005, CNS DRUGS, V19, P873, DOI 10.2165/00023210-200519100-00005; Johnson BA, 2004, ARCH GEN PSYCHIAT, V61, P905, DOI 10.1001/archpsyc.61.9.905; Johnson BA, 2003, LANCET, V361, P1677, DOI 10.1016/S0140-6736(03)13370-3; Miller WR, 2001, J STUD ALCOHOL, V62, P211, DOI 10.15288/jsa.2001.62.211; MILLER WR, 1991, BRIT J ADDICT, V86, P43; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; ROBINS JM, 1995, J AM STAT ASSOC, V90, P106, DOI 10.2307/2291134; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; White HS, 2000, EPILEPSIA, V41, pS17, DOI 10.1111/j.1528-1157.2000.tb06042.x	17	392	406	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1641	1651		10.1001/jama.298.14.1641	http://dx.doi.org/10.1001/jama.298.14.1641			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925516	Bronze			2022-12-28	WOS:000250009400020
J	Huber, JA; Mark Welch, D; Morrison, HG; Huse, SM; Neal, PR; Butterfield, DA; Sogin, ML				Huber, Julie A.; Mark Welch, David; Morrison, Hilary G.; Huse, Susan M.; Neal, Phillip R.; Butterfield, David A.; Sogin, Mitchell L.			Microbial population structures in the deep marine biosphere	SCIENCE			English	Article							DIVERSITY; SEA; PROCHLOROCOCCUS; RIDGE	The analytical power of environmental DNA sequences for modeling microbial ecosystems depends on accurate assessments of population structure, including diversity (richness) and relative abundance (evenness). We investigated both aspects of population structure for microbial communities at two neighboring hydrothermal vents by examining the sequences of more than 900,000 microbial small-subunit ribosomal RNA amplicons. The two vent communities have different population structures that reflect local geochemical regimes. Descriptions of archaeal diversity were nearly exhaustive, but despite collecting an unparalleled number of sequences, statistical analyses indicated additional bacterial diversity at every taxonomic level. We predict that hundreds of thousands of sequences will be necessary to capture the vast diversity of microbial communities, and that different patterns of evenness for both high- and low-abundance taxa may be important in defining microbial ecosystem dynamics.	Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98105 USA	Marine Biological Laboratory - Woods Hole; University of Washington; University of Washington Seattle	Huber, JA (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr, 7 MBL St, Woods Hole, MA 02543 USA.	jhuber@mbl.edu	Sogin, Mitchell/AAE-7186-2019; Butterfield, David/H-3815-2016	Butterfield, David/0000-0002-1595-9279; Mark Welch, David/0000-0001-9774-4580; Huber, Julie/0000-0002-4790-7633; Morrison, Hilary/0000-0003-0281-326X				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Butterfield DA, 2004, GEOPH MONOG SERIES, V144, P269, DOI 10.1029/144GM17; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; CHAO A, 1984, SCAND J STAT, V11, P265; DeLong E, 2007, NAT REV MICROBIOL, V5, P326, DOI 10.1038/nrmicro1674; EMBLEY R, 1999, EOS T AM GEOPHYS UN, V80, P213; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Huber JA, 2003, FEMS MICROBIOL ECOL, V43, P393, DOI 10.1111/j.1574-6941.2003.tb01080.x; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; JOHNSON HP, 1990, J GEOPHYS RES-SOLID, V95, P12689, DOI 10.1029/JB095iB08p12689; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Maruyama A, 1998, CAH BIOL MAR, V39, P249; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; RAUP D M, 1975, Paleobiology, V1, P333; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	23	683	719	2	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					97	100		10.1126/science.1146689	http://dx.doi.org/10.1126/science.1146689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916733				2022-12-28	WOS:000249915400049
J	McClellan, AJ; Xia, Y; Deutschbauer, AM; Davis, RW; Gerstein, M; Frydman, J				McClellan, Amie J.; Xia, Yu; Deutschbauer, Adam M.; Davis, Ron W.; Gerstein, Mark; Frydman, Judith			Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches	CELL			English	Article							SUPEROXIDE-DISMUTASE; IN-VIVO; PROTEIN; COMPLEX; GENOME; HEAT-SHOCK-PROTEIN-90; GELDANAMYCIN; REQUIREMENT; DELETION; DATABASE	A comprehensive understanding of the cellular functions of the Hsp90 molecular chaperone has remained elusive. Although Hsp90 is essential, highly abundant under normal conditions, and further induced by environmental stress, only a limited number of Hsp90 "clients'' have been identified. To define Hsp90 function, a panelofgenome-wide chemical-genetic screens in Saccharomyces cerevisiae were combined with bioinformatic analyses. This approach identified several unanticipated functions of Hsp90 under normal conditions and in response to stress. Under normal growth conditions, Hsp90 plays a major role in various aspects of the secretory pathway and cellular transport; during environmental stress, Hsp90 is required for the cell cycle, meiosis, and cytokinesis. Importantly, biochemical and cell biological analyses validated several of these Hsp90-dependent functions, highlighting the potential of our integrated global approach to uncover chaperone functions in the cell.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Stanford University; Stanford University; Yale University	Frydman, J (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Xia, Yu/W-6150-2019; McClellan, Amie/V-8950-2019	Xia, Yu/0000-0002-5596-5518; McClellan, Amie/0000-0002-8033-6748; , judith/0000-0003-2302-6943	NIGMS NIH HHS [GM64992, 5P50GM062413-03, GM56433] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433, F32GM064992, P50GM062413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bohen SP, 1998, MOL CELL BIOL, V18, P3330, DOI 10.1128/MCB.18.6.3330; Brachmann CB, 1998, YEAST, V14, P115; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Chiosis G, 2006, ACS CHEM BIOL, V1, P279, DOI 10.1021/cb600224w; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Giaever G, 2003, TRENDS PHARMACOL SCI, V24, P444, DOI 10.1016/S0165-6147(03)00225-6; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Lange BMH, 2002, EMBO J, V21, P5364, DOI 10.1093/emboj/cdf531; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; LIU XF, 1994, MOL CELL BIOL, V14, P7037, DOI 10.1128/MCB.14.11.7037; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mimnaugh EG, 2006, MOL CANCER RES, V4, P667, DOI 10.1158/1541-7786.MCR-06-0019; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Nomura M, 2004, J CELL PHYSIOL, V201, P374, DOI 10.1002/jcp.20090; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	54	370	384	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					121	135		10.1016/j.cell.2007.07.036	http://dx.doi.org/10.1016/j.cell.2007.07.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923092	Bronze			2022-12-28	WOS:000249934700016
J	Uchiyama, Y; Aharonian, FA; Tanaka, T; Takahashi, T; Maeda, Y				Uchiyama, Yasunobu; Aharonian, Felix A.; Tanaka, Takaaki; Takahashi, Tadayuki; Maeda, Yoshitomo			Extremely fast acceleration of cosmic rays in a supernova remnant	NATURE			English	Article							DIFFUSIVE SHOCK ACCELERATION; SNR RX J1713.7-3946; PARTICLE-ACCELERATION; MAGNETIC-FIELD; MAXIMUM ENERGY; XMM-NEWTON; X-RAYS; SHELL; AMPLIFICATION; EMISSION	Galactic cosmic rays (CRs) are widely believed to be accelerated by shock waves associated with the expansion of supernova ejecta into the interstellar medium(1). A key issue in this long-standing conjecture is a theoretical prediction that the interstellar magnetic field can be substantially amplified at the shock of a young supernova remnant (SNR) through magnetohydrodynamic waves generated by cosmic rays(2,3). Here we report a discovery of the brightening and decay of X-ray hot spots in the shell of the SNR RX J1713.7-3946 on a one-year timescale. This rapid variability shows that the X-rays are produced by ultrarelativistic electrons through a synchrotron process and that electron acceleration does indeed take place in a strongly magnetized environment, indicating amplification of the magnetic field by a factor of more than 100. The X-ray variability also implies that we have witnessed the ongoing shock-acceleration of electrons in real time. Independently, broadband X-ray spectro-metric measurements(4) of RX J1713.7-3946 indicate that electron acceleration proceeds in the most effective ('Bohm-diffusion') regime. Taken together, these two results provide a strong argument for acceleration of protons and nuclei to energies of 1 PeV (10(15) eV) and beyond in young supernova remnants.	Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept High Energy Astrophys, Kanagawa 2298510, Japan; Dublin Inst Adv Studies, Dublin 2, Ireland; Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Dublin Institute for Advanced Studies; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Uchiyama, Y (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept High Energy Astrophys, 3-1-1 Yoshinodai, Kanagawa 2298510, Japan.	uchiyama@astro.isas.jaxa.jp		Tanaka, Takaaki/0000-0002-4383-0368				Aharonian F, 2007, ASTRON ASTROPHYS, V464, P235, DOI 10.1051/0004-6361:20066381; Bamba A, 2003, ASTROPHYS J, V589, P827, DOI 10.1086/374687; Bell AR, 2004, MON NOT R ASTRON SOC, V353, P550, DOI 10.1111/j.1365-2966.2004.08097.x; Bell AR, 2001, MON NOT R ASTRON SOC, V321, P433, DOI 10.1046/j.1365-8711.2001.04063.x; Berezhko EG, 2006, ASTRON ASTROPHYS, V451, P981, DOI 10.1051/0004-6361:20054595; Berezhko EG, 2003, ASTRON ASTROPHYS, V412, pL11, DOI 10.1051/0004-6361:20031667; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Cassam-Chenai G, 2004, ASTRON ASTROPHYS, V427, P199, DOI 10.1051/0004-6361:20041154; Drury LO, 2001, SPACE SCI REV, V99, P329, DOI 10.1023/A:1013825905795; Fukui Y, 2003, PUBL ASTRON SOC JPN, V55, pL61, DOI 10.1093/pasj/55.5.L61; Hillas AM, 2005, J PHYS G NUCL PARTIC, V31, pR95, DOI 10.1088/0954-3899/31/5/R02; Hiraga JS, 2005, ASTRON ASTROPHYS, V431, P953, DOI 10.1051/0004-6361:20047015; JOKIPII JR, 1987, ASTROPHYS J, V313, P842, DOI 10.1086/165022; Koyama K, 1997, PUBL ASTRON SOC JPN, V49, pL7, DOI 10.1093/pasj/49.3.L7; LAGAGE PO, 1983, ASTRON ASTROPHYS, V125, P249; Lazendic JS, 2004, ASTROPHYS J, V602, P271, DOI 10.1086/380956; Malkov MA, 2006, ASTROPHYS J, V642, P244, DOI 10.1086/500445; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Pfeffermann E., 1996, Rontgenstrahlung from the Universe. International Conference on X-Ray Astronomy and Astrophysics. Conference Proceedings (MPE Report 263), P267; Reynolds SP, 1998, ASTROPHYS J, V493, P375, DOI 10.1086/305103; TAKAHASHI T, IN PRESS PUBL ASTRON; Uchiyama Y, 2003, ASTRON ASTROPHYS, V400, P567, DOI 10.1051/0004-6361:20021824; Vink J, 2003, ASTROPHYS J, V584, P758, DOI 10.1086/345832; Wang ZR, 1997, ASTRON ASTROPHYS, V318, pL59; Yamazaki R, 2004, ASTRON ASTROPHYS, V416, P595, DOI 10.1051/0004-6361:20034212; Zirakashvili VN, 2007, ASTRON ASTROPHYS, V465, P695, DOI 10.1051/0004-6361:20066494	26	384	387	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					576	578		10.1038/nature06210	http://dx.doi.org/10.1038/nature06210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914390	Green Submitted			2022-12-28	WOS:000249893500039
J	Altman, D; Granath, F; Cnattingius, S; Falconer, C				Altman, Daniel; Granath, Fredrik; Cnattingius, Sven; Falconer, Christian			Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study	LANCET			English	Article							NORWEGIAN EPINCONT; UNITED-STATES	Background Hysterectomy for benign indications has been associated with an increased risk for lower-urinary-tract sequela, but results have been inconclusive. We aimed to establish the risk for stress-urinary-incontinence surgery after hysterectomy for benign indications. Methods We did a nationwide, population-based, cohort study from 1973 to 2003 in Sweden. We identified our population from the Swedish Inpatient Registry. We selected 165 260 women who had undergone hysterectomy (exposed cohort) and a control group of 479 506 individuals who had not had this procedure (unexposed cohort), matched by year of birth and county of residence. In both cohorts, occurrence of stress-urinary-incontinence surgery was established from the Swedish Inpatient Registry. Hazard ratios with 95% CIs were calculated by Cox's proportional-hazards regression. Findings During the 30-year observational period, the rate of stress-urinary-incontinence surgery per 100000 person-years was 179 (95% CI 173-186) in the exposed cohort versus 76 (73-79) in the unexposed cohort. Correspondingly, individuals in the exposed cohort were at increased risk for stress-urinary-incontinence surgery compared with those in the unexposed cohort (hazard ratio 2-4; 95% CI 2.3-2.5), irrespective of surgical technique. Risk for stress-urinaryincontinence surgery varied slightly with time of follow-up: the highest overall risk was recorded within 5 years of surgery (2.7; 2.5-2.9) and the lowest risk was seen after an observation period of 10 years or more (2.1, 1.9-2.2). Interpretation Hysterectomy for benign indications, irrespective of surgical technique, increases the risk for subsequent stress-urinary-incontinence surgery. Women should be counselled on associated risks related to hysterectomy, and other treatment options should be considered before surgery.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; Karolinska Inst, Dept Clin Sci, Div Obstet & Gynecol, Danderyd Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet	Altman, D (corresponding author), Danderyd Hosp, Div Obstet & Gynecol, SE-18288 Stockholm, Sweden.	daniel.altman@ds.se						Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Broder MS, 2000, OBSTET GYNECOL, V95, P199, DOI 10.1016/S0029-7844(99)00519-0; Brown JS, 2000, LANCET, V356, P535, DOI 10.1016/S0140-6736(00)02577-0; CARLSON KJ, 1993, NEW ENGL J MED, V328, P856; Davies A, 2001, J Obstet Gynaecol, V21, P166; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O; DeLancey JOL, 1997, WORLD J UROL, V15, P268, DOI 10.1007/BF02202011; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Gimbel H, 2003, BJOG-INT J OBSTET GY, V110, P1088; Gimbel H, 2001, ACTA OBSTET GYN SCAN, V80, P267, DOI 10.1034/j.1600-0412.2001.080003267.x; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Hannestad YS, 2002, SCAND J PRIM HEALTH, V20, P102, DOI 10.1080/713796408; Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0; Johnson N, 2005, BMJ-BRIT MED J, V330, P1478, DOI 10.1136/bmj.330.7506.1478; JOHNSON N, 2005, COCHRANE DB SYST REV, V1; Kenton K, 2006, BJU INT, V98, P1, DOI 10.1111/j.1464-410X.2006.06299.x; KILKKU P, 1985, ACTA OBSTET GYN SCAN, V64, P375, DOI 10.3109/00016348509155151; Lethaby A, 2006, COCHRANE DB SYST REV, V2; Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056; Nilsson A C, 1994, Lakartidningen, V91, P603; PRIOR A, 1992, GUT, V33, P264, DOI 10.1136/gut.33.2.264; Siddique SA, 2006, INT UROGYNECOL J, V17, P642, DOI 10.1007/s00192-006-0088-8; SMITH PH, 1968, BRIT J SURG, V55, P929, DOI 10.1002/bjs.1800551212; Thakar R, 2002, NEW ENGL J MED, V347, P1318, DOI 10.1056/NEJMoa013336; Thakar R, 2005, BEST PRACT RES CL OB, V19, P403, DOI 10.1016/j.bpobgyn.2005.01.008; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x; WILCOX LS, 1994, OBSTET GYNECOL, V83, P549, DOI 10.1097/00006250-199404000-00011	27	121	126	1	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT-NOV	2007	370	9597					1494	1499		10.1016/S0140-6736(07)61635-3	http://dx.doi.org/10.1016/S0140-6736(07)61635-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964350				2022-12-28	WOS:000250487000026
J	Beyrer, C				Beyrer, Chris			Burma and the challenge of humanitarian assistance	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhsph.edu						JAGAN L, 2007, BANGKOK POST    0810; PAUNG S, 2007, IRRAWADDY MAG   0927; Stover E, 2007, GATHERING STORM INFE; World Health Organization, 2000, WORLD HLTH REP 2000; 2007, BURMA B          AUG; 2007, JUNTA HAMPERING FOOD	6	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT-NOV	2007	370	9597					1465	1467		10.1016/S0140-6736(07)61615-8	http://dx.doi.org/10.1016/S0140-6736(07)61615-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224ZN	17964335				2022-12-28	WOS:000250487000007
J	Kitakaze, M; Asakura, M; Kim, J; Shintani, Y; Asanuma, H; Hamasaki, T; Seguchi, O; Myoishi, M; Minamino, T; Ohara, T; Nagai, Y; Nanto, S; Watanabe, K; Fukuzawa, S; Hirayama, A; Nakamura, N; Kimura, K; Fujii, K; Ishihara, M; Saito, Y; Tomoike, H; Kitamura, S				Kitakaze, Masafumi; Asakura, Masanori; Kim, Jiyoong; Shintani, Yasunori; Asanuma, Hiroshi; Hamasaki, Toshimitsu; Seguchi, Osamu; Myoishi, Masafumi; Minamino, Tetsuo; Ohara, Takahiro; Nagai, Yoshiyuki; Nanto, Shinsuke; Watanabe, Kouki; Fukuzawa, Shigeru; Hirayama, Atsushi; Nakamura, Natsuki; Kimura, Kazuo; Fujii, Kenshi; Ishihara, Masaharu; Saito, Yoshihiko; Tomoike, Hitonobu; Kitamura, Soichiro		J-Wind Investigators	Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; JAPAN-WORKING GROUPS; K-ATP CHANNEL; THROMBOLYTIC THERAPY; NECROTIC DAMAGE; TROPONIN-T; ANGIOPLASTY; HEART; MULTICENTER; POTASSIUM	Background Patients who have acute myocardial infarction remain at major risk of cardiovascular events. We aimed to assess the effects of either human atrial natriuretic peptide or nicorandil on infarct size and cardiovascular outcome. Methods We enrolled 1216 patients who had acute myocardial infarction and were undergoing reperfusion treatment in two prospective, single-blind trials at 65 hospitals in Japan. We randomly assigned 277 patients to receive intravenous atrial natriuretic: peptide (0 - 025 mu g/kg per min for 3 days) and 292 the same dose of placebo. 276 patients were assigned to receive intravenous nicorandil (0-067 mg/kg as a bolus, followed by 1.67 mu g/kg per min as a 24-h continuous infusion), and 269 the same dose of placebo. Median follow-up was 2.7 (IQR 1 - 5-3 - 6) years for patients in the atrial natriuretic peptide trial and 2.5 (1.5-3.7) years for those in the nicorandil trial. Primary endpoints were infarct size (estimated from creatine kinase) and left ventricular ejection fraction (gauged by angiography of the left ventricle). Findings 43 patients withdrew consent after randomisation, and 59 did not have acute myocardial infarction. We did not assess infarct size in 50 patients for whom we had fewer than six samples of blood. We did not have angiographs of left ventricles in 383 patients. Total creatine kinase was 66459.9 IU/mL per h in patients given atrial natriuretic peptide, compared with 77878.9 IU/mL per h in controls, with a ratio of 0.85 between these groups (95% CI 0.75-0.97, p=0.016), which indicated a reduction of 14.7% in infarct size (95% CI 3.0-24.9%). The left ventricular ejection fraction at 6-12 months increased in the atrial natriuretic peptide group (ratio 1.05, 95% Cl 1.01-1.10 p=0.024). Total activity of creatine kinase did not differ between patients given nicorandil (70 520.5 IU/mL per h) Q controls (70 852.7 IU/mL per h) (ratio 0 - 995, 95% CI 0 - 878-1.138, p=0.94). Intravenous nicorandil did not affect the size of the left ventricular ejection fraction, although oral administration of nicorandil during follow-up increased the left ventricular ejection fraction between the chronic and acute phases. 29 patients in the atrial natriuretic: peptide group had severe hypotension, compared with one in the corresponding placebo group. Interpretation Patients with acute myocardial infarction who were given atrial natriuretic peptide had lower infarct size, fewer reperfusion injuries, and better outcomes than controls. We believe that atrial natriuretic: peptide could be a safe and effective adjunctive treatment in patients with acute myocardial infarction who receive percutaneous coronary intervention.	Natl Cardiovasc Ctr, Div Cardiovasc Med, Osaka 5658565, Japan; Natl Cardiovasc Ctr, Dept Clin Res & Dev, Osaka 5658565, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Osaka, Japan; Natl Cardiovasc Ctr, Res Inst, Osaka 5658565, Japan; Osaka Univ, Grad Sch Med, Dept Biomed Stat, Osaka, Japan; Rinku Gen Med Ctr, Dept Cardiol, Ctr Heart, Osaka, Japan; Kansai Rosai Hosp, Div Cardiovasc, Amagasaki, Hyogo, Japan; Uwajima City Hosp, Dept Cardiol, Uwajima, Ehime, Japan; Funabashi Municipal Med Ctr, Div Cardiol, Chiba, Japan; Osaka Police Hosp, Div Cardiovasc, Osaka, Japan; Shinbeppu Hosp, Dept Cardiol, Oita, Japan; Yokohama City Univ, Div Cardiol, Kanagawa, Japan; Sakurabashi Watanabe Hosp, Div Cardiol, Osaka, Japan; Hiroshima City Hosp, Dept Cardiol, Hiroshima, Japan; Nara Med Univ, Dept Med 1, Nara, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Osaka University; National Cerebral & Cardiovascular Center - Japan; Osaka University; Kansai Rosai Hospital; Osaka Police Hospital; Yokohama City University; Hiroshima City Hospital; Nara Medical University	Kitakaze, M (corresponding author), Natl Cardiovasc Ctr, Div Cardiovasc Med, Osaka 5658565, Japan.	kitakaze@hsp.ncvc.go.jp	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160; Shintani, Yasunori/0000-0001-9579-0727				[Anonymous], 1994, Lancet, V344, P91; Asakura M, 2004, CIRC J, V68, P95, DOI 10.1253/circj.68.95; CODY RJ, 1986, J CLIN INVEST, V78, P1362, DOI 10.1172/JCI112723; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; EMORI T, 1993, ENDOCRINOLOGY, V133, P2474, DOI 10.1210/en.133.6.2474; Fukuzawa S, 2000, J NUCL CARDIOL, V7, P447, DOI 10.1067/mnc.2000.107273; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; GROVER GJ, 1992, CIRCULATION, V86, P1310, DOI 10.1161/01.CIR.86.4.1310; Hayashi M, 2001, J AM COLL CARDIOL, V37, P1820, DOI 10.1016/S0735-1097(01)01233-5; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; HJALMARSON A, 1985, EUR HEART J, V6, P199; Ishii H, 2005, CIRCULATION, V112, P1284, DOI 10.1161/CIRCULATIONAHA.104.530329; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kitakaze M, 1996, AM J PHYSIOL-HEART C, V270, pH1744, DOI 10.1152/ajpheart.1996.270.5.H1744; Kloner RA, 2004, J AM COLL CARDIOL, V44, P276, DOI 10.1016/j.jacc.2004.03.068; Kuga H, 2003, CIRC J, V67, P443; LAMAS GA, 1995, CIRCULATION, V92, P1101, DOI 10.1161/01.CIR.92.5.1101; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Mahaffey KW, 1999, J AM COLL CARDIOL, V34, P1711, DOI 10.1016/S0735-1097(99)00418-0; Minamino T, 2004, CIRC J, V68, P101, DOI 10.1253/circj.68.101; Mizumura T, 1996, CARDIOVASC RES, V32, P274, DOI 10.1016/0008-6363(96)00061-2; Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061; Sakata Y, 1997, AM HEART J, V133, P616, DOI 10.1016/S0002-8703(97)70162-5; Sakurai K, 2003, CIRC J, V67, P209, DOI 10.1253/circj.67.209; Seino Y, 1996, JPN CIRC J, V60, P265, DOI 10.1253/jcj.60.265; Shiba N, 2005, CIRC J, V69, P143, DOI 10.1253/circj.69.143; Steen H, 2006, J AM COLL CARDIOL, V48, P2192, DOI 10.1016/j.jacc.2006.06.002; Sugimoto K, 2003, CIRC J, V67, P295; Thermeau TM, 2000, MODELING SURVIVAL DA; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; van der Horst ICC, 2003, J AM COLL CARDIOL, V42, P784, DOI 10.1016/S0735-1097(03)00830-1; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; VOLLMER RT, 1993, AM J CLIN PATHOL, V100, P293, DOI 10.1093/ajcp/100.3.293; WALL TC, 1994, CIRCULATION, V90, P114, DOI 10.1161/01.CIR.90.1.114; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644	35	366	396	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1483	1493		10.1016/S0140-6736(07)61634-1	http://dx.doi.org/10.1016/S0140-6736(07)61634-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964349				2022-12-28	WOS:000250487000025
J	Hill, N; Lenglet, A; Arnez, AM; Carneiro, I				Hill, N.; Lenglet, A.; Arnez, A. M.; Carneiro, I.			Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon	BRITISH MEDICAL JOURNAL			English	Article								Objective To determine the effectiveness in reducing malaria of combining an insect repellent with insecticide treated bed nets compared with the nets atone in an area where vector mosquitoes feed in the early evening. Design A double blind, placebo controlled cluster-randomised clinical study. Setting Rural villages and peri-urban districts in the Bolivian Amazon. Participants 4008 individuals in 860 households. Interventions All individuals slept under treated nets; one group also used a plant based insect repellent each evening, a second group used placebo. Main outcome measure Episodes of Plasmodium falciparum or P vivax malaria confirmed by rapid diagnostic test or blood slide, respectively. Results We analysed 15 174 person months at risk and found a highly significant 80% reduction in episodes of P vivax in the group that used treated nets and repellent (incidence rate ratio 0.20, 95% confidence interval 0.11 to 0.38, P<0.001). Numbers of P falciparum cases during the study were small and, after adjustment forage, an 82% protective effect was observed, although this was not significant (0.18, 0.02 to 1.40, P=0.10). Reported episodes of fever with any cause were reduced by 58% in the group that used repellent (0.42, 0.31 to 0.56, P<0.001). Conclusions Insect repellents can provide protection against malaria. In areas where vectors feed in the early evening, effectiveness of treated nets can be significantly increased by using repellent between dusk and bedtime. This has important implications in malaria vector control programmes outside Africa and shows that the combined use of treated nets and insect repellents, as advocated for most tourists travelling to high risk areas, is fully justified.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Minist Hlth, Natl Bur Malaria Control, La Paz, Bolivia	University of London; London School of Hygiene & Tropical Medicine	Hill, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	nigel.hill@lshtm.ac.uk	Lenglet, Annick/U-8949-2017	Lenglet, Annick/0000-0003-2013-8405				[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Bradley D J, 2003, Commun Dis Public Health, V6, P180; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; GOODYER LI, 2004, TRAVEL MED HLTH PROF, P139; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Harris AF, 2006, T ROY SOC TROP MED H, V100, P45, DOI 10.1016/j.trstmh.2005.07.001; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; *HLTH PROT AG, 2003, MAL IMP UK; Horton NJ, 1999, AM STAT, V53, P160, DOI 10.2307/2685737; KNOLS BGJ, 1998, P EXP APPL ENTOMOL, V8, P15; Maxwell CA, 1998, MED VET ENTOMOL, V12, P325, DOI 10.1046/j.1365-2915.1998.00108.x; Moore SJ, 2002, J AM MOSQUITO CONTR, V18, P107; *PAN AM HLTH ORG, BAS IND HLTH SIT AM; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x	15	85	86	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2007	335	7628					1023	1025		10.1136/bmj.39356.574641.55	http://dx.doi.org/10.1136/bmj.39356.574641.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	17940319	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-28	WOS:000251402800029
J	Attar, EC; Aquino, SL; Hasserjian, RP; Harris, NL				Attar, Eyal C.; Aquino, Suzanne L.; Hasserjian, Robert P.; Harris, Nancy Lee			A 49-year-old HIV-positive man with anemia - Pure red-cell aplasia associated with classic Hodgkin's lymphoma in an HIV-positive man.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARVOVIRUS B19 INFECTION; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ERYTHROPOIETIN; DISEASE; PLASMA; THERAPY; ERYTHROBLASTOPENIA; EPIDEMIOLOGY; PATIENT; PROTEIN		Massachusetts Gen Hosp, Hematol Oncol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Attar, EC (corresponding author), Massachusetts Gen Hosp, Hematol Oncol Unit, Boston, MA 02114 USA.							Bellas C, 1996, AM J SURG PATHOL, V20, P1520, DOI 10.1097/00000478-199612000-00012; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; BROWN KE, 1995, BLOOD REV, V9, P176, DOI 10.1016/0268-960X(95)90023-3; Carbone A, 1999, BLOOD, V93, P2319; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Casadevall N, 1996, NEW ENGL J MED, V334, P630, DOI 10.1056/NEJM199603073341004; Charles RJ, 1996, BLOOD, V87, P4831, DOI 10.1182/blood.V87.11.4831.bloodjournal87114831; Fisch P, 2000, BRIT J HAEMATOL, V111, P1010, DOI 10.1046/j.1365-2141.2000.02429.x; Forestier F, 1999, BRIT J HAEMATOL, V104, P925, DOI 10.1046/j.1365-2141.1999.01241.x; Franceschi S, 1999, INT J CANCER, V83, P481, DOI 10.1002/(SICI)1097-0215(19991112)83:4<481::AID-IJC8>3.3.CO;2-X; HELLER HM, 1993, NEW ENGL J MED, V329, P792, DOI 10.1056/NEJM199309093291109; Hermeling S, 2003, PHARM RES, V20, P1903, DOI 10.1023/B:PHAM.0000008034.61317.02; JANDL DL, 1987, BLOOD TXB HEMATOLOGY, P27; JEPSON JH, 1974, CANCER RES, V34, P1325; JEPSON JH, 1966, BLOOD-J HEMATOL, V27, P425, DOI 10.1182/blood.V27.4.425.425; JEPSON JH, 1968, CAN MED ASSOC J, V99, P99; KRANTZ SB, 1973, J CLIN INVEST, V52, P324, DOI 10.1172/JCI107188; KRANTZ SB, 1969, BLOOD-J HEMATOL, V34, P1; LACY MQ, 1996, BLOOD, V87, P300; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Lister TA, 1990, J CLIN ONCOL, V8, P1602; Liu W, 1997, HUM PATHOL, V28, P760, DOI 10.1016/S0046-8177(97)90146-5; MORGAN E, 1978, AM J HEMATOL, V5, P71, DOI 10.1002/ajh.2830050110; Natori Y, 1986, Rinsho Ketsueki, V27, P219; PESCHLE C, 1975, BRIT J HAEMATOL, V30, P411, DOI 10.1111/j.1365-2141.1975.tb01855.x; Thompson LDR, 2004, AM J CLIN PATHOL, V121, P727, DOI 10.1309/PNVQ0PQGXHVY6L7G; Villalobos AP, 2005, PHARM RES-DORDR, V22, P1186, DOI 10.1007/s11095-005-5356-7	28	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1745	1754		10.1056/NEJMcpc079027	http://dx.doi.org/10.1056/NEJMcpc079027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960016				2022-12-28	WOS:000250355100011
J	Grieneisen, VA; Xu, J; Maree, AFM; Hogeweg, P; Scheres, B				Grieneisen, Veronica A.; Xu, Jian; Maree, Athanasius F. M.; Hogeweg, Paulien; Scheres, Ben			Auxin transport is sufficient to generate a maximum and gradient guiding root growth	NATURE			English	Article							BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; EFFLUX; PIN; PHYLLOTAXIS; PATTERN; MERISTEM; RECEPTOR; NETWORK; TISSUES	The plant growth regulator auxin controls cell identity, cell division and cell expansion. Auxin efflux facilitators (PINs) are associated with auxin maxima in distal regions of both shoots and roots. Here we model diffusion and PIN-facilitated auxin transport in and across cells within a structured root layout. In our model, the stable accumulation of auxin in a distal maximum emerges from the auxin flux pattern. We have experimentally tested model predictions of robustness and self-organization. Our model explains pattern formation and morphogenesis at timescales from seconds to weeks, and can be understood by conceptualizing the root as an 'auxin capacitor'. A robust auxin gradient associated with the maximum, in combination with separable roles of auxin in cell division and cell expansion, is able to explain the formation, maintenance and growth of sharply bounded meristematic and elongation zones. Directional permeability and diffusion can fully account for stable auxin maxima and gradients that can instruct morphogenesis.	Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University	Scheres, B (corresponding author), Univ Utrecht, Dept Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	b.scheres@uu.nl	Xu, Jian/I-2921-2012; Hogeweg, paulien/D-1242-2011	Xu, Jian/0000-0001-6194-6316; Maree, Athanasius F. M./0000-0003-2689-2484; Scheres, Ben/0000-0001-5400-9578; Grieneisen, Veronica/0000-0001-6780-8301				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Beeckman T, 2001, J EXP BOT, V52, P403, DOI 10.1093/jexbot/52.suppl_1.403; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Berleth T, 2007, TRENDS PLANT SCI, V12, P151, DOI 10.1016/j.tplants.2007.03.005; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Feugier FG, 2005, J THEOR BIOL, V236, P366, DOI 10.1016/j.jtbi.2005.03.017; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; GOLDSMITH MHM, 1981, P NATL ACAD SCI-BIOL, V78, P976, DOI 10.1073/pnas.78.2.976; GUTKNECHT J, 1980, J MEMBRANE BIOL, V56, P65, DOI 10.1007/BF01869353; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jones AM, 1998, SCIENCE, V282, P2201, DOI 10.1126/science.282.5397.2201; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; KRAMER EM, 2007, J EXP BOT; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Leyser O, 2005, CELL, V121, P819, DOI 10.1016/j.cell.2005.06.005; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SACHS T, 1981, ADV BOT RES, V9, P152; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Went FW, 1942, PLANT PHYSIOL, V17, P236, DOI 10.1104/pp.17.2.236; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790	38	597	620	0	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1008	1013		10.1038/nature06215	http://dx.doi.org/10.1038/nature06215			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960234	Green Published			2022-12-28	WOS:000250395000042
J	Lin, X; Clark, AC; Chan, MHW				Lin, X.; Clark, A. C.; Chan, M. H. W.			Probable heat capacity signature of the supersolid transition	NATURE			English	Article							SUPERFLUID TRANSITION; HE-3; PHASE	Liquid He-4 enters the superfluid state and flows without friction below 2.176 K. Thin liquid films adsorbed on solid substrates undergo the same transformation, although at a lower temperature. When the substrate is subjected to oscillatory motion a portion of the film, known as the superfluid fraction, decouples from the oscillation. A similar phenomenon has been observed(1,2) in solid He-4, in which a fraction of the solid seems to decouple from the motion of the surrounding lattice. Although this observation has been replicated in various laboratories(3-6), no thermodynamic signature of the possible supersolid transition has been seen. Here we report the finding of a heat capacity peak that coincides with the onset of mass decoupling. This complementary experimental evidence supports the existence of a genuine transition between the normal solid and supersolid phases of He-4.	Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chan, MHW (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	chan@phys.psu.edu		Clark, Anthony/0000-0002-6503-1890				ALLEN AR, 1982, J LOW TEMP PHYS, V47, P289, DOI 10.1007/BF00683732; Anderson PW, 2007, NAT PHYS, V3, P160, DOI 10.1038/nphys539; Aoki Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015301; CASTLES SH, 1975, J LOW TEMP PHYS, V19, P397, DOI 10.1007/BF00114090; Clark AC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.135302; Clark AC, 2005, J LOW TEMP PHYS, V138, P853, DOI 10.1007/s10909-005-2314-z; EDWARDS DO, 1965, PHYS REV, V140, pA816, DOI 10.1103/PhysRev.140.A816; GARDNER WR, 1973, PHYS REV A, V7, P1029, DOI 10.1103/PhysRevA.7.1029; GRIGOREV VN, 2007, OBSERVATION GLASSY P; GRIGORIEV VN, 1973, J LOW TEMP PHYS, V13, P65, DOI 10.1007/BF00654398; Hebral B., 1980, Phonon Scattering in Condensed Matter. Proceedings of the Third International Conference, P169; HEBRAL B, 1981, PHYS REV LETT, V46, P42, DOI 10.1103/PhysRevLett.46.42; HELTEMES EC, 1962, PHYS REV, V128, P1512, DOI 10.1103/PhysRev.128.1512; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Kondo M, 2007, J LOW TEMP PHYS, V148, P695, DOI 10.1007/s10909-007-9471-1; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Nussinov Z, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014530; Penzev A, 2007, J LOW TEMP PHYS, V148, P677, DOI 10.1007/s10909-007-9452-4; Prokof'ev N, 2007, ADV PHYS, V56, P381, DOI 10.1080/00018730601183025; RICHARDS MG, 1972, PHYS REV LETT, V29, P708, DOI 10.1103/PhysRevLett.29.708; Rittner ASC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175302; Rittner ASC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165301; SCHRENK R, 1991, J LOW TEMP PHYS, V84, P133, DOI 10.1007/BF00681620; SINGSAAS A, 1984, PHYS REV B, V30, P5103, DOI 10.1103/PhysRevB.30.5103; SULLIVAN PF, 1968, PHYS REV, V173, P679, DOI 10.1103/PhysRev.173.679; Todoshchenko IA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165302; Todoshchenko IA, 2007, JETP LETT+, V85, P454, DOI 10.1134/S0021364007090093; Yoon J, 1997, PHYS REV LETT, V78, P4801, DOI 10.1103/PhysRevLett.78.4801; Zassenhaus GM, 1999, PHYS REV LETT, V83, P4800, DOI 10.1103/PhysRevLett.83.4800	30	62	62	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1025	1028		10.1038/nature06228	http://dx.doi.org/10.1038/nature06228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960238				2022-12-28	WOS:000250395000046
J	Wenzel, S; Wilbraham, D; Fuller, R; Getz, E; Lonphre, M				Wenzel, Sally; Wilbraham, Darren; Fuller, Rick; Burmeister Getz, Elise; Lonphre, Malinda			Effect of an interieukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies	LANCET			English	Article							ANTAGONIST BAY 16-9996; NITRIC-OXIDE; AIRWAY INFLAMMATION; IL-4; HYPERRESPONSIVENESS; INTERLEUKIN-13; BUDESONIDE; EXPRESSION; PRODUCTS; PRIMATE	Background Increases in T helper (Th) 2 cytorkine concentrations have been seen in atopic asthma, with interleukin 4 and interleukin 13 thought to have a role in the physiological response to allergen challenge. Our aim was to assess the therapeutic effect of pitrakinra, an interleukin-4 variant that targets allergic Th2 inflammation by potently inhibiting the binding of interleukin 4 and interleukin 13 to interleukin-4R alpha receptor complexes. Methods In two independent randomised, double-blind, placebo-controlled, parallel group phase 2a clinical trials, patients with atopic asthma were treated with pitrakinra or placebo via two routes. In study 1, patients were randomly assigned to receive either 25 mg pitrakinra (n=12) or placebo (n=12) by subcutaneous injection once daily. In study 2, patients were randomly assigned to receive either 60 mg pitrakinra (n=16) or placebo (n=16) by nebulisation twice daily. inhaled allergen challenge was done before and after 4 weeks of treatment. The primary endpoint for study 1 was maximum percentage decrease in forced expiratory volume in 1 s (FEV1) over 4-10 h after allergen challenge, whereas that in study 2 was average percentage decrease in FEV1 over 4-10 h after allergen challenge. All patients except those with baseline data only were included in our analyses. These trials are registered with ClinicalTrials.gov, numbers NCT00535028 and NCT00535031. Findings No patients dropped out or were lost to follow-up in study 1; in study 2, two patients in the placebo group and one in the pitrakinra group dropped out or were lost to follow-up. These individuals had baseline data only, and were excluded from the analyses. In study 1, there was a 17.1% maximum percentage decrease in FEV1 in the pitrakinra group; by contrast, the maximum decrease was 23.1% in the placebo group (difference 6%, 95% CI -4-37 to 16-32; p=0.243). In study 2, there was a 4.4% average percentage decrease in FEV1 in the pitrakinra group; by contrast, the average percentage decrease was 15.9% in the placebo group (3.7 [95% CI 2.08-6.25] times lower in the pitrakinra group; p=0.0001). There were fewer asthma-related adverse events (p=0.069) and fewer adverse events requiring beta-agonist rescue (p=0.031) after subcutaneous administration of pitrakinra than with placebo. There were too few asthma-related adverse events in study 2 to assess the effect of inhalation of pitrakinra on adverse events. Interpretation Local treatment, targeted at inhibition of interleukins 4 and 13 in the lung, could substantially diminish the symptoms of asthma.	Aerovance Inc, Berkeley, CA 94710 USA; Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; Quintiles Ltd, Guys Drug Res Unit, London, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IQVIA; University of London; King's College London	Lonphre, M (corresponding author), Aerovance Inc, 2929 7th St, Berkeley, CA 94710 USA.	malinda.longphre@aerovance.com		Burmeister Getz, Elise/0000-0003-2716-2088				Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Brown JL, 2007, CLIN EXP ALLERGY, V37, P688, DOI 10.1111/j.1365-2222.2007.02695.x; Cohn L, 1999, J IMMUNOL, V162, P6178; CONTI CR, 1994, CLIN CARDIOL, V17, P227, DOI 10.1002/clc.4960170502; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Fahy JV, 1999, AM J RESP CRIT CARE, V160, P1023, DOI 10.1164/ajrccm.160.3.9810012; Gauvreau GM, 1996, AM J RESP CRIT CARE, V154, P1267, DOI 10.1164/ajrccm.154.5.8912734; Gavett SH, 1997, AM J PHYSIOL-LUNG C, V272, pL253, DOI 10.1152/ajplung.1997.272.2.L253; Groves RW, 2007, J INVEST DERMATOL, V127, pS54; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo FH, 1998, ENVIRON HEALTH PERSP, V106, P1119, DOI 10.2307/3433973; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Harris P, 1999, AM J RESP CRIT CARE, V159, pA230; Hart PH, 1999, J LEUKOCYTE BIOL, V66, P575, DOI 10.1002/jlb.66.4.575; Hessel EM, 2005, J EXP MED, V202, P1563, DOI 10.1084/jem.20050631; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; JUNIPER EF, 1990, AM REV RESPIR DIS, V142, P832, DOI 10.1164/ajrccm/142.4.832; Kay AB, 2006, CHEM IMMUNOL ALLERGY, V91, P59; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; McKenzie ANJ, 2003, J EXP MED, V197, P675, DOI 10.1084/jem.20030096; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MILLER MR, 2006, EUR RESPIR J, V26, P154; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Morton M, 1999, AM J RESP CRIT CARE, V159, pA660; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; O'Byrne PM, 2004, TRENDS PHARMACOL SCI, V25, P244, DOI 10.1016/j.tips.2004.03.008; Padilla J, 2005, J IMMUNOL, V174, P8097, DOI 10.4049/jimmunol.174.12.8097; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; Suresh V, 2007, AM J RESP CELL MOL, V37, P97, DOI 10.1165/rcmb.2006-0419OC; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093; TAYLOR IK, 1991, LANCET, V337, P690, DOI 10.1016/0140-6736(91)90277-V; TOMKINSON A, 2006, P AM THORAC SOC, V3, pA521; TRUDEAU JB, 2006, P AM THORACIC SOC, V3, pA66; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wills-Karp M, 2000, IMMUNOPHARMACOLOGY, V48, P263, DOI 10.1016/S0162-3109(00)00223-X	38	482	534	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1422	1431		10.1016/S0140-6736(07)61600-6	http://dx.doi.org/10.1016/S0140-6736(07)61600-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950857				2022-12-28	WOS:000250386000019
J	Selkoe, DJ; Wolfe, MS				Selkoe, Dennis J.; Wolfe, Michael S.			Presenilin: Running with scissors in the membrane	CELL			English	Article							SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE COMPLEX; REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TALKING POINT; TNF-ALPHA; NICASTRIN; MUTATIONS; DOMAIN		Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu; mwolfe@rics.bwh.harvard.edu						Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; LE MS, 2007, CANCER RES, V67, P1879; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; SATO T, 2007, J BIOL CHEM; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Small DH, 2002, PEPTIDES, V23, P1317, DOI 10.1016/S0196-9781(02)00072-4; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	43	291	299	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					215	221		10.1016/j.cell.2007.10.012	http://dx.doi.org/10.1016/j.cell.2007.10.012			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956719	Bronze			2022-12-28	WOS:000250507700008
J	Boyle, MP				Boyle, Michael P.			Adult cystic fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG TRANSPLANTATION; CFTR MUTATIONS; PREDICTION; CLEARANCE; PREGNANCY; UPDATE; GENE; TIME	Cystic fibrosis is a multisystem disease characterized primarily by chronic pulmonary infection and bronchiectasis, pancreatic exocrine impairment, and elevated sweat chloride. In the last 4 decades, new treatment strategies and aggressive nutritional management have resulted in a significant increase in expected survival, with median predicted survival in cystic fibrosis now to older than 35 years. This increase in predicted survival has also been aided by a greater appreciation of the potential variability in the presentation and severity of cystic fibrosis, resulting in identification of a growing number of mild cases. As it is estimated that within the next decade more than half of all individuals with cystic fibrosis will be aged 18 years or older, adult medicine caregivers are increasingly likely to encounter patients with cystic fibrosis and be exposed to their unique medical management.	Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Johns Hopkins Adult Cyst Fibrosis Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Boyle, MP (corresponding author), Johns Hopkins Univ Hosp, Johns Hopkins Adult Cyst Fibrosis Program, 1830 E Monument St,5th Floor, Baltimore, MD 21205 USA.	mboyle@jhmi.edu		Boyle, Michael/0000-0002-9740-1630				Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; Boyle Michael P, 2007, Proc Am Thorac Soc, V4, P52, DOI 10.1513/pats.200605-129JG; Boyle MP, 2006, CURR OPIN PULM MED, V12, P453, DOI 10.1097/01.mcp.0000245708.59138.a4; Boyle MP, 2003, CURR OPIN PULM MED, V9, P498, DOI 10.1097/00063198-200311000-00009; Boyle MP, 2003, CHEST, V123, P3, DOI 10.1378/chest.123.1.3; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Cuppens H, 2004, INT J ANDROL, V27, P251, DOI 10.1111/j.1365-2605.2004.00485.x; *CYST FIBR WORLDW, 2006, ANN REP 2005; Cystic Fibrosis Foundation, 2006, PAT REG 2005 ANN REP; De Boeck K, 2006, THORAX, V61, P627, DOI 10.1136/thx.2005.043539; Desax MC, 2008, EUR J PEDIATR, V167, P299, DOI 10.1007/s00431-007-0485-0; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Flume PA, 2003, SEMIN RESP CRIT CARE, V24, P727; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gilljam M, 2000, CHEST, V118, P85, DOI 10.1378/chest.118.1.85; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Knowles MR, 1999, CYSTIC FIBROSIS IN ADULTS, P27; Lai HJ, 2006, CURR OPIN PULM MED, V12, P422, DOI 10.1097/01.mcp.0000245709.66762.f9; Liou TG, 2005, CHEST, V128, P472, DOI 10.1378/chest.128.1.472; Liou TG, 2005, AM J RESP CRIT CARE, V171, P1053, DOI 10.1164/rccm.200407-900OC; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Marshall BC, 2005, J PEDIATR-US, V146, P681, DOI 10.1016/j.jpeds.2004.12.039; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; McArdle JR, 2007, CLIN CHEST MED, V28, P347, DOI 10.1016/j.ccm.2007.02.005; McMullen AH, 2006, CHEST, V129, P706, DOI 10.1378/chest.129.3.706; Merlo CA, 2007, CHEST, V132, P562, DOI 10.1378/chest.06-2888; Moran A., 1999, Diabetes Research and Clinical Practice, V45, P61, DOI 10.1016/S0168-8227(99)00058-3; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Rock MJ, 2007, CLIN CHEST MED, V28, P297, DOI 10.1016/j.ccm.2007.02.008; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Saiman Lisa, 2003, American Journal of Infection Control, V31, pS1; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S	43	72	84	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1787	1793		10.1001/jama.298.15.1787	http://dx.doi.org/10.1001/jama.298.15.1787			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940235				2022-12-28	WOS:000250187300022
J	Pronovost, PJ; Miller, M; Wachter, RM				Pronovost, Peter J.; Miller, Marlene; Wachter, Robert M.			The GAAP in quality measurement and reporting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; HOSPITAL QUALITY; PERFORMANCE; CARE; PAY; IMPROVEMENT; PNEUMONIA; MORTALITY; OUTCOMES; PATIENT		Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Pronovost, PJ (corresponding author), 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Fee C, 2007, ANN EMERG MED, V49, P553, DOI 10.1016/j.annemergmed.2006.11.008; FIN. ACCOUNTING STANDARDS BD, 2007, FACTS FASB, P1; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hibbard JH, 2005, HEALTH AFFAIR, V24, P1150, DOI 10.1377/hlthaff.24.4.1150; Houston TK, 2005, AM J MED, V118, P269, DOI 10.1016/j.amjmed.2004.12.007; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Porter ME, 2007, JAMA-J AM MED ASSOC, V297, P1103, DOI 10.1001/jama.297.10.1103; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; PRONOVOST PJ, IN PRESS AM J MED QU; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Shortell SM, 2007, JAMA-J AM MED ASSOC, V298, P673, DOI 10.1001/jama.298.6.673; *US DEP HHS, HOSP COMP; Wharam JF, 2007, JAMA-J AM MED ASSOC, V298, P676, DOI 10.1001/jama.298.6.676	18	77	78	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1800	1802		10.1001/jama.298.15.1800	http://dx.doi.org/10.1001/jama.298.15.1800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940238				2022-12-28	WOS:000250187300025
J	Starrs, AM				Starrs, Ann M.			Delivering for women	LANCET			English	Editorial Material									Family Care Int, New York, NY 10012 USA; Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland		Starrs, AM (corresponding author), Family Care Int, New York, NY 10012 USA.	astarrs@familycareintl.org						Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Garrett L, 2007, FOREIGN AFF, V86, P14; Gill K, 2007, LANCET, V370, P1347, DOI 10.1016/S0140-6736(07)61577-3; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Starrs A., 1987, PREV TRAG MAT DEATHS; GLOBAL CAMPAIGN HLTH	8	27	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1285	1287		10.1016/S0140-6736(07)61549-9	http://dx.doi.org/10.1016/S0140-6736(07)61549-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220SC	17933629				2022-12-28	WOS:000250176600004
J	Baines, KH; Simon-Miller, AA; Orton, GS; Weaver, HA; Lunsford, A; Momary, TW; Spencer, J; Cheng, AF; Reuter, DC; Jennings, DE; Gladstone, GR; Moore, J; Stern, SA; Young, LA; Throop, H; Yanamandra-Fisher, P; Fisher, BM; Hora, J; Ressler, ME				Baines, Kevin H.; Simon-Miller, Amy A.; Orton, Glenn S.; Weaver, Harold A.; Lunsford, Allen; Momary, Thomas W.; Spencer, John; Cheng, Andrew F.; Reuter, Dennis C.; Jennings, Donald E.; Gladstone, G. R.; Moore, Jeffrey; Stern, S. Alan; Young, Leslie A.; Throop, Henry; Yanamandra-Fisher, Padma; Fisher, Brendan M.; Hora, Joseph; Ressler, Michael E.			Polar lightning and decadal-scale cloud variability on Jupiter	SCIENCE			English	Article							RADIO ASTRONOMY OBSERVATIONS; MEAN ZONAL FLOW; SPATIAL-DISTRIBUTION; GALILEO IMAGES; ATMOSPHERE; VOYAGER-1; SATURN	Although lightning has been seen on other planets, including Jupiter, polar lightning has been known only on Earth. Optical observations from the New Horizons spacecraft have identified lightning at high latitudes above Jupiter up to 80 degrees N and 74 degrees S. Lightning rates and optical powers were similar at each pole, and the mean optical flux is comparable to that at nonpolar latitudes, which is consistent with the notion that internal heat is the main driver of convection. Both near-infrared and ground-based 5-micrometer thermal imagery reveal that cloud cover has thinned substantially since the 2000 Cassini flyby, particularly in the turbulent wake of the Great Red Spot and in the southern half of the equatorial region, demonstrating that vertical dynamical processes are time-varying on seasonal scales at mid-and low latitudes on Jupiter.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; SW Res Inst, Boulder, CO 80302 USA; SW Res Inst, San Antonio, TX 78238 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; NASA Headquarters, Sci Mission Directorate, Washington, DC 20546 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Southwest Research Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Baines, KH (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.		Jennings, Donald/D-7978-2012; Simon, Amy/C-8020-2012; Orton, Glenn/AAD-9862-2020; Weaver, Harold A/D-9188-2016	Simon, Amy/0000-0003-4641-6186; Weaver, Harold A/0000-0003-0951-7762; Ressler, Michael/0000-0001-5644-8830; Hora, Joseph/0000-0002-5599-4650				ALLISON M, 1990, ICARUS, V83, P282, DOI 10.1016/0019-1035(90)90069-L; Baines KH, 2002, ICARUS, V159, P74, DOI 10.1006/icar.2002.6901; Borucki WJ, 1996, ICARUS, V123, P336, DOI 10.1006/icar.1996.0162; BORUCKI WJ, 1986, J GEOPHYS RES-ATMOS, V91, P9893, DOI 10.1029/JD091iD09p09893; BORUCKI WJ, 1982, ICARUS, V52, P492, DOI 10.1016/0019-1035(82)90009-4; BORUCKI WJ, 1992, ICARUS, V96, P1, DOI 10.1016/0019-1035(92)90002-O; CHENG AF, IN PRESS SPACE SCI R; COOK AF, 1979, NATURE, V280, P794, DOI 10.1038/280794a0; DEUTSCH L, 2002, SPIE, V4841, P106; Dyudina UA, 2004, ICARUS, V172, P24, DOI 10.1016/j.icarus.2004.07.014; Dyudina UA, 2002, ICARUS, V160, P336, DOI 10.1006/icar.2002.6977; Dyudina UA, 2007, ICARUS, V190, P545, DOI 10.1016/j.icarus.2007.03.035; Fischer G, 2007, ICARUS, V190, P528, DOI 10.1016/j.icarus.2007.04.002; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; INGERSOLL AP, 1981, J GEOPHYS RES-SPACE, V86, P8733, DOI 10.1029/JA086iA10p08733; LIMAYE SS, 1986, ICARUS, V65, P335, DOI 10.1016/0019-1035(86)90142-9; Little B, 1999, ICARUS, V142, P306, DOI 10.1006/icar.1999.6195; MAGALHAES JA, 1991, NATURE, V349, P311, DOI 10.1038/349311a0; PIRRAGLIA JA, 1984, ICARUS, V59, P169, DOI 10.1016/0019-1035(84)90020-4; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; RESSLER ME, 1994, EXP ASTRON, V3, P277; Reuter DC, 2007, SCIENCE, V318, P223, DOI 10.1126/science.1147618; REUTER DC, IN PRESS SPACE SCI R; SMITH BA, 1979, SCIENCE, V204, P951, DOI 10.1126/science.204.4396.951; Vasavada AR, 1998, ICARUS, V135, P265, DOI 10.1006/icar.1998.5984; WARWICK JW, 1981, SCIENCE, V212, P239, DOI 10.1126/science.212.4491.239; WARWICK JW, 1982, SCIENCE, V215, P582, DOI 10.1126/science.215.4532.582; WEIDENSCHILLING SJ, 1973, ICARUS, V20, P465, DOI 10.1016/0019-1035(73)90019-5	30	44	44	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					226	229		10.1126/science.1147912	http://dx.doi.org/10.1126/science.1147912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932285				2022-12-28	WOS:000250086100033
J	Laurent, S				Laurent, Stphane			Day or night blood pressures to predict cardiovascular events?	LANCET			English	Editorial Material							MORTALITY		Hop Europeen Georges Pompidou, INSERM, U652, F-75015 Paris, France; Hop Europeen Georges Pompidou, Dept Pharmacol, F-75015 Paris, France; Univ Paris 05, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Laurent, S (corresponding author), Hop Europeen Georges Pompidou, INSERM, U652, F-75015 Paris, France.	stephane.laurent@egp.aphp.fr	Laurent, Stephane/J-8624-2015					Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Fagard RH, 1997, J HYPERTENS, V15, P1493, DOI 10.1097/00004872-199715120-00018; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Kikuya M, 2007, CIRCULATION, V115, P2145, DOI 10.1161/CIRCULATIONAHA.106.662254; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Mancia G, 1997, CIRCULATION, V95, P1464; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; OBRIEN E, 1988, LANCET, V2, P397; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2007	370	9594					1192	1193		10.1016/S0140-6736(07)61523-2	http://dx.doi.org/10.1016/S0140-6736(07)61523-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920907				2022-12-28	WOS:000250091900005
J	Ma, A				Ma, Averil			Loss of T-bet sends host-microbe mutualism awry	CELL			English	Editorial Material							TRANSCRIPTION FACTOR; RECOGNITION; ACTIVATION; MICE	Immune homeostasis in the intestine involves complex interactions between microbial organisms and host cells. In this issue, Garrett et al. ( 2007) describe a communicable form of colitis that is induced by deficiency of the transcription factor T-bet in cells of the innate immune system.	Univ Calif San Francisco, Dept Med, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, Program Biomed Sci, 513 Parnassus Ave, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu						DUBOS R, 1966, PEDIATRICS, V38, P789; GARRETT WS, 2007, CELL; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422	10	4	4	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					15	17		10.1016/j.cell.2007.09.030	http://dx.doi.org/10.1016/j.cell.2007.09.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923080	Bronze			2022-12-28	WOS:000249934700003
J	Patt, AG; Ogallo, L; Hellmuth, M				Patt, Anthony G.; Ogallo, Laban; Hellmuth, Molly			Sustainability - Learning from 10 years of climate outlook forums in Africa	SCIENCE			English	Editorial Material							FORECASTS; FARMERS		Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; Boston Univ, Dept Geog & Environm, Boston, MA 02215 USA; Intergovt Author Dev Climate Predict & Applicat C, Nairobi, Kenya; Columbia Univ, Int Res Inst Climate & Soc, New York, NY USA	International Institute for Applied Systems Analysis (IIASA); Boston University; Columbia University	Patt, AG (corresponding author), Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria.	patt@iiasa.ac.at	Patt, Anthony/E-5437-2017					Axel J, 2007, ELEMENTS LIFE, P70; BABU AD, 2001, EVALUATION EC CONTRI; Betsill MM, 1997, ENVIRONMENT, V39, P6, DOI 10.1080/00139159709604775; Broad K, 2000, SCIENCE, V289, P1693; CANE MA, 1994, NATURE, V370, P204, DOI 10.1038/370204a0; CANE MA, 1986, NATURE, V321, P827, DOI 10.1038/321827a0; Cash DW, 2006, SCI TECHNOL HUM VAL, V31, P465, DOI 10.1177/0162243906287547; GLANTZ M, 2000, BURNED TWICE SHY LSS; Hansen JW, 2004, AGR FOREST METEOROL, V125, P143, DOI 10.1016/j.agrformet.2004.02.006; Hellmuth M.E., 2007, CLIMATE RISK MANAGEM; Ingram KT, 2002, AGR SYST, V74, P331, DOI 10.1016/S0308-521X(02)00044-6; JOHNSTON P, 2007, 30 ANN APPL GEOGR C; *NAT RES COUNC, 1996, LEARN PRED CLIM VAR; OLUDHE C, 2001, ASSESSMENT POTENTIAL; Patt A, 2005, P NATL ACAD SCI USA, V102, P12623, DOI 10.1073/pnas.0506125102; Phillips JG, 2002, AGR SYST, V74, P351, DOI 10.1016/S0308-521X(02)00045-8; Roncoli C, 2006, CLIM RES, V33, P81, DOI 10.3354/cr033081; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Vogel C, 2006, CLIM RES, V33, P111, DOI 10.3354/cr033111; WALKER S, 2001, ASSESSMENT COMMUNICA; Washington R, 2006, B AM METEOROL SOC, V87, P1355, DOI 10.1175/BAMS-87-10-1355; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	22	84	84	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					49	50		10.1126/science.1147909	http://dx.doi.org/10.1126/science.1147909			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916713				2022-12-28	WOS:000249915400027
J	Jasanoff, S				Jasanoff, Sheila			Technologies of humility	NATURE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Jasanoff, S (corresponding author), Harvard Univ, John F Kennedy Sch Govt, 79 John F Kennedy St, Cambridge, MA 02138 USA.								0	152	154	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					33	33		10.1038/450033a	http://dx.doi.org/10.1038/450033a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972866	Bronze			2022-12-28	WOS:000250585800025
J	Cheke, RA				Cheke, Robert A.			Thinking long term	SCIENCE			English	Editorial Material							OUTBREAKS; PLAGUES		Univ Greenwich Medway, Nat Resources Inst, Chatham ME4 4TB, Kent, England	University of Greenwich	Cheke, RA (corresponding author), Univ Greenwich Medway, Nat Resources Inst, Chatham ME4 4TB, Kent, England.	r.a.cheke@greenwich.ac.uk	Cheke, Robert/AAF-5017-2020	Cheke, Robert/0000-0002-7437-1934				CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Cheke RA, 2007, BIOSCIENCE, V57, P145, DOI 10.1641/B570209; Esper J, 2007, P ROY SOC B-BIOL SCI, V274, P671, DOI 10.1098/rspb.2006.0191; MA SHIHCHUN, 1965, Acta Entomologica Sinica, V14, P319; Stige LC, 2007, P NATL ACAD SCI USA, V104, P16188, DOI 10.1073/pnas.0706813104; SUGIHARA G, 1995, NATURE, V378, P559, DOI 10.1038/378559a0; Todd MC, 2002, J APPL ECOL, V39, P31, DOI 10.1046/j.1365-2664.2002.00691.x; TSAO C, 1950, CHINESE J AGR RES, V1, P57; WRIGHT DE, 1987, AUST J ECOL, V12, P423, DOI 10.1111/j.1442-9993.1987.tb00959.x; Zhang D.E, 2013, COMPENDIUM CHINESE M, P371	10	6	7	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					577	578		10.1126/science.1150636	http://dx.doi.org/10.1126/science.1150636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962543				2022-12-28	WOS:000250409200025
J	Contreras, M; Ceric, F; Torrealba, F				Contreras, Marco; Ceric, Francisco; Torrealba, Fernando			Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium	SCIENCE			English	Article							NEURAL SYSTEMS; CORTEX; RAT; ADDICTION; BRAIN; REINFORCEMENT; ATTENTION; AMYGDALA; STIMULI; NUCLEUS	Addiction profoundly alters motivational circuits so that drugs become powerful reinforcers of behavior. The interoceptive system continuously updates homeostatic and emotional information that are important elements in motivational decisions. We tested the idea that interoceptive information is essential in drug craving and in the behavioral signs of malaise. We inactivated the primary interoceptive cortex in amphetamine-experienced rats, which prevented the urge to seek amphetamine in a place preference task. Interoceptive insula inactivation also blunted the signs of malaise induced by acute lithium administration. Drug-seeking and malaise both induced Fos expression, a marker of neuronal activation, in the insula. We conclude that the insular cortex is a key structure in the perception of bodily needs that provides direction to motivated behaviors.	Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago 6513677, Chile	Pontificia Universidad Catolica de Chile	Torrealba, F (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago 6513677, Chile.	ftorrealba@bio.puc.cl		Torrealba, Fernando/0000-0002-0903-9230; Ceric Garrido, Francisco/0000-0002-5526-3399				Accarino AM, 1997, GASTROENTEROLOGY, V113, P415, DOI 10.1053/gast.1997.v113.pm9247458; Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; BERMUDEZRATTONI F, 1991, BRAIN RES, V549, P165, DOI 10.1016/0006-8993(91)90616-4; BERNSTEIN IL, 1992, BRAIN RES, V575, P132, DOI 10.1016/0006-8993(92)90432-9; Camprodon JA, 2007, DRUG ALCOHOL DEPEN, V86, P91, DOI 10.1016/j.drugalcdep.2006.06.002; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; CONTRERAS M, 2006, 36 ANN M SOC NEUR AT; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Saper C. B., 2004, RAT NERVOUS SYSTEM, V3rd, P761; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; Shi CJ, 1998, J COMP NEUROL, V399, P469, DOI 10.1002/(SICI)1096-9861(19981005)399:4<469::AID-CNE3>3.0.CO;2-#; SHI CJ, 1998, J COMP NEUROL, V399, P110; Stehberg J, 2001, NEUROSCIENCE, V106, P745, DOI 10.1016/S0306-4522(01)00316-5; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Zangen A, 2002, J NEUROSCI, V22, P7225; ZITO KA, 1988, PHARMACOL BIOCHEM BE, V30, P693, DOI 10.1016/0091-3057(88)90086-X	29	230	248	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					655	658		10.1126/science.1145590	http://dx.doi.org/10.1126/science.1145590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962567				2022-12-28	WOS:000250409200050
J	Voiculescu, O; Bertocchini, F; Wolpert, L; Keller, RE; Stern, CD				Voiculescu, Octavian; Bertocchini, Federica; Wolpert, Lewis; Keller, Ray E.; Stern, Claudio D.			The amniote primitive streak is defined by epithelial cell intercalation before gastrulation	NATURE			English	Article							CONVERGENT EXTENSION; CHICK-EMBRYO; SIGNALING PATHWAYS; MOVEMENTS; WNT; NEURULATION; HYPOBLAST; PATTERNS; TISSUE	During gastrulation, a single epithelial cell layer, the ectoderm, generates two others: the mesodermand the endoderm. In amniotes (birds and mammals), mesendoderm formation occurs through an axial midline structure, the primitive streak(1), the formation of which is preceded by massive 'polonaise' movements(2,3) of ectoderm cells. The mechanisms controlling these processes are unknown. Here, using multi-photon time-lapse microscopy of chick (Gallus gallus) embryos, we reveal a medio-lateral cell intercalation confined to the ectodermal subdomain where the streak will later form. This intercalation event differs from the convergent extension movements of the mesoderm described in fish and amphibians (anamniotes)(4-8): it occurs before gastrulation and within a tight columnar epithelium. Fibroblast growth factor from the extra-embryonic endoderm (hypoblast, a cell layer unique to amniotes) directs the expression of Wnt planar-cell-polarity pathway components to the intercalation domain. Disruption of this Wnt pathway causes the mesendoderm to form peripherally, as in anamniotes(1,9). We propose that the amniote primitive streak evolved from the ancestral blastopore by acquisition of an additional medio-lateral intercalation event, preceding gastrulation and acting independently of mesendoderm formation to position the primitive streak at the midline.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of London; University College London; University of Virginia	Voiculescu, O (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	o.voiculescu@ucl.ac.uk; c.stern@ucl.ac.uk	Voiculescu, Octavian/A-7571-2010; Voiculescu, Octavian/C-3543-2008; Stern, Claudio D/C-6265-2008; Stern, Claudio/AAZ-7381-2021	Voiculescu, Octavian/0000-0003-0714-1482; Stern, Claudio D/0000-0002-9907-889X; Stern, Claudio/0000-0002-9907-889X	Biotechnology and Biological Sciences Research Council [BB/C512753/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arendt D, 1999, MECH DEVELOP, V81, P3, DOI 10.1016/S0925-4773(98)00226-3; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Bodenstein L, 2005, J THEOR BIOL, V233, P253, DOI 10.1016/j.jtbi.2004.10.008; Chuai ML, 2006, DEV BIOL, V296, P137, DOI 10.1016/j.ydbio.2006.04.451; Cui C, 2005, DEV BIOL, V284, P37, DOI 10.1016/j.ydbio.2005.04.021; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Foley AC, 2000, DEVELOPMENT, V127, P3839; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Graper L., 1929, Archiv fuer Entwicklungsmechanik Berlin, V116, P382; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hertwig O, 1910, LEHRBUCH ENTWICKLUNG; KELLER R, 2004, GASTRULATION CELLS E, P291; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lawson A, 2001, GENESIS, V29, P188, DOI 10.1002/gene.1023; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Pasteels J, 1940, BIOL REV CAMB PHILOS, V15, P59, DOI 10.1111/j.1469-185X.1940.tb00942.x; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; Skromne I, 2001, DEVELOPMENT, V128, P2915; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Stern C.D., 2004, GASTRULATION CELLS E; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wei Y, 2000, DEVELOPMENT, V127, P87; Wetzel R., 1929, Archiv fuer Entwicklungsmechanik Berlin, V119, P188; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380	30	176	177	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1049	1052		10.1038/nature06211	http://dx.doi.org/10.1038/nature06211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17928866				2022-12-28	WOS:000250395000052
J	Marean, CW; Bar-Matthews, M; Bernatchez, J; Fisher, E; Goldberg, P; Herries, AIR; Jacobs, Z; Jerardino, A; Karkanas, P; Minichillo, T; Nilssen, PJ; Thompson, E; Watts, I; Williams, HM				Marean, Curtis W.; Bar-Matthews, Miryam; Bernatchez, Jocelyn; Fisher, Erich; Goldberg, Paul; Herries, Andy I. R.; Jacobs, Zenobia; Jerardino, Antonieta; Karkanas, Panagiotis; Minichillo, Tom; Nilssen, Peter J.; Thompson, Erin; Watts, Ian; Williams, Hope M.			Early human use of marine resources and pigment in South Africa during the Middle Pleistocene	NATURE			English	Article							STONE-AGE; SHELL BEADS; SEA; SYMBOLISM; ORIGIN; OCHRE	Genetic and anatomical evidence suggests that Homo sapiens arose in Africa between 200 and 100 thousand years (kyr) ago(1,2), and recent evidence indicates symbolic behaviour may have appeared similar to 135-75 kyr ago(3,4). From 195-130 kyr ago, the world was in a fluctuating but predominantly glacial stage ( marine isotope stage MIS6)(5); much of Africa was cooler and drier, and dated archaeological sites are rare(6,7). Here we show that by similar to 164 kyr ago (+/-12 kyr) at Pinnacle Point (on the south coast of South Africa) humans expanded their diet to include marine resources, perhaps as a response to these harsh environmental conditions. The earliest previous evidence for human use of marine resources and coastal habitats was dated to 125 kyr ago(8,9). Coincident with this diet and habitat expansion is an early use and modification of pigment, probably for symbolic behaviour, as well as the production of bladelet stone tool technology, previously dated to post-70 kyr ago(10-12). Shellfish may have been crucial to the survival of these early humans as they expanded their home ranges to include coastlines and followed the shifting position of the coast when sea level fluctuated over the length of MIS6.	Arizona State Univ, Inst Human Origins, POB 872402, Tempe, AZ 85287 USA; Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; Geol Survey Israel, IL-95501 Jerusalem, Israel; Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; Boston Univ, Dept Archaeol, Boston, MA 02215 USA; Univ New S Wales, Sch Med Sci, Human Origins Grp, Sydney, NSW 2052, Australia; Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; Minist Culture, Ephoreia Palaeoanthropol Speleol, Athens 11636, Greece; Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; Iziko S African Museum, Archaeol Div, ZA-8000 Cape Town, South Africa	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Geological Survey Israel; State University System of Florida; University of Florida; Boston University; University of New South Wales Sydney; University of Wollongong; University of Cape Town; University of Washington; University of Washington Seattle	Marean, CW (corresponding author), Arizona State Univ, Inst Human Origins, POB 872402, Tempe, AZ 85287 USA.	curtis.marean@asu.edu	Williams, Helen/GWV-2980-2022; Karkanas, Panagiotis/N-3168-2019; Karkanas, Panagiotis/F-7762-2011; Fisher, Erich/ABA-9374-2020; Karkanas, Panagiotis/AAD-1227-2020; Jacobs, Zenobia/B-2721-2012; Jerardino, Antonieta/K-3659-2014	Williams, Helen/0000-0001-5837-1590; Karkanas, Panagiotis/0000-0002-7156-671X; Karkanas, Panagiotis/0000-0002-7156-671X; Fisher, Erich/0000-0002-9499-6093; Jacobs, Zenobia/0000-0001-5424-5837; Jerardino, Antonieta/0000-0002-0078-7718; Herries, Andy/0000-0002-2905-2002				Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; Barham LS, 2002, CURR ANTHROPOL, V43, P181, DOI 10.1086/338292; BIGALKE E H, 1973, Annals of the Cape Provincial Museums Natural History, V9, P159; Branch GM, 2010, 2 OCEANS GUIDE MARIN; Broadhurst CL, 2002, COMP BIOCHEM PHYS B, V131, P653, DOI 10.1016/S1096-4959(02)00002-7; Bulbeck D, 2007, CURR ANTHROPOL, V48, P315, DOI 10.1086/512988; Deacon J., 1988, LATE QUATERNARY PALE; Dibble H.L., 2007, SAA ARCHAEOLOGICAL R, V7, P33; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; GENESTE JM, 1985, THESIS U BORDEAUX; HENDEY QB, 1986, QUATERNARY RES, V25, P189, DOI 10.1016/0033-5894(86)90056-6; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JERARDINO A, 1993, S AFR J SCI, V89, P6; Kingdon J., 1993, SELF MADE MAN HIS UN; Marean C.W., 2004, PALEOANTHROPOL, P14; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Newman WA, 1971, ANTARCTIC RES SERIES, V14; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Stahl, 2005, AFRICAN ARCHAEOLOGY, P93; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Tryon CA, 2002, J HUM EVOL, V42, P211, DOI 10.1006/jhev.2001.0513; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Villa P, 2005, J ARCHAEOL SCI, V32, P399, DOI 10.1016/j.jas.2004.11.007; Volman T.P., 1981, MIDDLE STONE AGE SO; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Watts I, 2002, S AFR ARCHAEOL BULL, V57, P1, DOI 10.2307/3889102	32	603	618	5	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					905	+		10.1038/nature06204	http://dx.doi.org/10.1038/nature06204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943129				2022-12-28	WOS:000250230600047
J	Sabeti, PC; Varilly, P; Fry, B; Lohmueller, J; Hostetter, E; Cotsapas, C; Xie, XH; Byrne, EH; McCarroll, SA; Gaudet, R; Schaffner, SF; Lander, ES				Sabeti, Pardis C.; Varilly, Patrick; Fry, Ben; Lohmueller, Jason; Hostetter, Elizabeth; Cotsapas, Chris; Xie, Xiaohui; Byrne, Elizabeth H.; McCarroll, Steven A.; Gaudet, Rachelle; Schaffner, Stephen F.; Lander, Eric S.		Int HapMap Consortium	Genome-wide detection and characterization of positive selection in human populations	NATURE			English	Article							DEATH DOMAIN; NMR STRUCTURE; RECOMBINATION; POLYMORPHISMS; PIGMENTATION; GENE	With the advent of dense maps of human genetic variation, it is now possible to detect positive natural selection across the human genome. Here we report an analysis of over 3 million polymorphisms from the International HapMap Project Phase 2 (HapMap2)(1). We used 'long-range haplotype' methods, which were developed to identify alleles segregating in a population that have undergone recent selection(2), and we also developed new methods that are based on cross-population comparisons to discover alleles that have swept to near-fixation within a population. The analysis reveals more than 300 strong candidate regions. Focusing on the strongest 22 regions, we develop a heuristic for scrutinizing these regions to identify candidate targets of selection. In a complementary analysis, we identify 26 non-synonymous, coding, single nucleotide polymorphisms showing regional evidence of positive selection. Examination of these candidates highlights three cases in which two genes in a common biological process have apparently undergone positive selection in the same population: LARGE and DMD, both related to infection by the Lassa virus(3), in West Africa; SLC24A5 and SLC45A2, both involved in skin pigmentation(4,5), in Europe; and EDAR and EDA2R, both involved in development of hair follicles(6), in Asia.	MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School	Sabeti, PC (corresponding author), MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pardis@broad.mit.edu	Tsui, Stephen Kwok-Wing/E-4385-2015; Tanaka, Toshihiro/J-9310-2014; Gaudet, Rachelle/Y-3985-2019; Altshuler, David M/A-4476-2009; McCarroll, Steven A/A-8433-2009; Deloukas, Panos/B-2922-2013; Tsunoda, Tatsuhiko/K-2061-2014; Jin, Li/M-5063-2019; Kwok, Pui-Yan/F-7725-2014; Qin, Zhaohui S/E-8196-2011; Wilson, Richard K./AAF-4139-2019; Johnson, Todd/Q-9944-2019; Xiao, Ming/E-7448-2012; Adebamowo, Clement/C-8778-2011; Qin, Zhaohui/Q-3133-2019; de Bakker, Paul IW/B-8730-2009; Schaffner, Stephen F/D-1189-2011; Song, You-qiang/C-4401-2009; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Abecasis, Goncalo R/B-7840-2010; Sabeti, Pardis/GQH-8610-2022; Jin, Li/C-1468-2009; Gaudet, Rachelle/I-4133-2014; Evans, David M/H-6325-2013; Smith, Albert Vernon/K-5150-2015; 郑, 征/C-8514-2011; Weinstock, George M/C-6314-2013; Myers, Simon R/A-6792-2015; Varilly, Patrick/C-8118-2013; Thorisson, Gudmundur/E-7359-2010; /C-4405-2009	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Tanaka, Toshihiro/0000-0001-6201-9784; Gaudet, Rachelle/0000-0002-9177-054X; Altshuler, David M/0000-0002-7250-4107; Deloukas, Panos/0000-0001-9251-070X; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Kwok, Pui-Yan/0000-0002-5087-3059; Qin, Zhaohui S/0000-0002-1583-146X; Wilson, Richard K./0000-0002-1992-1358; Johnson, Todd/0000-0003-3377-6692; Adebamowo, Clement/0000-0002-6571-2880; Qin, Zhaohui/0000-0002-1583-146X; de Bakker, Paul IW/0000-0001-7735-7858; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Jin, Li/0000-0002-4546-2415; Gaudet, Rachelle/0000-0002-9177-054X; Evans, David M/0000-0003-0663-4621; Smith, Albert Vernon/0000-0003-1942-5845; Weinstock, George M/0000-0002-2997-4592; Myers, Simon R/0000-0002-2585-9626; Phillips, Michael/0000-0003-1040-9080; Eyheramendy, Susana/0000-0003-4723-9660; Song, You-Qiang/0000-0001-9407-2256; Hunt, Sarah/0000-0002-8350-1235; Abecasis, Goncalo/0000-0003-1509-1825; He, Yungang/0000-0002-2931-2871; Cotsapas, Chris/0000-0002-7772-5910; Wong, J. Tze-Fei/0000-0001-8539-8537; Xie, Xiaohui/0000-0002-5479-6345; Stranger, Barbara/0000-0001-9021-7331; Wang, Haifeng/0000-0001-5022-0720; ajayi, Ikeoluwapo/0000-0001-7719-8746; Schaffner, Stephen/0000-0001-6699-3568; Chu, Xun/0000-0002-7440-1371; Fosker, Christine/0000-0002-3799-9474; Varilly, Patrick/0000-0003-4619-8174; Frazer, Kelly/0000-0002-6060-8902; Xue, Hong/0000-0002-8133-9828; Thorisson, Gudmundur/0000-0001-5635-1860; Macer, Darryl/0000-0001-9335-4235; /0000-0001-6231-3035; Kato, Kazuto/0000-0001-9006-9551; Richter, Daniel/0000-0002-9238-5571; Clayton, Ellen/0000-0002-0308-4110; Hinds, David/0000-0002-4911-803X; Maller, Julian/0000-0002-1565-9559; Kitamoto, Takuya/0000-0002-4008-5497; Sherry, Stephen/0000-0002-7982-076X; Bottolo, Leonardo/0000-0002-6381-2327; Saxena, Richa/0000-0003-2233-1065; Lin, Shin/0000-0003-0118-0413; Belmont, John/0000-0001-7409-3578; Lohmueller, Jason/0000-0001-6089-9992	Wellcome Trust [077046, 081682, 077011, 077008] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Botchkarev VA, 2005, J INVEST DERM SYMP P, V10, P247, DOI 10.1111/j.1087-0024.2005.10129.x; Chassaing N, 2006, HUM MUTAT, V27, P255, DOI 10.1002/humu.20295; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lasker MV, 2005, J IMMUNOL, V175, P4175, DOI 10.4049/jimmunol.175.7.4175; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Miller R.G.J., 1981, SIMULTANEOUS STAT IN, VXVI, P299; Park HH, 2006, J MOL BIOL, V357, P358, DOI 10.1016/j.jmb.2005.12.082; Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	34	1256	1303	9	300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					913	U12		10.1038/nature06250	http://dx.doi.org/10.1038/nature06250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943131	Green Submitted, Green Accepted			2022-12-28	WOS:000250230600049
J	Gladstone, GR; Stern, SA; Slater, DC; Versteeg, M; Davis, MW; Retherford, KD; Young, LA; Steffl, AJ; Throop, H; Parker, JW; Weaver, HA; Cheng, AF; Orton, GS; Clarke, JT; Nichols, JD				Gladstone, G. Randall; Stern, S. Alan; Slater, David C.; Versteeg, Maarten; Davis, Michael W.; Retherford, Kurt D.; Young, Leslie A.; Steffl, Andrew J.; Throop, Henry; Parker, Joel Wm.; Weaver, Harold A.; Cheng, Andrew F.; Orton, Glenn S.; Clarke, John T.; Nichols, Jonathan D.			Jupiter's nightside airglow and aurora	SCIENCE			English	Article							IO FLUX TUBE; EMISSIONS	Observations of Jupiter's nightside airglow (nightglow) and aurora obtained during the flyby of the New Horizons spacecraft show an unexpected lack of ultraviolet nightglow emissions, in contrast to the case during the Voyager flybys in 1979. The flux and average energy of precipitating electrons generally decrease with increasing local time across the nightside, consistent with a possible source region along the dusk flank of Jupiter's magnetosphere. Visible emissions associated with the interaction of Jupiter and its satellite Io extend to a surprisingly high altitude, indicating localized low-energy electron precipitation. These results indicate that the interaction between Jupiter's upper atmosphere and near-space environment is variable and poorly understood; extensive observations of the day side are no guide to what goes on at night.	SW Res Inst, San Antonio, TX 78238 USA; NASA Headquarters, Washington, DC 20546 USA; SW Res Inst, Boulder, CO 80302 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Boston Univ, Boston, MA 02215 USA	Southwest Research Institute; National Aeronautics & Space Administration (NASA); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Boston University	Gladstone, GR (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	rgladstone@swri.edu	Orton, Glenn/AAD-9862-2020; Nichols, Jonathan/F-5764-2010; Weaver, Harold A/D-9188-2016; Davis, Michael/AAK-3433-2021; Nichols, Jonathan/ABA-8695-2021; Clarke, John/C-8644-2013	Nichols, Jonathan/0000-0002-8004-6409; Weaver, Harold A/0000-0003-0951-7762; Davis, Michael/0000-0003-4338-1635; Nichols, Jonathan/0000-0002-8004-6409; Parker, Joel/0000-0002-3672-0603				Ajello JM, 2005, ICARUS, V178, P327, DOI 10.1016/j.icarus.2005.01.023; APPLETON EV, 1946, NATURE, V157, P691, DOI 10.1038/157691a0; Bhardwaj A, 2000, REV GEOPHYS, V38, P295, DOI 10.1029/1998RG000046; BROADFOOT AL, 1981, J GEOPHYS RES-SPACE, V86, P8259, DOI 10.1029/JA086iA10p08259; Christensen AB, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009918; Clarke JT, 2004, CAMB PLANET, P639; Clarke JT, 1998, J GEOPHYS RES-PLANET, V103, P20217, DOI 10.1029/98JE01130; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; DESSLER AJ, 1981, PLANET SPACE SCI, V29, P215, DOI 10.1016/0032-0633(81)90035-0; Gerard JC, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009410; Gladstone GR, 2004, PLANET SPACE SCI, V52, P415, DOI 10.1016/j.pss.2003.06.012; Grodent D, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009921; Grodent D, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA010017; Gustin J, 2002, ICARUS, V157, P91, DOI 10.1006/icar.2001.6784; HUNTEN DM, 1977, PLANET SPACE SCI, V25, P817, DOI 10.1016/0032-0633(77)90035-6; Khurana KK, 2004, CAMB PLANET, P593; LIVENGOOD TA, 1992, ICARUS, V97, P26, DOI 10.1016/0019-1035(92)90055-C; MCCONNELL JC, 1980, ICARUS, V43, P128, DOI 10.1016/0019-1035(80)90113-X; Pontius DH, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000331; Prange R, 1996, NATURE, V379, P323, DOI 10.1038/379323a0; Saur J, 1999, J GEOPHYS RES-SPACE, V104, P25105, DOI 10.1029/1999JA900304; Slanger TG, 2002, GEOPHYS MONOGR SER, V130, P77, DOI 10.1029/130GM06; Slater D.C., 2005, P SOC PHOTO-OPT INS, V5906, P368; STERN SA, 2005, P SOC PHOTO-OPT INS, V5906, P358; Vasavada AR, 1999, J GEOPHYS RES-PLANET, V104, P27133, DOI 10.1029/1999JE001055; Waite JH, 1997, SCIENCE, V276, P104, DOI 10.1126/science.276.5309.104; Yelle RV, 2004, CAMB PLANET, P185; YUNG YL, 1982, ASTROPHYS J, V254, pL65, DOI 10.1086/183757	29	18	18	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					229	231		10.1126/science.1147613	http://dx.doi.org/10.1126/science.1147613			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932286				2022-12-28	WOS:000250086100034
J	Cheetham, AK; Rao, CNR				Cheetham, Anthony K.; Rao, C. N. R.			There's room in the middle	SCIENCE			English	Editorial Material							METAL-ORGANIC FRAMEWORK; STRUCTURAL DIVERSITY; DESIGN		Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England; Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	University of Cambridge; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Cheetham, AK (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	akc30@cam.ac.uk; cnrrao@jncasr.ac.in	Rao, C.N.R./B-1569-2009	Rao, C.N.R./0000-0003-4088-0615				Cheetham AK, 2006, CHEM COMMUN, P4780, DOI 10.1039/b610264f; Feller RK, 2006, SOLID STATE SCI, V8, P1121, DOI 10.1016/j.solidstatesciences.2006.04.013; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Halder GJ, 2002, SCIENCE, V298, P1762, DOI 10.1126/science.1075948; HOSKINS BF, 1990, J AM CHEM SOC, V112, P1546, DOI 10.1021/ja00160a038; Jain R, 2007, NATURE, V445, P291, DOI 10.1038/nature05439; Kam KC, 2007, CRYST GROWTH DES, V7, P1522, DOI 10.1021/cg070388a; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Rao CNR, 2004, ANGEW CHEM INT EDIT, V43, P1466, DOI 10.1002/anie.200300588; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Tadokoro M, 2006, ANGEW CHEM INT EDIT, V45, P5144, DOI 10.1002/anie.200600553; Wang XY, 2004, INORG CHEM, V43, P4615, DOI 10.1021/ic0498081; WUNDERLICH CH, 1991, Z ANORG ALLG CHEM, V598, P371, DOI 10.1002/zaac.19915980134; Ye Q, 2006, J AM CHEM SOC, V128, P6554, DOI 10.1021/ja060856p	14	322	326	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					58	59		10.1126/science.1147231	http://dx.doi.org/10.1126/science.1147231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916720				2022-12-28	WOS:000249915400034
J	Mather, JC				Mather, John C.			Science and Sputnik	SCIENCE			English	Editorial Material									NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; NASA Headquarters, Sci Mission Directorate, Washington, DC 20546 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA)	Mather, JC (corresponding author), NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA.	John.C.Mather@nasa.gov						Mather J.C., 1996, VERY 1 LIGHT; *NAT RES COUNC, 2007, NASAS EINST PROGR AR	2	0	0	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					52	53		10.1126/science.1148553	http://dx.doi.org/10.1126/science.1148553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916715				2022-12-28	WOS:000249915400029
J	Dalton, R				Dalton, Rex			Researchers criticized for poor time-keeping	NATURE			English	News Item																			0	2	2	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					512	513		10.1038/449512a	http://dx.doi.org/10.1038/449512a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17972360				2022-12-28	WOS:000249893500004
J	Neutel, AM; Heesterbeek, JAP; van de Koppel, J; Hoenderboom, G; Vos, A; Kaldeway, C; Berendse, F; de Ruiter, PC				Neutel, Anje-Margriet; Heesterbeek, Johan A. P.; van de Koppel, Johan; Hoenderboom, Guido; Vos, An; Kaldeway, Coen; Berendse, Frank; de Ruiter, Peter C.			Reconciling complexity with stability in naturally assembling food webs	NATURE			English	Article							TROPHIC CASCADES; SOIL; PRODUCTIVITY; ECOSYSTEMS; DYNAMICS; REAL; COMMUNITIES; SYSTEM	Understanding how complex food webs assemble through time is fundamental both for ecological theory and for the development of sustainable strategies of ecosystem conservation and restoration. The build-up of complexity in communities is theoretically difficult, because in random-pattern models complexity leads to instability(1). There is growing evidence, however, that nonrandom patterns in the strengths of the interactions between predators and prey strongly enhance system stability(2-4). Here we show how such patterns explain stability in naturally assembling communities. We present two series of below-ground food webs along natural productivity gradients in vegetation successions(5,6). The complexity of the food webs increased along the gradients. The stability of the food webs was captured by measuring the weight of feedback loops(7) of three interacting 'species' locked in omnivory. Low predator-prey biomass ratios in these omnivorous loops were shown to have a crucial role in preserving stability as productivity and complexity increased during succession. Our results show the build-up of food-web complexity in natural productivity gradients and pin down the feedback loops that govern the stability of whole webs. They show that it is the heaviest three-link feedback loop in a network of predator-prey effects that limits its stability. Because the weight of these feedback loops is kept relatively low by the biomass build-up in the successional process, complexity does not lead to instability.	Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; Univ Utrecht, Fac Vet Med, NL-3508 TD Utrecht, Netherlands; Netherlands Inst Ecol, NIOO KNAW, Ctr Estuarine & Marine Ecol, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; Univ Wageningen & Res Ctr, Dept ICT, NL-6700 AB Wageningen, Netherlands; Univ Wageningen & Res Ctr, Soil Sci Ctr, NL-6700 AA Wageningen, Netherlands; Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6708 PB Wageningen, Netherlands; Univ Utrecht, Copernicus Inst Sustainable Dev & Innovat, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands	University of York - UK; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Utrecht University	Neutel, AM (corresponding author), British Antarctic Survey, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	anjute@bas.ac.uk	Van de Koppel, Johan/E-7266-2010	Heesterbeek, Hans/0000-0001-8537-6418	NERC [bas010021] Funding Source: UKRI; Natural Environment Research Council [bas010021] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2001, PLANT STRATEGIES VEG; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; BERENDSE F, 1990, PERSPECTIVES PLANT C, P94; BLOEM J, 1995, APPL ENVIRON MICROB, V61, P926, DOI 10.1128/AEM.61.3.926-936.1995; BRUSSAARD L, 1990, NETH J AGR SCI, V38, P283; Cohen J.E., 1990, COMMUNITY FOOD WEBS; DERUITER PC, 1993, PLANT SOIL, V157, P263, DOI 10.1007/BF00011055; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; GARDNER MR, 1970, NATURE, V228, P784, DOI 10.1038/228784a0; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Halaj J, 2001, AM NAT, V157, P262, DOI 10.1086/319190; HASSINK J, 1991, SOIL BIOL BIOCHEM, V23, P515, DOI 10.1016/0038-0717(91)90108-V; HOFBAUER J, 1988, THEORY EVOLUTION DYN, P204; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; MOORE JC, 1993, SCIENCE, V261, P906, DOI 10.1126/science.261.5123.906; MOORE JC, 1988, ANNU REV ENTOMOL, V33, P419, DOI 10.1146/annurev.en.33.010188.002223; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; OLFF H, 1993, J ECOL, V81, P693, DOI 10.2307/2261667; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103	29	261	272	6	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					599	U11		10.1038/nature06154	http://dx.doi.org/10.1038/nature06154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914396	Green Published, Green Submitted			2022-12-28	WOS:000249893500045
J	Bravata, DM; Gienger, AL; McDonald, KM; Sundaram, V; Perez, MV; Varghese, R; Kapoor, JR; Ardehali, R; Owens, DK; Hlatky, MA				Bravata, Dena M.; Gienger, Allison L.; McDonald, Kathryn M.; Sundaram, Vandana; Perez, Marco V.; Varghese, Robin; Kapoor, John R.; Ardehali, Reza; Owens, Douglas K.; Hlatky, Mark A.			Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; REVASCULARIZATION INVESTIGATION BARI; ARGENTINE RANDOMIZED-TRIAL; MULTIPLE-VESSEL DISEASE; LONG-TERM SURVIVAL; REFRACTORY MYOCARDIAL-ISCHEMIA; HIGH-GRADE STENOSIS; HIGH-RISK PATIENTS; 5-YEAR FOLLOW-UP; BODY-MASS INDEX	Background: The comparative effectiveness of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) for patients in whom both procedures are feasible remains poorly understood. Purpose: To compare the effectiveness of PCI and CABG in patients for whom coronary revascularization is clinically indicated. Data Sources: MEDLINE, EMBASE, and Cochrane databases (1966-2006); conference proceedings; and bibliographies of retrieved articles. Study Selection: Randomized, controlled trials (RCTs) reported in any language that compared clinical outcomes of PCI with those of CABG, and selected observational studies. Data Extraction: Information was extracted on study design, sample characteristics, interventions, and clinical outcomes. Data Synthesis: The authors identified 23 RCTs in which 5019 patients were randomly assigned to PCI and 4944 patients were randomly assigned to CABG. The difference in survival after PCI or CABG was less than 1% over 10 years of follow-up. Survival did not differ between PCI and CABG for patients with diabetes in the 6 trials that reported on this subgroup. Procedure-related strokes were more common after CABG than after PCI (1.2% vs. 0.6%; risk difference, 0.6%; P = 0.002). Angina relief was greater after CABG than after PCI, with risk differences ranging from 5% to 8% at 1 to 5 years (P < 0.001). The absolute rates of angina relief at 5 years were 79% after PCI and 84% after CABG. Repeated revascularization was more common after PCI than after CABG ( risk difference, 24% at 1 year and 33% at 5 years; P < 0.001); the absolute rates at 5 years were 46.1% after balloon angioplasty, 40.1% after PCI with stents, and 9.8% after CABG. In the observational studies, the CABG-PCI hazard ratio for death favored PCI among patients with the least severe disease and CABG among those with the most severe disease. Limitations: The RCTs were conducted in leading centers in selected patients. The authors could not assess whether comparative outcomes vary according to clinical factors, such as extent of coronary disease, ejection fraction, or previous procedures. Only 1 small trial used drug-eluting stents. Conclusion: Compared with PCI, CABG was more effective in relieving angina and led to fewer repeated revascularizations but had a higher risk for procedural stroke. Survival to 10 years was similar for both procedures.	Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA USA; Vet Affairs Palo Alto, Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Bravata, DM (corresponding author), Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	dbravata@stanford.edu		Hlatky, Mark/0000-0003-4686-9441	PHS HHS [290-02-0017] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700; Alazraki NP, 1999, AM J CARDIOL, V84, P1369, DOI 10.1016/S0002-9149(99)00578-0; Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Alderman EL, 1996, NEW ENGL J MED, V335, P217; Alderman EL, 2004, J AM COLL CARDIOL, V44, P766, DOI 10.1016/j.jacc.2004.05.041; Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122; [Anonymous], 1995, Lancet, V346, P1179; Aoki J, 2005, EUR HEART J, V26, P1488, DOI 10.1093/eurheartj/ehi288; Aoki J, 2004, AM J CARDIOL, V94, P627, DOI 10.1016/j.amjcard.2004.05.028; *ARTS, 1999, CARDIOVASC INTERVENT, V2, P41; Barsness GW, 1997, CIRCULATION, V96, P2551, DOI 10.1161/01.CIR.96.8.2551; Becker ER, 2000, AM J CARDIOL, V85, P685, DOI 10.1016/S0002-9149(99)00841-3; Berger PB, 2001, J AM COLL CARDIOL, V38, P1440, DOI 10.1016/S0735-1097(01)01571-6; Bittner V, 2002, CIRCULATION, V106, P2537, DOI 10.1161/01.CIR.0000038496.57570.06; BOURASSA MG, 1995, AM J CARDIOL, V75, pC3, DOI 10.1016/S0002-9149(99)80389-0; Bourassa MG, 1999, J AM COLL CARDIOL, V33, P1627, DOI 10.1016/S0735-1097(99)00077-7; BRAVATA DM, COMPARATIVE EFFECTIV; Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646; Brooks M M, 1999, Semin Interv Cardiol, V4, P191; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Brooks MM, 2000, CIRCULATION, V101, P2682, DOI 10.1161/01.CIR.101.23.2682; Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005; Carrie D, 1997, CIRCULATION, V96, P1; Chaitman BR, 1997, CIRCULATION, V96, P2162; Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028; Cisowski M, 2002, ANN THORAC SURG, V74, pS1334; CISOWSKI M, 2004, KARDIOL POL, V61, P252; Cisowski Marek, 2004, Kardiol Pol, V61, P253; de Feyter PJ, 2002, CIRCULATION, V105, P2367, DOI 10.1161/01.CIR.0000016643.34907.17; DeFrances Carol J, 2007, Adv Data, P1; Detre KM, 1999, CIRCULATION, V99, P633, DOI 10.1161/01.CIR.99.5.633; Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563; Diegeler A, 2000, EUR J CARDIO-THORAC, V17, P501, DOI 10.1016/S1010-7940(00)00400-0; Drenth DJ, 2004, AM J CARDIOL, V94, P1414, DOI 10.1016/j.amjcard.2004.08.016; Drenth DJ, 2004, EUR J CARDIO-THORAC, V25, P567, DOI 10.1016/j.ejcts.2004.01.015; Drenth DJ, 2002, J THORAC CARDIOV SUR, V124, P130, DOI 10.1067/mtc.2002.122525; Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6; Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072; Eagle Kim A, 2004, Circulation, V110, pe340; Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; Favarato D, 2003, CIRCULATION, V108, P21, DOI 10.1161/01.cir.0000087381.98299.7b; Feit F, 2000, CIRCULATION, V101, P2795, DOI 10.1161/01.CIR.101.24.2795; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Gibbons RJ, 2001, CIRCULATION, V103, P1076, DOI 10.1161/01.CIR.103.8.1076; GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8; Goy JJ, 2000, MAYO CLIN PROC, V75, P1116, DOI 10.4065/75.11.1116; Goy JJ, 1999, CIRCULATION, V99, P3255, DOI 10.1161/01.CIR.99.25.3255; Gruberg L, 2005, AM J CARDIOL, V95, P439, DOI 10.1016/j.amjcard.2004.10.007; Gurm HS, 2002, J AM COLL CARDIOL, V39, P834, DOI 10.1016/S0735-1097(02)01687-X; HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601; Hampton J R, 1999, Semin Interv Cardiol, V4, P169; HAMPTON JR, 1993, LANCET, V341, P573; Hannan EL, 1999, J AM COLL CARDIOL, V33, P63, DOI 10.1016/S0735-1097(98)00540-3; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3; HENDERSON RA, 1989, BRIT HEART J, V62, P411; Hlatky MA, 1997, CIRCULATION, V96, P11; Hlatky MA, 2004, CIRCULATION, V110, P1960, DOI 10.1161/01.CIR.0000143379.26342.5C; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; HLATKY MA, 1995, AM J CARDIOL, V75, pC34; Hlatky MA, 1998, ANN INTERN MED, V129, P543, DOI 10.7326/0003-4819-129-7-199810010-00006; Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; HUEB WA, 1995, J AM COLL CARDIOL, V26, P1600, DOI 10.1016/0735-1097(95)00384-3; Hueb WA, 1999, CIRCULATION, V100, P107; Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010; Jacobs AK, 1998, CIRCULATION, V98, P1279, DOI 10.1161/01.CIR.98.13.1279; Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1; Kaehler J, 2005, EUR HEART J, V26, P2148, DOI 10.1093/eurheartj/ehi385; Kapur A, 2005, AM HEART J, V149, P13, DOI 10.1016/j.ahj.2004.07.001; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045; King S B 3rd, 1999, Semin Interv Cardiol, V4, P185; King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; KINGSMORE SF, 1995, IMMUNOGENETICS, V42, P59, DOI 10.1007/BF00164988; Kip KE, 2002, CIRCULATION, V105, P1914, DOI 10.1161/01.CIR.0000014967.78190.BB; Kurbaan A S, 1999, Semin Interv Cardiol, V4, P179; Kurbaan AS, 1998, AM HEART J, V135, P703, DOI 10.1016/S0002-8703(98)70289-3; Kurbaan AS, 2001, INT J CARDIOL, V77, P207, DOI 10.1016/S0167-5273(00)00422-8; Kurbaan AS, 2001, AM J CARDIOL, V87, P947, DOI 10.1016/S0002-9149(01)01426-6; Kurbaan AS, 1998, AM J CARDIOL, V82, P272, DOI 10.1016/S0002-9149(98)00331-2; Legrand VMG, 2004, CIRCULATION, V109, P1114, DOI 10.1161/01.CIR.0000118504.61212.4B; Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392; Mercado N, 2005, J THORAC CARDIOV SUR, V130, P512, DOI 10.1016/j.jtcvs.2004.12.049; Morrison DA, 2002, J AM COLL CARDIOL, V40, P1951, DOI 10.1016/S0735-1097(02)02560-3; Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3; Morrison DA, 1999, CONTROL CLIN TRIALS, V20, P601, DOI 10.1016/S0197-2456(99)00033-1; Mullany CJ, 1999, ANN THORAC SURG, V67, P396, DOI 10.1016/S0003-4975(98)01191-6; Nathoe H M, 2005, Neth Heart J, V13, P259; Orwin R.G., 1994, HDB RES SYNTHESIS; Pell JP, 2001, HEART, V85, P662, DOI 10.1136/heart.85.6.662; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; Pohl T, 2004, CATHETER CARDIO INTE, V62, P323, DOI 10.1002/ccd.20060; *PROT BYP ANG REV, 1991, CIRCULATION, V86, pV1; Ramanathan KB, 2005, ANN THORAC SURG, V80, P1340, DOI 10.1016/j.athoracsur.2005.03.057; Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1; *REV MAN, 2003, REV MAN VERS 4 2 WIN; Rihal CS, 1999, CIRCULATION, V100, P171, DOI 10.1161/01.CIR.100.2.171; Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7; RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060, DOI 10.1016/0735-1097(93)90416-X; Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4; Rodriguez A, 2003, HEART, V89, P184, DOI 10.1136/heart.89.2.184; Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081; ROGERS WJ, 1995, AM J CARDIOL, V75, pC9; Rumsfeld JS, 2003, J AM COLL CARDIOL, V41, P1732, DOI 10.1016/S0735-1097(03)00330-9; Rupprecht HJ, 1996, EUR HEART J, V17, P1192; SCULPHER MJ, 1994, LANCET, V344, P927, DOI 10.1016/S0140-6736(94)92274-8; Sedlis SP, 2004, AM J CARDIOL, V94, P118, DOI 10.1016/j.amjcard.2004.03.041; Sedlis SP, 2002, J AM COLL CARDIOL, V40, P1555, DOI 10.1016/S0735-1097(02)02346-X; Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2; Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030; Serruys P W, 1999, Semin Interv Cardiol, V4, P209; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; Sigwart U, 2002, LANCET, V360, P965; Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Soares PR, 2006, CIRCULATION, V114, pI420, DOI 10.1161/CIRCULATIONAHA.105.000679; Stables R H, 1999, Semin Interv Cardiol, V4, P201; Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838; Sutton-Tyrrell K, 1998, AM J CARDIOL, V81, P375, DOI 10.1016/S0002-9149(97)00934-X; Szczech LA, 2002, CIRCULATION, V105, P2253, DOI 10.1161/01.CIR.0000016051.33225.33; Thiele H, 2005, CIRCULATION, V112, P3445, DOI 10.1161/CIRCULATIONAHA.105.578492; Unger F, 2003, J THORAC CARDIOV SUR, V125, P809, DOI 10.1067/mtc.2003.401; van den Brand MJBM, 2002, J AM COLL CARDIOL, V39, P559, DOI 10.1016/S0735-1097(01)01785-5; van Dijk D, 2000, CONTROL CLIN TRIALS, V21, P595, DOI 10.1016/S0197-2456(00)00103-3; Wahrborg P, 2004, CIRCULATION, V110, P3411, DOI 10.1161/01.CIR.0000148366.80443.2B; Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237; WEINTRAUB WS, 1995, CIRCULATION, V92, P2831, DOI 10.1161/01.CIR.92.10.2831; Weintraub WS, 2000, AM J CARDIOL, V86, P747, DOI 10.1016/S0002-9149(00)01074-2; Weintraub WS, 2004, HEART, V90, P782, DOI 10.1136/hrt.2003.015057; Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zhang ZF, 2005, AM HEART J, V150, P175, DOI 10.1016/j.ahj.2005.01.019; Zhang ZF, 2004, AM J CARDIOL, V93, P404, DOI 10.1016/j.amjcard.2003.10.032; Zhang ZF, 2003, CIRCULATION, V108, P1694, DOI 10.1161/01.CIR.0000087600.83707.FD; Zhao XQ, 1996, CIRCULATION, V93, P1954, DOI 10.1161/01.CIR.93.11.1954; Zhao Xue-Qiao, 2003, Med Sci Monit, V9, pCR48	142	222	237	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					703	U139		10.7326/0003-4819-147-10-200711200-00185	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00185			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	17938385				2022-12-28	WOS:000251259500005
J	Bond-Lamberty, B; Peckham, SD; Ahl, DE; Gower, ST				Bond-Lamberty, Ben; Peckham, Scott D.; Ahl, Douglas E.; Gower, Stith T.			Fire as the dominant driver of central Canadian boreal forest carbon balance	NATURE			English	Article							NET PRIMARY PRODUCTIVITY; REGIONAL APPLICATIONS; ECOSYSTEM PROCESSES; CLIMATE-CHANGE; NORTH-AMERICA; GENERAL-MODEL; CO2 EXCHANGE; DISTURBANCE; INCREASES; EMISSIONS	Changes in climate, atmospheric carbon dioxide concentration and fire regimes have been occurring for decades in the global boreal forest(1-3), with future climate change likely to increase fire frequency(4)-the primary disturbance agent in most boreal forests(3,5). Previous attempts to assess quantitatively the effect of changing environmental conditions on the net boreal forest carbon balance have not taken into account the competition between different vegetation types on a large scale(6-9). Here we use a process model with three competing vascular and non-vascular vegetation types to examine the effects of climate, carbon dioxide concentrations and fire disturbance on net biome production, net primary production and vegetation dominance in 100 Mha of Canadian boreal forest. We find that the carbon balance of this region was driven by changes in fire disturbance from 1948 to 2005. Climate changes affected the variability, but not the mean, of the landscape carbon balance, with precipitation exerting a more significant effect than temperature. We show that more frequent and larger fires in the late twentieth century resulted in deciduous trees and mosses increasing production at the expense of coniferous trees. Our model did not however exhibit the increases in total forest net primary production that have been inferred from satellite data(1,10). We find that poor soil drainage decreased the variability of the landscape carbon balance, which suggests that increased climate and hydrological changes have the potential to affect disproportionately the carbon dynamics of these areas. Overall, we conclude that direct ecophysiological changes resulting from global climate change have not yet been felt in this large boreal region. Variations in the landscape carbon balance and vegetation dominance have so far been driven largely by increases in fire frequency.	Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bond-Lamberty, B (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, 1630 Linden Dr, Madison, WI 53706 USA.	bpbond@wisc.edu	Bond-Lamberty, Benjamin/C-6058-2008	Bond-Lamberty, Benjamin/0000-0001-9525-4633				Amiro BD, 2001, CAN J FOREST RES, V31, P512, DOI 10.1139/cjfr-31-3-512; Amthor JS, 2001, J GEOPHYS RES-ATMOS, V106, P33623, DOI 10.1029/2000JD900850; [Anonymous], 1998, REGIONAL IMPACTS CLI; Balshi MS, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000380; Bond-Lamberty B, 2005, TREE PHYSIOL, V25, P413, DOI 10.1093/treephys/25.4.413; Bond-Lamberty B, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000123; Bond-Lamberty B, 2007, TREE PHYSIOL, V27, P703, DOI 10.1093/treephys/27.5.703; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; Deng F, 2007, TELLUS B, V59, P179, DOI [10.1111/j.1600-0889.2006.00235.x, 10.1111/j.1600-0889.2006.00235.X]; FLANNIGAN MD, 1991, CAN J FOREST RES, V21, P66, DOI 10.1139/x91-010; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Hicke JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013578; Hicke JA, 2003, GLOBAL CHANGE BIOL, V9, P1145, DOI 10.1046/j.1365-2486.2003.00658.x; Kang S, 2006, SCI TOTAL ENVIRON, V362, P85, DOI 10.1016/j.scitotenv.2005.11.014; KASISCHKE ES, 1995, ECOL APPL, V5, P437, DOI 10.2307/1942034; Kasischke ES, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000461; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; Li Z, 2003, CAN J FOREST RES, V33, P2340, DOI [10.1139/x03-168, 10.1139/X03-168]; Litvak M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000854; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Peng CH, 1999, ECOL MODEL, V122, P175, DOI 10.1016/S0304-3800(99)00137-4; R Development Core Team, 2006, R LANG ENV STAT COMP; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; RUNNING SW, 1991, TREE PHYSIOL, V9, P147, DOI 10.1093/treephys/9.1-2.147; Stocks B. J., 2003, Journal of Geophysical Research, V108, pFFR5, DOI 10.1029/2001JD000484; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973	30	369	380	16	223	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					89	+		10.1038/nature06272	http://dx.doi.org/10.1038/nature06272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972883	Green Published			2022-12-28	WOS:000250585800042
J	O'Brien, P; Nathanson, V				O'Brien, Pat; Nathanson, Vivienne			Is it all right for women to drink small amounts of alcohol in pregnancy?	BRITISH MEDICAL JOURNAL			English	Editorial Material												patrick.obrien@ucth.nhs.uk							0	17	18	0	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2007	335	7625					856	857		10.1136/bmj.39371.381308.AD	http://dx.doi.org/10.1136/bmj.39371.381308.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17962286	Green Published			2022-12-28	WOS:000250631000035
J	Koechlin, E; Hyafil, A				Koechlin, Etienne; Hyafil, Alexandre			Anterior prefrontal function and the limits of human decision-making	SCIENCE			English	Review							HUMAN COGNITION; WORKING-MEMORY; FRONTAL-CORTEX; AREA 10; INFORMATION; RETRIEVAL; INTEGRATION; MECHANISMS; MOTOR; FMRI	The frontopolar cortex (FPC), the most anterior part of the frontal lobes, forms the apex of the executive system underlying decision-making. Here, we review empirical evidence showing that the FPC function enables contingent interposition of two concurrent behavioral plans or mental tasks according to respective reward expectations, overcoming the serial constraint that bears upon the control of task execution in the prefrontal cortex. This function is mechanistically explained by interactions between FPC and neighboring prefrontal regions. However, its capacity appears highly limited, which suggests that the FPC is efficient for protecting the execution of long-term mental plans from immediate environmental demands and for generating new, possibly more rewarding, behavioral or cognitive sequences, rather than for complex decision-making and reasoning.	Univ Paris 06, Ecole Normale Super, INSERM, Dept Etud Cognit, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Koechlin, E (corresponding author), Univ Paris 06, Ecole Normale Super, INSERM, Dept Etud Cognit, 9 Quai St Bernard, F-75005 Paris, France.	koechlin@ccr.jussieu.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021; HYAFIL, Alexandre/A-7024-2018	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; HYAFIL, Alexandre/0000-0002-0566-651X				Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; De Pisapia N, 2007, CEREB CORTEX, V17, P993, DOI 10.1093/cercor/bhl010; Dobbins IG, 2006, CEREB CORTEX, V16, P1614, DOI 10.1093/cercor/bhj098; Dobbins IG, 2006, J COGNITIVE NEUROSCI, V18, P1439, DOI 10.1162/jocn.2006.18.9.1439; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Herron JE, 2004, NEUROIMAGE, V21, P302, DOI 10.1016/j.neuroimage.2003.09.039; HYAFIL A, 2005, COMP SYST NEUR INT C; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Pandya DN, 1996, RES PER NEUROSCI, P13; Pollmann S, 2004, EXP PSYCHOL, V51, P270, DOI 10.1027/1618-3169.51.4.270; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reynolds JR, 2006, CEREB CORTEX, V16, P519, DOI 10.1093/cercor/bhi131; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Velanova K, 2003, J NEUROSCI, V23, P8460; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	35	506	520	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					594	598		10.1126/science.1142995	http://dx.doi.org/10.1126/science.1142995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962551				2022-12-28	WOS:000250409200032
J	Baumann, T; Amthor, AM; Bazin, D; Brown, BA; Folden, CM; Gade, A; Ginter, TN; Hausmann, M; Matos, M; Morrissey, DJ; Portillo, M; Schiller, A; Sherrill, BM; Stolz, A; Tarasov, OB; Thoennessen, M				Baumann, T.; Amthor, A. M.; Bazin, D.; Brown, B. A.; Folden, C. M., III; Gade, A.; Ginter, T. N.; Hausmann, M.; Matos, M.; Morrissey, D. J.; Portillo, M.; Schiller, A.; Sherrill, B. M.; Stolz, A.; Tarasov, O. B.; Thoennessen, M.			Discovery of Mg-40 and Al-42 suggests neutron drip-line slant towards heavier isotopes	NATURE			English	Article							PARTICLE STABILITY; RICH NUCLEI; FRAGMENTATION; LIMITS; NA-37; NE-34; CA-48	A fundamental question in nuclear physics is what combinations of neutrons and protons can make up a nucleus. Many hundreds of exotic neutron-rich isotopes have never been observed; the limit of how many neutrons a given number of protons can bind is unknown for all but the lightest elements(1), owing to the delicate interplay between single particle and collective quantum effects in the nucleus. This limit, known as the neutron drip line, provides a benchmark for models of the atomic nucleus. Here we report a significant advance in the determination of this limit: the discovery of two new neutron-rich isotopes-Mg-40 and Al-42-that are predicted to be drip-line nuclei(2). In the past, several attempts to observe Mg-40 were unsuccessful(3,4); moreover, the observation of Al-42 provides an experimental indication that the neutron drip line may be located further towards heavier isotopes in this mass region than is currently believed. In stable nuclei, attractive pairing forces enhance the stability of isotopes with even numbers of protons and neutrons. In contrast, the present work shows that nuclei at the drip line gain stability from an unpaired proton, which narrows the shell gaps and provides the opportunity to bind many more neutrons(5,6).	Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Joint Inst Nucl Res, Flerov Lab Nucl React, Dubna 141980, Moscow Region, Russia	Michigan State University; Michigan State University; Michigan State University; Joint Institute for Nuclear Research - Russia	Baumann, T (corresponding author), Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA.	baumann@nscl.msu.edu	Sherrill, Bradley M/B-4098-2009; Bazin, Daniel/N-1226-2019; Sherrill, Bradley M/B-3378-2011; Gade, Alexandra/A-6850-2008; Tarasov, Oleg Borisovich/AAG-7101-2021; Folden, Charles M./F-1033-2015; Matos, Milan/G-6947-2012	Bazin, Daniel/0000-0002-5663-9693; Sherrill, Bradley M/0000-0002-5093-8190; Gade, Alexandra/0000-0001-8825-0976; Tarasov, Oleg Borisovich/0000-0003-0497-1421; Folden, Charles M./0000-0002-2814-3762; Matos, Milan/0000-0003-1722-9509; Amthor, Matt/0000-0003-2353-864X; Baumann, Thomas/0000-0002-2060-3672				ARTUKH AG, 1970, PHYS LETT B, VB 32, P43, DOI 10.1016/0370-2693(70)90332-1; Audi G, 2003, NUCL PHYS A, V729, P337, DOI 10.1016/j.nuclphysa.2003.11.003; Bazin D, 2003, NUCL INSTRUM METH B, V204, P629, DOI 10.1016/S0168-583X(02)02142-0; Brown BA, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.061303; Gelbke CK, 2004, PROG PART NUCL PHYS, V53, P363, DOI 10.1016/j.ppnp.2004.02.027; Goriely S, 2005, NUCL PHYS A, V750, P425, DOI 10.1016/j.nuclphysa.2005.01.009; GUILLEMAUDMUELLER D, 1990, PHYS REV C, V41, P937, DOI 10.1103/PhysRevC.41.937; LANGEVIN M, 1985, PHYS LETT B, V150, P71, DOI 10.1016/0370-2693(85)90140-6; Lukyanov SM, 2002, J PHYS G NUCL PARTIC, V28, pL41, DOI 10.1088/0954-3899/28/9/101; Lutostansky Yu.S., 2002, PART NUCL LETT, V115, P86; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; Morrissey DJ, 2003, NUCL INSTRUM METH B, V204, P90, DOI 10.1016/S0168-583X(02)01895-5; Notani M, 2002, PHYS LETT B, V542, P49, DOI 10.1016/S0370-2693(02)02337-7; Otsuka T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.162501; Retamosa J, 1997, PHYS REV C, V55, P1266, DOI 10.1103/PhysRevC.55.1266; Samyn M, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.044309; Tarasov O, 1997, PHYS LETT B, V409, P64, DOI 10.1016/S0370-2693(97)00901-5; Tarasov OB, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.064613; Thoennessen M, 2004, REP PROG PHYS, V67, P1187, DOI 10.1088/0034-4885/67/7/R04	20	154	155	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1022	1024		10.1038/nature06213	http://dx.doi.org/10.1038/nature06213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960237				2022-12-28	WOS:000250395000045
J	Krishnan, V; Han, MH; Graham, DL; Berton, O; Renthal, W; Russo, SJ; LaPlant, Q; Graham, A; Lutter, M; Lagace, DC; Ghose, S; Reister, R; Tannous, P; Green, TA; Neve, RL; Chakravarty, S; Kumar, A; Eisch, AJ; Self, DW; Lee, FS; Tamminga, CA; Cooper, DC; Gershenfeld, HK; Nestler, EJ				Krishnan, Vaishnav; Han, Ming-Hu; Graham, Danielle L.; Berton, Olivier; Renthal, William; Russo, Scott J.; LaPlant, Quincey; Graham, Ami; Lutter, Michael; Lagace, Diane C.; Ghose, Subroto; Reister, Robin; Tannous, Paul; Green, Thomas A.; Neve, Rachael L.; Chakravarty, Sumana; Kumar, Arvind; Eisch, Amelia J.; Self, David W.; Lee, Francis S.; Tamminga, Carol A.; Cooper, Donald C.; Gershenfeld, Howard K.; Nestler, Eric J.			Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions	CELL			English	Article							BDNF VAL66MET POLYMORPHISM; ACTIVITY-DEPENDENT SECRETION; DOPAMINE SYSTEM; STRESS; RESILIENCE; ASSOCIATION; DISORDERS; ALTERS; VULNERABILITY; TRAFFICKING	While stressful life events are an important cause of psychopathology, most individuals exposed to adversity maintain normal psychological functioning. The molecular mechanisms underlying such resilience are poorly understood. Here, we demonstrate that an inbred population of mice subjected to social defeat can be separated into susceptible and unsusceptible subpopulations that differ along several behavioral and physiological domains. By a combination of molecular and electrophysiological techniques, we identify signature adaptations within the mesolimbic dopamine circuit that are uniquely associated with vulnerability or insusceptibility. We show that molecular recapitulations of three prototypical adaptations associated with the unsusceptible phenotype are each sufficient to promote resistant behavior. Our results validate a multidisciplinary approach to examine the neurobiological mechanisms of variations in stress resistance, and illustrate the importance of plasticity within the brain's reward circuits in actively maintaining an emotional homeostasis.	Univ Texas, SW Med Ctr, Dept Psychait & Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Harvard Univ, McLean Hosp, Cambridge, MA 02478 USA; Harvard Univ, Dept Genet, Cambridge, MA 02478 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol & Psychiat, New York, NY 10021 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; McLean Hospital; Harvard University; Cornell University	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychait & Basic Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Russo, Scott/R-7107-2019; Kumar, Arvind/B-6094-2009; Han, Ming-Hu/G-8836-2012; Gershenfeld, Howard K/HGF-0536-2022; Graham, Danielle L/K-8459-2014; Ghose, Subroto/J-6732-2016	Russo, Scott/0000-0002-6470-1805; Renthal, William/0000-0003-0206-2101; Gershenfeld, Howard/0000-0002-4107-1513; Tannous, Paul/0000-0001-7972-9651; Eisch, Amelia/0000-0001-6476-5385; Krishnan, Vaishnav/0000-0002-2847-0069; Kumar, Arvind/0000-0003-2879-3826	NATIONAL INSTITUTE ON DRUG ABUSE [K01DA017750] Funding Source: NIH RePORTER; NIDA NIH HHS [K01 DA017750] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Avgustinovich D F, 2005, Neurosci Behav Physiol, V35, P917, DOI 10.1007/s11055-005-0146-6; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bonanno George A, 2003, Child Maltreat, V8, P302, DOI 10.1177/1077559503257066; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Curtis WJ, 2003, DEV PSYCHOPATHOL, V15, P773, DOI 10.1017/S0954579403000373; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Grace AA, 2000, ADDICTION, V95, pS119; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Grimm JW, 2003, J NEUROSCI, V23, P742; Hines LM, 2006, J NEUROSCI, V26, P12609, DOI 10.1523/JNEUROSCI.1040-06.2006; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Horger BA, 1999, J NEUROSCI, V19, P4110; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Liu XQ, 2003, J PSYCHIATR RES, V37, P249, DOI 10.1016/S0022-3956(03)00004-9; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Malatynska E, 2005, NEUROSCI BIOBEHAV R, V29, P715, DOI 10.1016/j.neubiorev.2005.03.014; Martinez M, 1998, AGGRESSIVE BEHAV, V24, P241; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Strauss J, 2005, MOL PSYCHIATR, V10, P861, DOI 10.1038/sj.mp.4001685; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Weiss JM, 1998, ANN NY ACAD SCI, V863, P364, DOI 10.1111/j.1749-6632.1998.tb10707.x; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028; Yoshida K, 2007, J PSYCHOPHARMACOL, V21, P650, DOI 10.1177/0269881106072192	50	1432	1466	3	156	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					391	404		10.1016/j.cell.2007.09.018	http://dx.doi.org/10.1016/j.cell.2007.09.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956738	Bronze			2022-12-28	WOS:000250507700027
J	Marti, K				Marti, Kurt			Sampling the sun	SCIENCE			English	Editorial Material							SOLAR-WIND		Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Marti, K (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	kmarti@ucsd.edu						Bizzarro M, 2007, SCIENCE, V316, P1178, DOI 10.1126/science.1141040; Geiss J, 2004, SPACE SCI REV, V110, P307, DOI 10.1023/B:SPAC.0000023409.54469.40; Grady M.M., 2006, METEORITES EARLY SOL, P3; Grimberg A, 2006, SCIENCE, V314, P1133, DOI 10.1126/science.1133568; KIM JS, 1995, NATURE, V375, P383, DOI 10.1038/375383a0; Meshik A, 2007, SCIENCE, V318, P433, DOI 10.1126/science.1145528; Sakamoto N, 2007, SCIENCE, V317, P231, DOI 10.1126/science.1142021	7	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					401	402		10.1126/science.1149379	http://dx.doi.org/10.1126/science.1149379			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947568				2022-12-28	WOS:000250230400029
J	Nussenzweig, A; Nussenzweig, MC				Nussenzweig, Andre; Nussenzweig, Michel C.			A backup DNA repair pathway moves to the forefront	CELL			English	Editorial Material							DOUBLE-STRAND BREAKS; CLASS SWITCH RECOMBINATION; GENE AMPLIFICATION; TRANSLOCATIONS; MUTATIONS; CELLS; AID		NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA.	nussenzweig@nih.gov	Nussenzweig, Michel/AAE-7292-2019		NCI NIH HHS [F31 CA260794] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bogue MA, 1997, IMMUNITY, V7, P37, DOI 10.1016/S1074-7613(00)80508-7; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Decottignies A, 2007, GENETICS, V176, P1403, DOI 10.1534/genetics.107.071621; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Jankovic M, 2007, NAT IMMUNOL, V8, P801, DOI 10.1038/ni1498; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	14	155	162	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					223	225		10.1016/j.cell.2007.10.005	http://dx.doi.org/10.1016/j.cell.2007.10.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956720	Bronze			2022-12-28	WOS:000250507700009
J	Riele, HT				Riele, Hein te			Retinoblastoma teaches a new lesson	CELL			English	Editorial Material							CELL; SUPPRESSOR; ORIGIN; P107; RB		Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Riele, HT (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	h.t.riele@nki.nl						AJIOKA I, 2007, CELL; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Foijer F, 2005, CANCER CELL, V8, P455, DOI 10.1016/j.ccr.2005.10.021; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P791, DOI 10.1001/archopht.1995.01100060117046; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Weinberg RA, 2006, BIOL CANC; Zhang JK, 2004, CELL CYCLE, V3, P952	10	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					227	229		10.1016/j.cell.2007.10.007	http://dx.doi.org/10.1016/j.cell.2007.10.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956722	Bronze			2022-12-28	WOS:000250507700011
J	Shin, YH; Grinberg, I; Chen, IW; Rappe, AM				Shin, Young-Han; Grinberg, Ilya; Chen, I-Wei; Rappe, Andrew M.			Nucleation and growth mechanism of ferroelectric domain-wall motion	NATURE			English	Article							THIN-FILMS; POLARIZATION REVERSAL; KINETICS; BATIO3; TITANATE	The motion of domain walls is critical to many applications involving ferroelectric materials, such as fast high-density non-volatile random access memory(1). In memories of this sort, storing a data bit means increasing the size of one polar region at the expense of another, and hence the movement of a domain wall separating these regions. Experimental measurements of domain growth rates in the well-established ferroelectrics PbTiO(3) and BaTiO(3) have been performed, but the development of new materials has been hampered by a lack of microscopic understanding of how domain walls move(2-11). Despite some success in interpreting domain-wall motion in terms of classical nucleation and growth models(12-16), these models were formulated without insight from first-principles-based calculations, and they portray a picture of a large, triangular nucleus that leads to unrealistically large depolarization and nucleation energies(5). Here we use atomistic molecular dynamics and coarse-grained Monte Carlo simulations to analyse these processes, and demonstrate that the prevailing models are incorrect. Our multi-scale simulations reproduce experimental domain growth rates in PbTiO(3) and reveal small, square critical nuclei with a diffuse interface. A simple analytic model is also proposed, relating bulk polarization and gradient energies to wall nucleation and growth, and thus rationalizing all experimental rate measurements in PbTiO(3) and BaTiO(3).	Univ Penn, Dept Chem, Makineni Theoret Labs, Philadelphia, PA 19104 USA; Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Rappe, AM (corresponding author), Univ Penn, Dept Chem, Makineni Theoret Labs, Philadelphia, PA 19104 USA.	rappe@sas.upenn.edu	Shin, Young-Han/M-1079-2019; Rappe, Andrew Marshall/HFZ-8855-2022; Shin, Young-Han/G-7562-2015	Shin, Young-Han/0000-0002-8537-1905; Chen, I-Wei/0000-0002-4045-4467				Ahn CH, 2004, SCIENCE, V303, P488, DOI 10.1126/science.1092508; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; BROWN ID, 1976, ACTA CRYSTALLOGR B, V32, P1957, DOI 10.1107/S0567740876006869; COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Ganpule CS, 2000, APPL PHYS LETT, V77, P292, DOI 10.1063/1.126954; Grigoriev A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.187601; Grinberg I, 2002, NATURE, V419, P909, DOI 10.1038/nature01115; Gruverman A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2010605; HAYASHI M, 1972, J PHYS SOC JPN, V33, P616, DOI 10.1143/JPSJ.33.616; Kashchiev D., 2000, NUCL BASIC THEORY AP; LANDAUER R, 1957, J APPL PHYS, V28, P227, DOI 10.1063/1.1722712; Li J, 2004, APPL PHYS LETT, V84, P1174, DOI 10.1063/1.1644917; LINES ME, 1977, PRINCIPLES APPLICATI, pCH4; MERZ WJ, 1954, PHYS REV, V95, P690, DOI 10.1103/PhysRev.95.690; Meyer B, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104111; MILLER RC, 1960, PHYS REV, V117, P1460, DOI 10.1103/PhysRev.117.1460; ORIHARA H, 1994, J PHYS SOC JPN, V63, P1031, DOI 10.1143/JPSJ.63.1031; Padilla J, 1996, PHYS REV B, V53, pR5969, DOI 10.1103/PhysRevB.53.R5969; SAVAGE A, 1960, J APPL PHYS, V31, P1546, DOI 10.1063/1.1735890; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; Shin YH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054104; Shur V, 1998, J APPL PHYS, V84, P445, DOI 10.1063/1.368047; So YW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1870126; STADLER HL, 1963, J APPL PHYS, V34, P3255, DOI 10.1063/1.1729173; Stolichnov I, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1845573; Tybell T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.097601	26	285	289	16	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					881	U7		10.1038/nature06165	http://dx.doi.org/10.1038/nature06165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17922002	Green Submitted			2022-12-28	WOS:000250230600041
J	Gayle, HD; Daulaire, N				Gayle, Helene D.; Daulaire, Nils			A better future for women and children	LANCET			English	Editorial Material									CARE USA, Atlanta, GA 30303 USA; Global Hlth Council, Washington, DC USA		Gayle, HD (corresponding author), CARE USA, Atlanta, GA 30303 USA.	hgayle@care.org						[Anonymous], 2006, M NEED STRENGTH FAM; Center for Global Development, 2007, MILL SAV PROV SUCC G; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P849; *GLOB HLTH COUNC, 2006, GLOB HLTH OPP 2006 U; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lawn J, 2005, PRICE TAG NEWBORN CH; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; *SAV CHILDR, 2007, STAT WORLDS MOTH 200; SONFIELD A, 2006, GUTTMACHER POLICY RE, V9, P10; UNICEF, 2006, STAT WORLDS CHILDR 2	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1297	1298		10.1016/S0140-6736(07)61557-8	http://dx.doi.org/10.1016/S0140-6736(07)61557-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933637				2022-12-28	WOS:000250176600012
J	Kerber, KJ; de Graft-Johnson, JE; Bhutta, ZA; Okong, P; Starrs, A; Lawn, JE				Kerber, Kate J.; de Graft-Johnson, Joseph E.; Bhutta, Zulfiqar A.; Okong, Pius; Starrs, Ann; Lawn, Joy E.			Continuum of care for maternal, newborn, and child health: from slogan to service delivery	LANCET			English	Review							SURVIVAL 1; INTERVENTIONS; STRATEGIES; SAVE	The continuum of care has become a rallying call to reduce the yearly toll of half a million maternal deaths, 4 million neonatal deaths, and 6 million child deaths. The continuum for maternal, newborn, and child health usually refers to continuity of individual care. Continuity of care is necessary throughout the lifecycle (adolescence, pregnancy, childbirth, the postnatal period, and childhood) and also between places of caregiving (including households and communities, outpatient and outreach services, and clinical-care settings). We define a population-level or public-health framework based on integrated service delivery throughout the lifecycle, and propose eight packages to promote health for mothers, babies, and children. These packages can be used to deliver more than 190 separate interventions, which would be difficult to scale up one by one. The packages encompass three which are delivered through clinical care (reproductive health, obstetric care, and care of sick newborn babies and children); four through outpatient and outreach services (reproductive health, antenatal care, postnatal care and child health services); and one through integrated family and community care throughout the lifecycle. Mothers and babies are at high risk in the first days after birth, and the lack of a defined postnatal care package is an important gap, which also contributes to discontinuity between maternal and child health programmes. Similarly, because the family and community package tends not to be regarded as part of the health system, few countries have made systematic efforts to scale it up or integrate it with other levels of care. Building the continuum of care for maternal, newborn, and child health with these packages will need effectiveness trials in various settings; policy support for integration; investment to strengthen health systems; and results-based operational management, especially at district level.	Saving Newborn Lives, Save Children, Washington, DC USA; ACCESS Program, Baltimore, MD USA; Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; Nsambya Hosp, Dept Obstet & Gynaecol, Kampala, Uganda; Int Federat Gynecol & Obstet, Comm Maternal & Newborn Hlth, London, England; Family Care Int, New York, NY USA; Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland	Save the Children; Aga Khan University	Lawn, JE (corresponding author), Saving Newborn Lives, Save Children US, 11 South Way, ZA-7405 Cape Town, South Africa.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443				BANG AT, 2005, J PERINATOL, V25, P108; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2007, LANCET, V369, P725, DOI 10.1016/S0140-6736(07)60339-0; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; BRYDEFOSTER M, 2005, J ADV NURS, V506, P624; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; De Graft-Johnson J., 2006, PARTNERSHIP MATERNAL, V2011, P23; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Egan A, 2005, TROP MED INT HEALTH, V10, P815, DOI 10.1111/j.1365-3156.2005.01474.x; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Gill K, 2007, LANCET, V370, P1347, DOI 10.1016/S0140-6736(07)61577-3; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; International Conference on Primary Health Care, 1978, DECL ALM AT; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn J, 2005, PRICE TAG NEWBORN CH; Lawn J, 2001, HLTH NEWBORN REFER 2; Lawn J, 2006, OPPORTUNITIES AFRICA; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LAWN JE, 2005, LANCET; Lawn JE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P531; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; LIEBOWITZ B, 1970, GERONTOLOGIST, V10, P11, DOI 10.1093/geront/10.1_Part_1.11; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mangiaterra V, 2006, SEMIN FETAL NEONAT M, V11, P37, DOI 10.1016/j.siny.2005.11.010; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; OECD, 2005, PARIS DECLARATION AI; OTCHERE S, 2005, BRINGING CARE CLOSER; PADMANATHAN I, 2003, INVESTING MATERNAL H; PMNCH, 2006, CONC I FRAM; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosenfield A, 2001, AM J PUBLIC HEALTH, V91, P703, DOI 10.2105/AJPH.91.5.703; *SAV CILDR, 2006, STAT WORLDS MOTH 200; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; STOLTENBERG J, 2007, COMMUNICATION   0516; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; TINKER A, 1993, 202 WORLD BANK; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UNICEF, 2007, STAT WORLDS CHILDR 2; *UNICEF, 2007, STOCKT REP CHILDR AI; *USAID, DEM HLTH SURV 2007; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; von Both Claudia, 2006, BMC Pregnancy Childbirth, V6, P22; WARREN C, 2006, OPPORTUNITIES AFRICA, P9; World Bank, 2004, WORLD DEV REP 2004 M, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X]; World Health Organization, 2005, WORLD HLTH REP 2005	57	551	560	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1358	1369		10.1016/S0140-6736(07)61578-5	http://dx.doi.org/10.1016/S0140-6736(07)61578-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933651				2022-12-28	WOS:000250176600030
J	McNutt, RL; Haggerty, DK; Hill, ME; Krimigis, SM; Livi, S; Ho, GC; Gurnee, RS; Mauk, BH; Mitchell, DG; Roelof, EC; McComas, DJ; Bagenal, F; Elliott, HA; Brown, LE; Kusterer, M; Vandegriff, J; Stern, SA; Weaver, HA; Spencer, JR; Moore, JM				McNutt, R. L., Jr.; Haggerty, D. K.; Hill, M. E.; Krimigis, S. M.; Livi, S.; Ho, G. C.; Gurnee, R. S.; Mauk, B. H.; Mitchell, D. G.; Roelof, E. C.; McComas, D. J.; Bagenal, F.; Elliott, H. A.; Brown, L. E.; Kusterer, M.; Vandegriff, J.; Stern, S. A.; Weaver, H. A.; Spencer, J. R.; Moore, J. M.			Energetic particles in the Jovian magnetotail	SCIENCE			English	Article							SPECTRAL-ANALYSIS; MAGNETOSPHERE; UPSTREAM; BURSTS; EVENTS; PLASMA; IONS	When the solar wind hits Jupiter's magnetic field, it creates a long magnetotail trailing behind the planet that channels material out of the Jupiter system. The New Horizons spacecraft traversed the length of the jovian magnetotail to >2500 jovian radii (R-J; 1 R-J = 71,400 kilometers), observing a high-temperature, multispecies population of energetic particles. Velocity dispersions, anisotropies, and compositional variation seen in the deep-tail (greater than or similar to 500 R-J) with a similar to 3-day periodicity are similar to variations seen closer to Jupiter in Galileo data. The signatures suggest plasma streaming away from the planet and injection sites in the near-tail region (similar to 200 to 400 R-J) that could be related to magnetic reconnection events. The tail structure remains coherent at least until it reaches the magnetosheath at 1655 R-J.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Acad Athens, Athens 10679, Greece; SW Res Inst, San Antonio, TX 78228 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; NASA Headquarters, Washington, DC 20546 USA; SW Res Inst, Boulder, CO 80302 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; Southwest Research Institute; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center	McNutt, RL (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	ralph.mcnutt@jhuapl.edu	Ho, George/GMW-9642-2022; Hill, Matthew/H-4312-2016; Ho, George/G-3650-2015; Mauk, Barry H/E-8420-2017; Weaver, Harold A/D-9188-2016; Kusterer, Martha/AAE-5505-2021; Mitchell, Donald G/H-4601-2016; Roelof, Edmond/G-6654-2019; McComas, David J/H-6202-2011; Krimigis, Stamatios/G-4591-2019; Haggerty, Dennis K/C-2507-2016; McNutt, Ralph L/E-8006-2010	Ho, George/0000-0003-1093-2066; Hill, Matthew/0000-0002-5674-4936; Ho, George/0000-0003-1093-2066; Mauk, Barry H/0000-0001-9789-3797; Weaver, Harold A/0000-0003-0951-7762; Mitchell, Donald G/0000-0003-1960-2119; Roelof, Edmond/0000-0002-2270-0652; McComas, David J/0000-0001-6160-1158; Krimigis, Stamatios/0000-0003-2781-2386; Haggerty, Dennis K/0000-0001-6395-8943; McNutt, Ralph L/0000-0002-4722-9166; Vandegriff, Jon/0000-0002-0781-1565; Kusterer, Martha/0000-0002-7943-1852				Haggerty D, 1999, J GEOPHYS RES-SPACE, V104, P4629, DOI 10.1029/1998JA900148; HAMILTON DC, 1981, J GEOPHYS RES-SPACE, V86, P8301, DOI 10.1029/JA086iA10p08301; Hill ME, 2001, J GEOPHYS RES-SPACE, V106, P8315, DOI 10.1029/2000JA000380; HORNE JH, 1986, ASTROPHYS J, V302, P757, DOI 10.1086/164037; KRIMIGIS SM, 1975, GEOPHYS RES LETT, V2, P561, DOI 10.1029/GL002i012p00561; Krimigis SM, 2002, NATURE, V415, P994, DOI 10.1038/415994a; KRIMIGIS SM, 1981, J GEOPHYS RES-SPACE, V86, P8227, DOI 10.1029/JA086iA10p08227; Kronberg EA, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011994; Krupp N, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010111; Krupp N, 2004, CAMB PLANET, P617; Krupp N, 2001, J GEOPHYS RES-SPACE, V106, P26017, DOI 10.1029/2000JA900138; Krupp N, 1998, GEOPHYS RES LETT, V25, P1249, DOI 10.1029/98GL00863; LEPPING RP, 1982, GEOPHYS RES LETT, V9, P885, DOI 10.1029/GL009i008p00885; LEPPING RP, 1983, J GEOPHYS RES-SPACE, V88, P8801, DOI 10.1029/JA088iA11p08801; MACDONALD GJ, 1989, REV GEOPHYS, V27, P449, DOI 10.1029/RG027i004p00449; Mauk BH, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010270; McComas DJ, 2007, SCIENCE, V318, P217, DOI 10.1126/science.1147393; MCCOMAS DJ, IN PRESS SPACE SCI R; NESS NF, 1969, REV GEOPHYS, V7, P97, DOI 10.1029/RG007i001p00097; PRESS WH, 1989, ASTROPHYS J, V338, P277, DOI 10.1086/167197; Radioti A, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012047; SCARF FL, 1981, NATURE, V292, P585, DOI 10.1038/292585a0; SCARGLE JD, 1982, APJ, V263, P835, DOI DOI 10.1086/160554; WILLIAMS DJ, 1992, SPACE SCI REV, V60, P385, DOI 10.1007/BF00216863; Woch J, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014080; Woch J, 1998, GEOPHYS RES LETT, V25, P1253, DOI 10.1029/98GL00861	26	43	43	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					220	222		10.1126/science.1148025	http://dx.doi.org/10.1126/science.1148025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932283				2022-12-28	WOS:000250086100031
J	Pagel, M; Atkinson, QD; Meade, A				Pagel, Mark; Atkinson, Quentin D.; Meade, Andrew			Frequency of word-use predicts rates of lexical evolution throughout Indo-European history	NATURE			English	Article							DIVERGENCE	Greek speakers say "ovpa", Germans "schwanz'' and the French "queue'' to describe what English speakers call a 'tail', but all of these languages use a related form of 'two' to describe the number after one. Among more than 100 Indo-European languages and dialects, the words for some meanings (such as 'tail') evolve rapidly, being expressed across languages by dozens of unrelated words, while others evolve much more slowly-such as the number 'two', for which all Indo-European language speakers use the same related word-form(1). No general linguistic mechanism has been advanced to explain this striking variation in rates of lexical replacement among meanings. Here we use four large and divergent language corpora (English(2), Spanish(3), Russian(4) and Greek(5)) and a comparative database of 200 fundamental vocabulary meanings in 87 Indo-European languages(6) to show that the frequency with which these words are used in modern language predicts their rate of replacement over thousands of years of Indo-European language evolution. Across all 200 meanings, frequently used words evolve at slower rates and infrequently used words evolve more rapidly. This relationship holds separately and identically across parts of speech for each of the four language corpora, and accounts for approximately 50% of the variation in historical rates of lexical replacement. We propose that the frequency with which specific words are used in everyday language exerts a general and law-like influence on their rates of evolution. Our findings are consistent with social models of word change that emphasize the role of selection, and suggest that owing to the ways that humans use language, some words will evolve slowly and others rapidly across all languages.	Univ Reading, Sch Biol Sci, Reading RG6 6AS, Berks, England; Santa Fe Inst, Santa Fe, NM 87501 USA	University of Reading; The Santa Fe Institute	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6AS, Berks, England.	m.pagel@reading.ac.uk		Atkinson, Quentin/0000-0002-8499-7535	Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Boyd R., 1985, CULTURE EVOLUTIONARY; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Croft William, 2000, EXPLAINING LANGUAGE; DAVIES M, 2005, CORPUS LINGUISTICS W, P167; DYEN I, 1992, T AM PHILOS SOC, V82, P1; DYEN I, 1967, LANGUAGE, V43, P150, DOI 10.2307/411390; Ellis NickC., 2002, STUD SECOND LANG ACQ, V24, P143, DOI [10.1017/S0272263102002024, DOI 10.1017/S0272263102002024]; Fontanari JF, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.042901; FRANCIS WN, 1982, FREQUENCY ANAL ENGLI; Gimbutas, 1973, J INDOEUROPEAN STUDI, V1, P163; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; GREENBERG JH, 2000, INDO EUROPEAN ITS CL, V1; *ILSP CORP, 1999, HELL NAT CORP HNC WE; KAISER M, 1988, ANNU REV ANTHROPOL, V17, P309; Kimura M., 1983, NEUTRAL THEORY MOL E; Kirby S., 1999, FUNCTION SELECTION I; KRUSKAL JB, 1971, MATH ARCHAEOLOGICAL, P361; Labov, 2001, PRINCIPLES LINGUISTI; Leech G, 2001, WORD FREQUENCIES WRI; Mackay Wesley, 2005, P 9 C COMPUTATIONAL, P40; Meade Andrew, 2006, PHYLOGENETIC METHODS, P173; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MILROY J, 1985, J LINGUIST, V21, P229; Nettle D, 1999, LINGUA, V108, P119, DOI 10.1016/S0024-3841(98)00047-3; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 2005, EVOLUTION CULTURAL D, P235; RENFREW C, 1987, ARCHAEOLOGY LANGUAE; STEEL MA, 1988, NATURE, V336, P118, DOI 10.1038/336118a0; SWADESH M, 1952, P AM PHILOS SOC, V96, P453; Thomason S. G., 1988, LANGUAGE CONTACT CRE; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; ZIPF GK, 1947, MOD LANG NOTES, V62, P522	35	266	270	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					717	U7		10.1038/nature06176	http://dx.doi.org/10.1038/nature06176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	218VV	17928860	Green Submitted			2022-12-28	WOS:000250045000043
J	Jones, R				Jones, Roger			Should general practitioners resume 24 hour responsibility for their patients? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England	University of London; King's College London	Jones, R (corresponding author), Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England.	roger.jones@kcl.ac.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 6	2007	335	7622					696	696		10.1136/bmj.39350.506991.AD	http://dx.doi.org/10.1136/bmj.39350.506991.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916851	Green Published			2022-12-28	WOS:000250156800027
J	Xiao, CC; Calado, DP; Galler, G; Thai, TH; Patterson, HC; Wang, J; Rajewsky, N; Bender, TP; Rajewsky, K				Xiao, Changchun; Calado, Dinis Pedro; Galler, Gunther; Thai, To-Ha; Patterson, Heide Christine; Wang, Jing; Rajewsky, Nikolaus; Bender, Timothy P.; Rajewsky, Klaus			MiR-150 controls B cell differentiation by targeting the transcription factor c-myb	CELL			English	Article							PERITONEAL-CELLS; GENE-EXPRESSION; MARGINAL ZONE; PROLIFERATION; MICRORNAS; APOPTOSIS; MOTIFS; RNAS; GUT	MiR-150 is a microRNA ( miRNA) specifically expressed in mature lymphocytes, but not their progenitors. A top predicted target of miR-150 is c-Myb, a transcription factor controlling multiple steps of lymphocyte development. Combining loss- and gain-of-function gene targeting approaches for miR-150 with conditional and partial ablation of c-Myb, we show that miR150 indeed controls c-Myb expression in vivo in a dose-dependent manner over a narrow range of miRNA and c-Myb concentrations and that this dramatically affects lymphocyte development and response. Our results identify a key transcription factor as a critical target of a stage-specifically expressed miRNA in lymphocytes and suggest that this and perhaps other miRNAs have evolved to control the expression of just a few critical target proteins in particular cellular contexts.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; New York University; University of Virginia	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Calado, Dinis/U-8379-2019	Calado, Dinis/0000-0001-8239-7184; Rajewsky, Nikolaus/0000-0002-4785-4332; Galler, Gunther/0000-0003-4507-5957; Rajewsky, Klaus/0000-0002-6633-6370	NCI NIH HHS [CA85842, R01 CA085842] Funding Source: Medline; NIAID NIH HHS [AI059294, AI064345, R01 AI059294, AI054636] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064345, R37AI054636, R01AI059294] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; GOLAY J, 1992, J IMMUNOL, V149, P300; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; PAUZA CD, 1987, MOL CELL BIOL, V7, P342, DOI 10.1128/MCB.7.1.342; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Salomoni P, 1997, P NATL ACAD SCI USA, V94, P3296, DOI 10.1073/pnas.94.7.3296; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Unoki M, 2003, INT J ONCOL, V22, P1217; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	39	805	871	2	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					146	159		10.1016/j.cell.2007.07.021	http://dx.doi.org/10.1016/j.cell.2007.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923094	Bronze			2022-12-28	WOS:000249934700018
J	Abramson, JS; Pickering, LK; Allos, BM; Baker, C; Beck, RL; Gilsdorf, JR; Hull, H; Lett, S; Lieu, T; Mootrey, GT; Morita, J; Morse, DL; Neuzil, K; Stinchfield, P; Sumaya, CV; Treanor, JJ; Womeodu, RJ				Abramson, Jon S.; Pickering, Larry K.; Allos, Ban Mishu; Baker, Carol; Beck, Robert L.; Gilsdorf, Janet R.; Hull, Harry; Lett, Susan; Lieu, Tracy; Mootrey, Gina T.; Morita, Julia; Morse, Dale L.; Neuzil, Kathleen; Stinchfield, Patricia; Sumaya, Ciro Valent; Treanor, John J.; Womeodu, Robin J.		Advisory Comm Immunization Practic	Recommended Adult Immunization Schedule: United States, October 2007-September 2008	ANNALS OF INTERNAL MEDICINE			English	Article									Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Mootrey, GT (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, 1600 Clifton Rd NE, Mailstop E52, Atlanta, GA 30333 USA.	gmootrey@cdc.gov						Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1	1	22	26	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					725	729		10.7326/0003-4819-147-10-200711200-00187	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00187			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	17947396				2022-12-28	WOS:000251259500007
J	Wood, LD; Parsons, DW; Jones, S; Lin, J; Sjoblom, T; Leary, RJ; Shen, D; Boca, SM; Barber, T; Ptak, J; Silliman, N; Szabo, S; Dezso, Z; Ustyanksky, V; Nikolskaya, T; Nikolsky, Y; Karchin, R; Wilson, PA; Kaminker, JS; Zhang, ZM; Croshaw, R; Willis, J; Dawson, D; Shipitsin, M; Willson, JKV; Sukumar, S; Polyak, K; Park, BH; Pethiyagoda, CL; Pant, PVK; Ballinger, DG; Sparks, AB; Hartigan, J; Smith, DR; Suh, E; Papadopoulos, N; Buckhaults, P; Markowitz, SD; Parmigiani, G; Kinzler, KW; Velculescu, VE; Vogelstein, B				Wood, Laura D.; Parsons, D. Williams; Jones, Sian; Lin, Jimmy; Sjoblom, Tobias; Leary, Rebecca J.; Shen, Dong; Boca, Simina M.; Barber, Thomas; Ptak, Janine; Silliman, Natalie; Szabo, Steve; Dezso, Zoltan; Ustyanksky, Vadim; Nikolskaya, Tatiana; Nikolsky, Yuri; Karchin, Rachel; Wilson, Paul A.; Kaminker, Joshua S.; Zhang, Zemin; Croshaw, Randal; Willis, Joseph; Dawson, Dawn; Shipitsin, Michail; Willson, James K. V.; Sukumar, Saraswati; Polyak, Kornelia; Park, Ben Ho; Pethiyagoda, Charit L.; Pant, P. V. Krishna; Ballinger, Dennis G.; Sparks, Andrew B.; Hartigan, James; Smith, Douglas R.; Suh, Erick; Papadopoulos, Nickolas; Buckhaults, Phillip; Markowitz, Sanford D.; Parmigiani, Giovanni; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert			The genomic landscapes of human breast and colorectal cancers	SCIENCE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PIK3CA GENE; MUTATIONAL ANALYSIS; MULTIPLE-MYELOMA; HIGH-FREQUENCY; PATHWAYS; PATTERNS; PROTEIN; SEQUENCES; ONCOGENE	Human cancer is caused by the accumulation of mutations in oncogenes and tumor suppressor genes. To catalog the genetic changes that occur during tumorigenesis, we isolated DNA from 11 breast and 11 colorectal tumors and determined the sequences of the genes in the Reference Sequence database in these samples. Based on analysis of exons representing 20,857 transcripts from 18,191 genes, we conclude that the genomic landscapes of breast and colorectal cancers are composed of a handful of commonly mutated gene "mountains" and a much larger number of gene "hills" that are mutated at low frequency. We describe statistical and bioinformatic tools that may help identify mutations with a role in tumorigenesis. These results have implications for understanding the nature and heterogeneity of human cancers and for using personal genomics for tumor diagnosis and therapy.	Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Med Inst, Dept Biostat, Baltimore, MD 21231 USA; GeneGo, St Joseph, MI 49085 USA; Vavilov Inst Gen Genet, Moscow, Russia; Johns Hopkins Univ, Inst Computat Med, Dept Biomed Engn, Baltimore, MD 21218 USA; Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; Univ S Carolina, Sch Med, Dept Pathol & Microbiol, Ctr Colon Canc Res, Columbia, SC 29229 USA; Univ S Carolina, S Carolina Canc Ctr, Div Basic Res, Columbia, SC 29229 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Perlegen Sci, Mountain View, CA 94043 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Howard Hughes Med Inst, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Russian Academy of Sciences; Vavilov Institute of General Genetics; Johns Hopkins University; Roche Holding; Genentech; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; Howard Hughes Medical Institute	Parmigiani, G (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	gp@jhu.edu; kinzlke@jhmi.edu; velculescu@jhmi.edu; vogelbe@welch.jhu.edu	Wood, Laura/ABF-1531-2020; Velculescu, Victor/ABF-4846-2020; Nikolskaya, Tatiana/M-5008-2013; Karchin, Rachel/A-3385-2010; Ustianskyi, Vadym/AAE-5400-2019; Boca, Simina/ABE-3747-2020; Jin, Ning/B-7956-2011; Jones, Sian/A-5050-2012; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; Boca, Simina/0000-0002-1400-3398; Karchin, Rachel/0000-0002-5069-1239; Parsons, Donald/0000-0002-8775-3501; Edsall, Lee Elizabeth/0000-0002-0326-2829	NCI NIH HHS [CA109274, CA 57345, CA 43460, P30-CA43703, CA62924, CA121113, CA112828] Funding Source: Medline; NCRR NIH HHS [RR017698] Funding Source: Medline; NIGMS NIH HHS [GM070219, GM07309] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA043703, R43CA112828, R01CA043460, R55CA109274, R01CA121113, R37CA057345, R01CA057345, R01CA109274, P50CA062924, R37CA043460, R44CA112828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM070219] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bardelli A, 2005, CURR OPIN GENET DEV, V15, P5, DOI 10.1016/j.gde.2004.12.009; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Diehl F, 2007, CURR OPIN ONCOL, V19, P36, DOI 10.1097/CCO.0b013e328011a8e7; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; KARCHIN R, STRUCTURAL MODELS MU; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087	32	2350	2495	2	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1108	1113		10.1126/science.1145720	http://dx.doi.org/10.1126/science.1145720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	17932254				2022-12-28	WOS:000250957900038
J	Park, D; Tosello-Trampont, AC; Elliott, MR; Lu, MJ; Haney, LB; Ma, Z; Klibanov, AL; Mandell, JW; Ravichandran, KS				Park, Daeho; Tosello-Trampont, Annie-Carole; Elliott, Michael R.; Lu, Mingjian; Haney, Lisa B.; Ma, Zhong; Klibanov, Alexander L.; Mandell, James W.; Ravichandran, Kodi S.			BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module	NATURE			English	Article							RAC ACTIVATION; PHOSPHATIDYLSERINE; THROMBOSPONDIN; MACROPHAGES; REPEATS; DOCK180; ANGIOGENESIS; PHAGOCYTOSIS; RECOGNITION; CED-12/ELMO	Engulfment and subsequent degradation of apoptotic cells is an essential step that occurs throughout life in all multicellular organisms(1-3). ELMO/ Dock(180)/Rac proteins are a conserved signalling module for promoting the internalization of apoptotic cell corpses(4,5); ELMO and Dock180 function together as a guanine nucleotide exchange factor (GEF) for the small GTPase Rac, and thereby regulate the phagocyte actin cytoskeleton during engulfment(4 -6). However, the receptor(s) upstream of the ELMO/ Dock180/ Rac module are still unknown. Here we identify brain-specific angiogenesis inhibitor 1 (BAI1) as a receptor upstream of ELMO and as a receptor that can bind phosphatidylserine on apoptotic cells. BAI1 is a seven-transmembrane protein belonging to the adhesion-type G-protein-coupled receptor family, with an extended extracellular region(7-9) and no known ligands. We show that BAI1 functions as an engulfment receptor in both the recognition and subsequent internalization of apoptotic cells. Through multiple lines of investigation, we identify phosphatidylserine, a key `eat-me' signal exposed on apoptotic cells(10-13), as a ligand for BAI1. The thrombospondin type 1 repeats within the extracellular region of BAI1 mediate direct binding to phosphatidylserine. As with intracellular signalling, BAI1 forms a trimeric complex with ELMO and Dock180, and functional studies suggest that BAI1 cooperates with ELMO/ Dock180/Rac to promote maximal engulfment of apoptotic cells. Last, decreased BAI1 expression or interference with BAI1 function inhibits the engulfment of apoptotic targets ex vivo and in vivo. Thus, BAI1 is a phosphatidylserine recognition receptor that can directly recruit a Rac-GEF complex to mediate the uptake of apoptotic cells.	Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Div Cardiovasc, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA.	ravi@virginia.edu	Lu, Mingjian/AGK-0751-2022; Lu, Mingjian/AAO-6179-2021	Lu, Mingjian/0000-0001-9328-4935; Elliott, Michael/0000-0002-0642-482X; Ravichandran, Kodi/0000-0001-9049-1410	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI055432] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cho HJ, 2007, PHYSIOL GENOMICS, V29, P149, DOI 10.1152/physiolgenomics.00051.2006; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gregory CD, 2005, NAT CELL BIOL, V7, P1161, DOI 10.1038/ncb1205-1161; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; Henson PM, 2005, CURR BIOL, V15, pR29, DOI 10.1016/j.cub.2004.12.017; Kang X, 2006, CANCER GENE THER, V13, P385, DOI 10.1038/sj.cgt.7700898; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	25	571	589	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					430	U10		10.1038/nature06329	http://dx.doi.org/10.1038/nature06329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17960134	Bronze			2022-12-28	WOS:000250918600057
J	Akbar, F; Maw, A; Bhowmick, A				Akbar, Fayyaz; Maw, Andrew; Bhowmick, Arnab			Anal ulceration induced by nicorandil	BRITISH MEDICAL JOURNAL			English	Review							PERIANAL ULCERATION; CASE SERIES		Glan Clwyd Gen Hosp, Dept Gen Surg, Rhyl LL18 5UJ, Wales		Akbar, F (corresponding author), Glan Clwyd Gen Hosp, Dept Gen Surg, Rhyl LL18 5UJ, Wales.	Andrew.Maw@cd-tr.wales.nhs.uk						Cooke NS, 2006, BRIT J DERMATOL, V154, P199, DOI 10.1111/j.1365-2133.2005.07025.x; Katory M, 2005, DIS COLON RECTUM, V48, P1442, DOI 10.1007/s10350-005-0027-7; KATORY M, 2004, COLORECTAL DIS, V6, P526; King PM, 2004, SURG-J R COLL SURG E, V2, P56, DOI 10.1016/S1479-666X(04)80140-9; Malik R, 2005, BRIT J DERMATOL, V152, P809, DOI 10.1111/j.1365-2133.2005.06501.x; Passeron T, 2004, BRIT J DERMATOL, V150, P394, DOI 10.1111/j.1365-2133.2003.05799.x; Renwick AA, 2004, ANZ J SURG, V74, P1128, DOI 10.1111/j.1445-1433.2004.03257.x; Toquero L, 2006, COLORECTAL DIS, V8, P717, DOI 10.1111/j.1463-1318.2006.00972.x; Vella M, 2002, LANCET, V360, P1979, DOI 10.1016/S0140-6736(02)11879-4; Watson A, 2004, Colorectal Dis, V6, P330, DOI 10.1111/j.1463-1318.2004.00599.x; Watson A, 2002, LANCET, V360, P546, DOI 10.1016/S0140-6736(02)09710-6; Wong T, 2005, BRIT J DERMATOL, V152, P1360, DOI 10.1111/j.1365-2133.2005.06600.x	12	5	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2007	335	7626					936	937		10.1136/bmj.39246.714896.BE	http://dx.doi.org/10.1136/bmj.39246.714896.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17974691	Green Published			2022-12-28	WOS:000250848300036
J	Khan, MM				Khan, Murad Moosa			Why I declined an invitation to a drug company seminar	BRITISH MEDICAL JOURNAL			English	Editorial Material									Aga Khan Univ, Karachi, Pakistan	Aga Khan University	Khan, MM (corresponding author), Aga Khan Univ, Karachi, Pakistan.	murad.khan@aku.edu	Khan, Murad/AAE-5134-2020						0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2007	335	7625					887	887		10.1136/bmj.39350.454039.68	http://dx.doi.org/10.1136/bmj.39350.454039.68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227BA	17962290	Green Published			2022-12-28	WOS:000250631000044
J	Sremcevic, M; Schmidt, J; Salo, H; Seiss, M; Spahn, F; Albers, N				Sremcevic, Miodrag; Schmidt, Juergen; Salo, Heikki; Seiss, Martin; Spahn, Frank; Albers, Nicole			A belt of moonlets in Saturn's A ring	NATURE			English	Article							PARTICLE-SIZE DISTRIBUTIONS; ASTEROID FAMILIES; SMALL SATELLITES; ENCKE GAP; CASSINI; OCCULTATION; SYSTEM; URANUS; WAKES	The origin and evolution of planetary rings is one of the prominent unsolved problems of planetary sciences, with direct implications for planet-forming processes in pre-planetary disks(1). The recent detection of four propeller-shaped features in Saturn's A ring(2) proved the presence of large boulder-sized moonlets in the rings(3-5). Their existence favours ring creation in a catastrophic disruption of an icy satellite rather than a co-genetic origin with Saturn, because bodies of this size are unlikely to have accreted inside the rings. Here we report the detection of eight new propeller features in an image sequence that covers the complete A ring, indicating embedded moonlets with radii between 30 m and 70 m. We show that the moonlets found are concentrated in a narrow 3,000-km-wide annulus 130,000 km from Saturn. Compared to the main population of ring particles(6-8) (radius s < 10 m), such embedded moonlets have a short lifetime(9) with respect to meteoroid impacts. Therefore, they are probably the remnants of a shattered ring-moon of Pan size or larger(2), locally contributing new material to the older ring. This supports the theory of catastrophic ring creation in a collisional cascade(9-12).	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; Univ Potsdam, Dept Phys, D-14469 Potsdam, Germany; Univ Oulu, Dept Phys Sci, Astron Div, Oulu 90014, Finland	University of Colorado System; University of Colorado Boulder; University of Potsdam; University of Oulu	Sremcevic, M (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, 392 UCB, Boulder, CO 80309 USA.	miodrag.sremcevic@lasp.colorado.edu	Spahn, Frank/AAP-6234-2020					Albers N, 2006, ICARUS, V181, P292, DOI 10.1016/j.icarus.2005.10.011; Burns JA, 2006, SCIENCE, V312, P1753, DOI 10.1126/science.1114856; COLWELL JE, 1992, J GEOPHYS RES-PLANET, V97, P10227, DOI 10.1029/92JE00788; Colwell JE, 2000, J GEOPHYS RES-PLANET, V105, P17589, DOI 10.1029/1999JE001209; Colwell JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025163; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; Daisaka H, 2001, ICARUS, V154, P296, DOI 10.1006/icar.2001.6716; DONES L, 1993, ICARUS, V105, P184, DOI 10.1006/icar.1993.1118; Durda DD, 2007, ICARUS, V186, P498, DOI 10.1016/j.icarus.2006.09.013; ESPOSITO LW, 1989, NATURE, V339, P605, DOI 10.1038/339605a0; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Hedman MM, 2007, ICARUS, V188, P89, DOI 10.1016/j.icarus.2006.11.017; Hedman MM, 2007, ASTRON J, V133, P2624, DOI 10.1086/516828; JULIAN WH, 1966, ASTROPHYS J, V146, P810, DOI 10.1086/148957; Karjalainen R, 2004, ICARUS, V172, P328, DOI 10.1016/j.icarus.2004.05.022; LEWIS MC, UNPUB ICARUS; MAROUF EA, 1983, ICARUS, V54, P189, DOI 10.1016/0019-1035(83)90192-6; Michel P, 2003, NATURE, V421, P608, DOI 10.1038/nature01364; Nicholson PD, 2000, ICARUS, V145, P474, DOI 10.1006/icar.2000.6356; Porco CC, 2005, SCIENCE, V307, P1226, DOI 10.1126/science.1108056; Salo H, 2004, ICARUS, V170, P70, DOI 10.1016/j.icarus.2004.03.012; Seiss M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022506; SHOWALTER MR, 1986, ICARUS, V66, P297, DOI 10.1016/0019-1035(86)90160-0; SHOWALTER MR, 1991, NATURE, V351, P709, DOI 10.1038/351709a0; SPAHN F, 1989, NATURE, V339, P607, DOI 10.1038/339607a0; Spahn F, 2000, ASTRON ASTROPHYS, V358, P368; Sremcevic M, 2002, MON NOT R ASTRON SOC, V337, P1139, DOI 10.1046/j.1365-8711.2002.06011.x; Tiscareno MS, 2006, NATURE, V440, P648, DOI 10.1038/nature04581; TISCARENO MS, UNPUB ASTRON J; Weidenschilling S.J., 1984, PLANETARY RINGS, P367; ZEBKER HA, 1985, ICARUS, V64, P531, DOI 10.1016/0019-1035(85)90074-0	31	64	64	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1019	1021		10.1038/nature06224	http://dx.doi.org/10.1038/nature06224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960236				2022-12-28	WOS:000250395000044
J	Vermorken, JB; Remenar, E; van Herpen, C; Gorlia, T; Mesia, R; Degardin, M; Stewart, JS; Jelic, S; Betka, J; Preiss, JH; van den Weyngaert, D; Awada, A; Cupissol, D; Kienzer, HR; Rey, A; Desaunois, I; Bernier, J; Lefebvre, JL				Vermorken, Jan B.; Remenar, Eva; van Herpen, Carla; Gorlia, Thierry; Mesia, Ricard; Degardin, Marian; Stewart, John S.; Jelic, Svetislav; Betka, Jan; Preiss, Joachim H.; van den Weyngaert, Danielle; Awada, Ahmad; Cupissol, Didier; Kienzer, Heinz R.; Rey, Augustin; Desaunois, Isabelle; Bernier, Jacques; Lefebvre, Jean-Louis		EORTC 24971 TAX 323 Stu	Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; ACCELERATED RADIOTHERAPY; INDUCTION CHEMOTHERAPY; SURVIVAL; THERAPY; CHEMORADIOTHERAPY; MANAGEMENT	Background Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF) plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of the head and neck. We compared TPF with PF as induction chemotherapy in patients with locoregionally advanced, unresectable disease. Methods We randomly assigned eligible patients between the ages of 18 and 70 years who had stage III or stage IV disease and no distant metastases to receive either TPF (docetaxel and cisplatin, day 1; fluorouracil by continuous infusion, days 1 to 5) or PF every 3 weeks for four cycles. Patients without progression of disease received radiotherapy within 4 to 7 weeks after completing chemotherapy. The primary end point was progression-free survival. Results A total of 358 patients underwent randomization, with 177 assigned to the TPF group and 181 to the PF group. At a median follow-up of 32.5 months, the median progression-free survival was 11.0 months in the TPF group and 8.2 months in the PF group (hazard ratio for disease progression or death in the TPF group, 0.72; P = 0.007). Treatment with TPF resulted in a reduction in the risk of death of 27% (P = 0.02), with a median overall survival of 18.8 months, as compared with 14.5 months in the PF group. There were more grade 3 or 4 events of leukopenia and neutropenia in the TPF group and more grade 3 or 4 events of thrombocytopenia, nausea, vomiting, stomatitis, and hearing loss in the PF group. The rates of death from toxic effects were 2.3% in the TPF group and 5.5% in the PF group. Conclusions As compared with the standard regimen of cisplatin and fluorouracil, induction chemotherapy with the addition of docetaxel significantly improved progression-free and overall survival in patients with unresectable squamous-cell carcinoma of the head and neck.	Univ Ziekenhuis Antwerpen, Dept Med Oncol, B-2650 Edegem, Belgium; Natl Inst Oncol, Budapest, Hungary; Univ Med Ctr Nijmegen, Nijmegen, Netherlands; EORTC Data Ctr, Brussels, Belgium; Inst Catala Oncol, Barcelona, Spain; Ctr Oscar Lambret, F-59020 Lille, France; Charing Cross Hosp, London, England; Inst Oncol & Radiol, Belgrade, Serbia; Univ Hosp Motol, Prague, Czech Republic; Caritasklin St Theresia, Saarbrucken, Germany; Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium; Inst Jules Bordet, B-1000 Brussels, Belgium; Ctr Reg Lutte Contre Canc Val Aurelle, Montpellier, France; Kaiser Franz Josef Spital, Vienna, Austria; Sanofi Aventis Global Oncol, Paris, France; Clin Genolier, Genolier, Switzerland	University of Antwerp; National Institute of Oncology Hungary; Radboud University Nijmegen; European Organisation for Research & Treatment of Cancer; Catalan Institute of Oncology; UNICANCER; Centre Oscar Lambret; Imperial College London; Institute for Oncology & Radiology of Serbia (IORS); Motol University Hospital; Institut Jules Bordet; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Kaiser-Franz-Josef Hospital; Sanofi-Aventis; Sanofi France; Clinique de Genolier	Vermorken, JB (corresponding author), Univ Ziekenhuis Antwerpen, Dept Med Oncol, Wilrijkstr 10, B-2650 Edegem, Belgium.	jan.b.vermorken@uza.be	van Herpen, Carla/N-3576-2014; Bernier, Jacques/AAE-7248-2020; AWADA, AHMAD/ABF-1137-2020; Betka, Jan/H-7497-2017	Bernier, Jacques/0000-0002-0138-9906; Betka, Jan/0000-0001-8772-317X				Adelstein DJ, 2006, J CLIN ONCOL, V24, P2624, DOI 10.1200/JCO.2005.05.3629; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Beauchesne PD, 2006, J CLIN ONCOL, V24, p75S; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Budach W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-28; DIMERY IW, 1993, JNCI-J NATL CANCER I, V85, P95, DOI 10.1093/jnci/85.2.95; Domenge C, 2000, BRIT J CANCER, V83, P1594, DOI 10.1054/bjoc.2000.1512; FREEDMAN LS, 1976, BIOMETRICS, V32, P691, DOI 10.2307/2529759; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; HITT R, 2006, J CLIN ONCOL, V24, P1015; HITT R, 2006, J CLIN ONCOL, V24, pS18; LEFEBVRE JL, 2005, ANN ONCOL S, V16, P7; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; PACCAGNELLA A, 2006, J CLIN ONCOL, V24, pS18; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Pignon JP, 2004, ANTI-CANCER DRUG, V15, P331, DOI 10.1097/00001813-200404000-00004; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Posner MR, 2005, ONCOLOGIST, V10, P11, DOI 10.1634/theoncologist.10-90003-11; ROONEY M, 1985, CANCER, V55, P1123, DOI 10.1002/1097-0142(19850301)55:5<1123::AID-CNCR2820550530>3.0.CO;2-8; Schrijvers D, 2004, ANN ONCOL, V15, P638, DOI 10.1093/annonc/mdh145; Schrijvers D, 2000, Oncologist, V5, P199, DOI 10.1634/theoncologist.5-3-199; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; SLUD EV, 1984, BIOMETRICS, V40, P587, DOI 10.2307/2530903; Zorat PL, 2004, JNCI-J NATL CANCER I, V96, P1714, DOI 10.1093/jnci/djh306	25	1180	1247	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1695	1704		10.1056/NEJMoa071028	http://dx.doi.org/10.1056/NEJMoa071028			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960012	Green Published			2022-12-28	WOS:000250355100005
J	Wang, HL; Xu, TD; Xu, J				Wang, Houli; Xu, Tengda; Xu, Jin			Factors contributing to high costs and inequality in China's health care system	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Emergency Med, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Wang, HL (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Emergency Med, Peking Union Med Coll, Beijing 100730, Peoples R China.	houli_wang@yahoo.com						*CHIN AC MED SCI P, 2006, NAT HLTH STAT YB 200, P19; *CHIN INS REG COMM, STAT INF 2007; Kang Yongjun, 2005, CHIN J HOSP ADM, V21, P220; LI HJ, 2006, MED IND INFORM, V3, P82; *NAT BUR STAT CHIN, 2006, CHIN SOC STAT YB 200, P214; National bureau of statistics of China, 2007, STAT COMM 2006 NAT E; National Center for Lesbian Rights, 2006, CHIN POP STAT YB 200, P3; National Legal Aid, 2006, COMMUNICATION, P5; SONG H, 2003, CHIN J HOSP ADM, V19, P517; *UN DEV PROGR, 2006, HUM DEV REP 2006 SCA, P283; *UN HLTH PARTN GRO, 2005, HLTH SIT ASS PEOPL R, P37; *US CENTR INT AG, 2007, WORLD FACTB; WANG XD, 2006, CHIN J HOSP ADM, V22, P20; WHO, 2000, WORLD HLTH REP 2000, P152; *WHO, NAT HLTH ACC; *WHO DEP CHIN STAT, 2006, CHIN HLTH POV EC DEV, P4; *WHO REG OFF W PAC, 2006, W PAC COUNTR HLTH IN, P47; Wu XL, 2001, CHIN HLTH EC, V20, P38; Yu D., 2005, CHINESE HLTH EC, V24, P5; YU DZ, 2006, CHIN J HOSP ADM, V22, P73	20	40	43	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1928	1930		10.1001/jama.298.16.1928	http://dx.doi.org/10.1001/jama.298.16.1928			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954544				2022-12-28	WOS:000250356700025
J	Danzig, J				Danzig, Jon			A patient's journey - Acromegaly	BRITISH MEDICAL JOURNAL			English	Editorial Material												jondanzig@aol.com							0	5	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2007	335	7624					824	825		10.1136/bmj.39253.602141.AD	http://dx.doi.org/10.1136/bmj.39253.602141.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AX	17947788	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000250630700041
J	Kang, BH; Plescia, J; Dohi, T; Rosa, J; Doxsey, SJ; Altieri, DC				Kang, Byoung Heon; Plescia, Janet; Dohi, Takehiko; Rosa, Jack; Doxsey, Stephen J.; Altieri, Dario C.			Regulation of tumor cell mitochondrial Homeostasis by an organelle-specific Hsp90 chaperone network	CELL			English	Article							PERMEABILITY TRANSITION; MOLECULAR CHAPERONE; CYTOCHROME-C; PROTEIN; ACTIVATION; AKT; HEAT-SHOCK-PROTEIN-90; APOPTOSIS; STRESS; KINASE	Molecular chaperones, especially members of the heat shock protein 90 ( Hsp90) family, are thought to promote tumor cell survival, but this function is not well understood. Here, we show that mitochondria of tumor cells, but not most normal tissues, contain Hsp90 and its related molecule, TRAP-1. These chaperones interact with Cyclophilin D, an immunophilin that induces mitochondrial cell death, and antagonize its function via protein folding/refolding mechanisms. Disabling this pathway using novel Hsp90 ATPase antagonists directed to mitochondria causes sudden collapse of mitochondrial function and selective tumor cell death. Therefore, Hsp90 directed chaperones are regulators of mitochondrial integrity, and their organelle-specific antagonists may provide a previously undescribed class of potent anticancer agents.	Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	dario.altieri@umassmed.edu	Kang, Byoung Heon/E-6165-2010	Kang, Byoung Heon/0000-0001-5902-0549	NATIONAL CANCER INSTITUTE [R01CA078810, R01CA090917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054131, R37HL054131] Funding Source: NIH RePORTER; NCI NIH HHS [CA78810, CA90917] Funding Source: Medline; NHLBI NIH HHS [HL54131] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Cechetto JD, 2000, EXP CELL RES, V260, P30, DOI 10.1006/excr.2000.4983; Chen CF, 1996, MOL CELL BIOL, V16, P4691; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Drysdale MJ, 2006, CURR OPIN DRUG DISC, V9, P483; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	39	341	355	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					257	270		10.1016/j.cell.2007.08.028	http://dx.doi.org/10.1016/j.cell.2007.08.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956728	Bronze			2022-12-28	WOS:000250507700017
J	King, DA; Thomas, SM				King, David A.; Thomas, Sandy M.			Big lessons for a healthy future	NATURE			English	Editorial Material																			0	12	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					791	792		10.1038/449791a	http://dx.doi.org/10.1038/449791a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221LY	17943108	Bronze			2022-12-28	WOS:000250230600022
J	Pallen, MJ; Wren, BW				Pallen, Mark J.; Wren, Brendan W.			Bacterial pathogenomics	NATURE			English	Article							ESCHERICHIA-COLI O157-H7; SINGLE-NUCLEOTIDE POLYMORPHISMS; COMPLETE GENOME SEQUENCE; III SECRETION SYSTEM; MICROBIAL PAN-GENOME; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN SECRETION; YERSINIA-PESTIS; CAMPYLOBACTER-JEJUNI; GENE-CLUSTER	Genomes from all of the crucial bacterial pathogens of humans, plants and animals have now been sequenced, as have genomes from many of the important commensal, symbiotic and environmental microorganisms. Analysis of these sequences has revealed the forces that shape pathogen evolution and has brought to light unexpected aspects of pathogen biology. The finding that horizontal gene transfer and genome decay have key roles in the evolution of bacterial pathogens was particularly surprising. It has also become evident that even the definitions for 'pathogen' and 'virulence factor' need to be re-evaluated.	Univ Birmingham, Ctr Syst Biol, Birmingham B15 2TT, W Midlands, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	University of Birmingham; University of London; London School of Hygiene & Tropical Medicine	Pallen, MJ (corresponding author), Univ Birmingham, Ctr Syst Biol, Birmingham B15 2TT, W Midlands, England.	m.pallen@bham.ac.uk; brendan.wren@lshtm.ac.uk		Pallen, Mark/0000-0003-1807-3657; Wren, Brendan/0000-0002-6140-9489	Biotechnology and Biological Sciences Research Council [EGA16167] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Albert-Weissenberger C, 2007, CELL MOL LIFE SCI, V64, P432, DOI 10.1007/s00018-006-6391-1; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Desvaux M, 2005, BBA-MOL CELL RES, V1745, P223, DOI 10.1016/j.bbamcr.2005.04.006; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dorer MS, 2006, MICROBES INFECT, V8, P1637, DOI 10.1016/j.micinf.2005.11.020; Dorrell N, 2005, CURR OPIN MICROBIOL, V8, P620, DOI 10.1016/j.mib.2005.08.012; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Ffrench-Constant RH, 2000, APPL ENVIRON MICROB, V66, P3310, DOI 10.1128/AEM.66.8.3310-3329.2000; Field D, 2006, CURR OPIN MICROBIOL, V9, P499, DOI 10.1016/j.mib.2006.08.008; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fraser-Liggett CM, 2005, GENOME RES, V15, P1603, DOI 10.1101/gr.3724205; FREEMAN VJ, 1951, J BACTERIOL, V61, P675, DOI 10.1128/JB.61.6.675-688.1951; Fux CA, 2005, TRENDS MICROBIOL, V13, P58, DOI 10.1016/j.tim.2004.11.001; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gutacker MM, 2002, GENETICS, V162, P1533; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HAYASHI T, 2001, DNA RES, V8, P96; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hobman JL, 2007, MOL MICROBIOL, V64, P881, DOI 10.1111/j.1365-2958.2007.05710.x; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; Lawrence Jeffrey G., 2005, V12, P255, DOI 10.1159/000081699; Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Meyers LA, 2003, P ROY SOC B-BIOL SCI, V270, P1667, DOI 10.1098/rspb.2003.2416; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Mora M, 2006, CURR OPIN MICROBIOL, V9, P532, DOI 10.1016/j.mib.2006.07.003; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parkhill J, 2002, TRENDS MICROBIOL, V10, P219, DOI 10.1016/S0966-842X(02)02353-3; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Ren CP, 2004, J BACTERIOL, V186, P3547, DOI 10.1128/JB.186.11.3547-3560.2004; Ren CP, 2005, J BACTERIOL, V187, P1430, DOI 10.1128/JB.187.4.1430-1440.2005; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Renesto P, 2003, LANCET, V362, P447, DOI 10.1016/S0140-6736(03)14071-8; Romero CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-228; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Skorpil P, 2005, MOL MICROBIOL, V57, P1304, DOI 10.1111/j.1365-2958.2005.04768.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchman JW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000220; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; van der Woude MW, 2006, FEMS MICROBIOL LETT, V254, P190, DOI 10.1111/j.1574-6968.2005.00038.x; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wernegreen JJ, 2005, CURR OPIN GENET DEV, V15, P572, DOI 10.1016/j.gde.2005.09.013; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Zhang LH, 2004, INFECT IMMUN, V72, P7282, DOI 10.1128/IAI.72.12.7282-7293.2004; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	99	278	293	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					835	842		10.1038/nature06248	http://dx.doi.org/10.1038/nature06248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943120				2022-12-28	WOS:000250230600033
J	Pastorello, A; Della Valle, M; Smartt, SJ; Zampieri, L; Benetti, S; Cappellaro, E; Mazzali, PA; Patat, F; Spiro, S; Turatto, M; Valenti, S				Pastorello, A.; Della Valle, M.; Smartt, S. J.; Zampieri, L.; Benetti, S.; Cappellaro, E.; Mazzali, P. A.; Patat, F.; Spiro, S.; Turatto, M.; Valenti, S.			A very faint core-collapse supernova in M85	NATURE			English	Letter							II-P SUPERNOVAE; LOW-MASS; GALAXIES; PROGENITORS; EXPLOSIONS; EVOLUTION; 2005CS		Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; Int Ctr Relativist Astrophys Network, I-65122 Pescara, Italy; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; Osserv Astron Padova, INAF, I-35122 Padua, Italy; Max Planck Inst Astrophys, D-85741 Garching, Germany; Osserv Astron Trieste, INAF, I-34131 Trieste, Italy; European So Observ, D-85748 Garching, Germany; Univ Ferrara, Dipartimento Fis, I-44100 Ferrara, Italy	Queens University Belfast; Istituto Nazionale Astrofisica (INAF); University of California System; University of California Santa Barbara; Istituto Nazionale Astrofisica (INAF); University of Padua; Max Planck Society; Istituto Nazionale Astrofisica (INAF); European Southern Observatory; University of Ferrara	Pastorello, A (corresponding author), Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland.	a.pastorello@qub.ac.uk	Della Valle, Massimo/AAE-8884-2021; Valenti, Stefano/M-5924-2017	Della Valle, Massimo/0000-0003-3142-5020; Valenti, Stefano/0000-0001-8818-0795; Turatto, Massimo/0000-0002-9719-3157; Patat, Ferdinando/0000-0002-0537-3573; Zampieri, Luca/0000-0002-6516-1329; Benetti, Stefano/0000-0002-3256-0016; Mazzali, Paolo/0000-0001-6876-8284; Cappellaro, Enrico/0000-0001-5008-8619				Chugai NN, 2000, ASTRON ASTROPHYS, V354, P557; Della Valle M, 2005, ASTROPHYS J, V629, P750, DOI 10.1086/430433; Fisher D, 1997, ASTRON J, V113, P950, DOI 10.1086/118312; Kitaura FS, 2006, ASTRON ASTROPHYS, V450, P345, DOI 10.1051/0004-6361:20054703; Kulkarni SR, 2007, NATURE, V447, P458, DOI 10.1038/nature05822; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Li WD, 2006, ASTROPHYS J, V641, P1060, DOI 10.1086/499916; MAUND JR, 2005, MNRAS, V364, P33; Pastorello A, 2006, MON NOT R ASTRON SOC, V370, P1752, DOI 10.1111/j.1365-2966.2006.10587.x; Pastorello A, 2004, MON NOT R ASTRON SOC, V347, P74, DOI 10.1111/j.1365-2966.2004.07173.x; Rau A, 2007, ASTROPHYS J, V659, P1536, DOI 10.1086/512672; Tonry JL, 2001, ASTROPHYS J, V546, P681, DOI 10.1086/318301; Zampieri L, 2003, MON NOT R ASTRON SOC, V338, P711, DOI 10.1046/j.1365-8711.2003.06082.x; PADOVA ASIAGO SUPERN; [No title captured]	15	63	66	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					E1	E2		10.1038/nature06282	http://dx.doi.org/10.1038/nature06282			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943088	Green Submitted			2022-12-28	WOS:000250230600034
J	Baron, RJ				Baron, Richard J.			Quality improvement with an electronic health record: Achievable, but not automatic	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE	With 68% of all physician-patient encounters occurring in physician groups of 4 or fewer, improvements in small practices will be necessary to close the well-documented national gaps in consistent delivery of high-quality care. Many believe that adoption of electronic health records (EHRs) is the key to success, and that improvement will almost automatically follow. However, EHR adoption occurs today in an environment shaped by paper chart thinking, which may limit success. Having successfully implemented an EHR in their small practice, the author and his practice colleagues attempted to use it to support a simple project to improve their mammography rate, Although they achieved a real 10% improvement in their rate with only modest additional expense, their experience highlighted critical elements for success beyond the adoption of the EHR, including physician appreciation of structured data, the need for widespread adoption of standards, and a restructuring of the primary team with additional resources. An approach supporting EHR adoption along with these system changes could substantially affect public health.	Greenhouse Internists, Philadelphia, PA 19119 USA		Baron, RJ (corresponding author), Greenhouse Internists, 345 E Mt Airy Ave, Philadelphia, PA 19119 USA.	rbaron@greenhouseinternists.com	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				*ACS, 2007, ACS ADV MRIS SOM HIG; *AM AC FAM PHYS, 2007, JOINT PRINC PAT MED; *AMB CAR QUAL ALL, 2005, CLIN PERF MEAS AMB C; American College of Physicians, 2006, IMP COLL PRIM CAR ME; Baron RJ, 2005, ANN INTERN MED, V143, P222, DOI 10.7326/0003-4819-143-3-200508020-00008; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; *COMM E31 25 HEALT, 2007, E236906 ASTM; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Langley Gj., 1996, IMPROVEMENT GUIDE PR; Liberman L, 2004, NEW ENGL J MED, V351, P497, DOI 10.1056/NEJMe048117; PAN E, 2005, VALUE HEALTHCARE INF; Reuben DB, 2007, AM J MED, V120, P99, DOI 10.1016/j.amjmed.2006.10.019; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Woodwell DA, 2004, NATL AMBULATORY MED	14	67	67	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					549	552		10.7326/0003-4819-147-8-200710160-00007	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938393				2022-12-28	WOS:000250437100004
J	Sagdeev, R				Sagdeev, Roald			Sputnik and the Soviets	SCIENCE			English	Editorial Material									Univ Maryland, Dept Phys, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Sagdeev, R (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	rsagdeev@gmail.com						CHERTOK B, 1999, ROCKETS PEOPLE FILIP; Eisenhower Susan, 2004, PARTNERS SPACE US RU; SAGDEEV RZ, 1994, MAKING SOVIET SCI; VANALLEN JA, 1983, ORIGINS MAGNETOSPHER	4	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					51	52		10.1126/science.1149240	http://dx.doi.org/10.1126/science.1149240			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916714				2022-12-28	WOS:000249915400028
J	Basu, S; Andrews, JR; Poolman, EM; Gandhi, NR; Shah, NS; Moll, A; Moodley, P; Galvani, AP; Friedland, GH				Basu, Sanjay; Andrews, Jason R.; Poolman, Eric M.; Gandhi, Neel R.; Shah, N. Sarita; Moll, Anthony; Moodley, Prashini; Galvani, Alison P.; Friedland, Gerald H.			Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study	LANCET			English	Article							NEW-YORK-CITY; PERSONAL RESPIRATORY PROTECTION; MYCOBACTERIUM-TUBERCULOSIS; INFECTION-CONTROL; OUTBREAK; ASSAY; TB; VENTILATION; DISEASE; COMPLEX	Background Extensively drug-resistant (XDR) tuberculosis has spread among hospitalised patients in South Africa, but the epidemic-level effect of hospital-based infection control strategies remains unknown. We modelled the plausible effect of rapidly available infection control strategies on the overall course of the XDR tuberculosis epidemic in a rural area of South Africa. Methods We investigated the effect of administrative, environmental, and personal infection control measures on the epidemic trajectory of XDR tuberculosis in the rural community of Tugela Ferry. Assessments were done with a mathematical model incorporating over 2 years of longitudinal inpatient and community-based data. The model simulated inpatient airborne tuberculosis transmission, community tuberculosis transmission, and the effect of HIV and antiretroviral therapy. Findings If no new interventions are introduced, about 1300 cases of XDR tuberculosis are predicted to occur in the area of Tugela Ferry by the end of 2012, more than half of which are likely to be nosocomially transmitted. Mask use alone would avert fewer than 10% of cases in the overall epidemic, but could prevent a large proportion of cases of XDR tuberculosis in hospital staff. The combination of mask use with reduced hospitalisation time and a shift to outpatient therapy could prevent nearly a third of XDR tuberculosis cases. Supplementing this approach with improved ventilation, rapid drug resistance testing, HIV treatment, and tuberculosis isolation facilities could avert 48% of XDR tuberculosis cases (range 34-50%) by the end of 2012. However, involuntary detention could result in an unexpected rise in incidence due to restricted isolation capacity. Interpretation A synergistic combination of available nosocomial infection control strategies could prevent nearly half of XDR tuberculosis cases, even in a resource-limited setting. XDR tuberculosis transmission will probably continue in the community, indicating the need to develop and implement parallel community-based programmes.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, AIDS Program, New Haven, CT 06520 USA; Albany Med Coll, Div Gen Internal Med, Bronx, NY USA; Albany Med Coll, Div Infect Dis, Bronx, NY USA; Albany Med Coll, Div Epidemiol, Bronx, NY USA; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; Church Scotland Hosp & Philanjalo, Kwa Zulu, South Africa	Yale University; Yale University; Albany Medical College; Albany Medical College; Albany Medical College; University of Kwazulu Natal	Basu, S (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St, New Haven, CT 06520 USA.	sanjay.basu@yale.edu		Moodley, Pravi/0000-0002-9946-8783; Andrews, Jason/0000-0002-5967-251X	NIAID NIH HHS [R01 AI068932, R01 AI072706-01, R01 AI072706] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07205-32, T32 GM007205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072706, R01AI068932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS J, 2007, THESIS YALE U; [Anonymous], GUID PREV TUB HLTH C; [Anonymous], 2006, M WHO GLOB TASK FORC; Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015; Biscotto CR, 2005, INT J TUBERC LUNG D, V9, P545; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Cooksey RC, 1997, J CLIN MICROBIOL, V35, P1281, DOI 10.1128/JCM.35.5.1281-1283.1997; da Silva PA, 2006, CLIN MICROBIOL INFEC, V12, P293, DOI 10.1111/j.1469-0691.2005.01355.x; de Luna FFA, 2006, J CLIN MICROBIOL, V44, P3025, DOI 10.1128/JCM.00068-06; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; ESCOMBE AR, 2007, PLOS MED, V4, pE38; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Fennelly KP, 2005, INT J TUBERC LUNG D, V9, P476; Fennelly KP, 1997, CLIN CHEST MED, V18, P1, DOI 10.1016/S0272-5231(05)70352-X; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gammaitoni L, 1997, EMERG INFECT DIS, V3, P335, DOI 10.3201/eid0303.970310; GANDHI N, 2006, 16 INT C AIDS; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; Jenssen HK, 2005, INDIANA U MATH J, V54, P1, DOI 10.1512/iumj.2005.54.2685; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; MAKHAYE C, DEADLY TB UPWARD SPI; MOLL A, 2006, 16 INT AIDS C TOR; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302; Narvskaya O, 2002, EUR J CLIN MICROBIOL, V21, P596, DOI 10.1007/s10096-002-0775-4; Noakes CJ, 2006, EPIDEMIOL INFECT, V134, P1082, DOI 10.1017/S0950268806005875; RICH ML, 2003, PIH GUIDE MED MANAGE; RILEY RL, 1957, AM REV TUBERC PULM, V75, P420; *S AFR DEP HLTH, KZN OUTBR; *S AFR PRESS ASS, 2007, XDR TB FOUND ALL PRO; Sacks LV, 1999, CLIN INFECT DIS, V29, P96, DOI 10.1086/520189; SHAH NS, WORLDWIDE EMERGENCE; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; STROUD LA, 1995, INFECT CONT HOSP EP, V16, P141; VELLA V, 2007, KWAZULU NATAL EPIDEM, V15, P8; WEYER K, 2007, C RETR OPP INF LOS A; WEYER K, 2001, NATL SURVEY TUBERCUL; *WHO, 2007, GLOB MAP INF XDR TB; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; 2006, MMWR, V55, P11176	44	147	153	4	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1500	1507		10.1016/S0140-6736(07)61636-5	http://dx.doi.org/10.1016/S0140-6736(07)61636-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964351	Green Accepted			2022-12-28	WOS:000250487000027
J	Ioannidis, JPA; Patsopoulos, NA; Evangelou, E				Ioannidis, John P. A.; Patsopoulos, Nikolaos A.; Evangelou, Evangelos			Uncertainty in heterogeneity estimates in meta-analyses	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; KAWASAKI-DISEASE; CORTICOSTEROID-THERAPY; BLOCKERS		Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece	University of Ioannina	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece.	Ioannidis.jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011; Evangelou, Evangelos/C-3033-2013	Evangelou, Evangelos/0000-0002-5488-2999; Patsopoulos, Nikolaos/0000-0003-3757-8941				COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dennis CL, 2005, BMJ-BRIT MED J, V331, P15, DOI 10.1136/bmj.331.7507.15; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Inoue Y, 2006, J PEDIATR-US, V149, P336, DOI 10.1016/j.jpeds.2006.05.025; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2006, J CLIN EPIDEMIOL, V59, P1023, DOI 10.1016/j.jclinepi.2006.02.013; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; McDonald MA, 2005, BMJ-BRIT MED J, V331, P873, DOI 10.1136/bmj.38595.518542.3A; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; Newburger JW, 2007, NEW ENGL J MED, V356, P663, DOI 10.1056/NEJMoa061235; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Sutton AJAK, 2000, METHODS METAANALYSIS; Taylor SJC, 2005, BMJ-BRIT MED J, V331, P485, DOI 10.1136/bmj.38512.664167.8F; Webster AC, 2005, BMJ-BRIT MED J, V331, P810, DOI 10.1136/bmj.38569.471007.AE; Wooditch AC, 2005, PEDIATRICS, V116, P989, DOI 10.1542/peds.2005-0504	20	801	802	1	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2007	335	7626					914	916		10.1136/bmj.39343.408449.80	http://dx.doi.org/10.1136/bmj.39343.408449.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17974687	Green Published			2022-12-28	WOS:000250848300029
J	Bleich, SN; Cutler, DM; Adams, AS; Lozano, R; Murray, CJL				Bleich, Sara N.; Cutler, David M.; Adams, Alyce S.; Lozano, Rafael; Murray, Christopher J. L.			Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCOME INEQUALITY; UNITED-STATES; PRIMARY-CARE; BLOOD-PRESSURE; MORTALITY; STROKE	Objective To examine the independent and combined contributions of insurance status and supply of health professionals on coverage of antihypertensive treatment among adults in Mexico. Design Population based study. Setting Mexico. Participants 4032 hypertensive adults (2967 uninsured and 1065 insured): 1065 uninsured adults matched with 1065 adults insured through Seguro Popular, a programme to expand health insurance coverage to uninsured people in Mexico. Main outcome measures Coverage of anti hypertensive treatment and coverage of antihypertensive treatment with control of blood pressure. Results Rates of treatment for hypertension varied by insurance status and supply of health professionals. Hypertensive adults insured through Seguro Popular had a significantly higher probability of receiving anti hypertensive treatment (odds ratio 1.50, 95% confidence interval 1.27 to 1.78) and receiving antihypertensive treatment with control of blood pressure (1.35, 1.00 to 1.82). Greater supply of health professionals in areas with coverage through Seguro Popular was a significant predictor of antihypertensive treatment after adjusting for covariates (1.49, 1.00 to 2.20). Conclusions Expansion of healthcare coverage to uninsured people in Mexico was associated with greater use of antihypertensive treatment and blood pressure control, particularly in areas with a greater supply of health professionals.	Johns Hopkins Sch Publ Hlth, Baltimore, MD 21205 USA; Harvard Univ, Fac Arts & Sci, Cambridge, England; Harvard Univ, Sch Med, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Secretaria Salud Mexico, Mexico City, DF, Mexico; Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Bleich, SN (corresponding author), Johns Hopkins Sch Publ Hlth, Baltimore, MD 21205 USA.	sbleich@jhsph.edu	Lozano, Rafael/T-5352-2018	Lozano, Rafael/0000-0002-7356-8823; Cutler, David/0000-0002-4949-8917				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Arredondo A, 2006, AM J HYPERTENS, V19, P553, DOI 10.1016/j.amjhyper.2005.10.028; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; *COM NAC PROT SOC, 2006, CAT UN SERV ES; *ENSANUT, 2006, ENC NAC SAL NUTR 200; Ferrante JM, 2000, J AM BOARD FAM PRACT, V13, P408, DOI DOI 10.3122/15572625-13-6-408; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; *GAO, 2002, NURS HOM EXP QUAL; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; He J, 1999, AM HEART J, V138, pS211, DOI 10.1016/S0002-8703(99)70312-1; He J, 2002, ARCH INTERN MED, V162, P1051, DOI 10.1001/archinte.162.9.1051; Huttin C, 2000, CLIN DRUG INVEST, V20, P181, DOI 10.2165/00044011-200020030-00006; *I NAC SAL PUBL SE, 2006, ENC NAC SAL NUTR; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Laditka JN, 2005, HEALTH SERV RES, V40, P1148, DOI 10.1111/j.1475-6773.2005.00403.x; LEVINE DM, 1993, HYPERTENSION PRIMER, P291; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; *MIN HLTH, 2005, SUBS INF EQ REC HUM; MOY E, 1995, ARCH INTERN MED, V155, P1497, DOI 10.1001/archinte.155.14.1497; Neal B, 2000, LANCET, V356, P1955; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Newhouse JP, 1993, FREE ALL LESSONS RAN; Nigenda G, 1997, HEALTH POLICY, V39, P107, DOI 10.1016/S0168-8510(96)00864-0; Perrin J M, 1986, Health Aff (Millwood), V5, P63, DOI 10.1377/hlthaff.5.4.63; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; *SECR SAL, 2005, EL CONC FIN OP; *SECR SAL, 2004, 123 SECR SAL; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Shi LY, 2003, STROKE, V34, P1958, DOI 10.1161/01.STR.0000082380.80444.A9; Shi LY, 2001, AM J PUBLIC HEALTH, V91, P1246, DOI 10.2105/AJPH.91.8.1246; Tomz M., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i02, DOI 10.18637/JSS.V008.I02]; WHELTON PK, 1999, CLIN TRIALS CARDIOVA, P341; WHO, 2006, MORT COUNTR FACT SHE; *WORLD BANK, 2006, WORLD DEV IND 2006	38	64	65	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2007	335	7625					875	B878		10.1136/bmj.39350.617616.BE	http://dx.doi.org/10.1136/bmj.39350.617616.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227BA	17954519	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000250631000041
J	Choi, JK; Bowles, S				Choi, Jung-Kyoo; Bowles, Samuel			The coevolution of parochial altruism and war	SCIENCE			English	Article							VISCOUS POPULATIONS; GROUP SELECTION; EVOLUTION; COOPERATION; CHIMPANZEES; HUMANS	Altruism-benefiting fellow group members at a cost to oneself-and parochialism-hostility toward individuals not of one's own ethnic, racial, or other group-are common human behaviors. The intersection of the two-which we term "parochial altruism"-is puzzling from an evolutionary perspective because altruistic or parochial behavior reduces one's payoffs by comparison to what one would gain by eschewing these behaviors. But parochial altruism could have evolved if parochialism promoted intergroup hostilities and the combination of altruism and parochialism contributed to success in these conflicts. Our game-theoretic analysis and agent-based simulations show that under conditions likely to have been experienced by late Pleistocene and early Holocene humans, neither parochialism nor altruism would have been viable singly, but by promoting group conflict, they could have evolved jointly.	Kyungpook Natl Univ, Sch Econ & Trade, Taegu 702701, South Korea; Santa Fe Inst, Santa Fe, NM USA; Univ Siena, Dipartimento Econ Polit, I-53100 Siena, Italy	Kyungpook National University; The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	bowles@santafe.edu						AOKI K, 1982, EVOLUTION, V36, P832, DOI [10.2307/2407896, 10.1111/j.1558-5646.1982.tb05449.x]; Axtell RL, 2001, SOCIAL DYNAMICS, P191; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Darwin Charles, 1998, DESCENT MAN; EMBER CR, 1992, J CONFLICT RESOLUT, V36, P242, DOI 10.1177/0022002792036002002; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; Hammond RA, 2006, THEOR POPUL BIOL, V69, P333, DOI 10.1016/j.tpb.2005.12.002; Keeley LH., 1996, WAR CIVILIZATION; Kelly R.C., 2000, WARLESS SOC ORIGIN W; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; LeBlanc SA, 2003, CONSTANT BATTLES; Lourandos H., 1997, CONTINENT HUNTER GAT; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; PEARSON K, 1894, FORTNIGHTLY REV, V56, P1; ROGERS AR, 1990, AM NAT, V135, P398, DOI 10.1086/285053; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Wiessner P, 2002, EVOL HUM BEHAV, V23, P407, DOI 10.1016/S1090-5138(02)00096-X; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Yamagishi T, 1999, ADV GROUP, V16, P161	28	593	607	6	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					636	640		10.1126/science.1144237	http://dx.doi.org/10.1126/science.1144237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962562				2022-12-28	WOS:000250409200044
J	Lescano, AG; Salmon-Mulanovich, G; Pedroni, E; Blazes, DL				Lescano, Andres G.; Salmon-Mulanovich, Gabriela; Pedroni, Elena; Blazes, David L.			Epidemiology - Outbreak investigation and response training	SCIENCE			English	Editorial Material							NETWORK		USN, Med Res Ctr Detachment, Lima, Peru; Natl Minist Hlth, Dept Epidemiol, Buenos Aires, DF, Argentina		Lescano, AG (corresponding author), USN, Med Res Ctr Detachment, Lima, Peru.	willy.lescano@med.navy.mil	Lescano, Andres G/B-8479-2008; Lescano, Andres G./M-9849-2019; Salmon-Mulanovich, Gabriela/L-7697-2016	Lescano, Andres G/0000-0001-9779-633X; Lescano, Andres G./0000-0001-9779-633X; Salmon-Mulanovich, Gabriela/0000-0002-8918-7689	FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW007393] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		BETTS CD, 1998, EVALUATION FIELD EPI; *CDC, 2006, FETP DEV HDB; Chretien JP, 2006, NATURE, V440, P25, DOI 10.1038/440025a; DUROSOIR JL, 1995, PRESSE MED, V24, P51; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Fine PEM, 2007, LANCET, V369, P1321, DOI 10.1016/S0140-6736(07)60533-9; *LESCANO AG, 2003, 36 ANN M SOC EP RES; Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144; Sadana R, 2007, B WORLD HEALTH ORGAN, V85, P163, DOI 10.2471/BLT.06.039321; Thacker SB, 2001, INT J EPIDEMIOL, V30, P320, DOI 10.1093/ije/30.2.320; White ME, 2001, AM J EPIDEMIOL, V154, P993, DOI 10.1093/aje/154.11.993; WHO, 2007, WORLD HLTH REP	12	13	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					574	575		10.1126/science.1146837	http://dx.doi.org/10.1126/science.1146837			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962541				2022-12-28	WOS:000250409200023
J	Bakir, B; Terzibasioglu, E				Bakir, Baris; Terzibasioglu, Ege			Tracheal bronchus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Istanbul Univ, Istanbul Med Sch, TR-34390 Istanbul, Turkey	Istanbul University	Bakir, B (corresponding author), Istanbul Univ, Istanbul Med Sch, TR-34390 Istanbul, Turkey.	drbarisbakir@yahoo.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1744	1744		10.1056/NEJMicm064503	http://dx.doi.org/10.1056/NEJMicm064503			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960015				2022-12-28	WOS:000250355100009
J	Foote, R				Foote, Richard			Mathematics and complex systems	SCIENCE			English	Review								Contemporary researchers strive to understand complex physical phenomena that involve many constituents, may be influenced by numerous forces, and may exhibit unexpected or emergent behavior. Often such "complex systems" are macroscopic manifestations of other systems that exhibit their own complex behavior and obey more elemental laws. This article proposes that areas of mathematics, even ones based on simple axiomatic foundations, have discernible layers, entirely unexpected "macroscopic" outcomes, and both mathematical and physical ramifications profoundly beyond their historical beginnings. In a larger sense, the study of mathematics itself, which is increasingly surpassing the capacity of researchers to verify "by hand," may be the ultimate complex system.	Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA	University of Vermont	Foote, R (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.	foote@math.uvm.edu						ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Aschbacher M, 2005, PHILOS T R SOC A, V363, P2401, DOI 10.1098/rsta.2005.1655; BORCHERDS RE, 1992, INVENT MATH, V109, P405, DOI 10.1007/BF01232032; CONWAY J. H., 1979, B LOND MATH SOC, V11, P308, DOI [DOI 10.1112/BLMS/11.3.308, 10.1112/blms/11.3.308]; Dummit D.S., 2004, ABSTRACT ALGEBRA; FEIT W, 1963, PAC J MATH, V13, P775, DOI 10.2140/pjm.1963.13.775; GAGNNON T, 2006, B LOND MATH SOC, V38, P1; GORENSTEIN D, 1985, SCI AM, V253, P104, DOI 10.1038/scientificamerican1285-104; GORENSTEIN D, 1994, AMS MATH SURV MONOGR, V40, P1; IVANOV AA, 2000, C ALG COMB MONST VER; THOMPSON JG, 1968, B AM MATH SOC, V74, P383, DOI 10.1090/S0002-9904-1968-11953-6; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89; WIGNER EP, 1960, COMMUN PUR APPL MATH, V13, P1, DOI 10.1002/cpa.3160130102; Wolfram S., 2002, NEW KIND SCI	15	33	35	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					410	412		10.1126/science.1141754	http://dx.doi.org/10.1126/science.1141754			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947574				2022-12-28	WOS:000250230400035
J	Gesta, S; Tseng, YH; Kahn, CR				Gesta, Stephane; Tseng, Yu-Hua; Kahn, C. Ronald			Developmental origin of fat: Tracking obesity to its source	CELL			English	Review							BROWN ADIPOSE-TISSUE; GENE-EXPRESSION; BETA-CATENIN; PREADIPOCYTE DIFFERENTIATION; MITOCHONDRIAL BIOGENESIS; UNCOUPLING PROTEIN-1; COREPRESSOR RIP140; TRANSGENIC MICE; GROWTH-FACTOR; STEM-CELLS	The development of obesity not only depends on the balance between food intake and caloric utilization but also on the balance between white adipose tissue, which is the primary site of energy storage, and brown adipose tissue, which is specialized for energy expenditure. In addition, some sites of white fat storage in the body are more closely linked than others to the metabolic complications of obesity, such as diabetes. In this Review, we consider how the developmental origins of fat contribute to its physiological, cellular, and molecular heterogeneity and explore how these factors may play a role in the growing epidemic of obesity.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Tseng, Yu-Hua/AAE-6471-2021; Kahn, Ronald/AAY-2435-2021	Tseng, Yu-Hua/0000-0003-2053-9559; Kahn, Ronald/0000-0002-7583-9228				Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Aubin J, 2002, DEVELOPMENT, V129, P4075; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Bluher M, 2004, J BIOL CHEM, V279, P31891, DOI 10.1074/jbc.M404569200; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Boeuf S, 2001, PHYSIOL GENOMICS, V7, P15, DOI 10.1152/physiolgenomics.00048.2001; BRONNERFRASER M, 1994, FASEB J, V8, P699, DOI 10.1096/fasebj.8.10.8050668; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cantile M, 2003, J CELL PHYSIOL, V194, P225, DOI 10.1002/jcp.10210; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; COUSIN B, 1993, ENDOCRINOLOGY, V133, P2255, DOI 10.1210/en.133.5.2255; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Diehl AM, 1999, J BIOENERG BIOMEMBR, V31, P493, DOI 10.1023/A:1005452624640; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; ENGLISH JT, 1973, RADIOLOGY, V107, P279, DOI 10.1148/107.2.279; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fortier M, 2005, J LIPID RES, V46, P1860, DOI 10.1194/jlr.M500081-JLR200; Fraser John K, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS33, DOI 10.1038/ncpcardio0444; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; HAUNER H, 1991, INT J OBESITY, V15, P121; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hu ED, 1998, BIOCHEM BIOPH RES CO, V247, P287, DOI 10.1006/bbrc.1998.8784; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; IBRAHIMI A, 1993, BIOCHEM J, V289, P141, DOI 10.1042/bj2890141; Iser WB, 2005, MECH AGEING DEV, V126, P1090, DOI 10.1016/j.mad.2005.04.002; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; KLAUS S, 1995, J CELL SCI, V108, P3171; Konishi M, 2000, J BIOL CHEM, V275, P12119, DOI 10.1074/jbc.275.16.12119; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; KOPECKY J, 1990, J BIOL CHEM, V265, P22204; Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9; LAU DCW, 1987, J CLIN INVEST, V79, P632, DOI 10.1172/JCI112859; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; LONCAR D, 1992, INT J DEV BIOL, V36, P265; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Miller KK, 1998, CLIN INFECT DIS, V27, P68, DOI 10.1086/514638; Moulin K, 2001, BIOCHEM J, V356, P659, DOI 10.1042/bj3560659; Mozo J, 2005, BIOSCIENCE REP, V25, P227, DOI 10.1007/s10540-005-2887-4; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nelson T L, 2000, Twin Res, V3, P43; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Permana PA, 2004, AM J PHYSIOL-ENDOC M, V286, pE958, DOI 10.1152/ajpendo.00544.2003; POND CM, 1992, P NUTR SOC, V51, P367, DOI 10.1079/PNS19920050; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tseng YH, 2007, CELL SCI REV, V3, P342; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; VANVLEET ES, 1984, COMP BIOCHEM PHYS B, V79, P549, DOI 10.1016/0305-0491(84)90364-X; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Vidal H, 2001, ANN MED, V33, P547, DOI 10.3109/07853890108995965; Villena JA, 2002, HORM METAB RES, V34, P664, DOI 10.1055/s-2002-38244; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu YJ, 2000, POULTRY SCI, V79, P1640, DOI 10.1093/ps/79.11.1640; Yamasaki M, 1999, BIOCHEM BIOPH RES CO, V258, P109, DOI 10.1006/bbrc.1999.0594; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	104	1011	1066	3	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					242	256		10.1016/j.cell.2007.10.004	http://dx.doi.org/10.1016/j.cell.2007.10.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956727	Bronze			2022-12-28	WOS:000250507700016
J	Kwok, T; Zabler, D; Urman, S; Rohde, M; Hartig, R; Wessler, S; Misselwitz, R; Berger, J; Sewald, N; Konig, W; Backert, S				Kwok, Terry; Zabler, Dana; Urman, Sylwia; Rohde, Manfred; Hartig, Roland; Wessler, Silja; Misselwitz, Rolf; Berger, Juergen; Sewald, Norbert; Koenig, Wolfgang; Backert, Steffen			Helicobacter exploits integrin for type IV secretion and kinase activation	NATURE			English	Article							GASTRIC EPITHELIAL-CELLS; PYLORI CAGA PROTEIN; BACTERIAL PATHOGENESIS; FIBRONECTIN; RECEPTORS; BINDING; ADHESIN; SYSTEMS; SRC	Integrins are important mammalian receptors involved in normal cellular functions as well as pathogenesis of chronic inflammation and cancer. We propose that integrins are exploited by the gastric pathogen and type-1 carcinogen Helicobacter pylori for injection of the bacterial oncoprotein cytotoxin-associated gene A (CagA) into gastric epithelial cells. Virulent H. pylori express a type-IV secretion pilus that injects CagA into the host cell; CagA then becomes tyrosine-phosphorylated by Src family kinases. However, the identity of the host cell receptor involved in this process has remained unknown. Here we show that the H. pylori CagL protein is a specialized adhesin that is targeted to the pilus surface, where it binds to and activates integrin alpha(5)beta(1) receptor on gastric epithelial cells through an arginine-glycine-aspartate motif. This interaction triggers CagA delivery into target cells as well as activation of focal adhesion kinase and Src. Our findings provide insights into the role of integrins in H.-pylori-induced pathogenesis. CagL may be exploited as a new molecular tool for our further understanding of integrin signalling.	Otto Von Guericke Univ, Dept Med Microbiol, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Dept Immunol, D-39120 Magdeburg, Germany; Univ Bielefeld, Dept Chem Organ & Bioorgan Chem, D-33615 Bielefeld, Germany; Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; Paul Ehrlich Inst, D-63225 Langen, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Otto von Guericke University; Otto von Guericke University; University of Bielefeld; Helmholtz Association; Helmholtz-Center for Infection Research; Paul Ehrlich Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Backert, S (corresponding author), Otto Von Guericke Univ, Dept Med Microbiol, Leipziger Str 44, D-39120 Magdeburg, Germany.	Steffen.Backert@med.ovgu.de	Wessler, Silja/C-6309-2015; Sewald, Norbert/A-2541-2012	Wessler, Silja/0000-0001-7011-6162; Sewald, Norbert/0000-0002-0309-2655; Kwok, Terry/0000-0002-5905-3233; Hartig, Roland/0000-0002-3706-7458				ARNIEVA MR, 2004, SCIENCE, V300, P1430; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; Eble J.A., 1997, INTEGRIN LIGAND INTE; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Zimmermann D, 2005, CHEMBIOCHEM, V6, P272, DOI 10.1002/cbic.200400279	24	454	473	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					862	U4		10.1038/nature06187	http://dx.doi.org/10.1038/nature06187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943123				2022-12-28	WOS:000250230600037
J	Majumder, A; Ghatak, A; Sharma, A				Majumder, Abhijit; Ghatak, Animangsu; Sharma, Ashutosh			Microfluidic adhesion induced by subsurface microstructures	SCIENCE			English	Article							GECKO FOOT-HAIR; CONTACT; DESIGN; PADS; FEET; FILM	Natural adhesives in the feet of different arthropods and vertebrates show strong adhesion as well as excellent reusability. Whereas the hierarchical structures on the surface are known to have a substantial effect on adhesion, the role of subsurface structures such as the network of microchannels has not been studied. Inspired by these bioadhesives, we generated elastomeric layers with embedded air- or oil-filled microchannels. These adhesives showed remarkable enhancement of adhesion (similar to 30 times), which results from the crack-arresting properties of the microchannels, together with the surface stresses caused by the capillary force. The importance of the thickness of the adhesive layer, channel diameter, interchannel spacing, and vertical position within the adhesive has been examined for developing an optimal design of this microfluidic adhesive.	Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India; Indian Inst Technol, Dept Sci, Kanpur 208016, Uttar Pradesh, India; Indian Inst Technol, Technol Unit Nanosci, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Ghatak, A (corresponding author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.	aghatak@iitk.ac.in	Sharma, Ashutosh/D-1034-2011	Sharma, Ashutosh/0000-0002-2653-0806				Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Chung JY, 2005, J R SOC INTERFACE, V2, P55, DOI 10.1098/rsif.2004.0020; Creton C, 2007, MRS BULL, V32, P466, DOI 10.1557/mrs2007.79; Crosby AJ, 2005, LANGMUIR, V21, P11738, DOI 10.1021/la051721k; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Ghatak A, 2005, LANGMUIR, V21, P1277, DOI 10.1021/la0484826; Ghatak A, 2004, P ROY SOC A-MATH PHY, V460, P2725, DOI 10.1098/rspa.2004.1313; Glassmaker NJ, 2005, ACTA BIOMATER, V1, P367, DOI 10.1016/j.actbio.2005.02.005; Glassmaker NJ, 2004, J R SOC INTERFACE, V1, P23, DOI 10.1098/rsif.2004.0004; Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135; Gorb SN, 2006, NATURE, V443, P407, DOI 10.1038/443407a; Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102; Jagota A, 2002, INTEGR COMP BIOL, V42, P1140, DOI 10.1093/icb/42.6.1140; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Scherge M., 2001, BIOL MICRO NANOTRIBO; Smith JM, 2006, J COMP PHYSIOL A, V192, P1193, DOI 10.1007/s00359-006-0151-4; Spolenak R, 2005, P ROY SOC A-MATH PHY, V461, P305, DOI 10.1098/rspa.2004.1326; Thomas T, 2006, J ADHESION, V82, P311, DOI 10.1080/00218460600646610; Verma MKS, 2006, LANGMUIR, V22, P10291, DOI 10.1021/la062516n	20	116	116	6	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					258	261		10.1126/science.1145839	http://dx.doi.org/10.1126/science.1145839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932295				2022-12-28	WOS:000250086100043
J	Yates, D; Aktar, R; Hill, J				Yates, David; Aktar, Rifna; Hill, Jennifer		Guideline Dev Grp	Guidelines - Assessment, investigation, and early management of head injury: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Royal Coll Surgeons England, Natl Collaborating Ctr Acute Care, London WC2A 3PE, England; Trauma Audit & Res Network, Manchester M6 8HD, Lancs, England	Royal College of Surgeons of England	Hill, J (corresponding author), Royal Coll Surgeons England, Natl Collaborating Ctr Acute Care, London WC2A 3PE, England.	NCC-AC@rcseng.ac.uk	Oliver, Kathryn/I-9905-2019	Oliver, Kathryn/0000-0002-4326-5258				Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; *NAT I HLTH CLIN E, 2007, 56 NICE	2	21	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2007	335	7622					719	720		10.1136/bmj.39331.702951.47	http://dx.doi.org/10.1136/bmj.39331.702951.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916856	Green Published			2022-12-28	WOS:000250156800035
J	Mishra, P; Socolich, M; Wall, MA; Graves, J; Wang, Z; Ranganathan, R				Mishra, Prashant; Socolich, Michael; Wall, Mark A.; Graves, Jennifer; Wang, ZiFen; Ranganathan, Rama			Dynamic scaffolding in a G protein-coupled signaling system	CELL			English	Article							PDZ-DOMAIN PROTEIN; DROSOPHILA PHOTORECEPTOR CELLS; IN-VIVO; RETINAL DEGENERATION; CA2+ CHANNEL; KINASE-C; COMPLEXES; TRP; PHOTOTRANSDUCTION; DEACTIVATION	The INAD scaffold organizes a multiprotein complex that is essential for proper visual signaling in Drosophila photoreceptor cells. Here we show that one of the INAD PDZ domains (PDZ5) exists in a redox-dependent equilibrium between two conformations-a reduced form that is similar to the structure of other PDZ domains, and an oxidized form in which the ligand-binding site is distorted through formation of a strong intramolecular disulfide bond. We demonstrate transient light-dependent formation of this disulfide bond in vivo and find that transgenic flies expressing a mutant INAD in which PDZ5 is locked in the reduced state display severe defects in termination of visual responses and visually mediated reflex behavior. These studies demonstrate a conformational switch mechanism for PDZ domain function and suggest that INAD behaves more like a dynamic machine rather than a passive scaffold, regulating signal transduction at the millisecond timescale through cycles of conformational change.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Green Ctr, Div Syst Biol, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75216 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75216 USA.	rama.ranganathan@utsouthwestern.edu		Socolich, Michael/0000-0002-0702-1061				Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CELNIKER SE, 2002, GENOME BIOL, V3; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FRANCESCHINI N, 1981, NATURE, V291, P241, DOI 10.1038/291241a0; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, J EXP BIOL, V204, P3403; HOLMQVIST MH, 1991, J COMP PHYSIOL A, V169, P451, DOI 10.1007/BF00197657; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Huber A, 2001, EUR J NEUROSCI, V14, P769, DOI 10.1046/j.0953-816x.2001.01704.x; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; HWANG C, 1995, METHOD ENZYMOL, V251, P212, DOI 10.1016/0076-6879(95)51123-7; Iakhine R, 2004, J NEUROSCI, V24, P2516, DOI 10.1523/JNEUROSCI.5426-03.2004; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Keese MA, 1999, FEBS LETT, V447, P135, DOI 10.1016/S0014-5793(99)00296-3; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Matsumoto H, 1999, Novartis Found Symp, V224, P225; Montell C, 2005, J PHYSIOL-LONDON, V567, P45, DOI 10.1113/jphysiol.2005.092551; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; OCarroll DC, 1996, NATURE, V382, P63, DOI 10.1038/382063a0; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; SAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SEIFERT P, 1990, J EVOLUTION BIOL, V3, P225, DOI 10.1046/j.1420-9101.1990.3030225.x; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WU CF, 1978, J GEN PHYSIOL, V71, P249, DOI 10.1085/jgp.71.3.249; Wyman R.J., 1984, P133	50	77	78	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					80	92		10.1016/j.cell.2007.07.037	http://dx.doi.org/10.1016/j.cell.2007.07.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923089	Bronze			2022-12-28	WOS:000249934700013
J	Kesavan, J; Borisovska, M; Bruns, D				Kesavan, Jaideep; Borisovska, Maria; Bruns, Dieter			v-SNARE actions during Ca2+-triggered exocytosis	CELL			English	Article							CORE VESICLE EXOCYTOSIS; TRANSMITTER RELEASE; CHROMAFFIN CELLS; MEMBRANE HEMIFUSION; CA2+ SENSOR; FUSION; SYNAPTOTAGMIN; COMPLEX; INTERMEDIATE; PROTEINS	Assembly of SNARE proteins between opposing membranes mediates fusion of synthetic liposomes, but it is unknown whether SNAREs act during exocytosis at the moment of Ca2+ increase, providing the molecular force for fusion of secretory vesicles. Here, we show that execution of pre- and postfusional steps during chromaffin granule exocytosis depends crucially on a short molecular distance between the complex forming SNARE motif and the transmembrane anchor of the vesicular SNARE protein synaptobrevin II. Extending the juxtamembrane region of synaptobrevin by insertion of flexible `` linkers'' reduces priming of granules, delays initiation of exocytosis upon stepwise elevation of intracellular calcium, attenuates fluctuations of early fusion pores, and slows rapid expansion of the pore in a linker-length dependent fashion. These observations provide evidence that v-SNARE proteins drive Ca2+- triggered membrane fusion at millisecond time scale and support a model wherein continuous molecular pulling by SNAREs guides the vesicle throughout the consecutive stages of exocytosis.	Univ Saarland, Inst Physiol, D-66424 Homburg, Germany	Saarland University	Bruns, D (corresponding author), Univ Saarland, Inst Physiol, Kirrberger St 8, D-66424 Homburg, Germany.	dieter.bruns@uniklinik-saarland.de		Kesavan, Jaideep/0000-0003-1933-1187; Borisovska, Maria/0000-0003-4087-0679				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bruns D, 2004, METHODS, V33, P312, DOI 10.1016/j.ymeth.2004.01.004; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colquhoun David, 1995, P483; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Han X, 2006, J CELL BIOL, V172, P281, DOI 10.1083/jcb.200510012; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HIGUCHI R, 1989, USING PCR ENG DNA; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong JL, 2007, DEV CELL, V12, P653, DOI 10.1016/j.devcel.2007.02.007; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zimmerberg J, 2006, NAT STRUCT MOL BIOL, V13, P301, DOI 10.1038/nsmb0406-301	52	93	93	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					351	363		10.1016/j.cell.2007.09.025	http://dx.doi.org/10.1016/j.cell.2007.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956735	Bronze, Green Submitted			2022-12-28	WOS:000250507700024
J	Brenner, SE				Brenner, Steven E.			Common sense for our genomes	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Brenner, SE (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.		Brenner, Steven E/A-8729-2008	Brenner, Steven E/0000-0001-7559-6185				Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Maurer SM, 2006, RES POLICY, V35, P839, DOI 10.1016/j.respol.2006.04.008	2	18	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2007	449	7164					783	784		10.1038/449783a	http://dx.doi.org/10.1038/449783a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943102	Bronze			2022-12-28	WOS:000250230600017
J	Dubi, Y; Meir, Y; Avishai, Y				Dubi, Yonatan; Meir, Yigal; Avishai, Yshai			Nature of the superconductor-insulator transition in disordered superconductors	NATURE			English	Article							2-DIMENSIONAL SUPERCONDUCTORS; CRITICAL FIELD; FILMS; FLUCTUATIONS; DENSITY; LIMIT	The interplay of superconductivity and disorder has intrigued scientists for several decades. Disorder is expected to enhance the electrical resistance of a system, whereas superconductivity is associated with a zero-resistance state. Although superconductivity has been predicted to persist even in the presence of disorder(1), experiments performed on thin films have demonstrated a transition from a superconducting to an insulating state with increasing disorder or magnetic field(2). The nature of this transition is still under debate, and the subject has become even more relevant with the realization that high-transition-temperature (high-T-c) superconductors are intrinsically disordered(3-5). Here we present numerical simulations of the superconductor-insulator transition in two-dimensional disordered superconductors, starting from a microscopic description that includes thermal phase fluctuations. We demonstrate explicitly that disorder leads to the formation of islands where the superconducting order is high. For weak disorder, or high electron density, increasing the magnetic field results in the eventual vanishing of the amplitude of the superconducting order parameter, thereby forming an insulating state. On the other hand, at lower electron densities or higher disorder, increasing the magnetic field suppresses the correlations between the phases of the superconducting order parameter in different islands, giving rise to a different type of superconductor-insulator transition. One of the important predictions of this work is that in the regime of high disorder, there are still superconducting islands in the sample, even on the insulating side of the transition. This result, which is consistent with experiments(6,7), explains the recently observed huge magneto-resistance peak in disordered thin films(8-10) and may be relevant to the observation of 'the pseudo-gap phenomenon' in underdoped high-T-c superconductors(11,12).	Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Ilse Katz Ctr Meso & Nano Scale Sci & Technol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Meir, Y (corresponding author), Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel.	ymeir@bgu.ac.il	MEIR, YIGAL/F-1888-2012; Dubi, Yonatan/G-5304-2013	Meir, Yigal/0000-0003-1606-8969; Dubi, Yonatan/0000-0002-8988-4935				Alvarez G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014514; ANDERSON PW, 1959, J PHYS CHEM SOLIDS, V11, P26, DOI 10.1016/0022-3697(59)90036-8; [Anonymous], 1966, SUPERCONDUCTIVITY ME; Aubin H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094521; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Baturina TI, 2004, JETP LETT+, V79, P337, DOI 10.1134/1.1765178; Crane R, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184530; Cren T, 2001, EUROPHYS LETT, V54, P84, DOI 10.1209/epl/i2001-00232-4; Das Gupta K, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104502; Dubi Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054509; Ephron D, 1996, PHYS REV LETT, V76, P1529, DOI 10.1103/PhysRevLett.76.1529; FISHER MPA, 1990, PHYS REV LETT, V65, P923, DOI 10.1103/PhysRevLett.65.923; FISHER MPA, 1990, PHYS REV LETT, V64, P587, DOI 10.1103/PhysRevLett.64.587; Galitski VM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.087001; GANTMAKHER VF, 1996, SOV PHYS JETP, V82, P951; Goldman AM, 1998, PHYS TODAY, V51, P39, DOI 10.1063/1.882069; HEBARD AF, 1990, PHYS REV LETT, V65, P927, DOI 10.1103/PhysRevLett.65.927; KOWAL D, 1994, SOLID STATE COMMUN, V90, P783, DOI 10.1016/0038-1098(94)90242-9; MA M, 1985, PHYS REV B, V32, P5658, DOI 10.1103/PhysRevB.32.5658; Mayr M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.217001; PAALANEN MA, 1992, PHYS REV LETT, V69, P1604, DOI 10.1103/PhysRevLett.69.1604; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Reich S, 2000, J SUPERCOND, V13, P855, DOI 10.1023/A:1007867710512; Sambandamurthy G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107005; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; YAZDANI A, 1995, PHYS REV LETT, V74, P3037, DOI 10.1103/PhysRevLett.74.3037	30	274	277	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					876	880		10.1038/nature06180	http://dx.doi.org/10.1038/nature06180			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17943125	Green Submitted			2022-12-28	WOS:000250230600040
J	Schiermeier, Q; Tollefson, J				Schiermeier, Quirin; Tollefson, Jeff			Climate change: a Nobel cause	NATURE			English	News Item																			0	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					766	767		10.1038/news.2007.164	http://dx.doi.org/10.1038/news.2007.164			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17968408				2022-12-28	WOS:000250230600008
J	Glynn, RJ; Ridker, PM; Goldhaber, SZ; Buring, JE				Glynn, Robert J.; Ridker, Paul M.; Goldhaber, Samuel Z.; Buring, Julie E.			Effect of low-dose aspirin on the occurrence of venous thromboembolism - A Randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; LOW-INTENSITY WARFARIN; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PULMONARY-EMBOLISM; PRIMARY PREVENTION; WOMENS HEALTH; LONG-TERM; D-DIMER; POPULATION	Background: Short-term aspirin therapy can lower the risk for venous thromboembolism (VTE) in high-risk patients, but whether the long-term use of low-dose aspirin reduces risk in healthy adults is uncertain. Objective: To test the efficacy of long-term aspirin therapy for preventing VTE. Design: Secondary analysis of a 10-year randomized, double-blind, placebo-controlled trial. Setting: U.S. female health care professionals in the Women's Health Study. Participants: 39 876 initially healthy women age 45 years or older (26 779 gave blood samples that were evaluated for factor V Leiden, G20210A prothrombin, and MTHFR 677C>T polymerphisms). Measurements: Documented VTE (deep venous thrombosis or pulmonary embolism) and unprovoked VTE (no recent surgery, trauma, or cancer diagnosis) were prospectively evaluated, secondary end points. Intervention: Aspirin, 100 mg, or placebo on alternate days. Intervention: Aspirin, 100 mg, or placebo on alternate days. Results: Venous thromboembolism occurred in 482 women during follow-up, an incidence higher than that of myocardial infarction and nearly equal to that of stroke. The incidence of VTE (per 1000 person-years) was 1.18 among women randomly assigned to active aspirin, compared with 1.25 among women randomly assigned to placebo (relative hazard, 0.95 (95% Cl, 0.79 to 1.13]; rate difference, -0.06 [Cl, -0.28 to 0.16]). For unprovoked VTE, the relative hazard was 0.90 (0, 0.70 to 1.16) and the rate difference was -0.06 (Cl, -0.21 to 0.10). Relative hazards associated with aspirin use in higher-risk subgroups were 0.83 (Cl, 0.50 to 1.39) among women with either factor V Leiden or the prothrombin mutation and 1.36 (Cl, 0.77 to 2.41) among those with a history of VTE. Limitation: Venous thromboembolism was a secondary end point in the Women's Health Study. Conclusion: These data suggest that long-term, low-dose aspirin treatment has little effect on the prevention of VTE in initially healthy women. Conclusion: These data suggest that long-term, low-dose aspirin treatment has little effect on the prevention of VTE in initially healthy women.	Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Glynn, RJ (corresponding author), Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	rglynn@rics.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA47988] Funding Source: Medline; NHLBI NIH HHS [HL7122, HL43851] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; *ASPIRE, CLIN TRIAL; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Hovens MMC, 2006, J THROMB HAEMOST, V4, P1470, DOI 10.1111/j.1538-7836.2006.01928.x; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Nicolaides AN, 2006, INT ANGIOL, V25, P101; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; O'Brien J, 2000, LANCET, V355, P1295; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ridker P M, 1996, J Cardiovasc Risk, V3, P209, DOI 10.1097/00043798-199604000-00013; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Shrivastava S, 2006, J THROMB HAEMOST, V4, P1208, DOI 10.1111/j.1538-7836.2006.01935.x; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Vaitkus PT, 2005, THROMB HAEMOSTASIS, V93, P76, DOI 10.1160/TH04-05-0323; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; *WARFASA, ASP PREV REC VEN THR; Zee RYL, 2004, HUM MOL GENET, V13, P389, DOI 10.1093/hmg/ddh039	32	57	57	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					525	533		10.7326/0003-4819-147-8-200710160-00004	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938390				2022-12-28	WOS:000250437100001
J	Cohen, S; Janicki-Deverts, D; Miller, GE				Cohen, Sheldon; Janicki-Deverts, Denise; Miller, Gregory E.			Psychological stress and disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-DISEASE; RISK-FACTORS; PATHOGENESIS; MORTALITY; PATHWAYS		Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Carnegie Mellon University; University of British Columbia	Cohen, S (corresponding author), Carnegie Mellon Univ, Dept Psychol, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	scohen@cmu.edu		Cohen, Sheldon/0000-0003-2248-4600				Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; BAUM A, 1993, PSYCHOSOM MED, V55, P274, DOI 10.1097/00006842-199305000-00005; Capitanio JP, 1998, P NATL ACAD SCI USA, V95, P4714, DOI 10.1073/pnas.95.8.4714; Cohen Sheldon, 1995, MEASURING STRESS GUI, P3; Cole SW, 2003, BIOL PSYCHIAT, V54, P1444, DOI 10.1016/S0006-3223(02)01888-7; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Duijts SFA, 2003, INT J CANCER, V107, P1023, DOI 10.1002/ijc.11504; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Heffner KL, 2003, BRAIN BEHAV IMMUN, V17, pS109; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Krantz DS, 2002, ANNU REV PSYCHOL, V53, P341, DOI 10.1146/annurev.psych.53.100901.135208; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Li J, 2002, CIRCULATION, V106, P1634, DOI 10.1161/01.CIR.0000031569.45667.58; Mazure CM, 1998, CLIN PSYCHOL-SCI PR, V5, P291, DOI 10.1111/j.1468-2850.1998.tb00151.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Pereira DB, 2003, J PSYCHOSOM RES, V54, P237, DOI 10.1016/S0022-3999(02)00494-4; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Turner-Cobb J.M., 2001, PSYCHONEUROIMMUNOLOG, V3rd, P565; Van Praag HM., 2004, STRESS BRAIN DEPRESS, DOI [10.1017/CBO9780511544422, DOI 10.1017/CBO9780511544422]; Vedhara K., 2005, HUMAN PSYCHONEUROIMM	24	1620	1679	8	252	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1685	1687		10.1001/jama.298.14.1685	http://dx.doi.org/10.1001/jama.298.14.1685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925521				2022-12-28	WOS:000250009400025
J	Herbert, H				Herbert, Helen			Should general practitioners resume 24 hour responsibility for their patients? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nedmunds@rcgp.org.uk							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2007	335	7622					697	697		10.1136/bmj.39350.516887.AD	http://dx.doi.org/10.1136/bmj.39350.516887.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916852	Green Published			2022-12-28	WOS:000250156800028
J	Karres, JS; Hilgers, V; Carrera, I; Treisman, J; Cohen, SM				Karres, Janina S.; Hilgers, Valerie; Carrera, Ines; Treisman, Jessica; Cohen, Stephen M.			The conserved microRNA MiR-8 tunes atrophin levels to prevent neurodegeneration in drosophila	CELL			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; PROTEINS; IMPACT; RNAS	microRNAs ( miRNAs) bind to specific messenger RNA targets to posttranscriptionally modulate their expression. Understanding the regulatory relationships between miRNAs and targets remains a major challenge. Many miRNAs reduce expression of their targets to inconsequential levels. It has also been proposed that miRNAs might adjust target expression to an optimal level. Here we analyze the consequences of mutating the conserved miRNA miR-8 in Drosophila. We identify atrophin as a direct target of miR-8. miR-8 mutant phenotypes are attributable to elevated atrophin activity, resulting in elevated apoptosis in the brain and in behavioral defects. Reduction of atrophin levels in miR-8-expressing cells to below the level generated by miR-8 regulation is detrimental, providing evidence for a "tuning target'' relationship between them. Drosophila atrophin is related to the atrophin family of mammalian transcriptional regulators, implicated in the neurodegenerative disorderDRPLA. The regulatory relationship between miR-8 and atrophin orthologs is conserved in mammals.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; NYU, Skirball Inst, New York, NY 10016 USA	European Molecular Biology Laboratory (EMBL); National University of Singapore; National University of Singapore; New York University	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhof Str 1, D-69117 Heidelberg, Germany.	cohen@tll.org.sg	Cohen, Stephen M/G-9930-2011; Hilgers, Valerie/J-2713-2015	Cohen, Stephen M/0000-0003-2858-9163; Hilgers, Valerie/0000-0002-4551-0931; Carrera, Ines/0000-0003-0903-4672; Treisman, Jessica/0000-0002-7453-107X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056131] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056131] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asai Y, 2006, P NATL ACAD SCI USA, V103, P9069, DOI 10.1073/pnas.0603453103; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Erkner A, 2002, DEVELOPMENT, V129, P1119; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fortier TA, 2003, DEV BIOL, V257, P153, DOI 10.1016/S0012-1606(03)00036-8; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Kanazawa I, 1999, PHILOS T ROY SOC B, V354, P1069, DOI 10.1098/rstb.1999.0460; Kariya S, 2006, NEUROSCI LETT, V392, P213, DOI 10.1016/j.neulet.2005.09.019; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; ROBERTSON HM, 1988, GENETICS, V118, P461; Ross CA, 1999, PHILOS T ROY SOC B, V354, P1005, DOI 10.1098/rstb.1999.0452; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	43	207	234	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					136	145		10.1016/j.cell.2007.09.020	http://dx.doi.org/10.1016/j.cell.2007.09.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923093	Bronze			2022-12-28	WOS:000249934700017
J	Ritchie, MG				Ritchie, Michael G.			Feathers, females, and fathers	SCIENCE			English	Editorial Material							SEXUAL SELECTION; MATE-CHOICE; SPECIATION; REINFORCEMENT; FLYCATCHERS		Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Ritchie, MG (corresponding author), Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland.	mgr@st-andrews.ac.uk	Ritchie, Michael G/F-7055-2013; Ritchie, Michael/B-7714-2008	Ritchie, Michael G/0000-0001-7913-8675; 				Albert AYK, 2005, EVOLUTION, V59, P927; Aoki K, 2001, EVOLUTION, V55, P25; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Hall DW, 2006, EVOLUTION, V60, P908; Irwin DE, 1999, HEREDITY, V82, P347, DOI 10.1038/sj.hdy.6885270; Ortiz-Barrientos D, 2005, SCIENCE, V310, P1467, DOI 10.1126/science.1121260; Owens IPF, 1999, TRENDS ECOL EVOL, V14, P131, DOI 10.1016/S0169-5347(98)01578-X; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Ritchie MG, 1998, ENDLESS FORMS, P291; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 1997, NATURE, V387, P589; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SERVEDIO MR, 2007, EVOL ECOL; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601; Verzijden MN, 2005, EVOLUTION, V59, P2097; Wallace A. R., 1889, DARWINISM	17	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					54	55		10.1126/science.1149597	http://dx.doi.org/10.1126/science.1149597			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916717				2022-12-28	WOS:000249915400031
J	Sundquist, WI; Hill, CP				Sundquist, Wesley I.; Hill, Christopher P.			How to assemble a capsid	CELL			English	Editorial Material							TERMINAL DOMAIN; PROTEIN; CORE	Retroviral capsids are composed of hexagonal arrays of the viral CA protein. In this issue of Cell, Ganser-Pornillos et al. ( 2007) provide a molecular model of the hexagonal HIV-1 CA lattice obtained from a new electron cryomicroscopic reconstruction. This study reveals the three principal stabilizing interfaces in the capsid lattice and explains how two different classes of inhibitors can block capsid assembly.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu			NIGMS NIH HHS [P50 GM082545] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; GANSERPORNILLOS BK, 2007, CELL; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; KELLY BN, 2007, MOL BIOL        0815, DOI DOI 10.1016/J.JMB.2007.07.070; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967	10	26	26	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					17	19		10.1016/j.cell.2007.09.028	http://dx.doi.org/10.1016/j.cell.2007.09.028			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923081	Bronze			2022-12-28	WOS:000249934700004
J	Zhang, XG; Siveter, DJ; Waloszek, D; Maas, A				Zhang, Xi-guang; Siveter, David J.; Waloszek, Dieter; Maas, Andreas			An epipodite-bearing crown-group crustacean from the Lower Cambrian	NATURE			English	Article							ORIGIN; EVOLUTION; POSITION	Crown-group crustaceans (Eucrustacea) are common in the fossil record of the past 500 million years back to the early Ordovician period, and very rare representatives are also known from the late Middle and Late Cambrian periods(1). Finds in Lower Cambrian rocks of the Phosphatocopina, the fossil sister group to eucrustaceans(2), imply that members of the eucrustacean stem lineage co-occurred, but it remained unclear whether crown-group members were also present at that time. 'Orsten'-type fossils are typically tiny embryos and cuticle-bearing animals, of which the cuticle is phosphatized and the material is three-dimensional and complete with soft parts. Such fossils are found predominantly in the Cambrian and Ordovician and provide detailed morphological and phylogenetic information on the early evolution of metazoans. Here we report an Orsten-type Konservat-Lagerstatte from the Lower Cambrian of China that contains at least three new arthropod species, of which we describe the most abundant form on the basis of exceptionally well preserved material of several growth stages. The limb morphology and other details of this new species are markedly similar to those of living cephalocarids, branchiopods and copepods and it is assigned to the Eucrustacea, thus representing the first undoubted crown-group crustacean from the early Cambrian. Its stratigraphical position provides substantial support to the proposition that the main cladogenic event that gave rise to the Arthropoda was before the Cambrian(3). Small leaf-shaped structures on the outer limb base of the new species provide evidence on the long-debated issue of the origin of epipodites(4,5): they occur in a set of three, derive from setae and are a ground-pattern feature of Eucrustacea.	Yunnan Univ, Key Lab Palaeobiol, Kunming 650091, Peoples R China; Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; Univ Ulm, Sect Biosystemat Documentat, D-98081 Ulm, Germany	Yunnan University; University of Leicester; Ulm University	Zhang, XG (corresponding author), Yunnan Univ, Key Lab Palaeobiol, Kunming 650091, Peoples R China.	xgzhang@ynu.edu.cn		Zhang, Xi-guang/0000-0003-4697-0531				Averof M, 1997, NATURE, V385, P627, DOI 10.1038/385627a0; Babbitt CC, 2005, CRUSTACEAN ISS, V16, P275, DOI 10.1201/9781420037548.ch11; Barlow D.I., 1980, P61; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; BURNETT BR, 1973, J ZOOL, V169, P381; Cannon H. G., 1927, Transactions of the Royal Society of Edinburgh, V55, P355; CANNON H. GRAHAM, 1931, DISCOVERY REPTS [GOVERNMENT DEPENDENCIES FALKLAND ISLS], V3, P199; Cannon HG, 1933, PHILOS T R SOC LON B, V222, P267; Carapelli A, 2005, CRUSTACEAN ISS, V16, P295, DOI 10.1201/9781420037548.ch12; Chen JY, 2001, P ROY SOC B-BIOL SCI, V268, P2181, DOI 10.1098/rspb.2001.1779; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Giribet G, 2005, CRUSTACEAN ISS, V16, P307; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; HAMNER WM, 1988, J CRUSTACEAN BIOL, V8, P149, DOI 10.2307/1548308; HESSLER RR, 1992, ACTA ZOOL-STOCKHOLM, V73, P315, DOI 10.1111/j.1463-6395.1992.tb01098.x; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2002, T ROY SOC EDIN-EARTH, V92, P347; LAUTERBACH KF, 1979, ZOOL ANZ, V202, P33; Luo H., 1982, SINIAN CAMBRIAN BOUN; Maas Andreas, 2003, Fossils and Strata, V49, P1; Olesen J, 2004, CRUSTACEAN ISS, V15, P217; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; Sanders H. L., 1963, Memoirs of the Connecticut Academy of Arts and Sciences, V15, P1; Schram FR, 2001, EVOL DEV, V3, P343, DOI 10.1046/j.1525-142X.2001.01038.x; Siveter DJ, 2003, SPEC PAP PALAEONTOL, P9; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Waloszek Dieter, 2003, P69; Wolff Carsten, 2006, Frontiers in Zoology, V3, P1; YAGER J, 1981, Journal of Crustacean Biology, V1, P328, DOI 10.2307/1547965	30	98	110	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					595	598		10.1038/nature06138	http://dx.doi.org/10.1038/nature06138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914395				2022-12-28	WOS:000249893500044
J	Rosenbaum, DM; Cherezov, V; Hanson, MA; Rasmussen, SGF; Thian, FS; Kobilka, TS; Choi, HJ; Yao, XJ; Weis, WI; Stevens, RC; Kobilka, BK				Rosenbaum, Daniel M.; Cherezov, Vadim; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Yao, Xiao-Jie; Weis, William I.; Stevens, Raymond C.; Kobilka, Brian K.			GPCR engineering yields high-resolution structural insights into beta(2)-adrenergic receptor function	SCIENCE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; PROTEIN-COUPLED-RECEPTORS; INDUCED CONFORMATIONAL-CHANGES; LIGAND-BINDING SPECIFICITY; RESONANCE ENERGY-TRANSFER; CONSERVED ASPARTIC-ACID; CONSTITUTIVE ACTIVATION; BETA-2-ADRENERGIC RECEPTORS; IDENTIFICATION; AGONISTS	The beta(2)-adrenergic receptor (beta(2)AR) is a well-studied prototype for heterotrimeric guanine nucleotide-binding protein ( G protein)-coupled receptors (GPCRs) that respond to diffusible hormones and neurotransmitters. To overcome the structural flexibility of the b2AR and to facilitate its crystallization, we engineered a b2AR fusion protein in which T4 lysozyme (T4L) replaces most of the third intracellular loop of the GPCR ("beta(2)AR-T4L") and showed that this protein retains near-native pharmacologic properties. Analysis of adrenergic receptor ligand-binding mutants within the context of the reported high-resolution structure of beta(2)AR-T4L provides insights into inverse-agonist binding and the structural changes required to accommodate catecholamine agonists. Amino acids known to regulate receptor function are linked through packing interactions and a network of hydrogen bonds, suggesting a conformational pathway from the ligand-binding pocket to regions that interact with G proteins.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Scripps Research Institute; Stanford University	Stevens, RC (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	stevens@scripps.edu; kobilka@stanford.edu	Cherezov, Vadim/L-9812-2013; Stevens, Raymond/K-7272-2015; Weis, William I/G-1437-2011	Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; Weis, William I/0000-0002-5583-6150; Choi, Hee-Jung/0000-0002-1167-1526; Rasmussen, Soren/0000-0002-1853-1841; Kobilka, Brian/0000-0001-5958-3990	NIGMS NIH HHS [R21 GM075811, R01 GM056169, P50 GM62411, P50 GM073197, F32 GM082028] Funding Source: Medline; NINDS NIH HHS [NS028471] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, F32GM082028, R01GM056169, P50GM062411, R21GM075811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; DeLano W.L, PYMOL MOL GRAPHICS S; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; KHORANA HG, 1992, J BIOL CHEM, V267, P1; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lohse MJ, 2007, ADV PROTEIN CHEM, V74, P167, DOI 10.1016/S0065-3233(07)74005-6; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; MORO O, 1994, J BIOL CHEM, V269, P6651; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Sugimoto Y, 2002, J PHARMACOL EXP THER, V301, P51, DOI 10.1124/jpet.301.1.51; SURYANARAYANA S, 1993, MOL PHARMACOL, V44, P111; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tao YX, 2000, MOL ENDOCRINOL, V14, P1272, DOI 10.1210/me.14.8.1272; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396; Zuscik MJ, 1998, J BIOL CHEM, V273, P3401, DOI 10.1074/jbc.273.6.3401	45	1124	1172	1	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1266	1273		10.1126/science.1150609	http://dx.doi.org/10.1126/science.1150609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	17962519				2022-12-28	WOS:000251086600034
J	Yin, H; Lin, HF				Yin, Hang; Lin, Haifan			An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster	NATURE			English	Article							HETEROCHROMATIN; RITS; SUPPRESSORS; PROTEIN	Heterochromatin, representing the silenced state of transcription, consists largely of transposon-enriched and highly repetitive sequences. Implicated in heterochromatin formation and transcriptional silencing in Drosophila are Piwi (P-element induced wimpy testis)(1,2) and repeat-associated small interfering RNAs (rasiRNAs)(3-5). Despite this, the role of Piwi in rasiRNA expression and heterochromatic silencing remains unknown. Here we report the identification and characterization of 12,903 Piwi-interacting RNAs (piRNAs) in Drosophila, showing that rasiRNAs represent a subset of piRNAs. We also show that Piwi promotes euchromatic histone modifications and piRNA transcription in subtelomeric heterochromatin (also known as telomere-associated sequence, or TAS), on the right arm of chromosome 3 (3R-TAS). Piwi binds to 3R-TAS and a piRNA uniquely mapped to 3R-TAS (3R-TAS1 piRNA). In piwi mutants, 3R-TAS loses euchromatic histone modifications yet accumulates heterochromatic histone modifications and Heterochromatin Protein 1a (HP1a). Furthermore, the expression of both the 3R-TAS1 piRNA and a white reporter gene in 3R-TAS becomes suppressed. A P element inserted 128 base pairs downstream of the 3R-TAS1 piRNA coding sequence restores the euchromatic histone modifications of 3R-TAS and the expression of 3R-TAS1 piRNA in piwi mutants, as well as partly rescuing their defects in germline stem-cell maintenance. These observations suggest that Piwi promotes the euchromatic character of 3R-TAS heterochromatin and its transcriptional activity, opposite to the known roles of Piwi and the RNA-mediated interference pathway in epigenetic silencing. This activating function is probably achieved through interaction with at least 3R-TAS1 piRNA and is essential for germline stem-cell maintenance.	Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06509 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06509 USA	Duke University; Yale University; Yale University	Lin, HF (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	haifan.lin@yale.edu	Yin, Hang/J-3613-2019	Yin, Hang/0000-0002-9621-0138				Ambros Victor, 2004, Methods Mol Biol, V265, P131; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Boivin A, 2003, GENETICS, V164, P195; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Mason JM, 2004, GENETICS, V168, P1353, DOI 10.1534/genetics.104.030676; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Smulders-Srinivasan TK, 2003, GENETICS, V165, P1971; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	27	318	340	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					304	U16		10.1038/nature06263	http://dx.doi.org/10.1038/nature06263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17952056				2022-12-28	WOS:000250746200062
J	Aponte, JJ; Aide, P; Renom, M; Mandomando, I; Bassat, Q; Sacarlal, J; Manaca, MN; Lafuente, S; Barbosa, A; Leach, A; Lievens, M; Vekemans, J; Sigaugue, B; Dubois, MC; Demoitie, MA; Sillman, M; Savarese, B; McNeil, JG; Macete, E; Ballou, WR; Cohen, J; Alonso, PL				Aponte, John J.; Aide, Pedro; Renom, Montse; Mandomando, Inacio; Bassat, Quique; Sacarlal, Jahit; Manaca, M. Nelia; Lafuente, Sarah; Barbosa, Arnoldo; Leach, Amanda; Lievens, Marc; Vekemans, Johan; Sigaugue, Betuel; Dubois, Marie-Claude; Demoitie, Marie-Ange; Sillman, Marla; Savarese, Barbara; McNeil, John G.; Macete, Eusebio; Ballou, W. Ripley; Cohen, Joe; Alonso, Pedro L.			Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial	LANCET			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM INFECTION; ROUTINE VACCINATIONS; CHILDREN; EFFICACY; DISEASE; TIME	Background Malaria remains a leading global health problem that requires the improved use of existing interventions and the accelerated development of new control methods. We aimed to assess the safety, immunogenicity, and initial efficacy of the malaria vaccine RTS,S/AS02D in infants in Africa. Methods We did a phase I/IIb double-blind randomised trial of 214 infants in Mozambique. Infants were randomly assigned to receive three doses either of RTS,S/AS02D or the hepatitis B vaccine Engerix-B at ages 10 weeks, 14 weeks, and 18 weeks of age, as well as routine immunisation vaccines given at 8, 12, and 16 weeks of age. The primary endpoint was safety of the RTS,S/AS02D during the first 6 months of the study, and analysis was by intention to treat. Secondary endpoints included immunogenicity and analysis of new Plasmodium falciparum infections during a 3-month follow up after the third dose. Time to new infections in the per-protocol cohort were compared between groups using Cox regression models. This study is registered with ClinicalTrials.gov, number NCT00197028. Findings There were 17 children (15.9%; 95% CI 9.5-24.2) with serious adverse events in each group. In the follow-up which ended on March 6, 2007, there were 31 serious adverse events in the RTS,S/AS02D group and 30 serious adverse events in the Engerix-B group, none of which were reported as related to vaccination. There were four deaths during this same follow-up period; all of them after the active detection of infection period had finished at study month 6 (two in RTSS/AS02D group and two in the Engerix-B group). RTS,S/AS02D induced high titres of anti-circumsporozoite antibodies. 68 first or only P falciparum infections were documented: 22 in the RTS,S/AS02D group and 46 in the control group. The adjusted vaccine efficacy was 65.9% (95% CI 42.6-79.8%, p<0.0001). Interpretation The RTS,S/AS02D malaria vaccine was safe, well tolerated, and immunogenic in young infants. These findings set the stage for expanded phase III efficacy studies to confirm vaccine efficacy against clinical malaria disease.	Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, CRESIB,Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain; Ctr Invest Saude Manhica, Manhica, Mozambique; NIH, Minist Hlth, Maputo, Mozambique; Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; Minist Hlth, Natl Directorate Hlth, Maputo, Mozambique; GlaxoSmithKline Biol, Rixensart, Belgium; PATH Malaria Vaccine Initiat, Bethesda, MD USA	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; Eduardo Mondlane University; GlaxoSmithKline	Alonso, PL (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, CRESIB,Inst Invest Biomed August Pi & Sunyer, C Rosello 132,4-2, E-08036 Barcelona, Spain.	palonso@clinic.ub.es	Mandomando, Inacio/ABD-8007-2020; Alonso, Pedro L/AAZ-3645-2020; Aide, Pedro/D-8771-2018; Leach, Amanda/AAS-1120-2020; Sacarlal, Jahit/R-3172-2016; Bassat, Quique/P-2341-2016	Mandomando, Inacio/0000-0002-1078-2187; Alonso, Pedro L/0000-0003-3292-3443; Leach, Amanda/0000-0002-7114-9967; Sacarlal, Jahit/0000-0003-1059-217X; Bassat, Quique/0000-0003-0875-7596; Barbosa, Arnoldo/0000-0001-8652-7396				Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Alonso PL, 2002, POPULATION HLTH DEV, P189; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Diallo DA, 2007, AM J TROP MED HYG, V76, P237, DOI 10.4269/ajtmh.2007.76.237; Hutton G, 2006, AM J TROP MED HYG, V75, P119, DOI 10.4269/ajtmh.2006.75.119; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6	14	201	210	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1543	1551		10.1016/S0140-6736(07)61542-6	http://dx.doi.org/10.1016/S0140-6736(07)61542-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17949807				2022-12-28	WOS:000250628800023
J	Lee, WS; Vishik, IM; Tanaka, K; Lu, DH; Sasagawa, T; Nagaosa, N; Devereaux, TP; Hussain, Z; Shen, ZX				Lee, W. S.; Vishik, I. M.; Tanaka, K.; Lu, D. H.; Sasagawa, T.; Nagaosa, N.; Devereaux, T. P.; Hussain, Z.; Shen, Z.-X.			Abrupt onset of a second energy gap at the superconducting transition of underdoped Bi2212	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; PSEUDOGAP; BI2SR2CACU2O8+DELTA; SPECTROSCOPY; DEPENDENCE; STATE	The superconducting gap-an energy scale tied to the superconducting phenomena-opens on the Fermi surface at the superconducting transition temperature (T-c) in conventional BCS superconductors. In underdoped high-T-c superconducting copper oxides, a pseudogap (whose relation to the superconducting gap remains a mystery) develops well above T-c (refs 1, 2). Whether the pseudogap is a distinct phenomenon or the incoherent continuation of the superconducting gap above T-c is one of the central questions in high-T-c research(3-8). Although some experimental evidence suggests that the two gaps are distinct(9-18), this issue is still under intense debate. A crucial piece of evidence to firmly establish this two-gap picture is still missing: a direct and unambiguous observation of a single-particle gap tied to the superconducting transition as function of temperature. Here we report the discovery of such an energy gap in underdoped Bi2Sr2CaCu2O8+delta in the momentum space region overlooked in previous measurements. Near the diagonal of Cu-O bond direction (nodal direction), we found a gap that opens at T-c and has a canonical (BCS-like) temperature dependence accompanied by the appearance of the so-called Bogoliubov quasi-particles, a classical signature of superconductivity. This is in sharp contrast to the pseudogap near the Cu-O bond direction (antinodal region) measured in earlier experiments(19-21).	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Univ Waterloo, Dept Phys, Waterloo, ON N2L 3G1, Canada	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tokyo; University of Waterloo	Shen, ZX (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	leews@stanford.edu; zxshen@stanford.edu	Nagaosa, Naoto/G-7057-2012; Vishik, Inna/AGU-2119-2022; Sasagawa, Takao/E-6666-2014	Sasagawa, Takao/0000-0003-0149-6696; TANAKA, Kiyohisa/0000-0003-2779-5870				ALEXANDROV AS, ARXIVCONDMAT0005315V; Benfatto L, 2000, EUR PHYS J B, V17, P95, DOI 10.1007/s100510070163; Boyer MC, 2007, NAT PHYS, V3, P802, DOI 10.1038/nphys725; CHARKRAVARTY S, 2001, PHYS REV B, V63; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Demsar J, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054519; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; Hosseini A, 1999, PHYS REV B, V60, P1349, DOI 10.1103/PhysRevB.60.1349; Kondo T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.267004; Krasnov VM, 2000, PHYS REV LETT, V84, P5860, DOI 10.1103/PhysRevLett.84.5860; KRISHANA K, 1995, PHYS REV LETT, V75, P3529, DOI 10.1103/PhysRevLett.75.3529; Le Tacon M, 2006, NAT PHYS, V2, P537, DOI 10.1038/nphys362; Li JX, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.184515; Loeser AG, 1997, PHYS REV B, V56, P14185, DOI 10.1103/PhysRevB.56.14185; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Millis AJ, 2006, SCIENCE, V314, P1888, DOI 10.1126/science.1137173; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Norman MR, 1998, PHYS REV B, V57, pR11093, DOI 10.1103/PhysRevB.57.R11093; Opel M, 2000, PHYS REV B, V61, P9752, DOI 10.1103/PhysRevB.61.9752; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Svistunov VM, 2000, JETP LETT+, V71, P289, DOI 10.1134/1.568336; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Valla T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184518; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; Yamasaki T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.140513	28	320	323	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					81	84		10.1038/nature06219	http://dx.doi.org/10.1038/nature06219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972881	Green Submitted			2022-12-28	WOS:000250585800040
J	Tritsch, NX; Yi, EY; Gale, JE; Glowatzki, E; Bergles, DE				Tritsch, Nicolas X.; Yi, Eunyoung; Gale, Jonathan E.; Glowatzki, Elisabeth; Bergles, Dwight E.			The origin of spontaneous activity in the developing auditory system	NATURE			English	Article							INNER HAIR-CELLS; MAMMALIAN COCHLEA; BRAIN-STEM; CALCIUM CURRENTS; HEARING; NERVE; RAT; EAR; ORGANIZATION; ASTROCYTES	Spontaneous activity in the developing auditory system is required for neuronal survival as well as the refinement and maintenance of tonotopic maps in the brain. However, the mechanisms responsible for initiating auditory nerve firing in the absence of sound have not been determined. Here we show that supporting cells in the developing rat cochlea spontaneously release ATP, which causes nearby inner hair cells to depolarize and release glutamate, triggering discrete bursts of action potentials in primary auditory neurons. This endogenous, ATP-mediated signalling synchronizes the output of neighbouring inner hair cells, which may help refine tonotopic maps in the brain. Spontaneous ATP-dependent signalling rapidly subsides after the onset of hearing, thereby preventing this experience-independent activity from interfering with accurate encoding of sound. These data indicate that supporting cells in the organ of Corti initiate electrical activity in auditory nerves before hearing, pointing to an essential role for peripheral, non-sensory cells in the development of central auditory pathways.	Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA; UCL, UCL Ear Inst, London WC1X 8EE, England; UCL, Dept Physiol, London WC1X 8EE, England	Johns Hopkins University; Johns Hopkins University; University of London; University College London; University of London; University College London	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Gale, Jonathan/AAG-6874-2019; Yi, Eunyoung/J-3173-2015; Tritsch, Nicolas/U-5266-2019; Bergles, Dwight/U-8343-2019	Yi, Eunyoung/0000-0002-9592-0736; Bergles, Dwight/0000-0002-7133-7378; Gale, Jonathan/0000-0003-4678-4878; Tritsch, Nicolas/0000-0003-3181-7681; Glowatzki, Elisabeth/0000-0003-3135-658X	NIDCD NIH HHS [R01 DC006476] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; CHARLES A, 2002, INTERCELLULAR CALCIU; Erazo-Fischer E, 2007, J NEUROSCI, V27, P1725, DOI 10.1523/JNEUROSCI.4116-06.2007; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Friauf E, 1999, CELL TISSUE RES, V297, P187, DOI 10.1007/s004410051346; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; Gabriele ML, 2000, J NEUROSCI, V20, P6939, DOI 10.1523/JNEUROSCI.20-18-06939.2000; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; GEALDOR M, 1993, HEARING RES, V69, P236, DOI 10.1016/0378-5955(93)90113-F; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; GUMMER AW, 1994, NEUROREPORT, V5, P685, DOI 10.1097/00001756-199402000-00006; HINOJOSA R, 1977, ACTA OTO-LARYNGOL, V84, P238, DOI 10.3109/00016487709123963; Housley GD, 2000, CLIN EXP PHARMACOL P, V27, P575, DOI 10.1046/j.1440-1681.2000.03314.x; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Jones TA, 2001, J NEUROSCI, V21, P8129, DOI 10.1523/JNEUROSCI.21-20-08129.2001; Jones TA, 2000, J NEUROPHYSIOL, V83, P1452, DOI 10.1152/jn.2000.83.3.1452; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOTAK VC, 1995, J NEUROPHYSIOL, V74, P1611, DOI 10.1152/jn.1995.74.4.1611; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lagostena L, 2001, CELL CALCIUM, V29, P191, DOI 10.1054/ceca.2000.0183; Leake PA, 2006, J COMP NEUROL, V497, P13, DOI 10.1002/cne.20968; Leao RN, 2006, J PHYSIOL-LONDON, V571, P563, DOI 10.1113/jphysiol.2005.098780; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; PUEL JL, 1987, DEV BRAIN RES, V37, P179, DOI 10.1016/0165-3806(87)90239-2; RETZIUS G, 1884, GEHORORGAN WIRBELTHI, V2; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; RUBSAMEN R, 1998, DEV AUDITORY SYSTEM, P193; Salih SG, 2002, NEUROPHARMACOLOGY, V42, P386, DOI 10.1016/S0028-3908(01)00184-8; Sugasawa M, 1996, J PHYSIOL-LONDON, V491, P707, DOI 10.1113/jphysiol.1996.sp021251; Wada T., 1923, American Anatomical Memoir, Vno. 10, P1; WALSH EJ, 1987, HEARING RES, V28, P97, DOI 10.1016/0378-5955(87)90157-2; Zhao HB, 2005, EUR J NEUROSCI, V21, P1859, DOI 10.1111/j.1460-9568.2005.04031.x	46	385	394	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					50	+		10.1038/nature06233	http://dx.doi.org/10.1038/nature06233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972875				2022-12-28	WOS:000250585800034
J	Roe, GH; Baker, MB				Roe, Gerard H.; Baker, Marcia B.			Why is climate sensitivity so unpredictable?	SCIENCE			English	Article							UNCERTAINTIES; FEEDBACKS; ENSEMBLE; EARTH	Uncertainties in projections of future climate change have not lessened substantially in past decades. Both models and observations yield broad probability distributions for long-term increases in global mean temperature expected from the doubling of atmospheric carbon dioxide, with small but finite probabilities of very large increases. We show that the shape of these probability distributions is an inevitable and general consequence of the nature of the climate system, and we derive a simple analytic form for the shape that fits recent published distributions very well. We show that the breadth of the distribution and, in particular, the probability of large temperature increases are relatively insensitive to decreases in uncertainties associated with the underlying climate processes.	Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Roe, GH (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	gerard@ess.washington.edu						Allen MR, 2006, AVOIDING DANGEROUS C, P281; Andronova NG, 2001, J GEOPHYS RES-ATMOS, V106, P22605, DOI 10.1029/2000JD000259; Bode H. W., 1945, NETWORK ANAL FEEDBAC; Bony S, 2006, J CLIMATE, V19, P3445, DOI 10.1175/JCLI3819.1; Colman R, 2003, CLIM DYNAM, V20, P865, DOI 10.1007/s00382-003-0310-z; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Graeme Jerald, 1997, OPTIMIZING OP AMP PE; Gregory JM, 2002, J CLIMATE, V15, P3117, DOI [10.1175/1520-0442(2002)015<3117:AOBEOT>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3117:AOBEOT&gt;2.0.CO;2]; Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Lindzen RS, 2001, B AM METEOROL SOC, V82, P417, DOI 10.1175/1520-0477(2001)082<0417:DTEHAA>2.3.CO;2; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; National Research Council, 2003, UND CLIM CHANG FEEDB; Piani C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024452; RAME DJ, 2005, GEOPHYS RES LETT, V32, DOI DOI 10.1029/2004GL022241; Royer DL, 2007, NATURE, V446, P530, DOI 10.1038/nature05699; Sanderson BM, 2008, CLIM DYNAM, V30, P175, DOI 10.1007/s00382-007-0280-7; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; Wallace J., 2006, ATMOSPHERIC SCI INTR, V2nd	23	374	385	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					629	632		10.1126/science.1144735	http://dx.doi.org/10.1126/science.1144735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962560				2022-12-28	WOS:000250409200042
J	Gazin, C; Wajapeyee, N; Gobeil, S; Virbasius, CM; Green, MR				Gazin, Claude; Wajapeyee, Narendra; Gobeil, Stephane; Virbasius, Ching-Man; Green, Michael R.			An elaborate pathway required for Ras-mediated epigenetic silencing	NATURE			English	Article							DNA HYPERMETHYLATION; ONCOGENIC RAS; METHYLATION; EXPRESSION; MECHANISM; APOPTOSIS; PROMOTER; GENES; FAS	The conversion of a normal cell to a cancer cell occurs in several steps and typically involves the activation of oncogenes and the inactivation of tumour suppressor and pro-apoptotic genes(1). In many instances, inactivation of genes critical for cancer development occurs by epigenetic silencing, often involving hypermethylation of CpG-rich promoter regions(2,3). It remains to be determined whether silencing occurs by random acquisition of epigenetic marks that confer a selective growth advantage or through a specific pathway initiated by an oncogene(4-6). Here we perform a genome-wide RNA interference (RNAi) screen in K-ras-transformed NIH 3T3 cells and identify 28 genes required for Ras-mediated epigenetic silencing of the pro-apoptotic Fas gene. At least nine of these RESEs (Ras epigenetic silencing effectors), including the DNA methyltransferase DNMT1, are directly associated with specific regions of the Fas promoter in K-ras-transformed NIH 3T3 cells but not in untransformed NIH3T3 cells. RNAi-mediated knockdown of any of the 28 RESEs results in failure to recruit DNMT1 to the Fas promoter, loss of Fas promoter hypermethylation, and derepression of Fas expression. Analysis of five other epigenetically repressed genes indicates that Ras directs the silencing of multiple unrelated genes through a largely common pathway. Last, we show that nine RESEs are required for anchorage-independent growth and tumorigenicity of K-ras-transformed NIH 3T3 cells; these nine genes have not previously been implicated in transformation by Ras. Our results show that Ras-mediated epigenetic silencing occurs through a specific, complex, pathway involving components that are required for maintenance of a fully transformed phenotype.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, 364 Plantat St, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Wajapeyee, Narendra/F-3011-2012		Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM033977-23, R01 GM033977] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Alfonso P, 2006, PROTEOMICS, V6, pS262, DOI 10.1002/pmic.200500350; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; Ehmann F, 2006, LEUKEMIA LYMPHOMA, V47, P1387, DOI 10.1080/10428190600565925; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Fenton RG, 1998, CANCER RES, V58, P3391; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jones PA, 1996, CANCER RES, V56, P2463; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Peli J, 1999, EMBO J, V18, P1824, DOI 10.1093/emboj/18.7.1824; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranganathan P, 2005, ANN NY ACAD SCI, V1059, P76, DOI 10.1196/annals.1339.046; Rubin JS, 2006, FRONT BIOSCI, V11, P2093, DOI 10.2741/1952; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	25	218	228	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1073	U10		10.1038/nature06251	http://dx.doi.org/10.1038/nature06251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960246	Green Accepted			2022-12-28	WOS:000250395000057
J	Nolte, I; Brockmann, MA				Noelte, Ingo; Brockmann, Marc A.			Magnetic resonance imaging of retinal detachment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Heidelberg, Med Fac Mannheim, D-68167 Mannheim, Germany	Ruprecht Karls University Heidelberg	Nolte, I (corresponding author), Univ Heidelberg, Med Fac Mannheim, D-68167 Mannheim, Germany.	ingo.noelte@rad.ma.uni-heidelberg.de	Nölte, Ingo/A-3301-2008						0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					E18	E18		10.1056/NEJMicm064937	http://dx.doi.org/10.1056/NEJMicm064937			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960008				2022-12-28	WOS:000250355100010
J	Klevens, RM; Morrison, MA; Nadle, J; Petit, S; Gershman, K; Ray, S; Harrison, LH; Lynfield, R; Dumyati, G; Townes, JM; Craig, AS; Zell, ER; Fosheim, GE; McDougal, LK; Carey, RB; Fridkin, SK				Klevens, R. Monina; Morrison, Melissa A.; Nadle, Joelle; Petit, Susan; Gershman, Ken; Ray, Susan; Harrison, Lee H.; Lynfield, Ruth; Dumyati, Ghinwa; Townes, John M.; Craig, Allen S.; Zell, Elizabeth R.; Fosheim, Gregory E.; McDougal, Linda K.; Carey, Roberta B.; Fridkin, Scott K.		ABCs MRSA Investigators	Invasive methicillin-resistant Staphylococcus aureus infections in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PANTON-VALENTINE LEUKOCIDIN; MULTIDRUG-RESISTANT; US HOSPITALS; RISK-FACTORS; PNEUMOCOCCAL DISEASE; SKIN INFECTIONS; EPIDEMIOLOGY; BACTEREMIA; PREVALENCE; EMERGENCE	Context As the epidemiology of infections with methicillin-resistant Staphylococcus aureus (MRSA) changes, accurate information on the scope and magnitude of MRSA infections in the US population is needed. Objectives To describe the incidence and distribution of invasive MRSA disease in 9 US communities and to estimate the burden of invasive MRSA infections in the United States in 2005. Design and Setting Active, population-based surveillance for invasive MRSA in 9 sites participating in the Active Bacterial Core surveillance (ABCs)/Emerging Infections Program Network from July 2004 through December 2005. Reports of MRSA were investigated and classified as either health care-associated (either hospital-onset or community-onset) or community-associated (patients without established health care risk factors for MRSA). Main Outcome Measures Incidence rates and estimated number of invasive MRSA infections and in-hospital deaths among patients with MRSA in the United States in 2005; interval estimates of incidence excluding 1 site that appeared to be an outlier with the highest incidence; molecular characterization of infecting strains. Results There were 8987 observed cases of invasive MRSA reported during the surveillance period. Most MRSA infections were health care-associated: 5250 (58.4%) were community-onset infections, 2389 (26.6%) were hospital-onset infections; 1234 (13.7%) were community-associated infections, and 114 (1.3%) could not be classified. In 2005, the standardized incidence rate of invasive MRSA was 31.8 per 100 000 (interval estimate, 24.4-35.2). Incidence rates were highest among persons 65 years and older (127.7 per 100 000; interval estimate, 92.6-156.9), blacks (66.5 per 100 000; interval estimate, 43.5-63.1), and males (37.5 per 100000; interval estimate, 26.8-39.5). There were 1598 in-hospital deaths among patients with MRSA infection during the surveillance period. In 2005, the standardized mortality rate was 6.3 per 100 000 (interval estimate, 3.3-7.5). Molecular testing identified strains historically associated with community-associated disease outbreaks recovered from cultures in both hospital-onset and community-onset health care-associated infections in all surveillance areas. Conclusions Invasive MRSA infection affects certain populations disproportionately. It is a major public health problem primarily related to health care but no longer confined to intensive care units, acute care hospitals, or any health care institution.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; Calif Emerging Infect Program, Oakland, CA USA; Connecticut Dept Hlth, Hartford, CT USA; Colorado Emerging Infect Program, Denver, CO USA; Grady Mem Hosp, Atlanta, GA USA; Maryland Emerging Infect Program, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Minneapolis, MN USA; Univ Rochester, Rochester Gen Hosp, Rochester, NY USA; Oregon Hlth & Sci Univ, Portland, OR USA; Tennessee Dept Hlth, Nashville, TN USA	Centers for Disease Control & Prevention - USA; California Emerging Infections Program; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Minnesota Department of Health (MHD); Rochester General Hospital; University of Rochester; Oregon Health & Science University; Tennessee Department Health	Klevens, RM (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd A-24, Atlanta, GA 30333 USA.	rmk2@cdc.gov		Ray, Susan/0000-0002-6327-088X				Adcock PM, 1998, J INFECT DIS, V178, P577, DOI 10.1086/517478; Bagger JP, 2004, LANCET, V363, P706, DOI 10.1016/S0140-6736(04)15647-X; Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Begier EM, 2004, CLIN INFECT DIS, V39, P1446, DOI 10.1086/425313; BOYCE JM, 1992, INFECT CONT HOSP EP, V13, P725; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P992; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P234; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P793; Centers for Disease Control and Prevention, ACT BACT COR SURV ME; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Hidron AI, 2005, CLIN INFECT DIS, V41, P159, DOI 10.1086/430910; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Klevens RM, 2006, EMERG INFECT DIS, V12, P1991; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868; Kyaw MH, 2005, J INFECT DIS, V192, P377, DOI 10.1086/431521; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ma XX, 2002, ANTIMICROB AGENTS CH, V46, P1147, DOI 10.1128/AAC.46.4.1147-1152.2002; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MCDOUGAL LK, 2004, AM SOC MICR 104 GEN; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; SARAVOLATZ LD, 1982, ANN INTERN MED, V96, P11, DOI 10.7326/0003-4819-96-1-11; Schramm GE, 2007, INFECT CONT HOSP EP, V28, P95, DOI 10.1086/509856; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Siegel JD, 2006, HEALTHCARE INFECT CO; Sunensbine RH, 2005, INFECT CONT HOSP EP, V26, P138, DOI 10.1086/502517; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wootton SH, 2004, INFECT CONT HOSP EP, V25, P402, DOI 10.1086/502413; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; ZINDERMAN CE, 2004, EMERG INFECT DIS, V25, P402	47	2530	2656	7	413	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2007	298	15					1763	1771		10.1001/jama.298.15.1763	http://dx.doi.org/10.1001/jama.298.15.1763			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220WF	17940231	Bronze			2022-12-28	WOS:000250187300019
J	Chong, EWT; Wong, TY; Kreis, AJ; Simpson, JA; Guymer, RH				Chong, Elaine W-T; Wong, Tien Y.; Kreis, Andreas J.; Simpson, Julie A.; Guymer, Robyn H.			Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CIGARETTE-SMOKING; VISUAL IMPAIRMENT; VITAMIN-E; PREVALENCE; MACULOPATHY; QUALITY; RANIBIZUMAB; CAROTENOIDS; PROGRESSION; TRIALS	Objective To evaluate the effectiveness of dietary antioxidants in the primary prevention of age related macular degeneration (AMD). Design Systematic review and meta-analysis. Data sources Search of seven databases without limits on year or language of publication, and retrieval of references in pertinent reviews and articles. Methods Two reviewers independently searched the databases and selected the studies, using standardised criteria. Randomised clinical trials and prospective cohort studies were included. Of the 4192 abstracts initially identified, 12 studies (nine prospective cohort studies and three randomised clinical trials) met the selection criteria and were included. Data extraction and study quality evaluation were independently reviewed, using standardised criteria. Results were pooled quantitatively using meta-analytic methods. Results The nine prospective cohort studies included 149 203 people, with 1878 incident cases of early AMD. The antioxidants investigated differed across studies, and not all studies contributed to the meta-analysis of each antioxidant. Pooled results from prospective cohort studies indicated that vitamin A, vitamin C, vitamin E, zinc, lutein, zeaxanthin, a carotene, P carotene, P cryptoxanthin, and lycopene have little or no effect in the primary prevention of early AMD. The three randomised clinical trials did not show that antioxidant supplements prevented early AMD. Conclusions There is insufficient evidence to support the role of dietary antioxidants, including the use of dietary antioxidant supplements, for the primary prevention of early AMD.	Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3002, Australia	Centre for Eye Research Australia; University of Melbourne; University of Melbourne	Chong, EWT (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Simpson, Julie A/P-7299-2014; Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Guymer, Robyn/0000-0002-9441-4356; Simpson, Julie/0000-0002-2660-2013				Arroyo JG, 2006, JAMA-J AM MED ASSOC, V295, P2394, DOI 10.1001/jama.295.20.2394; Baird PN, 2006, HUM MUTAT, V27, P337, DOI 10.1002/humu.20288; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; BRODY JE, 2001, NY TIMES        0313; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2006, BMJ-BRIT MED J, V333, P869, DOI 10.1136/bmj.39009.366736.80; Chopdar A, 2003, BRIT MED J, V326, P485, DOI 10.1136/bmj.326.7387.485; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; Clarke M, 2000, LANCET, V355, P756, DOI 10.1016/S0140-6736(05)72172-3; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Deeks J J, 2003, Health Technol Assess, V7, piii; Dickersin K, 2002, INT J EPIDEMIOL, V31, P6, DOI 10.1093/ije/31.1.6; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eter N, 2006, BIODRUGS, V20, P167, DOI 10.2165/00063030-200620030-00004; Evans JR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000254.pub2; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hall NF, 2002, BRIT MED J, V325, P1, DOI 10.1136/bmj.325.7354.1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOROWITZ JM, 2001, TIME MAGAZINE   1029; Jampol LM, 2001, JAMA-J AM MED ASSOC, V286, P2466; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kelly SP, 2004, BRIT MED J, V328, P537, DOI 10.1136/bmj.328.7439.537; KIRSCHFELD K, 1982, PROC R SOC SER B-BIO, V216, P71, DOI 10.1098/rspb.1982.0061; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Mares JA, 2004, ARCH OPHTHALMOL-CHIC, V122, P628, DOI 10.1001/archopht.122.4.628; Mares-Perlman JA, 2002, J NUTR, V132, p518S, DOI 10.1093/jn/132.3.518S; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; National Institutes of Health (NIH) United States National Library of Medicine, CLIN TRIALS DAT; *NIH, CLIN TRIAL DAT; Owen CG, 2003, BRIT J OPHTHALMOL, V87, P312, DOI 10.1136/bjo.87.3.312; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SCHMITZ HH, 1993, METHOD ENZYMOL, V214, P102; SEDDON JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P176, DOI 10.1001/archopht.1994.01090140052021; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5	49	151	160	0	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2007	335	7623					755	759		10.1136/bmj.39350.500428.47	http://dx.doi.org/10.1136/bmj.39350.500428.47			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224AX	17923720	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000250418600033
J	Lazzerini, M				Lazzerini, Marzia			Effect of zinc supplementation on child mortality	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; DIARRHEA; METAANALYSIS; INFANTS		IRCCS Burlo Garofolo, Dept Paediat, I-34100 Trieste, Italy; IRCCS Burlo Garofolo, Inst Child Hlth, Unit Res Hlth Serv & Int Hlth, I-34100 Trieste, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo	Lazzerini, M (corresponding author), IRCCS Burlo Garofolo, Dept Paediat, I-34100 Trieste, Italy.	lazzerini@burlo.trieste.it						Aggarwal R, 2007, PEDIATRICS, V119, P1120, DOI 10.1542/peds.2006-3481; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; BROWN KH, 2004, FOOD NUTR BULL, V1, pS91; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Caulfi eld L. E., 2004, COMP QUANTIFICATION; Guyatt G., 2001, USERS GUIDE MED LIT; *IZINCG, 2007, QUANT RISK ZINC DEF; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Walker CLF, 2007, AM J CLIN NUTR, V85, P887, DOI 10.1093/ajcn/85.3.887; Walker CLF, 2006, J PEDIATR GASTR NUTR, V43, P357, DOI 10.1097/01.mpg.0000232018.40907.00	14	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2007	370	9594					1194	1195		10.1016/S0140-6736(07)61524-4	http://dx.doi.org/10.1016/S0140-6736(07)61524-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219NM	17920908				2022-12-28	WOS:000250091900006
J	Park, SW; Kaimoyo, E; Kumar, D; Mosher, S; Klessig, DF				Park, Sang-Wook; Kaimoyo, Evans; Kumar, Dhirendra; Mosher, Stephen; Klessig, Daniel F.			Methyl salicylate is a critical mobile signal for plant systemic acquired resistance	SCIENCE			English	Article							ACID-BINDING PROTEIN-2; INNATE IMMUNITY; TOBACCO PLANTS; ARABIDOPSIS; EXPRESSION; VIRUS	In plants, the mobile signal for systemic acquired resistance (SAR), an organism-wide state of enhanced defense to subsequent infections, has been elusive. By stimulating immune responses in mosaic tobacco plants created by grafting different genetic backgrounds, we showed that the methyl salicylate (MeSA) esterase activity of salicylic acid-binding protein 2 (SABP2), which converts MeSA into salicylic acid (SA), is required for SAR signal perception in systemic tissue, the tissue that does not receive the primary (initial) infection. Moreover, in plants expressing mutant SABP2 with unregulated MeSA esterase activity in SAR signal-generating, primary infected leaves, SAR was compromised and the associated increase in MeSA levels was suppressed in primary infected leaves, their phloem exudates, and systemic leaves. SAR was also blocked when SA methyl transferase (which converts SA to MeSA) was silenced in primary infected leaves, and MeSA treatment of lower leaves induced SAR in upper untreated leaves. Therefore, we conclude that MeSA is a SAR signal in tobacco.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research	Kumar, D (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	dfk8@cornell.edu	Kalra, D/H-6661-2019	Kalra, D/0000-0001-5254-4067; Mosher, Stephen/0000-0002-3752-1606				CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Du H, 1997, PLANT PHYSIOL, V113, P1319, DOI 10.1104/pp.113.4.1319; Dudareva N, 1998, PLANT PHYSIOL, V116, P599, DOI 10.1104/pp.116.2.599; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; JENNS AE, 1979, PHYTOPATHOLOGY, V69, P753, DOI 10.1094/Phyto-69-753; Kumar D, 2006, PLANT J, V45, P863, DOI 10.1111/j.1365-313X.2005.02645.x; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Pallas JA, 1996, PLANT J, V10, P281, DOI 10.1046/j.1365-313X.1996.10020281.x; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; VERNOOIJ B, 1994, PLANT CELL, V6, P959, DOI 10.1105/tpc.6.7.959; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	18	630	687	7	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					113	116		10.1126/science.1147113	http://dx.doi.org/10.1126/science.1147113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916738				2022-12-28	WOS:000249915400054
J	Tang, XL; Gao, JS; Guan, YJ; McLane, KE; Yuan, ZL; Ramratnam, B; Chin, YE				Tang, Xiaoli; Gao, Jin-Song; Guan, Ying-Jie; McLane, Katya E.; Yuan, Zheng-Long; Ramratnam, Bharat; Chin, Y. Eugene			Acetylation-dependent signal transduction for type I interferon receptor	CELL			English	Article							ALPHA-STIMULATED TRANSCRIPTION; CRYSTAL-STRUCTURE; STAT2; DOMAIN; BINDING; PREASSOCIATION; AUTOINHIBITION; EXPRESSION; PROTEINS; FACTOR-3	Cytokine-activated receptors initiate intracellular signaling by recruiting protein kinases that phosphorylate the receptors on tyrosine residues, thus enabling docking of SH2 domainbearing activating factors. Here we report that in response to type 1 interferon (IFNa), IFNa receptors recruit cytoplasmic CREB-binding protein (CBP). By binding to IFN alpha R2 within the region where two adjacent proline boxes bear phospho-Ser364 and phospho-Ser384, CBP acetylates IFN alpha R2 on Lys399, which in turn serves as the docking site for interferon regulatory factor 9 (IRF9). IRF9 interacts with the acetyl-Lys399 motif by means of its IRF homology2 (IH2) domain, leading to formation of the ISGF3 complex that includes IRF9, STAT1, and STAT2. All three components are acetylated by CBP. Remarkably, acetylation within the DNA-binding domain (DBD) of both IRF9 and STAT2 is critical for the ISGF3 complex activation and its associated antiviral gene regulation. These results have significant implications concerning the central role of acetylation in cytokine receptor signal transduction.	Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Providence, RI 02903 USA; Upstate Chemicon Int Inc, Temecula, CA 92590 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Chin, YE (corresponding author), Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, 593 Eddy st, Providence, RI 02903 USA.	y_eugene_chin@brown.edu						Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; KALVAKOLANU DVR, 1991, P NATL ACAD SCI USA, V88, P7459, DOI 10.1073/pnas.88.17.7459; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Lin RT, 1999, MOL CELL BIOL, V19, P2465; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Saleh AZM, 2002, BIOCHEMISTRY-US, V41, P11261, DOI 10.1021/bi025913f; Sancho R, 2004, J BIOL CHEM, V279, P37349, DOI 10.1074/jbc.M401993200; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Wagner TC, 2002, J BIOL CHEM, V277, P1493, DOI 10.1074/jbc.M108928200; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	30	149	154	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					93	105		10.1016/j.cell.2007.07.034	http://dx.doi.org/10.1016/j.cell.2007.07.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923090	Bronze			2022-12-28	WOS:000249934700014
J	Whittaker, JM; Muller, RD; Leitchenkov, G; Stagg, H; Sdrolias, M; Gaina, C; Goncharov, A				Whittaker, J. M.; Mueller, R. D.; Leitchenkov, G.; Stagg, H.; Sdrolias, M.; Gaina, C.; Goncharov, A.			Major Australian-Antarctic plate reorganization at Hawaiian-Emperor bend time	SCIENCE			English	Article							SHIMANTO BELT; TECTONIC HISTORY; PACIFIC; SUBDUCTION; MOTIONS; CONVERGENCE; PREDICTION; INITIATION; NORTH; MODEL	A marked bend in the Hawaiian-Emperor seamount chain supposedly resulted from a recent major reorganization of the plate-mantle system there 50 million years ago. Although alternative mantle-driven and plate-shifting hypotheses have been proposed, no contemporaneous circum-Pacific plate events have been identified. We report reconstructions for Australia and Antarctica that reveal a major plate reorganization between 50 and 53 million years ago. Revised Pacific Ocean sea-floor reconstructions suggest that subduction of the Pacific-Izanagi spreading ridge and subsequent Marianas/Tonga-Kermadec subduction initiation may have been the ultimate causes of these events. Thus, these plate reconstructions solve long-standing continental fit problems and improve constraints on the motion between East and West Antarctica and global plate circuit closure.	Univ Sydney, Sch Geosci, EarthByte Grp, Sydney, NSW 2006, Australia; VNII Okeangeol, Antarctic Brnach, St Petersburg 190121, Russia; Geosci Australia, Canberra, ACT 2601, Australia; Geol Survey Norway, Ctr Geodynam, N-7491 Trondheim, Norway	University of Sydney; Geoscience Australia; Geological Survey of Norway	Whittaker, JM (corresponding author), Univ Sydney, Sch Geosci, EarthByte Grp, Sydney, NSW 2006, Australia.	j.whittaker@geosci.usyd.edu.au	Goncharov, Alexey/AAF-5171-2019; Whittaker, Joanne M/B-3695-2010; Seton, Maria/H-8272-2013; Gaina, Carmen/I-5213-2015; Müller, Dietmar/L-1200-2019	Whittaker, Joanne M/0000-0002-3170-3935; Seton, Maria/0000-0001-8541-1367; Gaina, Carmen/0000-0001-5533-8103; Müller, Dietmar/0000-0002-3334-5764; Leitchenkov, German/0000-0001-6316-8511				AGAR SM, 1989, J GEOL SOC LONDON, V146, P893, DOI 10.1144/gsjgs.146.6.0893; Anderson DL, 2001, SCIENCE, V293, P2016, DOI 10.1126/science.1065448; Brown M, 1998, J METAMORPH GEOL, V16, P3, DOI 10.1111/j.1525-1314.1998.00061.x; CANDE SC, 1982, EARTH PLANET SC LETT, V57, P63, DOI 10.1016/0012-821X(82)90173-X; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CARESS DW, 1988, J GEOPHYS RES-SOLID, V93, P2813, DOI 10.1029/JB093iB04p02813; CLAGUE DA, 1987, 1350 US GEOL SURV; Duclaux G, 2007, GEOLOGY, V35, P715, DOI 10.1130/G23540A.1; Engebretson D., 1985, GEOL SOC AM SPEC PAP, V206, P1, DOI DOI 10.1130/SPE206-P1; Finn C, 1999, GEOLOGY, V27, P1087, DOI 10.1130/0091-7613(1999)027<1087:ALOEPS>2.3.CO;2; Finn CA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000723; Gaina C, 1998, J GEOPHYS RES-SOL EA, V103, P12413, DOI 10.1029/98JB00386; Gaina C, 2007, GEOPHYS J INT, V170, P151, DOI 10.1111/j.1365-246X.2007.03450.x; Gurnis M, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000681; Hall CE, 2003, EARTH PLANET SC LETT, V212, P15, DOI 10.1016/S0012-821X(03)00242-5; King SD, 2002, EARTH PLANET SC LETT, V203, P83, DOI 10.1016/S0012-821X(02)00852-X; Lewis JC, 2001, TECTONICS, V20, P548, DOI 10.1029/2000TC001239; LONSDALE P, 1988, GEOL SOC AM BULL, V100, P733, DOI 10.1130/0016-7606(1988)100<0733:PHOTKP>2.3.CO;2; MENOT RP, 2007, ANTARCTICA KEYSTONE; MOLNAR P, 1987, NATURE, V327, P587, DOI 10.1038/327587a0; NORTON IO, 1995, TECTONICS, V14, P1080, DOI 10.1029/95TC01256; Onishi CT, 1995, TECTONICS, V14, P1273, DOI 10.1029/95TC01929; Otsuki K., 1992, ISL ARC, V1, P51, DOI DOI 10.1111/J.1440-1738.1992.TB00057.X; Royer JY, 1997, AUST J EARTH SCI, V44, P543, DOI 10.1080/08120099708728336; Sandwell DT, 2005, GEOPHYS J INT, V163, P79, DOI 10.1111/j.1365-246X.2005.02724.x; Schellart WP, 2007, NATURE, V446, P308, DOI 10.1038/nature05615; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; SMITH WHF, 1994, J GEOPHYS RES-SOL EA, V99, P21803, DOI 10.1029/94JB00988; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; Tikku AA, 1999, J GEOPHYS RES-SOL EA, V104, P661, DOI 10.1029/1998JB900034; Wessel P, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001000	32	211	224	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					83	86		10.1126/science.1143769	http://dx.doi.org/10.1126/science.1143769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916729				2022-12-28	WOS:000249915400044
J	Wolf, D; Goff, SP				Wolf, Daniel; Goff, Stephen P.			TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells	CELL			English	Article							LONG TERMINAL REPEAT; CARCINOMA-CELLS; RETROVIRUS EXPRESSION; NEGATIVE REGULATION; GENE-EXPRESSION; TRANSFER-RNA; REPRESSOR; COREPRESSOR; PROTEINS; TRANSCRIPTION	Moloney murine leukemia virus (M-MLV) replication is restricted in embryonic carcinoma (EC) and embryonic stem (ES) cells, likely to protect the germ line from insertional mutagenesis. Proviral DNAs are potently silenced at the level of transcription in these cells. This silencing is largely due to an unidentified trans-acting factor that is thought to bind to the primer binding site (PBS) of M-MLV and repress transcription from the viral promoter. We have partially purified a large PBS-mediated silencing complex and identified TRIM28 (Kap-1), a known transcriptional silencer, as an integral component of the complex. We show that RNAi-mediated knockdown of TRIM28 in EC and ES cells relieves the restriction and that TRIM28 is bound to the PBS in vivo when restriction takes place. The identification of TRIM28 as a retroviral silencer adds to the growing body of evidence that many TRIM family proteins are involved in retroviral restriction.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	goff@cancercenter.columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	NCI NIH HHS [R37 CA30488] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKGUN E, 1991, J VIROL, V65, P382; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; BERWIN B, 1993, NUCLEIC ACIDS RES, V21, P2399, DOI 10.1093/nar/21.10.2399; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Eberhardy SR, 2006, J VIROL, V80, P2873, DOI 10.1128/JVI.80.6.2873-2883.2006; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; FEUER G, 1989, J VIROL, V63, P2317, DOI 10.1128/JVI.63.5.2317-2324.1989; FLANAGAN JR, 1989, MOL CELL BIOL, V9, P739, DOI 10.1128/MCB.9.2.739; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GREZ M, 1990, P NATL ACAD SCI USA, V87, P9202, DOI 10.1073/pnas.87.23.9202; Haas DL, 2003, J VIROL, V77, P9439, DOI 10.1128/JVI.77.17.9439-9450.2003; HARADA F, 1979, J BIOL CHEM, V254, P979; HILBERG F, 1987, P NATL ACAD SCI USA, V84, P5232, DOI 10.1073/pnas.84.15.5232; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; Leung J, 2006, EMBO J, V25, P2155, DOI 10.1038/sj.emboj.7601097; LINNEY E, 1984, NATURE, V308, P470, DOI 10.1038/308470a0; LOH TP, 1988, J VIROL, V62, P4086, DOI 10.1128/JVI.62.11.4086-4095.1988; LOH TP, 1990, MOL CELL BIOL, V10, P4045, DOI 10.1128/MCB.10.8.4045; LOH TP, 1987, MOL CELL BIOL, V7, P3775, DOI 10.1128/MCB.7.10.3775; Modin C, 2000, J VIROL, V74, P11697, DOI 10.1128/JVI.74.24.11697-11707.2000; Modin C, 2000, VIROLOGY, V278, P368, DOI 10.1006/viro.2000.0683; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ng P, 2000, BIOTECHNIQUES, V29, P524, DOI 10.2144/00293st04; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; OSHIMA RG, 1982, J BIOL CHEM, V257, P3414; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; PENGUE G, 1995, J VIROL, V69, P6577, DOI 10.1128/JVI.69.10.6577-6580.1995; PETERSEN R, 1991, MOL CELL BIOL, V11, P1214, DOI 10.1128/MCB.11.3.1214; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; TSUKIYAMA T, 1989, MOL CELL BIOL, V9, P4670, DOI 10.1128/MCB.9.11.4670; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vernet M, 1996, J VIROL, V70, P5630, DOI 10.1128/JVI.70.8.5630-5633.1996; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; YAMAUCHI M, 1995, J VIROL, V69, P1142, DOI 10.1128/JVI.69.2.1142-1149.1995	43	251	269	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					46	57		10.1016/j.cell.2007.07.026	http://dx.doi.org/10.1016/j.cell.2007.07.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923087	Bronze			2022-12-28	WOS:000249934700010
J	Garwin, R				Garwin, Richard			How the mighty have fallen	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					543	543		10.1038/449543a	http://dx.doi.org/10.1038/449543a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914380	Bronze			2022-12-28	WOS:000249893500027
J	Luo, ZX; Ji, Q; Yuan, CX				Luo, Zhe-Xi; Ji, Qiang; Yuan, Chong-Xi			Convergent dental adaptations in pseudo-tribosphenic and tribosphenic mammals	NATURE			English	Article							UPPER MOLAR; EVOLUTION; DIVERSIFICATION; DENTITION; SKELETON; CHINA	Tribosphenic molars of basal marsupials and placentals are a major adaptation, with the protocone (pestle) of the upper molar crushing and grinding in the talonid basin (mortar) on the lower molar(1-4). The extinct pseudo-tribosphenic mammals have a reversed tribosphenic molar in which a pseudo-talonid is anterior to the trigonid, to receive the pseudo-protocone of the upper molar. The pseudo-protocone is analogous to the protocone, but the anteriorly placed pseudo-talonid is opposite to the posterior talonid basin of true tribosphenic mammals(5-7). Here we describe a mammal of the Middle Jurassic period with highly derived pseudo-tribosphenic molars but predominantly primitive mandibular and skeletal features, and place it in a basal position in mammal phylogeny. Its shoulder girdle and limbs show fossorial features similar to those of mammaliaforms and monotremes, but different compared with those of the earliest-known Laurasian tribosphenic (boreosphenid) mammals. The find reveals a much greater range of dental evolution in Mesozoic mammals than in their extant descendants, and strengthens the hypothesis of homoplasy of 'tribosphenic-like' molars among mammals.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Chinese Acad Geol Sci, Beijing 100037, Peoples R China	Chinese Academy of Geological Sciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemnh.org	Luo, Zhe-XI/AAU-2263-2021; Self, Casey J/B-6871-2011					Augee M, 2006, AUSTRAL NAT HIST SER, P1; CHOW M, 1982, Australian Mammalogy, V5, P127; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; JENKINS FA, 1976, PHILOS T ROY SOC B, V273, P387, DOI 10.1098/rstb.1976.0022; Jenkins Jr F. A., 1971, PEABODY MUS NAT HIST, V36, P1; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 1999, NATURE, V398, P326; KERMACK KA, 1987, ZOOL J LINN SOC-LOND, V89, P1, DOI 10.1111/j.1096-3642.1987.tb01342.x; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; KLIMA M, 1987, ADV ANAT EMBRYOL CEL, V109, P1; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Lopatin AV, 2006, SCIENCE, V313, P1092, DOI 10.1126/science.1128530; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Martin T, 2005, ZOOL J LINN SOC-LOND, V145, P219, DOI 10.1111/j.1096-3642.2005.00187.x; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Romer A.S., 1973, Breviora, VNo. 407, P1; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Sereno Paul C., 2006, P315; Sigogneau-Russell D, 1998, CR ACAD SCI II A, V327, P571, DOI 10.1016/S1251-8050(99)80040-8; Sues Hans-Dieter, 2006, P114; SUN A, 1985, VERTEBRAT PALASIATIC, V23, P135; Wang YQ, 1998, J VERTEBR PALEONTOL, V18, P777, DOI 10.1080/02724634.1998.10011106	30	94	118	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					93	97		10.1038/nature06221	http://dx.doi.org/10.1038/nature06221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972884				2022-12-28	WOS:000250585800043
J	Korobkin, R				Korobkin, Russell			Who should protect the public? The Supreme Court and medical device regulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA; Harvard Univ, Sch Law, Cambridge, MA 02138 USA	University of California System; University of California Los Angeles; Harvard University	Korobkin, R (corresponding author), Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA.							Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761	2	3	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1680	1681		10.1056/NEJMp078142	http://dx.doi.org/10.1056/NEJMp078142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223FN	17960010				2022-12-28	WOS:000250355100002
J	Prins, G; Rayner, S				Prins, Gwyn; Rayner, Steve			Time to ditch Kyoto	NATURE			English	Editorial Material									London Sch Econ Mackinder Ctr Study Long Wave Eve, London WC2A 2AE, England; Univ Oxford, James Martin Inst Sci & Civilizat, Oxford OX1 1HP, England	University of London; London School Economics & Political Science; University of Oxford	Prins, G (corresponding author), London Sch Econ Mackinder Ctr Study Long Wave Eve, London WC2A 2AE, England.			rayner, steve/0000-0001-6779-9345				ARTHUR WB, 1989, ECON J, V99, P131; *BRIT PETR, 2007, STAT REV WORLD E JUN; Pielke R, 2007, NATURE, V445, P597, DOI 10.1038/445597a; PRINS G, IN PRESS WRONG TROUS; Rayner S., 1998, HUMAN CHOICE CLIMATE, V4, P109; RAYNER S, 2004, INT CHALLENGE CLIMAT; Rees M, 2006, SCIENCE, V313, P591, DOI 10.1126/science.1132850; *US DOE, 1989, COMP OPT GOV POL ENC; Verweij M, 2006, PUBLIC ADMIN, V84, P817, DOI 10.1111/j.1540-8159.2005.09566.x-i1; Victor D.G., 2001, COLLAPSE KYOTO PROTO; Victor DG, 2006, SCIENCE, V311, P336; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a	12	138	138	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					973	975		10.1038/449973a	http://dx.doi.org/10.1038/449973a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960215				2022-12-28	WOS:000250395000021
J	Lagarde, M; Haines, A; Palmer, N				Lagarde, Mylene; Haines, Andy; Palmer, Natasha			Conditional cash transfers for improving uptake of health interventions in low-and middle-income countries - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-TRIALS; IMPACT; INCENTIVES; PROGRESA; CHILDREN	Context Cash transfers conditional on certain behaviors, intended to provide access to social services, have been introduced in several developing countries. The effectiveness of these strategies in different contexts has not previously been the subject of a systematic review. Objective To assess the effectiveness of conditional monetary transfers in improving access to and use of health services, as well as improving health outcomes, in low- and middle-income countries. Data Sources Relevant publications were identified via electronic medical and social science databases from inception to April 2006 (PubMED, EMBASE, POPLINE, CAB Direct, Healthcare Management Information Consortium, WHOLIS (World Health Organization Library Database), African Healthline, International Bibliography of the Social Sciences (IBSS), Eldis, British Library for Development Studies (BLDS), ID21, Journal Storage (Jstor), Inter-Science, ScienceDirect, Internet Documents in Economics Access Service (Research Papers in Economics) (IDEAS[Repec]), Latin American and Caribbean Health Sciences Literature (LILACS), MEDCARIB, Virtual Library in Health (ADOLEC), Pan American Health Organization (PAHO), FRANCIS, The Cochrane Central Register of Controlled Trials, the Database of Abstracts of Reviews of Effectiveness, and the Effective Practice and Organization of Care Group (EPOC) Register. Reference lists of relevant papers and "gray" literature resources were also searched. Study Selection To be included, a paper had to meet study design criteria (randomized controlled trial, interrupted time series analysis, and controlled before and after study) and include a measure of at least 1 of the following outcomes: health care utilization, health expenditure, or health outcomes. Twenty-eight papers were retrieved for assessment and 10 were included in this review. Data Extraction Methodological details and outcomes were extracted by 2 reviewers who independently assessed the quality of the papers. Results Overall, the evidence suggests that conditional cash transfer programs are effective in increasing the use of preventive services and sometimes improving health status. Conclusions Further research is needed to clarify the cost effectiveness of conditional cash transfer programs and better understand which components play a critical role. The potential success and desirability of such programs in low- income settings, with more limited health system capacity, also deserves more investigation.	Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Lagarde, M (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Keppel St, London WC1E 7HT, England.	mylene.lagarde@lshtm.ac.uk	Trajman, Anete/C-7679-2016; Lagarde, Mylene/GVS-9289-2022	Trajman, Anete/0000-0002-4000-4984; Haines, Andy/0000-0002-8053-4605				Attanasio O., 2005, SHORT TERM IMPACT CO; Attanasio O, 2005, 54 IFS BRIEF; Barham T, 2005, IMPACT MEXICAN CONDI; Behrman J. H. J., 2001, EVALUATION IMPACT PR; Behrman JR, 2005, OXFORD B ECON STAT, V67, P547, DOI 10.1111/j.1468-0084.2005.00131.x; BEHRMAN JR, 1999, RANDOMNESS EXPT SAMP; de Janvry A, 2006, WORLD BANK ECON REV, V20, P1, DOI 10.1093/wber/lhj002; Department for International Development, 2006, US SOC TRANSF IMPR H; ENSOR T, 2003, CONSUMER LED DEMAND; Ensor T., 2004, OVERCOMING BARRIERS; Freemantle N, 2001, BRIT MED J, V322, P989, DOI 10.1136/bmj.322.7292.989; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Gertler Paul, 2000, FINAL REPORT IMPACT; *GOV NEP, 2005, MAT INC SCHEM GUID; Handa S, 2006, DEV POLICY REV, V24, P513, DOI 10.1111/j.1467-7679.2006.00345.x; Hoddinott J, 2004, ECON DEV CULT CHANGE, V53, P37, DOI 10.1086/423252; Lord SJ, 2004, MED J AUSTRALIA, V181, P452, DOI 10.5694/j.1326-5377.2004.tb06376.x; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maluccio J. A., 2004, IMPACT EVALUATION CO, DOI [10.2499/0896291464RR141, DOI 10.2499/0896291464RR141]; Mauldon JG, 2003, J LAW MED ETHICS, V31, P351, DOI 10.1111/j.1748-720X.2003.tb00099.x; Meghir C., 2004, BASELINE REPORT EVAL; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Morris SS, 2004, J NUTR, V134, P2336, DOI 10.1093/jn/134.9.2336; Rawlings LB, 2005, WORLD BANK RES OBSER, V20, P29, DOI 10.1093/wbro/lki001; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; STECKLOV G, 2006, DEMOGRAPHIC EXTERNAT; Sunil TS, 1999, POPUL RES POLICY REV, V18, P563, DOI 10.1023/A:1006386010561; THOMTON R, 2006, DEMAND IMPACT LEARNI; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]; Weeden D, 1986, Asia Pac Popul J, V1, P31	30	411	421	2	77	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1900	1910		10.1001/jama.298.16.1900	http://dx.doi.org/10.1001/jama.298.16.1900			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223GC	17954541				2022-12-28	WOS:000250356700022
J	Young, T; Lee, HS				Young, Ton-Ho; Lee, Herng-Sheng			Recanalized umbilical vein	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Def Med Ctr, Taipei, Taiwan	National Defense Medical Center	Young, T (corresponding author), Natl Def Med Ctr, Taipei, Taiwan.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					E17	E17		10.1056/NEJMicm064291	http://dx.doi.org/10.1056/NEJMicm064291			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942868				2022-12-28	WOS:000250200500010
J	Drissner, D; Kunze, G; Callewaert, N; Gehrig, P; Tamasloukht, M; Boller, T; Felix, G; Amrhein, N; Bucher, M				Drissner, David; Kunze, Gernot; Callewaert, Nico; Gehrig, Peter; Tamasloukht, M'Barek; Boller, Thomas; Felix, Georg; Amrhein, Nikolaus; Bucher, Marcel			Lyso-phosphatidylcholine is a signal in the arbuscular mycorrhizal symbiosis	SCIENCE			English	Article							PHOSPHATE TRANSPORTER; MEDICAGO-TRUNCATULA; PHOSPHOLIPASE A(2); GENE-EXPRESSION; PLANTS; RESPONSES; DEFENSE; CELLS	The arbuscular mycorrhizal (AM) symbiosis represents the most widely distributed mutualistic root symbiosis. We report that root extracts of mycorrhizal plants contain a lipophilic signal capable of inducing the phosphate transporter genes StPT3 and StPT4 of potato (Solanum tuberosum L.), genes that are specifically induced in roots colonized by AM fungi. The same signal caused rapid extracellular alkalinization in suspension-cultured tomato (Solanum lycopersicum L.) cells and induction of the mycorrhiza-specific phosphate transporter gene LePT4 in these cells. The active principle was characterized as the lysolipid lyso-phosphatidylcholine (LPC) via a combination of gene expression studies, alkalinization assays in cell cultures, and chromatographic and mass spectrometric analyses. Our results highlight the importance of lysophospholipids as signals in plants and in particular in the AM symbiosis.	ETH, Inst Plant Sci, Expt Stn, CH-8315 Lindau, Switzerland; ETH, Zurich Glycom Initiat, CH-8093 Zurich, Switzerland; Univ Ghent, Dept Mol Biomed Res, VIB, B-9000 Ghent, Belgium; Univ Ghent, Dept Biochem Physiol & Microbiol, B-9000 Ghent, Belgium; Univ Zurich, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; ETH, CH-8057 Zurich, Switzerland; Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland; Univ Cologne, Inst Bot, D-50931 Cologne, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cologne	Bucher, M (corresponding author), ETH, Inst Plant Sci, Expt Stn, Eschikon 33, CH-8315 Lindau, Switzerland.	m.bucher@uni-koeln.de	Boller, Thomas/G-3500-2012; Bucher, Marcel/D-4596-2013	Boller, Thomas/0000-0001-6768-7503; Bucher, Marcel/0000-0003-1680-9413; Callewaert, Nico/0000-0003-2069-6917; Kunze, Gernot/0000-0002-2039-2836				Benitez S, 2006, BBA-MOL CELL BIOL L, V1761, P1014, DOI 10.1016/j.bbalip.2006.03.020; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; Karandashov V, 2004, P NATL ACAD SCI USA, V101, P6285, DOI 10.1073/pnas.0306074101; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Maeda D, 2006, PLANT CELL PHYSIOL, V47, P807, DOI 10.1093/pcp/pcj069; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Narvaez-Vasquez J, 1999, PLANT CELL, V11, P2249, DOI 10.1105/tpc.11.11.2249; Perrin-Cocon L, 2006, VACCINE, V24, P1254, DOI 10.1016/j.vaccine.2005.09.036; Petkovic M, 2002, ANAL BIOCHEM, V308, P61, DOI 10.1016/S0003-2697(02)00236-1; Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Tellstrom V, 2007, PLANT PHYSIOL, V143, P825, DOI 10.1104/pp.106.090985; Viehweger K, 2006, PLANT CELL, V18, P1510, DOI 10.1105/tpc.105.035121; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	21	116	125	6	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					265	268		10.1126/science.1146487	http://dx.doi.org/10.1126/science.1146487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932296				2022-12-28	WOS:000250086100045
J	Sinnamon, K; Mullan, R				Sinnamon, Kim; Mullan, Robert			Aneurysmal arteriovenous fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Antrim Area Hosp, Belfast BT41 2RL, Antrim, North Ireland		Sinnamon, K (corresponding author), Antrim Area Hosp, Belfast BT41 2RL, Antrim, North Ireland.	kimsinnamon@msn.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					E16	E16		10.1056/NEJMicm066807	http://dx.doi.org/10.1056/NEJMicm066807			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928591				2022-12-28	WOS:000250037000012
J	Wilfley, DE; Stein, RI; Saelens, BE; Mockus, DS; Matt, GE; Hayden-Wade, HA; Welch, RR; Schechtman, KB; Thompson, PA; Epstein, LH				Wilfley, Denise E.; Stein, Richard I.; Saelens, Brian E.; Mockus, Danyte S.; Matt, Georg E.; Hayden-Wade, Helen A.; Welch, R. Robinson; Schechtman, Kenneth B.; Thompson, Paul A.; Epstein, Leonard H.			Efficacy of maintenance treatment approaches for childhood overweight - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SOCIAL SUPPORT; PHYSICAL-ACTIVITY; WEIGHT-LOSS; CHILDREN; LIFE; OBESITY; INTERVENTION; PREVENTION; MANAGEMENT; BEHAVIORS	Context No trials for childhood overweight have examined maintenance interventions to augment the effects of initial weight loss programs. Objectives To determine the short-term and long-term efficacy of 2 distinct weight maintenance approaches vs no continued treatment control following standard family-based behavioral weight loss treatment for childhood overweight, and to examine children's social functioning as a moderator of outcome. Design, Setting, and Participants A parallel-group, randomized controlled trial conducted between October 1999 and July 2004 in a university-based weight control clinic. Participants were 204 healthy 7- to 12-year-olds, 20% to 100% above median body mass index (BMI) for age and sex, with at least 1 overweight parent. Children enrolled in 5 months of weight loss treatment and 150 were randomized to 1 of 3 maintenance conditions. Follow-up assessments occurred immediately following maintenance treatments and 1 and 2 years following randomization. Interventions Maintenance conditions included the control group or 4 months of behavioral skills maintenance (BSM) or social facilitation maintenance (SFM) treatment. Main Outcome Measures BMI z score and percentage overweight. Results Children receiving either BSM or SFM maintained relative weight significantly better than children assigned to the control group from randomization to post-weight maintenance (P <=.01 for all; effect sizes d=0.72-0.96; mean changes in BMI z scores=-0.04, -0.04, -0.05, and 0.05 for BSM alone, SFM alone, BSM and SFM together, and the control group, respectively). Active maintenance treatment efficacy relative to the control group declined during follow-up, but the effects of SFM alone (P=.03; d=0.45; mean change in BMI z score=-0.24) and when analyzed together with BSM (P=.04; d=0.38; mean change in BMI z score=-0.22) were significantly better than the control group (mean change in BMI z score=-0.06) when examining BMI z score outcomes from baseline to 2-year follow-up. Baseline child social problem scores moderated child relative weight change from baseline to 2-year follow-up, with low social problem children in SFM vs the control group having the best outcomes. Conclusions The addition of maintenance-targeted treatment improves short-term efficacy of weight loss treatment for children relative to no maintenance treatment. However, the waning of effects over follow-up, although moderated by child initial social problems, suggests the need for the bolstering of future maintenance treatments to sustain effects.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biostat, St Louis, MO 63110 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; San Diego State Univ, Joint Doctoral Program Epidemiol, San Diego, CA 92182 USA; San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92182 USA; Child & Adolescent Serv Res Ctr, San Diego, CA USA; Univ Buffalo, Dept Pediat, Buffalo, NY USA; Univ Buffalo, Dept Social & Prevent Med, Buffalo, NY USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; Seattle Children's Hospital; California State University System; San Diego State University; California State University System; San Diego State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wilfley, DE (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid,Box 8134, St Louis, MO 63110 USA.	wilfleyd@psychiatry.wustl.edu	Epstein, Leonard/AAE-5619-2021	Stein, Richard/0000-0003-1614-4845; Saelens, Brian/0000-0001-6998-6339; Matt, Georg/0000-0001-5604-4609	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, K23DK060476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH070446] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Achenbach T.M., 1991, MANUAL CHILD BEHAV C, DOI DOI 10.1023/A; Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Bronfenbrenner U., 2007, HDB CHILD PSYCHOL, P793, DOI [DOI 10.1002/9780470147658.CHPSY0114, 10.1002/9780470147658.chpsy0114]; BryantWaugh RJ, 1996, INT J EAT DISORDER, V19, P391, DOI 10.1002/(SICI)1098-108X(199605)19:4&lt;391::AID-EAT6&gt;3.0.CO;2-G; CLARKE GN, 1995, J CONSULT CLIN PSYCH, V63, P718, DOI 10.1037/0022-006X.63.5.718; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; Davison KK, 2002, DEV PSYCHOL, V38, P735, DOI 10.1037//0012-1649.38.5.735; Dietz WH, 2005, NEW ENGL J MED, V352, P2100, DOI 10.1056/NEJMcp043052; Duncan SC, 2005, HEALTH PSYCHOL, V24, P3, DOI 10.1037/0278-6133.24.1.3; Epstein L H, 1994, Obes Res, V2, P509; Epstein LH, 2000, ARCH PEDIAT ADOL MED, V154, P220, DOI 10.1001/archpedi.154.3.220; EPSTEIN LH, 1994, HEALTH PSYCHOL, V13, P373, DOI 10.1037/0278-6133.13.5.373; Epstein LH, 2001, J PEDIATR-US, V139, P58, DOI 10.1067/mpd.2001.115022; Epstein LH, 1998, PEDIATRICS, V101, P554; Faith MS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e23; Faith MS, 2001, BODY IMAGE, EATING DISORDERS, AND OBESITY IN YOUTH: ASSESSMENT, PREVENTION, AND TREATMENT, P313, DOI 10.1037/10404-013; FRANKEL F, 1996, PSYCHOSOCIAL TREATME, P595; GOLDFIELD GS, 2002, EATING DISORDERS OBE, P573; Hollingshead A., 1975, 4 FACTOR INDEX SOCIA; Hudson JL, 2001, COGN BEHAV PRACT, V8, P338, DOI 10.1016/S1077-7229(01)80007-9; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Jelalian E, 1999, J PEDIATR PSYCHOL, V24, P223, DOI 10.1093/jpepsy/24.3.223; KENDALL PC, 1995, J CONSULT CLIN PSYCH, V63, P702, DOI 10.1037/0022-006X.63.5.702; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kuczmarski RJ, 2000, Adv Data, P1; MARCUS MD, 2005, 11 ANN M EAT DIS RES; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; OGDEN CL, 2006, JAMA-J AM MED ASSOC, V2925, P1549; Paluch RA, 2007, AM J HUM BIOL, V19, P487, DOI 10.1002/ajhb.20608; PARCEL GS, 1995, J SCHOOL HEALTH, V65, P23, DOI 10.1111/j.1746-1561.1995.tb03335.x; Perri M. G., 2002, Handbook of obesity treatment, P357; Perri MG, 2001, J CONSULT CLIN PSYCH, V69, P722, DOI 10.1037/0022-006X.69.4.722; PIETROBELLI A, 1998, INT J OBES S4, V22, pS8; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Ritchie LD, 2006, J AM DIET ASSOC, V106, P925, DOI 10.1016/j.jada.2006.03.001; Roemmich JN, 1999, AM J HUM BIOL, V11, P209, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;209::AID-AJHB9&gt;3.0.CO;2-G; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Sallis JF, 2002, PEDIATR EXERC SCI, V14, P30, DOI 10.1123/pes.14.1.30; Saunders RP, 1997, PREV MED, V26, P241, DOI 10.1006/pmed.1996.0134; Savoye M, 2007, JAMA-J AM MED ASSOC, V297, P2697, DOI 10.1001/jama.297.24.2697; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Stewart SH, 2005, ALCOHOL CLIN EXP RES, V29, P278, DOI 10.1097/01.ALC.0000153547.34399.E8; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wang GJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e81; Wilfley DE, 2007, HEALTH PSYCHOL, V26, P521, DOI 10.1037/0278-6133.26.5.521; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Wing RR, 1999, J CONSULT CLIN PSYCH, V67, P132, DOI 10.1037/0022-006X.67.1.132; Zabinski MF, 2003, OBES RES, V11, P238, DOI 10.1038/oby.2003.37	50	184	186	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1661	1673		10.1001/jama.298.14.1661	http://dx.doi.org/10.1001/jama.298.14.1661			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	218IO	17925518	Bronze			2022-12-28	WOS:000250009400022
J	Barrows, TT; Lehman, SJ; Fifield, LK; De Deckker, P				Barrows, Timothy T.; Lehman, Scott J.; Fifield, L. Keith; De Deckker, Patrick			Absence of cooling in New Zealand and the adjacent ocean during the younger dryas chronozone	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; SOUTHERN-HEMISPHERE; CLIMATE-CHANGE; GREENLAND; ALPS; RADIOCARBON; ANTARCTICA; EVENT	As the climate warmed at the end of the last glacial period, a rapid reversal in temperature, the Younger Dryas (YD) event, briefly returned much of the North Atlantic region to near full-glacial conditions. The event was associated with climate reversals in many other areas of the Northern Hemisphere and also with warming over and near Antarctica. However, the expression of the YD in the mid- to low latitudes of the Southern Hemisphere (and the southwest Pacific region in particular) is much more controversial. Here we show that the Waiho Loop advance of the Franz Josef Glacier in New Zealand was not a YD event, as previously thought, and that the adjacent ocean warmed throughout the YD.	Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Nucl Phys, Canberra, ACT 0200, Australia; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia	Australian National University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Australian National University	Barrows, TT (corresponding author), Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Nucl Phys, Canberra, ACT 0200, Australia.	Tim.Barrows@anu.edu.au	Barrows, Timothy T/E-8471-2011; Barrows, Timothy/A-1428-2008	Barrows, Timothy T/0000-0003-2614-7177; Fifield, Leslie/0000-0003-2866-4944				Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barrows TT, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001328; Barrows TT, 2002, QUATERNARY SCI REV, V21, P159, DOI 10.1016/S0277-3791(01)00109-3; BECKER B, 1986, RADIOCARBON, V28, P961, DOI 10.1017/S0033822200060240; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Correge T, 2004, NATURE, V428, P927, DOI 10.1038/nature02506; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Ivy-Ochs S, 1999, GEOGR ANN A, V81A, P313, DOI 10.1111/1468-0459.00060; Lamy F, 2004, SCIENCE, V304, P1959, DOI 10.1126/science.1097863; MANGERUD J, 1974, Boreas (Oslo), V3, P109; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Pahnke K, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001191; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; PORTER SC, 1975, QUATERNARY RES, V5, P27, DOI 10.1016/0033-5894(75)90047-2; Porter SC, 2000, J QUATERNARY SCI, V15, P395, DOI 10.1002/1099-1417(200005)15:4<395::AID-JQS535>3.0.CO;2-H; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Singer C, 1998, SCIENCE, V281, P812, DOI 10.1126/science.281.5378.812; Stone JO, 1998, GEOLOGY, V26, P587, DOI 10.1130/0091-7613(1998)026<0587:EDAVOP>2.3.CO;2; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; Suggate RP, 2005, QUATERNARY SCI REV, V24, P1923, DOI 10.1016/j.quascirev.2004.11.007; Tyson PD, 1997, INT J CLIMATOL, V17, P1499, DOI 10.1002/(SICI)1097-0088(19971130)17:14<1499::AID-JOC207>3.0.CO;2-O; Vandergoes MJ, 2005, NATURE, V436, P242, DOI 10.1038/nature03826	25	123	127	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					86	89		10.1126/science.1145873	http://dx.doi.org/10.1126/science.1145873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916730	Green Published			2022-12-28	WOS:000249915400045
J	Learmonth, ID; Young, C; Rorabeck, C				Learmonth, Ian D.; Young, Claire; Rorabeck, Cecil			The operation of the century: total hip replacement	LANCET			English	Review							METAL-ON-METAL; LOW-FRICTION ARTHROPLASTY; 10-YEAR FOLLOW-UP; IMPROVED CEMENTING TECHNIQUES; CROSS-LINKED POLYETHYLENE; FEMORAL COMPONENTS; LONG-TERM; BONE INGROWTH; RESURFACING ARTHROPLASTY; ARTICULATING SURFACES	In the 1960s, total hip replacement revolutionised management of elderly patients crippled with arthritis, with very good long-term results. Today, young patients present for hip-replacement surgery hoping to restore their quality of life, which typically includes physically demanding activities. Advances in bioengineering technology have driven development of hip prostheses. Both cemented and uncemented hips can provide durable fixation. Better materials and design have allowed use of large-bore bearings, which provide an increased range of motion with enhanced stability and very low wear. Minimally invasive surgery limits soft-tissue damage and facilitates accelerated discharge and rehabilitation. Short-term objectives must not compromise long-term performance. Computer-assisted surgery will contribute to reproducible and accurate placement of implants. Universal economic constraints in healthcare services dictate that further developments in total hip replacement will be governed by their cost-effectiveness.	Bristol Royal Infirm & Gen Hosp, Dept Orthopaed, Bristol BS2 8HW, Avon, England; Cumberland Infirm, Carlisle CA2 7HY, England; Univ Western Ontario, Dept Orthopaed, London Hlth Serv, London, ON, Canada	Bristol Royal Infirmary; London Health Sciences Centre; Western University (University of Western Ontario)	Learmonth, ID (corresponding author), Bristol Royal Infirm & Gen Hosp, Dept Orthopaed, Bristol BS2 8HW, Avon, England.	ian.learmonth@bristol.ac.uk						AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7; Amstutz HC, 2004, J BONE JOINT SURG AM, V86A, P1874, DOI 10.2106/00004623-200409000-00003; Archibeck M J, 2001, Instr Course Lect, V50, P185; ASKEW M J, 1984, Journal of Orthopaedic Research, V1, P412; Bal BS, 2005, J BONE JOINT SURG AM, V87A, P2432, DOI 10.2106/JBJS.D.02847; BARRACK RL, 1993, J BONE JOINT SURG BR, V75, P688, DOI 10.1302/0301-620X.75B5.8376421; BARRACK RL, 1992, J BONE JOINT SURG BR, V74, P385, DOI 10.1302/0301-620X.74B3.1587883; Beaule PE, 2004, CLIN ORTHOP RELAT R, P87; BELL RS, 1985, J BONE JOINT SURG AM, V67A, P1165, DOI 10.2106/00004623-198567080-00004; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BERATO J, 1990, REV RHUM, V57, P397; Berger RA, 2004, ORTHOP CLIN N AM, V35, P163, DOI 10.1016/S0030-5898(03)00110-X; Berry DJ, 2002, J BONE JOINT SURG AM, V84A, P171, DOI 10.2106/00004623-200202000-00002; Berry DJ, 2005, J BONE JOINT SURG AM, V87A, P699, DOI 10.2106/JBJS.E.00126; Berry DJ, 2003, J BONE JOINT SURG AM, V85A, P2235, DOI 10.2106/00004623-200311000-00029; BOURNE RB, 1994, J BONE JOINT SURG AM, V76A, P1464, DOI 10.2106/00004623-199410000-00005; Bourne RB, 2001, CLIN ORTHOP RELAT R, P112; BOURNE RB, 2002, CLIN ORTHOP RELAT R, V441, P159; Bragdon CR, 2004, J BONE JOINT SURG AM, V86A, P105, DOI 10.2106/00004623-200412002-00015; Bragdon CR, 2003, CLIN ORTHOP RELAT R, P50, DOI 10.1097/01.blo.0000096811.78689.2b; Breusch SJ, 2000, J ARTHROPLASTY, V15, P921, DOI 10.1054/arth.2000.8098; Brodner W, 1997, J BONE JOINT SURG BR, V79B, P316, DOI 10.1302/0301-620X.79B2.7326; Buchanan WW., 1998, RHEUMATOLOGY, P1; Buergi ML, 2005, J ARTHROPLASTY, V20, P108, DOI 10.1016/j.arth.2004.09.042; Callaghan JJ, 2000, J BONE JOINT SURG AM, V82A, P487, DOI 10.2106/00004623-200004000-00004; Callaway GH, 1995, J ARTHROPLASTY, V10, P855; CAMPBELL ACL, 1992, J BONE JOINT SURG BR, V74, P63, DOI 10.1302/0301-620X.74B1.1732268; Capello WN, 2003, J BONE JOINT SURG AM, V85A, P885, DOI 10.2106/00004623-200305000-00017; CAPELLO WN, 1993, J BONE JOINT SURG BR, V75, P835, DOI 10.1302/0301-620X.75B5.8376454; CHANDLER HP, 1981, J BONE JOINT SURG AM, V63, P1426, DOI 10.2106/00004623-198163090-00008; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28, DOI 10.1302/0301-620X.42B1.28; CHARNLEY J, 1961, LANCET, V1, P1129; CHARNLEY J, 1975, CLIN ORTHOP RELAT R, P105; Charnley J., 1979, LOW FRICTION ARTHROP; Chimento GF, 2005, J ARTHROPLASTY, V20, P139, DOI 10.1016/j.arth.2004.09.061; Clarke MT, 2003, J BONE JOINT SURG BR, V85B, P913, DOI 10.1302/0301-620X.85B6.14166; Clohisy JC, 1999, J BONE JOINT SURG AM, V81A, P66, DOI 10.2106/00004623-199901000-00010; Cook S D, 1988, J Arthroplasty, V3, P249; Coventry MB., 1991, HIP ARTHROPLASTY; D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39; D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P143, DOI 10.1097/01.blo.0000194090.77500.b4; D'Antonio JA, 2001, CLIN ORTHOP RELAT R, P101; DALL DM, 1993, J BONE JOINT SURG BR, V75, P259, DOI 10.1302/0301-620X.75B2.8444947; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; DiGioia AM, 2002, J ARTHROPLASTY, V17, P359, DOI 10.1054/arth.2002.30411; DIGIOIA AM, 1998, CLIN ORTHOP RELAT R, V354, P8; DOBBS HS, 1980, J BONE JOINT SURG BR, V62, P168, DOI 10.1302/0301-620X.62B2.7364829; DORR LD, 1990, CLIN ORTHOP RELAT R, P215; Duffy P, 2004, J BONE JOINT SURG BR, V86B, P34, DOI 10.1302/0301-620X.86B1.13402; Eastaugh-Waring SJ, 2006, J ARTHROPLASTY, V21, P18, DOI 10.1016/j.arth.2005.04.016; EFTEKHAR NS, 1987, CLIN ORTHOP RELAT R, P207; ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45, DOI 10.1302/0301-620X.69B1.3818732; Fehring TK, 2005, J BONE JOINT SURG AM, V87A, P711, DOI 10.2106/JBJS.D.02666; Fender D, 1999, J BONE JOINT SURG BR, V81B, P577, DOI 10.1302/0301-620X.81B4.9859; FOX GM, 1994, J BONE JOINT SURG AM, V76A, P195, DOI 10.2106/00004623-199402000-00005; Freeman MAR, 1998, ORTHOPEDICS, V21, P959; FREEMAN MAR, 1978, CLIN ORTHOP RELAT R, P45; Fritsch EW, 1996, CLIN ORTHOP RELAT R, P129; GIE GA, 2004, EUR HIP SOC 23 26 JU; Gluck T, 1891, ARCH KLIN CHIR, V41, P187; GONZALEZ DV, 2001, J BONE JOINT SURG AM, V83, P553; Good V, 2003, J BONE JOINT SURG AM, V85A, P105, DOI 10.2106/00004623-200300004-00013; Gozzard C, 2003, ACTA ORTHOP SCAND, V74, P154, DOI 10.1080/00016470310013879; Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9; Harding I, 2002, J ARTHROPLASTY, V17, P893, DOI 10.1054/arth.2002.34539; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005; Harris WH, 2004, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01.blo.0000149821.72760.39; Havelin LI, 2002, J BONE JOINT SURG BR, V84B, P839, DOI 10.1302/0301-620X.84B6.12492; HEAD WC, 1981, J BONE JOINT SURG AM, V63, P420, DOI 10.2106/00004623-198163030-00017; Herberts P, 2000, ACTA ORTHOP SCAND, V71, P111, DOI 10.1080/000164700317413067; HERBERTS P, 2005, SWEDISH NATL HIP ART; Hewlett S, 2002, ANN RHEUM DIS, V61, P986, DOI 10.1136/ard.61.11.986; Huggler A H, 1993, Acta Orthop Belg, V59 Suppl 1, P215; JACOBSSON SA, 1996, CLIN ORTHOP S, V329, P60; Janse AJ, 2004, J CLIN EPIDEMIOL, V57, P653, DOI 10.1016/j.jclinepi.2003.11.013; JASTY M, 1992, CLIN ORTHOP RELAT R, P300; JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014; JOLLEY MN, 1982, J BONE JOINT SURG AM, V64, P366, DOI 10.2106/00004623-198264030-00006; JONES LC, 1987, CLIN ORTHOP RELAT R, P192; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavanagh B F, 1994, J Arthroplasty, V9, P229, DOI 10.1016/0883-5403(94)90076-0; Kearns SR, 2006, CLIN ORTHOP RELAT R, P103, DOI 10.1097/01.blo.0000238868.22852.dd; KEAVENY TM, 1995, J BONE JOINT SURG AM, V77A, P911, DOI 10.2106/00004623-199506000-00012; Kim YH, 2005, J BONE JOINT SURG BR, V87B, P623, DOI 10.1302/0301-620X.87B5.15554; KRAUSE WR, 1982, CLIN ORTHOP RELAT R, V163, P290; Langlais F, 2003, J BONE JOINT SURG BR, V85B, P17, DOI 10.1302/0301-620X.85B1.13948; Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff; Lavernia C, 2004, J ARTHROPLASTY, V19, P10, DOI 10.1016/j.arth.2004.06.023; Lerouge S, 1997, J BONE JOINT SURG BR, V79B, P135, DOI 10.1302/0301-620X.79B1.6621; Lewonowski K, 1994, J Arthroplasty, V9, P661, DOI 10.1016/0883-5403(94)90121-X; Louwerse RT, 1999, J ARTHROPLASTY, V14, P391, DOI 10.1016/S0883-5403(99)90070-0; MacDonald SJ, 2003, CLIN ORTHOP RELAT R, P282, DOI 10.1097/01.blo.0000043066.62337.9d; MAJKOWSKI RS, 1993, J BONE JOINT SURG BR, V75, P459, DOI 10.1302/0301-620X.75B3.8496223; Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002; MALCHAU H, 1996, 63 ANN M AM AC ORTH; MALCHAU H, 2002, 69 ANN M AM ORTH SUR; MALONEY WJ, 1990, J BONE JOINT SURG AM, V72A, P1025, DOI 10.2106/00004623-199072070-00011; MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966, DOI 10.1302/0301-620X.72B6.2246299; Massoud SN, 1997, J BONE JOINT SURG BR, V79B, P603, DOI 10.1302/0301-620X.79B4.7131; McAuley JP, 1998, CLIN ORTHOP RELAT R, P182; McKee G K, 1966, J Bone Joint Surg Br, V48, P245; McKellop H, 1996, CLIN ORTHOP RELAT R, pS128, DOI 10.1097/00003086-199608001-00013; McMinn D, 1996, CLIN ORTHOP RELAT R, pS89; Morrey BF, 2000, J BONE JOINT SURG BR, V82B, P952, DOI 10.1302/0301-620X.82B7.10420; MULLER ME, 1970, CLIN ORTHOP RELAT R, P46; MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757, DOI 10.1302/0301-620X.72B5.2211749; Naudie D, 2004, J ARTHROPLASTY, V19, P35, DOI 10.1016/j.arth.2004.06.020; *NICE, 2006, INT PROC GUID, V152; *NICE, 2005, INT PROC GUID, V112; Nogler Michael, 2004, Surg Technol Int, V12, P259; Ogonda L, 2005, J BONE JOINT SURG AM, V87A, P701, DOI 10.2106/JBJS.D.02645; Older J, 2002, J ARTHROPLASTY, V17, P675, DOI 10.1054/arth.2002.31973; Parvizi J, 2004, J ARTHROPLASTY, V19, P151, DOI 10.1016/j.arth.2003.10.003; Rasquinha VJ, 2002, J ARTHROPLASTY, V17, P113, DOI 10.1054/arth.2002.32810; Reitman RD, 2003, J ARTHROPLASTY, V18, P116, DOI 10.1016/S0883-5403(03)00344-9; Ries MD, 2001, J BONE JOINT SURG AM, V83A, P116, DOI 10.2106/00004623-200100022-00009; RIES MD, 1992, CLIN ORTHOP RELAT R, P164; Ring P A, 1968, J Bone Joint Surg Br, V50, P720; Saikko V, 2002, J BIOMED MATER RES, V63, P848, DOI 10.1002/jbm.10471; Schmalzried TP, 1996, J ARTHROPLASTY, V11, P322, DOI 10.1016/S0883-5403(96)80085-4; SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006; Semlitsch M, 1997, P I MECH ENG H, V211, P73, DOI 10.1243/0954411971534700; Shimmin AJ, 2005, J BONE JOINT SURG BR, V87B, P463, DOI 10.1302/0301-620X.87B4; SMITHPETERSEN MN, 1948, J BONE JOINT SURG BR, V30, P59, DOI 10.1302/0301-620X.30B1.59; Spitzer AI, 2005, ORTHOPEDICS, V28, pS841; STIEHL JB, 2003, NAVIGATION ROBOTICS; Tennent TD, 2000, ANN ROY COLL SURG, V82, P33; Treacy RBC, 2005, J BONE JOINT SURG BR, V87B, P167, DOI 10.1302/0301-620X.87B2.15030; Udomkiat P, 2002, J BONE JOINT SURG AM, V84A, P1195, DOI 10.2106/00004623-200207000-00016; Vernon-Roberts B, 1977, SCI BASIS JOINT REPL, P86; WARE JE, SF 12 EVEN SHORTER H; WILES P, 1958, BRIT J SURG, V45, P488, DOI 10.1002/bjs.18004519315; WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202; Williams HDW, 2002, J BONE JOINT SURG BR, V84B, P324, DOI 10.1302/0301-620X.84B3.12261; WOO RYG, 1982, J BONE JOINT SURG AM, V64, P1295, DOI 10.2106/00004623-198264090-00004; WRIGHT JG, 1994, J BONE JOINT SURG BR, V76B, P229, DOI 10.1302/0301-620X.76B2.8113282; Wroblewski BM, 1999, J BONE JOINT SURG BR, V81B, P427, DOI 10.1302/0301-620X.81B3.9521; Wroblewski BM, 2001, J ARTHROPLASTY, V16, P37, DOI 10.1054/arth.2001.28374; WROBLEWSKI BM, 1985, J BONE JOINT SURG BR, V67, P757, DOI 10.1302/0301-620X.67B5.4055876; Wylde V, 2006, MUSCULOSKELET CARE, V4, P152, DOI 10.1002/msc.86	142	1263	1340	3	183	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1508	1519		10.1016/S0140-6736(07)60457-7	http://dx.doi.org/10.1016/S0140-6736(07)60457-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964352				2022-12-28	WOS:000250487000028
J	Suhrcke, M; McKee, M; Rocco, L				Suhrcke, Marc; McKee, Martin; Rocco, Lorenzo			Health investment benefits economic development	LANCET			English	Editorial Material									WHO, European Off Investment Hlth & Dev, I-30124 Venice, Italy; London Sch Hyg & Trop Med, London WC1, England; European Observ Hlth Syst & Policies, London, England; Univ Padua, Dept Econ, Padua, Italy	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; European Observatory on Health Systems & Policies; University of Padua	Suhrcke, M (corresponding author), WHO, European Off Investment Hlth & Dev, I-30124 Venice, Italy.	msu@ihd.euro.who.int	Suhrcke, Marc/AAE-9024-2019; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Rocco, Lorenzo/0000-0002-4034-3724; Suhrcke, Marc/0000-0001-7263-8626	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alam A., 2005, GROWTH POVERTY INEQU; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Lessof S, 2004, HLTH SYSTEMS TRANSIT; McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3; Suhrcke M, 2005, B WORLD HEALTH ORGAN, V83, P920; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Suhrcke M, 2007, HLTH VITAL INVESTMEN; Suhrcke M, 2007, EC CONSEQUENCES NONC; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; *WHO REG OFF EUR C, 2006, HLTH EC DEV SE EUR	10	6	6	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1467	1468		10.1016/S0140-6736(07)61616-X	http://dx.doi.org/10.1016/S0140-6736(07)61616-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224ZN	17964336				2022-12-28	WOS:000250487000008
J	Sorek, R; Zhu, YW; Creevey, CJ; Francino, MP; Bork, P; Rubin, EM				Sorek, Rotem; Zhu, Yiwen; Creevey, Christopher J.; Francino, M. Pilar; Bork, Peer; Rubin, Edward M.			Genome-wide experimental determination of barriers to horizontal gene transfer	SCIENCE			English	Article							PHYLOGENETIC CLASSIFICATION; ESCHERICHIA-COLI; EVOLUTION; DNA; TREE	Horizontal gene transfer, in which genetic material is transferred from the genome of one organism to that of another, has been investigated in microbial species mainly through computational sequence analyses. To address the lack of experimental data, we studied the attempted movement of 246,045 genes from 79 prokaryotic genomes into Escherichia coli and identified genes that consistently fail to transfer. We studied the mechanisms underlying transfer inhibition by placing coding regions from different species under the control of inducible promoters. Our data suggest that toxicity to the host inhibited transfer regardless of the species of origin and that increased gene dosage and associated increased expression may be a predominant cause for transfer failure. Although these experimental studies examined transfer solely into E. coli, a computational analysis of gene-transfer rates across available bacterial and archaeal genomes supports that the barriers observed in our study are general across the tree of life.	Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, Berkeley, CA 94720 USA; European Mol Biol Lab, D-69012 Heidelberg, Germany	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL)	Rubin, EM (corresponding author), Joint Genome Inst, Dept Energy, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	EMRubin@lbl.gov	Bork, Peer/F-1813-2013; Francino, M.Pilar/H-9090-2015; Creevey, Christopher James/A-1836-2013	Bork, Peer/0000-0002-2627-833X; Francino, M.Pilar/0000-0002-4510-5653; Creevey, Christopher James/0000-0001-7183-1555				CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; DILLARD JP, 1991, J BACTERIOL, V173, P5105, DOI 10.1128/jb.173.16.5105-5109.1991; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; LEVINE MM, 1978, LANCET, V1, P1119; MULLIGAN ME, 1986, NUCLEIC ACIDS RES, V14, P109, DOI 10.1093/nar/14.1.109; Philippe H, 2003, CURR OPIN MICROBIOL, V6, P498, DOI 10.1016/j.mib.2003.09.008; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Smets BF, 2005, NAT REV MICROBIOL, V3, P675, DOI 10.1038/nrmicro1253; Summers D, 1998, MOL MICROBIOL, V29, P1137, DOI 10.1046/j.1365-2958.1998.01012.x; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234	19	272	290	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1449	1452		10.1126/science.1147112	http://dx.doi.org/10.1126/science.1147112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	17947550	Green Submitted			2022-12-28	WOS:000251246100045
J	Cherezov, V; Rosenbaum, DM; Hanson, MA; Rasmussen, SGF; Thian, FS; Kobilka, TS; Choi, HJ; Kuhn, P; Weis, WI; Kobilka, BK; Stevens, RC				Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.			High-resolution crystal structure of an engineered human beta(2)-adrenergic G protein-coupled receptor	SCIENCE			English	Article							BETA-ADRENERGIC-RECEPTOR; HUMAN BETA-2-ADRENERGIC RECEPTOR; MOLECULAR-MECHANISM; LIGAND-BINDING; ACTIVATION; RHODOPSIN; CRYSTALLIZATION; MEMBRANE; AGONIST; MODELS	Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane. We report the crystal structure of a human beta(2)-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resolution. The structure provides a high-resolution view of a human G protein-coupled receptor bound to a diffusible ligand. Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop. Cholesterol, a necessary component for crystallization, mediates an intriguing parallel association of receptor molecules in the crystal lattice. Although the location of carazolol in the beta(2)-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Stanford University; Scripps Research Institute; Stanford University; Scripps Research Institute	Stevens, RC (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu; stevens@scripps.edu	Weis, William I/G-1437-2011; soler, martha maricel m gomez/L-6025-2014; Cherezov, Vadim/L-9812-2013; Stevens, Raymond/K-7272-2015	Weis, William I/0000-0002-5583-6150; soler, martha maricel m gomez/0000-0002-4412-8108; Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; Kobilka, Brian/0000-0001-5958-3990; Choi, Hee-Jung/0000-0002-1167-1526; Rasmussen, Soren/0000-0002-1853-1841	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, R01GM089857, R21GM075811, F32GM082028, R01GM075915, P50GM073197, U54GM074961, P50GM062411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER; NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NIGMS NIH HHS [P50 GM073197-04, U54 GM074961-030001, R01 GM056169, R01 GM089857, Y1-GM-1104, F32 GM082028, P50 GM073197, U54 GM074961, GM075915, R21 GM075811, P50 GM062411] Funding Source: Medline; NINDS NIH HHS [R01 NS028471, NS028471, R37 NS028471] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BAI TR, 1992, LUNG, V170, P125; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARNES PJ, 1993, LIFE SCI, V52, P2101, DOI 10.1016/0024-3205(93)90725-I; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Caffrey M, 2000, CURR OPIN STRUC BIOL, V10, P486, DOI 10.1016/S0959-440X(00)00119-6; CARON MG, 1993, RECENT PROG HORM RES, V48, P277; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2006, J MOL BIOL, V364, P716, DOI 10.1016/j.jmb.2006.09.022; DEISENHOFER J, 1989, EMBO J, V8, P2149, DOI 10.1002/j.1460-2075.1989.tb08338.x; DeLano W.L., PYMOL MOL GRAPHICS S; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Fano A, 2006, J CHEM INF MODEL, V46, P1223, DOI 10.1021/ci050490k; Freddolino PL, 2004, P NATL ACAD SCI USA, V101, P2736, DOI 10.1073/pnas.0308751101; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Furse KE, 2003, J MED CHEM, V46, P4450, DOI 10.1021/jm0301437; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gouldson PR, 2004, PROTEINS, V56, P67, DOI 10.1002/prot.20108; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hein L, 1997, TRENDS CARDIOVAS MED, V7, P137, DOI 10.1016/S1050-1738(97)00034-0; Hobrath JV, 2006, J MED CHEM, V49, P4470, DOI 10.1021/jm0501634; Javitch JA, 2004, MOL PHARMACOL, V66, P1077, DOI 10.1124/mol.104.006320; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Landau EM, 2003, FEBS LETT, V555, P51, DOI 10.1016/S0014-5793(03)01082-2; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; MILLIGAN G, 1994, BIOCHEM PHARMACOL, V48, P1059; NODA K, 1994, J BIOL CHEM, V269, P6743; Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8; Nowak M, 2006, J MED CHEM, V49, P205, DOI 10.1021/jm050826h; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rohrer DK, 1998, J MOL MED-JMM, V76, P764, DOI 10.1007/s001090050278; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schertler GFX, 2005, CURR OPIN STRUC BIOL, V15, P408, DOI 10.1016/j.sbi.2005.07.010; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Smiley R M, 1996, J Matern Fetal Med, V5, P106; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Taylor MRG, 2007, PHARMACOGENOMICS J, V7, P29, DOI 10.1038/sj.tpj.6500393; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiang Y, 2005, RECEPTORS, P267; Yao ZP, 2005, ANAL BIOCHEM, V343, P344, DOI 10.1016/j.ab.2005.05.002; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013	67	2659	2750	8	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1258	1265		10.1126/science.1150577	http://dx.doi.org/10.1126/science.1150577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	17962520	Green Accepted			2022-12-28	WOS:000251086600033
J	Frank, MJ; Samanta, J; Moustafa, AA; Sherman, SJ				Frank, Michael J.; Samanta, Johan; Moustafa, Ahmed A.; Sherman, Scott J.			Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism	SCIENCE			English	Article							HIGH-FREQUENCY STIMULATION; OPTIMAL DECISION-MAKING; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; COGNITIVE CONTROL; REACTION-TIME; SELECTION; CHOICE; DOPAMINE; DISEASE	Deep brain stimulation (DBS) of the subthalamic nucleus markedly improves the motor symptoms of Parkinson's disease, but causes cognitive side effects such as impulsivity. We showed that DBS selectively interferes with the normal ability to slow down when faced with decision conflict. While on DBS, patients actually sped up their decisions under high-conflict conditions. This form of impulsivity was not affected by dopaminergic medication status. Instead, medication impaired patients' ability to learn from negative decision outcomes. These findings implicate independent mechanisms leading to impulsivity in treated Parkinson's patients and were predicted by a single neurocomputational model of the basal ganglia.	Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; Univ Arizona, Program Neurosci, Tucson, AZ 85721 USA; Banner Good Samaritan Med Ctr, Phoenix, AZ 85004 USA; Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; Banner Research; Banner Health; University of Arizona	Frank, MJ (corresponding author), Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA.	mfrank@u.arizona.edu	Moustafa, Ahmed/AAM-2836-2021; Frank, Michael J/B-2979-2008	Moustafa, Ahmed/0000-0001-5971-273X				Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Baunez C, 2007, EUR J NEUROSCI, V25, P1187, DOI 10.1111/j.1460-9568.2007.05373.x; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Benazzouz A, 2000, NEUROLOGY, V55, pS13; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Cools R, 2006, NEUROPSYCHOLOGIA, V44, P1663, DOI 10.1016/j.neuropsychologia.2006.03.030; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Drapier S, 2005, J NEUROL, V252, P583, DOI 10.1007/s00415-005-0704-4; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Hershey T, 2004, NEUROLOGY, V62, P1110, DOI 10.1212/01.WNL.0000118202.19098.10; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; LIU Y, 2006, NEUROSCI BIOBEHAV RE; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Meissner W, 2005, BRAIN, V128, P2372, DOI 10.1093/brain/awh616; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Orieux G, 2002, J NEUROSCI, V22, P8762; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Saint-Cyr JA, 2006, NEUROLOGY, V66, P1799, DOI 10.1212/01.wnl.0000227468.17113.07; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Simen P, 2006, NEURAL NETWORKS, V19, P1013, DOI 10.1016/j.neunet.2006.05.038; Thobois S, 2007, J CEREBR BLOOD F MET, V27, P1173, DOI 10.1038/sj.jcbfm.9600425; TVERSKY A, 1992, PSYCHOL SCI, V3, P358, DOI 10.1111/j.1467-9280.1992.tb00047.x; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Uslaner JM, 2006, EUR J NEUROSCI, V24, P2345, DOI 10.1111/j.1460-9568.2006.05117.x; Winstanley CA, 2005, EUR J NEUROSCI, V21, P3107, DOI 10.1111/j.1460-9568.2005.04143.x	35	759	778	2	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2007	318	5854					1309	1312		10.1126/science.1146157	http://dx.doi.org/10.1126/science.1146157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	17962524				2022-12-28	WOS:000251086600046
J	Machner, MP; Isberg, RR				Machner, Matthias P.; Isberg, Ralph R.			A bifunctional bacterial protein links GDI displacement to Rab1 activation	SCIENCE			English	Article							GTP-BINDING PROTEIN; LEGIONELLA-PNEUMOPHILA; DISSOCIATION INHIBITOR; ENDOPLASMIC-RETICULUM; SMG P25A; VESICULAR TRANSPORT; NUCLEOTIDE-EXCHANGE; GOLGI COMPARTMENTS; CYSTEINE MOTIFS; MEMBRANE	Rab guanosine triphosphatases (GTPases) regulate vesicle trafficking in eukaryotic cells by reversibly associating with lipid membranes. Inactive Rab GTPases are maintained in the cytosol by binding to GDP-dissociation inhibitor (GDI). It is believed that specialized proteins are required to displace GDI from Rab GTPases before Rab activation by guanosine diphosphate-guanosine 5'-triphosphate (GDP-GTP) exchange factors (GEFs). Here, we found that SidM from Legionella pneumophila could act as both GEF and GDI-displacement factor (GDF) for Rab1. Rab1 released from GDI was inserted into liposomal membranes and was used as a substrate for SidM-mediated nucleotide exchange. During host cell infection, recruitment of Rab1 to Legionella-containing vacuoles depended on the GDF activity of SidM. Thus, GDF and GEF activity can be promoted by a single protein, and GDF activity can coordinate Rab1 recruitment from the GDI-bound pool.	Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA	Tufts University; Howard Hughes Medical Institute; Tufts University	Isberg, RR (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	ralph.isberg@tufts.edu	Machner, Matthias/G-2758-2015	Machner, Matthias/0000-0002-6971-7451	NIDDK NIH HHS [P30DK34928] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAKI S, 1991, MOL CELL BIOL, V11, P1438, DOI 10.1128/MCB.11.3.1438; ARAKI S, 1990, J BIOL CHEM, V265, P13007; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; MUSHA T, 1992, J BIOL CHEM, V267, P9821; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; PETER M, 1992, J CELL SCI, V102, P857; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Wilson AL, 1996, J BIOL CHEM, V271, P10932, DOI 10.1074/jbc.271.18.10932; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	30	161	167	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					974	977		10.1126/science.1149121	http://dx.doi.org/10.1126/science.1149121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17947549				2022-12-28	WOS:000250788500043
J	Takagi, H; Kawai, N; Umemoto, T				Takagi, Hisato; Kawai, Norikazu; Umemoto, Takuya			Abdominal aortic aneurysm - Screening reduces all cause mortality in men	BMJ-BRITISH MEDICAL JOURNAL			English	Letter							TRIAL		Shizuoka Med Ctr, Shizuoka 4118611, Japan		Takagi, H (corresponding author), Shizuoka Med Ctr, Shizuoka 4118611, Japan.	kfgth973@ybb.ne.jp	Takagi, Hisato/C-8907-2014					Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Greenhalgh R, 2007, BMJ-BRIT MED J, V335, P732, DOI 10.1136/bmj.39307.634560.AD; Kim LG, 2007, ANN INTERN MED, V146, P699, DOI 10.7326/0003-4819-146-10-200705150-00003; Lindholt JS, 2006, EUR J VASC ENDOVASC, V32, P608, DOI 10.1016/j.ejvs.2006.06.008; TAKAGI H, IN PRESS J VASC SURG	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2007	335	7626					899	899		10.1136/bmj.39381.375972.BE	http://dx.doi.org/10.1136/bmj.39381.375972.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17974654	Green Published			2022-12-28	WOS:000250848300007
J	Mumby, PJ; Hastings, A; Edwards, HJ				Mumby, Peter J.; Hastings, Alan; Edwards, Helen J.			Thresholds and the resilience of Caribbean coral reefs	NATURE			English	Article							CLIMATE-CHANGE; STABLE STATES; MORTALITY; DYNAMICS	The deteriorating health of the world's coral reefs threatens global biodiversity, ecosystem function, and the livelihoods of millions of people living in tropical coastal regions(1). Reefs in the Caribbean are among the most heavily affected(2,3), having experienced mass disease-induced mortality of the herbivorous urchin Diadema antillarum(4) in 1983 and two framework-building species of coral(5). Declining reef health is characterized by increases in macroalgae. A critical question is whether the observed macroalgal bloom on Caribbean reefs is easily reversible. To answer this question, we must resolve whether algal-dominated reefs are an alternative stable state of the ecosystem or simply the readily reversible result of a phase change along a gradient of some environmental or ecological parameter(6). Here, using a fully parameterized simulation model in combination with a simple analytical model, we show that Caribbean reefs became susceptible to alternative stable states once the urchin mortality event of 1983 confined the majority of grazing to parrotfishes. We reveal dramatic hysteresis in a natural system(7,8) and define critical thresholds of grazing and coral cover beyond which resilience is lost. Most grazing thresholds lie near the upper level observed for parrotfishes in nature, suggesting that reefs are highly sensitive to parrotfish exploitation. Ecosystem thresholds can be combined with stochastic models of disturbance to identify targets for the restoration of ecosystem processes. We illustrate this principle by estimating the relationship between current reef state (coral cover and grazing) and the probability that the reef will withstand moderate hurricane intensity for two decades without becoming entrained in a shift towards a stable macroalgal-dominated state. Such targets may help reef managers face the challenge of addressing global disturbance at local scales.	Univ Exeter, Sch Biosci, Marine Spatial Ecol Lab, Exeter EX4 4PS, Devon, England; Univ Calif Davis, Davis, CA 95616 USA	University of Exeter; University of California System; University of California Davis	Mumby, PJ (corresponding author), Univ Exeter, Sch Biosci, Marine Spatial Ecol Lab, Prince Wales Rd, Exeter EX4 4PS, Devon, England.	p.j.mumby@ex.ac.uk	Hastings, Alan/A-7423-2008; Mumby, Peter/F-9914-2010; Edwards, Helen/D-1633-2009; Edwards, Helen/GPX-3511-2022; Hastings, Alan/O-6864-2019	Mumby, Peter/0000-0002-6297-9053; Edwards, Helen/0000-0003-1174-8009; Hastings, Alan/0000-0002-0717-8026	NERC [NE/E00606X/1] Funding Source: UKRI; Natural Environment Research Council [NE/E00606X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Done TJ, 1999, AM ZOOL, V39, P66; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Hildebrand F. B, 1987, INTRO NUMERICAL ANAL; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; KNOWLTON N, 1992, AM ZOOL, V32, P674; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Ludwig D., 1997, CONSERV ECOL, V1, P1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2005, CORAL REEFS, V24, P681, DOI 10.1007/s00338-005-0058-5; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; VANSTEVENINCK EDD, 1987, MAR ECOL PROG SER, V38, P241	26	588	604	10	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					98	101		10.1038/nature06252	http://dx.doi.org/10.1038/nature06252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972885				2022-12-28	WOS:000250585800044
J	Okada, Y; Scott, G; Ray, MK; Mishina, Y; Zhang, Y				Okada, Yuki; Scott, Greg; Ray, Manas K.; Mishina, Yuji; Zhang, Yi			Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis	NATURE			English	Article							CONDENSATION; METHYLATION; DOMAIN	Recent studies indicate that, similar to other covalent modifications, histone lysine methylation is subject to enzyme-catalysed reversion(1,2). So far, LSD1 (also known as AOF2) and the jumonji C (JmjC)-domain-containing proteins have been shown to possess histone demethylase activity. LSD1 catalyses removal of H3K4me2/H3K4me1 through a flavin-adenine-dinucleotide-dependent oxidation reaction(3). In contrast, JmjC-domain-containing proteins remove methyl groups from histones through a hydroxylation reaction that requires alpha-ketoglutarate and Fe(II) as cofactors(4). Although an increasing number of histone demethylases have been identified and biochemically characterized(1,2), their biological functions, particularly in the context of an animal model, are poorly characterized. Here we use a loss-of-function approach to demonstrate that the mouse H3K9me2/1-specific demethylase JHDM2A (JmjC-domain-containing histone demethylase 2A, also known as JMJD1A) is essential for spermatogenesis. We show that Jhdm2a-deficient mice exhibit post-meiotic chromatin condensation defects, and that JHDM2A directly binds to and controls the expression of transition nuclear protein 1 (Tnp1) and protamine 1 (Prm1) genes, the products of which are required for packaging and condensation of sperm chromatin. Thus, our work uncovers a role for JHDM2A in spermatogenesis and reveals transition nuclear protein and protamine genes as direct targets of JHDM2A.	Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; NIH, Knock Out Core, Res Triangle Pk, NC 27709 USA; NIH, Mol Dev Biol Grp, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Ariel, Pablo/AGJ-4118-2022	Zhang, Yi/0000-0002-2789-0811	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102425, ZIGES102425, Z01ES071003, ZICES102425] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; HOOG C, 1991, MOL REPROD DEV, V30, P173, DOI 10.1002/mrd.1080300302; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; KOSOWER NS, 1992, J ANDROL, V13, P342; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Traina ME, 2003, REPROD TOXICOL, V17, P25, DOI 10.1016/S0890-6238(02)00101-6; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019	23	269	295	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					119	+		10.1038/nature06236	http://dx.doi.org/10.1038/nature06236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17943087				2022-12-28	WOS:000250585800049
J	Young, S; Axon, DJ; Robinson, A; Hough, JH; Smith, JE				Young, S.; Axon, D. J.; Robinson, A.; Hough, J. H.; Smith, J. E.			The rotating wind of the quasar PG 1700+518	NATURE			English	Article							BROAD ABSORPTION-LINE; ACTIVE GALACTIC NUCLEI; DRIVEN DISK WINDS; EMISSION-LINE; ACCRETION DISKS; AGN FEEDBACK; BLACK-HOLES; CONTINUUM; DYNAMICS; POLARIZATION	It is now widely accepted that most galaxies undergo an active phase, during which a central super-massive black hole generates vast radiant luminosities through the gravitational accretion of gas(1,2). Winds launched from a rotating accretion disk surrounding the black hole are thought to play a critical role, allowing the disk to shed angular momentum that would otherwise inhibit accretion(3,4). Such winds are capable of depositing large amounts of mechanical energy in the host galaxy and its environs, profoundly affecting its formation and evolution(5-7), and perhaps regulating the formation of large-scale cosmological structures in the early Universe(8,9). Although there are good theoretical grounds for believing that outflows from active galactic nuclei originate as disk winds(10), observational verification has proven elusive. Here we show that structures observed in polarized light across the broad Ha emission line in the quasar PG 17001518 originate close to the accretion disk in an electron scattering wind. The wind has large rotational motions (similar to 4,000 km s(-1)), providing direct observational evidence that outflows from active galactic nuclei are launched from the disks. Moreover, the wind rises nearly vertically from the disk, favouring launch mechanisms that impart an initial acceleration perpendicular to the disk plane.	Rochester Inst Technol, Dept Phys, Rochester, NY 14623 USA; Univ Hertfordshire, Sci & Technol Res Inst, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	Rochester Institute of Technology; University of Hertfordshire	Young, S (corresponding author), Rochester Inst Technol, Dept Phys, 84 Lomb Mem Dr, Rochester, NY 14623 USA.	sxysps@rit.edu	lewchavaroj, runglawan/B-5191-2009		Science and Technology Facilities Council [PP/D000920/1] Funding Source: researchfish; STFC [PP/D000920/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BARVAINIS R, 1987, ASTROPHYS J, V320, P537, DOI 10.1086/165571; BEGELMAN MC, 1983, ASTROPHYS J, V271, P70, DOI 10.1086/161178; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Crenshaw DM, 2003, ANNU REV ASTRON ASTR, V41, P117, DOI 10.1146/annurev.astro.41.082801.100328; DEKOOL M, 1995, ASTROPHYS J, V455, P448, DOI 10.1086/176594; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Elvis M, 2000, ASTROPHYS J, V545, P63, DOI 10.1086/317778; Ferrarese L, 2005, SPACE SCI REV, V116, P523, DOI 10.1007/s11214-005-3947-6; Menci N, 2006, ASTROPHYS J, V647, P753, DOI 10.1086/505528; MURRAY N, 1995, ASTROPHYS J, V451, P498, DOI 10.1086/176238; Ogle PM, 1999, ASTROPHYS J SUPPL S, V125, P1, DOI 10.1086/313272; Oudmaijer RD, 1998, MON NOT R ASTRON SOC, V300, P170, DOI 10.1046/j.1365-8711.1998.01875.x; Peterson BM, 2004, ASTROPHYS J, V613, P682, DOI 10.1086/423269; PETTINI M, 1985, ASTROPHYS J, V294, pL73, DOI 10.1086/184512; Proga D, 2004, ASTROPHYS J, V616, P688, DOI 10.1086/425117; Proga D, 2000, ASTROPHYS J, V543, P686, DOI 10.1086/317154; REES MJ, 1984, ANNU REV ASTRON ASTR, V22, P471, DOI 10.1146/annurev.aa.22.090184.002351; Reichard TA, 2003, ASTRON J, V126, P2594, DOI 10.1086/379293; Rokaki E, 1999, MON NOT R ASTRON SOC, V307, P41, DOI 10.1046/j.1365-8711.1999.02565.x; Scannapieco E, 2005, ASTROPHYS J, V635, pL13, DOI 10.1086/499271; Schmidt GD, 1999, ASTROPHYS J, V512, P125, DOI 10.1086/306770; SHLOSMAN I, 1985, ASTROPHYS J, V294, P96, DOI 10.1086/163278; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Smith JE, 2005, MON NOT R ASTRON SOC, V359, P846, DOI 10.1111/j.1365-2966.2005.08895.x; STONE JM, 1994, ASTROPHYS J, V433, P746, DOI 10.1086/174684; TURNSHEK DA, 1984, ASTROPHYS J, V280, P51, DOI 10.1086/161967; WEYMANN RJ, 1991, ASTROPHYS J, V373, P23, DOI 10.1086/170020; Young S, 2000, MON NOT R ASTRON SOC, V312, P567, DOI 10.1046/j.1365-8711.2000.03177.x; YOUNG S, UNPUB ASTROPHYS J	30	50	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					74	76		10.1038/nature06319	http://dx.doi.org/10.1038/nature06319			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972879	Green Submitted			2022-12-28	WOS:000250585800038
J	Kay, S; Hahn, S; Marois, E; Hause, G; Bonas, U				Kay, Sabine; Hahn, Simone; Marois, Eric; Hause, Gerd; Bonas, Ulla			A bacterial effector acts as a plant transcription factor and induces a cell size regulator	SCIENCE			English	Article							CAMPESTRIS PV VESICATORIA; AVIRULENCE GENE AVRBS3; PROTEIN AVRBS3; NUCLEAR IMPORT; III SECRETION; HOST-PLANT; XANTHOMONAS; EXPRESSION; RESISTANCE; PEPPER	Pathogenicity of many Gram-negative bacteria relies on the injection of effector proteins by type III secretion into eukaryotic cells, where they modulate host signaling pathways to the pathogen's benefit. One such effector protein injected by Xanthomonas into plants is AvrBs3, which localizes to the plant cell nucleus and causes hypertrophy of plant mesophyll cells. We show that AvrBs3 induces the expression of a master regulator of cell size, upa20, which encodes a transcription factor containing a basic helix-loop-helix domain. AvrBs3 binds to a conserved element in the upa20 promoter via its central repeat region and induces gene expression through its activation domain. Thus, AvrBs3 and likely other members of this family provoke developmental reprogramming of host cells by mimicking eukaryotic transcription factors.	Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06120 Halle, Germany; Univ Halle Wittenberg, Biozentrum, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Bonas, U (corresponding author), Univ Halle Wittenberg, Dept Genet, Inst Biol, Weinbergweg 10, D-06120 Halle, Germany.	ulla.bonas@genetik.uni-halle.de	Marois, Eric/AAZ-5549-2021; Marois, Eric/H-9246-2016	Marois, Eric/0000-0003-4147-3747; Marois, Eric/0000-0003-4147-3747				Bai JF, 2000, MOL PLANT MICROBE IN, V13, P1322, DOI 10.1094/MPMI.2000.13.12.1322; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; BONAS U, 1993, MOL GEN GENET, V238, P261, DOI 10.1007/BF00279555; Chalupowicz L, 2006, PLANTA, V224, P429, DOI 10.1007/s00425-006-0229-9; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Gurlebeck D, 2005, PLANT J, V42, P175, DOI 10.1111/j.1365-313X.2005.02370.x; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Jordan T, 2006, THEOR APPL GENET, V113, P895, DOI 10.1007/s00122-006-0349-4; Kitagawa N, 2005, BIOINFORMATICS, V21, P1758, DOI 10.1093/bioinformatics/bti253; KNOOP V, 1991, J BACTERIOL, V173, P7142, DOI 10.1128/jb.173.22.7142-7150.1991; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LEYNS F, 1984, BOT REV, V50, P308, DOI 10.1007/BF02862635; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Szurek B, 2002, MOL MICROBIOL, V46, P13, DOI 10.1046/j.1365-2958.2002.03139.x; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Wichmann G, 2004, GENETICS, V166, P693, DOI 10.1534/genetics.166.2.693; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yang YN, 1996, MOL PLANT MICROBE IN, V9, P105, DOI 10.1094/MPMI-9-0105	29	399	537	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					648	651		10.1126/science.1144956	http://dx.doi.org/10.1126/science.1144956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962565				2022-12-28	WOS:000250409200048
J	Barker, N; van Es, JH; Kuipers, J; Kujala, P; van den Born, M; Cozijnsen, M; Haegebarth, A; Korving, J; Begthel, H; Peters, PJ; Clevers, H				Barker, Nick; van Es, Johan H.; Kuipers, Jeroen; Kujala, Pekka; van den Born, Maaike; Cozijnsen, Miranda; Haegebarth, Andrea; Korving, Jeroen; Begthel, Harry; Peters, Peter J.; Clevers, Hans			Identification of stem cells in small intestine and colon by marker gene Lgr5	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; MOUSE SMALL-INTESTINE; ADULT-MOUSE; EPITHELIAL PROGENITORS; EXPRESSION; CANCER; OVEREXPRESSION; MUSASHI-1; RENEWAL; GPR49	The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals. It is currently believed that four to six crypt stem cells reside at the +4 position immediately above the Paneth cells in the small intestine; colon stem cells remain undefined. Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5, also known as Gpr49) was selected from a panel of intestinal Wnt target genes for its restricted crypt expression. Here, using two knock-in alleles, we reveal exclusive expression of Lgr5 in cycling columnar cells at the crypt base. In addition, Lgr5 was expressed in rare cells in several other tissues. Using an inducible Cre knock-in allele and the Rosa26-lacZ reporter strain, lineage-tracing experiments were performed in adult mice. The Lgr5-positive crypt base columnar cell generated all epithelial lineages over a 60-day period, suggesting that it represents the stem cell of the small intestine and colon. The expression pattern of Lgr5 suggests that it marks stem cells in multiple adult tissues and cancers.	Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Netherlands Cancer Institute	Clevers, H (corresponding author), Hubrecht Inst, Uppsalalan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Barker, Nick/A-5535-2011; Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; van+Es, Johan/ABD-5411-2021	Barker, Nick/0000-0003-3566-4475; 				BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Peters P. J., 2006, CURRENT PROTOCOLS CE; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029	30	3719	3891	23	482	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1003	U1		10.1038/nature06196	http://dx.doi.org/10.1038/nature06196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17934449				2022-12-28	WOS:000250395000041
J	Holt, PG; Sly, PD				Holt, Patrick G.; Sly, Peter D.			Th2 cytokines in the asthma late-phase response	LANCET			English	Editorial Material							HOSPITAL ADMISSIONS; INFECTIONS; RISK		Telethon Inst Child Hlth Res, Subiaco, WA 6008, Australia	Telethon Kids Institute; University of Western Australia	Holt, PG (corresponding author), Telethon Inst Child Hlth Res, Subiaco, WA 6008, Australia.	patrick@ichr.uwa.edu.au	Holt, Patrick G/H-1548-2011; Sly, Peter D/F-1486-2010	Holt, Patrick G/0000-0003-1193-0935; Sly, Peter D/0000-0001-6305-2201				Ali FR, 2004, AM J RESP CRIT CARE, V169, P20, DOI 10.1164/rccm.200305-690OC; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Hart PH, 1999, J LEUKOCYTE BIOL, V66, P575, DOI 10.1002/jlb.66.4.575; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; Holt PG, 2004, NAT IMMUNOL, V5, P695, DOI 10.1038/ni0704-695; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; O'Byrne PM, 2004, TRENDS PHARMACOL SCI, V25, P244, DOI 10.1016/j.tips.2004.03.008; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6	12	14	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1396	1398		10.1016/S0140-6736(07)61587-6	http://dx.doi.org/10.1016/S0140-6736(07)61587-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950849				2022-12-28	WOS:000250386000005
J	Ajioka, I; Martins, RAP; Bayazitov, IT; Donovan, S; Johnson, DA; Frase, S; Cicero, SA; Boyd, K; Zakharenko, SS; Dyer, MA				Ajioka, Itsuki; Martins, Rodrigo A. P.; Bayazitov, Ildar T.; Donovan, Stacy; Johnson, Dianna A.; Frase, Sharon; Cicero, Samantha A.; Boyd, Kelli; Zakharenko, Stanislav S.; Dyer, Michael A.			Differentiated horizontal Interneurons clonally expand to form metastatic retinoblastoma in mice	CELL			English	Article							PROGENITOR-CELL PROLIFERATION; SUBVENTRICULAR ZONE; RETINAL DEVELOPMENT; MAMMALIAN RETINA; MOUSE RETINA; MULLER GLIA; NEURONS; RB; REGENERATION; FOREBRAIN	During neurogenesis, the progression from a progenitor cell to a differentiated neuron is believed to be unidirectional and irreversible. The Rb family of proteins ( Rb, p107, and p130) regulates cell-cycle exit and differentiation during retinogenesis. Rb and p130 are redundantly expressed in the neurons of the inner nuclear layer (INL) of the retina. We have found that in the adult Rb; p130-deficient retinae p107 compensation prevents ectopic proliferation of INL neurons. However, p107 is haploinsufficient in this process. Differentiated Rb (-/-); p107(+/-); p130(-/-) horizontal interneurons re-entered the cell cycle, clonally expanded, and formed metastatic retinoblastoma. Horizontal cells were not affected in Rb+/-; p107(-/-); p130(-/-) or Rb-/-; p107(-/-); p130(+/-), retinae suggesting that one copy of Rb or p130 was sufficient to prevent horizontal proliferation. We hereby report that differentiated neurons can proliferate and form cancer while maintaining their differentiated state including neurites and synaptic connections.	St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38105 USA; Univ Memphis, Integrated Microscopy Ctr, Memphis, TN 38152 USA; St Jude Childrens Hosp, Anim Resources Ctr, Div Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; St Jude Children's Research Hospital	Dyer, MA (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 332 N Lauderdale, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Martins, Rodrigo/W-7604-2019; Dyer, Michael/N-8134-2018; Zakharenko, Stanislav/D-3287-2013; Martins, Rodrigo A. P./A-4701-2010	Martins, Rodrigo/0000-0002-8420-6991; Zakharenko, Stanislav/0000-0001-8115-202X; Martins, Rodrigo A. P./0000-0002-8420-6991	NEI NIH HHS [R01 EY014867, R01 EY014867-05] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014867] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Cunningham JJ, 2002, MOL CELL NEUROSCI, V19, P359, DOI 10.1006/mcne.2001.1090; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Dyer MA, 2005, NAT REV CANCER, V5, P91, DOI 10.1038/nrc1545; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fischer AJ, 2002, J NEUROSCI, V22, P9387; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Johnson DA, 2007, CANCER RES, V67, P2701, DOI 10.1158/0008-5472.CAN-06-3754; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; MacPherson D, 2007, CANCER RES, V67, P7547, DOI 10.1158/0008-5472.CAN-07-0276; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Skapek SX, 2001, ONCOGENE, V20, P6742, DOI 10.1038/sj.onc.1204876; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Zhang JK, 2004, CELL CYCLE, V3, P952; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318	27	150	153	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					378	390		10.1016/j.cell.2007.09.036	http://dx.doi.org/10.1016/j.cell.2007.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956737	Green Accepted, Bronze			2022-12-28	WOS:000250507700026
J	Hyman, SE				Hyman, Steven E.			How mice cope with stressful social situations	CELL			English	Editorial Material							DOPAMINE; AMYGDALA	Individuals differ greatly in their psychological responses to chronic stress. As a step toward understanding the neural basis for these individual differences, Krishnan et al. ( 2007) reveal molecular changes in the brain's reward circuits that make some mice resistant to the effects of social defeat.	Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA	Harvard University	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Massachusetts Hall, Cambridge, MA 02138 USA.	seh@harvard.edu						Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; KRISHNAN V, 2007, CELL; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Storm EE, 2005, NEURON, V47, P483, DOI 10.1016/j.neuron.2005.08.004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	10	12	12	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					232	234		10.1016/j.cell.2007.10.008	http://dx.doi.org/10.1016/j.cell.2007.10.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956724	Bronze			2022-12-28	WOS:000250507700013
J	Freedman, LP; Graham, WJ; Brazier, E; Smith, JM; Ensor, T; Fauveau, V; Themmen, E; Currie, S; Agarwal, K				Freedman, Lynn P.; Graham, Wendy J.; Brazier, Ellen; Smith, Jeffrey M.; Ensor, Tim; Fauveau, Vincent; Themmen, Ellen; Currie, Sheena; Agarwal, Koki			Practical lessons from global safe motherhood initiatives: time for a new focus on implementation	LANCET			English	Article							EMERGENCY OBSTETRIC CARE; MATERNAL MORTALITY; PROCESS INDICATORS; HEALTH; RESOURCES; COUNTRIES; PROGRAMS; DEATHS	The time is right to shift the focus of the global maternal health community to the challenges of effective implementation of services within districts. 20 years after the launch of the Safe Motherhood Initiative, the community has reached a broad consensus about priority interventions, incorporated these interventions into national policy documents, and organised globally in coalition with the newborn and child health communities. With changes in policy processes to emphasise country ownership, funding harmonisation, and results-based financing, the capacity of countries to implement services urgently needs to be strengthened. In this article, four global maternal health initiatives draw on their complementary experiences to identify a set of the central lessons on which to build a new, collaborative effort to implement equitable, sustainable maternal health services at scale. This implementation effort should focus on specific steps for strengthening the capacity of the district health system to convert inputs into functioning services that are accessible to and used by all segments of the population.	Columbia Univ, Mailman Sch Publ Hlth, Averting Maternal Death & Disabil Program, New York, NY 10032 USA; Univ Aberdeen, Aberdeen, Scotland; Family Care Int, New York, NY USA; JHPIEGO, ACCESS Program, Baltimore, MD USA; UNFPA, Geneva, Switzerland	Columbia University; University of Aberdeen; Jhpiego; United Nations Population Fund	Freedman, LP (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Averting Maternal Death & Disabil Program, 60 Haven Ave,B3, New York, NY 10032 USA.	lpf1@columbia.edu	Ensor, Tim/ABD-5899-2020	Ensor, Tim/0000-0003-0279-9576; Graham, Wendy/0000-0003-1473-5342				Afsana K, 2004, REPROD HEALTH MATTER, V12, P171, DOI 10.1016/S0968-8080(04)24142-8; *AMDD, 2003, EM OBST CAR RES TOOL; *AMDD, 2006, AV MAT DEATH DIS PRO; *AMDD ENG HLTH, 2003, QUAL IMPR EM OBST CA; Ashford L., 2006, DESIGNING HLTH POPUL; BAGGALEY R, IN PRESS TROP MED IN; Bailey P., 2002, IMPROVING EMERGENCY; Bailey PE, 2002, INT J GYNECOL OBSTET, V76, P299, DOI 10.1016/S0020-7292(01)00592-6; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Bullough C, 2004, NUMBERS REV MATERNAL, P125; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; *ENG HLTH, 2001, COPE MAT HLTH SERV P; Ensor T, 2005, HEALTH POLICY, V75, P49, DOI 10.1016/j.healthpol.2005.02.002; Family Care international, 2007, TEST APPR INCR SKILL; Fauveau V, 2006, INT J GYNECOL OBSTET, V93, P308, DOI 10.1016/j.ijgo.2006.01.031; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Fottrell Edward, 2007, Popul Health Metr, V5, P1, DOI 10.1186/1478-7954-5-1; Freedman LP, 2003, INT J GYNECOL OBSTET, V82, P111, DOI 10.1016/S0020-7292(03)00147-4; GEORGE A, 2007, THESIS U SUSSEX; Graham Wendy J, 2007, Reprod Health Matters, V15, P211, DOI 10.1016/S0968-8080(07)30324-8; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; HALL S, 2005, A0502 SOUGH STAT SCI; Herberg R, 2005, INT NURS REV, V52, P123, DOI 10.1111/j.1466-7657.2005.00263.x; *HLTH METR NETW, 2006, REP TECHN M; HOUNTON S, 2006, BURKINA FASO EVALUAT; Hussein J, 2007, B WORLD HEALTH ORGAN, V85, P68, DOI 10.2471/BLT.06.033506; *IMMP, 2007, IMMP TOOLK GUID TOOL; *IMMP, 2005, POL BRIEF IMPL FREE; Islam MT, 2006, REPROD HEALTH MATTER, V14, P61, DOI 10.1016/S0968-8080(06)27229-X; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P299, DOI 10.1016/j.ijgo.2005.12.005; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; LEWIS G, 2006, INTEGRATED MANAGEMEN, P73; Lipsky M., 1980, STREET LEVEL BUREAUC, DOI DOI 10.1007/s13178-012-0092-3; MACKINTOSH M, 2002, GROUP BEHAV DEV IS M; Maine D, 2005, INT J GYNECOL OBSTET, V89, P218, DOI 10.1016/j.ijgo.2005.01.039; MAKOWIECKA K, IN PRESS HLTH POLICY; McGinn T, 1997, INT J GYNECOL OBSTET, V59, pS245, DOI 10.1016/S0020-7292(97)00172-0; Milne L, 2004, J MIDWIFERY WOM HEAL, V49, P338, DOI 10.1016/j.jmwh.2004.04.002; *MIN SAL, 2006, EV IMP PROYECT FEMME; MULLAN F, 2007, LANCET          0614, DOI DOI 10.1016/S0140-6736(07)60785-5; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; PAXTON A, 2003, AMDD WORKBOOK USING; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Pitchforth E, 2007, HEALTH POLICY PLANN, V22, P311, DOI 10.1093/heapol/czm022; Potter C, 2004, HEALTH POLICY PLANN, V19, P336, DOI 10.1093/heapol/czh038; Rana TG, 2007, INT J GYNECOL OBSTET, V98, P271, DOI 10.1016/j.ijgo.2007.05.017; Ronsmans C, 2004, BJOG-INT J OBSTET GY, V111, P1027, DOI 10.1111/j.1471-0528.2004.00247.x; RONSMANS C, 2001, SAFE MOTHERHOOD STRA, P317; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; *UNICEF, 2003, EM OBST CAR HOSP FAC; *UNICEF WHO UNFPA, 1997, GUID MON AV US OBST; *WHO COMM MACR HLT, 2002, IMPR HLTH OUTC POOR; Witter Sophie, 2007, Hum Resour Health, V5, P2, DOI 10.1186/1478-4491-5-2; World Bank, 2004, WORLD DEV REP 2004 M, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X]; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	65	117	120	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1383	1391		10.1016/S0140-6736(07)61581-5	http://dx.doi.org/10.1016/S0140-6736(07)61581-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220SC	17933654				2022-12-28	WOS:000250176600033
J	Csikor, FF; Motz, C; Weygand, D; Zaiser, M; Zapperi, S				Csikor, Ferenc F.; Motz, Christian; Weygand, Daniel; Zaiser, Michael; Zapperi, Stefano			Dislocation avalanches, strain bursts, and the problem of plastic forming at the micrometer scale	SCIENCE			English	Article							SINGLE-CRYSTALS; FLOW; VELOCITIES	Under stress, many crystalline materials exhibit irreversible plastic deformation caused by the motion of lattice dislocations. In plastically deformed microcrystals, internal dislocation avalanches lead to jumps in the stress-strain curves (strain bursts), whereas in macroscopic samples plasticity appears as a smooth process. By combining three-dimensional simulations of the dynamics of interacting dislocations with statistical analysis of the corresponding deformation behavior, we determined the distribution of strain changes during dislocation avalanches and established its dependence on microcrystal size. Our results suggest that for sample dimensions on the micrometer and submicrometer scale, large strain fluctuations may make it difficult to control the resulting shape in a plastic-forming process.	Univ Roma La Sapienza, Dipartimento Fis, CNR, Ist Nazl Fis Mat, I-00185 Rome, Italy; Eotvos Lorand Univ, Dept Mat Phys, H-1518 Budapest, Hungary; Univ Edinburgh, Ctr Mat Sci & Engn, Edinburgh EH9 3JL, Midlothian, Scotland; Univ Karlsruhe, Inst Zuverlassigkeit Bauteilen & Syst, D-76131 Karlsruhe, Germany; Inst Sci Interchange Fdn, I-10133 Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; Eotvos Lorand University; University of Edinburgh; Helmholtz Association; Karlsruhe Institute of Technology	Zapperi, S (corresponding author), Univ Roma La Sapienza, Dipartimento Fis, CNR, Ist Nazl Fis Mat, Ple A Moro 2, I-00185 Rome, Italy.	stefano.zapperi@roma1.infn.it	Weygand, Daniel/D-7203-2013; Zapperi, Stefano/C-9473-2009	Zapperi, Stefano/0000-0001-5692-5465; Zaiser, Michael/0000-0001-7695-0350	EPSRC [EP/E029825/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E029825/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Colla EV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017601; Dimiduk DM, 2006, SCIENCE, V312, P1188, DOI 10.1126/science.1123889; DURIN G, 2005, SCI HYSTERESIS, P181; GODON H, 1984, CRYST RES TECHNOL, V19, P373, DOI 10.1002/crat.2170190313; Kubin LP, 2002, DISLOCATIONS IN SOLIDS, VOL 11, P101, DOI 10.1016/S1572-4859(02)80008-0; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; PETRI A, 1994, PHYS REV LETT, V73, P3423, DOI 10.1103/PhysRevLett.73.3423; POTTHOFF HH, 1983, PHYS STATUS SOLIDI A, V77, P215, DOI 10.1002/pssa.2210770126; Richeton T, 2005, NAT MATER, V4, P465, DOI 10.1038/nmat1393; Richeton T, 2006, MAT SCI ENG A-STRUCT, V424, P190, DOI 10.1016/j.msea.2006.03.072; Salminen LI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.185503; Schwerdtfeger J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/04/L04001; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; TINDER RF, 1973, ACTA METALL MATER, V21, P975, DOI 10.1016/0001-6160(73)90154-5; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Weiss J, 2003, SCIENCE, V299, P89, DOI 10.1126/science.1079312; Weiss J, 2000, J GEOPHYS RES-SOL EA, V105, P433, DOI 10.1029/1999JB900312; Weiss J, 1997, J PHYS CHEM B, V101, P6113, DOI 10.1021/jp963157f; Weygand D, 2005, MAT SCI ENG A-STRUCT, V400, P158, DOI 10.1016/j.msea.2005.03.102; Weygand D, 2002, MODEL SIMUL MATER SC, V10, P437, DOI 10.1088/0965-0393/10/4/306; Zaiser M, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/08/P08004; Zaiser M, 2006, ADV PHYS, V55, P185, DOI 10.1080/00018730600583514; Zaiser M, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/04/P04013	23	435	442	9	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					251	254		10.1126/science.1143719	http://dx.doi.org/10.1126/science.1143719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932293				2022-12-28	WOS:000250086100041
J	Rubio, V; Deng, XW				Rubio, Vicente; Deng, Xing Wang			Standing on the shoulders of GIGANTEA	SCIENCE			English	Editorial Material							CIRCADIAN CLOCK; ARABIDOPSIS; DEGRADATION; PROTEIN; FKF1; GENE		CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Madrid 28049, Spain; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Yale University	Rubio, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Madrid 28049, Spain.	vrubio@cnb.uam.es; xingwang.deng@yale.edu	Deng, Xing Wang/ABF-4107-2020; Rubio, Vicente/M-2962-2014	Rubio, Vicente/0000-0002-8800-2400				Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; KIM WY, 2007, NATURE; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077	11	11	11	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					206	207		10.1126/science.1150213	http://dx.doi.org/10.1126/science.1150213			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932276				2022-12-28	WOS:000250086100024
J	Dorn, GW				Dorn, Gerald W., II			Periostin and myocardial repair, regeneration, and recovery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Cincinnati, Ctr Mol Cardiovasc Res, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Dorn, GW (corresponding author), Univ Cincinnati, Ctr Mol Cardiovasc Res, Cincinnati, OH 45221 USA.							Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44	5	55	59	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1552	1554		10.1056/NEJMcibr074816	http://dx.doi.org/10.1056/NEJMcibr074816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928607				2022-12-28	WOS:000250037000018
J	Hayes, DF; Thor, AD; Dressler, LG; Weaver, D; Edgerton, S; Cowan, D; Broadwater, G; Goldstein, LJ; Martino, S; Ingle, JN; Henderson, IC; Norton, L; Winer, EP; Hudis, CA; Ellis, MJ; Berry, DA				Hayes, Daniel F.; Thor, Ann D.; Dressler, Lynn G.; Weaver, Donald; Edgerton, Susan; Cowan, David; Broadwater, Gloria; Goldstein, Lori J.; Martino, Silvana; Ingle, James N.; Henderson, I. Craig; Norton, Larry; Winer, Eric P.; Hudis, Clifford A.; Ellis, Matthew J.; Berry, Donald A.		CALGB Investigators	HER2 and response to paclitaxel in node-positive breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADJUVANT CHEMOTHERAPY; C-ERBB-2 EXPRESSION; PREDICT RESPONSE; DOSE INTENSITY; TRASTUZUMAB; THERAPY; HER-2/NEU; AMPLIFICATION; DOXORUBICIN; RESISTANCE	Background The status of human epidermal growth factor receptor type 2 (HER2) in breast-cancer cells predicts clinical outcomes in women who receive adjuvant anthracycline-based chemotherapy. We hypothesized that HER2 positivity predicts a benefit from adjuvant doxorubicin doses above standard levels, from the addition of paclitaxel after adjuvant chemotherapy with doxorubicin plus cyclophosphamide, or from both. Methods We randomly selected 1500 women from 3121 women with node-positive breast cancer who had been randomly assigned to receive doxorubicin (60, 75, or 90 mg per square meter of body-surface area) plus cyclophosphamide (600 mg per square meter) for four cycles, followed by four cycles of paclitaxel (175 mg per square meter) or observation. Tissue blocks from 1322 of these 1500 women were available. Immunohistochemical analyses of these tissue specimens for HER2 with the CB11 monoclonal antibody against HER2 or with a polyclonal-antibody assay kit and fluorescence in situ hybridization for HER2 amplification were performed. Results No interaction was observed between HER2 positivity and doxorubicin doses above 60 mg per square meter. HER2 positivity was, however, associated with a significant benefit from paclitaxel. The interaction between HER2 positivity and the addition of paclitaxel to the treatment was associated with a hazard ratio for recurrence of 0.59 (P=0.01). Patients with a HER2-positive breast cancer benefited from paclitaxel, regardless of estrogen-receptor status, but paclitaxel did not benefit patients with HER2-negative, estrogen-receptor-positive cancers. Conclusions The expression or amplification, or both, of HER2 by a breast cancer is associated with a benefit from the addition of paclitaxel after adjuvant treatment with doxorubicin (<60 mg per square meter) plus cyclophosphamide in node-positive breast cancer, regardless of estrogen-receptor status. Patients with HER2-negative, estrogen-receptor-positive, node-positive breast cancer may gain little benefit from the administration of paclitaxel after adjuvant chemotherapy with doxorubicin plus cyclophosphamide.	Univ Michigan, Canc Ctr 6312, Breast Oncol Program, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ Vermont, Ctr Canc, Fletcher Allen Hlth Care, Burlington, VT USA; Duke Univ, Ctr Stat, Canc & Leukemia Grp B, Durham, NC USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Angeles Clin & Res Inst, Santa Monica, CA USA; Mayo Clin, Rochester, MN USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of Vermont; University of Vermont Medical Center; Duke University; Fox Chase Cancer Center; Angeles Clinic & Research Institute; Mayo Clinic; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Siteman Cancer Center; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	Hayes, DF (corresponding author), Univ Michigan, Canc Ctr 6312, Breast Oncol Program, Ctr Comprehens Canc, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	hayesdf@umich.edu	Hayes, Daniel/ABE-1129-2020; Hudis, Clifford/AAW-9482-2021	Hudis, Clifford/0000-0001-7144-8791; Norton, Larry/0000-0003-3701-9250	NATIONAL CANCER INSTITUTE [U10CA031946, U10CA033601, R01CA092461] Funding Source: NIH RePORTER; NCI NIH HHS [CA33601, CA31946, CA092461] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abuharbeid S, 2005, N-S ARCH PHARMACOL, V371, P141, DOI 10.1007/s00210-004-1016-4; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P2356; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Di Leo A, 2004, BREAST CANCER RES TR, V86, P197, DOI 10.1023/B:BREA.0000036783.88387.47; Dressler LG, 2005, J CLIN ONCOL, V23, P4287, DOI 10.1200/JCO.2005.11.012; Formenti SC, 2002, INT J RADIAT ONCOL, V52, P397, DOI 10.1016/S0360-3016(01)02655-4; Gonzalez-Angulo AM, 2004, CANCER-AM CANCER SOC, V101, P258, DOI 10.1002/cncr.20348; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Konecny GE, 2004, JNCI-J NATL CANCER I, V96, P1141, DOI 10.1093/jnci/djh198; LIPPMAN ME, 1978, NEW ENGL J MED, V298, P1223, DOI 10.1056/NEJM197806012982203; Mass Robert D, 2005, Clin Breast Cancer, V6, P240, DOI 10.3816/CBC.2005.n.026; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; MUSS HB, 1994, NEW ENGL J MED, V331, P211; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; Pegram MD, 2000, SEMIN ONCOL, V27, P21; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Regan MM, 2005, BREAST, V14, P582, DOI 10.1016/j.breast.2005.08.021; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Schmidt M, 2003, J CANCER RES CLIN, V129, P295, DOI 10.1007/s00432-003-0430-1; Sezgin C, 2005, J CHEMOTHERAPY, V17, P96, DOI 10.1179/joc.2005.17.1.96; Sjostrom J, 2002, EUR J CANCER, V38, P535, DOI 10.1016/S0959-8049(01)00403-8; SLAMON D, 2005, BREAST CANC RES TREA, V94; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith IE, 2006, BMJ-BRIT MED J, V332, P34, DOI 10.1136/bmj.332.7532.34; Tanabe K, 2003, INT J ONCOL, V22, P875; Thor AD, 1998, JNCI-J NATL CANCER I, V90, P1346, DOI 10.1093/jnci/90.18.1346; Tulbah AM, 2002, MED ONCOL, V19, P15; Ueno NT, 2000, CLIN CANCER RES, V6, P250; Ueno NT, 1997, ONCOGENE, V15, P953, DOI 10.1038/sj.onc.1201250; Van Poznak C, 2002, J CLIN ONCOL, V20, P2319, DOI 10.1200/JCO.2002.08.125; Witters LM, 2003, AM J CLIN ONCOL-CANC, V26, P50, DOI 10.1097/00000421-200302000-00011; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; WOOD WC, 1994, NEW ENGL J MED, V331, P139; WOOD WC, 1994, NEW ENGL J MED, V330, P1253, DOI 10.1056/NEJM199405053301801; Yamauchi H, 2001, J CLIN ONCOL, V19, P2334, DOI 10.1200/JCO.2001.19.8.2334; Yu DH, 2001, SEMIN ONCOL, V28, P12	45	442	464	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1496	1506		10.1056/NEJMoa071167	http://dx.doi.org/10.1056/NEJMoa071167			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928597				2022-12-28	WOS:000250037000006
J	Baurle, I; Smith, L; Baulcombe, DC; Dean, C				Baeurle, Isabel; Smith, Lisa; Baulcombe, David C.; Dean, Caroline			Widespread role for the flowering-time regulators FCA and FPA in RNA-mediated chromatin silencing	SCIENCE			English	Article							DIRECTED DNA METHYLATION; PROCESSING CENTER; ARABIDOPSIS; PROTEIN; HETEROCHROMATIN; SIRNA; IV; ARGONAUTE4; ENCODES; DOMAINS	The RRM-domain proteins FCA and FPA have previously been characterized as flowering-time regulators in Arabidopsis. We show that they are required for RNA-mediated chromatin silencing of a range of loci in the genome. At some target loci, FCA and FPA promote asymmetric DNA methylation, whereas at others they function in parallel to DNA methylation. Female gametophytic development and early embryonic development are particularly susceptible to malfunctions in FCA and FPA. We propose that FCA and FPA regulate chromatin silencing of single and low-copy genes and interact in a locus-dependent manner with the canonical small interfering RNA-directed DNA methylation pathway to regulate common targets.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baurle, I (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	isabel.baurle@bbsrc.ac.uk; caroline.dean@bbsrc.ac.uk	Bäurle, Isabel/ABD-6356-2021; Smith, Lisa/E-6506-2011	Bäurle, Isabel/0000-0001-5633-8068; Baulcombe, David/0000-0003-0780-6878; Smith, Lisa/0000-0003-2364-8187; Dean, Caroline/0000-0002-6555-3525	Natural Environment Research Council [NE/C507629/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Habu Y, 2006, EMBO REP, V7, P1279, DOI 10.1038/sj.embor.7400835; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; LIU F, IN PRESS MOL CELL; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Sarnowski TJ, 2002, NUCLEIC ACIDS RES, V30, P3412, DOI 10.1093/nar/gkf458; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	29	143	152	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					109	112		10.1126/science.1146565	http://dx.doi.org/10.1126/science.1146565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916737				2022-12-28	WOS:000249915400053
J	Hawkins, PT; Stephens, LR				Hawkins, Phillip T.; Stephens, Len R.			PI3K gamma is a key regulator of inflammatory responses and cardiovascular homeostasis	SCIENCE			English	Editorial Material							PHOSPHOINOSITIDE 3-KINASE P110-GAMMA; INHIBITION; SUBUNIT; KINASE	Class I phosphoinositide 3-kinase (PI3K) signaling pathways regulate several important cellular functions, including cellular growth, division, survival, and movement. Class IB PI3K (also known as PI3K gamma) links heterotrimeric GTP-binding protein-coupled receptors to these pathways. Activation of class IB PI3K results in the rapid synthesis of phosphatidylinositol-3,4,5-trisphosphate [PtdIns(3,4,5)P-3] and its dephosphorylation product PtdIns(3,4)P-2 in the plasma membrane. These two lipid messengers bind to pleckstrin homology domain-containing effectors that regulate a complex signaling web downstream of receptor activation. Characteristic features of this pathway are the regulation of protein kinases and the regulation of small guanosine triphosphatases that control cellular movement, adhesion, contraction, and secretion. Most of the ligands that activate class IB PI3K are involved in coordinating the body's response to injury and infection, and recent studies suggest that small molecule inhibitors of this enzyme may represent a novel class of anti-inflammatory therapeutic agents.	Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Hawkins, PT (corresponding author), Babraham Inst, Cambridge CB22 3AT, England.	phillip.hawkins@bbsrc.ac.uk; len.stephens@bbsrc.ac.uk		Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487				Andrews S., 2007, SCI STKE, V2007; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hirsch E, 2006, THROMB HAEMOSTASIS, V95, P29, DOI 10.1160/TH05-07-0476; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200	14	52	55	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					64	66		10.1126/science.1145420	http://dx.doi.org/10.1126/science.1145420			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916723				2022-12-28	WOS:000249915400037
J	Adamantidis, AR; Zhang, F; Aravanis, AM; Deisseroth, K; De Lecea, L				Adamantidis, Antoine R.; Zhang, Feng; Aravanis, Alexander M.; Deisseroth, Karl; De Lecea, Luis			Neural substrates of awakening probed with optogenetic control of hypocretin neurons	NATURE			English	Article							TRANSGENIC MICE; EXCITABLE CELLS; OPTICAL CONTROL; SLEEP; NARCOLEPSY; CHANNELRHODOPSIN-2; ACTIVATION; PHOTOSTIMULATION; CIRCUITRY; RESPONSES	The neural underpinnings of sleep involve interactions between sleep-promoting areas such as the anterior hypothalamus, and arousal systems located in the posterior hypothalamus, the basal forebrain and the brainstem(1,2). Hypocretin(3) (Hcrt, also known as orexin(4))-producing neurons in the lateral hypothalamus(5) are important for arousal stability(2), and loss of Hcrt function has been linked to narcolepsy(6-9). However, it is unknown whether electrical activity arising from Hcrt neurons is sufficient to drive awakening from sleep states or is simply correlated with it. Here we directly probed the impact of Hcrt neuron activity on sleep state transitions with in vivo neural photostimulation(10-18), genetically targeting channelrhodopsin-2 to Hcrt cells and using an optical fibre to deliver light deep in the brain, directly into the lateral hypothalamus, of freely moving mice. We found that direct, selective, optogenetic photostimulation of Hcrt neurons increased the probability of transition to wakefulness from either slow wave sleep or rapid eye movement sleep. Notably, photostimulation using 5-30 Hz light pulse trains reduced latency to wakefulness, whereas 1 Hz trains did not. This study establishes a causal relationship between frequency-dependent activity of a genetically defined neural cell type and a specific mammalian behaviour central to clinical conditions and neurobehavioural physiology.	Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; Stanford Univ, Dept Bioengn, James H Clark Ctr W083, Stanford, CA 94305 USA	Stanford University; Stanford University	De Lecea, L (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, 701B Welch Rd, Palo Alto, CA 94304 USA.	deissero@stanford.edu; llecea@stanford.edu	de Lecea, Luis/ABE-4005-2021; Macrae, Rhiannon/AAX-1536-2020	de Lecea, Luis/0000-0002-8921-5942; Adamantidis, Antoine/0000-0003-2531-5175	NIH HHS [DP1 OD000616] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bourgin P, 2000, J NEUROSCI, V20, P7760; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Eggermann E, 2003, J NEUROSCI, V23, P1557; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Smart D, 2001, BRIT J PHARMACOL, V132, P1179, DOI 10.1038/sj.bjp.0703953; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	29	856	902	6	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					420	U9		10.1038/nature06310	http://dx.doi.org/10.1038/nature06310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17943086	Green Accepted			2022-12-28	WOS:000250918600055
J	Chrysostomou, A; Lucas, PW; Hough, JH				Chrysostomou, Antonio; Lucas, Philip W.; Hough, James H.			Circular polarimetry reveals helical magnetic fields in the young stellar object HH 135-136	NATURE			English	Article							HERBIG-HARO OBJECTS; IMAGING POLARIMETRY; POLARIZATION; REGION; SCATTERING	Magnetic fields are believed to have a vital role in regulating and shaping the flow of material onto and away from protostars during their initial mass accretion phase. It is becoming increasingly accepted(1) that bipolar outflows are generated and collimated as material is driven along magnetic field lines and centrifugally accelerated off a rotating accretion disk. However, the precise role of the magnetic field is poorly understood and evidence for its shape and structure has not been forthcoming. Here we report imaging circular polarimetry in the near-infrared and Monte Carlo modelling showing that the magnetic field along the bipolar outflow of the HH 135-136 young stellar object is helical. The field retains this shape for large distances along the outflow, so the field structure can also provide the necessary magnetic pressure for collimation of the outflow. This result lends further weight to the hypothesis-central to any theory of star formation-that the outflow is an important instrument for the removal of high-angular-momentum material from the accretion disk, thereby allowing the central protostar to increase its mass.	Univ Hertfordshire, Sci & Technol Res Inst, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Lucas, PW (corresponding author), Univ Hertfordshire, Sci & Technol Res Inst, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England.	p.w.lucas@herts.ac.uk		Lucas, Philip/0000-0002-8872-4462				Arce H. G., 2007, PROTOSTARS PLANETS, P245; Bacciotti F, 2000, ASTROPHYS J, V537, pL49, DOI 10.1086/312745; Buschermohle M, 2005, ASTROPHYS J, V624, P821, DOI 10.1086/429244; Chrysostomou A, 2000, MON NOT R ASTRON SOC, V312, P103, DOI 10.1046/j.1365-8711.2000.03126.x; Chrysostomou A, 1997, MON NOT R ASTRON SOC, V285, P750, DOI 10.1093/mnras/285.4.750; CHRYSOSTOMOU A, 1994, MON NOT R ASTRON SOC, V268, P325, DOI 10.1093/mnras/268.2.325; Dougados C, 2000, ASTRON ASTROPHYS, V357, pL61; Ferreira J, 1997, ASTRON ASTROPHYS, V319, P340; Gledhill TM, 1996, MON NOT R ASTRON SOC, V282, P1418, DOI 10.1093/mnras/282.4.1418; Gredel R, 2006, ASTRON ASTROPHYS, V457, P157, DOI 10.1051/0004-6361:20054746; HARO G, 1952, ASTROPHYS J, V115, P572, DOI 10.1086/145576; Hartigan P, 1999, ASTROPHYS J, V512, P901, DOI 10.1086/306792; HERBIG GH, 1950, ASTROPHYS J, V111, P11, DOI 10.1086/145232; Lucas PW, 2005, ORIGINS LIFE EVOL B, V35, P29, DOI 10.1007/s11084-005-7770-6; Lucas PW, 2004, MON NOT R ASTRON SOC, V352, P1347, DOI 10.1111/j.1365-2966.2004.08026.x; Lucas PW, 2003, J QUANT SPECTROSC RA, V79, P921, DOI 10.1016/S0022-4073(02)00329-1; Menard F, 2000, ASTR SOC P, V213, P355; OGURA K, 1992, ASTROPHYS J, V400, P248, DOI 10.1086/171991; Pudritz R. E., 2007, PROTOSTARS PLANETS, P277; Ray T., 2007, PROTOSTARS PLANETS, P231; REIPURTH B, 1997, HERBIGHARO FLOWS BIR, V182; Rodrigues CV, 2007, ASTRON J, V133, P2334, DOI 10.1086/513318; Takami M, 2004, ASTRON ASTROPHYS, V416, P213, DOI 10.1051/0004-6361:20034531; Tamura M, 1997, MON NOT R ASTRON SOC, V287, P894, DOI 10.1093/mnras/287.4.894; Whitney BA, 2002, ASTROPHYS J, V574, P205, DOI 10.1086/340901	26	35	35	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					71	73		10.1038/nature06220	http://dx.doi.org/10.1038/nature06220			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972878	Green Submitted			2022-12-28	WOS:000250585800037
J	Kemiktarak, U; Ndukum, T; Schwab, KC; Ekinci, KL				Kemiktarak, U.; Ndukum, T.; Schwab, K. C.; Ekinci, K. L.			Radio-frequency scanning tunnelling microscopy	NATURE			English	Article							ATOMIC FORCE MICROSCOPE; SHOT-NOISE; NANOMECHANICAL RESONATOR; ELECTRONIC-STRUCTURE; SURFACE; TRANSDUCERS	The scanning tunnelling microscope (STM)(1) relies on localized electron tunnelling between a sharp probe tip and a conducting sample to attain atomic-scale spatial resolution. In the 25-year period since its invention, the STM has helped uncover a wealth of phenomena in diverse physical systems-ranging from semi-conductors(2,3) to superconductors(4) to atomic and molecular nanosystems(5-9). A severe limitation in scanning tunnelling microscopy is the low temporal resolution, originating from the diminished high-frequency response of the tunnel current readout circuitry. Here we overcome this limitation by measuring the reflection from a resonant inductor-capacitor circuit in which the tunnel junction is embedded, and demonstrate electronic bandwidths as high as 10 MHz. This similar to 100-fold bandwidth improvement on the state of the art translates into fast surface topography as well as delicate measurements in mesoscopic electronics and mechanics. Broadband noise measurements across the tunnel junction using this radio-frequency STM have allowed us to perform thermometry at the nanometre scale. Furthermore, we have detected high-frequency mechanical motion with a sensitivity approaching similar to 15 fm Hz(-1/2). This sensitivity is on par with the highest available from nanoscale optical and electrical displacement detection techniques, and the radio-frequency STM is expected to be capable of quantum-limited position measurements.	Boston Univ, Dept Aerosp & Mech Engn, Boston, MA 02215 USA; Boston Univ, Dept Phys, Boston, MA 02215 USA; Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Boston University; Boston University; Cornell University	Ekinci, KL (corresponding author), Boston Univ, Dept Aerosp & Mech Engn, Boston, MA 02215 USA.	ekinci@bu.edu	Ekinci, Kamil/A-1215-2009					BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; BIRK H, 1995, PHYS REV LETT, V75, P1610, DOI 10.1103/PhysRevLett.75.1610; Clerk AA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.121303; Durkan C, 2002, APPL PHYS LETT, V80, P458, DOI 10.1063/1.1434301; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Flowers-Jacobs NE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.096804; HALLMARK VM, 1987, PHYS REV LETT, V59, P2879, DOI 10.1103/PhysRevLett.59.2879; Hornbaker DJ, 2002, SCIENCE, V295, P828, DOI 10.1126/science.1068133; Jehl X, 2000, NATURE, V405, P50, DOI 10.1038/35011012; Kurokawa S, 1998, J APPL PHYS, V83, P7416, DOI 10.1063/1.367985; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; MAJUMDAR A, 1993, APPL PHYS LETT, V62, P2501, DOI 10.1063/1.109335; MAMIN HJ, 1994, J APPL PHYS, V75, P161, DOI 10.1063/1.355877; MANASSEN Y, 1989, PHYS REV LETT, V62, P2531, DOI 10.1103/PhysRevLett.62.2531; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; NUNES G, 1993, SCIENCE, V262, P1029, DOI 10.1126/science.262.5136.1029; Pan SH, 2000, NATURE, V403, P746, DOI 10.1038/35001534; PRESILLA C, 1992, PHYS REV B, V45, P3735, DOI 10.1103/PhysRevB.45.3735; Rost MJ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1915288; Schoelkopf RJ, 1998, SCIENCE, V280, P1238, DOI 10.1126/science.280.5367.1238; Spietz L, 2003, SCIENCE, V300, P1929, DOI 10.1126/science.1084647; STROSCIO JA, 1986, PHYS REV LETT, V57, P2579, DOI 10.1103/PhysRevLett.57.2579; Truitt PA, 2007, NANO LETT, V7, P120, DOI 10.1021/nl062278g; WEISS S, 1993, APPL PHYS LETT, V63, P2567, DOI 10.1063/1.110435; WHITMAN LJ, 1991, SCIENCE, V251, P1206, DOI 10.1126/science.251.4998.1206; WOLKOW R, 1988, PHYS REV LETT, V60, P1049, DOI 10.1103/PhysRevLett.60.1049; XU Y, 1995, APPL PHYS LETT, V67, P2305, DOI 10.1063/1.115134; YURKE B, 1990, PHYS REV B, V41, P8184, DOI 10.1103/PhysRevB.41.8184	30	81	84	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					85	+		10.1038/nature06238	http://dx.doi.org/10.1038/nature06238			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972882				2022-12-28	WOS:000250585800041
J	Raveendran, NS; Tharyan, P; Alexander, J; Adams, CE				Raveendran, Nirmal S.; Tharyan, Prathap; Alexander, Jacob; Adams, Clive Elliot		TREC-India II Collaborative Grp	Rapid tranquillisation in psychiatric emergency setting in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTELY AGITATED PATIENTS; DOUBLE-BLIND; LORAZEPAM; PLACEBO; EFFICACY; VIOLENT; SAFETY	Objective To compare the effect of intramuscular olanzapine with intramuscular haloperidol plus promethazine on rapid tranquillisation of agitated or violent adults with mental illness. Design Pragmatic, allocation concealed, randomised controlled trial. Setting Emergency services of a general hospital psychiatry department in Vellore, south India. Participants 300 adults with agitated orviolent behaviour as a result of mental illness; 150 randomised to intramuscular olanzapine and 150 randomised to intramuscular haloperidol plus promethazine. Interventions Open treatment with intramuscular olanzapine or intramuscular haloperidol plus promethazine. Main outcome measures Primary outcome was proportion of patients who were tranquil or asleep at 15 minutes and 240 minutes. Secondary outcomes were proportion of patients who were tranquil, asleep, restrained, absconding, or clinically improved at 15, 30, 60, 120, and 240 minutes; additional medical interventions and adverse effects over four hours; and compliance with oral drugs and adverse effects over two weeks. Results Of 300 people randomised to receive either intramuscular olanzapine or intramuscular haloperidol plus promethazine, follow-up data were available for primary outcomes for 298 (99%). Both treatments resulted in similar proportions of people being tranquil or asleep at 15 minutes (olanzapine 131/150 (87%), haloperidol plus promethazine 136/150 (91%); relative risk 0.96, 95% confidence interval 0.34 to 1.47) and 240 minutes (olanzapine 144/150 (96%), haloperidol plus promethazine 145/150 (97%.); relative risk 0.99, 0.95 to 1.03). However, more people given olanzapine than those given haloperidol plus promethazine required additional drugs over four hours (65/150 (43%) v 31/150 (21%); relative risk 2.07, 1.43 to 2.97). Adverse effects were uncommon with both treatments. Conclusions Intramuscular olanzapine and intramuscular haloperidol plus promethazine were effective at rapidly tranquillising or sedating agitated or violent adults with mental illness but the combination resulted in fewer additional medical interventions within four hours of intervention.	Univ Nottingham, Div Psychiat, Nottingham NG7 2RD, England	University of Nottingham	Tharyan, P (corresponding author), Christian Med Coll & Hosp, Vellore & BV Moses Ctr Clin Trials & Evidence Bas, Dept Psychiat, Vellore 632002, Tamil Nadu, India.	prathap@cmcvellore.ac.in						Alexander J, 2005, EVID-BASED MENT HEAL, V8, P7, DOI 10.1136/ebmh.8.1.7; Alexander J, 2004, BRIT J PSYCHIAT, V185, P63, DOI 10.1192/bjp.185.1.63; Battaglia J, 2002, SCHIZOPHR RES, V53, P182; Binder RL, 1999, PSYCHIATR SERV, V50, P1553, DOI 10.1176/ps.50.12.1553; Breier A, 2002, ARCH GEN PSYCHIAT, V59, P441, DOI 10.1001/archpsyc.59.5.441; David SR, 2001, EUROPEAN NEUROPSYCHO, V11, P276; *EXP CONS GUID GRO, 1999, J CLIN PSYCHIAT S11, V60, P3; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hillard JR, 1998, J CLIN PSYCHIAT, V59, P57; Huf G, 2003, BMJ-BRIT MED J, V327, P708; Huf G, 2007, BMJ-BRIT MED J, V335, P869, DOI 10.1136/bmj.39339.448819.AE; Huf G, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-4; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaplan HI., 1994, KAPLAN SADOCKS SYNOP; Kerwin Robert, 2002, Evid Based Ment Health, V5, P18; McAllister-Williams RH, 2002, BRIT J PSYCHIAT, V180, P485, DOI 10.1192/bjp.180.6.485; Meehan K, 2001, J CLIN PSYCHOPHARM, V21, P389, DOI 10.1097/00004714-200108000-00006; Meehan KM, 2002, NEUROPSYCHOPHARMACOL, V26, P494, DOI 10.1016/S0893-133X(01)00365-7; *NICE, 2005, VIOL CLIN PRACT GUID; Reddy V M, 1998, Indian J Psychiatry, V40, P149; TARDIFF K, 1985, AM J PSYCHIAT, V142, P960; *TRE COLL GROUP, 2003, BMJ-BRIT MED J, V327, P708; van Harten PN, 1999, BMJ-BRIT MED J, V319, P623, DOI 10.1136/bmj.319.7210.623; *WHO, 1999, WHO MOD LIST ESS DRU; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; World Medical Association, 2002, WORLD MED ASS DECL H; Wright P, 2001, AM J PSYCHIAT, V158, P1149, DOI 10.1176/appi.ajp.158.7.1149; Wright P, 2003, CAN J PSYCHIAT, V48, P716, DOI 10.1177/070674370304801102	29	71	75	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2007	335	7625					865	869		10.1136/bmj.39341.608519.BE	http://dx.doi.org/10.1136/bmj.39341.608519.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17954514	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000250631000038
J	Reynolds, T				Reynolds, Toby			Polio: An end in sight?	BRITISH MEDICAL JOURNAL			English	Article												Toby.reynolds@gmail.com						Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; *GLOB POL ER IN, WILD POL 2000 2007; Razum O, 2004, LANCET, V363, P2190, DOI 10.1016/S0140-6736(04)16516-1; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7	4	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2007	335	7625					852	854		10.1136/bmj.39367.426655.AD	http://dx.doi.org/10.1136/bmj.39367.426655.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17962284	Green Published			2022-12-28	WOS:000250631000033
J	Ciesla, FJ				Ciesla, Fred J.			Outward transport of high-temperature materials around the midplane of the solar nebula	SCIENCE			English	Article							PROTOPLANETARY ACCRETION DISKS; T-TAURI DISKS; COMET 81P/WILD-2; CRYSTALLINE SILICATES; PLANET FORMATION; DUST; INSTABILITY; EVOLUTION; STARDUST; SAMPLES	The Stardust samples collected from Comet 81P/Wild 2 indicate that large-scale mixing occurred in the solar nebula, carrying materials from the hot inner regions to cooler environments far from the Sun. Similar transport has been inferred from telescopic observations of protoplanetary disks around young stars. Models for protoplanetary disks, however, have difficulty explaining the observed levels of transport. Here I report the results of a new two-dimensional model that shows that outward transport of high-temperature materials in protoplanetary disks is a natural outcome of disk formation and evolution. This outward transport occurs around the midplane of the disk.	Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Ciesla, FJ (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	fciesla@ciw.edu						Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Cuzzi J. N., 2003, ICARUS, V127, P290; CUZZI JN, 2006, METEORITES EARLY SOL, V2, P353; Dullemond CP, 2005, ASTRON ASTROPHYS, V434, P971, DOI 10.1051/0004-6361:20042080; Flynn GJ, 2006, SCIENCE, V314, P1731, DOI 10.1126/science.1136141; Gail HP, 2001, ASTRON ASTROPHYS, V378, P192, DOI 10.1051/0004-6361:20011130; Gammie CF, 1996, ASTROPHYS J, V457, P355, DOI 10.1086/176735; Hallenbeck SL, 2000, ASTROPHYS J, V535, P247, DOI 10.1086/308810; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Keller C, 2004, ASTRON ASTROPHYS, V415, P1177, DOI 10.1051/0004-6361:20034629; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Mukhopadhyay B, 2005, ASTROPHYS J, V629, P383, DOI 10.1086/431419; Nuth JA, 2000, NATURE, V406, P275, DOI 10.1038/35018516; PRINGLE JE, 1981, ANNU REV ASTRON ASTR, V19, P137, DOI 10.1146/annurev.aa.19.090181.001033; Takeuchi T, 2002, ASTROPHYS J, V581, P1344, DOI 10.1086/344437; Urpin V. A., 1984, Soviet Astronomy, V28, P50; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	28	201	202	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					613	615		10.1126/science.1147273	http://dx.doi.org/10.1126/science.1147273			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962555				2022-12-28	WOS:000250409200037
J	Kolter, R				Kolter, Roberto			Deadly priming	SCIENCE			English	Editorial Material							CELL-DEATH; BACTERIA		Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kolter, R (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	rkolter@hms.harvard.edu						Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Sabato Ernesto., 1988, HOMBRES ENGRANAJES H; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81	8	3	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					578	579		10.1126/science.1150704	http://dx.doi.org/10.1126/science.1150704			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962544				2022-12-28	WOS:000250409200026
J	Romer, P; Hahn, S; Jordan, T; Strauss, T; Bonas, U; Lahaye, T				Roemer, Patrick; Hahn, Simone; Jordan, Tina; Strauss, Tina; Bonas, Ulla; Lahaye, Thomas			Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene	SCIENCE			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; BACTERIAL AVIRULENCE PROTEIN; CAMPESTRIS PV. VESICATORIA; AVRBS3 PROTEIN; CELL-DEATH; XANTHOMONAS; ARABIDOPSIS; EXPRESSION; SPECIFICITY; INSIGHTS	Plant disease resistance (R) proteins recognize matching pathogen avirulence proteins. Alleles of the pepper R gene Bs3 mediate recognition of the Xanthomonas campestris pv. vesicatoria (Xcv) type III effector protein AvrBs3 and its deletion derivative AvrBs3 Delta rep16. Pepper Bs3 and its allelic variant Bs3-E encode flavin monooxygenases with a previously unknown structure and are transcriptionally activated by the Xcv effector proteins AvrBs3 and AvrBs3 Delta rep16, respectively. We found that recognition specificity resides in the Bs3 and Bs3-E promoters and is determined by binding of AvrBs3 or AvrBs3 Delta rep16 to a defined promoter region. Our data suggest a recognition mechanism in which the Avr protein binds and activates the promoter of the cognate R gene.	Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06099 Halle, Germany	Martin Luther University Halle Wittenberg	Lahaye, T (corresponding author), Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06099 Halle, Germany.	lahaye@genetik.uni-halle.de	Strauss, Tina/N-9889-2018					Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; BONAS U, 1993, MOL GEN GENET, V238, P261, DOI 10.1007/BF00279555; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jordan T, 2006, THEOR APPL GENET, V113, P895, DOI 10.1007/s00122-006-0349-4; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; KNOOP V, 1991, J BACTERIOL, V173, P7142, DOI 10.1128/jb.173.22.7142-7150.1991; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Olszak B, 2006, PLANT SCI, V170, P614, DOI 10.1016/j.plantsci.2005.10.016; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Szurek B, 2002, MOL MICROBIOL, V46, P13, DOI 10.1046/j.1365-2958.2002.03139.x; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5	21	320	394	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					645	648		10.1126/science.1144958	http://dx.doi.org/10.1126/science.1144958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962564				2022-12-28	WOS:000250409200047
J	Gakidou, E; Oza, S; Fuertes, CV; Li, AY; Lee, DK; Sousa, A; Hogan, MC; Hoorn, SV; Ezzati, M				Gakidou, Emmanuela; Oza, Shefali; Fuertes, Cecilia Vidal; Li, Amy Y.; Lee, Diana K.; Sousa, Angelica; Hogan, Margaret C.; Hoorn, Stephen Vander; Ezzati, Majid			Improving child survival through environmental and nutritional interventions - The importance of targeting interventions toward the poor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REGIONAL BURDEN; RISK-FACTORS; HEALTH; MORTALITY; DETERMINANTS; INEQUALITIES; MALNUTRITION; PROGRESS; IMPACTS; DISEASE	Context The United Nations Millennium Development Goals (MDGs) set targets related to important global poverty, health, and sustainability issues. A critical but underinvestigated question for planning and allocating resources toward the MDGs is how interventions related to one MDG might affect progress toward other goals. Objectives To estimate the reduction in child mortality as a result of interventions related to the environmental and nutritional MDGs (improving child nutrition and providing clean water, sanitation, and fuels) and to estimate how the magnitude and distribution of the effects of interventions vary based on the economic status of intervention recipients. Design, Setting, and Population Population-level comparative risk assessment modeling the mortality effects of interventions on child nutrition and environmental risk factors, stratified by economic status. Data on economic status, child underweight, water and sanitation, and household fuels were from the nationally representative Demographic and Health Surveys for 42 countries in Latin America and the Caribbean, South Asia, and sub-Saharan Africa. Data on disease-specific child mortality were from the World Health Organization. Data on the hazardous effects of each MDG-related risk factor were from systematic reviews and meta-analyses of epidemiological studies. Main Outcome Measure Child mortality, stratified by comparable international quintiles of economic status. Results Implementing interventions that improve child nutrition and provide clean water and sanitation and clean household fuels to all children younger than 5 years would result in an estimated annual reduction in child deaths of 49 700 (14%) in Latin America and the Caribbean, 0.80 million (24%) in South Asia, and 1.47 million (31%) in sub-Saharan Africa. These benefits are equivalent to 30% to 48% of the current regional gaps toward the MDG target on reducing child mortality. Fifty percent coverage of the same environmental and nutritional interventions, as envisioned by the MDGs, would reduce child mortality by 26 900, 0.51 million, and 1.02 million in the 3 regions, respectively, if the interventions are implemented among the poor first. These reductions are 30% to 75% larger than those expected if the same 50% coverage first reached the wealthier households, who nonetheless are in need of similar interventions. Conclusions Interventions related to nutritional and environmental MDGs can also provide substantial gains toward the MDG of reducing child mortality. To maximize the reduction in childhood mortality, such integrated management of interventions should prioritize the poor.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland; University of Auckland	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	majid_ezzati@harvard.edu		Oza, Shefali/0000-0001-5872-486X				Bailis R, 2005, SCIENCE, V308, P98, DOI 10.1126/science.1106881; BICEGO G, 1996, DEMOGRAPHIC HLTH SUR, V20; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Eide GE, 2001, STAT METHODS MED RES, V10, P159, DOI 10.1191/096228001680195148; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fishman SM, 2004, COMP QUANTIFICATION, P39; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P17; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Moser KA, 2005, BRIT MED J, V331, P1180, DOI 10.1136/bmj.38659.588125.79; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; Pongou R, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-98; Pongou R, 2006, INT J EPIDEMIOL, V35, P648, DOI 10.1093/ije/dyl016; Preston S., 2000, DEMOGRAPHY MEASURING; PRUSSUSTUN A, 2004, COMP QUANTIFICATION, P1321; Rutstein S.O., 2004, DHS COMP REPORTS; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; SCRIMSHAW NS, 1968, WHO MONOGRAPH SERIES, V57; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UNICEF, 1990, STRAT IMPR NUTR CHIL; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; VISARIA P, 1980, 2 WORLD BANK LIV STA; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; WHO, 2002, RED RISKS PROM HLTH; Wirth ME, 2006, B WORLD HEALTH ORGAN, V84, P519, DOI 10.2471/BLT.04.019984; World Bank, 2004, WORLD DEV REP 2004 M	43	81	81	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1876	1887		10.1001/jama.298.16.1876	http://dx.doi.org/10.1001/jama.298.16.1876			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954539	Bronze			2022-12-28	WOS:000250356700020
J	Doshani, A; Teo, REC; Mayne, CJ; Tincello, DG				Doshani, Anjum; Teo, Roderick E. C.; Mayne, Christopher J.; Tincello, Douglas G.			Uterine prolapse	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PELVIC ORGAN PROLAPSE; GENITAL PROLAPSE; WOMEN; EPIDEMIOLOGY; HYSTERECTOMY; PROGRESSION; SYMPTOMS; SUPPORT; PESSARY; RISK		Univ Leicester, Leicester Royal Infirm, Robert Kilpatrick Clin Sci Unit, Reprod Sci Sect, Leicester LE2 7LX, Leics, England; Leicester Gen Hosp, Univ Hosp Leicester NHS Trust, Urogynaecol Dept, Womens Perinatal & Sexual Hlth Directorate, Leicester LE5 4PW, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Tincello, DG (corresponding author), Univ Leicester, Leicester Royal Infirm, Robert Kilpatrick Clin Sci Unit, Reprod Sci Sect, Leicester LE2 7LX, Leics, England.	dgt4@le.ac.uk						Barber Matthew D, 2005, Cleve Clin J Med, V72 Suppl 4, pS3; BARBER MD, 2003, AM UR SOC 24 ANN SCI; Chiaffarino F, 1999, EUR J OBSTET GYN R B, V82, P63, DOI 10.1016/S0301-2115(98)00175-4; Clemons JL, 2004, AM J OBSTET GYNECOL, V190, P1025, DOI 10.1016/j.ajog.2003.10.711; Colombo M, 1998, AM J OBSTET GYNECOL, V179, P13, DOI 10.1016/S0002-9378(98)70245-5; Cundiff GW, 2000, OBSTET GYNECOL, V95, P931, DOI 10.1016/S0029-7844(00)00788-2; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O; *DEP HLTH, 18 WEEK COMM PATHW P; Hagen S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003882.pub3; Hagen S, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004010.pub2., DOI 10.1002/14651858.CD004010.PUB2]; Hall AF, 1996, AM J OBSTET GYNECOL, V175, P1467, DOI 10.1016/S0002-9378(96)70091-1; Handa VL, 2004, AM J OBSTET GYNECOL, V190, P27, DOI 10.1016/j.ajog.2003.07.017; Handa VL, 2002, INT UROGYNECOL J PEL, V13, P349, DOI 10.1007/s001920200078; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Hospital Episode Statistics, 2005, HOSP EPISODE STAT; Maher C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004014.PUB3; Mant J, 1997, BRIT J OBSTET GYNAEC, V104, P579, DOI 10.1111/j.1471-0528.1997.tb11536.x; Maresh MJA, 2002, BJOG-INT J OBSTET GY, V109, P302, DOI 10.1111/j.1471-0528.2002.01282.x; Nygaard I, 2004, OBSTET GYNECOL, V104, P489, DOI 10.1097/01.AOG.0000136100.10818.d8; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Poma PA, 2000, J REPROD MED, V45, P789; Prolapse CL, 1995, DEWHURSTS TXB OBSTET, P642; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Swift SE, 2003, AM J OBSTET GYNECOL, V189, P372, DOI 10.1067/S0002-9378(03)00698-7; *U AB, 2007, PELV ORG PROL PHYS; *WELLB WOM, 2007, VAG RINGS PELV FLOOR	26	33	36	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2007	335	7624					819	823		10.1136/bmj.39356.604074.BE	http://dx.doi.org/10.1136/bmj.39356.604074.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AX	17947787	Green Published			2022-12-28	WOS:000250630700040
J	Levin, NW; Fishbane, S; Canedo, FV; Zeig, S; Nassar, GM; Moran, JE; Villa, G; Beyer, U; Guey, D				Levin, Nothan W.; Fishbane, Steven; Valdes Canedo, Francisco; Zeig, Steven; Nassar, George M.; Moran, John E.; Villa, Giuseppe; Beyer, Ulrich; Guey, Deiphine		MAXIMA Study Investigators	Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)	LANCET			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; RECEPTOR ACTIVATOR CERA; DARBEPOETIN-ALPHA; ANEMIA MANAGEMENT; STABLE HEMOGLOBIN; INTERVALS	Background Conventional treatment with epoetin to manage anaemia in chronic kidney disease needs frequent administrations, changes of dose, and close monitoring of haemoglobin concentrations. We aimed to compare the effectiveness of methoxy polyethylene glycol-epoetin beta, given intravenously at 2-week or 4-week intervals, with epoetin treatment one to three times per week for haemoglobin control in haemodialysis patients. Methods We screened 1115 adult patients from 96 centres who had stable chronic renal anaemia and were on dialysis treatment and intravenous maintenance epoetin. We did an open-label, parallel-group, non-inferiority trial to compare two dosing intervals of methoxy polyethylene glycol-epoetin beta with standard epoetin treatment. We established baseline haemoglobin concentration and eligibility over a 4-week run-in period. 223 patients were randomly assigned to receive methoxy polyethylene glycol-epoetin beta every 2 weeks, 224 to receive it every 4 weeks, and 226 to receive standard epoetin treatment. The initial dose was based on the average epoetin dose given during the week before the switch. The primary endpoint was change in haemoglobin concentration between baseline and the assessment period. We analysed patients both by intention to treat and per protocol. This study is registered with ClinicalTrials. gov, number NCT00077610. Findings We excluded 133 of the 673 randomised patients from the per-protocol analysis because they had inadequate iron status or fewer than five haemoglobin measurements during the assessment period or needed red blood cell transfusions. The mean change from baseline haemoglobin for patients who had switched to intravenous methoxy polyethylene glycol-epoetin beta every 2 weeks (-0.71 g/L, 95% CI -2.20 to 0.77) or every 4 weeks (-0.25 g/L, -1.79 to 1.29) was non-inferior to the mean change for patients who continued treatment with epoetin (-0.75 g/L, -2.26 to 0.75) (p< 0.0001 for both comparisons). Of the 666 patients who received at least one dose of study drug, the incidence of adverse events or serious adverse events did not differ between groups (p=0.30 and p=0.40, respectively). Interpretation This long-acting erythropoiesis-stimulating agent is as safe as conventional epoetin treatment, and can maintain anaemia management in haemodialysis patients when given intravenously at 4-week dosing intervals.	Renal Res Inst, New York, NY 10128 USA; Winthrop Univ Hosp, Mineola, NY 11501 USA; Hosp Juan Canalejo, La Coruna, Spain; Clin Res Inc, Pembroke Pines, FL USA; Renal Res Inst, Houston, TX USA; Satellite Healthcare Inc, Mountain View, CA USA; IRCCS, Fdn S Maugeri, Pavia, Italy; F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland	Renal Research Institute; Winthrop University Hospital; Complejo Hospitalario Universitario A Coruna; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Roche Holding	Levin, NW (corresponding author), Renal Res Inst, 207 E 94th St,Suite 303, New York, NY 10128 USA.	nlevin@rriny.com	Nassar, George/T-2400-2019	Beyer, Ulrich/0000-0001-5601-2201				Besarab A, 2007, CLIN THER, V29, P626, DOI 10.1016/j.clinthera.2007.04.014; Brunkhorst R, 2004, NEPHROL DIAL TRANSPL, V19, P1224, DOI 10.1093/ndt/gfh106; *CTR MED MED SERV, 2004, 2004 ANN REP END STA; Dougherty FC, 2004, J CLIN ONCOL, V22, p605S; Hertel J, 2006, AM J NEPHROL, V26, P149, DOI 10.1159/000092852; Horl WH, 2003, AM J KIDNEY DIS, V41, P49, DOI 10.1053/ajkd.2003.50018; *I MED COMM ID PRE, PREV MED ERR; Jadoul M, 2004, NEPHROL DIAL TRANSPL, V19, P898, DOI 10.1093/ndt/gfh021; *K DOQI, K DOQI CLIN PRACT GU; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P362, DOI 10.1093/ndt/18.2.362; Locatelli F, 2007, CURR MED RES OPIN, V23, P969, DOI 10.1185/030079907X182103; Macdougall IC, 2006, CLIN J AM SOC NEPHRO, V1, P1211, DOI 10.2215/CJN.00730306; Macdougall Iain C, 2005, Curr Hematol Rep, V4, P436; Manley Harold J, 2003, BMC Nephrol, V4, P10, DOI 10.1186/1471-2369-4-10; Nissenson AR, 2002, AM J KIDNEY DIS, V40, P110, DOI 10.1053/ajkd.2002.33919; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Provenzano R, 2007, CLIN NEPHROL, V67, P306; Ross SD, 2003, CLIN THER, V25, P1786, DOI 10.1016/S0149-2918(03)80170-4; Sulowicz W, 2007, CLIN J AM SOC NEPHRO, V2, P637, DOI 10.2215/CJN.03631006; Vanrenterghem Y, 2002, KIDNEY INT, V62, P2167, DOI 10.1046/j.1523-1755.2002.00657.x; Xue JL, 2002, AM J KIDNEY DIS, V40, P1153, DOI 10.1053/ajkd.2002.36861	21	118	127	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1415	1421		10.1016/S0140-6736(07)61599-2	http://dx.doi.org/10.1016/S0140-6736(07)61599-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223PY	17950856				2022-12-28	WOS:000250386000018
J	Landweber, LF				Landweber, Laura F.			Why genomes in pieces?	SCIENCE			English	Editorial Material							GENE; RNA; EVOLUTION; ORIGIN		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu			NIGMS NIH HHS [GM59708] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang WJ, 2005, P NATL ACAD SCI USA, V102, P15149, DOI 10.1073/pnas.0507682102; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Kamikawa R, 2007, PROTIST, V158, P239, DOI 10.1016/j.protis.2006.12.002; Malek O, 1997, P NATL ACAD SCI USA, V94, P553, DOI 10.1073/pnas.94.2.553; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Nakanishi K, 2005, MOL CELLS, V19, P157; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; PAN T, 1993, GENE, V125, P111, DOI 10.1016/0378-1119(93)90317-V; Robertson HM, 2007, GENETICS, V176, P1351, DOI 10.1534/genetics.107.070938; Soma A, 2007, SCIENCE, V318, P450, DOI 10.1126/science.1145718; Williams BAP, 2005, P NATL ACAD SCI USA, V102, P10936, DOI 10.1073/pnas.0501321102; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	14	12	15	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					405	+		10.1126/science.1150280	http://dx.doi.org/10.1126/science.1150280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17947572				2022-12-28	WOS:000250230400033
J	Chiodini, I; Mascia, ML; Muscarella, S; Battista, C; Minisola, S; Arosio, M; Santini, SA; Guglielmi, GE; Carnevale, V; Scillitani, A				Chiodini, Iacopo; Mascia, Maria Lucia; Muscarella, Silvana; Battista, Claudia; Minisola, Salvatore; Arosio, Maura; Santini, Stefano Angelo; Guglielmi, Giu Eppe; Carnevale, Vincenzo; Scillitani, Alfredo			Subclinical hypercortisolism among outpatients referred for osteoporosis	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MINERAL DENSITY; MIDNIGHT SERUM CORTISOL; CUSHINGS-SYNDROME; ADRENAL INCIDENTALOMA; GLUCOCORTICOID EXCESS; DIAGNOSIS; DISEASE; COMPLICATIONS; POPULATION; RISK	Background: Hypercortisolism is known to cause osteoporosis. Objective: To evaluate the prevalence of subclinical hypercortisolism in participants referred for evaluation of osteoporosis. Design: Cross-sectional study. Setting: Two community hospitals and research institutes in Italy. Patients: 219 patients without clinically overt hypercortisolism or other secondary causes of osteoporosis who were referred for evaluation of osteoporosis between January 2005 and December 2005. Measurements: Bone mineral density was measured by using dualenergy x-ray absorptiometry, and hypercortisolism was assessed with serum cortisol levels after a dexamethasone suppression test. Also measured were 24-hour urinary free cortisol levels and midnight plasma cortisol levels. Results: Seven of 65 patients with T-scores of 2.5 or less and vertebral fractures had subdinical hypercortisolism (prevalence, 10.8% [95% Cl, 3.23% to 18.31%]). This prevalence was 4.8% (Cl, 1.32% to 8.20%) among patients with osteoporosis. In multivariable analyses adjusted for age, sex, and body mass index, a positive clexamethasone suppression test result was associated with the presence of osteoporosis (odds ratio, 3.37 [Cl, 1.78 to 6.43]; P < 0.001) and vertebral fractures (odds ratio, 1.70 [Cl, 1.04 to 2.791; P = 0.035). Limitations: The study was conducted in a referral setting; its findings may not apply to the general population. Conclusions: Subdinical hypercortisolism may be more common than is generally recognized in patients with osteoporosis in whom secondary causes of osteoporosis have been excluded.	Casa Sollievo Sofferenza Sci Inst, Unit Endocrinol, I-71013 Foggia, Italy; Univ Milan, San Giuseppe Fatebenefratelli Hosp, Fatebebefratelli Res Assoc, Fdn Policlin,Mangiagalli & Regina Elena Sci Inst, Milan, Italy; Univ Roma La Sapienza, Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Milan; Sapienza University Rome	Scillitani, A (corresponding author), Casa Sollievo Sofferenza Sci Inst, Unit Endocrinol, Viale Cappuccini, I-71013 Foggia, Italy.	alscill@tin.it	Arosio, Maura/I-5153-2012; Scillitani, Alfredo/AAB-8948-2019; Iacopo, Chiodini/W-9911-2019; Battista, Claudia/AAB-2602-2019	Arosio, Maura/0000-0003-3988-3616; Scillitani, Alfredo/0000-0001-9954-4187; Iacopo, Chiodini/0000-0001-7594-3300; Battista, Claudia/0000-0002-0961-926X; Carnevale, Vincenzo/0000-0002-0447-1278				Angeli A, 2002, J CLIN ENDOCR METAB, V87, P4869, DOI 10.1210/jc.2002-021436; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; Barzon L, 2003, EUR J ENDOCRINOL, V149, P273, DOI 10.1530/eje.0.1490273; Catargi B, 2003, J CLIN ENDOCR METAB, V88, P5808, DOI 10.1210/jc.2003-030254; Chidiac RM, 1997, ENDOCRIN METAB CLIN, V26, P233, DOI 10.1016/S0889-8529(05)70242-5; Chiodini I, 2002, J CLIN ENDOCR METAB, V87, P5491, DOI 10.1210/jc.2002-020399; Chiodini I, 2001, J CLIN ENDOCR METAB, V86, P5337, DOI 10.1210/jc.86.11.5337; Chiodini L, 2005, EUR J ENDOCRINOL, V153, P837, DOI 10.1530/eje.1.02045; Devogelaer JP, 2001, EUR J ENDOCRINOL, V145, P237, DOI 10.1530/eje.0.1450237; Findling JW, 2001, ENDOCRIN METAB CLIN, V30, P729, DOI 10.1016/S0889-8529(05)70209-7; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; GUGLIELMI G, 1995, EUR RADIOL, V5, P269; Hadjidakis D, 2003, CLIN ENDOCRINOL, V58, P72, DOI 10.1046/j.1365-2265.2003.01676.x; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kann P, 2001, CLIN RHEUMATOL, V20, P25, DOI 10.1007/s100670170099; Khanine V, 2000, JOINT BONE SPINE, V67, P341; KLOOS RT, 1995, ENDOCR REV, V16, P460, DOI 10.1210/er.16.4.460; Leibowitz G, 1996, CLIN ENDOCRINOL, V44, P717, DOI 10.1046/j.1365-2265.1996.737558.x; Papanicolaou DA, 1998, J CLIN ENDOCR METAB, V83, P1163, DOI 10.1210/jc.83.4.1163; Raff H, 2003, ANN INTERN MED, V138, P980, DOI 10.7326/0003-4819-138-12-200306170-00010; Reincke M, 2000, ENDOCRIN METAB CLIN, V29, P43, DOI 10.1016/S0889-8529(05)70115-8; Reynolds RM, 2005, CALCIFIED TISSUE INT, V77, P134, DOI 10.1007/s00223-004-0270-2; Rossi R, 2000, J CLIN ENDOCR METAB, V85, P1440, DOI 10.1210/jc.85.4.1440; Shaker JL, 2005, ENDOCRIN METAB CLIN, V34, P341, DOI 10.1016/j.ecl.2005.01.014; Tauchmanova L, 2001, EUR J ENDOCRINOL, V145, P241, DOI 10.1530/eje.0.1450241; Terzolo M, 2005, EUR J ENDOCRINOL, V153, P307, DOI 10.1530/eje.1.01959; Terzolo M, 2002, J CLIN ENDOCR METAB, V87, P998, DOI 10.1210/jc.87.3.998; Terzolo M, 1998, CLIN ENDOCRINOL, V48, P89; Torlontano M, 1999, J CLIN ENDOCR METAB, V84, P2381, DOI 10.1210/jc.84.7.2381	29	125	133	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					541	548		10.7326/0003-4819-147-8-200710160-00006	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938392				2022-12-28	WOS:000250437100003
J	Fuccio, L; Minardi, ME; Zagari, RM; Grilli, D; Magrini, N; Bazzoli, F				Fuccio, Lorenzo; Minardi, Maria Eugenia; Zagari, Rocco Maurizio; Grilli, Diego; Magrini, Nicola; Bazzoli, Franco			Meta-analysis: duration of first-line proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication	ANNALS OF INTERNAL MEDICINE			English	Article							DUODENAL-ULCER; CLARITHROMYCIN; AMOXICILLIN; INFECTION; OMEPRAZOLE; 7-DAY; LANSOPRAZOLE; QUALITY; TRIALS; METRONIDAZOLE	Background: Proton-pump inhibitor (PPO-based triple therapy is the recommended first-line treatment for Helicobacter pylori infection. A consensus on treatment duration is lacking. Purpose: To summarize the benefits and harms of different durations of PPI-based triple therapy. Data Sources: PubMed, EMBASE, the Cochrane Library, and proceedings of major meetings through May 2007. Study Selection: English -language reports of randomized, controlled trials that compared duration (7, 10, or 14 days) of triple therapy and in which adequate testing confirmed the initial H. pylori infection and its eradication. Data Extraction: Two authors independently extracted data on study design, treatment, number of patients enrolled and number of patients with successful eradication, disease at enrollment, testing, adverse effects, year of publication, publication format, and country. Data Synthesis: of 21 included studies, 11 compared 7-day therapy with 10-day therapy, and 13 compared 7-day therapy with 14-day therapy. Meta-analysis yielded relative risks (RRs) for eradication of 1.05 (95% Cl, 1.01 to 1.10) for 7-day compared with 10-day amoxicillin-containing triple therapy (10 studies) and 1.07 (Cl, 1.02 to 1.12) for 7-day compared with 14-day therapy (11 studies). Meta-analysis of the 3 studies that compared 7-day with 14-day metroniclazole-containing therapy yielded an RR of 1.08 (Cl, 0.96 to 1.22). The 7-day versus 10-day comparisons yielded RRs of 1.03 (Cl, 0.97 to 1.10) for peptic ulcer disease and 1.10 (Cl, 1.02 to 1.20) for nonulcer dyspepsia. For the 7-day versus 14-day comparisons, the RRs were 1.04 (Cl, 0.99 to 1.09) and 1.03 (Cl, 0.88 to 1.20), respectively. The RRs for frequency of adverse events were 0.98 (Cl, 0.85 to 1.14) and 1.08 (Cl, 0.84 to 1.40) for 7-day therapy compared with 10- and 14-day therapy, respectively. Diarrhea and taste disturbance were the most frequently reported adverse events (5%). Limitations: Subgroup analyses were limited by the few studies evaluating different drug regimens and disease at enrollment. Seventeen of the included studies had poor methodological quality or inadequate reporting. Conclusion: Available data suggest that extending triple therapy beyond 7 days is unlikely to be a clinically useful strategy.	Univ Bologna, Policlin S Orsola, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy; Univ S Florida, Tampa, FL USA; Ctr Evaluat Effectiveness Hlth Care, Modena, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; State University System of Florida; University of South Florida	Bazzoli, F (corresponding author), Univ Bologna, Policlin S Orsola, Dipartimento Med Interna & Gastroenterol, Via Massarenti 9, I-40138 Bologna, Italy.	franco.bazzoli@unibo.it	Fuccio, Lorenzo/A-2557-2010; Zagari, Rocco Maurizio/AAA-1836-2021	Fuccio, Lorenzo/0000-0001-8618-2447; 				BAZZOLI F, 2000, GASTROENTEROLOGY S2, V118, pA2651; Bhasin DK, 2000, HELICOBACTER, V5, P84, DOI 10.1046/j.1523-5378.2000.00012.x; Calvet X, 2005, AM J GASTROENTEROL, V100, P1696, DOI 10.1111/j.1572-0241.2005.50019.x; Calvet X, 2000, ALIMENT PHARM THER, V14, P603; Ching C. K., 1998, Hong Kong Medical Journal, V4, P7; Dal Bo N, 1998, J GASTROEN HEPATOL, V13, P288, DOI 10.1111/j.1440-1746.1998.01557.x; Dammann HG, 2000, HELICOBACTER, V5, P41, DOI 10.1046/j.1523-5378.2000.00006.x; De Francesco V, 2004, DIGEST LIVER DIS, V36, P322, DOI 10.1016/j.dld.2003.12.015; de Silva H. A., 2004, Ceylon Medical Journal, V49, P118; Ford Alex, 2003, Can J Gastroenterol, V17 Suppl B, p36B; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Gisbert JP, 2005, AM J GASTROENTEROL, V100, P1935, DOI 10.1111/j.1572-0241.2005.00178.x; Gisbert JP, 2001, SCAND J GASTROENTERO, V36, P717, DOI 10.1080/003655201300191978; Gisbert JP, 2001, HEPATO-GASTROENTEROL, V48, P1383; Grade AJ, 1996, GASTROENTEROLOGY, V110, pA121; GREELAND S, 1999, MODERN EPIDEMIOLOGY, P643; Gumurdulu Y, 2004, WORLD J GASTROENTERO, V10, P668, DOI 10.3748/wjg.v10.i5.668; Hurenkamp GJB, 2000, ALIMENT PHARM THER, V14, P1065, DOI 10.1046/j.1365-2036.2000.00800.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KARATAPANIS S, 2005, GASTROENTEROLOGY S2, V124, pT958; KATICIC M, 1996, GUT, V39, pA144; Kim BG, 2007, HELICOBACTER, V12, P31, DOI 10.1111/j.1523-5378.2007.00538.x; KIYOTA K, 1993, J GASTROENTEROL S11, V34, P76; Laine L, 1996, ALIMENT PHARM THER, V10, P1029, DOI 10.1046/j.1365-2036.1996.111282000.x; Laine L, 2001, ANN INTERN MED, V134, P361, DOI 10.7326/0003-4819-134-5-200103060-00008; Lamouliatte H, 1998, GUT, V43, pA80; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Louw JA, 1998, ALIMENT PHARM THERAP, V12, P881, DOI 10.1046/j.1365-2036.1998.00382.x; Maconi G, 2001, AM J GASTROENTEROL, V96, P359; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moayyedi P, 1996, Helicobacter, V1, P71, DOI 10.1111/j.1523-5378.1996.tb00012.x; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOHER D, 1998, P 6 INT COCHR C SYST, V6, P70; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Mones J, 1997, GASTROENTEROLOGY, V112, pA224; Palmas F, 2002, PANMINERVA MED, V44, P145; Paoluzi P, 1998, GASTROENTEROLOGY, V114, pA252, DOI 10.1016/S0016-5085(98)81029-9; Paoluzi P, 2006, HELICOBACTER, V11, P562, DOI 10.1111/j.1523-5378.2006.00459.x; Scaccianoce G, 2006, CAN J GASTROENTEROL, V20, P113, DOI 10.1155/2006/258768; STERNE JAC, 2000, 3 S SYST REV BAS OXF; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Vakil N, 2004, ALIMENT PHARM THERAP, V20, P99, DOI 10.1111/j.1365-2036.2004.02029.x; Vergara M, 2003, ALIMENT PHARM THER, V18, P647, DOI 10.1046/j.1365-2036.2003.01746.x; Zagari RM, 2007, GUT, V56, P475, DOI 10.1136/gut.2006.102269; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	196	206	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					553	562		10.7326/0003-4819-147-8-200710160-00008	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17938394				2022-12-28	WOS:000250437100005
J	Hohng, S; Zhou, RB; Nahas, MK; Yu, J; Schulten, K; Lilley, DMJ; Ha, TJ				Hohng, Sungchul; Zhou, Ruobo; Nahas, Michelle K.; Yu, Jin; Schulten, Klaus; Lilley, David M. J.; Ha, Taekjip			Fluorescence-force spectroscopy maps two-dimensional reaction landscape of the Holliday junction	SCIENCE			English	Article							ENERGY-TRANSFER; DNA; MOLECULE; MECHANISM; DYNAMICS; SEQUENCE	Despite the recent advances in single-molecule manipulation techniques, purely mechanical approaches cannot detect subtle conformational changes in the biologically important regime of weak forces. We developed a hybrid scheme combining force and fluorescence that allowed us to examine the effect of subpiconewton forces on the nanometer scale motion of the Holliday junction (HJ) at 100-hertz bandwidth. The HJ is an exquisitely sensitive force sensor whose force response is amplified with an increase in its arm lengths, demonstrating a lever-arm effect at the nanometer-length scale. Mechanical interrogation of the HJ in three different directions helped elucidate the structures of the transient species populated during its conformational changes. This method of mapping two-dimensional reaction landscapes at low forces is readily applicable to other nucleic acid systems and their interactions with proteins and enzymes.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Howard Hughes Med Inst, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Univ Dundee, Nucl Acid Struct Res Grp, Canc Res UK, Dundee DD1 5EH, Scotland	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Cancer Research UK; University of Dundee	Ha, TJ (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@uiuc.edu	Schulten, Klaus/D-5561-2009; Ha, Taekjip/B-9506-2009; Yu, Jin/X-6895-2019	Ha, Taekjip/0000-0003-2195-6258; Yu, Jin/0000-0001-8224-1374; Zhou, Ruobo/0000-0001-8628-0282; Hohng, Sungchul/0000-0002-7131-2138	Cancer Research UK [11722] Funding Source: Medline; NIGMS NIH HHS [R01 GM065367, GM065367] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Grainger RJ, 1998, BIOCHEMISTRY-US, V37, P23, DOI 10.1021/bi9721492; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Lang Matthew J, 2003, J Biol, V2, P6, DOI 10.1186/1475-4924-2-6; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Meiners JC, 2000, PHYS REV LETT, V84, P5014, DOI 10.1103/PhysRevLett.84.5014; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Shroff H, 2005, NANO LETT, V5, P1509, DOI 10.1021/nl050875h; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tarsa PB, 2007, ANGEW CHEM INT EDIT, V46, P1999, DOI 10.1002/anie.200604546; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Yu J, 2004, NUCLEIC ACIDS RES, V32, P6683, DOI 10.1093/nar/gkh1006	27	207	215	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					279	283		10.1126/science.1146113	http://dx.doi.org/10.1126/science.1146113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932299	Green Accepted			2022-12-28	WOS:000250086100049
J	Spencer, JR; Stern, SA; Cheng, AF; Weaver, HA; Reuter, DC; Retherford, K; Lunsford, A; Moore, JM; Abramov, O; Lopes, RMC; Perry, JE; Kamp, L; Showalter, M; Jessup, KL; Marchis, F; Schenk, PM; Dumas, C				Spencer, J. R.; Stern, S. A.; Cheng, A. F.; Weaver, H. A.; Reuter, D. C.; Retherford, K.; Lunsford, A.; Moore, J. M.; Abramov, O.; Lopes, R. M. C.; Perry, J. E.; Kamp, L.; Showalter, M.; Jessup, K. L.; Marchis, F.; Schenk, P. M.; Dumas, C.			Io volcanism seen by New Horizons: A major eruption of the Tvashtar volcano	SCIENCE			English	Article							SILICATE VOLCANISM; PLUMES; PELE	Jupiter's moon Io is known to host active volcanoes. In February and March 2007, the New Horizons spacecraft obtained a global snapshot of Io's volcanism. A 350-kilometer- high volcanic plume was seen to emanate from the Tvashtar volcano (62 degrees N, 122 degrees W), and its motion was observed. The plume's morphology and dynamics support nonballistic models of large Io plumes and also suggest that most visible plume particles condensed within the plume rather than being ejected from the source. In images taken in Jupiter eclipse, nonthermal visible-wavelength emission was seen from individual volcanoes near Io's sub-Jupiter and anti-Jupiter points. Near-infrared emission from the brightest volcanoes indicates minimum magma temperatures in the 1150- to 1335-kelvin range, consistent with basaltic composition.	SW Res Inst, Boulder, CO 80302 USA; NASA Headquarters, Washington, DC 20546 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; SW Res Inst, San Antonio, TX 78228 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; Lunar & Planetary Inst, Houston, TX 77058 USA; European So Observ, Santiago 19, Chile	National Aeronautics & Space Administration (NASA); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Southwest Research Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; European Southern Observatory	Spencer, JR (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	spencer@boulder.swri.edu	Lopes, Rosaly M.C./D-1608-2016; Marchis, Franck/H-3971-2012; Weaver, Harold A/D-9188-2016	Lopes, Rosaly M.C./0000-0002-7928-3167; Weaver, Harold A/0000-0003-0951-7762; Abramov, Oleg/0000-0002-2884-2299				Davies AG, 2001, J GEOPHYS RES-PLANET, V106, P33079, DOI 10.1029/2000JE001357; Geissler P, 2004, ICARUS, V172, P127, DOI 10.1016/j.icarus.2004.01.008; Geissler PE, 2007, S-P B ASTRON PLANET, P163, DOI 10.1007/978-3-540-48841-5_8; Geissler PE, 2001, J GEOPHYS RES-SPACE, V106, P26137, DOI 10.1029/2000JA002511; Howell RR, 2001, J GEOPHYS RES-PLANET, V106, P33129, DOI 10.1029/2000JE001382; LAVER C, 2006, B AM ASTRON SOC, V38, P612; Lopes RMC, 2007, S-P B ASTRON PLANET, P307; Marchis F, 2005, ICARUS, V176, P96, DOI 10.1016/j.icarus.2004.12.014; Marchis F, 2002, ICARUS, V160, P124, DOI 10.1006/icar.2002.6955; MCEWEN AS, 1983, ICARUS, V55, P191, DOI 10.1016/0019-1035(83)90075-1; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; McEwen AS, 1998, SCIENCE, V281, P87, DOI 10.1126/science.281.5373.87; Milazzo MP, 2005, ICARUS, V179, P235, DOI 10.1016/j.icarus.2005.05.013; RATHBUN JA, 2007, 39 ANN AM ASTR SOC D; Retherford KD, 2007, SCIENCE, V318, P237, DOI 10.1126/science.1147594; Spencer JR, 2000, SCIENCE, V288, P1208, DOI 10.1126/science.288.5469.1208; Stansberry JA, 1997, GEOPHYS RES LETT, V24, P2455, DOI 10.1029/97GL02593; Strom R. G., 1982, SATELLITES JUPITER, P598; Turtle EP, 2004, ICARUS, V169, P3, DOI 10.1016/j.icarus.2003.10.014; Zhang J, 2004, ICARUS, V172, P479, DOI 10.1016/j.icarus.2004.06.016	20	77	77	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					240	243		10.1126/science.1147621	http://dx.doi.org/10.1126/science.1147621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932290				2022-12-28	WOS:000250086100038
J	Appelbaum, FR				Appelbaum, Frederick R.			Hematopoietic-cell transplantation at 50	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BONE-MARROW TRANSPLANTATION		Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; Univ Washington, Div Med Oncol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Appelbaum, FR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.							JACOBSON LO, 1949, J LAB CLIN MED, V34, P1538; THOMAS ED, 1979, NEW ENGL J MED, V301, P597, DOI 10.1056/NEJM197909133011109; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; THOMAS ED, 1975, NEW ENGL J MED, V292, P832, DOI 10.1056/NEJM197504172921605; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706	5	275	280	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2007	357	15					1472	1475		10.1056/NEJMp078166	http://dx.doi.org/10.1056/NEJMp078166			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218TE	17928594				2022-12-28	WOS:000250037000003
J	Colon-Ramos, DA; Margeta, MA; Shen, K				Colon-Ramos, Daniel A.; Margeta, Milica A.; Shen, Kang			Glia promote local synaptogenesis through UNC-6 (netrin) signaling in C-elegans	SCIENCE			English	Article							NERVOUS-SYSTEM; C-ELEGANS; CAENORHABDITIS-ELEGANS; COLORECTAL-CANCER; SYNAPSE FORMATION; RECEPTORS; NEURONS; AXONS; CUES; MORPHOGENESIS	Neural circuits are assembled through the coordinated innervation of pre- and postsynaptic partners. We show that connectivity between two interneurons, AIY and RIA, in Caenorhabditis elegans is orchestrated by a pair of glial cells that express UNC-6 (netrin). In the postsynaptic neuron RIA, the netrin receptor UNC-40 (DCC, deleted in colorectal cancer) plays a conventional guidance role, directing outgrowth of the RIA process ventrally toward the glia. In the presynaptic neuron AIY, UNC-40 (DCC) plays an unexpected and previously uncharacterized role: It cell-autonomously promotes assembly of presynaptic terminals in the immediate vicinity of the glial cell endfeet. These results indicate that netrin can be used both for guidance and local synaptogenesis and suggest that glial cells can function as guideposts during the assembly of neural circuits in vivo.	Stanford Univ, Dept Biol Sci, Herrin Labs 144, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, Herrin Labs 144, Stanford, CA 94305 USA.	kangshen@stanford.edu		Margeta, Milica/0000-0002-5902-4168	NIGMS NIH HHS [GM007365] Funding Source: Medline; NINDS NIH HHS [K99 NS057931-01, K99 NS057931] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS057931] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Juttner R, 2005, CELL MOL LIFE SCI, V62, P2811, DOI 10.1007/s00018-005-5299-5; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Leonardo ED, 1997, COLD SPRING HARB SYM, V62, P467; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yochem J, 2003, DEVELOPMENT, V130, P4761, DOI 10.1242/dev.00701	27	200	201	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					103	106		10.1126/science.1143762	http://dx.doi.org/10.1126/science.1143762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916735	Green Accepted			2022-12-28	WOS:000249915400051
J	Jensen, K; Call, J; Tomasello, M				Jensen, Keith; Call, Josep; Tomasello, Michael			Chimpanzees are rational maximizers in an ultimatum game	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT; GROUP MEMBERS; RECIPROCITY; EVOLUTION; COOPERATION; TOLERANCE; ECONOMICS; INEQUITY; FAIRNESS; CHILDREN	Traditional models of economic decision-making assume that people are self-interested rational maximizers. Empirical research has demonstrated, however, that people will take into account the interests of others and are sensitive to norms of cooperation and fairness. In one of the most robust tests of this finding, the ultimatum game, individuals will reject a proposed division of a monetary windfall, at a cost to themselves, if they perceive it as unfair. Here we show that in an ultimatum game, humans' closest living relatives, chimpanzees (Pan troglodytes), are rational maximizers and are not sensitive to fairness. These results support the hypothesis that other-regarding preferences and aversion to inequitable outcomes, which play key roles in human social organization, distinguish us from our closest living relatives.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Jensen, K (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	jensen@eva.mpg.de	Galantucci, Bruno/E-5770-2010	Call Balaguer, Josep/0000-0002-8597-8336				BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 1998, EUR ECON REV, V42, P845, DOI 10.1016/S0014-2921(97)00131-1; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FRANK RH, 1987, AM ECON REV, V77, P593; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Murnighan JK, 1998, J ECON PSYCHOL, V19, P415, DOI 10.1016/S0167-4870(98)00017-8; Nishida T, 1999, ANTHROPOL SCI, V107, P141, DOI 10.1537/ase.107.141; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; RABIN M, 1993, AM ECON REV, V83, P1281; Shinada M, 2004, EVOL HUM BEHAV, V25, P379, DOI 10.1016/j.evolhumbehav.2004.08.001; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Stevens JR, 2002, BEHAV ECOL, V13, P393, DOI 10.1093/beheco/13.3.393; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; WARNEKEN F, 2007, PLOS BIOL, V5, P1414, DOI ARTN e184	33	229	234	5	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					107	109		10.1126/science.1145850	http://dx.doi.org/10.1126/science.1145850			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916736				2022-12-28	WOS:000249915400052
J	Terry, I; Walter, GH; Moore, C; Roemer, R; Hull, C				Terry, Irene; Walter, Gimme H.; Moore, Chris; Roemer, Robert; Hull, Craig			Odor-mediated push-pull pollination in cycads	SCIENCE			English	Article							EVOLUTION		Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; University of Queensland; Utah System of Higher Education; University of Utah	Terry, I (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	terry@biology.utah.edu	Walter, Gimme/AAC-3635-2019	Walter, Gimme/0000-0003-1025-7101				Grimaldi D, 2004, J PALEONTOL, V78, P941, DOI 10.1666/0022-3360(2004)078<0941:MTAEEO>2.0.CO;2; PELLMYR O, 1986, TAXON, V35, P76, DOI 10.2307/1221036; Schiestl FP, 2001, OECOLOGIA, V126, P531, DOI 10.1007/s004420000552; Tang W., 2004, VISTAS PALAEOBOTANY, P383; Terry I, 2004, PLANT SYST EVOL, V243, P233, DOI 10.1007/s00606-003-0087-x; Terry LI, 2005, AM J BOT, V92, P931, DOI 10.3732/ajb.92.6.931	6	114	120	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					70	70		10.1126/science.1145147	http://dx.doi.org/10.1126/science.1145147			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916726				2022-12-28	WOS:000249915400040
J	Condamin, S; Benichou, O; Tejedor, V; Voituriez, R; Klafter, J				Condamin, S.; Benichou, O.; Tejedor, V.; Voituriez, R.; Klafter, J.			First-passage times in complex scale-invariant media	NATURE			English	Article							RANDOM-WALKS; DETERMINISTIC FRACTALS; ANOMALOUS DIFFUSION; DISORDERED MEDIA; NETWORKS; PROTEIN; MECHANISMS; MODELS; DNA	How long does it take a random walker to reach a given target point? This quantity, known as a first-passage time (FPT), has led to a growing number of theoretical investigations over the past decade(1). The importance of FPTs originates from the crucial role played by first encounter properties in various real situations, including transport in disordered media(2,3), neuron firing dynamics(4), spreading of diseases(5) or target search processes(6-9). Most methods of determining FPT properties in confining domains have been limited to effectively one-dimensional geometries, or to higher spatial dimensions only in homogeneous media(1). Here we develop a general theory that allows accurate evaluation of the mean FPT in complex media. Our analytical approach provides a universal scaling dependence of the mean FPT on both the volume of the confining domain and the source-target distance. The analysis is applicable to a broad range of stochastic processes characterized by length-scale-invariant properties. Our theoretical predictions are confirmed by numerical simulations for several representative models of disordered media(10), fractals(3), anomalous diffusion(11) and scale-free networks(12).	Univ Paris 06, Lab Phys Theor Mat Condensee, UMR 7600, F-75005 Paris, France; Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University	Benichou, O (corresponding author), Univ Paris 06, Lab Phys Theor Mat Condensee, UMR 7600, Case 121,4 Pl Jussieu, F-75005 Paris, France.	benichou@lptmc.jussieu.fr	voituriez, raphael/V-3418-2017; Tejedor, Vincent/C-6168-2009	Tejedor, Vincent/0000-0002-2980-434X; voituriez, raphael/0000-0001-8746-5713				Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARTON G, 1989, ELEMENTS GREEN FUNCT; ben Avraham D., 2000, DIFFUSION REACTIONS; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bollt EM, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/026; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Condamin S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260601; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Eliazar I, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/6/065140; Gallos LK, 2007, P NATL ACAD SCI USA, V104, P7746, DOI 10.1073/pnas.0700250104; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HAVLIN S, 1987, ADV PHYS, V36, P695, DOI 10.1080/00018738700101072; Holcman D, 2007, J STAT PHYS, V127, P471, DOI 10.1007/s10955-007-9282-4; Hughes BD, 1995, RANDOM WALKS RANDOM, V1, DOI [10.1079/PNS19950063, DOI 10.1079/PNS19950063]; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; MONTROLL EW, 1969, J MATH PHYS, V10, P753, DOI 10.1063/1.1664902; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Redner S., 2002, GUIDE 1 PASSAGE PROC; Rice S. A., 1985, DIFFUSION LTD REACTI; Shlesinger MF, 2006, NATURE, V443, P281, DOI 10.1038/443281a; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; VANDENBROECK C, 1989, PHYS REV A, V40, P7334, DOI 10.1103/PhysRevA.40.7334; Yuste SB, 1995, J PHYS A-MATH GEN, V28, P7027, DOI 10.1088/0305-4470/28/24/004	30	468	471	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					77	80		10.1038/nature06201	http://dx.doi.org/10.1038/nature06201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972880	Green Submitted			2022-12-28	WOS:000250585800039
J	Bolton-Moore, C; Mubiana-Mbewe, M; Cantrell, RA; Chintu, N; Stringer, EM; Chi, BH; Sinkala, M; Kankasa, C; Wilson, CM; Wilfert, CM; Mwango, A; Levy, J; Abrams, EJ; Bulterys, M; Stringer, JSA				Bolton-Moore, Carolyn; Mubiana-Mbewe, Mwangelwa; Cantrell, Ronald A.; Chintu, Namwinga; Stringer, Elizabeth M.; Chi, Benjamin H.; Sinkala, Moses; Kankasa, Chipepo; Wilson, Craig M.; Wilfert, Catherine M.; Mwango, Albert; Levy, Jens; Abrams, Elaine J.; Bulterys, Marc; Stringer, Jeffrey S. A.			Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIV-INFECTED CHILDREN; SCALING-UP; MORTALITY; AFRICA; CHALLENGES; COHORT; ADHERENCE; DIAGNOSIS; SURVIVAL; DISTRICT	Context The Zambian Ministry of Health provides pediatric antiretroviral therapy (ART) at primary care clinics in Lusaka, where, despite scale-up of perinatal prevention efforts, many children are already infected with the human immunodeficiency virus (HIV). Objective To report early clinical and immunologic outcomes of children enrolled in the pediatric treatment program. Design, Setting, and Patients Open cohort assessment using routinely collected clinical and outcome data from an electronic medical record system in use at 18 government primary health facilities in Lusaka, Zambia. Care was provided primarily by nurses and clinical officers ("physician extenders" akin to physician assistants in the United States). Patients were children (< 16 years of age) presenting for HIV care between May 1, 2004, and June 29, 2007. Intervention Three-drug ART (zidovudine or stavudine plus lamivudine plus nevirapine or efavirenz) for children who met national treatment criteria. Main Outcome Measures Survival, weight gain, CD4 cell count, and hemoglobin response. Results After enrollment of 4975 children into HIV care, 2938 (59.1%) started ART. Of those initiating ART, the median age was 81 months (interquartile range, 36-125), 1531 (52.1%) were female, and 2087 (72.4%) with World Health Organization stage information were in stage III or IV. At the time of analysis, 158 children (5.4%) had withdrawn from care and 382 (13.0%) were at least 30 days late for follow-up. Of the remaining 2398 children receiving ART, 198 (8.3%) died over 3018 child-years of follow-up (mortality rate, 6.6 deaths per 100 child-years; 95% confidence interval [CI], 5.7-7.5); of these deaths, 112 (56.6%) occurred within 90 days of therapy initiation (early mortality rate, 17.4/100 child-years; post-90-day mortality rate, 2.9/100 child-years). Mortality was associated with CD4 cell depletion, lower weight-for-age, younger age, and anemia in multivariate analysis. The mean CD4 cell percentage at ART initiation among the 1561 children who had at least 1 repeat measurement was 12.9% (95% CI, 12.5%-13.3%) and increased to 23.7% (95% CI, 23.1%-24.3%) at 6 months, 27.0% (95% CI, 26.3%-27.6%) at 12 months, 28.0% (95% CI, 27.2%-28.8%) at 18 months, and 28.4% (95% CI, 27.4%-29.4%) at 24 months. Conclusions Care provided by clinicians such as nurses and clinical officers can result in good outcomes for HIV-infected children in primary health care settings in sub-Saharan Africa. Mortality during the first 90 days of therapy is high, pointing to a need for earlier intervention.	CIDRZ, Lusaka, Zambia; Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; Univ Teaching Hosp, Lusaka, Zambia; Zambian Minist Hlth, Lusaka, Zambia; Elizabeth Glaser Pediat AIDS Fdn, Santa Monica, CA USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; US Ctr Dis Control & Prevent, Global AIDS Program, Lusaka, Zambia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Zambia; Columbia University	Stringer, JSA (corresponding author), CIDRZ, Plot 1275 Lubutu Rd,POB 34681, Lusaka, Zambia.	stringer@cidrz.org	Stringer, Jeffrey S. A./AAU-2342-2021	Bolton Moore, Carolyn/0000-0001-9103-7746; Stringer, Jeffrey/0000-0002-9590-7216; Mubiana-Mbewe, Mwangelwa/0000-0002-7122-842X; Wilson, Craig/0000-0001-6869-1053	FOGARTY INTERNATIONAL CENTER [K01TW006670, K01TW005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, K08AI001411] Funding Source: NIH RePORTER; FIC NIH HHS [K01-TW05708, K01-TW06670] Funding Source: Medline; NIAID NIH HHS [P30-AI027767, K23-AI01411] Funding Source: Medline; PHS HHS [U62/CCU12354] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aledort Julia E, 2006, Nature, V444 Suppl 1, P19, DOI 10.1038/nature05443; Allison P. D., 1995, SURVIVAL ANAL USING; ANABWANI GM, 2006, 16 INT AIDS C AUG 13; BARRY G, 2006, 16 INT AIDS C AUG 13; Berhane R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e7; Bobat R, 1998, ANN TROP PAEDIATR, V18, P187, DOI 10.1080/02724936.1998.11747946; Bobat R, 2001, ANN TROP PAEDIATR, V21, P203, DOI 10.1080/02724930120077772; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Centers for Disease Control and Prevention, SAS PROGR CDC GROWTH; De Baets AJ, 2007, PEDIATR INFECT DIS J, V26, P163, DOI 10.1097/01.inf.0000253040.82669.22; DUMAS S, 2006, 16 INT AIDS C AUG 13; FUSCO H, 2005, 3 IAS C HIV PATH TRE; George E, 2007, J INFECT DIS, V195, P1411, DOI 10.1086/514823; Ginsburg AS, 2006, PEDIATR INFECT DIS J, V25, P1057, DOI 10.1097/01.inf.0000243157.16405.f0; *GLOB FUND FIGHT A, ZAMB GLOB FUND PORTF; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; KAMINSAKABANJE S, 2006, 16 INT AIDS C AUG 13; KANKASA C, 2007, 14 C RETR OPP INF FE; Kline MW, 2006, PEDIATRICS, V117, P1388, DOI 10.1542/peds.2005-1348; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Kuhn L, 2005, AIDS, V19, P1677, DOI 10.1097/01.aids.0000186817.38112.da; Laufer MK, 2006, PEDIATR INFECT DIS J, V25, P623, DOI 10.1097/01.inf.0000220264.45692.a0; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; McConnell MS, 2005, JAIDS-J ACQ IMM DEF, V38, P488, DOI 10.1097/01.qai.0000134744.72079.cc; Mwinga A, 2005, LANCET, V365, P97, DOI 10.1016/S0140-6736(05)17713-7; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; OLSON D, 2006, 16 INT AIDS C AUG 13; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; *UN CHILDR FUND, COUNTR PROF ZAMB; UNAIDS, 2006, REP GLOB AIDS EP; *US PRES EM PLAN A, COUNTR PROF ZAMB; VIOLARI A, 2007, 4 IAS C HIV PATH TRE; *WHO, 2005, TAK STOCK HIV CHILDR; WHO, 2006, COTR PROPH HIV REL I; *WHO, 3 5 IN AIDS TREATM C; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2005, INT WHO CLIN STAG HI; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; *ZAMB NAT AIDS COU, 2004, NAT GUID LIN MAN CAR	45	265	267	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1888	1899		10.1001/jama.298.16.1888	http://dx.doi.org/10.1001/jama.298.16.1888			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954540	Bronze			2022-12-28	WOS:000250356700021
J	Babbitt, CC; Haygood, R; Wray, GA				Babbitt, Courtney C.; Haygood, Ralph; Wray, Gregory A.			When two is better than one	CELL			English	Editorial Material							DUPLICATION; EVOLUTION; GENES		Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University; Duke University	Wray, GA (corresponding author), Duke Univ, Inst Genome Sci & Policy, Box 90338, Durham, NC 27708 USA.	gwray@duke.edu						Force A, 1999, GENETICS, V151, P1531; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Ohno S., 1970, EVOLUTION GENE DUPLI; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Rubio-Texeira M, 2005, FEMS YEAST RES, V5, P1115, DOI 10.1016/j.femsyr.2005.05.003; WEBSTER TD, 1988, NUCLEIC ACIDS RES, V16, P8011, DOI 10.1093/nar/16.16.8011	10	7	7	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					225	227		10.1016/j.cell.2007.10.001	http://dx.doi.org/10.1016/j.cell.2007.10.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956721	Bronze			2022-12-28	WOS:000250507700010
J	Rosenthal, MB				Rosenthal, Meredith B.			Nonpayment for performance? Medicare's new reimbursement rule	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184				Ball RM, 1995, HEALTH AFFAIR, V14, P62, DOI 10.1377/hlthaff.14.4.62; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Medicare program, 2007, FED REGISTER, V72, P47379	3	202	206	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1573	1575		10.1056/NEJMp078184	http://dx.doi.org/10.1056/NEJMp078184			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	221AY	17942869				2022-12-28	WOS:000250200500001
J	Fredrick, B				Fredrick, Beth			Eliminating unsafe abortion worldwide	LANCET			English	Editorial Material							LAW		Int Womens Hlth Coalit, New York, NY 10001 USA		Fredrick, B (corresponding author), Int Womens Hlth Coalit, New York, NY 10001 USA.	bfredrick@iwhc.org						*AFR UN C MIN HLTH, 2006, MAP PLAN ACT OP CONT; Berer M, 2004, REPROD HEALTH MATTER, V12, P1, DOI 10.1016/S0968-8080(04)24024-1; Boonstra H.D., 2007, GUTTMACHER POLICY RE, V10, P12; COHEN S, 2002, GUTTMACHER REPORT PU, V5, P13; *CTR REPR RIGHTS, 2007, BRIEF PAP AB WORLDW; Dickson KE, 2003, STUD FAMILY PLANN, V34, P277, DOI 10.1111/j.1728-4465.2003.00277.x; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Hirve SS, 2004, REPROD HEALTH MATTER, V12, P114, DOI 10.1016/S0968-8080(04)24017-4; NUNES FE, 1997, REPROD HEALTH MATTER, V9, P66; SEDGH G, 2007, OCCASIONAL REPORT WO; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Shakya G, 2004, REPROD HEALTH MATTER, V12, P75, DOI 10.1016/S0968-8080(04)24007-1; The Center for Reproductive Rights, 2003, BREAK SIL GLOB GAG R; *UNECOSOC UNFPA, 1994, PROGR ACT; VLASSOFF M, 2007, EC IMPACT UNSAFE ABO; World Health Organization, 2003, SAF AB TECHN POL GUI	16	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1295	1297		10.1016/S0140-6736(07)61556-6	http://dx.doi.org/10.1016/S0140-6736(07)61556-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933636				2022-12-28	WOS:000250176600011
J	Shiffman, J; Smith, S				Shiffman, Jeremy; Smith, Stephanie			Generation of political priority for global health initiatives: a framework and case study of maternal mortality	LANCET			English	Article							SAFE MOTHERHOOD; DEVELOPING-COUNTRIES; SURVIVAL 1; POLICY; STRATEGIES; RESOURCES; HONDURAS; HISTORY; SECTOR; STATE	Why do some global health initiatives receive priority from international and national political leaders whereas others receive little attention? To analyse this question we propose a framework consisting of four categories: the strength of the actors involved in the initiative, the power of the ideas they use to portray the issue, the nature of the political contexts in which they operate, and characteristics of the issue itself. We apply this framework to the case of a global initiative to reduce maternal mortality, which was launched in 1987. We undertook archival research and interviewed people connected with the initiative, using a process-tracing method that is commonly employed in qualitative research. We report that despite two decades of effort the initiative remains in an early phase of development, hampered by difficulties in all these categories. However, the initiative's 20th year, 2007, presents opportunities to build political momentum. To generate political priority, advocates will need to address several challenges, including the creation of effective institutions to guide the initiative and the development of a public positioning of the issue to convince political leaders to act. We use the framework and case study to suggest areas for future research on the determinants of political priority for global health initiatives, which is a subject that has attracted much speculation but little scholarship.	Syracuse Univ, Maxwell Sch, Dept Publ Adm, Syracuse, NY 13244 USA	Syracuse University	Shiffman, J (corresponding author), Syracuse Univ, Maxwell Sch, Dept Publ Adm, 306 Eggers Hall, Syracuse, NY 13244 USA.	jrshiffm@maxwell.syr.edu		Smith, Stephanie L./0000-0003-2987-6252; Shiffman, Jeremy/0000-0002-1693-4671				AbouZahr C., 2001, SAFE MOTHERHOOD STRA, V17, P384; Baumgartner F. R., 1993, AGENDAS INSTABILITY; Berman S, 2001, COMP POLIT, V33, P231, DOI 10.2307/422380; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Brugha R, 2000, HEALTH POLICY PLANN, V15, P239, DOI 10.1093/heapol/15.3.239; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Buse K, 2005, MAKING HLTH POLICY M; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; CAMPBELL OMR, 2001, SAFE MOTHERHOOD STRA, V17, P415; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; *DEP INT DEV, 2007, DFIDS MAT HLTH STRAT; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Finnemore M, 2001, ANNU REV POLIT SCI, V4, P391, DOI 10.1146/annurev.polisci.4.1.391; Finnemore M, 1998, INT ORGAN, V52, P887, DOI 10.1162/002081898550789; Florini A.M., 2012, 3 FORCE RISE TRANSNA; Freedman LP, 2001, INT J GYNECOL OBSTET, V75, P51, DOI 10.1016/S0020-7292(01)00473-8; GOUREVITCH P, 1978, INT ORGAN, V32, P881, DOI 10.1017/S002081830003201X; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; Grindle M., 1991, PUBLIC CHOICES POLIC; HAAS PM, 1992, INT ORGAN, V46, P1, DOI 10.1017/S0020818300001442; Harris PG, 2007, GLOBAL POLITICS AIDS; HAY C, 2000, MED ANTHROPOL, V18, P243; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Johnston H., 2005, FRAMES PROTEST SOCIA; Keck ME., 2014, ACTIVISTS BORDERS AD; Kingdon JohnW., 2003, AGENDAS ALTERNATIVES; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee K, 1996, BRIT MED J, V312, P302; Leichter H.M., 1979, COMP APPROACH POLICY; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; McAdam D, 1996, PREFACE COMP PERSPEC; Miller S, 2003, J MIDWIFERY WOM HEAL, V48, P10, DOI 10.1016/S1526-9523(02)00369-0; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Prins G, 2004, INT AFF, V80, P931, DOI 10.1111/j.1468-2346.2004.00426.x; REICH MR, 1995, HEALTH POLICY, V32, P47, DOI 10.1016/0168-8510(95)00728-B; Roll Back Malaria, 2005, WORLD MAL REP 2005; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; Sabatier PA, 1998, J EUR PUBLIC POLICY, V5, P98, DOI 10.1080/13501768880000051; Shiffman J, 2007, BJOG-INT J OBSTET GY, V114, P785, DOI 10.1111/j.1471-0528.2007.01374.x; Shiffman J, 2007, BJOG-INT J OBSTET GY, V114, P127, DOI 10.1111/j.1471-0528.2006.01184.x; Shiffman J, 2006, POPUL DEV REV, V32, P53, DOI 10.1111/j.1728-4457.2006.00105.x; Shiffman J, 2004, HEALTH POLICY PLANN, V19, P380, DOI 10.1093/heapol/czh053; Shiffman J, 2003, SOC SCI MED, V56, P1197, DOI 10.1016/S0277-9536(02)00119-3; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; SNOW DA, 1986, AM SOCIOL REV, V51, P464, DOI 10.2307/2095581; Stanton C., 1997, DHS MATERNAL MORTALI; STARRS A, 1987, PREVENTING TRAGEDY M; STARRS A, 1998, SAFE MOTHERHOOD ACTI; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; STONE DA, 1989, POLIT SCI QUART, V104, P281, DOI 10.2307/2151585; Tarrow SidneyG., 1994, POWER MOVEMENT; *UNAIDS, 2006, AIDS EP UPD; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; WALT G, 2001, INT PUBLIC HLTH; Weil O, 1999, LANCET, V354, P940, DOI 10.1016/S0140-6736(99)02369-7; *WHO, 1990, MAT HLTH SAFE MOTHER; *WHO, 2007, 104 WHO; WHO, 2004, MAT MORT 2000 EST DE; World Health Organization, 2005, WORLD HLTH REP 2005; Yin R.K., 1994, CASE STUDY RES; 2005, DELHI DECLARATION MA	65	427	432	1	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1370	1379		10.1016/S0140-6736(07)61579-7	http://dx.doi.org/10.1016/S0140-6736(07)61579-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933652				2022-12-28	WOS:000250176600031
J	Merchant, SS; Prochnik, SE; Vallon, O; Harris, EH; Karpowicz, SJ; Witman, GB; Terry, A; Salamov, A; Fritz-Laylin, LK; Marechal-Drouard, L; Marshall, WF; Qu, LH; Nelson, DR; Sanderfoot, AA; Spalding, MH; Kapitonov, VV; Ren, QH; Ferris, P; Lindquist, E; Shapiro, H; Lucas, SM; Grimwood, J; Schmutz, J; Cardol, P; Cerutti, H; Chanfreau, G; Chen, CL; Cognat, V; Croft, MT; Dent, R; Dutcher, S; Fernandez, E; Fukuzawa, H; Gonzalez-Ballester, D; Gonzalez-Halphen, D; Hallmann, A; Hanikenne, M; Hippler, M; Inwood, W; Jabbari, K; Kalanon, M; Kuras, R; Lefebvre, PA; Lemaire, SD; Lobanov, AV; Lohr, M; Manuell, A; Meir, I; Mets, L; Mittag, M; Mittelmeier, T; Moroney, JV; Moseley, J; Napoli, C; Nedelcu, AM; Niyogi, K; Novoselov, SV; Paulsen, IT; Pazour, G; Purton, S; Ral, JP; Riano-Pachon, DM; Riekhof, W; Rymarquis, L; Schroda, M; Stern, D; Umen, J; Willows, R; Wilson, N; Zimmer, SL; Allmer, J; Balk, J; Bisova, K; Chen, CJ; Elias, M; Gendler, K; Hauser, C; Lamb, MR; Ledford, H; Long, JC; Minagawa, J; Page, MD; Pan, JM; Pootakham, W; Roje, S; Rose, A; Stahlberg, E; Terauchi, AM; Yang, PF; Ball, S; Bowler, C; Dieckmann, CL; Gladyshev, VN; Green, P; Jorgensen, R; Mayfield, S; Mueller-Roeber, B; Rajamani, S; Sayre, RT; Brokstein, P; Dubchak, I; Goodstein, D; Hornick, L; Huang, YW; Jhaveri, J; Luo, YG; Martinez, D; Ngau, WCA; Otillar, B; Poliakov, A; Porter, A; Szajkowski, L; Werner, G; Zhou, KM; Grigoriev, IV; Rokhsar, DS; Grossman, AR				Merchant, Sabeeha S.; Prochnik, Simon E.; Vallon, Olivier; Harris, Elizabeth H.; Karpowicz, Steven J.; Witman, George B.; Terry, Astrid; Salamov, Asaf; Fritz-Laylin, Lillian K.; Marechal-Drouard, Laurence; Marshall, Wallace F.; Qu, Liang-Hu; Nelson, David R.; Sanderfoot, Anton A.; Spalding, Martin H.; Kapitonov, Vladimir V.; Ren, Qinghu; Ferris, Patrick; Lindquist, Erika; Shapiro, Harris; Lucas, Susan M.; Grimwood, Jane; Schmutz, Jeremy; Cardol, Pierre; Cerutti, Heriberto; Chanfreau, Guillaume; Chen, Chun-Long; Cognat, Valerie; Croft, Martin T.; Dent, Rachel; Dutcher, Susan; Fernandez, Emilio; Fukuzawa, Hideya; Gonzalez-Ballester, David; Gonzalez-Halphen, Diego; Hallmann, Armin; Hanikenne, Marc; Hippler, Michael; Inwood, William; Jabbari, Kamel; Kalanon, Ming; Kuras, Richard; Lefebvre, Paul A.; Lemaire, Stephane D.; Lobanov, Alexey V.; Lohr, Martin; Manuell, Andrea; Meier, Iris; Mets, Laurens; Mittag, Maria; Mittelmeier, Telsa; Moroney, James V.; Moseley, Jeffrey; Napoli, Carolyn; Nedelcu, Aurora M.; Niyogi, Krishna; Novoselov, Sergey V.; Paulsen, Ian T.; Pazour, Greg; Purton, Saul; Ral, Jean-Philippe; Riano-Pachon, Diego Mauricio; Riekhof, Wayne; Rymarquis, Linda; Schroda, Michael; Stern, David; Umen, James; Willows, Robert; Wilson, Nedra; Zimmer, Sara Lana; Allmer, Jens; Balk, Janneke; Bisova, Katerina; Chen, Chong-Jian; Elias, Marek; Gendler, Karla; Hauser, Charles; Lamb, Mary Rose; Ledford, Heidi; Long, Joanne C.; Minagawa, Jun; Page, M. Dudley; Pan, Junmin; Pootakham, Wirulda; Roje, Sanja; Rose, Annkatrin; Stahlberg, Eric; Terauchi, Aimee M.; Yang, Pinfen; Ball, Steven; Bowler, Chris; Dieckmann, Carol L.; Gladyshev, Vadim N.; Green, Pamela; Jorgensen, Richard; Mayfield, Stephen; Mueller-Roeber, Bernd; Rajamani, Sathish; Sayre, Richard T.; Brokstein, Peter; Dubchak, Inna; Goodstein, David; Hornick, Leila; Huang, Y. Wayne; Jhaveri, Jinal; Luo, Yigong; Martinez, Diego; Ngau, Wing Chi Abby; Otillar, Bobby; Poliakov, Alexander; Porter, Aaron; Szajkowski, Lukasz; Werner, Gregory; Zhou, Kemin; Grigoriev, Igor V.; Rokhsar, Daniel S.; Grossman, Arthur R.		Chlamydomonas Annotation; JGI Annotation Team	The Chlamydomonas genome reveals the evolution of key animal and plant functions	SCIENCE			English	Article							HEME-BINDING PROTEIN; PHOTOSYNTHETIC EUKARYOTES; INTRAFLAGELLAR TRANSPORT; PROTEOMIC ANALYSIS; FINE-STRUCTURE; HUMAN-DISEASE; REINHARDTII; FLAGELLAR; INSIGHTS; GENES	Chlamydomonas reinhardtii is a unicellular green alga whose lineage diverged from land plants over 1 billion years ago. It is a model system for studying chloroplast-based photosynthesis, as well as the structure, assembly, and function of eukaryotic flagella (cilia), which were inherited from the common ancestor of plants and animals, but lost in land plants. We sequenced the similar to 120-megabase nuclear genome of Chlamydomonas and performed comparative phylogenomic analyses, identifying genes encoding uncharacterized proteins that are likely associated with the function and biogenesis of chloroplasts or eukaryotic flagella. Analyses of the Chlamydomonas genome advance our understanding of the ancestral eukaryotic cell, reveal previously unknown genes associated with photosynthetic and flagellar functions, and establish links between ciliopathy and the composition and function of flagella.	US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Paris 06, CNRS, Inst Biol Physicochim, F-75005 Paris, France; Duke Univ, Dept Biol, Durham, NC 27708 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Zhongshan Univ, Biotechnol Res Ctr, Guangzhou 510275, Peoples R China; Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; Univ Tennessee, Ctr Excellence Genom & Bioinformat, Memphis, TN 38163 USA; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; Genet Informat Res Inst, Mountain View, CA 94043 USA; Inst Genom Res, Rockville, MD 20850 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; Univ Liege, Inst Plant Biol, Dept Life Sci, B-4000 Liege, Belgium; Univ Nebraska, Sch Biol Sci Plant Sci Initiat, Lincoln, NE 68588 USA; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Calif Berkeley, Dept Plant & Mol Biol, Berkeley, CA 94720 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Cordoba, Fac Ciencias, Dept Bioquim & Biol Mol, E-14071 Cordoba, Argentina; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; Carnegie Inst, Dept Plant Biol, Stanford, CA 94306 USA; Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico; Univ Bielefeld, Dept Celluar & Dev Biol Plants, D-33615 Bielefeld, Germany; Univ Munster, Inst Plant Biochem & Biotechnol, Dept Biol, D-48143 Munster, Germany; Ecole Normale Super, CNRS, UMR 8186, Dept Biol, F-75230 Paris, France; Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Melbourne, Vic 3010, Australia; Univ Paris Sud, Inst Biotechnol Plantes, CNRS, UMR 8618, Orsay, France; Univ Nebraska, N151 Beadle Ctr, Dept Biochem, Lincoln, NE 68588 USA; Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55099 Mainz, Germany; Scripps Clin & Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Clin & Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Ohio State Univ, PCMB & Plant Biotechnol Ctr, Columbus, OH 43210 USA; Univ Chicago, Chicago, IL 60637 USA; Univ Jena, Inst Allgemeine Bot & Pflanzenphysiol, D-07743 Jena, Germany; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada; Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01605 USA; UCL, Dept Biol, London WC1E 6BT, England; Univ Sci & Technol Lille, IFR 118, CNRS, UMR 8576,Unite Glycobiol Struct & Fonctionnelle, Lille, France; Univ Potsdam, Inst Biochem & Biol, D-14476 Golm, Germany; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; Inst Biol 2 Plant Biochem, D-79104 Freiburg, Germany; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; Oklahoma State Univ, Ctr Hlth Sci, Dept Anat & Cell Biol, Tulsa, OK 74107 USA; Izmir Univ Econ, TR-35330 Izmir, Turkey; Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; Charles Univ Prague, Fac Sci, Dept Plant Physiol, CS-12844 Prague, Czech Republic; St Edwards Univ, Bioinformat Program, Austin, TX 78704 USA; Univ Puget Sound, Dept Biol, Tacoma, WA 98407 USA; Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; Tsinghua Univ, Dept Biol, Beijing 100084, Peoples R China; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Appalachian State Univ, Boone, NC 28608 USA; Marquette Univ, Dept Biol, Milwaukee, WI 53233 USA; CNRS, Biol Chem Lab, UMR 8576, F-59655 Villeneuve Dascq, France; Stn Zool, Cell Signal Lab, I-80121 Naples, Italy; Ohio State Univ, Grad Program Biophys, Columbus, OH 43210 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Duke University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California San Francisco; Sun Yat Sen University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; J. Craig Venter Institute; Salk Institute; Stanford University; University of Liege; University of Nebraska System; University of Nebraska Lincoln; University of Cambridge; University of California System; University of California Berkeley; Washington University (WUSTL); National University of Cordoba; Kyoto University; Carnegie Institution for Science; Universidad Nacional Autonoma de Mexico; University of Bielefeld; University of Munster; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Melbourne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Nebraska System; University of Nebraska Lincoln; Johannes Gutenberg University of Mainz; Scripps Research Institute; Scripps Research Institute; University System of Ohio; Ohio State University; University of Chicago; Friedrich Schiller University of Jena; University of Arizona; Louisiana State University System; Louisiana State University; University of Arizona; University of New Brunswick; University of Massachusetts System; University of Massachusetts Worcester; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; University of Potsdam; National Jewish Health; University of Delaware; Cornell University; Boyce Thompson Institute for Plant Research; Macquarie University; Oklahoma State University System; Oklahoma State University Center for Health Sciences; Izmir Ekonomi Universitesi; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Hokkaido University; Tsinghua University; Washington State University; University of North Carolina; Appalachian State University; Marquette University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; University System of Ohio; Ohio State University	Rokhsar, DS (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	dsrokhsar@lbl.gov; arthurg@stanford.edu	Hallmann, Armin/G-5823-2011; Stern, David B/H-7852-2012; Bišová, Kateřina/H-2625-2014; Gonzalez-Ballester, David/AFT-1441-2022; Allmer, Jens/E-2335-2016; Lemaire, Stéphane D/A-3530-2008; Schmutz, Jeremy/N-3173-2013; Schroda, Michael/A-2651-2015; Cardol, Pierre/AAA-3090-2019; Elias, Marek/D-6851-2014; Ral, Jean-Philippe/Q-1711-2019; Grimwood, Jane/ABD-5737-2021; Riaño-Pachón, Diego Mauricio/B-4891-2014; Umen, James G/K-9120-2013; VALLON, Olivier/AAM-7737-2021; Fukuzawa, Hideya/I-5906-2018; Ral, Jean-Philippe/H-5632-2012; Gladyshev, Vadim N/A-9894-2013; Drouard, Laurence/D-2385-2010; Riaño-Pachón, Diego M/A-1755-2010; Bowler, Chris/AAC-6256-2019; Hanikenne, Marc/Y-4642-2019; Mueller-Roeber, Bernd/Z-4052-2019; Rajamani, Sathish/H-5732-2011; Fernandez, Emilio/H-2892-2015; Gonzalez-Ballester, David/M-5551-2013; Gladyshev, Vadim N/J-6187-2013; Lohr, Martin/A-1214-2009; CHEN, Chunlong/D-7096-2011; Pootakham, Wirulda/F-2358-2011; Gonzalez-Halphen, Diego/C-2664-2013; Lefebvre, Philippe/F-2685-2010; Chen, Chong-Jian/B-6190-2009; Willows, Robert/C-1537-2010; Pan, Junmin/H-2673-2014; Pootakham, Wirulda/Q-9366-2019; Terry, Astrid Y/A-2538-2011; Paulsen, Ian T/K-3832-2012; Stern, David/E-8678-2016	Hallmann, Armin/0000-0001-5977-6143; Bišová, Kateřina/0000-0003-1997-0894; Gonzalez-Ballester, David/0000-0003-0024-1886; Allmer, Jens/0000-0002-2164-7335; Lemaire, Stéphane D/0000-0001-6442-0547; Schmutz, Jeremy/0000-0001-8062-9172; Schroda, Michael/0000-0001-6872-0483; Cardol, Pierre/0000-0001-9799-0546; Elias, Marek/0000-0003-0066-6542; Ral, Jean-Philippe/0000-0002-3226-6204; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Umen, James G/0000-0003-4094-9045; Fukuzawa, Hideya/0000-0003-0963-5662; Drouard, Laurence/0000-0001-6537-524X; Riaño-Pachón, Diego M/0000-0001-9803-3465; Hanikenne, Marc/0000-0002-8964-9601; Rajamani, Sathish/0000-0002-5277-6578; Gonzalez-Ballester, David/0000-0003-0024-1886; Lohr, Martin/0000-0002-4335-9887; CHEN, Chunlong/0000-0002-4795-0295; Pootakham, Wirulda/0000-0001-6721-6453; Gonzalez-Halphen, Diego/0000-0003-0654-655X; Lefebvre, Philippe/0000-0002-9366-5129; Willows, Robert/0000-0002-0731-2950; Pootakham, Wirulda/0000-0001-6721-6453; Terry, Astrid Y/0000-0002-5234-1224; Paulsen, Ian T/0000-0001-9015-9418; Stern, David/0000-0001-9278-7303; Fernandez Reyes, Emilio/0000-0001-5957-5392; Minagawa, Jun/0000-0002-3028-3203; Sayre, Richard/0000-0002-3153-7084; Bowler, Chris/0000-0003-3835-6187; Fritz-Laylin, Lillian/0000-0002-9237-9403; Goodstein, David/0000-0001-6287-2697; Qu, Liang-Hu/0000-0003-3657-2863; Gladyshev, Vadim/0000-0002-0372-7016; Nelson, David/0000-0003-0583-5421; Purton, Saul/0000-0002-9342-1773; Rymarquis, Linda/0000-0003-0297-8371; Michael, Hippler/0000-0001-9670-6101; Witman, George/0000-0002-9497-9218; Novoselov, Sergey/0000-0003-0104-6492; Rokhsar, Daniel/0000-0002-8704-2224; Ball, Steven/0000-0003-1629-1650; Roje, Sanja/0000-0002-6302-5382; Zimmer, Sara/0000-0002-1707-1839; Sanderfoot, Anton/0000-0003-3660-7632; Pazour, Gregory/0000-0002-6285-8796; Grigoriev, Igor/0000-0002-3136-8903	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032843, R29GM042143, R01GM062915, R01GM042143, R37GM030626, R37GM042143, T32GM007185] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM042143-09, R01 GM032843, R01 GM062915-06, GM07185, R37 GM030626, R01 GM042143, T32 GM007185, R37 GM042143, GM42143] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BERNHARD DL, 1995, BRYOLOGIST, V98, P52, DOI 10.2307/3243642; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; *DOE JOINT GEN I, CHLAM REINH V 3 0; *DOE JOINT GEN I, PHAEOD TRIC V 2 0; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Gaillard AR, 2006, MOL BIOL CELL, V17, P2626, DOI 10.1091/mbc.E06-02-0095; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Gonzalez-Ballester D, 2005, PLANT PHYSIOL, V137, P522, DOI 10.1104/pp.104.050914; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Grossman A, 2001, ANNU REV PLANT PHYS, V52, P163, DOI 10.1146/annurev.arplant.52.1.163; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; HASEGAWA E, 1987, CELL MOTIL CYTOSKEL, V8, P302, DOI 10.1002/cm.970080403; HEATH IB, 1972, J PHYCOL, V8, P51, DOI 10.1111/j.0022-3646.1972.00051.x; Jain M, 2007, NUCLEIC ACIDS RES, V35, P2074, DOI 10.1093/nar/gkm081; Kathir P, 2003, EUKARYOT CELL, V2, P362, DOI 10.1128/EC.2.2.362-379.2003; Keeling P, 2004, PROTIST, V155, P3, DOI 10.1078/1434461000156; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Lamb MR, 1999, GENETICS, V153, P721; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; MANTON I, 1970, J CELL SCI, V6, P131; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; PASQUALE SM, 1987, J CELL BIOL, V105, P2279, DOI 10.1083/jcb.105.5.2279; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Pollock SV, 2005, PHOTOSYNTH RES, V86, P475, DOI 10.1007/s11120-005-4048-9; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rymarquis LA, 2005, PLANT PHYSIOL, V137, P557, DOI 10.1104/pp.104.054221; Sato E, 2004, BIOCHEMISTRY-US, V43, P14189, DOI 10.1021/bi048742i; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Schmidt M, 2006, PLANT CELL, V18, P1908, DOI 10.1105/tpc.106.041749; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; STORMS R, 1977, EXP CELL RES, V104, P39, DOI 10.1016/0014-4827(77)90066-0; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Vilchez C, 2001, BIORESOURCE TECHNOL, V78, P55, DOI 10.1016/S0960-8524(00)00162-0; Yandell M, 2006, PLOS COMPUT BIOL, V2, P113, DOI 10.1371/journal.pcbi.0020015; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Yuan QP, 2005, PLANT PHYSIOL, V138, P17, DOI 10.1104/pp.104.059063; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zylka MJ, 1999, MOL BRAIN RES, V74, P175, DOI 10.1016/S0169-328X(99)00277-6	55	1852	2060	19	635	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					245	251		10.1126/science.1143609	http://dx.doi.org/10.1126/science.1143609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932292	Green Accepted, Green Submitted			2022-12-28	WOS:000250086100040
J	Shukla, J				Shukla, Jagadish			Monsoon mysteries	SCIENCE			English	Editorial Material							PREDICTION; RAINFALL		George Mason Univ, Calverton, MD 20705 USA; Inst Global Environm & Soc, Calverton, MD 20705 USA	George Mason University	Shukla, J (corresponding author), George Mason Univ, Calverton, MD 20705 USA.	shukla@cola.iges.org						Blanford HF., 1884, P R SOC LOND, V37, P3, DOI DOI 10.1098/RSPL.1884.0003; Charney J.G., 1981, MONSOON DYNAMICS, P99, DOI [10.1017/cbo9780511897580.009, DOI 10.1017/CBO9780511897580.009]; DelSole T, 2002, J CLIMATE, V15, P3645, DOI 10.1175/1520-0442(2002)015&lt;3645:LPOIMR&gt;2.0.CO;2; Gadgil S, 2005, CURR SCI INDIA, V88, P1389; NORMAND C, 1953, Q J ROY METEOR SOC, V79, P463, DOI 10.1002/qj.49707934202; WALKER GT, 1924, MEM INDIA METEOR DEP, V24, P333; Wang B, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022734; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; 2007, CELEBRATING MONSSON	9	19	21	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					204	205		10.1126/science.1150045	http://dx.doi.org/10.1126/science.1150045			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17932275				2022-12-28	WOS:000250086100023
J	Toop, L; Mangin, D				Toop, Les; Mangin, Dee			Industry funded patient information and the slippery slope to New Zealand	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand	University of Otago	Toop, L (corresponding author), Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand.	les.toop@otago.ac.nz		Mangin, Dee/0000-0003-2149-9376					0	17	17	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 6	2007	335	7622					694	695		10.1136/bmj.39346.525764.AD	http://dx.doi.org/10.1136/bmj.39346.525764.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220KY	17916850	Green Published			2022-12-28	WOS:000250156800026
J	Aschwanden, C				Aschwanden, Christie			Seeking an international dialogue on research integrity	CELL			English	Editorial Material								Scientific misconduct is a global problem, yet protocols for addressing it remain highly fragmented and uneven. A conference held last month in Lisbon aimed to encourage international efforts to promote research integrity and to prevent misconduct.											0	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					9	11		10.1016/j.cell.2007.09.032	http://dx.doi.org/10.1016/j.cell.2007.09.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923078	Bronze			2022-12-28	WOS:000249934700001
J	Hu, HL; Real, E; Takamiya, K; Kang, MG; Ledoux, J; Huganir, RL; Malinow, R				Hu, Hailan; Real, Eleonore; Takamiya, Kogo; Kang, Myoung-Goo; Ledoux, Joseph; Huganir, Richard L.; Malinow, Roberto			Emotion enhances learning via norepinephrine regulation of AMPA-Receptor trafficking	CELL			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; HIPPOCAMPAL CA1 REGION; BETA-ADRENERGIC-RECEPTORS; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; GLUR1 SUBUNIT; VISUAL-CORTEX; FREQUENCY STIMULATION; PHOSPHORYLATION SITES	Emotion enhances our ability to form vivid memories of even trivial events. Norepinephrine ( NE), a neuromodulator released during emotional arousal, plays a central role in the emotional regulation of memory. However, the underlying molecular mechanism remains elusive. Toward this aim, we have examined the role of NE in contextual memory formation and in the synaptic delivery of GluR1-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid ( AMPA)-type glutamate receptors during longterm potentiation (LTP), a candidate synaptic mechanism for learning. We found that NE, as well as emotional stress, induces phosphorylation of GluR1 at sites critical for its synaptic delivery. Phosphorylation at these sites is necessary and sufficient to lower the threshold for GluR1 synaptic incorporation during LTP. In behavioral experiments, NE can lower the threshold for memory formation in wild-type mice but not in mice carrying mutations in the GluR1 phosphorylation sites. Our results indicate that NE-driven phosphorylation of GluR1 facilitates the synaptic delivery of GluR1-containing AMPARs, lowering the threshold for LTP, thereby providing a molecular mechanism for how emotion enhances learning and memory.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; NYU, New York, NY 10003 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Johns Hopkins University; New York University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Hu, Hailan/0000-0002-0425-5057; Takamiya, Kogo/0000-0001-7240-6307; Kang, Myoung-Goo/0000-0003-2649-219X; Real, Dr Eleonore/0000-0002-5523-4408	NIMH NIH HHS [R01 MH049159] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049159] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christianson Sven -Ake, 1992, HDB EMOTION MEMORY; CLERN RL, 2006, NEURON, V49, P663; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Gelinas JN, 2005, J NEUROSCI, V25, P3294, DOI 10.1523/JNEUROSCI.4175-04.2005; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hayley S, 2001, BRAIN RES, V892, P293, DOI 10.1016/S0006-8993(00)03262-5; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUANG CC, 1993, NEUROSCI LETT, V161, P207, DOI 10.1016/0304-3940(93)90295-V; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandel E., 2000, PRINCIPLES NEURAL SC; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Kopec CD, 2007, NEUROPHARMACOLOGY, V52, P228, DOI 10.1016/j.neuropharm.2006.07.028; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; LIANG KC, 1986, BRAIN RES, V368, P125, DOI 10.1016/0006-8993(86)91049-8; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Richter-Levin G, 2003, BRAIN RES REV, V43, P247, DOI 10.1016/j.brainresrev.2003.08.005; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; SARVEY JM, 1989, J NEUROSCI METH, V28, P109, DOI 10.1016/0165-0270(89)90016-2; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silva AJ, 1998, NEUROBIOL LEARN MEM, V70, P44, DOI 10.1006/nlme.1998.3837; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	75	358	383	5	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					160	173		10.1016/j.cell.2007.09.017	http://dx.doi.org/10.1016/j.cell.2007.09.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923095	Bronze			2022-12-28	WOS:000249934700019
J	Mackillop, LH; Germain, SJ; Neson-Piercy, C				Mackillop, Lucy H.; Germain, Sarah J.; Neson-Piercy, Catherine			Pregnancy plus - Systemic lupus erythematosus	BRITISH MEDICAL JOURNAL			English	Article							ANTIPHOSPHOLIPID SYNDROME; MANAGEMENT		Queen Charlottes & Chelsea Hosp, London W12 0HS, England; St Thomas Hosp, London SE1 7EH, England; St Thomas Hosp, London, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Mackillop, LH (corresponding author), Queen Charlottes & Chelsea Hosp, London W12 0HS, England.	lucymackillop@hotrnail.com		Mackillop, Lucy/0000-0002-1927-1594				Branch DW, 2003, OBSTET GYNECOL, V101, P1333, DOI 10.1016/S0029-7844(03)00363-6; Clowse MEB, 2005, ARTHRITIS RHEUM-US, V52, P514, DOI 10.1002/art.20864; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; D'Cruz DP, 2006, BMJ-BRIT MED J, V332, P890, DOI 10.1136/bmj.332.7546.890; Derksen RHWM, 2004, ARTHRITIS RHEUM-US, V50, P1028, DOI 10.1002/art.20105; Khamashta MA, 2006, BEST PRACT RES CL RH, V20, P685, DOI 10.1016/j.berh.2006.04.003; Lim W, 2007, BMJ-BRIT MED J, V334, P1318, DOI 10.1136/bmj.39205.484572.55; Moroni G, 2003, J NEPHROL, V16, P161; Ostensen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1957; RuizIrastorza G, 1996, BRIT J RHEUMATOL, V35, P133; Stratta P, 2006, J NEPHROL, V19, P135	11	24	24	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 3	2007	335	7626					933	936		10.1136/bmj.39358.519491.AD	http://dx.doi.org/10.1136/bmj.39358.519491.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230AS	17974690	Green Published			2022-12-28	WOS:000250848300035
J	Galloway, M; Hamilton, M				Galloway, Michael; Hamilton, Malcolm			Macrocytosis: pitfalls in testing and summary of guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-B12; COBALAMIN; ACID	Low vitamin B-12 levels can occur without deficiency being present, and normal levels don't always rule out vitamin B-12 deficiency. A clinical assessment, together with blood count and blood film results, can ensure a correct interpretation of vitamin B-12 and folate levels.	Sunderland Royal Hosp, City Hosp Sunderland NHS Fdn Trust, Sunderland SR4 7TP, England; Royal Devon & Exeter NHS Fdn Trust, Dept Haematol, Exeter EX2 5DW, Devon, England	Sunderland Royal Hospital; University of Exeter	Galloway, M (corresponding author), Sunderland Royal Hosp, City Hosp Sunderland NHS Fdn Trust, Sunderland SR4 7TP, England.	mike.galloway@nhs.net						CHARACHE S, 1992, BLOOD, V79, P2555; Devalia V, 2006, BMJ-BRIT MED J, V333, P385, DOI 10.1136/bmj.333.7564.385; FIELD EA, 1995, J ORAL PATHOL MED, V24, P468, DOI 10.1111/j.1600-0714.1995.tb01136.x; Goringe A, 2006, HAEMATOL-HEMATOL J, V91, P231; LANCET J, 1999, DIAGNOSTIC STRATEGIE, P575; METZ J, 1995, AM J HEMATOL, V48, P251, DOI 10.1002/ajh.2830480409; PORTER SR, 1988, ORAL SURG ORAL MED O, V66, P41, DOI 10.1016/0030-4220(88)90064-3; Smellie WSA, 2005, J CLIN PATHOL, V58, P1016, DOI 10.1136/jcp.2004.025049; SNOWER DP, 1993, AM J CLIN PATHOL, V99, P57, DOI 10.1093/ajcp/99.1.57; Solomon LR, 2005, BLOOD, V105, P978, DOI 10.1182/blood-2004-04-1641; STABLER SP, 1990, BLOOD, V76, P871; WRAY D, 1975, BRIT MED J, V2, P490, DOI 10.1136/bmj.2.5969.490	12	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2007	335	7625					884	886		10.1136/bmj.39325.689641.471	http://dx.doi.org/10.1136/bmj.39325.689641.471			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17962289	Green Published			2022-12-28	WOS:000250631000043
J	Arrow, H				Arrow, Holly			The sharp end of altruism	SCIENCE			English	Editorial Material							COMPETITION; EVOLUTION		Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; Univ Oregon, Inst Cognit & Decis Sci, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Arrow, H (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	harrow@uoregon.edu						ARROW H, 2007, CONFLICT ORG TEAMS N, P113; BORNSTEIN G, 1994, INT J CONFL MANAGE, V5, P271, DOI 10.1108/eb022747; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Keeley L. H., 1997, WAR CIVILIZATION MYT; Sober E., 1998, OTHERS EVOLUTION PSY; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x	10	19	19	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					581	582		10.1126/science.1150316	http://dx.doi.org/10.1126/science.1150316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223XL	17962546				2022-12-28	WOS:000250409200028
J	Burnell, JB				Burnell, Jocelyn Bell			Pulsars 40 years on	SCIENCE			English	Editorial Material									Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England	University of Oxford	Burnell, JB (corresponding author), Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England.	jocelyn@astro.ox.ac.uk						Bell-Burnell S. J, 1977, ANN NY ACAD SCI, V302, P685, DOI [10.1111/j.1749-6632.1977.tb37085.x, DOI 10.1111/J.1749-6632.1977.TB37085.X]; HEWISH A, 1968, NATURE, V217, P709, DOI 10.1038/217709a0; Kramer M, 2006, SCIENCE, V312, P549, DOI 10.1126/science.1124060; Lyne A, 2005, PHYS WORLD, V18, P29; McLaughlin MA, 2006, NATURE, V439, P817, DOI 10.1038/nature04440	5	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					579	581		10.1126/science.1150039	http://dx.doi.org/10.1126/science.1150039			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962545				2022-12-28	WOS:000250409200027
J	Sanfey, AG				Sanfey, Alan G.			Social decision-making: Insights from game theory and neuroscience	SCIENCE			English	Review							NEURAL BASIS; PREFRONTAL CORTEX; RESPONSES; REWARD; FAIRNESS; TRUST; COOPERATION; MIND; REPRESENTATION; STIMULATION	By combining the models and tasks of Game Theory with modern psychological and neuroscientific methods, the neuroeconomic approach to the study of social decision-making has the potential to extend our knowledge of brain mechanisms involved in social decisions and to advance theoretical models of how we make decisions in a rich, interactive environment. Research has already begun to illustrate how social exchange can act directly on the brain's reward system, how affective factors play an important role in bargaining and competitive games, and how the ability to assess another's intentions is related to strategic play. These findings provide a fruitful starting point for improved models of social decision-making, informed by the formal mathematical approach of economics and constrained by known neural mechanisms.	Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA	University of Arizona	Sanfey, AG (corresponding author), Univ Arizona, Dept Psychol, 1503 E Univ Blvd, Tucson, AZ 85721 USA.	asanfey@u.arizona.edu	Sanfey, Alan G/D-2350-2010	Sanfey, Alan/0000-0002-7421-8294				[Anonymous], 1998, THEORY LEARNING GAME; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; CAMERER C, 2002, J ECON LIT, V43, P9; Camerer C, 2003, BEHAV GAME THEORY; Critchley HD, 2000, J NEUROSCI, V20, P3033; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Dufwenberg M, 2004, GAME ECON BEHAV, V47, P268, DOI 10.1016/j.geb.2003.06.003; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; HARLE K, IN PRESS EMOTION; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed	53	389	426	13	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					598	602		10.1126/science.1142996	http://dx.doi.org/10.1126/science.1142996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223XL	17962552				2022-12-28	WOS:000250409200033
J	Wilson, RI				Wilson, Rachel I.			Neural circuits underlying chemical perception	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Wilson, Rachel/0000-0001-8573-9266	NIDCD NIH HHS [R01 DC008174, R01 DC008174-02] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BHANDAWAT V, 2007, NAT NEUROSCI    1007; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	11	4	4	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					584	585		10.1126/science.1151362	http://dx.doi.org/10.1126/science.1151362			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962548	Green Accepted			2022-12-28	WOS:000250409200030
J	Woolf, SH				Woolf, Steven H.			Future health consequences of the current decline in US household income	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; LIFE EXPECTANCY; MORTALITY; INEQUALITY		Virginia Commonwealth Univ, Dept Family Med, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, Dept Family Med, West Hosp, 1200 E Broad St,POB 980251,MCV Stn, Richmond, VA 23298 USA.	swoolf@vcu.edu						Altman Roger C., 2006, EC STRATEGY ADV OPPO; BAI M, 2007, NY TIMES MAGAZI 0610; Benzeval M, 2001, SOC SCI MED, V52, P1371, DOI 10.1016/S0277-9536(00)00244-6; BUCKS BK, 2006, FEDERAL RESERVE B; Catlin A, 2007, HEALTH AFFAIR, V26, P142, DOI 10.1377/hlthaff.26.1.142; *COMM FUND, 2005 BIENN HLTH INS; DeNavas-Walt C, 2006, INCOME POVERTY HLTH, P60; DENAVASWALT C, 2007, US CENSUS BUREAU CON; *EC POL I, CEOS MAK DAY WHAT AV; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; *GEN ACC OFF, 2007, GAO07344; Goldman N, 2001, ANN NY ACAD SCI, V954, P118; LABONTE M, 2006, WHY IS HOUSEHOLD INC; Lin CC, 2003, ETHNIC DIS, V13, P240; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Piketty T, 2003, Q J ECON, V118, P1, DOI 10.1162/00335530360535135; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; STRAUSS G, 2003, US TODAY        0331; Thomas AJ, 2005, AM J PUBLIC HEALTH, V95, P1417, DOI 10.2105/AJPH.2004.048165; Wilkinson R, 1999, SOCIAL DETERMINANTS, pp256; Woolf SH, 2007, AM J PUBLIC HEALTH, V97, P679, DOI 10.2105/AJPH.2005.084848; Woolf SH, 2006, AM J PREV MED, V31, P332, DOI 10.1016/j.amepre.2006.06.022	24	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2007	298	16					1931	1933		10.1001/jama.298.16.1931	http://dx.doi.org/10.1001/jama.298.16.1931			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223GC	17954545				2022-12-28	WOS:000250356700026
J	Darzi, A				Darzi, Ara			What next for the NHS?	LANCET			English	Editorial Material									Dept Hlth, London SW1A 2NS, England		Darzi, A (corresponding author), Dept Hlth, London SW1A 2NS, England.	ournhs@dh.gsi.gov.uk						Berwick D, 2001, BRIT MED J, V323, P616, DOI 10.1136/bmj.323.7313.616; Bierman AS, 2007, BMJ-BRIT MED J, V334, P1333, DOI 10.1136/bmj.39251.660127.AD; Darzi A., 2007, HEALTHCARE LONDON FR; Davis K, 2007, MIRROR MIRROR WALL I; DENAVASWLAT C, 2007, P60233 CURR POP; *DEP HLH, DEP REP 2007; Department of Health, 2003, WINN WAYS WORK RED H; Guthrie B, 2007, BMJ-BRIT MED J, V335, P542, DOI 10.1136/bmj.39259.400069.AD; HIGGINSON IJ, 2003, PARTNERSHIP PALLIATI; Lord Darzi A., 2007, OUR NHS OUR FUTURE N	10	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2007	370	9596					1400	1401		10.1016/S0140-6736(07)61588-8	http://dx.doi.org/10.1016/S0140-6736(07)61588-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223PY	17950850				2022-12-28	WOS:000250386000007
J	Garattini, S; Bertele', V				Garattini, Silvio; Bertele', Vittorio			How can we regulate medicines better?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIALS; DRUG REGULATION; QUALITY; EUROPE					garattini@marionegri.it	Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297				Angell M., 2004, TRUTH DRUG CO THEY D; Apolone G, 2005, BRIT J CANCER, V93, P504, DOI 10.1038/sj.bjc.6602750; Chalmers L, 2004, NEW SCI, V181, P19; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Garattini S, 2003, BMJ-BRIT MED J, V326, P1199, DOI 10.1136/bmj.326.7400.1199; Garattini S, 2001, LANCET, V358, P64, DOI 10.1016/S0140-6736(00)05258-2; Godlee F, 2006, BMJ-BRIT MED J, V2006, P333; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Herxheimer A, 2004, BRIT MED J, V329, P64, DOI 10.1136/bmj.329.7457.64; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Maynard A, 2005, PHARMACOECONOMICS, V23, P421, DOI 10.2165/00019053-200523050-00001; *MED EUR, 2004, PRESCRIRE INT, V13; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Mossialos E, 2004, REGULATING PHARM EUR, P1; Ray WA, 2006, NEW ENGL J MED, V354, P194, DOI 10.1056/NEJMsb053432; Spence D, 2006, BMJ-BRIT MED J, V332, P1155, DOI 10.1136/bmj.332.7550.1155-c; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181; Waller PC, 2003, PHARMACOEPIDEM DR S, V12, P17, DOI 10.1002/pds.773; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203	19	38	38	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2007	335	7624					803	805		10.1136/bmj.39281.615706.94	http://dx.doi.org/10.1136/bmj.39281.615706.94			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AX	17947785	Green Published			2022-12-28	WOS:000250630700031
J	Tran, EJ; Bolger, TA; Wente, SR				Tran, Elizabeth J.; Bolger, Timothy A.; Wente, Susan R.			SnapShot: Nuclear transport	CELL			English	Editorial Material							EXPORT RECEPTOR; IMPORT; RNA; LOCALIZATION		Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Tran, EJ (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.		Tran, Elizabeth/G-7818-2018	Tran, Elizabeth/0000-0002-9541-004X	NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009582] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Caesar S, 2006, MOL CELL BIOL, V26, P3170, DOI 10.1128/MCB.26.8.3170-3180.2006; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Hodges JL, 2005, MOL BIOL CELL, V16, P3200, DOI 10.1091/mbc.E04-11-0990; James BP, 2007, MOL BIOL CELL, V18, P4190, DOI 10.1091/mbc.E06-07-0659; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PRADEEPA MM, 2007, MOL CELL BIOL; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	18	43	43	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2							420.e1	10.1016/j.cell.2007.10.015	http://dx.doi.org/10.1016/j.cell.2007.10.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956740	Bronze			2022-12-28	WOS:000250507700001
J	Mayrand, M; Duarte-Franco, E; Rodrigues, I; Walter, SD; Hanley, J; Ferenczy, A; Ratnam, S; Coutlee, F; Franco, EL				Mayrand, Marie-Helene; Duarte-Franco, Eliane; Rodrigues, Isabel; Walter, Stephen D.; Hanley, James; Ferenczy, Alex; Ratnam, Sam; Coutle, Francois; Franco, Eduardo L.		Canadian Cervical Canc Scree	Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LOW-RESOURCE SETTINGS; LIQUID-BASED CYTOLOGY; PARTICLE VACCINE; FOLLOW-UP; WOMEN; HPV; NEOPLASIA; MANAGEMENT; PROVINCE	Background To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods. Methods We compared HPV testing, using an assay approved by the Food and Drug Administration, with conventional Pap testing as a screening method to identify high-grade cervical intraepithelial neoplasia in women ages 30 to 69 years in Montreal and St. John's, Canada. Women with abnormal Pap test results or a positive HPV test (at least 1 pg of high-risk HPV DNA per milliliter) underwent colposcopy and biopsy, as did a random sample of women with negative tests. Sensitivity and specificity estimates were corrected for verification bias. Results A total of 10,154 women were randomly assigned to testing. Both tests were performed on all women in a randomly assigned sequence at the same session. The sensitivity of HPV testing for cervical intraepithelial neoplasia of grade 2 or 3 was 94.6% (95% confidence interval [CI], 84.2 to 100), whereas the sensitivity of Pap testing was 55.4% (95% CI, 33.6 to 77.2; P=0.01). The specificity was 94.1% (95% CI, 93.4 to 94.8) for HPV testing and 96.8% (95% CI, 96.3 to 97.3; P<0.001) for Pap testing. Performance was unaffected by the sequence of the tests. The sensitivity of both tests used together was 100%, and the specificity was 92.5%. Triage procedures for Pap or HPV testing resulted in fewer referrals for colposcopy than did either test alone but were less sensitive. No adverse events were reported. Conclusions As compared with Pap testing, HPV testing has greater sensitivity for the detection of cervical intraepithelial neoplasia.	McGill Univ, Div Canc Epidemiol, Dept Oncol & Epidemiol & Biostat, Montreal, PQ H2W 1S6, Canada; McGill Univ, Dept Family Med, Montreal, PQ H2W 1S6, Canada; McGill Univ, Dept Pathol, Montreal, PQ H2W 1S6, Canada; Univ Montreal, Dept Obstet Gynecol, Montreal, PQ, Canada; Univ Montreal, Dept Med Familiale, Montreal, PQ, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada; Newfoundland Publ Hlth Lab, St John, NF, Canada; Ctr Hosp Univ Montreal, Hop Notre Dame, Dept Microbiol Infectiol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; McMaster University; McGill University; Universite de Montreal	Franco, EL (corresponding author), McGill Univ, Div Canc Epidemiol, Dept Oncol & Epidemiol & Biostat, 546 Pine Ave W, Montreal, PQ H2W 1S6, Canada.	eduardo.franco@mcgill.ca	Walter, Stephen/AAB-5548-2022; Franco, Eduardo/C-6445-2014	Walter, Stephen/0000-0003-4157-8928; Franco, Eduardo/0000-0002-4409-8084				Anhang R, 2004, CANCER-AM CANCER SOC, V100, P315, DOI 10.1002/cncr.20007; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Belinson J, 2001, GYNECOL ONCOL, V83, P439, DOI 10.1006/gyno.2001.6370; Belinson J, 2002, GYNECOL ONCOL, V84, P355, DOI 10.1006/gyno.2001.6554; Belinson JL, 2003, INT J GYNECOL CANCER, V13, P819, DOI 10.1111/j.1525-1438.2003.13611.x; Blumenthal PD, 2001, INT J GYNECOL OBSTET, V72, P47, DOI 10.1016/S0020-7292(00)00329-5; Clavel C, 2001, BRIT J CANCER, V84, P1616, DOI 10.1054/bjoc.2001.1845; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; CUZICK J, 1999, HEALTH TECHNOL ASSES, V3, P1; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Ferenczy A, 1996, OBSTET GYNECOL, V87, P332, DOI 10.1016/0029-7844(95)00453-X; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Koutsky LA, 2006, VACCINE, V24, P114, DOI 10.1016/j.vaccine.2006.06.014; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; Mayrand MH, 2006, INT J CANCER, V119, P615, DOI 10.1002/ijc.21897; NOORANI HZ, 2003, LIQUID BASED CYTOLOG; Obwegeser JH, 2001, ACTA CYTOL, V45, P709, DOI 10.1159/000328292; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petry KU, 2003, BRIT J CANCER, V88, P1570, DOI 10.1038/sj.bjc.6600918; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Sankaranarayanan R, 2004, INT J CANCER, V109, P461, DOI 10.1002/ijc.11726; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; Schneider A, 2000, INT J CANCER, V89, P529, DOI 10.1002/1097-0215(20001120)89:6&lt;529::AID-IJC11&gt;3.0.CO;2-G; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2003, ARCH PATHOL LAB MED, V127, P935; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Zhou XH, 1998, J ROY STAT SOC C-APP, V47, P135, DOI 10.1111/1467-9876.00102	38	747	791	1	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1579	1588		10.1056/NEJMoa071430	http://dx.doi.org/10.1056/NEJMoa071430			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17942871	Bronze			2022-12-28	WOS:000250200500003
J	Filippi, V; Ganaba, R; Baggaley, RF; Marshall, T; Storeng, KT; Sombie, I; Ouattara, F; Ouedraogo, T; Akoum, M; Meda, N				Filippi, Veronique; Ganaba, Rasmane; Baggaley, Rebecca F.; Marshall, Tom; Storeng, Katerini T.; Sombie, Issiaka; Ouattara, Fatoumata; Ouedraogo, Thomas; Akoum, Melanie; Meda, Nicolas			Health of women after severe obstetric complications in Burkina Faso: a longitudinal study	LANCET			English	Article							MORBIDITY; RECALL; DHAKA; INDIA	Background Little is known about the health of women who survive obstetric complications in poor countries. Our aim was to determine how severe obstetric complications in Burkina Faso affect a range of health, social, and economic indicators in the first year Post partum. Methods We did a prospective cohort study of women with severe obstetric complications recruited in hospitals when their pregnancy ended with a livebirth (n=199), perinatal death (74), or a lost pregnancy (64). For every woman with severe obstetric complications, two unmatched control women with uncomplicated delivery were sampled in the same hospital (677). All women were followed up for 1 year. Findings Women with severe obstetric complications were poorer and less educated at baseline than were women with uncomplicated delivery. Women with severe obstetric complications, and their babies, were significantly more likely to die after discharge: six (2%) of the 337 women with severe obstetric complications died within 1 year, compared with none of the women with uncomplicated delivery (unadjusted p=0.001); 17 babies of women with severe obstetric complications died within 1 year, compared with 18 of those born by uncomplicated delivery (hazard ratio for mortality 4.67, 95% CI 1.68-13.04, adjusted for loss to follow-up and confounders; p=0.003). Women with severe obstetric complications were significantly more likely to have experienced depression and anxiety at 3 months (odds ratio 1.82, 95% CI 1.18-2.80), to have experienced suicidal thoughts within the past year at all time points (2.27, 1.33-3.89 at 3 months; 2.30, 1.17-4.50 at 6 months; 2.26, 1.30-3.95 at 12 months), and to report the pregnancy having had a negative effect on their lives at all time points (1.54, 1.04-2.30 at 3 months; 2.30, 1.56-3.39 at 6 months; 2.44, 1.63-3.65 at 12 months) than were women with uncomplicated delivery. Interpretation Women who give birth with severe obstetric complications are at greater risk of death and mental-health problems than are women with uncomplicated delivery. Greater resources are needed to ensure that these women receive adequate care before and after discharge from hospital.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Ctr Muraz, Bobo Dioulasso, Burkina Faso; Inst Rech Dev, Ouagadougou, Burkina Faso	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz; Institut de Recherche pour le Developpement (IRD)	Filippi, V (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Veronique.Filippi@lshtm.ac.uk		Storeng, Katerini/0000-0003-0032-7006; Baggaley, Rebecca/0000-0002-4688-3924				BAGGALEY R, IN PRESS TROP MED IN; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Bhatia J, 2000, STUD FAMILY PLANN, V31, P267, DOI 10.1111/j.1728-4465.2000.00267.x; Bhatia JC, 1996, SOC SCI MED, V43, P1507, DOI 10.1016/0277-9536(96)00105-0; Bulut A, 1997, STUD FAMILY PLANN, V28, P35, DOI 10.2307/2137969; Defo BK, 1997, SOC SCI MED, V44, P1023, DOI 10.1016/S0277-9536(96)00228-6; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FORTNEY JA, 1996, BASE ICEBERG PREVALC; Fronczak N, 2005, INT J GYNECOL OBSTET, V91, P271, DOI 10.1016/j.ijgo.2005.09.006; GOODBURN EA, 1994, MATERNAL MORBIDITY B; HUDSONTHOMAS M, 1994, B WORLD HEALTH ORGAN, V72, P423; INSD et ORC Macro, 2004, ENQ DEM SANT BURK FA; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; KHATTAB H, 1999, WMEN REPROD HLTH RUR; KIELMANN K, 2002, MED ANTHROPOL, V21, P1115; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; OBERMEYER CM, 2001, CLTURAL PERSPECTIVES; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; RONSMANS C, 2004, WHO NUMBERS REV MATE; Sadana R, 2000, B WORLD HEALTH ORGAN, V78, P640; Saurel-Cubizolles MJ, 2000, BRIT J OBSTET GYNAEC, V107, P1202, DOI 10.1111/j.1471-0528.2000.tb11608.x; Siltberg H, 1997, ACTA OBSTET GYN SCAN, V76, P28; Sserunjogi L, 2003, HEALTH POLICY PLANN, V18, P225, DOI 10.1093/heapol/czg027; STEWART MK, 1995, INT J GYNECOL OBSTET, V48, pS53, DOI 10.1016/0020-7292(95)02320-C; STORENG K, IN PRESS SOC SCI MED; *U AB, 2007, IMMP TOOLK GUID TOOL; *UNDP, 2006, HUM DEV REP HUM DEV; Uzma A, 1999, SOC SCI MED, V48, P313, DOI 10.1016/S0277-9536(98)00319-0; Walraven G, 2001, LANCET, V357, P1161, DOI 10.1016/S0140-6736(00)04333-6; World Health Organization, 1996, STUD UNS AB PRACT GU; World Health Organization (WHO), 2005, INT STAT CLASS DIS H	32	93	95	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1329	1337		10.1016/S0140-6736(07)61574-8	http://dx.doi.org/10.1016/S0140-6736(07)61574-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933647				2022-12-28	WOS:000250176600026
J	Maine, D				Maine, Deborah			Detours and shortcuts on the road to maternal mortality reduction	LANCET			English	Article									Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA 02118 USA	Boston University	Maine, D (corresponding author), Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA 02118 USA.	dpm1@bu.edu		Maine, Deborah/0000-0001-9804-9061				Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Freedman LP, 2005, WHOS GOT POWER TRANS; Goodburn EA, 2000, HEALTH POLICY PLANN, V15, P394, DOI 10.1093/heapol/15.4.394; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Koblinsky M., 2003, REDUCING MATERNAL MO; Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Pathmanathan I., 2003, INT BANK RECONSTRUCT; Ronsmans C, 1997, LANCET, V350, P1810, DOI 10.1016/S0140-6736(97)08012-4; ROSENFIELD A, 1985, LANCET, V2, P83; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; WHO, WHY DO SO MAN WOM ST; *WHO, ROAD TRAFF CRASH LEA; *WHO ICM FIGO, 2004, MAK PREGN SAF CRIT R	15	25	28	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2007	370	9595					1380	1382		10.1016/S0140-6736(07)61580-3	http://dx.doi.org/10.1016/S0140-6736(07)61580-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220SC	17933653				2022-12-28	WOS:000250176600032
J	Spitale, JN; Porco, CC				Spitale, Joseph N.; Porco, Carolyn C.			Association of the jets of Enceladus with the warmest regions on its south-polar fractures	NATURE			English	Article								Jets of material have been seen emanating from the south-polar terrain of Saturn's satellite Enceladus(1). Observations have shown that this region is anomalously warm(2), with the hottest measured temperatures coinciding with the four 'tiger stripe' fractures, named Alexandria, Cairo, Baghdad and Damascus, that straddle the region(1,2). Here we use Cassini images taken from a variety of viewing directions over two years to triangulate the source locations for the most prominent jets, and compare these with the infrared hotspot locations and the predictions from a recent model of tidally induced shear heating within the fractures(3). We find that the jets emanate from the four tiger stripes, with the strongest sources on Baghdad and Damascus. All the jets from each fracture seem to lie in the same nearly vertical plane. There is a strong spatial coincidence between our geographical sources and the locations of increased temperature revealed by the infrared experiment. Comparison with the shear heating model shows broad agreement; the exception is the prediction that Baghdad is the least active lineament, whereas we find it to be the most active. We predict that several new hotspots remain to be discovered by future thermal observations.	Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA		Spitale, JN (corresponding author), Space Sci Inst, Cassini Imaging Cent Lab Operat, 4750 Walnut St, Boulder, CO 80301 USA.	spitale@lpl.arizona.edu						Hurford TA, 2007, NATURE, V447, P292, DOI 10.1038/nature05821; Milazzo MP, 2001, J GEOPHYS RES-PLANET, V106, P33121, DOI 10.1029/2000JE001410; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; SPENCER JR, 2006, LUNAR PLANET SCI C, V37, P2252	7	114	114	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					695	697		10.1038/nature06217	http://dx.doi.org/10.1038/nature06217			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17928854				2022-12-28	WOS:000250045000037
J	Kim, C; Facchetti, A; Marks, TJ				Kim, Choongik; Facchetti, Antonio; Marks, Tobin J.			Polymer gate dielectric surface viscoelasticity modulates pentacene transistor performance	SCIENCE			English	Article							THIN-FILM TRANSISTORS; FIELD-EFFECT TRANSISTOR; GLASS-TRANSITION TEMPERATURE; ORGANIC SEMICONDUCTORS; LENGTH SCALE; POLYSTYRENE; RELAXATION; INTERFACE; TRANSPORT; DYNAMICS	Nanoscopically confined polymer films are known to exhibit substantially depressed glass transition temperatures (T-g's) as compared to the corresponding bulk materials. We report here that pentacene thin films grown on polymer gate dielectrics at temperatures well below their bulk T-g's exhibit distinctive and abrupt morphological and microstructural transitions and thin-film transistor (TFT) performance discontinuities at well-defined growth temperatures. The changes reflect the higher chain mobility of the dielectric in its rubbery state and are independent of dielectric film thickness. Optimization of organic TFT performance must recognize this fundamental buried interface viscoelasticity effect, which is detectable in the current-voltage response.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Mat Res Ctr, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Facchetti, A (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	a-facchetti@northwestern.edu; t-marks@northwestern.edu	Marks, Tobin/AAG-1472-2019; Facchetti, Antonio/B-8034-2014	Facchetti, Antonio/0000-0002-8175-7958				Berthier L, 2005, SCIENCE, V310, P1797, DOI 10.1126/science.1120714; Briseno AL, 2006, NATURE, V444, P913, DOI 10.1038/nature05427; BROWN AR, 1995, SCIENCE, V270, P972, DOI 10.1126/science.270.5238.972; Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Deschenes LA, 2001, SCIENCE, V292, P255, DOI 10.1126/science.1056430; Dimitrakopoulos CD, 1996, J APPL PHYS, V80, P2501, DOI 10.1063/1.363032; Dimitrakopoulos CD, 1999, SCIENCE, V283, P822, DOI 10.1126/science.283.5403.822; Ellison CJ, 2005, MACROMOLECULES, V38, P1767, DOI 10.1021/ma047846y; Facchetti A, 2005, ADV MATER, V17, P1705, DOI 10.1002/adma.200500517; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Forrest JA, 2001, ADV COLLOID INTERFAC, V94, P167, DOI 10.1016/S0001-8686(01)00060-4; Forrest JA, 1997, PHYS REV E, V56, P5705, DOI 10.1103/PhysRevE.56.5705; Fukao K, 2000, PHYS REV E, V61, P1743, DOI 10.1103/PhysRevE.61.1743; Ge S, 2000, PHYS REV LETT, V85, P2340, DOI 10.1103/PhysRevLett.85.2340; Guruvenket S, 2004, APPL SURF SCI, V236, P278, DOI 10.1016/j.apsusc.2004.04.033; JACKSON CL, 1991, J NON-CRYST SOLIDS, V131, P221, DOI 10.1016/0022-3093(91)90305-P; Kawana S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021501; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Knipp D, 2003, J APPL PHYS, V93, P347, DOI 10.1063/1.1525068; Panzer MJ, 2005, J AM CHEM SOC, V127, P6960, DOI 10.1021/ja051579+; Paynter RW, 2002, SURF INTERFACE ANAL, V33, P862, DOI 10.1002/sia.1464; Prucker O, 1998, MACROMOL CHEM PHYSIC, V199, P1435, DOI 10.1002/macp.1998.021990723; Puntambekar K, 2006, ADV FUNCT MATER, V16, P879, DOI 10.1002/adfm.200500816; Rogers JA, 2003, THIN-FILM TRANSISTORS, P377; Ruiz R, 2005, ADV MATER, V17, P1795, DOI 10.1002/adma.200402077; Salleo A, 2002, APPL PHYS LETT, V81, P4383, DOI 10.1063/1.1527691; Smith DL., 1995, THIN FILM DEPOSITION; Steudel S, 2004, APPL PHYS LETT, V85, P4400, DOI 10.1063/1.1815042; Stutzmann N, 2003, SCIENCE, V299, P1881, DOI 10.1126/science.1081279; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; Takahashi T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2166698; Tanaka K, 2000, MACROMOLECULES, V33, P7588, DOI 10.1021/ma000406w; Unni KNN, 2006, J MATER SCI, V41, P317, DOI 10.1007/s10853-005-2331-y; Yanagisawa H, 2004, THIN SOLID FILMS, V464, P398, DOI 10.1016/j.tsf.2004.06.065; Yoon MH, 2006, J AM CHEM SOC, V128, P12851, DOI 10.1021/ja063290d; Zhang ZY, 1997, SCIENCE, V276, P377, DOI 10.1126/science.276.5311.377	37	352	361	4	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					76	80		10.1126/science.1146458	http://dx.doi.org/10.1126/science.1146458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916727				2022-12-28	WOS:000249915400042
J	Schall, JD; Pare, M; Woodman, GF				Schall, Jeffrey D.; Pare, Martin; Woodman, Geoffrey F.			Comment on "Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices"	SCIENCE			English	Editorial Material							FRONTAL EYE FIELD; VISUAL-SEARCH TASK; TARGET SELECTION; CORTEX; SACCADES		Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA; Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Vanderbilt University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA.	jeffrey.d.schall@vanderbilt.edu						Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; Thomas NWD, 2007, J NEUROPHYSIOL, V97, P942, DOI 10.1152/jn.00413.2006; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005	15	22	22	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847								10.1126/science.1144865	http://dx.doi.org/10.1126/science.1144865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916712				2022-12-28	WOS:000249915400021
J	Binshtok, AM; Bean, BP; Woolf, CJ				Binshtok, Alexander M.; Bean, Bruce P.; Woolf, Clifford J.			Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers	NATURE			English	Article							LOCAL-ANESTHETICS; RECEPTOR; TETRODOTOXIN; CAPSAICIN; LIDOCAINE; CURRENTS; NEURONS; ACCESS; SITE; RATS	Most local anaesthetics used clinically are relatively hydrophobic molecules that gain access to their blocking site on the sodium channel by diffusing into or through the cell membrane(1). These anaesthetics block sodium channels and thereby the excitability of all neurons, not just sensory neurons. We tested the possibility of selectively blocking the excitability of primary sensory nociceptor (pain-sensing) neurons by introducing the charged, membrane-impermeant lidocaine derivative QX-314 through the pore of the noxious-heat-sensitive TRPV1 channel. Here we show that charged sodium-channel blockers can be targeted into nociceptors by the application of TRPV1 agonists to produce a pain-specific local anaesthesia. QX-314 applied externally had no effect on the activity of sodium channels in small sensory neurons when applied alone, but when applied in the presence of the TRPV1 agonist capsaicin, QX-314 blocked sodium channels and inhibited excitability. Inhibition by co-applied QX-314 and capsaicin was restricted to neurons expressing TRPV1. Injection of QX-314 together with capsaicin into rat hindpaws produced a long-lasting (more than 2 h) increase in mechanical and thermal nociceptive thresholds. Long-lasting decreases in pain sensitivity were also seen with regional injection of QX-314 and capsaicin near the sciatic nerve; however, in contrast to the effect of lidocaine, the application of QX-314 and capsaicin together was not accompanied by motor or tactile deficits.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University	Bean, BP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bruce_bean@hms.harvard.edu	Woolf, Clifford/A-9784-2010	Binshtok, Alexander/0000-0002-3620-8116				Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; CAHALAN MD, 1979, BIOPHYS J, V27, P39, DOI 10.1016/S0006-3495(79)85201-7; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; FRAZIER DT, 1970, J PHARMACOL EXP THER, V171, P45; Hara K, 2004, ANESTH ANALG, V98, P1380, DOI 10.1213/01.AE.00001079935.84035.48; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Liu L, 2001, J NEUROPHYSIOL, V85, P745, DOI 10.1152/jn.2001.85.2.745; Meyers JR, 2003, J NEUROSCI, V23, P4054; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; Sluka KA, 1997, PAIN, V71, P165, DOI 10.1016/S0304-3959(97)03371-X; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Sunami A, 2000, P NATL ACAD SCI USA, V97, P2326, DOI 10.1073/pnas.030438797; YEH JZ, 1978, BIOPHYS J, V24, P569, DOI 10.1016/S0006-3495(78)85403-4	16	316	340	5	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					607	U13		10.1038/nature06191	http://dx.doi.org/10.1038/nature06191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914397				2022-12-28	WOS:000249893500047
J	Tjian, R				Tjian, Robert			Daniel E. Koshland, Jr. 1920-2007	CELL			English	Biographical-Item									Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jmlim@uclink4.berkeley.edu							0	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2007	130	4					579	580		10.1016/j.cell.2007.08.011	http://dx.doi.org/10.1016/j.cell.2007.08.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17915359	Bronze			2022-12-28	WOS:000249319400005
J	Tuteja, G; Kaestner, KH				Tuteja, Geetu; Kaestner, Klaus H.			SnapShot: Forkhead transcription factors I	CELL			English	Editorial Material									Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Tuteja, G (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Katoh M, 2004, INT J ONCOL, V25, P1495; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387	5	113	120	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6							1160.e1	10.1016/j.cell.2007.09.005	http://dx.doi.org/10.1016/j.cell.2007.09.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889656	Bronze			2022-12-28	WOS:000250507500001
